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ABSTRACT 
Todd A. Durham: Can Novel Competing Risks Prediction Models Improve Population Health In 
Adults With Newly Diagnosed Atrial Fibrillation? 
(Under the direction of Kristen Hassmiller Lich) 
  
Atrial fibrillation (AF) is a cardiac rhythm disorder that affects more than 33 million 
people worldwide, including 1-4% of adults in Western Europe, the United States, and Australia. 
AF increases the risk of ischemic or thromboembolic stroke by 5 times.  The risk of stroke is 
reduced significantly by the use of oral anticoagulants (OACs); however, anticoagulation 
increases the risk of major bleeding.  To help physicians weigh these consequences of 
treatment for individual patients, clinical guidelines recommend the use of risk prediction 
models.  The existing risk prediction models have limited clinical utility in part because they 
estimate only OAC-associated bleeding risk and do not differentiate bleeding events by low vs. 
high mortality.   
This research addresses the following three aims using data from the United Kingdom 
Clinical Practice Research Datalink:  (1) To examine treatment patterns of OACs among 
patients first diagnosed with nonvalvular AF (NVAF) in the period from 2010-2014; (2) To 
develop and validate new prediction models for the one-year risks of the competing first events 
of stroke, intracranial hemorrhage, extracranial hemorrhage, and death as a function of 
treatment and other important predictors; and (3) To determine, through simulation, whether and 
how the new risk prediction models impact 1-year AF-related health outcomes when used to 
individualize treatment decisions in patients with incident AF.   
We show that prescribing of OACs in moderate-to-high risk patients in the UK has 
increased annually with 70% of patients prescribed therapy in 2014 while 1/3 of very low risk 
patients were prescribed OACs contrary to guidance.  We developed new prediction models 
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that: confirmed prognostic factors from the currently-advocated CHA2DS2-VASc and HAS-BLED 
risk schemes; and performed well in terms of discrimination (c-statistics ranging from 55 to 74) 
and calibration.  When our new model is used to select patients for OAC only if they have 1-year 
stroke risk ≥1%, quality-adjusted life expectancy is improved compared to current treatment 
patterns.  This treatment strategy was superior to others intended to balance stroke and 
bleeding risk.  Our result reinforces the current use of CHA2DS2-VASc for stroke risk 
stratification.  Treatment decisions should focus on minimizing strokes — not bleeding — to 
maximize population health. 
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CHAPTER 1 : INTRODUCTION 
Atrial fibrillation (AF) is a cardiac rhythm disorder that affects more than 33 million 
people worldwide, including 1-4% of adults in Western Europe, the United States, and Australia 
(1). Due to the abnormal rhythm, clots may form in the atrium, travel to the brain, and cause 
neurological damage. AF increases the risk of such an event — ischemic or thromboembolic 
stroke — by 5 times (2).  The risk of stroke is reduced significantly by the use of anticoagulants; 
however, anticoagulation increases the risk of major bleeding including intracranial hemorrhage 
or hemorrhagic stroke (3). In light of this serious trade-off, for physicians who treat patients with 
AF, the decision whether to treat to prevent stroke has always been difficult.   
There are a number of oral anticoagulants (OACs) available for stroke prevention in AF 
although they differ in terms of benefits, risks, convenience and cost (Table 1). Warfarin was the 
only OAC available until recently. (3)  Between 2010 and 2013, three target-specific oral 
anticoagulants (TSOAC) were approved for marketing in the United States (US) and the United 
Kingdom (UK).  All three TSOACs, dabigatran, rivaroxaban, and apixaban, are as effective as 
warfarin in preventing stroke but cause fewer intracranial hemorrhages (4-6). Although the 
TSOACs demonstrated a favorable risk-benefit profile versus warfarin in registration clinical 
trials, there are concerns about their suitability in real-world patients. The TSOACs must be 
used with caution, if at all, in patients with kidney dysfunction: Unlike warfarin, the TSOACs are 
eliminated to varying extents by the kidneys (4-6).  TSOACs may complicate or delay urgent 
invasive procedures because there are limited options for reversing their effects.  TSOACs, 
unlike warfarin, do not require monitoring of anticoagulant effect, i.e., international normalized 
ratio (INR).  Lastly, because the TSOACs are not available in generic forms, they may be more 
expensive to patients (in the case of co-payments) or the health care system.  Physicians and 
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their patients consider all of these factors to identify the best treatment option for their individual 
situation.  These newer treatment options have made clinical decision making more complex. In 
some instances, aspirin, a platelet inhibitor, may be the thromboprophylactic of choice even 
though there are very limited data to support its use as monotherapy for stroke prevention in AF 
(3,7).   
Despite the availability of the TSOACs and the well-established efficacy of warfarin, less 
than 40% of eligible patients receive recommended treatment to prevent ischemic stroke (9).  
There is ample evidence of under-treatment even among the highest risk individuals, those with 
a prior stroke or transient ischemic attack. In these individuals, reported oral anticoagulant use 
was <60% in 21 out of 29 studies (10).  
Quantitative and qualitative research has shown that there are numerous reasons for 
underutilization of anticoagulants. At the level of the patient, underutilization may be attributed to 
medication non-adherence or noncompliance with required monitoring for warfarin (11). 
Monitoring may inconvenience some patients, but it may reinforce adherence (12,13). In 
addition to patient-level compliance, research has found that physician experience with or fear 
of bleeding events and significant uncertainty about the risks and benefits of anticoagulation can 
also lead to underuse (14,15). Physicians may be reluctant to prescribe any anticoagulant due 
to the potential for major bleeding events, especially intracranial hemorrhage (3). The reluctance 
to treat is, perhaps, understandable.  Withholding treatment may lead to an ischemic stroke with 
a 30-day risk of death of 20%-30%; treating may cause an intracranial hemorrhage with a 30-
day risk of death as high as 60% (16).  Weighing the benefits and risks of treatment is, indeed, 
complex and consequential.  
Clinical guidelines call for the use of risk stratification to help physicians weigh the 
benefits and risks of treatment (3,17,18). However, the existing risk schemes are less relevant 
now with the availability of the TSOACs, new evidence on risk factors, and the need to consider 
kidney function. Researchers have developed numerous risk schemes to help physicians decide 
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whether or not to initiate OAC: The schemes categorize either the risk of stroke without any 
anticoagulation or the risk of major bleeding from warfarin (3). The existing risk schemes have 
limited clinical utility because they estimate only warfarin-associated bleeding risk, do not 
include kidney function as a predictor of ischemic stroke, and do not differentiate bleeding 
events by low vs. high mortality (19-21).  Because most major bleeding events are not fatal, 
physicians cannot easily weigh the risks of major bleeding vs. ischemic stroke. Hence, 
physicians may view “high” bleeding risk as a justification for not using OAC.  Consequently, 
reliance on existing risk schemes may lead to underutilization (22).  Importantly, the existing risk 
schemes do not inform the decision about which treatment to use.  My research is intended to 
fill these gaps by developing new, integrated, and treatment-specific risk prediction models for 
ischemic stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
My long-term goal is to help physicians and their patients make more informed decisions 
about treatments and ultimately improve patients’ lives.  The overall objective of this dissertation 
is to develop and demonstrate the utility of new risk schemes for stroke, intracranial 
hemorrhage, extracranial hemorrhage, and death. My central hypothesis is that using the new 
risk schemes in treatment decisions has the potential to reduce strokes and all-cause deaths 
compared to the status quo. My research addresses the following aims:   
Aim 1: To examine treatment patterns of OACs among patients first diagnosed with 
nonvalvular AF (NVAF) in the period from 2010-2014.  To address this aim, I used electronic 
health records (EHR) from the Clinical Practice Research Datalink (CPRD) in the UK to describe 
the time from diagnosis to OAC initiation; to examine the patient characteristics associated with 
prescribed treatment; and to describe the timing and cumulative incidence of switching OACs.   
Aim 2: To develop and validate new prediction models for the one-year risks of the 
competing first events of death, stroke, intracranial hemorrhage, and extracranial hemorrhage 
as a function of treatment status and other important predictors.  To address this aim, I used 
competing risks regression models to estimate the associations between previously-identified 
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predictors and the first event among stroke, intracranial hemorrhage, extracranial hemorrhage, 
and death in a CPRD cohort of patients with incident NVAF.  C-statistics were used to describe 
the ability of the models to discriminate events from non-events.  To validate the predictive 
performance of the new risk schemes, I used calibration plots to compare the predicted and 
observed event probabilities after fitting the prediction models to a hold-out sample.  
Aim 3: To determine whether and how the new risk prediction models from Aim 2 impact 
1-year AF-related health outcomes when used as a clinical decision tool to individualize 
treatment decisions in patients with incident AF.  Using individual-based simulation and the 
cohort from Aim 2, I estimated the number of strokes, intracranial hemorrhages, extracranial 
hemorrhages, and deaths that would occur under the status quo and each of several treatment 
decision rules.  I simulated the severity and fatality of each intermediate outcome and then 
converted each patient’s one-year experience into quality-adjusted life months (QALMs).  
Results from these three aims may have implications for clinical care, policy 
development, and future research. Although treatment decisions involve a number of complex 
and inter-related factors, application of the new risk models may improve decision making in the 
clinical setting. The risk models will serve to update recent bleeding risk schemes that focus on 
overall major bleeding.  Lastly, this work serves as a case example of a methodologic approach 
to evaluating the clinical utility of risk prediction models.  
The remainder of this dissertation is organized as follows:  Chapter 2 is a literature 
review of existing risk schemes used in atrial fibrillation.  For this literature review, I focused on 
five elements of existing schemes: the data sources; the statistical modeling approaches; the 
independent variables included in the models; the outcomes studied; and measures of 
concordance. Chapters 3-5 are individual manuscripts that correspond to Aims 1-3.    
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Chapters 3-5 are concise as these chapters are intended to be re-formatted and 
submitted to peer-reviewed journals.  Additional technical details for each chapter are provided 
as separate appendices.  Chapter 6 is a synthesis of this entire research effort: I discuss the 
overall findings, limitations, and implications for policy and future research.    
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Tables 
Table 1.1 Oral Anticoagulants for Atrial Fibrillation 
Characteristic Warfarin Dabigatran Rivaroxaban Apixaban 
Class Vitamin K 
antagonist 
Direct thrombin 
inhibitor 
Direct factor Xa 
inhibitor 
Direct factor Xa 
inhibitor 
Availability: US/UK 1950s 2009 / 2012 2010 / 2012 2011 / 2013 
Dosing Regimen QD, INR-adj. BID, Fixed QD, Fixed BID, Fixed 
1 Route Elimination Liver Kidney (80%) Kidney (67%) Fecal (75%) 
Half-life  in normals 36-42 h 12-17 h 5-9 h 12 h 
Interactions?     
   Food Yes No No No 
   Drugs Yes Yes Yes Yes 
Monitoring Required? Yes No No No 
Reversible? Yes No No No 
Contraindications?     
   Mechanical valves No Yes Yes Yes 
   End-stage CKD No Yes Yes No 
   Severe dementia Yes Yes Yes Yes 
   Bleeding disorder Yes Yes Yes Yes 
     
References (8) (4) (5) (6) 
QD = once a day; INR = international normalized ratio; adj. = adjusted; BID = twice a day; h = hours; CKD = chronic kidney 
disease 
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CHAPTER 2 : LITERATURE REVIEW 
The Role of Clinical Prediction Models 
Clinical prediction models, also known as clinical prediction rules, prognostic models, 
nomograms, and risk prediction models (1, 2), have a long history in cardiovascular medicine.  
Clinical prediction models are calculators that take as inputs individual patient characteristics 
such as age, medical history, and treatment to predict the likelihood of a diagnosis or prognosis 
(2).  The relationships between the inputs (or predictors) and the outcome are typically 
estimated using a statistical model. The likelihood of the outcome, the model output, may be 
expressed as an absolute probability, a score, or a risk category (low, moderate or high).  One 
of the best known clinical prediction models is the Framingham risk model that estimates the 10-
year risk of MI as a function of baseline age, sex, blood pressure, total cholesterol, high-density 
lipoprotein (HDL) cholesterol, and low-density lipoprotein (LDL) cholesterol (3).  
Risk Prediction Models in Atrial Fibrillation 
As of March 2015, there were 20 published risk prediction models for stroke or major 
bleeding in patients with atrial fibrillation. Wang and Bajorek recently identified 19 published risk 
prediction models. Of these 19, three are not relevant for this work: Two models were 
developed for venous thrombosis and one was an integrated and computerized tool that used 
one pre-existing model each for stroke and bleeding (4).  Since Wang and Bajorek included only 
articles published through 2012, I searched for additional risk prediction models published since 
then.  Using PubMed, I searched for articles that included the term “atrial fibrillation” and any 
one of the following: “stroke risk factors,” “stroke risk assessment,” “stroke risk stratification,” 
“bleeding risk factors,” “bleeding risk assessment,” and “bleeding risk stratification.”  I applied 
filters to retain English full text articles published since 2013.  Out of 1,019 search results, I 
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identified four additional risk assessment tools that were not listed in the work by Wang and 
Bajorek.  From the relevant articles, I extracted the population studied, the statistical model 
used, the independent and dependent variables, and the results in terms of model 
discrimination.  Details about each model are listed in Appendix A. In the remainder of this 
section, I summarize the methods and results from the 20 published risk prediction models, 13 
of which apply to stroke and 7 of which apply to major bleeding.     
Among the 13 published stroke models, there are a number of features that have 
informed my approach.  All but one of the 13 stroke models was developed exclusively in AF 
patients.  Hippisley-Cox and colleagues developed QStroke for a general population and, 
separately, for individuals with AF (5).  In most cases, the study populations were either 
participants in clinical trials who were assigned to aspirin, placebo, or a sub-therapeutic dose of 
warfarin, or patients from observational studies who were not taking warfarin at the study start.  
The statistical modeling approach was also consistent for the majority of models: All but one of 
the stroke models used Cox proportional hazards models to estimate the associations between 
the predictors and the hazard of stroke.  One model, CHA2DS2-VASc, used a logistic regression 
model that resulted in the exclusion of 31% of patients whose outcome status was unknown.   
Another consistent feature among the stroke models was the number and type of predictors.  
Most of the stroke models have 4-8 predictor variables, but one, QStroke, has 15 predictors (5). 
In addition, a majority of the stroke models share a common set of predictors: age, 
hypertension, prior stroke/TIA, diabetes, heart failure, and sex.  A larger number of model 
predictors does not necessarily improve a model’s discrimination, as measured by the 
concordance or c-statistic. For example, the CHADS2 model with 5 predictors had a greater 
ability to discriminate events from non-events than the CHA2DS2-VASc model with 7 predictors 
(c-statistics of 0.82 and 0.61, Table 2.1).    
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None of the 7 published bleeding risk models is particularly useful in assessing bleeding 
risk associated with the TSOACs; however, these models provide a useful methodologic 
framework for the current research.  The existing models were published over a period of 16 
years from 1998 to 2014. (Appendix A) The most recent model, QBleed, was developed for a 
general population; however, Hippisley-Cox and colleagues reported separate results for 
patients with AF who were using OAC (18).  Five of the bleeding risk models, including QBleed, 
were developed in cohorts of patients who were using warfarin. Two models, HEMORR2HAGES 
and HAS-BLED, were developed in observational cohorts of patients who were using warfarin, 
an antiplatelet drug (aspirin or clopidogrel), or no antithrombotic.  All but one of the bleeding risk 
models focused strictly on major bleeding as the outcome of interest.  The recently published 
AMADEUS model combined ischemic stroke and major bleeding into a single composite 
outcome (19). Not only were the study populations and outcomes similar among the models, but 
so were the statistical approaches. Five out of 7 bleeding risk models used Cox proportional 
hazards models and the remaining two, HAS-BLED and AMADEUS, used logistic regression.  
None of the bleeding risk models — like the stroke risk models — accounted for the competing 
risk of death.  Compared to the published stroke models, the risk models for major bleeding 
have a greater variety in the number and types of model predictors. The number of predictors 
ranges from 4 to 18.  Eight common predictors are included in a majority of the bleeding risk 
models: age, prior major bleed, prior stroke/TIA, kidney disease, anemia, hypertension, alcohol 
intake, and antiplatelet drugs (Table 2.1).  
Clinical guidelines in North America, the UK and Europe suggest that risk prediction 
models be used in the management of patients with AF. Medical societies in all of these regions 
recommend that antithrombotic therapy (i.e., OAC or platelet inhibitors) should be individualized 
to each patient by considering preferences and the benefits and risks of treatment.  The 
European Society of Cardiology (ESC) and the National Institute for Health and Care Excellence 
(NICE) recommend the routine use of CHA2DS2-VASc and HAS-BLED to assess stroke and 
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bleeding risk, respectively (26). Similarly, guidelines in the US recommend the use of CHA2DS2-
VASc to assess an individual’s stroke risk to determine whether OAC should be initiated (27).   
CHA2DS2-VASc is favored for its ability to identify very low risk patients for whom treatment may 
not be worthwhile, but the Canadian Cardiovascular Society favors the use of a simpler 
algorithm based on CHADS2 in making treatment decisions (28). Considering all of these 
guidelines, two overall themes emerge.  First, stroke risk assessment should be used to identify 
a treatment threshold, i.e. to ascertain whether an individual’s risk of stroke is high enough to 
warrant a treatment for which the benefit (stroke risk reduction) outweighs the expected harm 
(increased major bleeding).  Second, bleeding risk assessment is most useful to identify and 
address modifiable risk factors. The current state of risk assessment in AF can be summarized 
as follows. Despite recent and ongoing refinements to risk models, current medical practice is 
based on the assessment of risk using the “CHADS” models for stroke and the HAS-BLED 
model for major bleeding.  These existing tools, however, do not enable a physician or patient to 
explicitly consider the consequences of all treatment options, which now include the TSOACs in 
addition to warfarin and aspirin. 
Significance and Contribution 
Wang and Bajorek recently noted that “although separate tools are available to assess 
stroke risk and bleeding risk independently, they do not estimate the relative risk versus benefit 
of available treatment options in an individual patient.” (4) My work is intended to address this 
limitation and others by: 
1. Explicitly accounting for the dependence among stroke and bleeding complications by 
using a competing risks approach for the time to first event. This is important in AF 
because one serious event, either a stroke or major bleeding complication, affects short-
term medical management and morbidity and the risk for future untoward events. The 
competing risks framework allows physicians to answer questions such as “Given my 
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patient’s history, current health, and treatment options, which is more likely to occur in 
the next year, intracranial hemorrhage or stroke?”    
2. Estimating bleeding risk separately by anatomical site: Providing a separate risk 
assessment for intracranial and extracranial bleeding will enable decision making based 
on the seriousness of outcomes.   
3. Including kidney function for all three outcomes since this factor has become an 
important consideration especially for the TSOACs.   
4. Accounting for the competing risk of death to provide less biased risk estimates than 
existing models.   
Using these new models, physicians will be able to estimate and integrate the risks of four 
untoward outcomes for both treatment options (OAC or not) and provide their patients with 
evidence-based, individualized treatment recommendations.        
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Table 2.1 Existing Risk Schemes for Stroke in AF Patients 
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Prior stroke/TIA              
Diabetes              
Heart failure              
Sex               
Vascular disease              
Kidney disease               
Duration of AF >1 year              
Alcohol intake              
Hyperthyroidism              
Proteinuria              
Systolic blood pressure              
Total:HDL cholesterol              
Townsend deprivation              
Smoking status              
Ethnicity              
Family history of CHD              
Rheumatoid arthritis              
Valvular disease              
Number of predictors 4 4 5 5 5 5 5 6 5 7 8 8 15 
Number of events 81 73 78 78 130 94 111 --- --- 25 --- 685 1,892 
c-statistic --- --- --- --- --- 0.82 0.66 --- 0.72 0.61 --- 0.73 0.65 
Dots indicate predictor variables included in each model.   
TIA = transient ischemic attack; AF = atrial fibrillation; HDL = high-density lipoprotein; CHD = coronary heart disease 
  
 15 
Table 2.2 Existing Risk Schemes for Major Bleeding in AF Patients  
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Prior stroke/TIA        
Kidney disease         
Anemia         
Hypertension        
Alcohol intake        
Antiplatelet drug        
Chronic liver disease        
Diabetes        
Malignancy        
Thrombocytopenia        
NSAIDs        
Vascular disease        
Genetic factors        
Prior falls risk        
Sex         
Labile INR <60%        
Time in therapeutic range        
Heart failure        
Townsend deprivation        
Smoking status        
Ethnicity        
Esophageal varices        
Venous thromboembolism        
Anticoagulant        
Corticosteroids        
Antidepressants        
Phenytoin or carbamazepine        
Number of predictors 7 12 7 7 5 4 18 
Number of events 65 67 --- 48 461 50 878 
c-statistic 0.72 0.67 0.63 0.72 0.74 0.73 0.75 
Dots indicate predictor variables included in each model.   
TIA = transient ischemic attack; NSAID = nonsteroidal anti-inflammatory drug; INR = international 
normalized ratio; AF = atrial fibrillation 
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CHAPTER 3 : UTILIZATION OF STANDARD AND TARGET-SPECIFIC ORAL 
ANTICOAGULANTS AMONG ADULTS IN THE UNITED KINGDOM WITH INCIDENT 
NON-VALVULAR ATRIAL FIBRILLATION: A RETROSPECTIVE COHORT STUDY 
Overview 
Objectives 
Two recent developments in managing atrial fibrillation (AF) — new oral anticoagulants 
(OAC) and updated risk stratification — have the potential to improve the quality of care. The 
objectives of this study were to examine quality of AF care by describing: the time from AF 
diagnosis to initiation of OAC; patient characteristics associated with treatment; and the timing 
and cumulative incidence of switching OACs. 
Design 
Retrospective cohort study of patients with newly diagnosed AF.  
Setting 
647 primary care practices participating in the United Kingdom Clinical Practice 
Research Datalink (CPRD)  
Participants 
The 23,018 individuals in our cohort had a first recorded diagnosis of AF in primary care 
between January 2010 and March 2014; were ≥18 years old; were registered at a clinic meeting 
CPRD data and quality standards for at least one year prior to diagnosis; were eligible for 
linkage with hospitalization episodes; did not have valvular disease; had no prior exposure to 
OACs; and had not been prescribed aspirin within 90 days of diagnosis. 
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Main outcome measures 
Outcomes included time from AF diagnosis to OAC initiation (based on stroke risk and 
year of AF diagnosis), first prescribed treatment within 90 days following AF diagnosis, and time 
from OAC initiation to a switch (if one occurred) to a different OAC.  In exploratory analyses, we 
examined the impact of death as a competing event on the cumulative incidence of OAC 
initiation. 
Results 
In patients with moderate-to-high stroke risk (CHA2DS2-VASc≥2), the percentage 
prescribed OACs increased every year from 51% in 2010 to 70% in 2014. Over the same 
period, the median time between diagnosis and OAC initiation for these patients decreased from 
10 months to 2 months.  Among patients at very low stroke risk (CHA2DS2-VASc=0), the 
percentage of patients receiving OAC prescriptions was 29% after 90 days and 40% after one 
year. Physicians were more likely to prescribe OACs to patients with prior stroke or TIA, heart 
failure, hypertension, and diabetes.  Patients with absolute contraindications were less likely to 
receive a prescription than patients with none (12% vs. 20%). There was little evidence of a 
preference among the OACs for any characteristic.   
Conclusions 
Prescribing of OACs in moderate-to-high risk patients in the UK has increased annually 
with 70% of patients prescribed therapy in 2014; 1/3 of very low risk patients were prescribed 
OACs contrary to guidance. Future research should refine decision-making tools to minimize the 
unwanted effects of under- and over-utilization of OACs.    
Introduction 
Atrial fibrillation (AF) is a serious and common rhythm disorder that affects more than 33 
million people worldwide including 1% of adults in Australia, Europe, and the US. (1)  AF is 
associated with increased risks of several serious events including myocardial infarction (MI), 
heart failure, mortality, and stroke.  (2)  The risk of stroke is significantly reduced by the use of 
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oral anticoagulants (OACs), which prevent the formation of stroke-causing clots. (3)  For over 50 
years, the vitamin K antagonist (VKA) warfarin was the only OAC available.  This changed 
between 2010 and 2013 when the first of three new target-specific oral anticoagulants 
(TSOACs) were approved for use in the US and UK.  (4-6) In registration trials, the new agents, 
dabigatran, rivaroxaban, and apixaban, were at least as effective as warfarin in reducing 
strokes, and they caused fewer intracranial hemorrhages.  The new agents provide other 
advantages over warfarin in the form of convenience: They do not interact with food, they are 
given in fixed doses, and they do not require monitoring for anticoagulant effect.  Despite these 
favorable attributes, the TSOACs may not be preferred over warfarin in some situations.  The 
TSOACs should be used carefully, if at all, in patients with severe kidney disease because all of 
the TSOACs are eliminated at least to some extent by the kidneys.   The TSOACs also may not 
be appropriate for patients who may require urgent invasive interventions because there are 
limited options for reversal of effect.  Lastly, because the TSOACs are not available in generic 
forms, they may be more expensive to patients (in the case of co-payments) or the health care 
system.   
The new OACs became available at the same time that European clinical guidelines 
were updated to recommend against initiating OAC in patients at low risk of stroke.  According 
to the guidelines, patients at the lowest risk of stroke — a CHA2DS2-VASc score of 0 for men or 
a score of 1 for women — should not be offered OAC.  (7)  A similar risk-stratification approach 
was advocated by the National Institute for Health and Care Excellence (NICE) in June 2014. 
(8)  Both guidance documents recommended that the TSOACs should be considered for risk-
appropriate patients with non-valvular AF (NVAF), but the choice among OACs (warfarin vs. a 
TSOAC) was left to the physician and patient based on the patient’s clinical characteristics and 
preferences.   
All of the TSOACs have been shown to be cost-effective alternatives to warfarin in the 
UK, (9-11) but there are few published reports showing how the availability of the TSOACs has 
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changed prescribing patterns. When warfarin and other VKAs were the only treatment options, 
they were underutilized, especially in patients at high risk of stroke: Between 1997 and 2008, 
utilization in patients with a prior stroke or TIA was <60% in 25 out of 29 studies examined.  (12) 
This long-standing under-utilization could potentially be relieved by the more convenient 
TSOACs, the first of which was available in the UK in 2012.  Thus, for this study, our overall aim 
was to examine treatment patterns of OACs among patients first diagnosed with NVAF in the 
period from 2010-2014.  The objectives were three-fold: to describe the time from diagnosis to 
OAC initiation; to examine the patient characteristics associated with prescribed treatment; and 
to describe the timing and cumulative incidence of switching OACs.  To address these three 
objectives, we analyzed data from a retrospective cohort of adult patients who we identified from 
the UK’s Clinical Practice Research Datalink (CPRD) as being newly diagnosed with NVAF in 
the years 2010-2014.  The study protocol was reviewed and approved by the CPRD 
Independent Scientific Advisory Committee for Medicines and Healthcare Products Regulatory 
Agency (MHRA) Database Research (CPRD Protocol No.15_224).    
Methods 
Study Population 
We identified a cohort of adult patients newly diagnosed with NVAF in primary care 
between 2010 and 2014 using CPRD.  CPRD is a longitudinal electronic health record (EHR) 
that contains data from primary care including clinical observations (e.g., height and weight), 
diagnostic tests, and details on prescriptions issued. (13)  In addition to data from primary care, 
CPRD provides linkages to hospitalization and mortality data for a subset of consenting 
individuals.  As of 2011, CPRD contained records for over 12 million individuals from England 
and Wales, which represents approximately 20% of the total population. (14)  Active patients in 
CPRD are representative of the national population in terms of age and sex. (13) 
 23 
The eligibility criteria were used to identify patients with incident AF, whose data were 
acceptable for research purposes, and who were potential candidates for a TSOAC. Patients 
were eligible for inclusion if they met all of the following criteria: 
 Had a first recorded diagnosis for AF in primary care any time between January 1, 
2010 and March 31, 2014 (the latest date for which hospitalization diagnoses were 
available to define pre-diagnosis comorbidities); 
 Were at least 18 years of age at the time of AF diagnosis;  
 Were registered at a clinic that met CPRD quality standards for at least one year 
prior to the AF diagnosis;  
 Had data that were considered acceptable for research purposes, based on CPRD 
criteria for registration status, valid age and gender, and recording of events; and  
 Were eligible for linkage with hospitalization episode statistics. 
Patients were excluded for any of the following reasons: 
 Were not a candidate for a TSOAC because they had valvular disease prior to the 
AF diagnosis: 
o Had been diagnosed with mitral stenosis;  
o Had prosthetic heart valves or mitral valve repair; 
 Had ever been prescribed an oral anticoagulant or had an international normalized 
ratio (INR) measurement prior to the AF diagnosis;  
 Were prescribed aspirin (300 mg) within 3 months prior to the AF diagnosis;  
 Had an invalid age or unknown sex. 
Eligibility was determined using Read codes for primary care diagnoses, which are provided in 
Appendix B. 
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Patient Involvement 
This is a secondary analysis of existing data. Patients had no involvement in the 
conception of the research questions, study design or conduct of this study.  Beyond this 
publication, the authors have no plans to disseminate these study results to the anonymous 
patients who generously consented to share their electronic health data for research purposes.  
Outcomes 
The outcomes of interest included the time (in days) from AF diagnosis to OAC initiation, 
the first selected treatment within 90 days following AF diagnosis, and the time (in days) from 
first OAC initiation to a switch to a different OAC.  OAC initiation was defined as the date of the 
first prescription for an OAC (including warfarin/VKA, dabigatran, rivaroxaban, and apixaban) on 
or after the date of diagnosis. Treatment was the first OAC prescribed, if any, within 90 days of 
the AF diagnosis. The time of an OAC switch was defined as the number of days from the first 
OAC initiation to the first prescription for a different OAC. 
Independent Variables 
Independent variables (Table 3.1) included: risk factors for stroke and/or bleeding, 
contraindications for one or more of the OACs, and concurrent use of drugs that may interact 
with one or more OAC.  All independent variables were defined for the period prior to the 
diagnosis date using coded diagnoses from primary care, hospitalization episodes (since 1997), 
or drug codes.  A full list of codes is provided in Appendix B.  We stratified patients into the 
following stroke risk categories according to their CHA2DS2-VASc score: very low risk (score of 
0); intermediate risk (score of 1); and moderate-to-high risk (≥2).  A prior major bleed was 
defined as an intracranial hemorrhage or a bleeding event associated with hospitalization.  
Laboratory values and lifestyle factors (e.g., heavy drinking and smoking status) were defined 
as the most recent value in the year prior to the AF diagnosis date.  If a value was not available 
for the prior year, it was reported as missing. Estimated glomerular filtration rate (eGFR) using 
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the Modification in Diet for Renal Disease (MDRD) Study equations was obtained directly from 
the patient’s record or converted from the serum creatinine value as a function of sex and age 
and assuming Caucasian race.  (15)    Medications were considered to be concurrently used if a 
prescription was issued in primary care in the 90 days prior to the AF diagnosis date. 
Statistical Analysis 
We summarized baseline (pre-diagnosis) characteristics for the entire cohort overall and 
by prescribed treatment. Continuous variables were summarized using the mean and standard 
deviation (SD) and categorical variables were summarized using counts and percentages.  We 
present 95% confidence intervals (CI) for outcomes.   
Using the Kaplan-Meier estimator, the cumulative incidence of OAC initiation was 
estimated for each stratum defined by the CHA2DS2-VASc stroke risk score (0, 1, ≥2) and, 
separately, by year of AF diagnosis among patients with CHA2DS2-VASc score ≥2.  Follow-up 
for patients who did not initiate OAC was censored at the earliest date among the following: 
patient transfer out of the practice, last data transfer from the practice, CPRD derived date of 
death, and 12/31/2014 (the end of the data collection period from primary care). Since the 
Kaplan-Meier estimates could be biased by deaths occurring before the first prescription for 
OAC, we also estimated the cumulative incidence of OAC initiation accounting for death as a 
competing event using a time-dependent weighted product-limit estimator. (16) For this 
exploratory analysis, we defined the time to death as the days from AF diagnosis to the CPRD 
derived date of death. Accounting for death as a competing event required us to modify the 
censoring time for patients who remained event-free: We defined the censoring time for patients 
who did not receive a prescription for OAC and did not die as the earliest of the following dates: 
patient transferred out of the practice, the last data transfer from the practice, and 12/31/2014.   
To account for the rapid emergence of the TSOACs between 2012 and 2013, we used 
two treatment groupings to examine the association between patient characteristics and the first 
prescribed treatment. For the first grouping — applicable to the period 2010-2014 — treatment 
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was coded as a binomial outcome of no OAC within the first 90 days vs. OAC within the first 90 
days (warfarin and the three TSOACs).  For the second grouping — restricted to the years 
2013-2014 when all TSOACs were available in the UK — treatment was a multinomial outcome 
representing warfarin and the three available TSOACs with or without no OAC as an option.  
Associations between each patient characteristic and the first selected treatment were tested 
using binomial logistic regression or multinomial logistic regression.  We calculated the relative 
risk (and 95% CI) of any OAC prescription within the first 90 days for individual patient 
characteristics. 
The analysis of treatment switching was also restricted to patients diagnosed in 2013 or 
later to better understand utilization patterns when all treatment options were available.  We 
used a Kaplan-Meier estimator, stratified by the initial OAC prescribed, to estimate the 
cumulative incidence of a treatment switch by 3, 6, 9, and 12 months.  The follow-up times for 
patients who did not switch OAC were censored at the earliest of the following dates: patient 
transfer out of the practice, last data transfer from the practice, CPRD derived date of death, 
and 12/31/2014.   
We used Stata, version 13.1, to analyze the data. (17) All p-values were considered 
descriptive in nature. 
Results 
Study Population 
A total of 23,018 patients met all eligibility criteria and were included in the study cohort 
(Figure 3.1). The mean (SD) length of follow-up was 750 (475) days. 
The characteristics of the overall study cohort were as expected for a population of older 
adults with multiple cardiovascular comorbidities (Table 3.2). The mean (SD) age of patients in 
the overall cohort was 74 (12) years.  The most prevalent components of the CHA2DS2-VASc 
stroke risk score were hypertension (79%), age ≥75 years (55%), female sex (47%), and 
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vascular disease (31%).  Overall, 86% of patients were at moderate-to-high risk of stroke, as 
indicated by a CHA2DS2-VASc score ≥2.  The most common risk factors for major bleeding 
were hypertension (79%), age>65 (71%), and antiplatelet use (50%).  Although all patients were 
naïve to anticoagulants, 18% had experienced a major bleed some time prior to their AF 
diagnosis.  
Time from AF Diagnosis to First Prescription for OAC 
Patients at the greatest risk of stroke (CHA2DS2-VASc score ≥2) were issued 
prescriptions for OAC earlier than patients at the lowest risk of stroke (CHA2DS2-VASc score of 
0) (Figure 3.2). Among patients in the lowest stroke risk category (CHA2DS2-VASc score of 0), 
the cumulative incidence (and 95% CI) of a first OAC prescription was 29% (26% to 32%), 37% 
(34% to 40%), and 40% (37% to 43%) after 90, 180, and 360 days following AF diagnosis 
(Appendix C, Supplemental Table 1).  Among patients in the moderate-to-high stroke risk 
category (CHA2DS2-VASc score ≥2), the cumulative incidence of a first OAC prescription was 
46% (45% to 46%), 53% (53% to 54%), and 58% (57% to 58%) after 90, 180, and 360 days 
post AF diagnosis.  Compared to the naïve Kaplan-Meier estimates, accounting for death as a 
competing first event had very little impact on the estimated probability of receiving a first 
prescription for OAC (Appendix C, Supplemental Figure 1).    
Between 2010 and 2014, physicians prescribing of OACs increased year-over-year for 
patients at moderate-to-high risk of stroke (CHA2DS2-VASc score ≥2) (Figure 3.3).  By one year 
following the AF diagnosis, prescriptions for OAC had been issued to 51-57% of patients 
diagnosed between 2010 and 2012 compared to 67-70% for patients diagnosed after 2012.  
Prescriptions for OAC were issued earlier for patients diagnosed after 2012 than for patients 
diagnosed between 2010 and 2012 (medians of 48-75 days vs. 143-301 days).   
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Patient Characteristics Associated with Prescribed Treatment 
For patients diagnosed with AF between 2010 and 2014, treatment with OAC was 
significantly associated and consistent with the indications and contraindications.   The stroke 
risk factors, prior stroke or TIA, heart failure, hypertension, vascular disease, and diabetes, were 
more common in patients prescribed OAC than in patients without a prescription. (Table 3.2 and 
Figure 3.4) Compared to those who did not receive a prescription for an OAC, those who did 
were more likely to be 65-84 years of age, but less likely to be 85 and older.  End stage renal 
disease and significant liver disease were also less common in patients prescribed OAC. 
Patients with absolute contraindications for OAC were less likely to receive a prescription than 
patients with no absolute contraindications (12% vs. 20%).  The individual contraindications 
most strongly associated with an avoidance of OAC prescription were severe dementia or 
psychosis (5.1% no OAC vs. 1.6% OAC) and terminal condition (3.4% no OAC vs. 1.2% OAC).   
During the period when all three TSOACs were first available, selection among all 
treatment options (including none) was significantly associated and consistent with indications 
and contraindications; however, there was little evidence of a prescribing preference among 
OACs for any particular patient characteristic (Appendix C, Supplemental Table 2).  A number of 
the established stroke risk factors (e.g., prior stroke or TIA, hypertension, and vascular disease) 
were more common among patients who were prescribed an OAC than patients receiving no 
prescription.  These findings are reflected in the mean CHA2DS2-VASc score which was 
somewhat higher for patients prescribed one of the OACs (3.4-3.8) than for patients receiving 
none (3.4).  Similarly, compared to patients prescribed an OAC, patients receiving no 
prescription were more likely to have a number of absolute contraindications including the 
following: recent major bleeding, intracranial hemorrhage or brain tumor, malignancy within 6 
months, and terminal condition.  The evidence supporting a preference among the OACs was 
inconsistent and likely due to the smaller sample sizes for the TSOACs compared to warfarin.  
End-stage renal disease, a condition that favors the use of warfarin over the TSOACs, was 
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present in 3% of patients prescribed warfarin and 2-4% of patients prescribed one of the 
TSOACs.  Absolute contraindications apply to all OACs, but patients issued a prescription for 
rivaroxaban were almost twice as likely as patients receiving other OACs to have at least one 
contraindication (21% vs. 11-13%).  Two individual contraindications, severe dementia or 
psychosis and recent accidental fall, account for most of this variation in prescribed treatment.  
Switches from the First OAC 
Compared to patients who initiated warfarin, patients who initiated dabigatran were more 
likely to switch to another OAC in the first year as evidenced by the cumulative incidence (95% 
CI) of 5.9% (5.0% to 7.0%) vs. 18.9% (13.6% to 26.0%) (Appendix C, Supplemental Table 3). 
The cumulative incidences of a switch from rivaroxaban and apixaban by one year were similar 
to warfarin, but their CIs were wider. The difference between dabigatran and the other OACs in 
the timing of switches was apparent in the first 60 days of use (Figure 3.5). Of the 175 patients 
who switched from warfarin at any time, the most commonly prescribed second OAC was 
rivaroxaban (50%).  Among the 52 patients who were initially prescribed one of the TSOACs 
and subsequently switched, 50% switched to warfarin and 50% switched to a different TSOAC.  
Discussion 
Principal Findings 
We studied OAC prescribing patterns in a cohort of 23,018 primary care patients with 
new diagnoses of NVAF following two important policy changes in the UK: Clinical guidelines 
were updated in 2012 to recommend against OAC treatment in low risk individuals and three 
TSOACs became available in 2013.  On the basis of the guidelines and stroke risk, 86% of the 
patients in this cohort should have been offered OAC, while 4% should not have been offered 
OAC.  We observed a substantial improvement in the quality of care for patients who stand to 
gain the most from treatment with OAC, patients with moderate-to-high risk of stroke.  In this 
large subpopulation, the percentage of patients receiving OAC prescriptions after one year 
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increased from 50% in the years 2010-2012 to approximately 65% in the years 2013-2014.  In 
addition, the median time from recorded AF diagnosis to OAC prescription was reduced over 
this period by 10 months.  On the other hand, although the low risk patients were unlikely to 
benefit from OACs, physicians issued OAC prescriptions to 29% of them in the 3 months 
following their AF diagnosis. This finding is important because these individuals were very 
unlikely to experience a stroke without OAC, but were put at increased risk of major bleeding 
with the use of OAC; hence, the benefit-risk ratio would not be favorable for these patients.   
Another finding related to potentially excess risk was that OACs were prescribed to 12% of 
patients with absolute contraindications.  This could not be explained by their stroke risk: The 
mean CHA2DS2-VASc scores were 4 both for patients receiving and not receiving OAC 
prescriptions (data not shown).  
Physicians prescribed the four OACs consistently with most of the indications and 
contraindications, but our study revealed some important differences among the OACs with 
regard to prescribing patterns.  We found that patients prescribed rivaroxaban were more likely 
to have an absolute contraindication than patients prescribed one of the other OACs. This 
apparent preference may reflect concerns over non-adherence: patients receiving prescriptions 
for once-daily rivaroxaban were more likely to have dementia or psychosis — risk factors for 
nonadherence — than patients receiving prescriptions for the twice-daily OACs.  Another 
important finding is that patients were switched from dabigatran to another OAC more often than 
patients who were initially prescribed warfarin.  Although this study cannot shed light on why 
more patients were switched from dabigatran than other OACs, one plausible explanation — 
especially considering the early switches within 60 days — is that dabigatran was poorly 
tolerated in some patients.  In the RE-LY registration study, dyspepsia was the only adverse 
effect significantly more common in dabigatran-treated patients (11%) than warfarin-treated 
patients (6%). (18)   
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Comparison to Other Studies 
Our primary findings about OAC utilization between 2010 and 2014 are consistent with 
three recent studies that used data from general practices in the UK. We observed increasing 
OAC utilization at one year in patients at moderate-to-high risk of stroke.  This observed trend 
extends the results of a recent CPRD study reported by Scowcroft and colleagues whose study 
showed increasing utilization of OACs by adults at moderate and high risk of stroke between the 
years 2000 (40-50%) and 2011 (50-60%). (19)  For the period between 2009 and 2011, Cowan 
and colleagues reported similar OAC prescribing (55%) for patients with at least moderate 
stroke risk (CHADS2≥2). (20) In our study, we found similar percentages of patients using OACs 
in 2011 with increasing utilization every year up to 70% by 2014.  A nearly identical result was 
reported by Martinez and colleagues, (21) whose CPRD study showed overall prescribing of 
OACs increasing between 2011 and 2014, while prescribing of warfarin and other VKAs 
remained level between 2012 and 2014.  In addition to similar rates of utilization, we also noted 
consistency in the prevalence of contraindications among patients prescribed OACs between 
our study and the study reported by Cowan and colleagues (12% vs. 9%).  
Strengths and Limitations 
A number of features of our study strengthen our overall conclusions.  We used a rich 
and detailed dataset obtained from a nationally-representative population to study treatment 
selection in a general practice setting.  Compared to many studies of treatment utilization, we 
defined treatment on the basis of prescriptions issued rather than prescriptions filled; thus our 
study is a more accurate reflection of physician intent. The large size of our cohort enabled us to 
examine the extent to which prescribing was consistent with treatment indications over a 
number of years.  Our characterization of the study population was extensive.  We described a 
large number of patient characteristics including conditions that are difficult to study from other 
secondary data sources (e.g., recent accidental falls).  We used data from both primary care 
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and hospitalization episodes to define comorbidities, which minimized the chances that we 
under-reported indications for OAC like previous stroke or TIA.  A unique contribution of our 
study, at least to our knowledge, is our description of the time from AF diagnosis to the initiation 
of OAC treatment in a general practice setting.  Considering the stroke-preventing benefits of 
OAC, we believe this measure is a valuable quality indicator.   
Our study has several limitations.  Although we reported the magnitude of over-
treatment of low-risk individuals and under-treatment of high-risk individuals, we cannot explain 
physician prescribing behaviors.  Similar to other studies of secondary data, we have to rely on 
the accuracy of conditions and diagnoses recorded in the EHR: We assume patients did not 
have a condition if it was not recorded in their GPs medical record or if it was not coded as a 
diagnosis during a hospitalization.  Despite our use of these two data sources, it is possible that 
certain conditions were under-reported.  Due to smaller sample sizes, it is difficult to draw any 
firm conclusions about preferences for the TSOACs over warfarin.  Similarly, the number of 
patients prescribed aspirin as mono-therapy was quite small so we did not examine this 
separately. Lastly, the results of this study must be viewed as descriptive and hypothesis-
generating. We made no adjustment for the numerous p-values we presented; therefore, any 
nominally statistically significant results may represent spurious findings. 
Conclusions and Implications 
Oral anticoagulation has been recognized for decades as an effective strategy to reduce 
the morbidity and mortality associated with atrial fibrillation.  Despite these benefits, numerous 
studies have documented underutilization of warfarin and other VKAs - as low as 40% in all 
eligible patients and less than 60% in patients with a prior stroke.  (12)  Utilization of these 
therapies, as we and others have shown, has improved substantially in the UK from 50% in 
2000 to approximately 70% in 2014. This change was undoubtedly brought about through 
quality improvement efforts, refinements to risk stratification, timely updates to clinical guidance 
and the availability of new therapies with reduced requirements for monitoring.  All of these 
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strategies will be needed to address the remaining gap in underutilization among high risk 
individuals and reduce over-utilization among low-risk individuals.  Although very low risk 
individuals represented a minority of our cohort, their use of OACs has the potential to incur 
significant health care resource utilization. We found that within 90 days of their diagnosis (a 
short time during which we would expect little to change in terms of risk), 30% of these 
individuals were prescribed OACs despite 2012 guidance to the contrary.   
Our perspectives on appropriate utilization will continue to evolve in the next several 
years as we learn more about the TSOACs.  Experience with these newer agents is limited in 
this cohort, but initial indications from this study suggest that the preference for any particular 
OAC may reflect greater convenience.  Even with our large cohort, we could not discern — as 
we expected — a preference for warfarin over the TSOACs among individuals with renal failure.     
Future studies should examine this and other aspects of appropriate use to build upon the 
quality improvements from the last 15 years.  This work is important because the previously-
studied barriers to appropriate utilization, and the strategies to minimize them, may have 
changed since warfarin was the only treatment option.  For example, some well-understood 
barriers like concerns over monitoring or uncertainty about risk-benefit may not apply to the 
TSOACs which are more convenient to use and cause less intracranial bleeding than warfarin. 
Conversely, the need for sufficient renal function and the potential for drug-drug interactions are 
new concerns for the TSOACs.   Differences like these can complicate treatment selection; but 
tools that ease the decision-making burden will be welcomed by physicians and their patients 
who ultimately bear the consequences.   
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Tables 
Table 3.1 Independent Variables 
Variable Source Definition 
Year of diagnosis GP Calendar year of AF diagnosis (2010-2014) 
Established risk factors for stroke and/or bleeding: 
   Female GP Female sex  
   Age GP Age at diagnosis (years) 
   Prior stroke or TIA GP/HES Any prior ischemic stroke or transient ischemic attack  
   Heart failure  GP/HES Diagnosed with heart failure   
   Hypertension GP/Rx Diagnosed with hypertension or concurrent use of antihypertensive medication  
   Diabetes mellitus GP/Rx Diagnosed with diabetes or concurrent treatment with oral hypoglycemic agent or 
insulin  
   Vascular disease GP/HES Diagnosed with MI, angina pectoris, aortic plaque, intermittent claudication, arterial  
thrombosis, venous thrombosis; or had prior PCI or CABG  
   CHA2DS2-VASc score (0-9) Derived Sum of points for: heart failure (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes 
(1 pt); prior stroke/TIA (2 pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 
pt). 
   Prior major bleed GP/HES Intracranial hemorrhage or any prior major bleed associated with hospitalization 
   Estimated GFR  GP Most recent kidney function (mL/min), estimated using MDRD equation   
   Abnormal kidney function GP/HES Most recent kidney function <15mL/min or diagnosis of ESRD or dialysis 
   Abnormal liver function    GP/HES Diagnosed with cirrhosis or liver failure, or most recent bilirubin > 2 x ULN and 
AST/ALT > 3 x ULN  
   NSAID use Rx Concurrent use of NSAIDs  
   Antiplatelet use  Rx Concurrent use of antiplatelet drugs (e.g., clopidogrel, dypridamole, and aspirin at 
doses other than 300 mg)   
   Alcoholism or heavy drinking GP/HES Ever had a diagnosis for alcoholism, a referral to alcohol abuse treatment, or 
reported heavy drinking in 12 months prior to diagnosis date 
   HAS-BLED score (0-8) Derived Sum of points for: hypertension; abnormal kidney function (≤ 15 mL/min); abnormal 
liver function; prior stroke/TIA; prior major bleeding; age >65; NSAID or antiplatelet 
drug use; heavy alcohol use.  A ninth risk factor for HAS-BLED, labile INR<60%, 
was excluded because eligible patients are naïve to OAC treatment, including 
warfarin.    
Rx = prescriptions issued in primary care; AF = atrial fibrillation; OAC = oral anticoagulant; GP = general practitioner conditions, diagnoses, and 
test results obtained from Read coding system; TIA = transient ischemic attack; HES = hospitalization episode conditions and diagnoses obtained 
from ICD-10 coding system; MI = myocardial infarction; PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft; ESRD = 
end stage renal disease; ULN = upper limit of normal; NSAID = nonsteroidal anti-inflammatory drug; INR = international normalized ratio; CHD = 
coronary heart disease. 
 
  
 
3
5
 
Table 3.1. Independent variables (continued) 
 
Variable Source Definition 
Absolute contraindications for OAC:  
   Major bleeding within 3 
      months 
GP/HES Bleed resulting in hospitalization within 3 months prior to diagnosis 
   Liver failure or cirrhosis GP/HES Diagnosed with liver failure or cirrhosis 
   Intracranial hemorrhage,  
      intracerebral aneurysm or  
      tumor 
GP/HES Any prior intracranial hemorrhage, intracerebral aneurysm or tumor 
   Impaired hemostasis GP Diagnosed with impaired hemostasis (e.g., hemophilia) 
   Severe dementia or 
      psychosis 
GP Diagnosed with severe dementia or psychosis 
   Diabetic proliferative 
      retinopathy 
GP/HES Diagnosed with diabetic proliferative retinopathy 
   Malignancy within 6 months GP/HES Had a malignancy within 6 months of diagnosis 
   Recent ophthalmic surgery GP Ophthalmic surgery within 3 months of diagnosis 
   Terminal condition GP/HES Palliative care or diagnosis consistent with a terminal condition, including 
malignancies of the brain, stomach, esophagus, liver, pancreas, and ovary 
   Accidental fall within 6 months GP Had an accidental fall within 6 months of diagnosis 
Other potential risk factors for stroke and/or bleeding: 
   At high risk of falls GP/Rx Diagnosed with dementia or Parkinson disease or concurrent use of psychotropic 
drugs (antipsychotics, antidepressants, and benzodiazepines)  
   Anemia GP Diagnosed with anemia    
   Thrombocytopenia GP Diagnosed with thrombocytopenia    
   Hyperthyroidism GP Diagnosed with hyperthyroidism  
   Proteinuria GP Diagnosed with proteinuria   
   BMI GP Most recent body mass index 
   Smoking  GP Smoking status (never, former, current – including passive) 
   Rheumatoid arthritis GP Diagnosed with rheumatoid arthritis  
Rx = prescriptions issued in primary care; AF = atrial fibrillation; OAC = oral anticoagulant; GP = general practitioner conditions, diagnoses, and 
test results obtained from Read coding system; TIA = transient ischemic attack; HES = hospitalization episode conditions and diagnoses obtained 
from ICD-10 coding system; MI = myocardial infarction; PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft; ESRD = 
end stage renal disease; ULN = upper limit of normal; NSAID = nonsteroidal anti-inflammatory drug; INR = international normalized ratio; CHD = 
coronary heart disease. 
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Table 3.1. Independent variables (continued) 
 
Variable Source Definition 
Drugs that may interact with one or more OAC: 
   Corticosteroids Rx Concurrent use of systemic corticosteroids (oral, intravenous, intramuscular)  
   Antidepressants Rx Concurrent use of antidepressants  
   Phenytoin Rx Concurrent use of phenytoin  
   Carbamazepine Rx Concurrent use of carbamazepine  
   Systemic azole antifungals Rx Concurrent use of systemic azole antifungals (oral, intravenous) 
   Cyclosporine Rx Concurrent use of systemic cyclosporine (oral, intravenous) 
   Tacrolimus Rx Concurrent use of systemic tacrolimus (oral, intravenous) 
   Dronedarone Rx Concurrent use of dronedarone 
   Rifampicin Rx Concurrent use of rifampicin 
   St. John’s wort (hypericum) Rx Concurrent use of St. John’s wort 
   Psychotropics Rx Concurrent use of psychotropics (antidepressants, antipsychotics, and 
benzodiazepines) 
Rx = prescriptions issued in primary care; AF = atrial fibrillation; OAC = oral anticoagulant; GP = general practitioner conditions, diagnoses, and 
test results obtained from Read coding system; TIA = transient ischemic attack; HES = hospitalization episode conditions and diagnoses obtained 
from ICD-10 coding system; MI = myocardial infarction; PCI = percutaneous coronary intervention; CABG = coronary artery bypass graft; ESRD = 
end stage renal disease; ULN = upper limit of normal; NSAID = nonsteroidal anti-inflammatory drug; INR = international normalized ratio; CHD = 
coronary heart disease. 
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Table 3.2 Characteristics of Patients Newly Diagnosed with NVAF in the Years 2010-2014 
  First Treatment within 90 Days of 
Diagnosis 
 
 
Characteristic 
All 
(N=23,018) 
No OAC 
(N=13,415) 
OAC 
(N=9,603) 
p-value† 
Year of AF Diagnosis     
   2010 5,431 (23.6%) 3,428 (25.6%) 2,003 (20.9%)  
   2011  5,502 (23.9%) 3,381 (25.2%) 2,121 (22.1%)  
   2012 5,783 (25.1%) 3,431 (25.6%) 2,352 (24.5%)  
   2013 5,107 (22.2%) 2,641 (19.7%) 2,466 (25.7%)  
   2014 1,195 (5.2%) 534 (4.0%) 661 (6.9%)  
Established risk factors for stroke and/or bleeding: 
Female 10,753 (46.7%) 6,512 (48.5%) 4,241 (44.2%) <0.001 
Age, mean (SD), years 74.3 (12.0) 74.6 (13.1) 73.9 (10.4) <0.001 
Age category       <0.001 
   <65 4,331 (18.8%) 2,726 (20.3%) 1,605 (16.7%)  
   65-74 5,982 (26.0%) 3,180 (23.7%) 2,802 (29.2%)  
   75-84 8,128 (35.3%) 4,212 (31.4%) 3,916 (40.8%)  
   ≥85 4,577 (19.9%) 3,297 (24.6%) 1,280 (13.3%)  
Prior stroke or TIA 3,413 (14.8%) 1,747 (13.0%) 1,666 (17.3%) <0.001 
Heart failure  3,242 (14.1%) 1,811 (13.5%) 1,431 (14.9%) 0.003 
Hypertension 18,107 (78.7%) 10,186 (75.9%) 7,921 (82.5%) <0.001 
Diabetes mellitus 3,593 (15.6%) 1,956 (14.6%) 1,637 (17.0%) <0.001 
Vascular disease 7,179 (31.2%) 4,102 (30.6%) 3,077 (32.0%) 0.018 
CHA2DS2-VASc, mean (SD) 3.5 (1.8) 3.4 (1.8) 3.6 (1.7) <0.001 
CHA2DS2-VASc, category       <0.001 
   0 980 (4.3%) 709 (5.3%) 271 (2.8%)  
   1 2,132 (9.3%) 1,433 (10.7%) 699 (7.3%)  
   ≥2 19,906 (86.5%) 11,273 (84.0%) 8,633 (89.9%)  
Prior major bleed 4,060 (17.6%) 2,521 (18.8%) 1,539 (16.0%) <0.001 
Abnormal kidney function 951 (4.1%) 623 (4.6%) 328 (3.4%) <0.001 
Estimated GFR          <0.001 
   <15 mL/min 88 (0.4%) 64 (0.5%) 24 (0.2%)  
   15-29 mL/min 401 (1.7%) 271 (2.0%) 130 (1.4%)  
   30-49 mL/min 2,482 (10.8%) 1,489 (11.1%) 993 (10.3%)  
   50-80 mL/min 9,770 (42.4%) 5,349 (39.9%) 4,421 (46.0%)  
   >80 mL/min 5,308 (23.1%) 3,141 (23.4%) 2,167 (22.6%)  
   Missing 4,969 (21.6%) 3,101 (23.1%) 1,868 (19.5%)  
Abnormal liver function 103 (0.4%) 77 (0.6%) 26 (0.3%) <0.001 
NSAID use 1,499 (6.5%) 849 (6.3%) 650 (6.8%) 0.183 
Antiplatelet use 11,557 (50.2%) 6,842 (51.0%) 4,715 (49.1%) 0.004 
Heavy alcohol use 189 (0.8%) 133 (1.0%) 56 (0.6%) 0.001 
HAS-BLED, mean (SD) 2.5 (1.2) 2.5 (1.2) 2.5 (1.1) <0.001 
HAS-BLED, category       <0.001 
   0 1,324 (5.8%) 953 (7.1%) 371 (3.9%)  
   1 3,098 (13.5%) 1,873 (14.0%) 1,225 (12.8%)  
   2 6,546 (28.4%) 3,605 (26.9%) 2,941 (30.6%)  
   ≥3 12,050 (52.4%) 6,984 (52.1%) 5,066 (52.7%)  
† P-values for each independent variable were obtained from binomial logistic regression models. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = 
glomerular filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = 
coronary heart disease; NE = not estimable.  CHA2DS2-VASc score was calculated by summing the points associated 
with each characteristic: heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior 
stroke/TIA (2 pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 
1 point for each characteristic: hypertension; abnormal kidney function; abnormal liver function; prior stroke or TIA; prior 
bleeding; age >65; NSAID or antiplatelet drug use; heavy alcohol use.   
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Table 3.2. Characteristics of Patients Newly Diagnosed with NVAF in the Years 2010-2014 
 
 
 
 
First Treatment within 90 Days of 
Diagnosis 
 
 
Characteristic 
All 
(N=23,018) 
No OAC 
(N=13,415) 
OAC 
(N=9,603) 
p-value† 
Absolute contraindications for OAC: 
Any absolute contraindication 3,846 (16.7%) 2,725 (20.3%) 1,121 (11.7%) <0.001 
   Major bleeding within 3 months 572 (2.5%) 410 (3.1%) 162 (1.7%) <0.001 
   Liver failure or cirrhosis 102 (0.4%) 76 (0.6%) 26 (0.3%) 0.001 
   ICH, aneurysm, or brain tumor 372 (1.6%) 281 (2.1%) 91 (0.9%) <0.001 
   Impaired hemostasis 17 (0.1%) 13 (0.1%) 4 (0.0%) 0.115 
   Severe dementia or psychosis 840 (3.6%) 688 (5.1%) 152 (1.6%) <0.001 
   Diabetic prolif. retinopathy 212 (0.9%) 129 (1.0%) 83 (0.9%) 0.445 
   Malignancy within 6 months 1,114 (4.8%) 765 (5.7%) 349 (3.6%) <0.001 
   Recent ophthalmic surgery 224 (1.0%) 119 (0.9%) 105 (1.1%) 0.118 
   Terminal condition 572 (2.5%) 452 (3.4%) 120 (1.2%) <0.001 
   Accidental fall within 6 months 656 (2.8%) 490 (3.7%) 166 (1.7%) <0.001 
Other potential risk factors for stroke and/or bleeding: 
At high risk of falls 2,232 (9.7%) 1,549 (11.5%) 683 (7.1%) <0.001 
Anemia 3,229 (14.0%) 2,083 (15.5%) 1,146 (11.9%) <0.001 
Thrombocytopenia 134 (0.6%) 99 (0.7%) 35 (0.4%) <0.001 
Hyperthyroidism 538 (2.3%) 320 (2.4%) 218 (2.3%) 0.568 
Proteinuria 478 (2.1%) 265 (2.0%) 213 (2.2%) 0.204 
BMI, mean (SD), kg/m2 28.8 (6.5) 28.3 (6.4) 29.5 (6.5) <0.001 
BMI, category, kg/m2       <0.001 
   Underweight (<18.5) 555 (2.4%) 387 (2.9%) 168 (1.7%)  
   Normal (18.5-24.9) 2,627 (11.4%) 1,562 (11.6%) 1,065 (11.1%)  
   Overweight (25.0-29.9) 4,010 (17.4%) 2,233 (16.6%) 1,777 (18.5%)  
   Obese (≥30.0) 4,133 (18.0%) 2,082 (15.5%) 2,051 (21.4%)  
   Missing 11,693 (50.8%) 7,151 (53.3%) 4,542 (47.3%)  
Smoking       <0.001 
   Current 1,709 (7.4%) 1,055 (7.9%) 654 (6.8%)  
   Former 6,663 (28.9%) 3,699 (27.6%) 2,964 (30.9%)  
   Never 6,333 (27.5%) 3,598 (26.8%) 2,735 (28.5%)  
   Missing 8,313 (36.1%) 5,063 (37.7%) 3,250 (33.8%)  
Rheumatoid arthritis 455 (2.0%) 282 (2.1%) 173 (1.8%) 0.105 
† P-values for each independent variable were obtained from binomial logistic regression models. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = glomerular 
filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = coronary heart 
disease; NE = not estimable.  CHA2DS2-VASc score was calculated by summing the points associated with each characteristic: 
heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 pts); vascular disease (1 
pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: hypertension; 
abnormal kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or antiplatelet drug use; 
heavy alcohol use. 
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Table 3.2. Characteristics of Patients Newly Diagnosed with NVAF in the Years 2010-2014 
  First Treatment within 90 Days 
of Diagnosis 
 
 
Characteristic 
All 
(N=23,018) 
No OAC 
(N=13,415) 
OAC 
(N=9,603) 
p-value† 
Drugs that may interact with one or more OAC: 
   Psychotropics 3,191 (13.9%) 2,015 (15.0%) 1,176 (12.2%) <0.001 
   Antidepressants 2,116 (9.2%) 1,355 (10.1%) 761 (7.9%) <0.001 
   Corticosteroids 1,927 (8.4%) 1,107 (8.3%) 820 (8.5%) 0.439 
   Carbamazepine 121 (0.5%) 70 (0.5%) 51 (0.5%) 0.924 
   Systemic azole antifungals 113 (0.5%) 77 (0.6%) 36 (0.4%) 0.031 
   Phenytoin 50 (0.2%) 35 (0.3%) 15 (0.2%) 0.086 
   Cyclosporine 12 (0.1%) 8 (0.1%) 4 (0.0%) 0.551 
   Tacrolimus 11 (0.0%) 6 (0.0%) 5 (0.1%) 0.802 
   Dronedarone 5 (0.0%) 3 (0.0%) 2 (0.0%) 0.938 
   Rifampicin 1 (0.0%) 1 (0.0%) 0 (0.0%) NE 
   St. John's wort 1 (0.0%) 1 (0.0%) 0 (0.0%) NE 
† P-values for each independent variable were obtained from binomial logistic regression models. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = 
glomerular filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = 
coronary heart disease; NE = not estimable.  CHA2DS2-VASc score was calculated by summing the points associated with 
each characteristic: heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 
pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each 
characteristic: hypertension; abnormal kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; 
NSAID or antiplatelet drug use; heavy alcohol use. 
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Figures 
Figure 3.1 CONSORT Diagram  
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Figure 3.2 Kaplan-Meier Estimate of the Cumulative Incidence Function of First OAC 
Prescription by CHA2DS2-VASc Risk Score 
 
 
 
  
log-rank p-value<0.001
0
.0
0
0
.2
5
0
.5
0
0
.7
5
1
.0
0
C
u
m
u
la
ti
v
e
 P
ro
b
a
b
ili
ty
 o
f 
F
ir
s
t 
P
re
s
c
ri
p
ti
o
n
19906 9012 7193 59942
2132 1271 1082 9451
980 625 555 4770
Number at risk
0 60 120 180 240 300 360
Time to First Prescription (days)
CHA2DS2-VASc=0
CHA2DS2-VASc=1
CHA2DS2-VASc 2
 42 
Figure 3.3 Kaplan-Meier Estimate of the Cumulative Incidence of First Prescription for 
OAC by Year of AF Diagnosis - Patients with CHA2DS2-VASc≥2 
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Figure 3.4 Relative Risk (95% CI) of OAC vs. No OAC within 90 days of AF Diagnosis - 
Patients Diagnosed with NVAF Between 2010 and 2014  
 
Patient characteristics are grouped into established risk factors of stroke and/or bleeding (blue), other potential risk factors (gray), 
and contraindications for OAC (red). Relative risk (RR) = (proportion of patients receiving OAC prescription with attribute) / 
(proportion of patients not receiving OAC prescription with attribute).  RR > 1 indicates an attribute that is more common in patients 
receiving an OAC prescription than in patients not receiving an OAC prescription.  RR < 1 indicates an attribute that is less common 
in patients receiving an OAC prescription than in patients not receiving an OAC prescription.  
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Figure 3.5 Kaplan-Meier Estimate of the Cumulative Incidence of an OAC Switch - 
Patients Diagnosed with NVAF in the Years 2013-2014 
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CHAPTER 4 : NOVEL PREDICTION MODELS FOR THE ONE-YEAR COMPETING 
RISKS OF STROKE, INTRACRANIAL HEMORRHAGE, EXTRACRANIAL 
HEMORRHAGE, AND DEATH IN ADULTS WITH INCIDENT NON-VALVULAR 
ATRIAL FIBRILLATION 
Overview 
Background 
Treatment decisions in atrial fibrillation (AF) are often guided by risk stratification 
schemes for stroke and bleeding.  However, the existing risk schemes do not permit direct 
comparisons of treatment-specific risks. Our objectives were to develop and validate new 
prediction models for the 1-year competing risks of stroke, intracranial hemorrhage, extracranial 
hemorrhage, and death among adults with AF.      
Methods 
We identified a cohort of adult patients newly diagnosed with AF between 2010 and 
2014 in primary care practices participating in the UK Clinical Practice Research Datalink, which 
links primary care data from general practitioners with hospitalization and central mortality data. 
Patients with incident AF were eligible if they were candidates for oral anticoagulants (OAC) 
without absolute contraindications.  Using regression models for competing risks, we estimated 
the associations between previously-identified predictors and the first event among stroke, 
intracranial hemorrhage, extracranial hemorrhage, and death.  We internally validated the 
models using calibration plots.   
Results 
The cohort included 15,483 patients, 46% of whom had been prescribed OACs (mostly 
warfarin) by the index date.  The mean age was 74 years; 55% of patients with prior stroke or 
transient ischemic attack (TIA) were prescribed OACs.  The prediction models confirmed the 
 48 
prognostic importance of several factors that comprise the currently-advocated CHA2DS2-VASc 
and HAS-BLED risk schemes, including advanced age, female sex, hypertension, prior stroke, 
prior major bleeding, anemia, and kidney dysfunction.  OAC was negatively associated with 
stroke and death and positively associated with extracranial and intracranial bleeding. The 
models performed well in terms of discrimination (c-statistics ranging from 55 to 74) and 
calibration.  The average 1-year predicted risks for the lowest and highest risk deciles ranged 
from 0.5% to 10% for stroke and 2% to 10% for extracranial hemorrhage.  The average 
predicted risks within risk quantiles agreed closely with estimated cumulative incidence. 
Conclusions 
Our internally-validated models offer more clinically useful information than the existing 
risk schemes.  Future research should focus on whether the new models improve health 
outcomes, how the risk information will be used in shared decision making, and whether the 
models can be validated in other settings.    
Introduction 
Atrial fibrillation (AF) is a cardiac rhythm disorder that affects more than 33 million 
people worldwide, including 1-4% of adults in Western Europe, the United States, and Australia.  
(1) AF increases the risk of ischemic or thromboembolic stroke by 5 times.(2) The risk of stroke 
is reduced significantly by the use of oral anticoagulants (OAC) like warfarin and the newer 
target-specific oral anticoagulants (TSOACs); however, anticoagulation increases the risk of 
major bleeding including intracranial hemorrhage or hemorrhagic stroke. (3)  Considering this 
serious trade-off, physicians and patients with AF face a difficult decision, whether or not to treat 
to prevent stroke.   
 Despite the well-established efficacy of warfarin and the availability of newer TSOACs, 
fewer than 50% of moderate-to-high risk patients receive recommended treatment to prevent 
ischemic stroke. (4)  There is ample evidence of under-treatment even among the highest risk 
individuals, those with a prior stroke or transient ischemic attack (TIA). In these individuals, 
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reported OAC use was <60% in 21 of 29 studies. (5)  Underutilization of OACs has been 
attributed to numerous physician- and patient-level factors: medication non-adherence; non-
adherence with required monitoring for warfarin; experience with or fear of bleeding events; and 
significant uncertainty about the risks and benefits of anticoagulation. (6-8)  
Clinical guidelines recommend that physicians use risk prediction models to weigh the 
benefits and risks of initiating OAC. (3, 9, 10)  To help with this decision, researchers have 
developed numerous risk schemes that stratify patients according to their risk of stroke without 
anticoagulation and, separately, their risk of major bleeding from warfarin. (3)  Commonly-used 
risk schemes in current medical practice are the CHADS models for stroke and the HAS-BLED 
model for major bleeding. However, both of these risk schemes have limited clinical utility 
because they: (1) do not include kidney function as a predictor of stroke; (2) provide only an 
integer score which is assigned an arbitrary label such as low, moderate, and high risk; and (3) 
do not differentiate bleeding events by low vs. high mortality (11-13). These limitations make it 
difficult for physicians to easily weigh the risks when deciding whether to initiate OACs.  In the 
absence of the risk trade-offs, physicians may view “high” bleeding risk as a justification for not 
using OAC, a bias which may continue to support underutilization. (14)   
 This study was designed to address some of the limitations of existing risk prediction 
models that are used when making decisions about initiating OACs in patients with AF.  
Specifically, we sought to improve upon existing tools by estimating treatment-specific event 
probabilities; separating risks of intracranial bleeds from extracranial bleeds; and considering 
kidney function which has become more relevant for the renally-eliminated TSOACs.   Thus, our 
objectives were to: (1) develop new prediction models for the one-year risks of the competing 
first events of death, stroke, intracranial hemorrhage, and extracranial hemorrhage as a function 
of treatment status and other important predictors; and (2) internally validate the calibration of 
the risk prediction models on the original cohort.   
 
 50 
Methods 
Study Population and Data Source 
We identified a cohort of adult patients newly diagnosed with AF in primary care 
between 2010 and 2014 participating in the Clinical Practice Research Datalink (CPRD).  CPRD 
is an anonymized primary care database from general practitioners in the United Kingdom. 
CPRD includes a longitudinal electronic health record (EHR) that contains data from primary 
care on diagnoses, diagnostic tests, and prescriptions issued; it also provides linkages to 
hospitalization and mortality data for a subset of consenting individuals (15).  As of 2011, CPRD 
contained records for over 12 million individuals from 674 practices in England and Wales, 
which represents approximately 20% of the total population (15,16). Active patients in CPRD 
are representative of the national population in terms of age and sex (15).  
The eligibility criteria were used to identify patients with incident AF who were potential 
candidates for an OAC (including not having absolute contraindications for OAC).  Because the 
TSOACs have not been studied extensively in patients with mitral stenosis or prosthetic valves, 
we excluded patients with these conditions.  We refer to this targeted indication as “non-valvular 
atrial fibrillation” (NVAF).  Patients were eligible for inclusion if they met all of the following 
criteria: 
 Had a first recorded diagnosis for AF in primary care between January 1, 2010 and 
March 31, 2014 (the latest date for which hospitalization diagnoses were available to 
define pre-diagnosis comorbidities); 
 Were at least 18 years of age at the time of AF diagnosis;  
 Were registered at a clinic that met CPRD quality standards for at least one year 
prior to the AF diagnosis;  
 Had data that were considered acceptable for research purposes based on CPRD 
criteria for registration status, valid age and gender, and recording of events;   
 51 
 Were eligible for linkage with hospitalization episode and mortality statistics; 
 Had received at least one prescription in primary care for any condition within one 
year prior to the AF diagnosis. 
Patients were excluded for any of the following reasons: 
 Had previously been diagnosed with mitral stenosis or has prosthetic heart valves or 
mitral valve repair; 
 Had ever been prescribed an OAC or had an international normalized ratio (INR) 
measurement prior to the AF diagnosis;  
 Were prescribed aspirin (300 mg) within 3 months prior to the AF diagnosis;  
 Had an invalid age or unknown sex; or 
 Had an absolute contraindication for OAC due to high risk of bleeding or non-
adherence prior to AF diagnosis including a diagnosis or history of: 
o intracranial hemorrhage/surgery or intracerebral aneurysm or tumor; 
o impaired hemostasis (e.g., hemophilia or von Willebrand disease); 
o severe liver disease (e.g., cirrhosis); 
o dementia (e.g., Alzheimer’s disease) or psychosis;  
o diabetic proliferative retinopathy; 
o alcoholism or reported heavy drinking in 12 months prior to AF diagnosis; 
o any malignancy (including of the skin) within 6 months of AF diagnosis; 
o accidental fall within 6 months of AF diagnosis; 
o hospitalized for any major bleeding within 3 months of AF diagnosis; 
o ophthalmic surgery within 3 months of AF diagnosis; and 
o terminal condition (e.g., referral to palliative care, malignancy of the 
esophagus, stomach, lung, pancreas, ovary or brain) any time prior to AF 
diagnosis. 
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Eligibility was determined using the diagnoses from primary and secondary care (the National 
Health Service’s clinical classification called Read codes and ICD-10 codes, respectively) or 
from the drug codes for prescriptions issued in primary care. The codes are available upon 
request from the corresponding author. 
Outcomes 
The outcome of interest was time from the index date (AF diagnosis plus 90 days) to the 
first event among ischemic stroke, intracranial hemorrhage, extracranial hemorrhage, and 
death. If a patient did not experience a clinical event, the time to first event was censored at the 
earliest date among the following: patient transfer out of the practice, last data transfer from the 
practice, end of data collected from hospitalization episodes statistics (HES), or 365 days post-
index. Each event was treated as a competing first event so the analysis required the time to 
first event and an event type (corresponding to the clinical events of interest or none for 
censored event times).  We used a landmark approach (17, 18) to define the index date as 90 
days after the AF diagnosis based on earlier work which showed that the majority of patients 
prescribed OAC within one year of AF diagnosis received their prescriptions within 90 days.  
Stroke, intracranial hemorrhage, and extracranial hemorrhage were ascertained using ICD-10 
codes from HES and, if applicable, death certificates (for date of death).  
Independent Variables 
We defined two sets of predictors (Table 4.1).  Set 1 included well-established predictors 
of stroke or bleeding from previously published risk models, treatment at index, and days since 
initiating OAC.  Set 2 was a mutually exclusive set of less commonly-cited candidate predictors; 
interactions between OAC and estimated glomerular filtration rate (eGFR); variables 
representing relative contraindications; and drug interactions with OAC.     
All independent variables were defined for the period prior to the index date using coded 
diagnoses from the EHR, diagnoses from hospitalization episodes, or drug codes from 
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prescriptions issued in primary care.  Treatment at index was determined using the dates of 
prescriptions issued in primary care.  Patients who had a prescription issued for any OAC 
(warfarin, dabigatran, rivaroxaban, or apixaban) after the AF diagnosis but prior to the index 
date were considered to be in the “OAC” treatment category.  Patients who had not been 
prescribed any OAC prior to the index date were considered to be in the “no OAC” treatment 
category.  The assigned treatment status remained constant even if there were changes in 
prescriptions (e.g., initiation or discontinuation) after the index date: we adopted this analytic 
convention from the CHA2DS2-VASc and HAS-BLED models (11, 12).  Similarly, we did not 
censor survival outcomes for changes in treatment status.   Comorbidities were defined using 
Read and ICD-10 codes from primary care and HES alone or in combination with prescriptions.  
We used the most recent diagnostic testing results within one year prior to the index date.  
eGFR, as measured by  the Modification in Diet for Renal Disease Study equations (19), was 
obtained directly from the patient’s record or converted from the serum creatinine value as a 
function of sex and age and assuming Caucasian race. Medications were considered to be 
concurrent if a prescription had been issued any time between the AF diagnosis and up to 90 
days post diagnosis.   
For diagnoses, we assumed that missing values implied the absence of a condition.  
Approximately 11% of patients were missing smoking status.  So that we could include this 
information in our models without imputation, we coded smoking as current smoker vs. all 
others under the assumption that primary care practices are incentivized to record current 
smoking.  Approximately 15% of eligible patients were missing values of eGFR within one year.   
Because we had a particular interest in renal function, we imputed missing eGFR values. If a 
patient had a coded diagnosis of end-stage renal disease or dialysis, we imputed a value of <30 
mL/min; otherwise, we used the most recently recorded value within three years of the index 
date, assuming that renal function changes relatively slowly.  We did not impute values for the 
remaining 5% of patients with missing eGFR values. 
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Statistical Analysis 
We summarized baseline (pre-index date) characteristics for the entire cohort overall 
and by prescribed treatment.  Continuous variables were summarized using the mean and 
standard deviation (SD) and categorical variables were summarized using counts and 
percentages.  We tested the association between patient characteristics and index treatment 
using logistic regression.   
Using a 70% development sample stratified by treatment, we used Fine and Gray’s 
competing risks regression model (20) to estimate the associations between the independent 
variables and the subdistribution hazards of the first event among stroke, intracranial 
hemorrhage, extracranial hemorrhage, and death.  
For the outcomes of stroke, extracranial hemorrhage, and death, we forced inclusion of 
well-accepted predictors of stroke and bleeding (Set 1) and allowed other potentially useful 
predictors from Set 2 to enter the models based on statistical criteria and clinical considerations.  
We approached the model-building strategy in the following three stages: (1) inclusion of all 
predictors from Set 1; (2) evaluation of first-order terms from Set 2 among comorbidities and 
concurrent drugs (used in >0.5% of patients); (3) evaluation of OAC-by-eGFR interactions and 
OAC-by-concurrent drug interactions.  At Stage 1, we did not allow uninformative predictors 
(i.e., characteristics with no events) to enter the model because their inclusion would lead to 
perfect separation and instability in model fitting.  At Stage 2, we first included the predictors 
from Set 1 and then screened the predictors for additional comorbidities one at a time: Individual 
predictors from Set 2 were not considered further if they failed to reach a nominal p-value (Z-
score) ≤0.05.  If one or more predictors met this criterion, the decision to retain them in 
subsequent models was made using the Akaike Information Criterion (AIC).  At Stage 3, we 
evaluated whether the model fit would be improved further by including interactions with 
treatment.  For drug-drug interactions, we fitted models that included a term representing the 
interaction between the previously-included concurrent drug and OAC. We used a similar 
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approach to evaluate the OAC-by-eGFR interaction.  The model building strategy continued 
until no remaining interactions improved the model fit by the AIC.  For each clinical outcome, we 
computed the average c-statistic over 100 bootstrap samples using methods for competing risks 
models. (21)  
Because intracranial hemorrhage was rare, we took a slightly different model-building 
approach than for the more common outcomes.  With few events per model predictor, the 
regression coefficients may be unstable, severely biased, and difficult to replicate in external 
samples (22).  This problem has led to the rule of thumb that proportional hazards models 
should have at least 10 events per predictor (23).  Following this guideline for intracranial 
hemorrhage, we used the full study sample and limited our model predictors to 5 degrees of 
freedom.  We identified potential predictors by their associations with intracranial hemorrhage 
after inclusion of treatment and days on OAC.  Then we fitted all 5 degrees of freedom models 
that included treatment, days on OAC, and three additional previously-screened predictors.  Of 
these candidate models, we selected the model with the greatest discrimination (c-statistic).   
Since we used the full study cohort to develop the model for intracranial hemorrhage, we did not 
evaluate its internal validity. 
We evaluated the internal validity of the development models for stroke, extracranial 
hemorrhage, and death using data from the 30% validation sample: we produced calibration 
plots which compared the average predicted risk to the observed cumulative incidence within 
groups of predicted risk.  The risk groups were formed by quantiles of the predicted probability 
(e.g., binned at the quartiles for the validation sample).  The observed cumulative incidence at 
365 days and its 95% confidence interval (CI) were calculated using the competing risks 
estimator described by Aalen and Johansen. (24)  We re-estimated the three models using data 
from the full study cohort, which (in addition to the model for intracranial hemorrhage) we refer 
to as the final models.  The final models were interpreted using the exponentiated model 
coefficients, i.e., subdistribution hazard ratios (SHR) and the effect of OAC on event risks was 
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summarized using the number needed to treat (NNT, 25).  Details on the calculation of the 
predicted 1-year risks are provided in the supplemental methods. 
We conducted two sensitivity analyses to evaluate the robustness of the primary results.  
For the first, we re-estimated the final models using alternative landmarks of 30 and 60 days 
post-diagnosis.  For the second, we examined the potential for selection bias from observable 
characteristics not included in the models by using propensity score adjustment in the final 
models (see Appendix D, Supplemental Methods for details). For all sensitivity analyses, model 
coefficients were compared qualitatively between the primary analysis and the sensitivity 
analyses.    
We used Stata, version 13.1 (26) to construct the analytic dataset, summarize the 
baseline characteristics, generate the calibration and prediction plots, and estimate the 
propensity scores.  The competing risks regression models were fitted using the R package 
“cmprsk”, Subdistribution Analysis of Competing Risks version 2.2-7 (27).  The c-statistics were 
calculated using the R package “pec”, Prediction Error Curves for risk prediction models in 
survival analysis. (28)  
Informed Consent 
Ethical approval for this study was granted by the National Research Ethics Service 
Committee by virtue of the protocol approval by the Independent Scientific Advisory Committee 
for the MHRA Database Research (CPRD Protocol No.15_251).  The Office of Human 
Research Ethics at the University of North Carolina also approved this study and issued a 
waiver for informed consent.    
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Results 
Study Population 
Of 17,282 patients who met all eligibility criteria (Appendix D, Supplemental Figure 1), 
16,320 (94.4%) were evaluable at the index date; the remainder died (55 patients) or had an 
index date later than the cut-off for hospitalization data (907 patients).  Of the evaluable 
patients, 15,483 had non-missing or imputed eGFR and were included in the prediction models.  
The resulting full study cohort was randomly divided into the development (10,829 patients) and 
validation (4,654 patients) samples.  The mean (SD) length of follow-up was 289 (116) days.   
The characteristics of the full study cohort were as expected for a population of older 
adults (mean age = 74 years) with multiple cardiovascular comorbidities (Table 4.2). Although 
all patients were naïve to OACs, 15% had experienced a major bleed prior to their AF diagnosis.  
Patients prescribed OAC comprised 46% of the overall cohort; 96% of these patients were 
prescribed warfarin.  Compared to patients not receiving prescriptions for OAC, patients 
prescribed OAC were significantly (p<0.05) more likely to have well-established stroke risk 
factors of prior stroke or TIA, heart failure, hypertension, and vascular disease.  However, only 
56% of patients with a prior stroke or TIA had been prescribed OAC on the index date.  There 
was a pronounced difference in the prevalence of antiplatelet use between patients not 
prescribed OAC and those who were (73% vs. 40%).     
Development Models 
In the full study cohort, 13,886 patients (90%) experienced no event during follow-up; the 
remaining patients’ first events were distributed as follows: 359 strokes, 52 intracranial 
hemorrhages, 573 extracranial hemorrhages, and 613 deaths.  All of the clinical events had a 
cumulative incidence <6% after one year, but there were differences between treatments in the 
unadjusted probabilities of clinical events:  Death was the most likely clinical event among 
patients not prescribed OAC at the index date (5.5%), while extracranial hemorrhage was the 
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most likely clinical event among patients prescribed OAC (4.9%) (Appendix D, Supplemental 
Figures 2 and 3). Among patients who had not been prescribed OAC at the index date, 23% 
were prescribed OAC within one year. 
For a first clinical event of stroke, no events were reported among patients with 
thrombocytopenia or rheumatoid arthritis (Appendix D, Supplemental Figure 4) so these 
predictors were not included.  Beyond the predictors included a priori, no other predictors (main 
effects or interactions) met the statistical criteria for inclusion in the model for stroke (Appendix 
D, Supplemental Table 1).  However, for the first events of extracranial hemorrhage and death, 
predictors that met the statistical criteria included two predictors for extracranial hemorrhage 
(hyperthyroidism and proteinuria) and four predictors for death (current smoking, high risk of 
falls, corticosteroids, and antidepressants).  The model for intracranial hemorrhage as a first 
event was estimated using data from the full study cohort and included three additional 
predictors (age ≥85 years, heart failure, and prior major bleed) which maximized the c-statistic 
among all 5-degrees of freedom models. (Table 4.3)   In the development sample, the c-
statistics for stroke, extracranial hemorrhage, and death were 73.8, 61.4, and 65.3, respectively.    
For intracranial hemorrhage, we used the full sample; the c-statistic was 54.8 
Internal Validation 
The development models for stroke, extracranial hemorrhage, and death yielded 
average predicted 1-year risks that were well-calibrated with the non-parametric estimates of 
the cumulative incidence at 1-year.  (Appendix D, Supplemental Figures 5, 6, and 7)    
Final Models 
Our final models, estimated using the full study cohort, confirmed well-established 
relationships between comorbidities (e.g., advanced age and prior events) and stroke and 
bleeding, as well as the benefits and risks of OAC. (Table 4.3)  The characteristic most strongly 
and positively associated with each outcome, based on the Z-score, was prior stroke or TIA for 
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stroke (SHR=4.6), age ≥85 (SHR=2.4) for intracranial hemorrhage, prior major bleed for 
extracranial hemorrhage (SHR=1.9), and heart failure for death (SHR=2.6).   Characteristics 
other than treatment that were significant predictors for more than one event type included: 
female sex (stroke, extracranial hemorrhage, and death), age 75-84 (stroke, extracranial 
hemorrhage, and death), age ≥85 (stroke, intracranial hemorrhage, extracranial hemorrhage, 
and death), prior major bleed (intracranial hemorrhage and extracranial hemorrhage), eGFR<30 
mL/min (extracranial hemorrhage and death), and anemia (extracranial hemorrhage and death).  
OAC was significantly associated with stroke (SHR=0.4), intracranial hemorrhage (SHR=2.1), 
extracranial hemorrhage (SHR=1.2), and death (SHR=0.7).  Severe kidney dysfunction 
(eGFR<30 mL/min) was significantly associated with extracranial hemorrhage (SHR=1.6) and 
death (SHR =1.5).   
The prediction models performed well in terms of discrimination and calibration.  In the 
final models, the c-statistics for stroke, intracranial hemorrhage, extracranial hemorrhage, and 
death were 73.6, 54.8, 58.6, and 63.4. The calibration plots show that the models accurately 
predicted all four clinical events over the range of risk quantiles. For example, the lowest and 
highest deciles of risk for stroke have average 1-year predicted risks of 0.5% and 10.3%, both of 
which agree well with the 95% CI about the nonparametric estimated cumulative incidence 
(Figure 4.1).   Likewise, the lowest and highest deciles of risk for extracranial hemorrhage have 
1-year predicted risks of 1.8% and 9.9%, respectively; both closely agree with the observed 
cumulative incidence (Figure 4.3).  The prediction model for death is also well-calibrated (Figure 
4.4) as is the model for intracranial hemorrhage, albeit with only two risk groups examined 
(Figure 4.2).  
Model Predictions and Population Impact (NNT) 
The overall effect of OAC on various outcomes can be estimated from the average 1-
year predicted risks of competing events for the full study cohort (Appendix D, Supplemental 
Figure 8).  For example, the 1-year risk of any untoward event (i.e., sum of predicted risks) is 
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13.1% without OAC compared to 10.5% with OAC, for an absolute risk difference of 2.6% or a 
NNT of 39.  The average predicted 1-year risk of stroke as a first event without OAC is 3.7% 
compared to 1.7% with OAC, which corresponds to a NNT of 50. 
Taken together, the four prediction models illustrate the risk trade-offs associated with 
initiating OAC in patients with different risk profiles.  The 1-year predicted risks of the competing 
clinical events for three prototypical patients at varying levels of stroke risk represent 298, 246, 
and 21 actual patients in the full study cohort (Figure 4.5).    When the stroke risk is <1% (e.g., 
patient with low stroke risk per CHA2DS2-VASc score of 1), there is little benefit of OAC:  the risk 
of any untoward event with OAC is nearly identical to the risk without OAC (3.9% vs. 4.1%; 
NNT=500).  However, when the stroke risk is 3.1% (e.g., second patient with moderate-to-high 
stroke risk per CHA2DS2-VASc score of 4) the benefits of OAC are more apparent. The 
predicted stroke risk is reduced to 1.4%, the predicted risk of death is reduced from 2.4% to 
1.6%, but with an increased risk of extracranial hemorrhage from 2.7% to 3.4%.  The overall risk 
reduction for any event (1.7%) corresponds to a NNT of 59 for this subpopulation.  Lastly, 
patients with 16.6% stroke risk (e.g., patient at high stroke risk per CHA2DS2-VASc score of 6) 
can expect a reduction in overall event risk from 24.8% without OAC to 15.9% with OAC 
(NNT=11).  The reduction in stroke risk for these patients comes at the expense of increased 
risks of extracranial hemorrhage (from 3.7% to 4.5%) and intracranial hemorrhage (0.4% to 
0.8%).  Similar trade-offs are apparent for patients with varying degrees of renal dysfunction 
(Appendix D, Supplemental Figure 9).                
Sensitivity Analyses 
Both sets of sensitivity analyses supported the conclusions of the primary analysis.  
First, with regard to the choice of landmark for the index date, the model coefficients were 
consistent between the primary analysis with a landmark of 90 days post-AF diagnosis and the 
models estimated using alternative landmarks of 30 and 60 days post-AF diagnosis (Appendix 
D, Supplemental Tables 2 and 3).  Second, with regard to the potential for selection bias arising 
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from observed characteristics, the final model coefficients were largely unaffected by inclusion 
of the propensity score, which was also a non-significant predictor in each of the four models 
(Appendix D, Supplemental Table 4).  This finding was further supported by two other results 
from the propensity score estimation itself: The distributions of estimated propensity scores 
overlap to a large degree (Appendix D, Supplemental Figure 10) and predictors already 
included in the prediction models had the greatest influence on the estimated propensity score 
(hypertension with 67% influence, antiplatelet use with 13%, and prior stroke or TIA with 12%).    
Discussion 
Principal Findings 
In a cohort of 15,483 newly-diagnosed AF patients without contraindications for OAC, we 
developed and internally validated prediction models for four clinically important competing 
events:  stroke, intracranial hemorrhage, extracranial hemorrhage and death.  Our models 
confirmed the prognostic importance of several factors that comprise the currently-advocated 
CHA2DS2-VASc (11) and HAS-BLED (12) risk schemes, including advanced age, female sex, 
hypertension, prior stroke, prior major bleeding, anemia, and kidney dysfunction.  We also found 
the expected associations between OAC and the incidence of each cause of the first event: 
OAC was positively associated with extracranial hemorrhage (SHR=1.2) and intracranial 
hemorrhage (SHR=2.1), but negatively associated with stroke (SHR=0.4) and death (SHR=0.7).  
Finally, our models performed well in terms of discrimination and calibration: The c-statistics for 
stroke, intracranial hemorrhage, extracranial hemorrhage, and death were 74, 55, 59, 63, 
respectively, and the models were in close agreement with the observed cumulative incidences 
across the range of risk groups.   
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Comparison to CHA2DS2-VASc and HAS-BLED 
By design, our prediction models shared some attributes with CHA2DS2-VASc (11) and 
HAS-BLED (12) as well as the ability to stratify patients into short-term (1-year) risk categories.  
Our model confirmed a number of the strongest associations that are used in weighting the 
CHA2DS2-VASc and HAS-BLED scores, particularly advanced age, female sex, prior stroke and 
prior bleeding.  Unlike HAS-BLED, we did not include labile INR and significant liver disease 
because we excluded patients with prior exposure to OAC and patients who had 
contraindications for OAC.  These differences in eligibility make direct comparisons of our model 
performance with CHA2DS2-VASc and HAS-BLED difficult.  Any apparent differences may also 
be attributable to statistical methods: because we used survival methods, our models are not 
optimized for any single time point, unlike the logistic regression models used for CHA2DS2-
VASc and HAS-BLED.  With these caveats, we note that our c-statistic for stroke is greater than 
CHA2DS2-VASc (74 vs. 61) and our c-statistic for extracranial hemorrhage is less than for HAS-
BLED (59 vs. 72).     
Our prediction models are unique in many ways that make them potentially more useful 
in clinical decision-making than CHA2DS2-VASc and HAS-BLED.  First, our competing events 
framework can quantify and directly compare four event risks associated with treatment or no 
treatment.  By contrast, the existing schemes can only be used to rank order the risks of stroke 
in the absence of OAC and bleeding associated with OAC.  Second, unlike HAS-BLED that 
estimates overall bleeding risk, our models separate the mutually exclusive risks for intracranial 
hemorrhage and extracranial hemorrhage. We use the predictors from CHA2DS2-VASc and 
HAS-BLED, but also incorporate other predictors which we found to improve the model fit, 
including thrombocytopenia, hyperthyroidism and proteinuria for extracranial bleeding.  Third, 
our use of electronic health records dictated certain differences in defining model predictors that 
may, in turn, be more readily implemented in other EHRs.  For example, we defined 
hypertension on the basis of diagnostic codes and prescriptions (which are regularly recorded in 
 63 
EHRs), whereas CHA2DS2-VASc and HAS-BLED defined hypertension as “uncontrolled” on the 
basis of systolic blood pressure >160 (11, 12).  One final advantage of our models is that they 
serve as a foundation for future models that can be expanded to include separate risk estimates 
for all available OACs, including the TSOACs.     
Strengths and Limitations 
We used a high-quality, clinically-rich dataset of a large, contemporary cohort of patients 
receiving care from general practitioners. The cohort size provided us with large numbers of 
clinical events (except intracranial hemorrhage) on which to base our prediction models.  Since 
we used competing risks regression, our models for stroke and bleeding complications provide 
correct estimates of these risks unlike if we had censored follow-up at the time of death (29).  
Our final model results were supported by our sensitivity analyses which showed that the 
primary results were robust to alternative definitions of the landmark date and that there is 
limited potential for selection bias from observed characteristics.   
There are several limitations of our study. As with any study using secondary data, we 
had to rely on the accuracy of conditions and diagnoses recorded in the patient’s record.  
Considering that CPRD imposes some quality standards and incentivizes GPs for the quality of 
their data collection (15), its data quality may be superior to other secondary data sources.    
Although we attempted to address selection bias through various analytic approaches, residual 
confounding may still bias the risk estimates. We were not able to evaluate the contribution of 
some potential predictors because of extensive missing data (e.g., ethnicity, family history of 
CHD, control of anticoagulation).  Due to limited exposures of the TSOACs, we pooled all OACs 
and thus we were unable to characterize any differences among the currently-available 
anticoagulants.  We also did not account for changes in treatment status from the index date 
(initiating, switching, or discontinuing OACs), which might affect the risk estimates.  Our final 
risk models may not generalize to other settings, to periods later than 3 months post-AF 
diagnosis, or to patients with previous exposure to OACs.  Lastly, the predicted event risks may 
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not be easily interpreted by physicians or patients and, thus, their use in clinical practice may be 
limited.   
Conclusions and Implications 
We have developed and internally validated a novel set of prediction models for stroke, 
intracranial hemorrhage, extracranial hemorrhage, and death that may be useful to physicians 
and patients newly diagnosed with AF as they make decisions about the use of OACs.  We 
believe these models and our competing events framework have significant advantages over 
existing risk tools in AF because stroke and bleeding, whichever occurs first, have the potential 
to alter the course of  treatment decisions.  A newly-diagnosed AF patient who first experiences 
a major bleeding event is not a candidate for OAC for a period of time during which she will not 
benefit from the stroke-reducing effects of OAC.  However, the urgency for initiating OAC is 
even greater if she were to first experience a stroke.  These serious consequences make the 
treatment decision a complex one; but our prediction models may clarify the alternatives and 
subsequently improve outcomes. Before these potential benefits can be realized, however, 
these new prediction models should be evaluated further by determining whether the new 
models improve health outcomes, examining how the risk information will be used in shared 
decision making, and validating the models in other settings.    
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Figures 
Figure 4.1 Calibration Plot for Stroke as a First Clinical event - Full Study Cohort 
(N=15,483) 
 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the full cohort model to the observations in the full cohort and averaging the predictions within 10 
approximately equal-sized groups defined by the deciles.  The observed cumulative incidence (95% CI) at one year, plotted on the 
y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence lies along the 
diagonal reference line, the prediction model is considered to be well-calibrated. 
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Figure 4.2 Calibration Plot for Intracranial Hemorrhage as a First Clinical Event - Full 
Study Cohort (N=15,483) 
 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the full cohort model to the observations in the full cohort and averaging the predictions within two 
approximately equal-sized groups defined by the median.  The observed cumulative incidence (95% CI) at one year, plotted on the 
y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence lies along the 
diagonal reference line, the prediction model is considered to be well-calibrated. 
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Figure 4.3 Calibration Plot for Extracranial Hemorrhage as a First Clinical Event - Full 
Study Cohort (N=15,483) 
 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the full cohort model to the observations in the full cohort and averaging the predictions within 10 
approximately equal-sized groups defined by the deciles.  The observed cumulative incidence (95% CI) at one year, plotted on the 
y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence lies along the 
diagonal reference line, the prediction model is considered to be well-calibrated. 
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Figure 4.4 Calibration Plot for Death as a First Clinical Event - Full Study Cohort 
(N=15,483) 
 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the full cohort model to the observations in the full cohort and averaging the predictions within 10 
approximately equal-sized groups defined by the deciles.  The observed cumulative incidence (95% CI) at one year, plotted on the 
y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence lies along the 
diagonal reference line, the prediction model is considered to be well-calibrated. 
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Figure 4.5 Predicted 1-year Risks of Competing First Clinical Events for Patients at 
Varying Stroke Risk 
  
 
These predictions assume that patients initiated OAC on the day of AF diagnosis and that no other risk factors are present. 
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Tables 
Table 4.1 Independent Variables 
Variable Source Definition 
Set 1: Established risk factors for stroke and/or bleeding: 
   OAC on index date Rx Any oral anticoagulant prescribed by index date (no OAC = ref) 
   Days on OAC treatment Rx Days on OAC since AF diagnosis (0-90 days; 0 for patients not prescribed OAC) 
   Female GP Female sex  
   Age category  GP Age at index date (years) 
     <65 (ref)   
     65-74   
     75-84   
     ≥85   
   Prior stroke or TIA GP/HES Any prior ischemic stroke or transient ischemic attack  
   Heart failure  GP/HES Diagnosed with heart failure   
   Hypertension GP/Rx Diagnosed with hypertension or concurrent use of antihypertensive medication  
   Diabetes mellitus GP/Rx Diagnosed with diabetes or concurrent treatment with oral hypoglycemic agent or 
insulin  
   Vascular disease GP/HES Diagnosed with MI, angina pectoris, aortic plaque, intermittent claudication, arterial  
thrombosis, venous thrombosis; or had prior PCI or CABG  
   Prior major bleed GP/HES Intracranial hemorrhage or any prior major bleed associated with hospitalization 
   Estimated GFR  GP Most recent kidney function (mL/min), estimated using MDRD equation   
     <30 mL/min   
     30-59 mL/min (ref)   
     ≥60 mL/min   
   NSAID use Rx Concurrent use of NSAIDs  
   Antiplatelet use  Rx Concurrent use of antiplatelet drugs (e.g., clopidogrel, dypridamole, and aspirin)  
   Alcoholism or heavy drinking GP/HES Ever had a diagnosis for alcoholism, a referral to alcohol abuse treatment, or 
reported heavy drinking in 12 months prior to index date 
   Anemia GP Diagnosed with anemia    
   Thrombocytopenia GP Diagnosed with thrombocytopenia    
OAC = oral anticoagulant; Rx = prescriptions issued in primary care; Ref = referent; AF = atrial fibrillation; GP = general practitioner conditions, 
diagnoses, and test results obtained from Read coding system; TIA = transient ischemic attack; OAC = oral anticoagulant; HES = hospitalization 
episode conditions and diagnoses obtained from ICD-10 coding system; MI = myocardial infarction; PCI = percutaneous coronary intervention; 
CABG = coronary artery bypass graft; eGFR = estimate glomerular filtration rate; MDRD = Modification in Diet for Renal Disease; NSAID = 
nonsteroidal anti-inflammatory drug 
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Table 4.1. Independent Variables 
 
Variable Source Definition 
Set 2: Additional Candidates for Inclusion 
Comorbidities:   
   Hyperthyroidism GP Diagnosed with hyperthyroidism  
   Proteinuria GP Diagnosed with proteinuria   
   Smoking GP Most recent smoking status (never, former, current – including passive) 
   Rheumatoid arthritis GP Diagnosed with rheumatoid arthritis  
   At high risk of falls GP/Rx Diagnosed with dementia or Parkinson disease or concurrent use of psychotropic 
drugs (antipsychotics, antidepressants, and benzodiazepines)  
   
Interaction of OAC and kidney function 
   OAC x eGFR  Interaction between OAC and eGFR (2 interaction terms) 
 
Drugs that may interact with one or more OAC: 
   Psychotropics Rx Concurrent use of psychotropics (antidepressants, antipsychotics, and 
benzodiazepines) 
   Antidepressants Rx Concurrent use of antidepressants  
   Corticosteroids Rx Concurrent use of systemic corticosteroids (oral, intravenous, intramuscular)  
   Carbamazepine Rx Concurrent use of carbamazepine  
   Systemic azole antifungals Rx Concurrent use of systemic azole antifungals (oral, intravenous) 
   Phenytoin Rx Concurrent use of phenytoin  
   Dronedarone Rx Concurrent use of dronedarone 
   Cyclosporine Rx Concurrent use of systemic cyclosporine (oral, intravenous) 
   Tacrolimus Rx Concurrent use of systemic tacrolimus (oral, intravenous) 
   Rifampicin Rx Concurrent use of rifampicin 
   St. John’s wort (hypericum) Rx Concurrent use of St. John’s wort 
   
OAC = oral anticoagulant; Rx = prescriptions issued in primary care; Ref = referent; AF = atrial fibrillation; GP = general practitioner conditions, 
diagnoses, and test results obtained from Read coding system; TIA = transient ischemic attack; OAC = oral anticoagulant; HES = hospitalization 
episode conditions and diagnoses obtained from ICD-10 coding system; MI = myocardial infarction; PCI = percutaneous coronary intervention; 
CABG = coronary artery bypass graft; eGFR = estimate glomerular filtration rate; MDRD = Modification in Diet for Renal Disease; NSAID = 
nonsteroidal anti-inflammatory drug 
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Table 4.2 Characteristics on Index Date of Patients Newly Diagnosed with NVAF- Full 
Study Cohort 
  
  Treatment on Index Date  
 
Characteristic 
All 
(N=15,483) 
No OAC 
(N=8,379) 
OAC 
(N=7,104) p-value† 
Year of AF Diagnosis*     
   2010 3,857 (24.9%) 2,278 (27.2%) 1,579 (22.2%)  
   2011  3,965 (25.6%) 2,258 (26.9%) 1,707 (24.0%)  
   2012 4,091 (26.4%) 2,206 (26.3%) 1,885 (26.5%)  
   2013 3,570 (23.1%) 1,637 (19.5%) 1,933 (27.2%)  
Established risk factors for stroke and/or bleeding 
Female 7,354 (47.5%) 4,145 (49.5%) 3,209 (45.2%) <0.001 
Age, mean (SD), years 74.5 (11.2) 74.6 (12.2) 74.4 (9.9) 0.210 
Age category       <0.001 
   <65 2,736 (17.7%) 1,650 (19.7%) 1,086 (15.3%)  
   65-74 4,204 (27.2%) 2,129 (25.4%) 2,075 (29.2%)  
   75-84 5,661 (36.6%) 2,697 (32.2%) 2,964 (41.7%)  
   ≥85 2,882 (18.6%) 1,903 (22.7%) 979 (13.8%)  
Prior stroke or TIA 2,289 (14.8%) 1,000 (11.9%) 1,289 (18.1%) <0.001 
Heart failure  2,587 (16.7%) 1,260 (15.0%) 1,327 (18.7%) <0.001 
Hypertension 14,107 (91.1%) 7,384 (88.1%) 6,723 (94.6%) <0.001 
Diabetes mellitus 2,501 (16.2%) 1,262 (15.1%) 1,239 (17.4%) <0.001 
Vascular disease 5,249 (33.9%) 2,738 (32.7%) 2,511 (35.3%) <0.001 
Prior major bleed 2,387 (15.4%) 1,317 (15.7%) 1,070 (15.1%) 0.260 
Estimated GFR          0.005 
   <30 mL/min 366 (2.4%) 222 (2.6%) 144 (2.0%)  
   30-60 mL/min 4,158 (26.9%) 2,188 (26.1%) 1,970 (27.7%)  
   >60 mL/min 10,959 (70.8%) 5,969 (71.2%) 4,990 (70.2%)  
NSAID use 639 (4.1%) 402 (4.8%) 237 (3.3%) <0.001 
Antiplatelet use 8,912 (57.6%) 6,073 (72.5%) 2,839 (40.0%) <0.001 
Heavy alcohol use 144 (0.9%) 83 (1.0%) 61 (0.9%) 0.393 
Anemia 2,191 (14.2%) 1,285 (15.3%) 906 (12.8%) <0.001 
Thrombocytopenia 81 (0.5%) 55 (0.7%) 26 (0.4%) 0.011 
 
* Patients who were diagnosed with AF in 2014 were not included in the cohort for the primary analysis because the 
index date (90 days post AF diagnosis) occurred later than the last available date (3/31/2014) for hospitalization 
episode statistics, which were used to define baseline comorbidities.  
† P-values for each independent variable were obtained from binomial logistic regression models. 
OAC treatment on index date includes patients prescribed warfarin/VKA (N=6,814), dabigatran (N=171), rivaroxaban 
(N=96), and apixaban (N=23). 
Due to small cell sizes, we do not report results for the following concurrent drugs: cyclosporine, tacrolimus, rifampicin, 
and St. John’s wort.  
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = 
glomerular filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = 
coronary heart disease; NE = not estimable; NR = not reported due to sample size <5.   
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Table 4.2. Characteristics on Index Date of Patients Newly Diagnosed with NVAF –  
Full Study Cohort 
  Treatment on Index Date  
 
Characteristic 
All 
(N=15,483) 
No OAC 
(N=8,379) 
OAC 
(N=7,104) p-value† 
Potential risk factors for stroke and/or bleeding      
Hyperthyroidism 380 (2.5%) 217 (2.6%) 163 (2.3%) 0.236 
Proteinuria 313 (2.0%) 154 (1.8%) 159 (2.2%) 0.078 
Smoking       <0.001 
   Current 1,204 (7.8%) 709 (8.5%) 495 (7.0%)  
   Former 6,007 (38.8%) 3,163 (37.7%) 2,844 (40.0%)  
   Never 6,565 (42.4%) 3,523 (42.0%) 3,042 (42.8%)  
   Missing 1,707 (11.0%) 984 (11.7%) 723 (10.2%)  
Rheumatoid arthritis 328 (2.1%) 189 (2.3%) 139 (2.0%) 0.197 
At high risk of falls 1,050 (6.8%) 622 (7.4%) 428 (6.0%) 0.001 
Drugs that may interact with one or more OAC      
Psychotropics 2,017 (13.0%) 1,179 (14.1%) 838 (11.8%) <0.001 
Antidepressants 1,380 (8.9%) 816 (9.7%) 564 (7.9%) <0.001 
Corticosteroids 981 (6.3%) 545 (6.5%) 436 (6.1%) 0.350 
Carbamazepine 75 (0.5%) 35 (0.4%) 40 (0.6%) 0.195 
Systemic azole antifungals 41 (0.3%) 27 (0.3%) 14 (0.2%) 0.127 
Phenytoin 34 (0.2%) 19 (0.2%) 15 (0.2%) 0.836 
Dronedarone 22 (0.1%) 7 (0.1%) 15 (0.2%) 0.035 
 
* Patients who were diagnosed with AF in 2014 were not included in the cohort for the primary analysis because the index date 
(90 days post AF diagnosis) occurred later than the last available date (3/31/2014) for hospitalization episode statistics, which 
were used to define baseline comorbidities.  
† P-values for each independent variable were obtained from binomial logistic regression models. 
OAC treatment on index date includes patients prescribed warfarin/VKA (N=6,814), dabigatran (N=171), rivaroxaban (N=96), 
and apixaban (N=23). 
Due to small cell sizes, we do not report results for the following concurrent drugs: cyclosporine, tacrolimus, rifampicin, and St. 
John’s wort.  
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = glomerular 
filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = coronary heart 
disease; NE = not estimable; NR = not reported due to sample size <5.   
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Table 4.3 Fine-Gray Competing Risks Regression Model for the Time to First Clinical 
Event by Cause - Full Study Cohort (N=15,483) 
 
 Cause of First Clinical Event = Stroke 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.001 0.999 0.004 -0.25 0.800 
OAC  -0.805 0.447 0.170 -4.72 <0.001 
Female 0.248 1.281 0.110 2.26 0.024 
Age 65-74 0.449 1.567 0.250 1.79 0.073 
Age 75-84 0.987 2.683 0.236 4.18 <0.001 
Age ≥85 1.219 3.385 0.249 4.90 <0.001 
Prior stroke or TIA 1.521 4.578 0.111 13.69 <0.001 
Heart failure 0.140 1.151 0.138 1.02 0.310 
Hypertension 0.600 1.823 0.251 2.39 0.017 
Diabetes mellitus 0.057 1.059 0.144 0.40 0.690 
Vascular disease 0.017 1.017 0.114 0.15 0.880 
Prior major bleed 0.239 1.270 0.134 1.78 0.075 
Estimated GFR <30 mL/min 0.003 1.003 0.297 0.01 0.990 
Estimated GFR ≥60 mL/min 0.111 1.118 0.120 0.93 0.350 
NSAIDs -0.351 0.704 0.325 -1.08 0.280 
Antiplatelet drugs -0.086 0.918 0.126 -0.68 0.500 
Alcoholism or heavy drinking 0.348 1.416 0.571 0.61 0.540 
Anemia -0.032 0.969 0.140 -0.23 0.820 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.640 
      
C-index (bootstrap) = 73.6 
Pseudo Log-likelihood = -3248  
Pseudo likelihood ratio test = 324  on 18 df 
 
Predicted 1-year risk of stroke as first clinical event = 1 − exp⁡(− exp(𝑋?̂?)0,365̂), where 
 0,365̂ = 0.004897208⁡𝑎𝑛𝑑⁡𝑋?̂? = (−0.001 ∗ 𝑑𝑎𝑦𝑠⁡𝑜𝑛⁡𝑂𝐴𝐶⁡𝑎𝑡⁡𝑖𝑛𝑑𝑒𝑥) + (−0.805 ∗ 𝑂𝐴𝐶) + (0.248 ∗
𝑓𝑒𝑚𝑎𝑙𝑒) + (0.449 ∗ 𝑎𝑔𝑒⁡65 − 74) + (0.987 ∗ 𝑎𝑔𝑒⁡75 − 84) + (1.219 ∗ 𝑎𝑔𝑒 ≥ 85) + (1.521 ∗
𝑝𝑟𝑖𝑜𝑟⁡𝑠𝑡𝑟𝑜𝑘𝑒⁡𝑜𝑟⁡𝑇𝐼𝐴) + (0.140 ∗ 𝐻𝐹) + (0.600 ∗ 𝐻𝑇𝑁) + (0.057 ∗ 𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠) + (0.017 ∗
𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟⁡𝑑𝑖𝑠𝑒𝑎𝑠𝑒) + (0.239 ∗ 𝑝𝑟𝑖𝑜𝑟⁡𝑏𝑙𝑒𝑒𝑑) + (0.003 ∗ 𝑒𝐺𝐹𝑅 < 30) + (0.111 ∗ 𝑒𝐺𝐹𝑅 ≥ 60) +
(−0.351 ∗ 𝑁𝑆𝐴𝐼𝐷𝑠) + (−0.086 ∗ 𝑎𝑛𝑡𝑖𝑝𝑙𝑎𝑡𝑒𝑙𝑒𝑡) + (0.348 ∗ ℎ𝑒𝑎𝑣𝑦⁡𝑎𝑙𝑐𝑜ℎ𝑜𝑙) + (−0.032 ∗ 𝑎𝑛𝑒𝑚𝑖𝑎) 
 
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  
Thrombocytopenia and rheumatoid arthritis were not considered for inclusion in the model for stroke because 
there were no events among patients with these characteristics and inclusion of these predictors would cause 
model instability. 
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Table 4.3. Fine-Gray Competing Risks Regression Model for the Time to First Clinical 
Event by Cause – Full Study Cohort (N=15,483) 
 
 Cause of First Clinical Event = ICH 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.002 0.998 0.007 -0.28 0.780 
OAC  0.738 2.092 0.338 2.19 0.029 
Age ≥85 0.883 2.417 0.310 2.85 0.004 
Heart failure 0.591 1.806 0.308 1.92 0.055 
Prior major bleed 0.780 2.181 0.308 2.53 0.011 
      
C-index (bootstrap) = 54.8 
Pseudo Log-likelihood = -482  
Pseudo likelihood ratio test = 24  on 5 df 
 
Predicted 1-year risk of intracranial hemorrhage as first clinical event = 1 − exp⁡(− exp(𝑋?̂?)0,365̂), 
where  0,365̂ = 0.001607227⁡⁡𝑎𝑛𝑑⁡𝑋?̂? = (−0.002 ∗ 𝑑𝑎𝑦𝑠⁡𝑜𝑛⁡𝑂𝐴𝐶⁡𝑎𝑡⁡𝑖𝑛𝑑𝑒𝑥) + (0.738 ∗ 𝑂𝐴𝐶) +
(0.883 ∗ 𝑎𝑔𝑒 ≥ 85) + (0.591 ∗ 𝐻𝐹) + (0.780 ∗ 𝑝𝑟𝑖𝑜𝑟⁡𝑏𝑙𝑒𝑒𝑑) 
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  Because 
of the limited number of events, the inclusion of predictors beyond days on index treatment and OAC was limited 
to three additional predictors which were screened based on their significance and selected to maximize the 
bootstrap c-index.   
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Table 4.3. Fine-Gray Competing Risks Regression Model for the Time to First Clinical 
Event by Cause – Full Study Cohort (N=15,483) 
 
 Cause of First Clinical Event = Extracranial 
Hemorrhage 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.001 1.001 0.002 0.57 0.570 
OAC  0.204 1.226 0.114 1.79 0.073 
Female -0.174 0.840 0.087 -2.00 0.046 
Age 65-74 0.126 1.135 0.157 0.80 0.420 
Age 75-84 0.429 1.535 0.151 2.84 0.005 
Age ≥85 0.618 1.855 0.166 3.72 <0.001 
Prior stroke or TIA 0.110 1.116 0.111 0.99 0.320 
Heart failure -0.109 0.897 0.114 -0.96 0.340 
Hypertension -0.003 0.997 0.167 -0.02 0.980 
Diabetes mellitus -0.043 0.958 0.115 -0.37 0.710 
Vascular disease 0.286 1.331 0.091 3.15 0.002 
Prior major bleed 0.654 1.923 0.097 6.76 <0.001 
Estimated GFR <30 mL/min 0.480 1.616 0.199 2.41 0.016 
Estimated GFR ≥60 mL/min -0.182 0.833 0.095 -1.91 0.056 
NSAIDs -0.155 0.857 0.228 -0.68 0.500 
Antiplatelet drugs 0.044 1.045 0.092 0.48 0.630 
Alcoholism or heavy drinking -0.433 0.649 0.575 -0.75 0.450 
Anemia 0.306 1.358 0.106 2.88 0.004 
Thrombocytopenia 0.030 1.030 0.583 0.05 0.960 
Hyperthyroidism -0.853 0.426 0.413 -2.06 0.039 
Proteinuria 0.321 1.378 0.234 1.37 0.170 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.002 
      
C-index (bootstrap) = 58.6 
Pseudo Log-likelihood = -5352  
Pseudo likelihood ratio test = 159 on 21 df 
 
Predicted 1-year risk of extracranial hemorrhage as first clinical event = 1 − exp⁡(− exp(𝑋?̂?)0,365̂), 
where  0,365̂ = 0.0248335349⁡𝑎𝑛𝑑⁡𝑋?̂? = (0.001 ∗ 𝑑𝑎𝑦𝑠⁡𝑜𝑛⁡𝑂𝐴𝐶⁡𝑎𝑡⁡𝑖𝑛𝑑𝑒𝑥) + (0.204 ∗ 𝑂𝐴𝐶) +
(−0.174 ∗ 𝑓𝑒𝑚𝑎𝑙𝑒) + (0.126 ∗ 𝑎𝑔𝑒⁡65 − 74) + (0.429 ∗ 𝑎𝑔𝑒⁡75 − 84) + (0.618 ∗ 𝑎𝑔𝑒 ≥ 85) +
(0.110 ∗ 𝑝𝑟𝑖𝑜𝑟⁡𝑠𝑡𝑟𝑜𝑘𝑒⁡𝑜𝑟⁡𝑇𝐼𝐴) + (−0.109 ∗ 𝐻𝐹) + (−0.003 ∗ 𝐻𝑇𝑁) + (−0.043 ∗ 𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠) +
(0.286 ∗ 𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟⁡𝑑𝑖𝑠𝑒𝑎𝑠𝑒) + (0.654 ∗ 𝑝𝑟𝑖𝑜𝑟⁡𝑏𝑙𝑒𝑒𝑑) + (0.480 ∗ 𝑒𝐺𝐹𝑅 < 30) + (−0.182 ∗ 𝑒𝐺𝐹𝑅 ≥ 60) +
(−0.155 ∗ 𝑁𝑆𝐴𝐼𝐷𝑠) + (0.044 ∗ 𝑎𝑛𝑡𝑖𝑝𝑙𝑎𝑡𝑒𝑙𝑒𝑡) + (−0.433 ∗ ℎ𝑒𝑎𝑣𝑦⁡𝑎𝑙𝑐𝑜ℎ𝑜𝑙) + (0.306 ∗ 𝑎𝑛𝑒𝑚𝑖𝑎) +
(0.030 ∗ 𝑡ℎ𝑟𝑜𝑚𝑏𝑜𝑐𝑦𝑡𝑜𝑝𝑒𝑛𝑖𝑎) + (0.321 ∗ 𝑝𝑟𝑜𝑡𝑒𝑖𝑛𝑢𝑟𝑖𝑎) + (−0.853 ∗ ℎ𝑦𝑝𝑒𝑟𝑡ℎ𝑦𝑟𝑜𝑖𝑑𝑖𝑠𝑚) 
 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Table 4.3. Fine-Gray Competing Risks Regression Model for the Time to First Clinical 
Event by Cause – Full Study Cohort (N=15,483) 
 
 Cause of First Clinical Event = Death 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.000 1.000 0.003 0.10 0.920 
OAC  -0.413 0.662 0.127 -3.26 0.001 
Female -0.172 0.842 0.085 -2.04 0.042 
Age 65-74 0.665 1.945 0.213 3.13 0.002 
Age 75-84 1.301 3.672 0.201 6.47 <0.001 
Age ≥85 1.994 7.344 0.206 9.70 <0.001 
Prior stroke or TIA -0.115 0.891 0.115 -1.00 0.320 
Heart failure 0.972 2.644 0.090 10.78 <0.001 
Hypertension 0.204 1.226 0.187 1.09 0.280 
Diabetes mellitus 0.213 1.237 0.103 2.07 0.039 
Vascular disease 0.105 1.111 0.089 1.18 0.240 
Prior major bleed 0.072 1.075 0.103 0.70 0.490 
Estimated GFR <30 mL/min 0.389 1.476 0.182 2.14 0.033 
Estimated GFR ≥60 mL/min -0.115 0.891 0.090 -1.28 0.200 
NSAIDs 0.243 1.275 0.196 1.24 0.210 
Antiplatelet drugs -0.186 0.830 0.095 -1.95 0.052 
Alcoholism or heavy drinking 0.714 2.042 0.329 2.17 0.030 
Anemia 0.312 1.367 0.098 3.18 0.002 
Thrombocytopenia 0.383 1.466 0.435 0.88 0.380 
Current smoker 0.570 1.768 0.142 4.00 <0.001 
High risk of falls 0.497 1.644 0.124 4.00 <0.001 
Corticosteroids 0.812 2.253 0.118 6.89 <0.001 
Antidepressants 0.728 2.072 0.111 6.54 <0.001 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.017 
 
C-index (bootstrap) = 63.4 
Pseudo Log-likelihood = -5489  
Pseudo likelihood ratio test = 651  on 23 df 
 
Predicted 1-year risk of death as first clinical event = 1 − exp⁡(− exp(𝑋?̂?)0,365̂), where 
 0,365̂ = 0.008482781⁡𝑎𝑛𝑑⁡𝑋?̂? = (0.0003 ∗ 𝑑𝑎𝑦𝑠⁡𝑜𝑛⁡𝑂𝐴𝐶⁡𝑎𝑡⁡𝑖𝑛𝑑𝑒𝑥) + (−0.413 ∗ 𝑂𝐴𝐶) + (−0.172 ∗
𝑓𝑒𝑚𝑎𝑙𝑒) + (0.665 ∗ 𝑎𝑔𝑒⁡65 − 74) + (1.301 ∗ 𝑎𝑔𝑒⁡75 − 84) + (1.994 ∗ 𝑎𝑔𝑒 ≥ 85) + (−0.115 ∗
𝑝𝑟𝑖𝑜𝑟⁡𝑠𝑡𝑟𝑜𝑘𝑒⁡𝑜𝑟⁡𝑇𝐼𝐴) + (0.972 ∗ 𝐻𝐹) + (0.204 ∗ 𝐻𝑇𝑁) + (0.213 ∗ 𝑑𝑖𝑎𝑏𝑒𝑡𝑒𝑠) + (0.105 ∗
𝑣𝑎𝑠𝑐𝑢𝑙𝑎𝑟⁡𝑑𝑖𝑠𝑒𝑎𝑠𝑒) + (0.072 ∗ 𝑝𝑟𝑖𝑜𝑟⁡𝑏𝑙𝑒𝑒𝑑) + (0.389 ∗ 𝑒𝐺𝐹𝑅 < 30) + (−0.115 ∗ 𝑒𝐺𝐹𝑅 ≥ 60) +
(0.243 ∗ 𝑁𝑆𝐴𝐼𝐷𝑠) + (−0.186 ∗ 𝑎𝑛𝑡𝑖𝑝𝑙𝑎𝑡𝑒𝑙𝑒𝑡) + (0.714 ∗ ℎ𝑒𝑎𝑣𝑦⁡𝑎𝑙𝑐𝑜ℎ𝑜𝑙) + (0.312 ∗ 𝑎𝑛𝑒𝑚𝑖𝑎) +
(0.383 ∗ 𝑡ℎ𝑟𝑜𝑚𝑏𝑜𝑐𝑦𝑡𝑜𝑝𝑒𝑛𝑖𝑎) + (0.570 ∗ 𝑐𝑢𝑟𝑟𝑒𝑛𝑡⁡𝑠𝑚𝑜𝑘𝑒𝑟) + (0.497 ∗ ℎ𝑖𝑔ℎ⁡𝑟𝑖𝑠𝑘⁡𝑜𝑓⁡𝑓𝑎𝑙𝑙𝑠) +
(0.812 ∗ 𝑐𝑜𝑟𝑡𝑖𝑐𝑜𝑠𝑡𝑒𝑟𝑜𝑖𝑑𝑠) + (0.728 ∗ 𝑎𝑛𝑡𝑖𝑑𝑒𝑝𝑟𝑒𝑠𝑠𝑎𝑛𝑡𝑠) 
 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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CHAPTER 5 : STROKE VERSUS BLEEDING RISK AND THE DECISION TO 
PRESCRIBE ORAL ANTICOAGULANTS IN NEWLY DIAGNOSED ATRIAL 
FIBRILLATION: AN INDIVIDUAL-BASED SIMULATION STUDY 
Overview 
Background 
Treatment decisions about oral anticoagulation in atrial fibrillation (AF) are often guided 
by risk scores for stroke and bleeding, but existing scores do not enable physicians to explicitly 
weigh the risk of stroke vs. the risk of bleeding.  We developed new risk prediction models for 
the competing events of stroke, intracranial hemorrhage (ICH), extracranial hemorrhage (ECH), 
and death. This study evaluates the usefulness of our new prediction models using individual-
based simulation.    
Methods 
This study is a simulated experiment for which the “exposure” corresponds to how 
treatment (no OAC vs. OAC) is selected for an individual; we studied 11 such treatment 
selection rules including current treatment patterns.  We simulated health outcomes conditional 
on treatment and patient characteristics from a cohort of patients with incident AF.  Outcomes 
included the four competing events, total deaths, and quality-adjusted life months (QALMs).   
Results 
In 70% of the simulations, three strategies — treat if stroke risk>1%, treat all, and treat if 
CHA2DS2-VASc ≥2 — resulted in more ECH, but fewer overall competing events, strokes, and 
total deaths.  Compared to current treatment, these rules resulted in average reductions of 
overall competing events (11%), strokes (34-36%), and total deaths (18%). These effects 
translated to an average gain of 1.6 quality-adjusted life days per patient over the year. 
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Conclusions 
Maximizing treatment in patients with a CHA2DS2-VASc score ≥2 or, alternatively, a 1-
year risk of stroke ≥1% by our new risk model, will have the greatest population health impact.  
Future research should focus on how to increase OAC utilization in eligible patients. 
Introduction 
Atrial fibrillation (AF) is the most common heart rhythm disorder in developed countries, 
affecting 1% of adults in the US, Europe, and Australia (1).  AF is associated with increased 
risks of myocardial infarction, heart failure, mortality, and stroke.  Because the risk of stroke is 
as much as 5-fold greater in individuals with AF (2), current clinical guidelines recommend that 
oral anticoagulants (OACs) should be offered to patients for whom the stroke-reducing benefits 
outweigh the risk of anticoagulant-associated bleeding (3, 4).  Recognizing that bleeding 
complications can be serious, physicians often make their treatment decisions using risk scores 
like CHA2DS2-VASc (5) and HAS-BLED (6) to quantify the 1-year risks of stroke and OAC-
associated bleeding.  
One limitation of existing risk scores is that they consider stroke and bleeding 
separately; therefore, physicians cannot explicitly weigh the risk of stroke vs. the risk of bleeding 
complications. We sought to address this limitation in an earlier study by developing and 
internally validating novel risk prediction models for the first competing events of stroke, ICH, 
ECH, and death. Our new risk prediction models had modest-to-very good discrimination, and 
were well-calibrated overall when applied to an independent sample (manuscript under review).  
Although our new risk prediction models have several theoretical advantages, it is not known 
whether or how their use in clinical decision making might improve health outcomes on a 
population level.   
The overall objective of this study was to determine whether using our new risk 
prediction models as a clinical decision tool to individualize treatment decisions could improve 
population health. This improvement is measured against health outcomes that occur when 
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physicians prescribe treatment as we actually observe, i.e., under current treatment patterns. 
The specific aims were to: (a) estimate the numbers of patients with clinical events in 1 year 
under current treatment patterns and different treatment selection rules; (b) estimate quality-
adjusted life months (QALMs) within 1 year under current treatment patterns and different 
treatment selection rules; and (c) compare the outcomes obtained using alternative treatment 
selection rules versus the current treatment patterns.  To address these objectives, we 
simulated outcomes for a heterogeneous patient population under current treatment patterns 
and clinically reasonable treatment selection rules. 
Methods 
Study Cohort and Data Source 
We identified a cohort of patients who were newly diagnosed with AF in primary care 
between 2010 and 2013 in practices participating in the United Kingdom’s Clinical Practice 
Research Datalink (CPRD).  Our data comprised electronic health records from primary care 
that were linked with hospitalization episodes and national mortality data (7).   
The eligibility criteria were intended to identify patients who: had incident AF, were 
potential candidates for an OAC, and did not have absolute contraindications for OAC.  
Furthermore, since the prediction models developed in our earlier work used an index date of 
AF diagnosis plus 90 days, patients in our cohort survived the first 90 days of their AF 
diagnosis. Patients were eligible for inclusion if they met all of the following criteria: 
 Had a first recorded diagnosis for AF in primary care between January 1, 2010 and  
December 31, 2013; 
 Were at least 18 years of age at the time of AF diagnosis;  
 Were registered at a primary care clinic that met CPRD quality standards for at least one 
year prior to the AF diagnosis;  
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 Had data that were considered acceptable for research purposes, based on CPRD 
criteria for registration status, valid age and sex, and recording of events;   
 Were eligible for linkage with hospitalization episode and mortality statistics; 
 Had received at least one prescription in primary care for any condition within one year 
prior to the AF diagnosis (to minimize bias associated with non-users who never receive 
prescriptions from their general practitioner);  
 Had non-missing kidney function data (estimated glomerular filtration rate, eGFR) within 
3 years of the AF diagnosis or had a diagnosis of end stage renal disease so that 
eGFR<30 mL/min could be imputed;  
 Were still alive 90 days post-AF diagnosis and had at least some follow-up available 
from hospitalization episode statistics (HES). 
Patients were excluded for any of the following reasons: 
 Were not a candidate for a target-specific OAC (TSOAC) because they had valvular 
disease prior to the AF diagnosis: 
o Had been diagnosed with mitral stenosis;  
o Had prosthetic heart valve(s) or mitral valve repair; 
 Had ever been prescribed an OAC or had an international normalized ratio (INR) 
measurement prior to the AF diagnosis;  
 Were prescribed aspirin (300 mg) within 3 months prior to the AF diagnosis.  (Note 
that these patients were excluded from the previous study because they may not be 
true candidates for OAC due to reliance on aspirin monotherapy for stroke 
prevention and were excluded here for convenience; this criterion excludes <1% of 
otherwise eligible patients.); or 
 Had an absolute contraindication for OAC due to high risk of bleeding or non-
adherence including a diagnosis or history of: 
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o ICH/surgery or intracerebral aneurysm or tumor; 
o impaired hemostasis (e.g., hemophilia or von Willebrand disease); 
o severe liver disease (e.g., cirrhosis); 
o dementia (e.g., Alzheimer’s disease) or psychosis;  
o diabetic proliferative retinopathy; 
o alcoholism or reported heavy drinking  in 12 months prior to AF diagnosis; 
o any malignancy (including of the skin) any time within 6 months of AF 
diagnosis; 
o accidental fall within 6 months of AF diagnosis; 
o hospitalized for any major bleeding within 3 months of AF diagnosis; 
o ophthalmic surgery within 3 months of AF diagnosis; and 
o terminal condition (e.g., referral to palliative care, malignancy of the 
esophagus, stomach, lung, pancreas, ovary or brain) prior to AF diagnosis. 
Eligibility was determined using the diagnoses from primary and secondary care (the National 
Health Service’s Read codes and ICD-10 codes, respectively) or from the drug codes for 
prescriptions issued in primary care.  The code lists are provided in Appendix B. 
Outcomes 
Simulated outcomes included the competing events (stroke, ICH, ECH, and death) and 
death following a non-fatal competing event. The simulated outcomes were used to derive two 
additional outcomes: total deaths and QALMs. We calculated QALMs as the weighted (by the 
health utility weight) average time spent in a given health state. For example, the maximum 
possible value of QALMs for a patient who remained event-free (or “well with AF”) for 365 days 
was 9.7 = (365 days * 0.81)/30.42 days per month, where the utility for time spent well with AF 
was 0.81 (8).   
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Independent Variables 
This study is a simulated experiment for which the “exposure” corresponds to how the 
treatment (no OAC vs. OAC) was selected for an individual; we studied 11 such treatment 
selection rules grouped into four main approaches (Table 5.1): 
1. Current treatment patterns: Patients were prescribed the same treatment that was 
observed in the real-world cohort.   
2. New risk prediction models: Use the new risk models to select the treatment that 
minimizes event risks or to target OAC for patients whose stroke risk exceeds one of two 
thresholds.  
3. Treat none or all patients.  
4. Use existing risk schemes: Select OAC on the basis of the CHA2DS2-VASc score alone 
or in combination with the HAS-BLED score. 
Patient characteristics (Appendix E Supplemental Table 1) were defined using Read codes (the 
National Health Service’s coding system used in primary care), ICD-10 codes used for 
diagnoses made during hospitalization, and prescriptions issued in primary care.  All attributes 
correspond to patient status at 90 days post-AF diagnosis, which we refer to as T0 for the 
simulation. Days on OAC since AF diagnosis was a control variable in our previous study, but 
we found that it was not significantly associated with any event.  Therefore, we assumed for 
simplicity that prescriptions for OAC, if issued, were first issued at T0. As in our earlier study, 
concurrent use of medications was defined as any prescription within 90 days prior to T0. 
Generation of Simulated Outcomes 
Simulation Framework 
To account for patient heterogeneity and incorporate parameter uncertainty into our 
estimates of population health impact, we built an individual-based simulation model (Figure 
5.1) that follows AF patients from T0 for one year.  Patient characteristics (Appendix E 
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Supplemental Table 1) and the selected treatment were inputs to the simulation and remained 
static.  In the simulation, treatment at To was selected according to one of multiple rules.  In 
subsequent steps, the simulation generated outcomes by applying the patient’s characteristics 
and selected treatment to the risk prediction models.  Over the one year period, the patient may 
first experience stroke, ICH, ECH, death, or remain event-free.  If the patient experienced a non-
fatal AF-related event, he or she may die.  If the event was non-fatal, it may have resulted in 
temporary or permanent disability. We assume that patients do not experience more than one 
stroke or bleeding complication within the year, an assumption that is supported by data from 
our cohort: of the 984 patients who first experienced a stroke or bleeding complication, only 28 
(3%) experienced a second non-fatal event within the year of follow-up.   Details about the 
generation of events and event times are provided in the Supplemental Methods. 
Simulation Model Parameters 
Simulation model parameters (Appendix E Supplemental Table 2) determined whether 
or not a competing event occurred, whether or not the competing event was fatal, and the 
severity of non-fatal strokes and ICH.  To estimate the probability of each clinical event, we 
simulated: the baseline cumulative sub-distribution hazard (CSH); and the regression 
coefficients. The baseline CSH was simulated using log-scale Weibull parameters and their 
variance-covariance matrices.  We verified the Weibull fit to the non-parametric cumulative sub-
distribution hazard graphically (see Appendix E).  The regression coefficients and their 
corresponding variance-covariance matrices were estimated from Fine Gray competing risks 
regression models in our earlier work.  To simulate death following a competing event, we 
obtained beta distribution parameters ( and ) from age-specific frequency tables of our study 
cohort.  If e out of n patients experienced an event, we defined the parameters as =e and =n-
e.  If no patients experienced an event, we assumed a weak uninformative prior by adding 1 to 
the numerator and denominator so that =1 and =n.   We used published literature for the 
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distribution of stroke/ICH severity (9) and the health utility weights (8, 9).  We used separate 
health utility weights for the first vs. subsequent months following non-fatal stroke or ICH 
because stroke patients from the Oxford Vascular study (9) reported an improvement in their 
health-related quality of life after the first month.        
Methods to Account for Uncertainty in Model Parameters 
Uncertainty in the model parameters was reflected in the results through Monte Carlo 
simulation.  We ran 10,000 iterations of the model which we determined iteratively to ensure 
convergence of the mean differences in outcomes between the current treatment patterns and 
other treatment selection rules.  We used a common set of random numbers for each of the 
treatment selection rules.   
Statistical Analysis 
We summarized baseline characteristics for the entire cohort overall and by the 
observed prescribed treatment.  Continuous variables were summarized using the mean and 
standard deviation (SD) and categorical variables were summarized using counts and 
percentages.  We tested the association between patient characteristics and index treatment 
using logistic regression.   
We tabulated the number of patients prescribed treatment under each selection rule.  
We calculated descriptive statistics for the outcomes (e.g., the mean and empirical 95% 
confidence intervals) for each treatment selection rule and for the difference between each 
selection rule and the status quo.  To characterize the magnitude of differences versus the 
status quo, we plotted the complement cumulative distribution functions for outcomes avoided 
and QALMs gained by treatment selection rule. 
We used Stata, version 13.1 (10) for the Monte Carlo simulation and all statistical 
analyses.  
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Informed Consent 
Ethical approval for this study was granted by the National Research Ethics Service 
Committee by virtue of the protocol approval by the Independent Scientific Advisory Committee 
for the MHRA Database Research (CPRD Protocol No.16_134R).  The Office of Human 
Research Ethics at the University of North Carolina also approved this study and issued a 
waiver for informed consent.    
Results 
Study Cohort 
As expected, patients in the cohort were older (mean 74 years) and had comorbidities 
commonly associated with stroke risk (Table 5.2). The most prevalent individual risk factors for 
stroke were hypertension (91%) and age>65 (82%).  According to the CHA2DS2-VASc index for 
stroke risk, 1% of patients were at the lowest risk of stroke (score=0), 8% were at intermediate 
risk (score=1), and over 90% were at moderate-to-high risk of stroke (score≥2). Stroke risk and 
OAC prescribing were positively associated: OACs were prescribed within 3 months of the AF 
diagnosis to 16%, 33%, and 47% of patients in the low, intermediate, and high risk strata.  
Outcomes by Treatment Selection Rule 
As the number of patients treated with OAC increased according to the treatment 
selection rules, there were, on average, more bleeding complications (ICH and ECH), fewer 
strokes and  deaths as competing events, and greater QALMs (Appendix E Supplemental 
Figures 1-6).   Of the 11 rules we studied, the current treatment patterns (Rule 0: patients 
received the treatment actually observed in our cohort) ranked 3rd highest in terms of mean 
overall competing events, strokes, and deaths; it also ranked 3rd lowest in terms of mean ICH 
and ECH.  The mean number of patients with overall competing events (stroke, ICH, ECH, or 
death) in one year ranged over the treatment selection rules from approximately 1500 (10%) to 
1800 (12%) of patients (Appendix E Supplemental Figure 1).  Although the 95% confidence 
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intervals for all events largely overlapped, the stroke-reducing benefits of OAC were apparent 
when comparing Rule 2 (treat none) to other rules that required most or all patients to be treated 
(Appendix E Supplemental Figure 2); these included Rule 3 (treat all), Rule 4-1 (treat only if 
CHA2DS2-VASc ≥2), Rule 4-2 (treat only if CHA2DS2-VASc ≥1 [unless female is the only factor]), 
and Rule 1-1 (treat only if stroke risk without OAC >1%).  For example, treating all patients 
resulted in a mean reduction of approximately 350 strokes (approximately 50%) compared to 
treating none. 
Outcomes Avoided by Treatment Selection Rule 
Compared to the current treatment patterns, there were fewer overall competing events, 
fewer total deaths, and more QALMs for most of the treatment selection rules (Table 5.3).  
When more patients were selected to receive OAC than under the current treatment patterns, 
the result was a net increase in the average number of bleeding complications (ICH and ECH) 
and a net decrease in the average number of strokes and total deaths.  Relative to the mean for 
the current treatment patterns, Rules 1-1, 3, 4-1, and 4-2 resulted in a decreased population 
burden of expected competing events (11%), strokes (34-36%), and total deaths (18%).  These 
treatment selection strategies also resulted in net increases of ECH (10-12%).  The 95% 
confidence intervals about the events avoided all included zero, but there is at least 70% 
probability that the treatment selection Rules 1-1, 3, 4-1, and 4-2 are associated with fewer 
overall competing events, strokes, and total deaths than the current treatment patterns 
(Appendix E Supplemental Figures 7-9).  These strategies were also associated with more ECH 
than the current treatment patterns 40% of the time. (Appendix E Supplemental Figure 10) 
QALMs Gained by Treatment Selection Rule 
The treatment selection rules with the most favorable effects on reducing overall 
competing events, strokes, and total deaths translated to more QALMs. Compared to the 
current treatment patterns, treatment selection according to Rules 1-1 (treat only if stroke risk 
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without OAC >1%), 3 (treat all), 4-1 (treat only if CHA2DS2-VASc ≥2), and 4-2 (treat only if 
CHA2DS2-VASc ≥1 [unless female is the only factor]) resulted in average gains of 808-835 total 
QALMs (1.6 days per patient) over the year (Table 5.3).  For these rules, the 95% confidence 
intervals for QALMs gained included zero, but the complement cumulative distribution functions 
show that these treatment selection strategies are probably superior to the current treatment 
patterns.  Over the 10,000 simulations, the estimated probability that QALMs gained>0 is ≥0.72 
for these selection rules (Figures 5.2A, 5.2B, 5.2C) which have nearly identical distributions of 
QALMs gained (Figure 5.2D). 
Discussion 
Principal Findings 
Our primary result is that treatment selection strategies that lead to most or all patients 
being prescribed OACs are superior both to the current treatment patterns and to strategies 
intended to balance the benefits (stroke reduction) and risks (increased bleeding) of OAC.  We 
found that using our novel prediction models as a clinical decision tool, initiating OAC only in 
patients with a 1-year stroke risk of >1% (Rule 1-1) was more likely than the others to improve 
clinical outcomes and QALMs over one year when compared to current treatment patterns.  
Specifically, applying Rule 1-1 resulted in ~70% probability of observing fewer overall competing 
events (stroke, bleeding complications, and death), strokes, and total deaths than the current 
treatment patterns.  These effects translate to >70% probability of increasing QALMs.  Notably, 
nearly identical favorable effects were observed for the other treatment selection rules: treat all 
patients with OAC (Rule 3), treat only patients with CHA2DS2-VASc≥2 (Rule 4-1), and treat only 
male patients with CHA2DS2-VASc≥1 and female patients CHA2DS2-VASc>1 (Rule 4-2).  All of 
these strategies were superior to the others including treatment selection Rules 1-3 and 4-3 that 
were intended to mitigate excess bleeding events. 
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Strengths and Limitations 
A number of factors strengthen our findings.  The findings represent real world practice 
because we studied various clinically-sensible treatment selection rules and clinically 
meaningful outcomes upon which physicians and patients make treatment decisions.  Moreover, 
we used data from a real (not synthetic) cohort of patients who represent four full years of 
incident AF cases in the UK.  Also we examined the sensitivity of results to various assumptions 
about treatment choice.  Our simulated health outcomes included not only the competing events 
that were the focus of our previous risk models, but their sequelae including case fatality and 
diminished health-related quality of life.   
This study has several limitations.  We assumed that our individual-based simulation 
represents the correct model of outcomes.  This limitation may not preclude our ability to rank 
the optimal strategies because the simulation is used to contrast outcomes under various 
treatment selection rules compared to the current treatment patterns.  As with our previous 
study, we assume that our statistical models are correct and accurately reflect true treatment 
differences rather than unmeasured confounding.  Another limitation is that the simulation does 
not explicitly account for a number of real-life considerations: our model reflects only one year of 
experience and it does not incorporate the clinical realities of discontinuing OAC, dynamic 
changes in health, and the effects of patient non-adherence.  Because our simulation imposes 
perfect physician and patient adherence to treatment recommendations, any apparent benefits 
of the new risk models in this study may over-estimate the benefits that may be seen in real 
practice.  Finally, our study results may not extend to populations beyond our own cohort 
(especially those with greater utilization of the newer OACs) or to time periods later than 3 
months post-AF diagnosis.   
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Conclusions and Implications 
Current recommend that over 90% of patients in our cohort should use OAC for stroke 
prevention; however, fewer than half were prescribed OAC within 3 months of their AF 
diagnosis.    Increasing OAC utilization in eligible patients would have a substantial impact on 
the population burden of strokes, overall competing events (including bleeding), and total 
mortality.  In terms of population health, three treatment decision-making strategies had nearly 
identical impact: treating all patients with OAC, treating patients with a CHA2DS2-VASc score ≥ 
2, and treating patients with a 1-year stroke risk of at least 1% by our new risk model.   
This study has implications for policy, practice, and research.  As we have shown, 
reducing the population burden of stroke and mortality is attainable with greater utilization of 
OAC. Therefore, physicians should continue to recommend OAC for their eligible patients who 
stand to benefit by reducing their risks of stroke and death.  Our findings reinforce the approach 
of current clinical guidelines (3, 4) which recommend that treatment decisions be made primarily 
on the basis of stroke risk, rather than explicit simultaneous considerations of both stroke and 
bleeding risk.  Identifying appropriate patients for OACs may not be sufficient to close the 
treatment gap in practice; doing so may require research to address persistent physician and 
patient barriers to using OACs.   Future studies might include qualitative research on how 
physicians make decisions about prescribing OACs, identifying information gaps, and evaluating 
whether our new risk models provide physicians with greater assurance in prescribing OACs.  
Until the information needs of AF patients and their physicians are better understood, the most 
urgent need is to reduce the burden of AF-related strokes.  This can be accomplished through 
greater utilization of OACs in eligible patients who are identified using the CHA2DS2-VASc score 
alone.    
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Figures 
Figure 5.1 Framework for Individual-Based Simulation 
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Figure 5.2 Complement Cumulative Distribution Function of QALMs Gained vs. Current Treatment Patterns 
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Tables 
Table 5.1 Treatment Selection Rules 
Approach Rule Treatment Selection 
Current 
treatment 
patterns 
0 Select treatment as observed in the cohort 
New risk 
prediction 
models  
1-1 Select OAC only if stroke risk (no OAC) >1% 
1-2 Select OAC only if stroke risk (no OAC) >2% 
1-3 Select OAC only if the stroke risk (no OAC) > bleeding (ICH+ECH) risk (OAC)     
1-4 Select OAC only if OAC is associated with a reduction of at least 1% absolute 
risk of any untoward event (stroke, ICH, ECH, or death)  
1-5 Select OAC only if OAC is associated with a reduction of at least 15% relative 
risk of any untoward event (stroke, ICH, ECH, or death) 
Treat 
none or all 
2 Select no OAC for all patients 
3 Select OAC for all patients 
Existing 
risk 
schemes 
4-1 Select OAC only if CHA2DS2-VASc ≥2 
4-2 Select OAC only if CHA2DS2-VASc ≥1 (unless female is the only factor) 
4-3 Select OAC only if CHA2DS2-VASc ≥2 (unless HAS-BLED>3) 
Event risks are obtained by applying the coefficients of the new risk models to the selected treatment and individual patient 
characteristics; ICH = intracranial hemorrhage; ECH = extracranial hemorrhage 
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Table 5.2 Characteristics at Time Zero of Patients Newly Diagnosed with NVAF between 
2010-2013 
  Observed Treatment  
 
Characteristic 
All 
(N=15,483) 
No OAC 
(N=8,379) 
OAC 
(N=7,104) p-value* 
Demographics 
Female 7,354 (47.5%) 4,145 (49.5%) 3,209 (45.2%) <0.001 
Age, mean (SD), years 74.5 (11.2) 74.6 (12.2) 74.4 (9.9) 0.210 
Age category       <0.001 
   <65 2,736 (17.7%) 1,650 (19.7%) 1,086 (15.3%)  
   65-74 4,204 (27.2%) 2,129 (25.4%) 2,075 (29.2%)  
   75-84 5,661 (36.6%) 2,697 (32.2%) 2,964 (41.7%)  
   ≥85 2,882 (18.6%) 1,903 (22.7%) 979 (13.8%)  
        
Comorbidities / medical history 
Hypertension 14,107 (91.1%) 7,384 (88.1%) 6,723 (94.6%) <0.001 
Vascular disease 5,249 (33.9%) 2,738 (32.7%) 2,511 (35.3%) <0.001 
Heart failure  2,587 (16.7%) 1,260 (15.0%) 1,327 (18.7%) <0.001 
Diabetes mellitus 2,501 (16.2%) 1,262 (15.1%) 1,239 (17.4%) <0.001 
Prior major bleed 2,387 (15.4%) 1,317 (15.7%) 1,070 (15.1%) 0.260 
Prior stroke or TIA 2,289 (14.8%) 1,000 (11.9%) 1,289 (18.1%) <0.001 
Anemia 2,191 (14.2%) 1,285 (15.3%) 906 (12.8%) <0.001 
Current smoker 1,204 (7.8%) 709 (8.5%) 495 (7.0%) 0.001 
At high risk of falls 1,050 (6.8%) 622 (7.4%) 428 (6.0%) 0.001 
Hyperthyroidism 380 (2.5%) 217 (2.6%) 163 (2.3%) 0.236 
Rheumatoid arthritis 328 (2.1%) 189 (2.3%) 139 (2.0%) 0.197 
Proteinuria 313 (2.0%) 154 (1.8%) 159 (2.2%) 0.078 
Heavy alcohol use 144 (0.9%) 83 (1.0%) 61 (0.9%) 0.393 
Thrombocytopenia 81 (0.5%) 55 (0.7%) 26 (0.4%) 0.011 
Estimated GFR          0.005 
   <30 mL/min 366 (2.4%) 222 (2.6%) 144 (2.0%)  
   30-60 mL/min 4,158 (26.9%) 2,188 (26.1%) 1,970 (27.7%)  
   >60 mL/min 10,959 (70.8%) 5,969 (71.2%) 4,990 (70.2%)  
CHA2DS2-VASc score       <0.001 
   0 209 (1.4%) 175 (2.1%) 34 (0.5%)  
   1 1,201 (7.8%) 810 (9.7%) 391 (5.5%)  
   ≥2 14,073 (90.9%) 7,394 (88.2%) 6,679 (94.0%)  
HAS-BLED score       <0.001 
   0 237 (1.5%) 206 (2.5%) 31 (0.4%)  
   1 1,365 (8.8%) 692 (8.3%) 673 (9.5%)  
   ≥2 13,881 (89.7%) 7,481 (89.3%) 6,400 (90.1%)  
* P-values for each independent variable were obtained from binomial logistic regression models. 
OAC = oral anticoagulant; NVAF = nonvalvular atrial fibrillation; SD = standard deviation; TIA = transient ischemic 
attack; GFR = glomerular filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug. 
CHA2DS2-VASc score was calculated by summing the points associated with each characteristic: heart failure / 
LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 pts); vascular disease (1 pt); 
age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: 
hypertension; abnormal kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or 
antiplatelet drug use; heavy alcohol use.     
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  Observed Treatment  
 
Characteristic 
All 
(N=15,483) 
No OAC 
(N=8,379) 
OAC 
(N=7,104) p-value* 
Concurrent medications      
Antiplatelet use 8,912 (57.6%) 6,073 (72.5%) 2,839 (40.0%) <0.001 
Psychotropics 2,017 (13.0%) 1,179 (14.1%) 838 (11.8%) <0.001 
Antidepressants 1,380 (8.9%) 816 (9.7%) 564 (7.9%) <0.001 
Corticosteroids 981 (6.3%) 545 (6.5%) 436 (6.1%) 0.350 
NSAIDs 639 (4.1%) 402 (4.8%) 237 (3.3%) <0.001 
* P-values for each independent variable were obtained from binomial logistic regression models. 
OAC = oral anticoagulant; NVAF = nonvalvular atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR 
= glomerular filtration rate; min = minutes; NSAID = nonsteroidal anti-inflammatory drug. 
CHA2DS2-VASc score was calculated by summing the points associated with each characteristic: heart failure / LVEF≤35% (1 
pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 pts); vascular disease (1 pt); age 65-74 (1 pt); 
female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: hypertension; abnormal kidney 
function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or antiplatelet drug use; heavy alcohol 
use.     
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Table 5.3 Effect (vs. Current Treatment Patterns) of Treatment Selection Rule on Simulated Outcomes (10,000 runs) 
  Treatment Selection Rule 
  1-1 1-2 1-3 1-4 1-5 2 3 4-1 4-2 4-3 
No OAC N   1,687   6,225 13,114   5,376 6,596 15,483          0   1,410      329   4,002 
OAC N 13,796   9,258   2,369 10,107 8,887          0 15,483 14,073 15,154 11,481 
Additional OAC*  N   6,692   2,154  -4,735   3,003 1,783  -7,104   8,379   6,969   8,050   4,377 
            
Overall 
competing 
events avoided     
Mean 177.7 144.7 -25.5 161.9 138.0 -176.8 176.7 180.5 170.6 50.2 
95% LL -713.0 -746.5 -1020.0 -735.5 -769.0 -1244.0 -714.0 -721.0 -720.0 -891.0 
95% UL 1096.0 1065.5 943.5 1073.0 1067.0 842.0 1101.0 1111.0 1089.5 974.0 
            
Strokes avoided 
     
Mean 166.0 120.8 -31.8 128.5 97.6 -179.7 174.3 169.2 172.2 37.2 
95% LL -356.0 -432.0 -733.0 -433.5 -482.0 -1041.5 -340.0 -357.5 -349.5 -613.5 
95% UL 792.0 750.5 662.5 752.0 728.0 549.5 779.5 786.5 783.0 683.0 
            
ICHs avoided 
     
Mean -30.9 -17.8 16.2 -20.5 -11.7 26.2 -33.9 -30.2 -34.1 -15.4 
95% LL -170.0 -139.0 -54.0 -144.0 -121.5 -36.0 -172.0 -162.0 -177.0 -129.5 
95% UL 72.0 83.0 102.0 79.0 83.0 107.5 72.0 74.0 73.0 80.0 
            
ECHs avoided 
     
Mean -58.3 -29.8 34.7 -33.7 -12.4 52.6 -69.1 -58.6 -69.6 -30.2 
95% LL -622.0 -558.0 -430.0 -575.0 -516.5 -408.0 -631.5 -614.5 -637.0 -552.0 
95% UL 452.0 476.0 532.0 478.0 475.0 530.5 452.0 454.5 454.5 473.0 
            
Deaths as 
competing 
events avoided     
Mean 100.9 71.6 -44.5 87.5 64.5 -75.9 105.4 100.2 102.1 58.7 
95% LL -344.0 -390.0 -566.5 -364.5 -406.5 -613.5 -341.5 -347.0 -344.0 -395.0 
95% UL 571.5 546.0 452.0 559.5 550.0 440.0 577.5 568.0 577.0 531.0 
* Additional OAC = net increase vs, current treatment patterns in the number of patients prescribed OAC. 
OAC = oral anticoagulant; SD = standard deviation; LL = lower limit; UL = upper limit; ICH = intracranial hemorrhage; ECH = extracranial hemorrhage 
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 Treatment Selection Rule 
  1-1 1-2 1-3 1-4 1-5 2 3 4-1 4-2 4-3 
Deaths after non-
fatal competing 
event avoided 
Mean 22.0 21.3 5.6 21.5 19.7 -23.1 21.8 23.2 21.0 0.5 
95% LL -118.0 -124.0 -163.0 -119.0 -126.0 -222.0 -123.0 -117.0 -120.0 -160.0 
95% UL 180.0 176.5 172.0 180.0 179.0 156.0 182.0 181.0 180.0 162.0 
            
Total deaths 
avoided 
     
Mean 122.9 92.8 -39.0 109.0 84.2 -98.9 127.1 123.4 123.1 59.2 
95% LL -342.0 -387.5 -592.0 -367.0 -405.0 -667.0 -335.5 -343.5 -340.0 -425.0 
95% UL 610.0 588.5 482.5 607.5 592.0 445.0 620.0 617.0 619.0 555.0 
            
QALMs gained Mean 807.7 611.5 -230.4 705.6 549.4 -689.2 834.8 813.7 810.4 347.4 
 
95% LL -1920.4 -2277.1 -3547.2 -2075.7 -2386.0 -4164.5 -1889.8 -1943.7 -1917.9 -2542.9 
 
95% UL 3689.2 3569.7 2878.3 3700.7 3569.2 2567.8 3766.4 3713.6 3781.7 3329.1 
* Additional OAC = net increase vs, current treatment patterns in the number of patients prescribed OAC. 
OAC = oral anticoagulant; SD = standard deviation; LL = lower limit; UL = upper limit; ICH = intracranial hemorrhage; ECH = extracranial hemorrhage 
 
 101 
REFERENCES 
1. Rahman F, Kwan GF, Benjamin EJ. Global epidemiology of atrial fibrillation. Nat Rev 
Cardiol. 2014;11(11):639-54. 
2. Stewart S, Hart CL, Hole DJ, McMurray JJ. A population-based study of the long-term 
risks associated with atrial fibrillation: 20-year follow-up of the Renfrew/Paisley study. 
Am J Med.  2002;113(5):359-64. 
3. Camm AJ, Lip GY, De Caterina R, Savelieva I, Atar D, Hohnloser SH, Hindricks G, 
Kirchhof P. 2012 focused update of the ESC Guidelines for the management of atrial 
fibrillation: an update of the 2010 ESC Guidelines for the management of atrial 
fibrillation--developed with the special contribution of the European Heart Rhythm 
Association. Europace. 2012;14:1385-413. 
4. January CT, Wann LS, Alpert JS, Calkins H, Cleveland JC Jr, Cigarroa JE, Conti JB, 
Ellinor PT, Ezekowitz MD, Field ME, Murray KT, Sacco RL, Stevenson WG, Tchou PJ, 
Tracy CM, Yancy CW. 2014 AHA/ACC/HRS Guideline for the Management of Patients 
With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart 
Association Task Force on Practice Guidelines and the Heart Rhythm Society. J Am Coll 
Cardiol. 2014;64:e1-76. 
5. Lip GY, Nieuwlaat R, Pisters R, Lane DA, Crijns HJ. Refining clinical risk stratification for 
predicting stroke and thromboembolism in atrial fibrillation using a novel risk factor-
based approach: the euro heart survey on atrial fibrillation. Chest 2010;137(2):263-72. 
6. Pisters R, Lane DA, Nieuwlaat R, de Vos CB, Crijns HJGM, Lip GYH. A novel user-
friendly score (has-bled) to assess 1-year risk of major bleeding in patients with atrial 
fibrillation: The euro heart survey. Chest 2010;138(5):1093-1100. 
7. Herrett E, Gallagher AM, Bhaskaran K, Forbes H, Mathur R, van Staa T, Smeeth L. Data 
Resource Profile: Clinical Practice Research Datalink (CPRD). Int J Epidemiol. 
2015;44(3):827-36. 
8. Luengo-Fernandez R, Gray AM, Bull L, Welch S, Cuthbertson F, Rothwell PM. Quality of 
life after TIA and stroke: ten-year results of the oxford vascular study.  Neurology 
2013;81(1):588-595.  
9. Meckley LM, Gudgeon JM, Anderson JL, Williams MS, Veenstra DL. A policy model to 
evaluate the benefits, risks and costs of warfarin pharmacogenomic testing. 
Pharmacoeconomics 2010;28(1):61-74. 
10. StataCorp. Stata Statistical Software: Release 13. College Station, TX: StataCorp LP; 
2013. 
    
  
 102 
CHAPTER 6 : CONCLUSIONS 
In this final chapter I highlight the main findings and limitations of this work, offer my own 
insights, and highlight the implications of this research. 
Across the three aims of this dissertation I focused on two themes: the quality of stroke 
prevention care for patients with AF; and the use of prognostic information to improve treatment 
decisions and impact population health.  As I discussed in the introductory Chapter 1, neither of 
these issues is new to AF.  The under-utilization of OACs has been well-documented for many 
years and numerous risk models for stroke and bleeding had already been developed (Chapter 
2).  Considering all of this previous work, the introduction of the TSOACs as alternatives to 
warfarin, and desiring to cover new ground, a number of questions motivated my research:   
1. Do physicians follow clinical guidelines and prescribe OACs only to individuals whose 
stroke risk exceeds a minimum threshold?    
2. If, as qualitative research suggests, physicians struggle to weigh the risks and benefits 
of OACs, how can you develop prediction models to clarify the alternatives? 
3. If the new prediction models were used to guide treatment decisions, would they offer an 
advantage over the existing risk schemes in terms of population health?    
I provide high-level answers to these questions in the following section.  
Main Findings 
In Chapter 3, we examined the prescribing patterns of OACs in the UK between 2010 
and 2014.  We showed that prescribing to guideline-appropriate patients (those with at least 
moderate stroke risk) improved annually over the study period reaching 70% of patients in 2014.  
However, OACs were prescribed to one-third of patients at the lowest stroke risk.  Generally, 
prescribing of OACs was consistent with individual indications for treatment: compared to 
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patients not prescribed OAC, patients prescribed OACs were significantly more likely to have 
risk factors for stroke (prior stroke or TIA, heart failure, hypertension, and diabetes) and less 
likely to have contraindications.   
In Chapter 4, we used competing risks regression models to develop prediction 
equations for the 1-year risks of four clinical events of interest: stroke, intracranial hemorrhage, 
extracranial hemorrhage, and death.  We developed the models using a cohort of 15,483 
patients who were free of contraindications for OACs.  The prediction models confirmed the 
prognostic importance of several factors that comprise the currently-advocated CHA2DS2-VASc 
and HAS-BLED risk schemes, including advanced age, female sex, hypertension, prior stroke, 
prior major bleeding, anemia, and kidney dysfunction.  We confirmed the expected associations 
between OAC (mostly warfarin) and clinical outcomes:  OAC was negatively associated with 
stroke and death and positively associated with extracranial and intracranial bleeding. The 
models performed well in terms of discrimination (c-statistics ranging from 55 to 74) and 
calibration.  The average 1-year predicted risks for the lowest and highest risk deciles ranged 
from 0.5% to 10% for stroke and 2% to 10% for extracranial hemorrhage.  The average 
predicted risks within risk quantiles agreed closely with estimated cumulative incidence.  We 
illustrated the potential clinical use of the prediction models by comparing the four event risks for 
treated vs. untreated conditions.   
In Chapter 5, we used individual-based simulation to demonstrate that our new 
prediction models could positively impact population health compared to current treatment 
patterns in the UK, but this strategy yielded similar outcomes to using the existing risk scheme 
for stroke.  According to the simulation results, three treatment selection strategies — treat if 
stroke risk>1%, treat all, and treat if CHA2DS2-VASc ≥2 — resulted in more extracranial bleeds 
but fewer competing events, strokes, and all-cause deaths.  When OAC was prescribed 
according to these rules, the average impact compared to the current treatment patterns was a 
reduction of 11% in competing events, 34-36% in strokes, and 18% in total deaths. These 
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effects on clinical outcomes translated to an average gain of 1.6 quality-adjusted life days per 
patient over the year.  Considering mean quality-adjusted life months as the primary outcome of 
interest, strategies that were intended to mitigate bleeding risk were inferior to the treatment 
selection strategies that resulted in most or all patients being treated.   
Insights 
The knowledge I gained through this research extends beyond the substantive research 
questions.  The first major insight is the difficulty physicians face with a limited number of 
informational tools to recommend OACs: they can be life-saving, but they can also cause life-
threatening bleeding.  Because the consequences of both courses of action were so significant, 
I concluded that the decision to prescribe OACs would benefit greatly from the transparency of a 
decision-analytic perspective using real-world patients, clinically-sensible treatment selection 
rules, and outcomes that matter to both patients and physicians.  A well-constructed analysis 
could incorporate most of the health consequences (stroke, bleeding, and death) into the 
decision.  The analytic method we used for this analysis was competing events regression.  By 
applying this methodology I learned that the competing risks regression models are 
straightforward to implement and therefore could be considered for applications in other areas 
of health services research (e.g., 30-day risk of hospital readmission by cause of readmission).  
A final insight is an appreciation for how valuable observational data sources can be.  I was able 
to leverage data from the CPRD which meant I had access to data from primary care, 
secondary care, and mortality statistics.  If it were not for my affiliation with Bristol Myers Squibb 
this research would not have been possible.        
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Implications 
Considering all three studies together, these are the implications for practice, policy, and 
research:  
 Physicians should focus on reducing stroke risk by prescribing OACs for their 
eligible patients;  
 Physicians should not use bleeding risk as a reason to avoid prescribing OACs; 
 To minimize the population health burden of atrial fibrillation, quality improvement 
efforts in the UK should focus both on increasing utilization of OACs in patients with 
at least moderate stroke risk and minimizing utilization of OACs in patients at very 
low stroke risk;  
 Future research should focus on the following questions: 
o Do our new prediction models with integrated risks of stroke, bleeding 
complications, and death provide physicians with greater confidence to 
prescribe OACs than the CHA2DS2-VASc score alone? 
o How is risk information best used in shared decision making about the use of 
OACs? 
o Would OAC-specific (TSOACs vs. warfarin) prediction models be more 
useful in terms of improving population health? 
o Is information the most important remaining barrier to underutilization? 
o How does fear of bleeding affect a physician’s recommendation to prescribe 
OACs?  For example, does the fear of anticoagulant-associated bleeding 
over-ride the fear of untreated stroke?  If so, how can we make untreated 
strokes as salient as anticoagulant-associated bleeding? 
o What other information do prescribers and their patients need to make 
informed decisions? 
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Conclusion 
Predictions about an AF patient’s prognosis can change the course of treatment and, as 
a result, improve patient outcomes on a population level. The predictive information that can be 
obtained from our new risk models is a tool just like OACs themselves.  If these tools are to 
have their greatest impact on population health, future research and quality improvement efforts 
will need to focus on how to use them appropriately.  For this, it is reasonable to expect that 
technology and patient involvement will play a central role.   
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APPENDIX A: SUPPLEMENTAL MATERIAL FOR CHAPTER 2 
See Chapter 2 for full citations. 
Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
AFI, 1994 Design: 
Individual patient data meta-analysis 
 
Sample: 
1,238 AF patients participating in one 
of 5 clinical trials of warfarin  
 
Setting: 
US (3 studies); Denmark; Canada 
 
Method: 
Multivariate Cox models with effects 
for treatment (control vs. warfarin) 
and study 
Dependent variable: 
Time to first stroke  
 
Independent variables: 
Age; 
Previous stroke/TIA; 
History of hypertension; 
Diabetes mellitus; 
 
c-statistics:  
not reported 
 
Number of events = 81 
 
 
(a) Predictive accuracy was 
not reported; 
(b) Limited external validity 
(well controlled studies and 
adherent patients) 
SPAF, 1995  Design: 
Post hoc analysis of data from two 
randomized trials 
 
Sample: 
854 patients randomly assigned to 
receive aspirin followed for mean 2 
years 
 
Setting: 
18 clinical centers between 1987-
1992 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to stroke or systemic 
embolism 
 
Independent variables: 
Sex; 
Age >75 years; 
Systolic blood pressure <160 
mmHg; 
Impaired LV function (recent 
CHF or fractional 
shortening<25%) 
c-statistics: 
not reported 
 
Number of events = 73 
 
(a) Predictive accuracy was 
not reported 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
EAFT, 1995 
 
Design: 
Randomized clinical trial (European 
Atrial Fibrillation Trial) 
 
Sample: 
375 patients with non-rheumatic AF 
who had experience a prior stroke or 
TIA and were randomly assigned to 
placebo; followed for mean of 1.6 
years 
 
Setting: 
Multicenter clinical trial  
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to stroke 
 
Independent variables: 
Sex; 
Age<60 (ref); 
Age 60-69; 
Age 70-79; 
Age ≥80; 
Prior thromboembolism; 
Systolic blood pressure >160 
mmHg; 
Duration of AF >1 year 
c-statistic: 
not reported 
 
Number of events = 78 
(a) Investigators also 
examined a composite 
outcome; 
(b) Predictive accuracy was 
not reported 
 
AFI, 1998 Design: 
Randomized clinical trials (SPAF, 
SPINAF, BAATAF) 
 
Sample: 
1,066 patients with AF who were 
enrolled in one of three clinical trials 
and followed for an average of 1.6 
years 
 
Setting: 
Not reported 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to stroke 
 
Independent variables: 
Age; 
Prior stroke or TIA; 
Diabetes; 
Hypertension; 
Heart failure 
 
c-statistic: 
not reported 
 
Number of events = 78 
(a) Predictive accuracy was 
not reported 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
OBRI, 1998 Design: 
Cohort study of outpatients 
 
Sample: 
556 AF patients who started warfarin 
after hospital discharge and were 
followed for 2 years 
 
Setting: 
Brigham and Women’s Hospital in 
Boston, MA, US between 1977 and 
1983 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to first major bleed , 
defined as a loss of ≥2 units in 
≤7 days or otherwise life-
threatening 
 
Independent variables: 
Age; 
Prior stroke/TIA; 
Prior GI bleed; 
Recent MI; 
Hematocrit<30%; 
Creatinine clearance >1.5 
mg/dL; 
Diabetes 
 
c-statistic: 
0.72 
 
Number of events = 65 
(a) Data are also presented 
for the validation cohort 
(N=264); 
(b) Complete outcome 
ascertainment for all 
patients 
 
SPAF I-III, 
1999 
Design: 
Randomized clinical trial (SPAF I-III) 
 
Sample: 
2,012 adults with NVAF in one of 
three clinical trials who were randomly 
assigned to aspirin or fixed, low-dose 
warfarin and followed for mean of 2 
years 
 
Setting: 
Multiple centers in the US 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to ischemic stroke 
 
Independent variables: 
Age; 
Sex; 
History of hypertension; 
Systolic blood pressure >160 
mmHg; 
Alcohol use (≥14 drinks/week); 
Prior stroke or TIA 
c-statistic: 
Not reported 
 
Number of events = 
130  
(a) Sex was only important 
in subjects >75 years of 
age (suggests age x sex 
interaction) 
(b) Predictive accuracy was 
not reported 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
CHADS2, 
2001 
 
 
 
 
Design: 
Retrospective analysis of data from 
National Registry of AF 
 
Sample: 
1,733 Medicare beneficiaries with 
nonrheumatic AF ages 65-95 not 
prescribed warfarin at hospital 
discharge; 
 
Setting: 
5 quality improvement organizations 
serving 7 US states 
 
Method:  
Exponential survival model  
Dependent variable: 
Time to hospitalization for 
stroke 
 
Independent variables: 
Prior stroke/TIA; 
History of hypertension; 
Diabetes mellitus; 
Recent CHF exacerbation; 
Age≥75 
c-statistics (95% CI): 
CHADS2 = 0.82 (0.80-
0.84) 
 
AFI = 0.68 (0.65-0.71) 
 
SPAF = 0.74 (0.71-
0.76) 
 
Number of events = 94 
 
 
(a) Study excluded 1,269 
otherwise eligible patients 
who were discharged with a 
prescription for warfarin 
(b) Used ICD-9 codes for 
outcome assessment 
 
Framingham
, 2003 
Design: 
Prospective, community, cohort study 
 
Sample: 
868 adults with new onset AF  
 
Setting: 
Framingham, MA, USA 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to first stroke 
 
Independent variables: 
Age; 
Female; 
Hypertension; 
Diabetes mellitus; 
Prior stroke or TIA 
c-statistic (SE): 
Framingham = 0.66 
(0.03) 
 
CHADS2 = 0.62 
 
AFI = 0.61 
 
Number of events = 
111  
(a) Analyzed all patients, 
whether on warfarin or not ; 
(b) Authors assigned 
scores for each factor in 
steps to calculate an overall 
score, which is then used in 
a lookup table for absolute 
risk; 
(c) Highlighted need to 
identify patients who are at 
low risk of stroke (which 
includes some older) 
(d) Some were receiving 
ASA; 
(e) Cohort is majority white 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
Birmingham, 
2006 
Design: 
N/A 
 
Sample: 
N/A 
 
Setting: 
N/A 
 
Method: 
Qualitative synthesis of existing risk 
schemes into practical guidelines 
 
Dependent variable: 
Ischemic stroke 
 
Independent variables: 
Prior stroke or TIA; 
Age; 
Diabetes; 
Vascular disease; 
Hypertension; 
Heart failure 
c-statistic: 
Not reported 
 
Number of events = 
N/A 
(a) This scheme was not 
derived from a statistical 
model, but rather more like 
a decision algorithm based 
on the presence of high, 
moderate or low risk 
characteristics. 
Gage, 2006 Design:  
Analysis of data from National 
Registry of AF 
 
Sample: 
3,791 Medicare beneficiaries with 
atrial fibrillation - 1,604 discharged on 
warfarin, 660 on aspirin, and 1,527 on 
neither 
 
Setting:  
5 quality improvement organizations 
serving 7 US states 
 
Method: 
Cox survival model 
Dependent variable: 
Time to hospitalization for 
hemorrhage 
 
Independent variables: 
Prior bleed;  
Hepatic or renal disease;  
Ethanol abuse;  
Malignancy;  
Age>75;  
Reduced platelet count or 
function; Uncontrolled 
hypertension;  
Anemia;  
Genetic factors;  
Excessive fall risk; and  
Prior stroke 
c-statistics (SD) 
warfarin: 
HEMORRHAGES = 
0.67 (0.04) 
 
Landefeld and 
Goldman and Beyth et 
al. = 
0.65 (0.03) 
 
Kuijer et al. = 
0.58 (0.03) 
 
Kearon et al. = 
0.66 (0.03) 
 
Number of events 
(warfarin) = 67 
(a) Note a potentially useful 
search strategy for bleeding 
risk schemes in the method 
section. 
(b) Could not identify 
changes in treatment after 
discharge 
(c) The Medicare data were 
not used to re-estimate 
coefficients (which are the 
basis of points for each 
factor). 
 
 
  
 
1
1
2
 
Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
Shireman, 
2006 
 
Design: 
Retrospective cohort analysis using 
data from the National Registry of 
Atrial Fibrillation 
 
Sample: 
Patients 65 years and older who were 
discharged from hospital while on 
warfarin  
 
Setting: 
United States 
 
Method: 
Cox proportional hazards 
Dependent variable: 
Time to major bleeding event 
requiring hospitalization within 
90 days; major bleeding was 
defined as gastrointestinal or 
intracranial hemorrhage 
  
Independent variables: 
Age; 
Sex; 
Remote (in time) prior bleed; 
Recent prior bleed; 
Alcohol or drug abuse; 
Diabetes; 
Anemia; 
Antiplatelet drug 
c-statistic: 
0.632  
 
Number of events = 
Not reported 
(a) Note the follow-up 
period was only 90 days 
 
Modified 
CHADS2, 
2008 
Design: 
Observational study of incident AF 
 
Sample: 
51,087 adults 40 and older with a 
diagnosis of chronic AF; 253,759 
matched controls 
 
Setting: 
General practitioners in the UK with 
new AF patients from 1987 onward 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to stroke 
 
Independent variables: 
Age; 
Diabetes; 
Prior stroke/TIA; 
Heart failure; 
Hypertension 
c-statistic (95% CI): 
0.72 (0.72-0.73) 
 
Number of events = 
Not reported 
(a) There are useful details 
about case definition in the 
methods section; 
(b) Time to stroke was 
censored at time of death; 
(c) Primary outcome was 
all-cause stroke;  
(d) CHADS2 was modified 
by changing the scoring 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
CHA2DS2-
VASc, 2010 
 
 
 
 
Design:  
Retrospective analysis of the Euro 
Heart Survey of AF  
 
Sample:  
1,577 atrial fibrillation patients without 
mitral stenosis or previous mitral 
valve surgery not using either warfarin 
or heparin at discharge 
 
Setting:  
Cardiology practices of 182 hospitals 
among 35 countries in 2003-2004 
 
Method:  
Multivariable logistic regression 
Dependent variable: 
Thromboembolism (stroke) 
within one year  
 
Independent variables: 
Congestive heart failure (LV 
dysfunction); 
Hypertension; 
Age ≥75 years; 
Diabetes mellitus; 
Stroke/TIA/TE; 
Vascular disease (MI, PAD, 
aortic plaque); 
Age 65-74 years; 
Female gender 
c-statistics (95% CI): 
 
CHA2DS2-VASc 
(“Birmingham 2009”) = 
0.606 (0.513-0.699) 
 
Framingham (comp.) = 
0.638 (0.532-0.744) 
 
Number of events = 25 
 
(a) Significant missing data: 
missing TE status at one 
year of 493/1,577 (31%) 
patients; 
 
HAS-BLED, 
2010 
 
 
 
 
Design: 
Retrospective analysis of the Euro 
Heart Survey of AF 
 
Sample: 
3,456 atrial fibrillation patients without 
mitral stenosis or previous mitral 
valve surgery 
 
Setting: 
Cardiology practices of 182 hospitals 
among 35 countries in 2003-2004 
 
Method: 
Multivariable logistic regression  
Dependent variable: 
Major bleeding within one year 
 
Independent variables: 
Hypertension (SBP>160); 
Abnormal kidney function; 
Abnormal liver function; 
Prior stroke; 
Prior bleeding; 
Labile INR<60%; 
Age>65; 
NSAID use or antiplatelet drug 
use; 
Heavy alcohol use 
 
 
c-statistics (95% CI) at 
1 year: 
HAS-BLED =  
0.72 (0.65-0.79) 
 
HEMOR2RHAGES =  
0.66 (0.57-0.74) 
 
Number of events = 48 
(a) Missing data from 25% 
of patients in one year; 
(b) Also reported c-statistics 
for cohorts of patients on 
various treatments. 
(c) Include a useful 
discussion of benefit-risk 
tradeoffs using CHADS2 
and HAS-BLED. 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
ACC/AHA/ 
ESC, 2011 
Design: 
N/A 
 
Sample: 
N/A 
 
Setting: 
N/A 
 
Method: 
Qualitative synthesis of all existing 
evidence 
 
Dependent variable: 
Thromboembolism (stroke) 
 
Independent variables: 
Sex; 
Age; 
Coronary artery disease; 
Thyrotoxicosis; 
Hypertension; 
Heart failure; 
LV ejection fraction 35% or 
less; 
Diabetes; 
Prior stroke/TIA; 
Mitral stenosis (N/A for NVAF); 
Prosthetic heart valve (N/A for 
NVAF) 
c-statistics: 
N/A 
 
Number of events =  
N/A 
(a) Table 13 in the 2011 
reference lists risk factors 
that correspond to 
recommended therapy 
ATRIA 
Bleed, 2011 
Design: 
Prospective cohort study of adults 
with nonvalvular AF 
 
Sample: 
9,186 atrial fibrillation patients using 
warfarin 
 
Setting:  
Enrollees in Kaiser Permanente, 
Northern California 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to major hemorrhage 
(fatal, requiring transfusion ≥ 2 
U packed RBCs, or 
intracranial/retroperitoneal) 
 
Independent variables:  
Anemia (HGB <13 g/dL in men 
and <12 g/dL in women) ; 
Severe renal disease (GFR<30 
mL/min or dialysis); 
Age≥75; 
Any prior bleeding; 
Hypertension 
c-statistics (95% CI): 
ATRIA =  
0.74 (0.72-0.76) 
 
HEMORR2HAGES = 
0.71 (0.69-0.73) 
 
Number of events = 
461 
(a) No assessment of 
NSAID and ASA exposure 
since available without 
prescription (Note: likely the 
case with most other 
studies) 
(b) C-statistics for other 
schemes were also 
reported. 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
AMADEUS 
Composite, 
2013 
Design: 
Post hoc analysis of multicenter 
randomized clinical trials of fixed-dose 
idraparinux with conventional 
anticoagulation vs. dose-adjusted 
warfarin 
 
Sample: 
2,293 NVAF patients randomized to 
warfarin 
 
Setting: 
Multiple centers between 2003-2006 
 
Method: 
Logistic regression 
Dependent variables: 
(1) Stroke or thromboembolism 
or major bleeding; 
(2) Stroke or thromboembolism 
or VTE or MI or cardiovascular 
death or major bleeding 
 
Independent variables: 
Outcome (1) –  
Age; 
Previous stroke or TIA; 
Concomitant aspirin; 
Time in therapeutic range 
 
Outcome (2) –  
Age; 
Left ventricular dysfunction; 
Previous stroke or TIA; 
Concomitant aspirin; 
Time in therapeutic range 
c-statistics (95% CI) 
Outcome (1): 
0.728 (0.659-0.798) 
 
Outcome (2): 
0.707 (0.655-0.758) 
 
Number of events  
Outcome (1): 50 
 
Outcome (2): 94 
(a) Only risks associated 
with warfarin were 
estimated; 
(b) Authors claim study 
population was at low risk 
of stroke and bleeding 
events; 
(c) Study did not include AF 
patients with high risk of 
bleeding, liver 
abnormalities, and kidney 
dysfunction 
(d) Geographic location of 
centers was not reported. 
ATRIA 
Stroke, 2013 
Design: 
Retrospective cohort  
  
Sample: 
13,559 adults (≥18) with an outpatient 
diagnosis of AF who were not using 
warfarin 
 
Setting: 
Enrollees in Kaiser Permanente of 
Northern California between 1996-
1997 
 
Method: 
Cox proportional hazards model 
Dependent variable: 
Time to stroke (sudden onset of 
neurological deficit >24 hours of 
duration not attributable to other 
causes) 
 
Independent variables: 
Age 65-74; 
Age 75-84; 
Age ≥85; 
Prior stroke; 
Sex; 
Diabetes; 
Chronic heart failure; 
Hypertension; 
Proteinuria; 
eGFR<45 or ESRD 
Age category x prior stroke 
c-statistic (95% CI): 
0.73 (0.71-0.75) 
 
Number of events =  
685 
 
 
(a) Time to stroke censored 
at death 
(b) Include comparison of 
event rates for ATRIA vs. 
CHADS2 vs. CHA2DS2-
VASc 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
QStroke, 
2013 
Design: 
Prospective open cohort study 
 
Sample: 
3,549,478 adult patients aged 25-84 
who were not using anticoagulants 
  
Setting: 
676 primary care practices that use 
the EMIS computer system in 
England and Wales between 1998 
and 2012 
 
Method: 
Cox proportional hazards model 
 
Dependent variable: 
Time to ischemic stroke or TIA 
 
Independent variables: 
Sex; 
Systolic blood pressure; 
Total cholesterol:HDL 
cholesterol; 
Townsend deprivation score; 
Smoking status; 
Ethnicity; 
Family history of CHD; 
AF; 
CHD; 
Heart failure; 
Diabetes (Type 1 and 2); 
Treated hypertension; 
Rheumatoid arthritis; 
Chronic kidney disease; 
Valvular heart disease 
c-statistic (95% CI): 
0.65 (0.62-0.67) for 
women patients with 
AF 
 
0.71 (0.69-0.73) for 
men patients with AF 
 
Number of events 
=1,892 (among AF 
patients) 
 
 
 
(a) Separate models were 
fitted for men and women; 
(b) AF was treated as a risk 
factor for stroke 
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Model, Year  
 
Design and Methods 
 
Major Variables 
C-statistic / 
Number of events 
Limitations/ 
Comments 
QBleed, 
2014 
Design: 
Cohort study 
 
Sample: 
over 4 million patients in the 
development sample, with 
approximately 24,000 initiating oral 
anticoagulants 
 
Setting:  
565 general practices in England 
 
Method: 
Four separate Cox proportional 
hazards models; 2 outcomes (ICH 
and GI bleed) x 2 sex-specific 
models. 
 
Dependent variables: 
Time to intracranial 
hemorrhage; 
Time to gastrointestinal bleed 
 
Independent variables: 
Townsend score;  
Smoking status;  
Ethnicity; 
Alcohol intake; 
Previous bleed;  
Oesophageal varices; 
Chronic liver 
disease/pancreatitis; 
Atrial fibrillation; 
Venous thromboembolism; 
Congestive cardiac failure; 
Treated hypertension; 
Cancer; 
Platelet count; 
Anticoagulants; 
Antiplatelet drug; 
NSAID; 
Corticosteroids; 
Antidepressants; 
Phenytoin or carbamazepine 
c-statistics:  
 
0.766 (0.785-0.775) 
women, GI; 
0.747 (0.738-0.756) 
men, GI; 
0.847 (0.838-0.856) 
women, ICH; 
0.812 (0.80-0.824) 
men, ICH  
 
Number of events = 
498 (GI bleeds over 5 
years); 
370 (ICH over 5 years) 
(a) Separate Cox models 
estimated;  
(b) Limited data on new oral 
anticoagulants; 
(c) Note the ICD-10 codes 
to identify bleeding events 
are provided in an 
appendix.  
 
  
  
 
1
1
8
 
APPENDIX B: CODE LISTS FOR DIAGNOSES (READ AND ICD-10) AND PRESCRIPTION DRUGS 
 
Condition / Diagnosis Coding System Code Description 
Accidental fall Read TC...00 Accidental falls 
Accidental fall Read TC...11 Fall - accidental 
Accidental fall Read TC0..00 Fall on or from stairs or steps 
Accidental fall Read TC00.00 Fall on or from escalator 
Accidental fall Read TC00000 Fall on escalator 
Accidental fall Read TC01.00 Fall on or from stairs 
Accidental fall Read TC01000 Fall on stairs 
Accidental fall Read TC01100 Fall from stairs 
Accidental fall Read TC01z00 Fall on or from stairs NOS 
Accidental fall Read TC02.00 Fall on or from steps 
Accidental fall Read TC02000 Fall on steps 
Accidental fall Read TC02100 Fall from steps 
Accidental fall Read TC02z00 Fall on or from steps NOS 
Accidental fall Read TC0z.00 Fall on or from stairs or steps NOS 
Accidental fall Read TC1..00 Fall on or from ladders or scaffolding 
Accidental fall Read TC10.00 Fall from ladder 
Accidental fall Read TC11.00 Fall from scaffolding 
Accidental fall Read TC1z.00 Fall from ladder or scaffolding NOS 
Accidental fall Read TC2..00 Fall from or out of building or other structure 
Accidental fall Read TC20.00 Fall from balcony 
Accidental fall Read TC21.00 Fall from bridge 
Accidental fall Read TC22.00 Fall from building 
Accidental fall Read TC23.00 Fall from flagpole 
Accidental fall Read TC25.00 Fall from turret 
Accidental fall Read TC26.00 Fall from viaduct 
Accidental fall Read TC27.00 Fall from wall 
Accidental fall Read TC28.00 Fall from window 
Accidental fall Read TC29.00 Fall through roof 
Accidental fall Read TC2z.00 Fall from or out of building or other structure NOS 
Accidental fall Read TC3..00 Fall into hole or other opening in surface 
Accidental fall Read TC30.00 Accident caused by diving or jumping into water 
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Condition / Diagnosis Coding System Code Description 
Accidental fall Read TC30000 Hit against bottom when diving into shallow water 
Accidental fall Read TC30300 Hit board of swimming pool 
Accidental fall Read TC30400 Accident caused by hitting water surface 
Accidental fall Read TC30500 Accident caused by fall into swimming pool 
Accidental fall Read TC30z00 Accident caused by diving or jumping into water NOS 
Accidental fall Read TC31.00 Accidental fall into well 
Accidental fall Read TC32.00 Accidental fall into manhole 
Accidental fall Read TC32000 Accidental fall into manhole, unspecified 
Accidental fall Read TC32100 Accidental fall into storm drain 
Accidental fall Read TC3y.00 Fall into other hole or other opening in surface 
Accidental fall Read TC3y000 Fall into cavity, unspecified 
Accidental fall Read TC3y100 Fall into dock 
Accidental fall Read TC3y200 Fall into hole 
Accidental fall Read TC3y300 Fall into pit 
Accidental fall Read TC3y400 Fall into quarry 
Accidental fall Read TC3y600 Fall into tank 
Accidental fall Read TC3yz00 Fall into other hole, unspecified 
Accidental fall Read TC3z.00 Fall into hole NOS 
Accidental fall Read TC4..00 Other fall from one level to another 
Accidental fall Read TC40.00 Fall from playground equipment 
Accidental fall Read TC41.00 Fall from cliff 
Accidental fall Read TC42.00 Fall from chair or bed 
Accidental fall Read TC42000 Fall from chair 
Accidental fall Read TC42100 Fall from bed 
Accidental fall Read TC42z00 Fall from chair or bed NOS 
Accidental fall Read TC4y.00 Other fall from one level to another 
Accidental fall Read TC4y000 Fall from embankment 
Accidental fall Read TC4y100 Fall from haystack 
Accidental fall Read TC4y200 Fall from stationary vehicle 
Accidental fall Read TC4y300 Fall from tree 
Accidental fall Read TC4yz00 Other fall from one level to another NOS 
Accidental fall Read TC4z.00 Fall from one level to another NOS 
Accidental fall Read TC5..00 Fall on same level from slipping, tripping or stumbling 
Accidental fall Read TC50.00 Fall on same level from slipping 
Accidental fall Read TC51.00 Fall on same level from tripping 
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Condition / Diagnosis Coding System Code Description 
Accidental fall Read TC52.00 Fall on same level from stumbling 
Accidental fall Read TC5z.00 Fall on same level from slipping, tripping or stumbling NOS 
Accidental fall Read TC6..00 Fall on same level- collision/push/shove by/with oth person 
Accidental fall Read TC60.00 Fall on same level from sports contact 
Accidental fall Read TC60000 Fall on same level from tackle in sport 
Accidental fall Read TC60y00 Other fall in sport 
Accidental fall Read TC60z00 Fall on same level from sports contact NOS 
Accidental fall Read TC6y.00 Fall on same level from other push/shove/collide oth person 
Accidental fall Read TC6y000 Fall on same level from collision with other person, unspec 
Accidental fall Read TC6y100 Fall on same level from pushing by other person, unspecified 
Accidental fall Read TC6y200 Fall on same level from shoving by other person, unspecified 
Accidental fall Read TC6yz00 Other fall on same level- push/shove/collide-oth person NOS 
Accidental fall Read TC6z.00 Fall on same level- push/shove/collide - other person NOS 
Accidental fall Read TC7..00 Fracture, cause unspecified 
Accidental fall Read TCy..00 Other falls 
Accidental fall Read TCy0.00 Fall from bump against object 
Accidental fall Read TCyz.00 Other accidental fall NOS 
Accidental fall Read TCz..00 Accidental falls NOS 
Alcholism or heavy drinking ICD-10 E250.14 Intoxication - alcohol 
Alcholism or heavy drinking ICD-10 E24.4 Alcohol-induced pseudo-Cushing's syndrome 
Alcholism or heavy drinking ICD-10 F10 Mental and behavioural disorders due to use of alcohol 
Alcholism or heavy drinking ICD-10 F10.1 
Mental and behavioural disorders due to use of alcohol: harmful 
use 
Alcholism or heavy drinking ICD-10 F10.2 
Mental and behavioural disorders due to use of alcohol: 
dependence syndrome 
Alcholism or heavy drinking ICD-10 F10.3 
Mental and behavioural disorders due to use of alcohol: 
withdrawal state 
Alcholism or heavy drinking ICD-10 F10.4 
Mental and behavioural disorders due to use of alcohol: 
withdrawal state with delirium 
Alcholism or heavy drinking ICD-10 F10.5 
Mental and behavioural disorders due to use of alcohol: psychotic 
disorder 
Alcholism or heavy drinking ICD-10 F10.6 
Mental and behavioural disorders due to use of alcohol: amnesic 
syndrome 
Alcholism or heavy drinking ICD-10 F10.7 
Mental and behavioural disorders due to use of alcohol: residual 
and late-onset psychotic disorder 
Alcholism or heavy drinking ICD-10 F10.8 
Mental and behavioural disorders due to use of alcohol: other 
mental and behavioural disorders 
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Condition / Diagnosis Coding System Code Description 
Alcholism or heavy drinking ICD-10 F10.9 
Mental and behavioural disorders due to use of alcohol: 
unspecified mental and behavioural disorder 
Alcholism or heavy drinking ICD-10 G31.2 Degeneration of nervous system due to alcohol 
Alcholism or heavy drinking ICD-10 G62.1 Alcoholic polyneuropathy 
Alcholism or heavy drinking ICD-10 G72.1 Alcoholic myopathy 
Alcholism or heavy drinking ICD-10 I42.6 Alcoholic cardiomyopathy 
Alcholism or heavy drinking ICD-10 K29.2 Alcoholic gastritis 
Alcholism or heavy drinking ICD-10 K70 Alcoholic liver disease 
Alcholism or heavy drinking ICD-10 K70.0 Alcoholic fatty liver 
Alcholism or heavy drinking ICD-10 K70.1 Alcoholic fibrosis and sclerosis of liver 
Alcholism or heavy drinking ICD-10 K70.3 Alcoholic cirrhosis of liver 
Alcholism or heavy drinking ICD-10 K70.4 Alcoholic hepatic failure 
Alcholism or heavy drinking ICD-10 K70.9 Alcoholic liver disease, unspecified 
Alcholism or heavy drinking ICD-10 K85.2 Alcohol induced acute pancreatitis 
Alcholism or heavy drinking ICD-10 K86.0 Alcohol-induced chronic pancreatitis 
Alcholism or heavy drinking ICD-10 O35.4 Maternal care for (suspected) damage to fetus from alcohol 
Alcholism or heavy drinking ICD-10 P04.3 Newborn (suspected to be) affected by maternal use of alcohol 
Alcholism or heavy drinking ICD-10 Q86.0 Fetal alcohol syndrome (dysmorphic) 
Alcholism or heavy drinking ICD-10 Z71.4 Alcohol abuse counseling and surveillance of alcoholic 
Alcholism or heavy drinking Read 1365 Heavy drinker - 7-9u/day 
Alcholism or heavy drinking Read 1366 Very heavy drinker - >9u/day 
Alcholism or heavy drinking Read 1462 H/O: alcoholism 
Alcholism or heavy drinking Read 2577.11 O/E - alcoholic breath 
Alcholism or heavy drinking Read 136K.00 Alcohol intake above recommended sensible limits 
Alcholism or heavy drinking Read 136P.00 Heavy drinker 
Alcholism or heavy drinking Read 136Q.00 Very heavy drinker 
Alcholism or heavy drinking Read 136S.00 Hazardous alcohol use 
Alcholism or heavy drinking Read 136T.00 Harmful alcohol use 
Alcholism or heavy drinking Read 136W.00 Alcohol misuse 
Alcholism or heavy drinking Read 13Y8.00 Alcoholics anonymous 
Alcholism or heavy drinking Read 13ZY.00 Disqualified from driving due to excess alcohol 
Alcholism or heavy drinking Read 1B1c.00 Alcohol induced hallucinations 
Alcholism or heavy drinking Read 63C7.00 Maternal alcohol abuse 
Alcholism or heavy drinking Read 66e..00 Alcohol disorder monitoring 
Alcholism or heavy drinking Read 66e0.00 Alcohol abuse monitoring 
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Condition / Diagnosis Coding System Code Description 
Alcholism or heavy drinking Read 7P22100 Delivery of rehabilitation for alcohol addiction 
Alcholism or heavy drinking Read 8BA8.00 Alcohol detoxification 
Alcholism or heavy drinking Read 8CAv.00 Advised to contact primary care alcohol worker 
Alcholism or heavy drinking Read 8G32.00 Aversion therapy - alcoholism 
Alcholism or heavy drinking Read 8H35.00 Admitted to alcohol detoxification centre 
Alcholism or heavy drinking Read 8H7p.00 Referral to community alcohol team 
Alcholism or heavy drinking Read 8HHe.00 Referral to community drug and alcohol team 
Alcholism or heavy drinking Read 8HkG.00 Referral to specialist alcohol treatment service 
Alcholism or heavy drinking Read 8HkJ.00 Referral to alcohol brief intervention service 
Alcholism or heavy drinking Read 8IAF.00 Brief intervention for excessive alcohol consumptn declined 
Alcholism or heavy drinking Read 8IAJ.00 Declined referral to specialist alcohol treatment service 
Alcholism or heavy drinking Read 8IAt.00 Extended interven for excessive alcohol consumption declined 
Alcholism or heavy drinking Read 8IEA.00 Referral to community alcohol team declined 
Alcholism or heavy drinking Read 9k1..00 Alcohol misuse - enhanced services administration 
Alcholism or heavy drinking Read 9k12.00 Alcohol misuse - enhanced service completed 
Alcholism or heavy drinking Read 9k14.00 Alcohol counselling by other agencies 
Alcholism or heavy drinking Read 9k1A.00 Brief intervention for excessive alcohol consumptn completed 
Alcholism or heavy drinking Read 9k1B.00 Extended intervention for excessive alcohol consumptn complt 
Alcholism or heavy drinking Read 9NN2.00 Under care of community alcohol team 
Alcholism or heavy drinking Read C150500 Alcohol-induced pseudo-Cushing's syndrome 
Alcholism or heavy drinking Read E01..00 Alcoholic psychoses 
Alcholism or heavy drinking Read E010.00 Alcohol withdrawal delirium 
Alcholism or heavy drinking Read E011.00 Alcohol amnestic syndrome 
Alcholism or heavy drinking Read E011000 Korsakov's alcoholic psychosis 
Alcholism or heavy drinking Read E011100 Korsakov's alcoholic psychosis with peripheral neuritis 
Alcholism or heavy drinking Read E011z00 Alcohol amnestic syndrome NOS 
Alcholism or heavy drinking Read E012.00 Other alcoholic dementia 
Alcholism or heavy drinking Read E012.11 Alcoholic dementia NOS 
Alcholism or heavy drinking Read E012000 Chronic alcoholic brain syndrome 
Alcholism or heavy drinking Read E013.00 Alcohol withdrawal hallucinosis 
Alcholism or heavy drinking Read E014.00 Pathological alcohol intoxication 
Alcholism or heavy drinking Read E015.00 Alcoholic paranoia 
Alcholism or heavy drinking Read E01y.00 Other alcoholic psychosis 
Alcholism or heavy drinking Read E01y000 Alcohol withdrawal syndrome 
Alcholism or heavy drinking Read E01yz00 Other alcoholic psychosis NOS 
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Condition / Diagnosis Coding System Code Description 
Alcholism or heavy drinking Read E01z.00 Alcoholic psychosis NOS 
Alcholism or heavy drinking Read E23..00 Alcohol dependence syndrome 
Alcholism or heavy drinking Read E23..11 Alcoholism 
Alcholism or heavy drinking Read E23..12 Alcohol problem drinking 
Alcholism or heavy drinking Read E230.00 Acute alcoholic intoxication in alcoholism 
Alcholism or heavy drinking Read E230.11 Alcohol dependence with acute alcoholic intoxication 
Alcholism or heavy drinking Read E230000 Acute alcoholic intoxication, unspecified, in alcoholism 
Alcholism or heavy drinking Read E230100 Continuous acute alcoholic intoxication in alcoholism 
Alcholism or heavy drinking Read E230200 Episodic acute alcoholic intoxication in alcoholism 
Alcholism or heavy drinking Read E230300 Acute alcoholic intoxication in remission, in alcoholism 
Alcholism or heavy drinking Read E230z00 Acute alcoholic intoxication in alcoholism NOS 
Alcholism or heavy drinking Read E231.00 Chronic alcoholism 
Alcholism or heavy drinking Read E231000 Unspecified chronic alcoholism 
Alcholism or heavy drinking Read E231100 Continuous chronic alcoholism 
Alcholism or heavy drinking Read E231200 Episodic chronic alcoholism 
Alcholism or heavy drinking Read E231z00 Chronic alcoholism NOS 
Alcholism or heavy drinking Read E23z.00 Alcohol dependence syndrome NOS 
Alcholism or heavy drinking Read E250.00 Nondependent alcohol abuse 
Alcholism or heavy drinking Read E250000 Nondependent alcohol abuse, unspecified 
Alcholism or heavy drinking Read E250100 Nondependent alcohol abuse, continuous 
Alcholism or heavy drinking Read E250200 Nondependent alcohol abuse, episodic 
Alcholism or heavy drinking Read E250z00 Nondependent alcohol abuse NOS 
Alcholism or heavy drinking Read Eu10.00 [X]Mental and behavioural disorders due to use of alcohol 
Alcholism or heavy drinking Read Eu10000 [X]Mental & behav dis due to use alcohol: acute intoxication 
Alcholism or heavy drinking Read Eu10011 [X]Acute alcoholic drunkenness 
Alcholism or heavy drinking Read Eu10100 [X]Mental and behav dis due to use of alcohol: harmful use 
Alcholism or heavy drinking Read Eu10200 [X]Mental and behav dis due to use alcohol: dependence syndr 
Alcholism or heavy drinking Read Eu10211 [X]Alcohol addiction 
Alcholism or heavy drinking Read Eu10212 [X]Chronic alcoholism 
Alcholism or heavy drinking Read Eu10300 [X]Mental and behav dis due to use alcohol: withdrawal state 
Alcholism or heavy drinking Read Eu10411 [X]Delirium tremens, alcohol induced 
Alcholism or heavy drinking Read Eu10500 [X]Mental & behav dis due to use alcohol: psychotic disorder 
Alcholism or heavy drinking Read Eu10511 [X]Alcoholic hallucinosis 
Alcholism or heavy drinking Read Eu10512 [X]Alcoholic jealousy 
Alcholism or heavy drinking Read Eu10513 [X]Alcoholic paranoia 
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Condition / Diagnosis Coding System Code Description 
Alcholism or heavy drinking Read Eu10514 [X]Alcoholic psychosis NOS 
Alcholism or heavy drinking Read Eu10600 [X]Mental and behav dis due to use alcohol: amnesic syndrome 
Alcholism or heavy drinking Read Eu10611 [X]Korsakov's psychosis, alcohol induced 
Alcholism or heavy drinking Read Eu10711 [X]Alcoholic dementia NOS 
Alcholism or heavy drinking Read Eu10712 [X]Chronic alcoholic brain syndrome 
Alcholism or heavy drinking Read Eu10800 [X]Alcohol withdrawal-induced seizure 
Alcholism or heavy drinking Read Eu10y00 [X]Men & behav dis due to use alcohol: oth men & behav dis 
Alcholism or heavy drinking Read Eu10z00 [X]Ment & behav dis due use alcohol: unsp ment & behav dis 
Alcholism or heavy drinking Read F11x011 Alcoholic encephalopathy 
Alcholism or heavy drinking Read F25B.00 Alcohol-induced epilepsy 
Alcholism or heavy drinking Read F375.00 Alcoholic polyneuropathy 
Alcholism or heavy drinking Read F394100 Alcoholic myopathy 
Alcholism or heavy drinking Read G555.00 Alcoholic cardiomyopathy 
Alcholism or heavy drinking Read G852300 Oesophageal varices in alcoholic cirrhosis of the liver 
Alcholism or heavy drinking Read J153.00 Alcoholic gastritis 
Alcholism or heavy drinking Read J610.00 Alcoholic fatty liver 
Alcholism or heavy drinking Read J611.00 Acute alcoholic hepatitis 
Alcholism or heavy drinking Read J612.00 Alcoholic cirrhosis of liver 
Alcholism or heavy drinking Read J612000 Alcoholic fibrosis and sclerosis of liver 
Alcholism or heavy drinking Read J613.00 Alcoholic liver damage unspecified 
Alcholism or heavy drinking Read J613000 Alcoholic hepatic failure 
Alcholism or heavy drinking Read J617.00 Alcoholic hepatitis 
Alcholism or heavy drinking Read J617000 Chronic alcoholic hepatitis 
Alcholism or heavy drinking Read J670800 Alcohol-induced acute pancreatitis 
Alcholism or heavy drinking Read J671000 Alcohol-induced chronic pancreatitis 
Alcholism or heavy drinking Read L254.11 Suspect fetal damage from maternal alcohol 
Alcholism or heavy drinking Read L255300 Maternal care for (suspected) damage to fetus from alcohol 
Alcholism or heavy drinking Read PK83.00 Fetus and newborn affected by maternal use of alcohol 
Alcholism or heavy drinking Read Q007100 Fetus/neonate affected by placental/breast transfer alcohol 
Alcholism or heavy drinking Read R103.00 [D]Alcohol blood level excessive 
Alcholism or heavy drinking Read SLH3.00 Alcohol deterrent poisoning 
Alcholism or heavy drinking Read SM0..00 Alcohol causing toxic effect 
Alcholism or heavy drinking Read SM00.00 Ethyl alcohol causing toxic effect 
Alcholism or heavy drinking Read SM00100 Denatured alcohol causing toxic effect 
Alcholism or heavy drinking Read SM00z00 Ethyl alcohol causing toxic effect NOS 
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Condition / Diagnosis Coding System Code Description 
Alcholism or heavy drinking Read SM01.00 Methyl alcohol causing toxic effect 
Alcholism or heavy drinking Read SM01100 Wood alcohol causing toxic effect 
Alcholism or heavy drinking Read SM02.00 Isopropyl alcohol causing toxic effect 
Alcholism or heavy drinking Read SM02200 Rubbing alcohol causing toxic effect 
Alcholism or heavy drinking Read SM03000 Amyl alcohol causing toxic effect 
Alcholism or heavy drinking Read SM03100 Butyl alcohol causing toxic effect 
Alcholism or heavy drinking Read SM0y.00 Other alcohol causing toxic effect 
Alcholism or heavy drinking Read SM0z.00 Alcohol causing toxic effect NOS 
Alcholism or heavy drinking Read TJH3.00 Adverse reaction to alcohol deterrents 
Alcholism or heavy drinking Read U209y00 [X]Int self poison alcohol other spec place 
Alcholism or heavy drinking Read U209z00 [X]Intent self poison alcohol unspecif place 
Alcholism or heavy drinking Read U409400 [X]Pois/expos ?intent alcohol in street/highway 
Alcholism or heavy drinking Read U60H300 [X]Alcohol deterrents caus adverse effects in therapeut use 
Alcholism or heavy drinking Read U60H311 [X] Adverse reaction to alcohol deterrents 
Alcholism or heavy drinking Read U81..00 [X]Evid of alcohol involv determind by level of intoxication 
Alcholism or heavy drinking Read Z191.00 Alcohol detoxification 
Alcholism or heavy drinking Read Z191100 Alcohol withdrawal regime 
Alcholism or heavy drinking Read Z191211 Alcohol reduction programme 
Alcholism or heavy drinking Read Z4B1.00 Alcoholism counselling 
Alcholism or heavy drinking Read ZV11300 [V]Personal history of alcoholism 
Alcholism or heavy drinking Read ZV11311 [V]Problems related to lifestyle alcohol use 
Alcholism or heavy drinking Read ZV57A00 [V]Alcohol rehabilitation 
Alcholism or heavy drinking Read ZV6D600 [V]Alcohol abuse counselling and surveillance 
Anemia ICD-10 D50 Iron deficiency anaemia 
Anemia ICD-10 D50.0 Iron deficiency anaemia secondary to blood loss (chronic) 
Anemia ICD-10 D50.1 Sideropenic dysphagia 
Anemia ICD-10 D50.8 Other iron deficiency anaemias 
Anemia ICD-10 D50.9 Iron deficiency anaemia, unspecified 
Anemia ICD-10 D51 Vitamin B 12 deficiency anaemia 
Anemia ICD-10 D51.0 Vitamin B deficiency anaemia due to intrinsic factor deficiency 
Anemia ICD-10 D51.1 
Vitamin B deficiency anaemia due to selective vitamin B 
malabsorption with proteinuria 
Anemia ICD-10 D51.2 Transcobalamin II deficiency 
Anemia ICD-10 D51.3 Other dietary vitamin B deficiency anaemia 
Anemia ICD-10 D51.8 Other vitamin B deficiency anaemias 
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Condition / Diagnosis Coding System Code Description 
Anemia ICD-10 D51.9 Vitamin B deficiency anaemia, unspecified 
Anemia ICD-10 D52 Folate deficiency anaemia 
Anemia ICD-10 D52.0 Dietary folate deficiency anaemia 
Anemia ICD-10 D52.1 Drug-induced folate deficiency anaemia 
Anemia ICD-10 D52.8 Other folate deficiency anaemias 
Anemia ICD-10 D52.9 Folate deficiency anaemia, unspecified 
Anemia ICD-10 D53 Other nutritional anaemias 
Anemia ICD-10 D53.0 Protein deficiency anaemia 
Anemia ICD-10 D53.1 Other megaloblastic anaemias, not elsewhere classified 
Anemia ICD-10 D53.2 Scorbutic anaemia 
Anemia ICD-10 D53.8 Other specified nutritional anaemias 
Anemia ICD-10 D53.9 Nutritional anaemia, unspecified 
Anemia ICD-10 D55 Anaemia due to enzyme disorders 
Anemia ICD-10 D55.0 
Anaemia due to glucose-6-phosphate dehydrogenase [G6PD] 
deficiency 
Anemia ICD-10 D55.1 Anaemia due to other disorders of glutathione metabolism 
Anemia ICD-10 D55.2 Anaemia due to disorders of glycolytic enzymes 
Anemia ICD-10 D55.3 Anaemia due to disorders of nucleotide metabolism 
Anemia ICD-10 D55.8 Other anaemias due to enzyme disorders 
Anemia ICD-10 D55.9 Anaemia due to enzyme disorder, unspecified 
Anemia ICD-10 D56 Thalassaemia 
Anemia ICD-10 D56.0 Alpha thalassaemia 
Anemia ICD-10 D56.1 Beta thalassaemia 
Anemia ICD-10 D56.2 Delta-beta thalassaemia 
Anemia ICD-10 D56.3 Thalassaemia trait 
Anemia ICD-10 D56.4 Hereditary persistence of fetal haemoglobin [HPFH] 
Anemia ICD-10 D56.8 Other thalassaemias 
Anemia ICD-10 D56.9 Thalassaemia, unspecified 
Anemia ICD-10 D57 Sickle-cell disorders 
Anemia ICD-10 D57.0 Sickle-cell anaemia with crisis 
Anemia ICD-10 D57.1 Sickle-cell anaemia without crisis 
Anemia ICD-10 D57.2 Double heterozygous sickling disorders 
Anemia ICD-10 D57.3 Sickle-cell trait 
Anemia ICD-10 D57.8 Other sickle-cell disorders 
Anemia ICD-10 D58 Other hereditary haemolytic anaemias 
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Anemia ICD-10 D58.0 Hereditary spherocytosis 
Anemia ICD-10 D58.1 Hereditary elliptocytosis 
Anemia ICD-10 D58.2 Other haemoglobinopathies 
Anemia ICD-10 D58.8 Other specified hereditary haemolytic anaemias 
Anemia ICD-10 D58.9 Hereditary haemolytic anaemia, unspecified 
Anemia ICD-10 D59 Acquired haemolytic anaemia 
Anemia ICD-10 D59.0 Drug-induced autoimmune haemolytic anaemia 
Anemia ICD-10 D59.1 Other autoimmune haemolytic anaemias 
Anemia ICD-10 D59.2 Drug-induced nonautoimmune haemolytic anaemia 
Anemia ICD-10 D59.3 Haemolytic-uraemic syndrome 
Anemia ICD-10 D59.4 Other nonautoimmune haemolytic anaemias 
Anemia ICD-10 D59.5 Paroxysmal nocturnal haemoglobinuria [Marchiafava-Micheli] 
Anemia ICD-10 D59.6 Haemoglobinuria due to haemolysis from other external causes 
Anemia ICD-10 D59.8 Other acquired haemolytic anaemias 
Anemia ICD-10 D59.9 Acquired haemolytic anaemia, unspecified 
Anemia ICD-10 D60 Acquired pure red cell aplasia [erythroblastopenia] 
Anemia ICD-10 D60.0 Chronic acquired pure red cell aplasia 
Anemia ICD-10 D60.1 Transient acquired pure red cell aplasia 
Anemia ICD-10 D60.8 Other acquired pure red cell aplasias 
Anemia ICD-10 D60.9 Acquired pure red cell aplasia, unspecified 
Anemia ICD-10 D61 Other aplastic anaemias 
Anemia ICD-10 D61.0 Constitutional aplastic anaemia 
Anemia ICD-10 D61.1 Drug-induced aplastic anaemia 
Anemia ICD-10 D61.2 Aplastic anaemia due to other external agents 
Anemia ICD-10 D61.3 Idiopathic aplastic anaemia 
Anemia ICD-10 D61.8 Other specified aplastic anaemias 
Anemia ICD-10 D61.9 Aplastic anaemia, unspecified 
Anemia ICD-10 D62 Acute posthaemorrhagic anaemia 
Anemia ICD-10 D63 Anaemia in chronic diseases classified elsewhere 
Anemia ICD-10 D63.0 Anaemia in neoplastic disease 
Anemia ICD-10 D63.8 Anaemia in other chronic diseases classified elsewhere 
Anemia ICD-10 D64 Other anaemias 
Anemia ICD-10 D64.0 Hereditary sideroblastic anaemia 
Anemia ICD-10 D64.1 Secondary sideroblastic anaemia due to disease 
Anemia ICD-10 D64.2 Secondary sideroblastic anaemia due to drugs and toxins 
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Anemia ICD-10 D64.3 Other sideroblastic anaemias 
Anemia ICD-10 D64.4 Congenital dyserythropoietic anaemia 
Anemia ICD-10 D64.8 Other specified anaemias 
Anemia ICD-10 D64.9 Anaemia, unspecified 
Anemia Read 2C2..00 O/E - anaemia 
Anemia Read 2C2Z.00 O/E - anaemia NOS 
Anemia Read B937000 Refractory anaemia without sideroblasts, so stated 
Anemia Read B937100 Refractory anaemia with sideroblasts 
Anemia Read B937200 Refractory anaemia with excess of blasts 
Anemia Read B937300 Refractory anaemia with excess of blasts with transformation 
Anemia Read B937600 Refractory anaemia without ring sideroblasts 
Anemia Read B937700 Refractory anaemia with ring sideroblasts 
Anemia Read B937800 Refractory anaemia with multilineage dysplasia 
Anemia Read B937X00 Refractory anaemia, unspecified 
Anemia Read BBmA.00 [M] Refractory anaemia with sideroblasts 
Anemia Read BBmB.00 [M]Refractory anaemia+excess of blasts with transformation 
Anemia Read BBmL.00 [M] Refractory anaemia with excess of blasts 
Anemia Read D0...00 Deficiency anaemias 
Anemia Read D0...11 Asiderotic anaemia 
Anemia Read D0...12 Sideropenic anaemia 
Anemia Read D00..00 Iron deficiency anaemias 
Anemia Read D00..11 Hypochromic - microcytic anaemia 
Anemia Read D00..12 Microcytic - hypochromic anaemia 
Anemia Read D000.00 Iron deficiency anaemia due to chronic blood loss 
Anemia Read D000.11 Normocytic anaemia due to chronic blood loss 
Anemia Read D000.12 Iron deficiency anaemia due to blood loss 
Anemia Read D001.00 Iron deficiency anaemia due to dietary causes 
Anemia Read D00y.00 Other specified iron deficiency anaemia 
Anemia Read D00y100 Microcytic hypochromic anaemia 
Anemia Read D00yz00 Other specified iron deficiency anaemia NOS 
Anemia Read D00z.00 Unspecified iron deficiency anaemia 
Anemia Read D00z000 Achlorhydric anaemia 
Anemia Read D00z100 Chlorotic anaemia 
Anemia Read D00z200 Idiopathic hypochromic anaemia 
Anemia Read D00zz00 Iron deficiency anaemia NOS 
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Anemia Read D01..00 Other deficiency anaemias 
Anemia Read D01..11 Megaloblastic anaemia 
Anemia Read D010.00 Pernicious anaemia 
Anemia Read D010.11 Addison's anaemia 
Anemia Read D010.12 Biermer's congenital pernicious anaemia 
Anemia Read D011.00 Other vitamin B12 deficiency anaemias 
Anemia Read D011.11 Vitamin B12 deficiency anaemia 
Anemia Read D011000 Vitamin B12 deficiency anaemia due to dietary causes 
Anemia Read D011013 Vegan's anaemia 
Anemia Read D011100 Vit B12 defic anaemia due to malabsorption with proteinuria 
Anemia Read D011X00 Vitamin B12 deficiency anaemia, unspecified 
Anemia Read D011z00 Other vitamin B12 deficiency anaemia NOS 
Anemia Read D012.00 Folate-deficiency anaemia 
Anemia Read D012.11 Folic acid deficiency anaemia 
Anemia Read D012100 Folate-deficiency anaemia due to dietary causes 
Anemia Read D012111 Goat's milk anaemia 
Anemia Read D012112 Megaloblastic anaemia due to dietary causes 
Anemia Read D012200 Folate-deficiency anaemia, drug induced 
Anemia Read D012300 Folate-deficiency anaemia due to malabsorption 
Anemia Read D012400 Folate-deficiency anaemia due to liver disorders 
Anemia Read D012500 Macrocytic anaemia unspecified cause 
Anemia Read D012z00 Folate-deficiency anaemia NOS 
Anemia Read D013.00 Other specified megaloblastic anaemia NEC 
Anemia Read D013000 Combined B12 and folate deficiency anaemia 
Anemia Read D013z00 Other specified megaloblastic anaemia NEC NOS 
Anemia Read D014.00 Protein-deficiency anaemia 
Anemia Read D014000 Amino-acid deficiency anaemia 
Anemia Read D014z00 Protein-deficiency anaemia NOS 
Anemia Read D01y.00 Other specified nutritional deficiency anaemia 
Anemia Read D01y000 Vitamin C deficiency anaemia 
Anemia Read D01y100 Vitamin E deficiency anaemia 
Anemia Read D01yy00 Other specified other nutritional deficiency anaemia 
Anemia Read D01yz00 Other specified nutritional deficiency anaemia NOS 
Anemia Read D01z.00 Other deficiency anaemias NOS 
Anemia Read D01z.11 Megaloblastic anaemia NOS 
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Anemia Read D01z000 [X]Megaloblastic anaemia NOS 
Anemia Read D0y..00 Other specified deficiency anaemias 
Anemia Read D0z..00 Deficiency anaemias NOS 
Anemia Read D1...00 Haemolytic anaemias 
Anemia Read D10..00 Hereditary haemolytic anaemias 
Anemia Read D102.00 Haemolytic anaemia due to glutathione metabolism disorder 
Anemia Read D102000 Glucose-6-phosphate dehydrogenase deficiency anaemia 
Anemia Read D102200 Drug-induced enzyme deficiency anaemia 
Anemia Read D103100 Haemolytic anaemia due to pyruvate kinase deficiency 
Anemia Read D103300 Anaemia due to disorders of nucleotide metabolism 
Anemia Read D104.12 Mediterranean anaemia 
Anemia Read D104011 Thalassaemia major - Cooley's anaemia 
Anemia Read D104z11 Mediterranean anaemia 
Anemia Read D106.00 Sickle-cell anaemia 
Anemia Read D106000 Sickle-cell anaemia of unspecified type 
Anemia Read D106100 Sickle-cell anaemia with no crisis 
Anemia Read D106200 Sickle-cell anaemia with crisis 
Anemia Read D106300 Sickle-cell anaemia with haemoglobin C disease 
Anemia Read D106400 Sickle-cell anaemia with haemoglobin D disease 
Anemia Read D106500 Sickle-cell anaemia with haemoglobin E disease 
Anemia Read D106z00 Sickle-cell anaemia NOS 
Anemia Read D107000 Congenital Heinz-body anaemia 
Anemia Read D10y.00 Other specified hereditary haemolytic anaemias 
Anemia Read D10yz00 Other specified hereditary haemolytic anaemia NOS 
Anemia Read D10z.00 Hereditary haemolytic anaemia NOS 
Anemia Read D11..00 Acquired haemolytic anaemias 
Anemia Read D110.00 Autoimmune haemolytic anaemias 
Anemia Read D110000 Primary cold-type haemolytic anaemia 
Anemia Read D110100 Primary warm-type haemolytic anaemia 
Anemia Read D110200 Secondary cold-type haemolytic anaemia 
Anemia Read D110400 Drug-induced autoimmune haemolytic anaemia 
Anemia Read D110z00 Autoimmune haemolytic anaemia NOS 
Anemia Read D111.00 Non-autoimmune haemolytic anaemia 
Anemia Read D111000 Mechanical haemolytic anaemia 
Anemia Read D111100 Microangiopathic haemolytic anaemia 
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Anemia Read D111400 Drug-induced haemolytic anaemia 
Anemia Read D111500 Infective haemolytic anaemia 
Anemia Read D111y00 Other specified non-autoimmune haemolytic anaemia 
Anemia Read D111z00 Non-autoimmune haemolytic anaemia NOS 
Anemia Read D112z12 Acquired haemolytic anaemia with haemoglobinuria NEC 
Anemia Read D11z.00 Acquired haemolytic anaemia NOS 
Anemia Read D1y..00 Other specified haemolytic anaemias 
Anemia Read D1z..00 Haemolytic anaemias NOS 
Anemia Read D2...00 Aplastic and other anaemias 
Anemia Read D20..00 Aplastic anaemia 
Anemia Read D200.00 Constitutional aplastic anaemia 
Anemia Read D200.15 Hypoplastic anaemia - familial 
Anemia Read D200000 Congenital hypoplastic anaemia 
Anemia Read D200011 Constitutional aplastic anaemia without malformation 
Anemia Read D200100 Fanconi's familial refractory anaemia 
Anemia Read D200111 Fanconi's hypoplastic anaemia 
Anemia Read D200200 Constitutional aplastic anaemia with malformation 
Anemia Read D200y00 Other specified constitutional aplastic anaemia 
Anemia Read D201.00 Acquired aplastic anaemia 
Anemia Read D201.11 Normocytic anaemia due to aplasia 
Anemia Read D201000 Aplastic anaemia due to chronic disease 
Anemia Read D201100 Aplastic anaemia due to drugs 
Anemia Read D201111 Hypoplastic anaemia due to drug or chemical substance 
Anemia Read D201200 Aplastic anaemia due to infection 
Anemia Read D201211 Hypoplastic anaemia due to infection 
Anemia Read D201311 Radiation aplastic anaemia 
Anemia Read D201400 Aplastic anaemia due to toxic cause 
Anemia Read D201412 Hypoplastic anaemia due to toxic cause 
Anemia Read D201700 Transient hypoplastic anaemia 
Anemia Read D201z00 Acquired aplastic anaemia NOS 
Anemia Read D204.00 Idiopathic aplastic anaemia 
Anemia Read D20z.00 Aplastic anaemia NOS 
Anemia Read D21..00 Other and unspecified anaemias 
Anemia Read D210.00 Sideroblastic anaemia 
Anemia Read D210000 Congenital sideroblastic anaemia 
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Anemia Read D210100 Acquired sideroblastic anaemia 
Anemia Read D210200 Pyridoxine-responsive sideroblastic anaemia 
Anemia Read D210300 Secondary sideroblastic anaemia due to disease 
Anemia Read D210400 Secondary sideroblastic anaemia due to drugs and toxins 
Anemia Read D210z00 Sideroblastic anaemia NOS 
Anemia Read D211.00 Acute posthaemorrhagic anaemia 
Anemia Read D211.11 Normocytic anaemia following acute bleed 
Anemia Read D212.00 Anaemia in neoplastic disease 
Anemia Read D212000 Anaemia in ovarian carcinoma 
Anemia Read D213.00 Refractory Anaemia 
Anemia Read D214.00 Chronic anaemia 
Anemia Read D215.00 Anaemia secondary to renal failure 
Anemia Read D215000 Anaemia secondary to chronic renal failure 
Anemia Read D21y.00 Other specified anaemias 
Anemia Read D21y000 Congenital dyshaematopoietic anaemia 
Anemia Read D21y011 Congenital dyserythropoietic anaemia 
Anemia Read D21y200 Leukoerythroblastic anaemia 
Anemia Read D21yy00 Other specified other anaemia 
Anemia Read D21yz00 Other specified anaemia NOS 
Anemia Read D21z.00 Anaemia unspecified 
Anemia Read D21z.11 Secondary anaemia NOS 
Anemia Read D21z.12 Normocytic anaemia due to unspecified cause 
Anemia Read D21z.13 Macrocytic anaemia of unspecified cause 
Anemia Read D2y..00 Other specified anaemias 
Anemia Read D2z..00 Other anaemias NOS 
Anemia Read D41yz11 Macrocytosis - no anaemia 
Anemia Read Dyu0.00 [X]Nutritional anaemias 
Anemia Read Dyu0000 [X]Other iron deficiency anaemias 
Anemia Read Dyu0100 [X]Other dietary vitamin B12 deficiency anaemia 
Anemia Read Dyu0200 [X]Other vitamin B12 deficiency anaemias 
Anemia Read Dyu0300 [X]Other folate deficiency anaemias 
Anemia Read Dyu0600 [X]Vitamin B12 deficiency anaemia, unspecified 
Anemia Read Dyu1.00 [X]Haemolytic anaemias 
Anemia Read Dyu1500 [X]Other autoimmune haemolytic anaemias 
Anemia Read Dyu2200 [X]Anaemia in other chronic diseases classified elsewhere 
  
 
1
3
3
 
Condition / Diagnosis Coding System Code Description 
Anemia Read Dyu2400 [X]Other specified anaemias 
Anemia Read F381500 Myasthenic syndrome due to pernicious anaemia 
Anemia Read L182.00 Anaemia during pregnancy, childbirth and the puerperium 
Anemia Read L182000 Anaemia - unspecified whether in pregnancy or the puerperium 
Anemia Read L182100 Anaemia during pregnancy - baby delivered 
Anemia Read L182200 Anaemia in the puerperium - baby delivered 
Anemia Read L182300 Anaemia during pregnancy - baby not yet delivered 
Anemia Read L182400 Anaemia in the puerperium - baby previously delivered 
Anemia Read L182500 Iron deficiency anaemia of pregnancy 
Anemia Read L182z00 Anaemia during pregnancy/childbirth/puerperium NOS 
Anemia Read Q430.00 Perinatal jaundice from hereditary haemolytic anaemias 
Anemia Read Q430z00 Perinatal jaundice from hereditary haemolytic anaemia NOS 
Anemia Read Q455.00 Congenital anaemia 
Anemia Read Qyu5C00 [X]Other congenital anaemias, not elsewhere classified 
Atrial fibrillation Read 3272.00 ECG: atrial fibrillation  
Atrial fibrillation Read 662S.00  Atrial fibrillation monitoring  
Atrial fibrillation Read 6A9..00  Atrial fibrillation annual review  
Atrial fibrillation Read 7936A00  Implant intravenous pacemaker for atrial fibrillation  
Atrial fibrillation Read 9Os..00  Atrial fibrillation monitoring administration  
Atrial fibrillation Read 9Os0.00  Atrial fibrillation monitoring first letter  
Atrial fibrillation Read 9Os1.00  Atrial fibrillation monitoring second letter  
Atrial fibrillation Read 9Os2.00  Atrial fibrillation monitoring third letter  
Atrial fibrillation Read 9Os3.00  Atrial fibrillation monitoring verbal invite  
Atrial fibrillation Read 9Os4.00  Atrial fibrillation monitoring telephone invite  
Atrial fibrillation Read G573.00  Atrial fibrillation and flutter  
Atrial fibrillation Read G573000  Atrial fibrillation  
Atrial fibrillation Read G573200 Paroxysmal atrial fibrillation 
Atrial fibrillation Read G573300  Non-rheumatic atrial fibrillation  
Atrial fibrillation Read G573400  Permanent atrial fibrillation  
Atrial fibrillation Read G573500 Persistent atrial fibrillation 
Atrial fibrillation Read G573z00 Atrial fibrillation and flutter NOS 
Dementia ICD-10 F00 Dementia in Alzheimer disease 
Dementia ICD-10 F00.0 Dementia in Alzheimer disease with early onset 
Dementia ICD-10 F00.1 Dementia in Alzheimer disease with late onset 
Dementia ICD-10 F00.2 Dementia in Alzheimer disease, atypical or mixed type 
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Dementia ICD-10 F00.9 Dementia in Alzheimer disease, unspecified 
Dementia ICD-10 F01 Vascular dementia 
Dementia ICD-10 F01.0 Vascular dementia of acute onset   
Dementia ICD-10 F01.1 Multi-infarct dementia   
Dementia ICD-10 F01.2 Subcortical vascular dementia   
Dementia ICD-10 F01.3 Mixed cortical and subcortical vascular dementia   
Dementia ICD-10 F01.8 Other vascular dementia   
Dementia ICD-10 F01.9 Vascular dementia, unspecified 
Dementia ICD-10 F02 Dementia in other diseases classified elsewhere 
Dementia ICD-10 F02.0 Dementia in Pick disease  
Dementia ICD-10 F02.1 Dementia in Creutzfeldt-Jakob disease  
Dementia ICD-10 F02.2 Dementia in Huntington diseas 
Dementia ICD-10 F02.3 Dementia in Parkinson disease  
Dementia ICD-10 F02.4 Dementia in human immunodeficiency virus [HIV] disease 
Dementia ICD-10 F02.8 Dementia in other specified diseases classified elsewhere 
Dementia ICD-10 F03 Unspecified dementia 
Dementia ICD-10 G30 Alzheimer disease 
Dementia ICD-10 G30.0 Alzheimer disease with early onset 
Dementia ICD-10 G30.1 Alzheimer disease with late onset 
Dementia ICD-10 G30.8 Other Alzheimer disease 
Dementia ICD-10 G30.9 Alzheimer disease, unspecified 
Dementia Read 1461 H/O: dementia 
Dementia Read 3AE3.00 GDS level 4 - moderate cognitive decline 
Dementia Read 3AE4.00 GDS level 5 - moderately severe cognitive decline 
Dementia Read 3AE5.00 GDS level 6 - severe cognitive decline 
Dementia Read 3AE6.00 GDS level 7 - very severe cognitive decline 
Dementia Read 66h..00 Dementia monitoring 
Dementia Read 6AB..00 Dementia annual review 
Dementia Read 8Hla.00 Referral to dementia care advisor 
Dementia Read 9Ou..00 Dementia monitoring administration 
Dementia Read 9Ou1.00 Dementia monitoring first letter 
Dementia Read 9Ou2.00 Dementia monitoring second letter 
Dementia Read 9Ou3.00 Dementia monitoring third letter 
Dementia Read 9Ou4.00 Dementia monitoring verbal invite 
Dementia Read 9Ou5.00 Dementia monitoring telephone invite 
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Dementia Read E00..00 Senile and presenile organic psychotic conditions 
Dementia Read E00..11 Senile dementia 
Dementia Read E00..12 Senile/presenile dementia 
Dementia Read E000.00 Uncomplicated senile dementia 
Dementia Read E001.00 Presenile dementia 
Dementia Read E001000 Uncomplicated presenile dementia 
Dementia Read E001100 Presenile dementia with delirium 
Dementia Read E001200 Presenile dementia with paranoia 
Dementia Read E001300 Presenile dementia with depression 
Dementia Read E001z00 Presenile dementia NOS 
Dementia Read E002.00 Senile dementia with depressive or paranoid features 
Dementia Read E002000 Senile dementia with paranoia 
Dementia Read E002100 Senile dementia with depression 
Dementia Read E002z00 Senile dementia with depressive or paranoid features NOS 
Dementia Read E003.00 Senile dementia with delirium 
Dementia Read E004.00 Arteriosclerotic dementia 
Dementia Read E004.11 Multi infarct dementia 
Dementia Read E004000 Uncomplicated arteriosclerotic dementia 
Dementia Read E004100 Arteriosclerotic dementia with delirium 
Dementia Read E004200 Arteriosclerotic dementia with paranoia 
Dementia Read E004300 Arteriosclerotic dementia with depression 
Dementia Read E004z00 Arteriosclerotic dementia NOS 
Dementia Read E00z.00 Senile or presenile psychoses NOS 
Dementia Read E011000 Korsakov's alcoholic psychosis 
Dementia Read E011100 Korsakov's alcoholic psychosis with peripheral neuritis 
Dementia Read E011200 Wernicke-Korsakov syndrome 
Dementia Read E012.00 Other alcoholic dementia 
Dementia Read E012.11 Alcoholic dementia NOS 
Dementia Read E02y100 Drug-induced dementia 
Dementia Read E03..00 Transient organic psychoses 
Dementia Read E030.00 Acute confusional state 
Dementia Read E030.12 Toxic confusional state 
Dementia Read E030000 Acute confusional state, post traumatic 
Dementia Read E030100 Acute confusional state, of infective origin 
Dementia Read E030200 Acute confusional state, of endocrine origin 
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Dementia Read E030300 Acute confusional state, of metabolic origin 
Dementia Read E030400 Acute confusional state, of cerebrovascular origin 
Dementia Read E030z00 Acute confusional state NOS 
Dementia Read E031.00 Subacute confusional state 
Dementia Read E031100 Subacute confusional state, of infective origin 
Dementia Read E031300 Subacute confusional state, of metabolic origin 
Dementia Read E031400 Subacute confusional state, of cerebrovascular origin 
Dementia Read E031z00 Subacute confusional state NOS 
Dementia Read E03y000 Organic delusional syndrome 
Dementia Read E040.00 Non-alcoholic amnestic syndrome 
Dementia Read E040.11 Korsakoff's non-alcoholic psychosis 
Dementia Read E041.00 Dementia in conditions EC 
Dementia Read E042.00 Chronic confusional state 
Dementia Read Eu00.00 [X]Dementia in Alzheimer's disease 
Dementia Read Eu00000 [X]Dementia in Alzheimer's disease with early onset 
Dementia Read Eu00011 [X]Presenile dementia,Alzheimer's type 
Dementia Read Eu00012 [X]Primary degen dementia, Alzheimer's type, presenile onset 
Dementia Read Eu00013 [X]Alzheimer's disease type 2 
Dementia Read Eu00100 [X]Dementia in Alzheimer's disease with late onset 
Dementia Read Eu00111 [X]Alzheimer's disease type 1 
Dementia Read Eu00112 [X]Senile dementia,Alzheimer's type 
Dementia Read Eu00113 [X]Primary degen dementia of Alzheimer's type, senile onset 
Dementia Read Eu00200 [X]Dementia in Alzheimer's dis, atypical or mixed type 
Dementia Read Eu00z00 [X]Dementia in Alzheimer's disease, unspecified 
Dementia Read Eu00z11 [X]Alzheimer's dementia unspec 
Dementia Read Eu01.00 [X]Vascular dementia 
Dementia Read Eu01.11 [X]Arteriosclerotic dementia 
Dementia Read Eu01000 [X]Vascular dementia of acute onset 
Dementia Read Eu01100 [X]Multi-infarct dementia 
Dementia Read Eu01111 [X]Predominantly cortical dementia 
Dementia Read Eu01200 [X]Subcortical vascular dementia 
Dementia Read Eu01300 [X]Mixed cortical and subcortical vascular dementia 
Dementia Read Eu01y00 [X]Other vascular dementia 
Dementia Read Eu01z00 [X]Vascular dementia, unspecified 
Dementia Read Eu02.00 [X]Dementia in other diseases classified elsewhere 
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Dementia Read Eu02000 [X]Dementia in Pick's disease 
Dementia Read Eu02100 [X]Dementia in Creutzfeldt-Jakob disease 
Dementia Read Eu02200 [X]Dementia in Huntington's disease 
Dementia Read Eu02300 [X]Dementia in Parkinson's disease 
Dementia Read Eu02400 [X]Dementia in human immunodef virus [HIV] disease 
Dementia Read Eu02500 [X]Lewy body dementia 
Dementia Read Eu02y00 [X]Dementia in other specified diseases classif elsewhere 
Dementia Read Eu02z00 [X] Unspecified dementia 
Dementia Read Eu02z11 [X] Presenile dementia NOS 
Dementia Read Eu02z13 [X] Primary degenerative dementia NOS 
Dementia Read Eu02z14 [X] Senile dementia NOS 
Dementia Read Eu02z16 [X] Senile dementia, depressed or paranoid type 
Dementia Read Eu04000 [X]Delirium not superimposed on dementia, so described 
Dementia Read Eu04100 [X]Delirium superimposed on dementia 
Dementia Read Eu10711 [X]Alcoholic dementia NOS 
Dementia Read Eu84311 [X]Dementia infantalis 
Dementia Read F110.00 Alzheimer's disease 
Dementia Read F110000 Alzheimer's disease with early onset 
Dementia Read F110100 Alzheimer's disease with late onset 
Dementia Read Fyu3000 [X]Other Alzheimer's disease 
Dementia Read ZR1K.00 Alzheimer's disease assessment scale 
Dementia Read ZS7C500 Language disorder of dementia 
Diabetes Read C10..00 Diabetes mellitus 
Diabetes Read C100.00 Diabetes mellitus with no mention of complication 
Diabetes Read C100000 Diabetes mellitus, juvenile type, no mention of complication 
Diabetes Read C100011 Insulin dependent diabetes mellitus 
Diabetes Read C100100 Diabetes mellitus, adult onset, no mention of complication 
Diabetes Read C100112 Non-insulin dependent diabetes mellitus 
Diabetes Read C100z00 Diabetes mellitus NOS with no mention of complication 
Diabetes Read C101.00 Diabetes mellitus with ketoacidosis 
Diabetes Read C101000 Diabetes mellitus, juvenile type, with ketoacidosis 
Diabetes Read C101100 Diabetes mellitus, adult onset, with ketoacidosis 
Diabetes Read C101y00 Other specified diabetes mellitus with ketoacidosis 
Diabetes Read C101z00 Diabetes mellitus NOS with ketoacidosis 
Diabetes Read C102.00 Diabetes mellitus with hyperosmolar coma 
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Diabetes Read C102000 Diabetes mellitus, juvenile type, with hyperosmolar coma 
Diabetes Read C102100 Diabetes mellitus, adult onset, with hyperosmolar coma 
Diabetes Read C102z00 Diabetes mellitus NOS with hyperosmolar coma 
Diabetes Read C103.00 Diabetes mellitus with ketoacidotic coma 
Diabetes Read C103000 Diabetes mellitus, juvenile type, with ketoacidotic coma 
Diabetes Read C103100 Diabetes mellitus, adult onset, with ketoacidotic coma 
Diabetes Read C103y00 Other specified diabetes mellitus with coma 
Diabetes Read C103z00 Diabetes mellitus NOS with ketoacidotic coma 
Diabetes Read C104.00 Diabetes mellitus with renal manifestation 
Diabetes Read C104000 Diabetes mellitus, juvenile type, with renal manifestation 
Diabetes Read C104100 Diabetes mellitus, adult onset, with renal manifestation 
Diabetes Read C104y00 Other specified diabetes mellitus with renal complications 
Diabetes Read C104z00 Diabetes mellitus with nephropathy NOS 
Diabetes Read C105.00 Diabetes mellitus with ophthalmic manifestation 
Diabetes Read C105000 Diabetes mellitus, juvenile type, + ophthalmic manifestation 
Diabetes Read C105100 Diabetes mellitus, adult onset, + ophthalmic manifestation 
Diabetes Read C105y00 Other specified diabetes mellitus with ophthalmic complicatn 
Diabetes Read C105z00 Diabetes mellitus NOS with ophthalmic manifestation 
Diabetes Read C106.00 Diabetes mellitus with neurological manifestation 
Diabetes Read C106.12 Diabetes mellitus with neuropathy 
Diabetes Read C106.13 Diabetes mellitus with polyneuropathy 
Diabetes Read C106000 Diabetes mellitus, juvenile, + neurological manifestation 
Diabetes Read C106100 Diabetes mellitus, adult onset, + neurological manifestation 
Diabetes Read C106y00 Other specified diabetes mellitus with neurological comps 
Diabetes Read C106z00 Diabetes mellitus NOS with neurological manifestation 
Diabetes Read C107.00 Diabetes mellitus with peripheral circulatory disorder 
Diabetes Read C107.11 Diabetes mellitus with gangrene 
Diabetes Read C107000 Diabetes mellitus, juvenile +peripheral circulatory disorder 
Diabetes Read C107100 Diabetes mellitus, adult, + peripheral circulatory disorder 
Diabetes Read C107200 Diabetes mellitus, adult with gangrene 
Diabetes Read C107z00 Diabetes mellitus NOS with peripheral circulatory disorder 
Diabetes Read C108.00 Insulin dependent diabetes mellitus 
Diabetes Read C108.11 IDDM-Insulin dependent diabetes mellitus 
Diabetes Read C108.12 Type 1 diabetes mellitus 
Diabetes Read C108.13 Type I diabetes mellitus 
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Diabetes Read C108000 Insulin-dependent diabetes mellitus with renal complications 
Diabetes Read C108011 Type I diabetes mellitus with renal complications 
Diabetes Read C108012 Type 1 diabetes mellitus with renal complications 
Diabetes Read C108100 Insulin-dependent diabetes mellitus with ophthalmic comps 
Diabetes Read C108112 Type 1 diabetes mellitus with ophthalmic complications 
Diabetes Read C108200 Insulin-dependent diabetes mellitus with neurological comps 
Diabetes Read C108211 Type I diabetes mellitus with neurological complications 
Diabetes Read C108212 Type 1 diabetes mellitus with neurological complications 
Diabetes Read C108300 Insulin dependent diabetes mellitus with multiple complicatn 
Diabetes Read C108400 Unstable insulin dependent diabetes mellitus 
Diabetes Read C108411 Unstable type I diabetes mellitus 
Diabetes Read C108412 Unstable type 1 diabetes mellitus 
Diabetes Read C108500 Insulin dependent diabetes mellitus with ulcer 
Diabetes Read C108511 Type I diabetes mellitus with ulcer 
Diabetes Read C108512 Type 1 diabetes mellitus with ulcer 
Diabetes Read C108600 Insulin dependent diabetes mellitus with gangrene 
Diabetes Read C108700 Insulin dependent diabetes mellitus with retinopathy 
Diabetes Read C108711 Type I diabetes mellitus with retinopathy 
Diabetes Read C108712 Type 1 diabetes mellitus with retinopathy 
Diabetes Read C108800 Insulin dependent diabetes mellitus - poor control 
Diabetes Read C108811 Type I diabetes mellitus - poor control 
Diabetes Read C108812 Type 1 diabetes mellitus - poor control 
Diabetes Read C108911 Type I diabetes mellitus maturity onset 
Diabetes Read C108912 Type 1 diabetes mellitus maturity onset 
Diabetes Read C108A11 Type I diabetes mellitus without complication 
Diabetes Read C108B00 Insulin dependent diabetes mellitus with mononeuropathy 
Diabetes Read C108B11 Type I diabetes mellitus with mononeuropathy 
Diabetes Read C108C00 Insulin dependent diabetes mellitus with polyneuropathy 
Diabetes Read C108D00 Insulin dependent diabetes mellitus with nephropathy 
Diabetes Read C108D11 Type I diabetes mellitus with nephropathy 
Diabetes Read C108E00 Insulin dependent diabetes mellitus with hypoglycaemic coma 
Diabetes Read C108E11 Type I diabetes mellitus with hypoglycaemic coma 
Diabetes Read C108E12 Type 1 diabetes mellitus with hypoglycaemic coma 
Diabetes Read C108F00 Insulin dependent diabetes mellitus with diabetic cataract 
Diabetes Read C108F11 Type I diabetes mellitus with diabetic cataract 
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Diabetes Read C108H00 Insulin dependent diabetes mellitus with arthropathy 
Diabetes Read C108H11 Type I diabetes mellitus with arthropathy 
Diabetes Read C108J11 Type I diabetes mellitus with neuropathic arthropathy 
Diabetes Read C108J12 Type 1 diabetes mellitus with neuropathic arthropathy 
Diabetes Read C108y00 Other specified diabetes mellitus with multiple comps 
Diabetes Read C108z00 Unspecified diabetes mellitus with multiple complications 
Diabetes Read C109.00 Non-insulin dependent diabetes mellitus 
Diabetes Read C109.11 NIDDM - Non-insulin dependent diabetes mellitus 
Diabetes Read C109.12 Type 2 diabetes mellitus 
Diabetes Read C109.13 Type II diabetes mellitus 
Diabetes Read C109000 Non-insulin-dependent diabetes mellitus with renal comps 
Diabetes Read C109011 Type II diabetes mellitus with renal complications 
Diabetes Read C109012 Type 2 diabetes mellitus with renal complications 
Diabetes Read C109100 Non-insulin-dependent diabetes mellitus with ophthalm comps 
Diabetes Read C109111 Type II diabetes mellitus with ophthalmic complications 
Diabetes Read C109112 Type 2 diabetes mellitus with ophthalmic complications 
Diabetes Read C109200 Non-insulin-dependent diabetes mellitus with neuro comps 
Diabetes Read C109211 Type II diabetes mellitus with neurological complications 
Diabetes Read C109212 Type 2 diabetes mellitus with neurological complications 
Diabetes Read C109300 Non-insulin-dependent diabetes mellitus with multiple comps 
Diabetes Read C109400 Non-insulin dependent diabetes mellitus with ulcer 
Diabetes Read C109411 Type II diabetes mellitus with ulcer 
Diabetes Read C109412 Type 2 diabetes mellitus with ulcer 
Diabetes Read C109500 Non-insulin dependent diabetes mellitus with gangrene 
Diabetes Read C109511 Type II diabetes mellitus with gangrene 
Diabetes Read C109512 Type 2 diabetes mellitus with gangrene 
Diabetes Read C109600 Non-insulin-dependent diabetes mellitus with retinopathy 
Diabetes Read C109611 Type II diabetes mellitus with retinopathy 
Diabetes Read C109612 Type 2 diabetes mellitus with retinopathy 
Diabetes Read C109700 Non-insulin dependent diabetes mellitus - poor control 
Diabetes Read C109711 Type II diabetes mellitus - poor control 
Diabetes Read C109712 Type 2 diabetes mellitus - poor control 
Diabetes Read C109900 Non-insulin-dependent diabetes mellitus without complication 
Diabetes Read C109912 Type 2 diabetes mellitus without complication 
Diabetes Read C109A00 Non-insulin dependent diabetes mellitus with mononeuropathy 
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Diabetes Read C109A11 Type II diabetes mellitus with mononeuropathy 
Diabetes Read C109B00 Non-insulin dependent diabetes mellitus with polyneuropathy 
Diabetes Read C109B11 Type II diabetes mellitus with polyneuropathy 
Diabetes Read C109C00 Non-insulin dependent diabetes mellitus with nephropathy 
Diabetes Read C109C11 Type II diabetes mellitus with nephropathy 
Diabetes Read C109C12 Type 2 diabetes mellitus with nephropathy 
Diabetes Read C109D00 Non-insulin dependent diabetes mellitus with hypoglyca coma 
Diabetes Read C109D11 Type II diabetes mellitus with hypoglycaemic coma 
Diabetes Read C109D12 Type 2 diabetes mellitus with hypoglycaemic coma 
Diabetes Read C109E00 Non-insulin depend diabetes mellitus with diabetic cataract 
Diabetes Read C109E11 Type II diabetes mellitus with diabetic cataract 
Diabetes Read C109E12 Type 2 diabetes mellitus with diabetic cataract 
Diabetes Read C109F11 Type II diabetes mellitus with peripheral angiopathy 
Diabetes Read C109F12 Type 2 diabetes mellitus with peripheral angiopathy 
Diabetes Read C109G00 Non-insulin dependent diabetes mellitus with arthropathy 
Diabetes Read C109G11 Type II diabetes mellitus with arthropathy 
Diabetes Read C109G12 Type 2 diabetes mellitus with arthropathy 
Diabetes Read C109H11 Type II diabetes mellitus with neuropathic arthropathy 
Diabetes Read C109H12 Type 2 diabetes mellitus with neuropathic arthropathy 
Diabetes Read C109J00 Insulin treated Type 2 diabetes mellitus 
Diabetes Read C109J11 Insulin treated non-insulin dependent diabetes mellitus 
Diabetes Read C109J12 Insulin treated Type II diabetes mellitus 
Diabetes Read C109K00 Hyperosmolar non-ketotic state in type 2 diabetes mellitus 
Diabetes Read C10A.00 Malnutrition-related diabetes mellitus 
Diabetes Read C10A000 Malnutrition-related diabetes mellitus with coma 
Diabetes Read C10A100 Malnutrition-related diabetes mellitus with ketoacidosis 
Diabetes Read C10B.00 Diabetes mellitus induced by steroids 
Diabetes Read C10B000 Steroid induced diabetes mellitus without complication 
Diabetes Read C10C.00 Diabetes mellitus autosomal dominant 
Diabetes Read C10D.00 Diabetes mellitus autosomal dominant type 2 
Diabetes Read C10E.00 Type 1 diabetes mellitus 
Diabetes Read C10E.11 Type I diabetes mellitus 
Diabetes Read C10E.12 Insulin dependent diabetes mellitus 
Diabetes Read C10E000 Type 1 diabetes mellitus with renal complications 
Diabetes Read C10E012 Insulin-dependent diabetes mellitus with renal complications 
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Diabetes Read C10E100 Type 1 diabetes mellitus with ophthalmic complications 
Diabetes Read C10E111 Type I diabetes mellitus with ophthalmic complications 
Diabetes Read C10E112 Insulin-dependent diabetes mellitus with ophthalmic comps 
Diabetes Read C10E200 Type 1 diabetes mellitus with neurological complications 
Diabetes Read C10E212 Insulin-dependent diabetes mellitus with neurological comps 
Diabetes Read C10E300 Type 1 diabetes mellitus with multiple complications 
Diabetes Read C10E311 Type I diabetes mellitus with multiple complications 
Diabetes Read C10E312 Insulin dependent diabetes mellitus with multiple complicat 
Diabetes Read C10E400 Unstable type 1 diabetes mellitus 
Diabetes Read C10E411 Unstable type I diabetes mellitus 
Diabetes Read C10E412 Unstable insulin dependent diabetes mellitus 
Diabetes Read C10E500 Type 1 diabetes mellitus with ulcer 
Diabetes Read C10E511 Type I diabetes mellitus with ulcer 
Diabetes Read C10E512 Insulin dependent diabetes mellitus with ulcer 
Diabetes Read C10E600 Type 1 diabetes mellitus with gangrene 
Diabetes Read C10E611 Type I diabetes mellitus with gangrene 
Diabetes Read C10E700 Type 1 diabetes mellitus with retinopathy 
Diabetes Read C10E711 Type I diabetes mellitus with retinopathy 
Diabetes Read C10E712 Insulin dependent diabetes mellitus with retinopathy 
Diabetes Read C10E800 Type 1 diabetes mellitus - poor control 
Diabetes Read C10E811 Type I diabetes mellitus - poor control 
Diabetes Read C10E812 Insulin dependent diabetes mellitus - poor control 
Diabetes Read C10E900 Type 1 diabetes mellitus maturity onset 
Diabetes Read C10E911 Type I diabetes mellitus maturity onset 
Diabetes Read C10EA00 Type 1 diabetes mellitus without complication 
Diabetes Read C10EA11 Type I diabetes mellitus without complication 
Diabetes Read C10EB00 Type 1 diabetes mellitus with mononeuropathy 
Diabetes Read C10EC00 Type 1 diabetes mellitus with polyneuropathy 
Diabetes Read C10EC11 Type I diabetes mellitus with polyneuropathy 
Diabetes Read C10EC12 Insulin dependent diabetes mellitus with polyneuropathy 
Diabetes Read C10ED00 Type 1 diabetes mellitus with nephropathy 
Diabetes Read C10ED12 Insulin dependent diabetes mellitus with nephropathy 
Diabetes Read C10EE00 Type 1 diabetes mellitus with hypoglycaemic coma 
Diabetes Read C10EE12 Insulin dependent diabetes mellitus with hypoglycaemic coma 
Diabetes Read C10EF00 Type 1 diabetes mellitus with diabetic cataract 
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Diabetes Read C10EF12 Insulin dependent diabetes mellitus with diabetic cataract 
Diabetes Read C10EG00 Type 1 diabetes mellitus with peripheral angiopathy 
Diabetes Read C10EH00 Type 1 diabetes mellitus with arthropathy 
Diabetes Read C10EJ00 Type 1 diabetes mellitus with neuropathic arthropathy 
Diabetes Read C10EK00 Type 1 diabetes mellitus with persistent proteinuria 
Diabetes Read C10EL00 Type 1 diabetes mellitus with persistent microalbuminuria 
Diabetes Read C10EL11 Type I diabetes mellitus with persistent microalbuminuria 
Diabetes Read C10EM00 Type 1 diabetes mellitus with ketoacidosis 
Diabetes Read C10EM11 Type I diabetes mellitus with ketoacidosis 
Diabetes Read C10EN00 Type 1 diabetes mellitus with ketoacidotic coma 
Diabetes Read C10EN11 Type I diabetes mellitus with ketoacidotic coma 
Diabetes Read C10EP00 Type 1 diabetes mellitus with exudative maculopathy 
Diabetes Read C10EP11 Type I diabetes mellitus with exudative maculopathy 
Diabetes Read C10EQ00 Type 1 diabetes mellitus with gastroparesis 
Diabetes Read C10ER00 Latent autoimmune diabetes mellitus in adult 
Diabetes Read C10F.00 Type 2 diabetes mellitus 
Diabetes Read C10F.11 Type II diabetes mellitus 
Diabetes Read C10F000 Type 2 diabetes mellitus with renal complications 
Diabetes Read C10F011 Type II diabetes mellitus with renal complications 
Diabetes Read C10F100 Type 2 diabetes mellitus with ophthalmic complications 
Diabetes Read C10F111 Type II diabetes mellitus with ophthalmic complications 
Diabetes Read C10F200 Type 2 diabetes mellitus with neurological complications 
Diabetes Read C10F211 Type II diabetes mellitus with neurological complications 
Diabetes Read C10F300 Type 2 diabetes mellitus with multiple complications 
Diabetes Read C10F311 Type II diabetes mellitus with multiple complications 
Diabetes Read C10F400 Type 2 diabetes mellitus with ulcer 
Diabetes Read C10F411 Type II diabetes mellitus with ulcer 
Diabetes Read C10F500 Type 2 diabetes mellitus with gangrene 
Diabetes Read C10F511 Type II diabetes mellitus with gangrene 
Diabetes Read C10F600 Type 2 diabetes mellitus with retinopathy 
Diabetes Read C10F611 Type II diabetes mellitus with retinopathy 
Diabetes Read C10F700 Type 2 diabetes mellitus - poor control 
Diabetes Read C10F711 Type II diabetes mellitus - poor control 
Diabetes Read C10F900 Type 2 diabetes mellitus without complication 
Diabetes Read C10F911 Type II diabetes mellitus without complication 
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Diabetes Read C10FA00 Type 2 diabetes mellitus with mononeuropathy 
Diabetes Read C10FA11 Type II diabetes mellitus with mononeuropathy 
Diabetes Read C10FB00 Type 2 diabetes mellitus with polyneuropathy 
Diabetes Read C10FB11 Type II diabetes mellitus with polyneuropathy 
Diabetes Read C10FC00 Type 2 diabetes mellitus with nephropathy 
Diabetes Read C10FC11 Type II diabetes mellitus with nephropathy 
Diabetes Read C10FD00 Type 2 diabetes mellitus with hypoglycaemic coma 
Diabetes Read C10FD11 Type II diabetes mellitus with hypoglycaemic coma 
Diabetes Read C10FE00 Type 2 diabetes mellitus with diabetic cataract 
Diabetes Read C10FE11 Type II diabetes mellitus with diabetic cataract 
Diabetes Read C10FF00 Type 2 diabetes mellitus with peripheral angiopathy 
Diabetes Read C10FF11 Type II diabetes mellitus with peripheral angiopathy 
Diabetes Read C10FG00 Type 2 diabetes mellitus with arthropathy 
Diabetes Read C10FG11 Type II diabetes mellitus with arthropathy 
Diabetes Read C10FH00 Type 2 diabetes mellitus with neuropathic arthropathy 
Diabetes Read C10FJ00 Insulin treated Type 2 diabetes mellitus 
Diabetes Read C10FJ11 Insulin treated Type II diabetes mellitus 
Diabetes Read C10FK00 Hyperosmolar non-ketotic state in type 2 diabetes mellitus 
Diabetes Read C10FL00 Type 2 diabetes mellitus with persistent proteinuria 
Diabetes Read C10FL11 Type II diabetes mellitus with persistent proteinuria 
Diabetes Read C10FM00 Type 2 diabetes mellitus with persistent microalbuminuria 
Diabetes Read C10FM11 Type II diabetes mellitus with persistent microalbuminuria 
Diabetes Read C10FN00 Type 2 diabetes mellitus with ketoacidosis 
Diabetes Read C10FN11 Type II diabetes mellitus with ketoacidosis 
Diabetes Read C10FP00 Type 2 diabetes mellitus with ketoacidotic coma 
Diabetes Read C10FP11 Type II diabetes mellitus with ketoacidotic coma 
Diabetes Read C10FQ00 Type 2 diabetes mellitus with exudative maculopathy 
Diabetes Read C10FR00 Type 2 diabetes mellitus with gastroparesis 
Diabetes Read C10FS00 Maternally inherited diabetes mellitus 
Diabetes Read C10G.00 Secondary pancreatic diabetes mellitus 
Diabetes Read C10G000 Secondary pancreatic diabetes mellitus without complication 
Diabetes Read C10H.00 Diabetes mellitus induced by non-steroid drugs 
Diabetes Read C10M.00 Lipoatrophic diabetes mellitus 
Diabetes Read C10N.00 Secondary diabetes mellitus 
Diabetes Read C10N000 Secondary diabetes mellitus without complication 
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Diabetes Read C10N100 Cystic fibrosis related diabetes mellitus 
Diabetes Read C10y.00 Diabetes mellitus with other specified manifestation 
Diabetes Read C10y100 Diabetes mellitus, adult, + other specified manifestation 
Diabetes Read C10yy00 Other specified diabetes mellitus with other spec comps 
Diabetes Read C10yz00 Diabetes mellitus NOS with other specified manifestation 
Diabetes Read C10z.00 Diabetes mellitus with unspecified complication 
Diabetes Read C10z000 Diabetes mellitus, juvenile type, + unspecified complication 
Diabetes Read C10z100 Diabetes mellitus, adult onset, + unspecified complication 
Diabetes Read C10zy00 Other specified diabetes mellitus with unspecified comps 
Diabetes Read C10zz00 Diabetes mellitus NOS with unspecified complication 
Diabetes Read Cyu2.00 [X]Diabetes mellitus 
Diabetes Read Cyu2000 [X]Other specified diabetes mellitus 
Diabetes Read Cyu2300 [X]Unspecified diabetes mellitus with renal complications 
Diabetic proliferative retinopathy ICD-10 H36.0 Diabetic retinopathy 
Diabetic proliferative retinopathy Read 2BBk.00 O/E - right eye stable treated prolif diabetic retinopathy 
Diabetic proliferative retinopathy Read 2BBl.00 O/E - left eye stable treated prolif diabetic retinopathy 
Diabetic proliferative retinopathy Read 2BBo.00 O/E - sight threatening diabetic retinopathy 
Diabetic proliferative retinopathy Read 2BBT.00 O/E - right eye proliferative diabetic retinopathy 
Diabetic proliferative retinopathy Read 2BBV.00 O/E - left eye proliferative diabetic retinopathy 
Diabetic proliferative retinopathy Read F420100 Proliferative diabetic retinopathy 
Diabetic proliferative retinopathy Read F422.00 Other proliferative retinopathy 
Diabetic proliferative retinopathy Read F422100 Proliferative retinopathy due to sickle cell disease 
Diabetic proliferative retinopathy Read F422z00 Proliferative retinopathy NOS 
Diabetic proliferative retinopathy Read FyuF700 [X]Other proliferative retinopathy 
End stage renal disease ICD-10  I12.0 Hypertensive renal disease with renal failure 
End stage renal disease ICD-10  I13.1 Hypertensive heart and renal with renal failure 
End stage renal disease ICD-10  I13.2 
Hypertensive heart and renal disease with both (congestive) heart 
failure and renal failure 
End stage renal disease ICD-10  N18.5 Chronic kidney disease, stage 5 
End stage renal disease ICD-10  Y84.1 Kidney dialysis 
End stage renal disease Read 14V2.00 H/O: renal dialysis 
End stage renal disease Read 14V2.11 H/O: kidney dialysis 
End stage renal disease Read 1Z14.00 Chronic kidney disease stage 5 
End stage renal disease Read 1Z1K.00 Chronic kidney disease stage 5 with proteinuria 
End stage renal disease Read 1Z1K.11 CKD stage 5 with proteinuria 
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End stage renal disease Read 1Z1L.00 Chronic kidney disease stage 5 without proteinuria 
End stage renal disease Read 1Z1L.11 CKD stage 5 without proteinuria 
End stage renal disease Read 4I29.00 Peritoneal dialysis sample 
End stage renal disease Read 4N0..00 Dialysis fluid urea level 
End stage renal disease Read 4N2..00 Dialysis fluid glucose level 
End stage renal disease Read 7A60600 Creation of graft fistula for dialysis 
End stage renal disease Read 7A61900 Ligation of arteriovenous dialysis fistula 
End stage renal disease Read 7B00212 Cadaveric renal transplant 
End stage renal disease Read 7B00600 Xenograft renal transplant 
End stage renal disease Read 7L1A.00 Compensation for renal failure 
End stage renal disease Read 7L1A.11 Dialysis for renal failure 
End stage renal disease Read 7L1A000 Renal dialysis 
End stage renal disease Read 7L1A011 Thomas intravascular shunt for dialysis 
End stage renal disease Read 7L1A100 Peritoneal dialysis 
End stage renal disease Read 7L1A200 Haemodialysis NEC 
End stage renal disease Read 7L1A400 Automated peritoneal dialysis 
End stage renal disease Read 7L1A500 Continuous ambulatory peritoneal dialysis 
End stage renal disease Read 7L1A600 Peritoneal dialysis NEC 
End stage renal disease Read 7L1Ay00 Other specified compensation for renal failure 
End stage renal disease Read 7L1Az00 Compensation for renal failure NOS 
End stage renal disease Read 7L1B.00 Placement ambulatory apparatus compensation renal failure 
End stage renal disease Read 7L1B.11 Placement ambulatory dialysis apparatus - compens renal fail 
End stage renal disease Read 7L1B000 Insertion of ambulatory peritoneal dialysis catheter 
End stage renal disease Read 7L1B100 Removal of ambulatory peritoneal dialysis catheter 
End stage renal disease Read 7L1B200 Flushing of peritoneal dialysis catheter 
End stage renal disease Read 7L1By00 Placement ambulatory apparatus- compensate renal failure OS 
End stage renal disease Read 7L1C.00 Placement other apparatus for compensation for renal failure 
End stage renal disease Read 7L1C000 Insertion of temporary peritoneal dialysis catheter 
End stage renal disease Read 7L1Cz00 Placement other apparatus- compensate for renal failure NOS 
End stage renal disease Read 7L1f000 Extracorporeal albumin haemodialysis 
End stage renal disease Read 8L50.00 Renal transplant planned 
End stage renal disease Read D215000 Anaemia secondary to chronic renal failure 
End stage renal disease Read G222.00 Hypertensive renal disease with renal failure 
End stage renal disease Read G233.00 Hypertensive heart and renal disease with renal failure 
End stage renal disease Read G72C.00 Ruptured aneurysm of dialysis vascular access 
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End stage renal disease Read G72D200 Aneurysm of anastomotic site of dialysis AV fistula 
End stage renal disease Read K05..00 Chronic renal failure 
End stage renal disease Read K05..12 End stage renal failure 
End stage renal disease Read K050.00 End stage renal failure 
End stage renal disease Read K055.00 Chronic kidney disease stage 5 
End stage renal disease Read K06..00 Renal failure unspecified 
End stage renal disease Read K0D..00 End-stage renal disease 
End stage renal disease Read K0E..00 Acute-on-chronic renal failure 
End stage renal disease Read Kyu1C00 [X]Renal tubulo-interstitial disorders/transplant rejection 
End stage renal disease Read Kyu2.00 [X]Renal failure 
End stage renal disease Read Kyu2100 [X]Other chronic renal failure 
End stage renal disease Read Q48y000 Congenital renal failure 
End stage renal disease Read SP01500 Mechanical complication of dialysis catheter 
End stage renal disease Read SP05613 [X] Peritoneal dialysis associated peritonitis 
End stage renal disease Read SP06B00 Continuous ambulatory peritoneal dialysis associated perit 
End stage renal disease Read SP07G00 Stenosis of arteriovenous dialysis fistula 
End stage renal disease Read SP08D00 Acute-on-chronic rejection of renal transplant 
End stage renal disease Read SP08E00 Acute rejection of renal transplant - grade I 
End stage renal disease Read SP08F00 Acute rejection of renal transplant - grade II 
End stage renal disease Read SP08G00 Acute rejection of renal transplant - grade III 
End stage renal disease Read SP08H00 Acute rejection of renal transplant 
End stage renal disease Read SP08J00 Chronic rejection of renal transplant 
End stage renal disease Read SP08N00 Unexplained episode of renal transplant dysfunction 
End stage renal disease Read SP08R00 Renal transplant rejection 
End stage renal disease Read SP08W00 Vascular complication of renal transplant 
End stage renal disease Read SP0G.00 Anaphylactoid reaction due to haemodialysis 
End stage renal disease Read SP15400 Renal failure as a complication of care 
End stage renal disease Read TA02000 Accid cut,puncture,perf,h'ge - kidney dialysis 
End stage renal disease Read TA22000 Failure of sterile precautions during kidney dialysis 
End stage renal disease Read TB00111 Renal transplant with complication, without blame 
End stage renal disease Read TB11.00 Kidney dialysis with complication, without blame 
End stage renal disease Read TB11.11 Renal dialysis with complication, without blame 
End stage renal disease Read Z1A..00 Dialysis training 
End stage renal disease Read Z1A1.00 Peritoneal dialysis training 
End stage renal disease Read Z1A2.00 Haemodialysis training 
  
 
1
4
8
 
Condition / Diagnosis Coding System Code Description 
End stage renal disease Read Z919.00 Care of haemodialysis equipment 
End stage renal disease Read Z919100 Priming haemodialysis lines 
End stage renal disease Read Z919300 Reversing haemodialysis lines 
End stage renal disease Read Z91A.00 Peritoneal dialysis bag procedure 
End stage renal disease Read ZV45100 [V]Renal dialysis status 
End stage renal disease Read ZV56.00 [V]Aftercare involving intermittent dialysis 
End stage renal disease Read ZV56000 [V]Aftercare involving extracorporeal dialysis 
End stage renal disease Read ZV56011 [V]Aftercare involving renal dialysis NOS 
End stage renal disease Read ZV56100 [V]Preparatory care for dialysis 
End stage renal disease Read ZV56y00 [V]Other specified aftercare involving intermittent dialysis 
End stage renal disease Read ZV56y11 [V]Aftercare involving peritoneal dialysis 
End stage renal disease Read ZV56z00 [V]Unspecified aftercare involving intermittent dialysis 
End stage renal disease Read ZVu3G00 [X]Other dialysis 
Extracranial hemorrhage ICD-10 D68.3 Haemorrhagic disorder due to circulating anticoagulants 
Extracranial hemorrhage ICD-10 H35.6 Retinal haemorrhage 
Extracranial hemorrhage ICD-10 H43.1 Vitreous haemorrhage 
Extracranial hemorrhage ICD-10 H45.0 Vitreous haemorrhage in diseases classified elsewhere 
Extracranial hemorrhage ICD-10 H92.2 Otorrhagia 
Extracranial hemorrhage ICD-10 I23.0 Haemopericardium as curr comp folow acut myocard infarct 
Extracranial hemorrhage ICD-10 I31.2 Haemopericardium, not elsewhere classified 
Extracranial hemorrhage ICD-10 I71.1 Thoracic aortic aneurysm, ruptured 
Extracranial hemorrhage ICD-10 I71.3 Abdominal aortic aneurysm, ruptured 
Extracranial hemorrhage ICD-10 I71.5 Thoracoabdominal aortic aneurysm, ruptured 
Extracranial hemorrhage ICD-10 I71.8 Aortic aneurysm of unspecified site, ruptured 
Extracranial hemorrhage ICD-10 I84.1 Internal haemorrhoids with other complications 
Extracranial hemorrhage ICD-10 I84.3 External thrombosed haemorrhoids 
Extracranial hemorrhage ICD-10 I84.4 External haemorrhoids with other complications 
Extracranial hemorrhage ICD-10 I84.8 Unspecified haemorrhoids with other complications 
Extracranial hemorrhage ICD-10 I85.0 Oesophageal varices with bleeding 
Extracranial hemorrhage ICD-10 J94.2 Haemothorax 
Extracranial hemorrhage ICD-10 K25.0 Gastric ulcer, acute with haemorrhage 
Extracranial hemorrhage ICD-10 K25.2 Gastric ulcer, acute with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K25.4 Gastric ulcer, chronic or unspecified with haemorrhage 
Extracranial hemorrhage ICD-10 K25.6 Chronic or unspecified with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K26.0 Duodenal ulcer, acute with haemorrhage 
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Extracranial hemorrhage ICD-10 K26.2 Duodenal ulcer, acute with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K26.4 Duodenal ulcer, chronic or unspecified with haemorrhage 
Extracranial hemorrhage ICD-10 K26.6 Chronic or unspecified with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K27.0 Peptic ulcer, acute with haemorrhage 
Extracranial hemorrhage ICD-10 K27.2 Peptic ulcer, acute with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K27.4 Peptic ulcer, chronic or unspecified with haemorrhage 
Extracranial hemorrhage ICD-10 K27.6 Chronic or unspecified with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K28.0 Gastrojejunal ulcer, acute with haemorrhage 
Extracranial hemorrhage ICD-10 K28.2 Acute with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K28.4 Gastrojejunal ulcer, chronic or unspecified with haemorrhage 
Extracranial hemorrhage ICD-10 K28.6 Chronic or unspecified with both haemorrhage and perforation 
Extracranial hemorrhage ICD-10 K29.0 Acute haemorrhagic gastritis 
Extracranial hemorrhage ICD-10 K62.5 Haemorrhage of anus and rectum 
Extracranial hemorrhage ICD-10 K66.1 Haemoperitoneum 
Extracranial hemorrhage ICD-10 K92.0 Haematemesis 
Extracranial hemorrhage ICD-10 K92.1 Melaena 
Extracranial hemorrhage ICD-10 K92.2 Gastrointestinal haemorrhage, unspecified 
Extracranial hemorrhage ICD-10 N02 Recurrent and persistent haematuria 
Extracranial hemorrhage ICD-10 N02.6 Recurrent and persistent haematuria, dense deposit disease 
Extracranial hemorrhage ICD-10 N02.8 Recurrent and persistent haematuria, other 
Extracranial hemorrhage ICD-10 N02.9 Recurrent and persistent haematuria, unspecified 
Extracranial hemorrhage ICD-10 N42.1 Congestion and haemorrhage of prostate 
Extracranial hemorrhage ICD-10 N83.6 Haematosalpinx 
Extracranial hemorrhage ICD-10 N85.7 Haematometra 
Extracranial hemorrhage ICD-10 N89.7 Haematocolpos 
Extracranial hemorrhage ICD-10 N92.1 Excessive and frequent menstruation with irregular cycle 
Extracranial hemorrhage ICD-10 N92.5 Other specified irregular menstruation 
Extracranial hemorrhage ICD-10 N92.6 Irregular menstruation, unspecified 
Extracranial hemorrhage ICD-10 N93 Other abnormal uterine and vaginal bleeding 
Extracranial hemorrhage ICD-10 N93.8 Other specified abnormal uterine and vaginal bleeding 
Extracranial hemorrhage ICD-10 N93.9 Abnormal uterine and vaginal bleeding, unspecified 
Extracranial hemorrhage ICD-10 N95.0 Postmenopausal bleeding 
Extracranial hemorrhage ICD-10 R04 Haemorrhage from respiratory passages 
Extracranial hemorrhage ICD-10 R04.0 Epistaxis 
Extracranial hemorrhage ICD-10 R04.1 Haemorrhage from throat 
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Extracranial hemorrhage ICD-10 R04.2 Haemoptysis 
Extracranial hemorrhage ICD-10 R04.8 Haemorrhage from other sites in respiratory passages 
Extracranial hemorrhage ICD-10 R04.9 Haemorrhage from respiratory passages, unspecified 
Extracranial hemorrhage ICD-10 R23.3 Spontaneous ecchymoses 
Extracranial hemorrhage ICD-10 R31 Unspecified haematuria 
Extracranial hemorrhage ICD-10 R58 Haemorrhage, not elsewhere classified 
Extracranial hemorrhage ICD-10 T79.2 Traumatic secondary and recurrent haemorrhage 
Extracranial hemorrhage ICD-10 T81.0 Haemorrhage and haematoma complicating a procedure NEC 
Heart failure ICD-10 I09.9 Rheumatic heart disease, unspecified 
Heart failure ICD-10 I11.0 Hypertensive heart disease with heart failure 
Heart failure ICD-10 I11.9 Hypertensive heart disease without heart failure 
Heart failure ICD-10 I13.0 
Hypertensive heart and chronic kidney disease with heart failure 
and stage 1 through stage 4 chronic kidney disease, or 
unspecified chronic kidney disease 
Heart failure ICD-10 I13.2 
Hypertensive heart and chronic kidney disease with heart failure 
and with stage 5 chronic kidney disease, or end stage renal 
disease 
Heart failure ICD-10 I50 Heart failure  
Heart failure ICD-10 I50.0 Congestive heart failure 
Heart failure ICD-10 I50.1 Left ventricular heart failure 
Heart failure ICD-10 I50.9 Heart failure, unspecified 
Heart failure ICD-10 I97.1 Other functional disturbances following cardiac surgery 
Heart failure Read 14A6.00 H/O: heart failure 
Heart failure Read 14AM.00 H/O: Heart failure in last year 
Heart failure Read 1O1..00 Heart failure confirmed 
Heart failure Read 661M500 Heart failure self-management plan agreed 
Heart failure Read 662p.00 Heart failure 6 month review 
Heart failure Read 662T.00 Congestive heart failure monitoring 
Heart failure Read 662W.00 Heart failure annual review 
Heart failure Read 679W100 Education about deteriorating heart failure 
Heart failure Read 67D4.00 Heart failure information given to patient 
Heart failure Read 8CL3.00 Heart failure care plan discussed with patient 
Heart failure Read 8CMK.00 Has heart failure management plan 
Heart failure Read 8H2S.00 Admit heart failure emergency 
Heart failure Read 8HBE.00 Heart failure follow-up 
Heart failure Read 8Hg8.00 Discharge from practice nurse heart failure clinic 
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Heart failure Read 8HgD.00 Discharge from heart failure nurse service 
Heart failure Read 8HHb.00 Referral to heart failure nurse 
Heart failure Read 8HHz.00 Referral to heart failure exercise programme 
Heart failure Read 8Hk0.00 Referred to heart failure education group 
Heart failure Read 8HTL.00 Referral to heart failure clinic 
Heart failure Read 8IB8.00 Referral to heart failure exercise programme not indicated 
Heart failure Read 8IE1.00 Referral to heart failure exercise programme declined 
Heart failure Read 9hH..00 Exception reporting: heart failure quality indicators 
Heart failure Read 9hH0.00 Excepted heart failure quality indicators: Patient unsuitabl 
Heart failure Read 9hH1.00 Excepted heart failure quality indicators: Informed dissent 
Heart failure Read 9N0k.00 Seen in heart failure clinic 
Heart failure Read 9N2p.00 Seen by community heart failure nurse 
Heart failure Read 9N4s.00 Did not attend practice nurse heart failure clinic 
Heart failure Read 9N4w.00 Did not attend heart failure clinic 
Heart failure Read 9N6T.00 Referred by heart failure nurse specialist 
Heart failure Read 9Or..00 Heart failure monitoring administration 
Heart failure Read 9Or0.00 Heart failure review completed 
Heart failure Read 9Or1.00 Heart failure monitoring telephone invite 
Heart failure Read 9Or2.00 Heart failure monitoring verbal invite 
Heart failure Read 9Or3.00 Heart failure monitoring first letter 
Heart failure Read 9Or4.00 Heart failure monitoring second letter 
Heart failure Read 9Or5.00 Heart failure monitoring third letter 
Heart failure Read G232.00 Hypertensive heart&renal dis wth (congestive) heart failure 
Heart failure Read G58..00 Heart failure 
Heart failure Read G580.00 Congestive heart failure 
Heart failure Read G580.12 Right heart failure 
Heart failure Read G580000 Acute congestive heart failure 
Heart failure Read G580100 Chronic congestive heart failure 
Heart failure Read G580400 Congestive heart failure due to valvular disease 
Heart failure Read G582.00 Acute heart failure 
Heart failure Read G58z.00 Heart failure NOS 
Heart failure Read G5y4z00 Post cardiac operation heart failure NOS 
Heart failure Read SP11111 Heart failure as a complication of care 
Hypertension Read 8BL0.00 Patient on maximal tolerated antihypertensive therapy 
Hypertension Read G2...00 Hypertensive disease 
  
 
1
5
2
 
Condition / Diagnosis Coding System Code Description 
Hypertension Read G2...11 BP - hypertensive disease 
Hypertension Read G20..00 Essential hypertension 
Hypertension Read G20..11 High blood pressure 
Hypertension Read G200.00 Malignant essential hypertension 
Hypertension Read G201.00 Benign essential hypertension 
Hypertension Read G202.00 Systolic hypertension 
Hypertension Read G203.00 Diastolic hypertension 
Hypertension Read G20z.00 Essential hypertension NOS 
Hypertension Read G20z.11 Hypertension NOS 
Hypertension Read G21..00 Hypertensive heart disease 
Hypertension Read G210.00 Malignant hypertensive heart disease 
Hypertension Read G210100 Malignant hypertensive heart disease with CCF 
Hypertension Read G210z00 Malignant hypertensive heart disease NOS 
Hypertension Read G211.00 Benign hypertensive heart disease 
Hypertension Read G211000 Benign hypertensive heart disease without CCF 
Hypertension Read G211100 Benign hypertensive heart disease with CCF 
Hypertension Read G21z.00 Hypertensive heart disease NOS 
Hypertension Read G21z000 Hypertensive heart disease NOS without CCF 
Hypertension Read G21z011 Cardiomegaly - hypertensive 
Hypertension Read G21z100 Hypertensive heart disease NOS with CCF 
Hypertension Read G21zz00 Hypertensive heart disease NOS 
Hypertension Read G22..00 Hypertensive renal disease 
Hypertension Read G220.00 Malignant hypertensive renal disease 
Hypertension Read G221.00 Benign hypertensive renal disease 
Hypertension Read G222.00 Hypertensive renal disease with renal failure 
Hypertension Read G22z.00 Hypertensive renal disease NOS 
Hypertension Read G22z.11 Renal hypertension 
Hypertension Read G23..00 Hypertensive heart and renal disease 
Hypertension Read G230.00 Malignant hypertensive heart and renal disease 
Hypertension Read G232.00 Hypertensive heart&renal dis wth (congestive) heart failure 
Hypertension Read G233.00 Hypertensive heart and renal disease with renal failure 
Hypertension Read G234.00 Hyperten heart&renal dis+both(congestv)heart and renal fail 
Hypertension Read G24..00 Secondary hypertension 
Hypertension Read G240.00 Secondary malignant hypertension 
Hypertension Read G240000 Secondary malignant renovascular hypertension 
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Hypertension Read G240z00 Secondary malignant hypertension NOS 
Hypertension Read G241.00 Secondary benign hypertension 
Hypertension Read G241000 Secondary benign renovascular hypertension 
Hypertension Read G241z00 Secondary benign hypertension NOS 
Hypertension Read G244.00 Hypertension secondary to endocrine disorders 
Hypertension Read G24z.00 Secondary hypertension NOS 
Hypertension Read G24z000 Secondary renovascular hypertension NOS 
Hypertension Read G24zz00 Secondary hypertension NOS 
Hypertension Read G2y..00 Other specified hypertensive disease 
Hypertension Read G2z..00 Hypertensive disease NOS 
Hypertension Read G672.11 Hypertensive crisis 
Hypertension Read Gyu2.00 [X]Hypertensive diseases 
Hypertension Read U60C51A [X] Adverse reaction to antihypertensives NOS 
Hyperthyroidism ICD-10  E05 Thyrotoxicosis [hyperthyroidism] 
Hyperthyroidism ICD-10  E05.0 Thyrotoxicosis with diffuse goitre 
Hyperthyroidism ICD-10  E05.1 Thyrotoxicosis with toxic single thyroid nodule 
Hyperthyroidism ICD-10  E05.2 Thyrotoxicosis with toxic multinodular goitre 
Hyperthyroidism ICD-10  E05.3 Thyrotoxicosis from ectopic thyroid tissue 
Hyperthyroidism ICD-10  E05.4 Thyrotoxicosis factitia 
Hyperthyroidism ICD-10  E05.5 Thyroid crisis or storm 
Hyperthyroidism ICD-10  E05.8 Other thyrotoxicosis 
Hyperthyroidism ICD-10  E05.9 Thyrotoxicosis, unspecified 
Hyperthyroidism Read 1431 H/O: hyperthyroidism 
Hyperthyroidism Read 1431.11 H/O: thyrotoxicosis 
Hyperthyroidism Read 9N4T.00 DNA - Did not attend hyperthyroidism clinic 
Hyperthyroidism Read C00z.11 Thyroid enlargement 
Hyperthyroidism Read C02..00 Thyrotoxicosis 
Hyperthyroidism Read C02..11 Hyperthyroidism 
Hyperthyroidism Read C02..12 Toxic goitre 
Hyperthyroidism Read C020.00 Toxic diffuse goitre 
Hyperthyroidism Read C020.11 Basedow's disease 
Hyperthyroidism Read C020.12 Graves' disease 
Hyperthyroidism Read C020000 Toxic diffuse goitre with no crisis 
Hyperthyroidism Read C020100 Toxic diffuse goitre with crisis 
Hyperthyroidism Read C020z00 Toxic diffuse goitre NOS 
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Hyperthyroidism Read C021.00 Toxic uninodular goitre 
Hyperthyroidism Read C021000 Toxic uninodular goitre with no crisis 
Hyperthyroidism Read C021z00 Toxic uninodular goitre NOS 
Hyperthyroidism Read C022.00 Toxic multinodular goitre 
Hyperthyroidism Read C022000 Toxic multinodular goitre with no crisis 
Hyperthyroidism Read C022z00 Toxic multinodular goitre NOS 
Hyperthyroidism Read C023.00 Toxic nodular goitre unspecified 
Hyperthyroidism Read C023000 Toxic nodular goitre unspecified with no crisis 
Hyperthyroidism Read C023100 Toxic nodular goitre unspecified with crisis 
Hyperthyroidism Read C023z00 Toxic nodular goitre NOS 
Hyperthyroidism Read C024.00 Thyrotoxicosis from ectopic thyroid nodule 
Hyperthyroidism Read C024000 Thyrotoxicosis from ectopic thyroid nodule with no crisis 
Hyperthyroidism Read C024z00 Thyrotoxicosis from ectopic thyroid nodule NOS 
Hyperthyroidism Read C02y.00 Thyrotoxicosis of other specified origin 
Hyperthyroidism Read C02y.11 Factitia thyrotoxicosis 
Hyperthyroidism Read C02y000 Thyrotoxicosis of other specified origin with no crisis 
Hyperthyroidism Read C02y100 Thyrotoxicosis of other specified origin with crisis 
Hyperthyroidism Read C02y200 Thyrotoxicosis factitia 
Hyperthyroidism Read C02yz00 Thyrotoxicosis of other specified origin NOS 
Hyperthyroidism Read C02z.00 Thyrotoxicosis without mention of goitre or other cause 
Hyperthyroidism Read C02z000 Thyrotoxicosis without mention of goitre or cause no crisis 
Hyperthyroidism Read C02z100 Thyrotoxicosis without mention of goitre, cause with crisis 
Hyperthyroidism Read C02zz00 Thyrotoxicosis NOS 
Hyperthyroidism Read C052.00 Chronic lymphocytic thyroiditis 
Hyperthyroidism Read C05y.00 Other and unspecified chronic thyroiditis 
Hyperthyroidism Read C05y400 Chronic thyroiditis with transient thyrotoxicosis 
Hyperthyroidism Read Cyu1300 [X]Other thyrotoxicosis 
Hyperthyroidism Read F381600 Myasthenic syndrome due to thyrotoxicosis 
Hyperthyroidism Read F395400 Myopathy due to thyrotoxicosis 
Impaired hemostasis ICD-10 D65 Disseminated intravascular coagulation [defibrination syndrome] 
Impaired hemostasis ICD-10 D66 Hereditary factor VIII deficiency 
Impaired hemostasis ICD-10 D67 Hereditary factor IX deficiency 
Impaired hemostasis ICD-10 D68 Other coagulation defects 
Impaired hemostasis ICD-10 D68.0 Von Willebrand disease 
Impaired hemostasis ICD-10 D68.1 Hereditary factor XI deficiency 
  
 
1
5
5
 
Condition / Diagnosis Coding System Code Description 
Impaired hemostasis ICD-10 D68.2 Hereditary deficiency of other clotting factors 
Impaired hemostasis ICD-10 D68.4 Acquired coagulation factor deficiency 
Impaired hemostasis ICD-10 D68.5 Activated thrombophilia 
Impaired hemostasis ICD-10 D68.6 Other thrombophilia 
Impaired hemostasis ICD-10 D68.8 Other specified coagulation defects 
Impaired hemostasis ICD-10 D68.9 Coagulation defect, unspecified 
Impaired hemostasis ICD-10 D69.1 Qualitative platelet defects 
Impaired hemostasis Read D3...00 Clotting and bleeding disorders 
Impaired hemostasis Read D30..00 Coagulation defects 
Impaired hemostasis Read D30..11 Bleeding disorders 
Impaired hemostasis Read D300.00 Haemophilia-A (factor VIII deficiency) 
Impaired hemostasis Read D300.11 Antihaemophilic globulin deficiency 
Impaired hemostasis Read D300.12 Haemophilia A 
Impaired hemostasis Read D301.00 Haemophilia-B (factor IX deficiency) 
Impaired hemostasis Read D301.11 Christmas disease 
Impaired hemostasis Read D301.12 Haemophilia B 
Impaired hemostasis Read D302.00 Haemophilia-C (factor XI deficiency) 
Impaired hemostasis Read D302.11 Haemophilia C 
Impaired hemostasis Read D302.12 Rosenthal's disease 
Impaired hemostasis Read D303.00 Congenital deficiency of other clotting factors 
Impaired hemostasis Read D303000 Congenital afibrinogenaemia 
Impaired hemostasis Read D303100 Deficiency of factor II or prothrombin 
Impaired hemostasis Read D303111 Hypoprothrombinaemia 
Impaired hemostasis Read D303200 Deficiency of factor V or labile factor 
Impaired hemostasis Read D303300 Deficiency of factor VII or stable factor 
Impaired hemostasis Read D303400 Deficiency of factor X or Stuart-Prower factor 
Impaired hemostasis Read D303500 Deficiency of factor XII or Hageman factor 
Impaired hemostasis Read D303600 Deficiency of factor XIII or fibrin stabilizing factor 
Impaired hemostasis Read D303611 Fibrin stabilising factor deficiency 
Impaired hemostasis Read D303700 Factor V Leiden mutation 
Impaired hemostasis Read D303800 Homozygous factor V Leiden mutation 
Impaired hemostasis Read D303900 Heterozygous factor V Leiden mutation 
Impaired hemostasis Read D303y00 Congenital deficiency of other clotting factor OS 
Impaired hemostasis Read D303z00 Congenital deficiency of other clotting factor NOS 
Impaired hemostasis Read D304.00 Von Willebrand's disease 
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Impaired hemostasis Read D305000 Haemorrhagic disorder due to antithrombinaemia 
Impaired hemostasis Read D306.00 Defibrination syndrome 
Impaired hemostasis Read D306.11 Afibrinogenaemia - acquired 
Impaired hemostasis Read D307.00 Acquired coagulation factor deficiency 
Impaired hemostasis Read D307000 Deficiency of coagulation factor due to liver disease 
Impaired hemostasis Read D307100 Deficiency of coagulation factor due to vitamin K deficiency 
Impaired hemostasis Read D307200 Acquired factor II deficiency 
Impaired hemostasis Read D307211 Acquired prothrombin deficiency 
Impaired hemostasis Read D307212 Acquired hypoprothrombinaemia 
Impaired hemostasis Read D307y00 Other specified acquired coagulation factor deficiency 
Impaired hemostasis Read D307z00 Acquired coagulation factor deficiency NOS 
Impaired hemostasis Read D30z.00 Coagulation defect NOS 
Impaired hemostasis Read D311.00 Qualitative platelet defects 
Impaired hemostasis Read D311.11 Bernard - Soulier thrombopathy 
Impaired hemostasis Read D311000 Hereditary haemorrhagic thrombasthenia 
Impaired hemostasis Read D311011 Glanzmann's syndrome 
Impaired hemostasis Read D311z00 Qualitative platelet deficiency NOS 
Impaired hemostasis Read D313.11 Evan's syndrome 
Impaired hemostasis Read D313211 TAR syndrome 
Impaired hemostasis Read D31X.00 Haemorrhagic condition, unspecified 
Impaired hemostasis Read D31yz00 Other specified haemorrhagic condition NOS 
Impaired hemostasis Read D31z.00 Haemorrhagic condition NOS 
Impaired hemostasis Read D3y..00 Other specified disorders of clotting or bleeding 
Impaired hemostasis Read D3z..00 Clotting or bleeding disorder NOS 
Intracerebral aneurysm ICD-10 I67.1 Cerebral aneurysm, nonruptured 
Intracerebral aneurysm Read 7A23.00 Cerebral artery and circle of Willis aneurysm operations 
Intracerebral aneurysm Read 7A23.11 Cerebral artery aneurysm operations 
Intracerebral aneurysm Read 7A23.12 Circle of Willis aneurysm operations 
Intracerebral aneurysm Read 7A23000 Excision of aneurysm of cerebral artery 
Intracerebral aneurysm Read 7A23100 Excision of aneurysm of circle of Willis 
Intracerebral aneurysm Read 7A23200 Clipping of aneurysm of cerebral artery 
Intracerebral aneurysm Read 7A23300 Clipping of aneurysm of circle of Willis 
Intracerebral aneurysm Read 7A23500 Ligation of aneurysm of circle of Willis NEC 
Intracerebral aneurysm Read 7A23600 Obliteration of aneurysm of cerebral artery NEC 
Intracerebral aneurysm Read 7A23700 Obliteration of aneurysm of circle of Willis NEC 
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Intracerebral aneurysm Read 7A23800 Percutaneous coil embolisation of cerebral artery aneurysm 
Intracerebral aneurysm Read 7A23y00 Operation on cerebral artery/ circle of Willis aneurysm OS 
Intracerebral aneurysm Read 7A23z00 Operation on cerebral artery/ circle of Willis aneurysm NOS 
Intracerebral aneurysm Read A94y600 Rupture of syphilitic cerebral aneurysm 
Intracerebral aneurysm Read G673.00 Cerebral aneurysm, nonruptured 
Intracerebral aneurysm Read P7y0100 Congenital cerebral arteriovenous aneurysm 
Intracerebral aneurysm Read P7y0200 Congenital brain aneurysm NEC 
Intracerebral tumor ICD-10 C71.0 Malignant neoplasm of cerebrum, except lobes and ventricles 
Intracerebral tumor ICD-10 C71.1 Malignant neoplasm: frontal lobe 
Intracerebral tumor ICD-10 C71.2 Malignant neoplasm: temporal lobe 
Intracerebral tumor ICD-10 C71.3 Malignant neoplasm: parietal lobe 
Intracerebral tumor ICD-10 C71.4 Malignant neoplasm: occipital lobe 
Intracerebral tumor ICD-10 C71.5 Malignant neoplasm: cerebral ventricle 
Intracerebral tumor ICD-10 C71.6 Malignant neoplasm: cerebellum 
Intracerebral tumor ICD-10 C71.7 Malignant neoplasm: brain stem 
Intracerebral tumor ICD-10 C71.8 Malignant neoplasm: overlapping sites of brain 
Intracerebral tumor ICD-10 C71.9 Malignant neoplasm: brain, unspecified 
Intracerebral tumor ICD-10 C72.0 Malignant neoplasm of spinal cord 
Intracerebral tumor ICD-10 C72.1 Malignant neoplasm of cauda equina 
Intracerebral tumor ICD-10 C72.2 Malignant neoplasm of olfactory nerve 
Intracerebral tumor ICD-10 C72.3 Malignant neoplasm of optic nerve 
Intracerebral tumor ICD-10 C72.4 Malignant neoplasm of acoustic nerve 
Intracerebral tumor ICD-10 C72.5 Malignant neoplasm of other and unspecified cranial nerves 
Intracerebral tumor ICD-10 C72.8 
Overlapping lesion of brain and other parts of central nervous 
system 
Intracerebral tumor ICD-10 C72.9 Malignant neoplasm of central nervous system, unspecified 
Intracerebral tumor Read B51..00 Malignant neoplasm of brain 
Intracerebral tumor Read B51..11 Cerebral tumour - malignant 
Intracerebral tumor Read B510.00 Malignant neoplasm cerebrum (excluding lobes and ventricles) 
Intracerebral tumor Read B510000 Malignant neoplasm of basal ganglia 
Intracerebral tumor Read B510100 Malignant neoplasm of cerebral cortex 
Intracerebral tumor Read B510300 Malignant neoplasm of globus pallidus 
Intracerebral tumor Read B510400 Malignant neoplasm of hypothalamus 
Intracerebral tumor Read B510500 Malignant neoplasm of thalamus 
Intracerebral tumor Read B510z00 Malignant neoplasm of cerebrum NOS 
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Intracerebral tumor Read B511.00 Malignant neoplasm of frontal lobe 
Intracerebral tumor Read B512.00 Malignant neoplasm of temporal lobe 
Intracerebral tumor Read B512000 Malignant neoplasm of hippocampus 
Intracerebral tumor Read B512z00 Malignant neoplasm of temporal lobe NOS 
Intracerebral tumor Read B513.00 Malignant neoplasm of parietal lobe 
Intracerebral tumor Read B514.00 Malignant neoplasm of occipital lobe 
Intracerebral tumor Read B515.00 Malignant neoplasm of cerebral ventricles 
Intracerebral tumor Read B515000 Malignant neoplasm of choroid plexus 
Intracerebral tumor Read B516.00 Malignant neoplasm of cerebellum 
Intracerebral tumor Read B517.00 Malignant neoplasm of brain stem 
Intracerebral tumor Read B517000 Malignant neoplasm of cerebral peduncle 
Intracerebral tumor Read B517100 Malignant neoplasm of medulla oblongata 
Intracerebral tumor Read B517200 Malignant neoplasm of midbrain 
Intracerebral tumor Read B517300 Malignant neoplasm of pons 
Intracerebral tumor Read B517z00 Malignant neoplasm of brain stem NOS 
Intracerebral tumor Read B51y.00 Malignant neoplasm of other parts of brain 
Intracerebral tumor Read B51y000 Malignant neoplasm of corpus callosum 
Intracerebral tumor Read B51y200 Malignant neoplasm, overlapping lesion of brain 
Intracerebral tumor Read B51yz00 Malignant neoplasm of other part of brain NOS 
Intracerebral tumor Read B51z.00 Malignant neoplasm of brain NOS 
Intracerebral tumor Read B520.00 Malignant neoplasm of cranial nerves 
Intracerebral tumor Read B520000 Malignant neoplasm of olfactory bulb 
Intracerebral tumor Read B520100 Malignant neoplasm of optic nerve 
Intracerebral tumor Read B520200 Malignant neoplasm of acoustic nerve 
Intracerebral tumor Read B520z00 Malignant neoplasm of cranial nerves NOS 
Intracerebral tumor Read B521.00 Malignant neoplasm of cerebral meninges 
Intracerebral tumor Read B521z00 Malignant neoplasm of cerebral meninges NOS 
Intracerebral tumor Read B52W.00 Malig neopl, overlap lesion brain & other part of CNS 
Intracerebral tumor Read B52X.00 Malignant neoplasm of meninges, unspecified 
Intracerebral tumor Read B542.00 Malignant neoplasm pituitary gland and craniopharyngeal duct 
Intracerebral tumor Read B542000 Malignant neoplasm of pituitary gland 
Intracerebral tumor Read B542100 Malignant neoplasm of craniopharyngeal duct 
Intracerebral tumor Read B543.00 Malignant neoplasm of pineal gland 
Intracerebral tumor Read B545000 Malignant neoplasm of glomus jugulare 
Intracerebral tumor Read B560400 Secondary and unspec malig neop deep parotid lymph nodes 
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Intracerebral tumor Read B583.00 Secondary malignant neoplasm of brain and spinal cord 
Intracerebral tumor Read B583000 Secondary malignant neoplasm of brain 
Intracerebral tumor Read B583200 Cerebral metastasis 
Intracerebral tumor Read BBb3.12 [M]Subependymal astrocytoma NOS 
Intracerebral tumor Read BBb4.00 [M]Subependymal giant cell astrocytoma 
Intracerebral tumor Read BBbG.00 [M]Pilocytic astrocytoma 
Intracerebral tumor Read BBbG.12 [M]Piloid astrocytoma 
Intracerebral tumor Read BBc7.11 [M]Neuroastrocytoma 
Intracranial bleed ICD-10 I60 Subarachnoid haemorrhage 
Intracranial bleed ICD-10 I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation 
Intracranial bleed ICD-10 I60.1 Subarachnoid haemorrhage from middle cerebral artery 
Intracranial bleed ICD-10 I60.2 Subarachnoid haemorrhage from anterior communicating artery 
Intracranial bleed ICD-10 I60.3 Subarachnoid haemorrhage from posterior communicating artery 
Intracranial bleed ICD-10 I60.4 Subarachnoid haemorrhage from basilar artery 
Intracranial bleed ICD-10 I60.5 Subarachnoid haemorrhage from vertebral artery 
Intracranial bleed ICD-10 I60.6 Subarachnoid haemorrhage from other intracranial arteries 
Intracranial bleed ICD-10 I60.7 Subarachnoid haemorrhage from intracranial artery, unspec 
Intracranial bleed ICD-10 I60.8 Other subarachnoid haemorrhage 
Intracranial bleed ICD-10 I60.9 Subarachnoid haemorrhage, unspecified 
Intracranial bleed ICD-10 I61 Intracerebral haemorrhage 
Intracranial bleed ICD-10 I61.0 Intracerebral haemorrhage in hemisphere, subcortical 
Intracranial bleed ICD-10 I61.1 Intracerebral haemorrhage in hemisphere, cortical 
Intracranial bleed ICD-10 I61.2 Intracerebral haemorrhage in hemisphere, unspecified 
Intracranial bleed ICD-10 I61.3 Intracerebral haemorrhage in brain stem 
Intracranial bleed ICD-10 I61.4 Intracerebral haemorrhage in cerebellum 
Intracranial bleed ICD-10 I61.5 Intracerebral haemorrhage, intraventricular 
Intracranial bleed ICD-10 I61.6 Intracerebral haemorrhage, multiple localized 
Intracranial bleed ICD-10 I61.8 Other intracerebral haemorrhage 
Intracranial bleed ICD-10 I61.9 Intracerebral haemorrhage, unspecified 
Intracranial bleed ICD-10 I62 Other nontraumatic intracranial haemorrhage 
Intracranial bleed ICD-10 I62.0 Subdural haemorrhage (acute)(nontraumatic) 
Intracranial bleed ICD-10 I62.1 Nontraumatic extradural haemorrhage 
Intracranial bleed ICD-10 I62.9 Intracranial haemorrhage (nontraumatic), unspecified 
Intracranial bleed ICD-10 I69.0 Sequelae of subarachnoid haemorrhage 
Intracranial bleed ICD-10 I69.1 Sequelae of intracerebral haemorrhage 
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Intracranial bleed ICD-10 I69.2 Sequelae of other nontraumatic intracranial haemorrhage 
Intracranial bleed ICD-10 S06.4 Epidural haemorrhage 
Intracranial bleed ICD-10 S06.5 Traumatic subdural haemorrhage 
Intracranial bleed ICD-10 S06.6 Traumatic subarachnoid haemorrhage 
Intracranial bleed Read 7004200 Evacuation of haematoma from cerebellum 
Intracranial bleed Read 7004300 Evacuation of intracerebral haematoma NEC 
Intracranial bleed Read 7008200 Aspiration of haematoma of brain tissue 
Intracranial bleed Read 7017000 Evacuation of subdural haematoma 
Intracranial bleed Read 7032000 Evacuation of extradural haematoma 
Intracranial bleed Read F161300 Myelopathy due to haematomyelia 
Intracranial bleed Read G60..00 Subarachnoid haemorrhage 
Intracranial bleed Read G601.00 Subarachnoid haemorrhage from carotid siphon and bifurcation 
Intracranial bleed Read G602.00 Subarachnoid haemorrhage from middle cerebral artery 
Intracranial bleed Read G603.00 Subarachnoid haemorrhage from anterior communicating artery 
Intracranial bleed Read G604.00 Subarachnoid haemorrhage from posterior communicating artery 
Intracranial bleed Read G605.00 Subarachnoid haemorrhage from basilar artery 
Intracranial bleed Read G606.00 Subarachnoid haemorrhage from vertebral artery 
Intracranial bleed Read G60z.00 Subarachnoid haemorrhage NOS 
Intracranial bleed Read G61..00 Intracerebral haemorrhage 
Intracranial bleed Read G61..11 CVA - cerebrovascular accid due to intracerebral haemorrhage 
Intracranial bleed Read G61..12 Stroke due to intracerebral haemorrhage 
Intracranial bleed Read G610.00 Cortical haemorrhage 
Intracranial bleed Read G611.00 Internal capsule haemorrhage 
Intracranial bleed Read G612.00 Basal nucleus haemorrhage 
Intracranial bleed Read G613.00 Cerebellar haemorrhage 
Intracranial bleed Read G616.00 External capsule haemorrhage 
Intracranial bleed Read G617.00 Intracerebral haemorrhage, intraventricular 
Intracranial bleed Read G618.00 Intracerebral haemorrhage, multiple localized 
Intracranial bleed Read G61X.00 Intracerebral haemorrhage in hemisphere, unspecified 
Intracranial bleed Read G61X000 Left sided intracerebral haemorrhage, unspecified 
Intracranial bleed Read G61X100 Right sided intracerebral haemorrhage, unspecified 
Intracranial bleed Read G61z.00 Intracerebral haemorrhage NOS 
Intracranial bleed Read G62..00 Other and unspecified intracranial haemorrhage 
Intracranial bleed Read G620.00 Extradural haemorrhage - nontraumatic 
Intracranial bleed Read G621.00 Subdural haemorrhage - nontraumatic 
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Intracranial bleed Read G622.00 Subdural haematoma - nontraumatic 
Intracranial bleed Read G623.00 Subdural haemorrhage NOS 
Intracranial bleed Read G62z.00 Intracranial haemorrhage NOS 
Intracranial bleed Read Gyu6100 [X]Other subarachnoid haemorrhage 
Intracranial bleed Read Gyu6200 [X]Other intracerebral haemorrhage 
Intracranial bleed Read Gyu6F00 [X]Intracerebral haemorrhage in hemisphere, unspecified 
Intracranial bleed Read S62..00 Cerebral haemorrhage following injury 
Intracranial bleed Read S62..11 Extradural haemorrhage following injury 
Intracranial bleed Read S62..12 Subarachnoid haemorrhage following injury 
Intracranial bleed Read S62..13 Subdural haemorrhage following injury 
Intracranial bleed Read S62..14 Traumatic cerebral haemorrhage 
Intracranial bleed Read S620.00 Closed traumatic subarachnoid haemorrhage 
Intracranial bleed Read S621.00 Open traumatic subarachnoid haemorrhage 
Intracranial bleed Read S622.00 Closed traumatic subdural haemorrhage 
Intracranial bleed Read S623.00 Open traumatic subdural haemorrhage 
Intracranial bleed Read S624.00 Closed traumatic extradural haemorrhage 
Intracranial bleed Read S624.11 Epidural haematoma following injury 
Intracranial bleed Read S625.00 Open traumatic extradural haemorrhage 
Intracranial bleed Read S626.00 Epidural haemorrhage 
Intracranial bleed Read S627.00 Traumatic subarachnoid haemorrhage 
Intracranial bleed Read S628.00 Traumatic subdural haemorrhage 
Intracranial bleed Read S629.00 Traumatic subdural haematoma 
Intracranial bleed Read S629000 Traumatic subdural haematoma without open intracranial wound 
Intracranial bleed Read S629100 Traumatic subdural haematoma with open intracranial wound 
Intracranial bleed Read S62A.00 Traumatic extradural haematoma 
Intracranial bleed Read S62z.00 Cerebral haemorrhage following injury NOS 
Intracranial bleed Read S63..00 Other cerebral haemorrhage following injury 
Intracranial bleed Read S630.12 Intracranial haematoma following injury 
Intracranial bleed Read S63z.00 Other cerebral haemorrhage following injury NOS 
Intracranial hemorrhage ICD-10 I60 Subarachnoid haemorrhage 
Intracranial hemorrhage ICD-10 I60.0 Subarachnoid haemorrhage from carotid siphon and bifurcation 
Intracranial hemorrhage ICD-10 I60.1 Subarachnoid haemorrhage from middle cerebral artery 
Intracranial hemorrhage ICD-10 I60.2 Subarachnoid haemorrhage from anterior communicating artery 
Intracranial hemorrhage ICD-10 I60.3 Subarachnoid haemorrhage from posterior communicating artery 
Intracranial hemorrhage ICD-10 I60.4 Subarachnoid haemorrhage from basilar artery 
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Intracranial hemorrhage ICD-10 I60.5 Subarachnoid haemorrhage from vertebral artery 
Intracranial hemorrhage ICD-10 I60.6 Subarachnoid haemorrhage from other intracranial arteries 
Intracranial hemorrhage ICD-10 I60.7 Subarachnoid haemorrhage from intracranial artery, unspec 
Intracranial hemorrhage ICD-10 I60.8 Other subarachnoid haemorrhage 
Intracranial hemorrhage ICD-10 I60.9 Subarachnoid haemorrhage, unspecified 
Intracranial hemorrhage ICD-10 I61 Intracerebral haemorrhage 
Intracranial hemorrhage ICD-10 I61.0 Intracerebral haemorrhage in hemisphere, subcortical 
Intracranial hemorrhage ICD-10 I61.1 Intracerebral haemorrhage in hemisphere, cortical 
Intracranial hemorrhage ICD-10 I61.2 Intracerebral haemorrhage in hemisphere, unspecified 
Intracranial hemorrhage ICD-10 I61.3 Intracerebral haemorrhage in brain stem 
Intracranial hemorrhage ICD-10 I61.4 Intracerebral haemorrhage in cerebellum 
Intracranial hemorrhage ICD-10 I61.5 Intracerebral haemorrhage, intraventricular 
Intracranial hemorrhage ICD-10 I61.6 Intracerebral haemorrhage, multiple localized 
Intracranial hemorrhage ICD-10 I61.8 Other intracerebral haemorrhage 
Intracranial hemorrhage ICD-10 I61.9 Intracerebral haemorrhage, unspecified 
Intracranial hemorrhage ICD-10 I62 Other nontraumatic intracranial haemorrhage 
Intracranial hemorrhage ICD-10 I62.0 Subdural haemorrhage (acute)(nontraumatic) 
Intracranial hemorrhage ICD-10 I62.1 Nontraumatic extradural haemorrhage 
Intracranial hemorrhage ICD-10 I62.9 Intracranial haemorrhage (nontraumatic), unspecified 
Intracranial hemorrhage ICD-10 I69.0 Sequelae of subarachnoid haemorrhage 
Intracranial hemorrhage ICD-10 I69.1 Sequelae of intracerebral haemorrhage 
Intracranial hemorrhage ICD-10 I69.2 Sequelae of other nontraumatic intracranial haemorrhage 
Intracranial hemorrhage ICD-10 S06.4 Epidural haemorrhage 
Intracranial hemorrhage ICD-10 S06.5 Traumatic subdural haemorrhage 
Intracranial hemorrhage ICD-10 S06.6 Traumatic subarachnoid haemorrhage 
Liver failure or cirrhosis ICD-10 K70.3 Alcoholic cirrhosis of liver 
Liver failure or cirrhosis ICD-10 K70.4 Alcoholic hepatic failure 
Liver failure or cirrhosis ICD-10 K71.1 Toxic liver disease with hepatic necrosis 
Liver failure or cirrhosis ICD-10 K71.7 Toxic liver disease with fibrosis and cirrhosis of liver 
Liver failure or cirrhosis ICD-10 K72 Hepatic failure, not elsewhere classified 
Liver failure or cirrhosis ICD-10 K72.0 Acute and subacute hepatic failure 
Liver failure or cirrhosis ICD-10 K72.1 Chronic hepatic failure 
Liver failure or cirrhosis ICD-10 K72.9  Hepatic failure, unspecified 
Liver failure or cirrhosis ICD-10 K74.3 Primary biliary cirrhosis 
Liver failure or cirrhosis ICD-10 K74.4 Secondary biliary cirrhosis 
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Liver failure or cirrhosis ICD-10 K74.5 Biliary cirrhosis, unspecified 
Liver failure or cirrhosis ICD-10 K74.6 Other an unspecified cirrhosis of liver 
Liver failure or cirrhosis Read J60..00 Acute and subacute liver necrosis 
Liver failure or cirrhosis Read J600.00 Acute necrosis of liver 
Liver failure or cirrhosis Read J600000 Acute hepatic failure 
Liver failure or cirrhosis Read J600011 Acute liver failure 
Liver failure or cirrhosis Read J601.00 Subacute necrosis of liver 
Liver failure or cirrhosis Read J601000 Subacute hepatic failure 
Liver failure or cirrhosis Read J601z00 Subacute necrosis of liver NOS 
Liver failure or cirrhosis Read J60z.00 Acute and subacute liver necrosis NOS 
Liver failure or cirrhosis Read J61..00 Cirrhosis and chronic liver disease 
Liver failure or cirrhosis Read J612.00 Alcoholic cirrhosis of liver 
Liver failure or cirrhosis Read J612.11 Florid cirrhosis 
Liver failure or cirrhosis Read J612.12 Laennec's cirrhosis 
Liver failure or cirrhosis Read J613000 Alcoholic hepatic failure 
Liver failure or cirrhosis Read J615.00 Cirrhosis - non alcoholic 
Liver failure or cirrhosis Read J615.11 Portal cirrhosis 
Liver failure or cirrhosis Read J615100 Multilobular portal cirrhosis 
Liver failure or cirrhosis Read J615300 Diffuse nodular cirrhosis 
Liver failure or cirrhosis Read J615400 Fatty portal cirrhosis 
Liver failure or cirrhosis Read J615500 Hypertrophic portal cirrhosis 
Liver failure or cirrhosis Read J615600 Capsular portal cirrhosis 
Liver failure or cirrhosis Read J615700 Cardiac portal cirrhosis 
Liver failure or cirrhosis Read J615800 Juvenile portal cirrhosis 
Liver failure or cirrhosis Read J615812 Indian childhood cirrhosis 
Liver failure or cirrhosis Read J615C00 Xanthomatous portal cirrhosis 
Liver failure or cirrhosis Read J615D00 Bacterial portal cirrhosis 
Liver failure or cirrhosis Read J615H00 Infectious cirrhosis NOS 
Liver failure or cirrhosis Read J615y00 Portal cirrhosis unspecified 
Liver failure or cirrhosis Read J615z00 Non-alcoholic cirrhosis NOS 
Liver failure or cirrhosis Read J615z11 Macronodular cirrhosis of liver 
Liver failure or cirrhosis Read J615z12 Cryptogenic cirrhosis of liver 
Liver failure or cirrhosis Read J615z13 Cirrhosis of liver NOS 
Liver failure or cirrhosis Read J616.00 Biliary cirrhosis 
Liver failure or cirrhosis Read J616000 Primary biliary cirrhosis 
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Liver failure or cirrhosis Read J616100 Secondary biliary cirrhosis 
Liver failure or cirrhosis Read J616200 Biliary cirrhosis of children 
Liver failure or cirrhosis Read J616z00 Biliary cirrhosis NOS 
Liver failure or cirrhosis Read J622.00 Hepatic coma 
Liver failure or cirrhosis Read J624.00 Hepatorenal syndrome 
Liver failure or cirrhosis Read J625.00 [X] Hepatic failure 
Liver failure or cirrhosis Read J625.11 [X] Liver failure 
Liver failure or cirrhosis Read J62y.11 Hepatic failure NOS 
Liver failure or cirrhosis Read J62y.12 Liver failure NOS 
Liver failure or cirrhosis Read J62y.13 Hepatic failure 
Liver failure or cirrhosis Read J635100 Toxic liver disease with hepatic necrosis 
Liver failure or cirrhosis Read J635600 Toxic liver disease with fibrosis and cirrhosis of liver 
Liver failure or cirrhosis Read J635700 Acute hepatic failure due to drugs 
Liver failure or cirrhosis Read J636.00 Central haemorrhagic necrosis of liver 
Malignancy ICD-10 C00 Malignant neoplasm of lip 
Malignancy ICD-10 C00.0 Malignant neoplasm: External upper lip 
Malignancy ICD-10 C00.1 Malignant neoplasm: External lower lip 
Malignancy ICD-10 C00.2 Malignant neoplasm: External lip, unspecified 
Malignancy ICD-10 C00.3 Malignant neoplasm: Upper lip, inner aspect 
Malignancy ICD-10 C00.4 Malignant neoplasm: Lower lip, inner aspect 
Malignancy ICD-10 C00.5 Malignant neoplasm: Lip, unspecified, inner aspect 
Malignancy ICD-10 C00.6 Malignant neoplasm: Commissure of lip 
Malignancy ICD-10 C00.8 Malignant neoplasm: Overlapping lesion of lip 
Malignancy ICD-10 C00.9 Malignant neoplasm: Lip, unspecified 
Malignancy ICD-10 C01 Malignant neoplasm of base of tongue 
Malignancy ICD-10 C02 Malignant neoplasm of other and unspecified parts of tongue 
Malignancy ICD-10 C02.0 Malignant neoplasm: Dorsal surface of tongue 
Malignancy ICD-10 C02.1 Malignant neoplasm: Border of tongue 
Malignancy ICD-10 C02.2 Malignant neoplasm: Ventral surface of tongue 
Malignancy ICD-10 C02.3 
Malignant neoplasm: Anterior two-thirds of tongue, part 
unspecified 
Malignancy ICD-10 C02.4 Malignant neoplasm: Lingual tonsil 
Malignancy ICD-10 C02.8 Malignant neoplasm: Overlapping lesion of tongue 
Malignancy ICD-10 C02.9 Malignant neoplasm: Tongue, unspecified 
Malignancy ICD-10 C03 Malignant neoplasm of gum 
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Malignancy ICD-10 C03.0 Malignant neoplasm: Upper gum 
Malignancy ICD-10 C03.1 Malignant neoplasm: Lower gum 
Malignancy ICD-10 C03.9 Malignant neoplasm: Gum, unspecified 
Malignancy ICD-10 C04 Malignant neoplasm of floor of mouth 
Malignancy ICD-10 C04.0 Malignant neoplasm: Anterior floor of mouth 
Malignancy ICD-10 C04.1 Malignant neoplasm: Lateral floor of mouth 
Malignancy ICD-10 C04.8 Malignant neoplasm: Overlapping lesion of floor of mouth 
Malignancy ICD-10 C04.9 Malignant neoplasm: Floor of mouth, unspecified 
Malignancy ICD-10 C05 Malignant neoplasm of palate 
Malignancy ICD-10 C05.0 Malignant neoplasm: Hard palate 
Malignancy ICD-10 C05.1 Malignant neoplasm: Soft palate 
Malignancy ICD-10 C05.2 Malignant neoplasm: Uvula 
Malignancy ICD-10 C05.8 Malignant neoplasm: Overlapping lesion of palate 
Malignancy ICD-10 C05.9 Malignant neoplasm: Palate, unspecified 
Malignancy ICD-10 C06 Malignant neoplasm of other and unspecified parts of mouth 
Malignancy ICD-10 C06.0 Malignant neoplasm: Cheek mucosa 
Malignancy ICD-10 C06.1 Malignant neoplasm: Vestibule of mouth 
Malignancy ICD-10 C06.2 Malignant neoplasm: Retromolar area 
Malignancy ICD-10 C06.8 
Malignant neoplasm: Overlapping lesion of other and unspecified 
parts of mouth 
Malignancy ICD-10 C06.9 Malignant neoplasm: Mouth, unspecified 
Malignancy ICD-10 C07 Malignant neoplasm of parotid gland 
Malignancy ICD-10 C08 
Malignant neoplasm of other and unspecified major salivary 
glands 
Malignancy ICD-10 C08.0 Malignant neoplasm: Submandibular gland 
Malignancy ICD-10 C08.1 Malignant neoplasm: Sublingual gland 
Malignancy ICD-10 C08.8 Malignant neoplasm: Overlapping lesion of major salivary glands 
Malignancy ICD-10 C08.9 Malignant neoplasm: Major salivary gland, unspecified 
Malignancy ICD-10 C09 Malignant neoplasm of tonsil 
Malignancy ICD-10 C09.0 Malignant neoplasm: Tonsillar fossa 
Malignancy ICD-10 C09.1 Malignant neoplasm: Tonsillar pillar (anterior)(posterior) 
Malignancy ICD-10 C09.8 Malignant neoplasm: Overlapping lesion of tonsil 
Malignancy ICD-10 C09.9 Malignant neoplasm: Tonsil, unspecified 
Malignancy ICD-10 C10 Malignant neoplasm of oropharynx 
Malignancy ICD-10 C10.0 Malignant neoplasm: Vallecula 
Malignancy ICD-10 C10.1 Malignant neoplasm: Anterior surface of epiglottis 
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Malignancy ICD-10 C10.2 Malignant neoplasm: Lateral wall of oropharynx 
Malignancy ICD-10 C10.3 Malignant neoplasm: Posterior wall of oropharynx 
Malignancy ICD-10 C10.4 Malignant neoplasm: Branchial cleft 
Malignancy ICD-10 C10.8 Malignant neoplasm: Overlapping lesion of oropharynx 
Malignancy ICD-10 C10.9 Malignant neoplasm: Oropharynx, unspecified 
Malignancy ICD-10 C11 Malignant neoplasm of nasopharynx 
Malignancy ICD-10 C11.0 Malignant neoplasm: Superior wall of nasopharynx 
Malignancy ICD-10 C11.1 Malignant neoplasm: Posterior wall of nasopharynx 
Malignancy ICD-10 C11.2 Malignant neoplasm: Lateral wall of nasopharynx 
Malignancy ICD-10 C11.3 Malignant neoplasm: Anterior wall of nasopharynx 
Malignancy ICD-10 C11.8 Malignant neoplasm: Overlapping lesion of nasopharynx 
Malignancy ICD-10 C11.9 Malignant neoplasm: Nasopharynx, unspecified 
Malignancy ICD-10 C12 Malignant neoplasm of piriform sinus 
Malignancy ICD-10 C13 Malignant neoplasm of hypopharynx 
Malignancy ICD-10 C13.0 Malignant neoplasm: Postcricoid region 
Malignancy ICD-10 C13.1 Malignant neoplasm: Aryepiglottic fold, hypopharyngeal aspect 
Malignancy ICD-10 C13.2 Malignant neoplasm: Posterior wall of hypopharynx 
Malignancy ICD-10 C13.8 Malignant neoplasm: Overlapping lesion of hypopharynx 
Malignancy ICD-10 C13.9 Malignant neoplasm: Hypopharynx, unspecified 
Malignancy ICD-10 C14 
Malignant neoplasm of other and ill-defined sites in the lip, oral 
cavity and pharynx 
Malignancy ICD-10 C14.0 Malignant neoplasm: Pharynx, unspecified 
Malignancy ICD-10 C14.2 Malignant neoplasm: Waldeyer ring 
Malignancy ICD-10 C14.8 
Malignant neoplasm: Overlapping lesion of lip, oral cavity and 
pharynx 
Malignancy ICD-10 C15 Malignant neoplasm of oesophagus 
Malignancy ICD-10 C15.0 Malignant neoplasm: Cervical part of oesophagus 
Malignancy ICD-10 C15.1 Malignant neoplasm: Thoracic part of oesophagus 
Malignancy ICD-10 C15.2 Malignant neoplasm: Abdominal part of oesophagus 
Malignancy ICD-10 C15.3 Malignant neoplasm: Upper third of oesophagus 
Malignancy ICD-10 C15.4 Malignant neoplasm: Middle third of oesophagus 
Malignancy ICD-10 C15.5 Malignant neoplasm: Lower third of oesophagus 
Malignancy ICD-10 C15.8 Malignant neoplasm: Overlapping lesion of oesophagus 
Malignancy ICD-10 C15.9 Malignant neoplasm: Oesophagus, unspecified 
Malignancy ICD-10 C16 Malignant neoplasm of stomach 
Malignancy ICD-10 C16.0 Malignant neoplasm: Cardia 
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Malignancy ICD-10 C16.1 Malignant neoplasm: Fundus of stomach 
Malignancy ICD-10 C16.2 Malignant neoplasm: Body of stomach 
Malignancy ICD-10 C16.3 Malignant neoplasm: Pyloric antrum 
Malignancy ICD-10 C16.4 Malignant neoplasm: Pylorus 
Malignancy ICD-10 C16.5 Malignant neoplasm: Lesser curvature of stomach, unspecified 
Malignancy ICD-10 C16.6 Malignant neoplasm: Greater curvature of stomach, unspecified 
Malignancy ICD-10 C16.8 Malignant neoplasm: Overlapping lesion of stomach 
Malignancy ICD-10 C16.9 Malignant neoplasm: Stomach, unspecified 
Malignancy ICD-10 C17 Malignant neoplasm of small intestine 
Malignancy ICD-10 C17.0 Malignant neoplasm: Duodenum 
Malignancy ICD-10 C17.1 Malignant neoplasm: Jejunum 
Malignancy ICD-10 C17.2 Malignant neoplasm: Ileum 
Malignancy ICD-10 C17.3 Malignant neoplasm: Meckel diverticulum 
Malignancy ICD-10 C17.8 Malignant neoplasm: Overlapping lesion of small intestine 
Malignancy ICD-10 C17.9 Malignant neoplasm: Small intestine, unspecified 
Malignancy ICD-10 C18 Malignant neoplasm of colon 
Malignancy ICD-10 C18.0 Malignant neoplasm: Caecum 
Malignancy ICD-10 C18.1 Malignant neoplasm: Appendix 
Malignancy ICD-10 C18.2 Malignant neoplasm: Ascending colon 
Malignancy ICD-10 C18.3 Malignant neoplasm: Hepatic flexure 
Malignancy ICD-10 C18.4 Malignant neoplasm: Transverse colon 
Malignancy ICD-10 C18.5 Malignant neoplasm: Splenic flexure 
Malignancy ICD-10 C18.6 Malignant neoplasm: Descending colon 
Malignancy ICD-10 C18.7 Malignant neoplasm: Sigmoid colon 
Malignancy ICD-10 C18.8 Malignant neoplasm: Overlapping lesion of colon 
Malignancy ICD-10 C18.9 Malignant neoplasm: Colon, unspecified 
Malignancy ICD-10 C19 Malignant neoplasm of rectosigmoid junction 
Malignancy ICD-10 C20 Malignant neoplasm of rectum 
Malignancy ICD-10 C21 Malignant neoplasm of anus and anal canal 
Malignancy ICD-10 C21.0 Malignant neoplasm: Anus, unspecified 
Malignancy ICD-10 C21.1 Malignant neoplasm: Anal canal 
Malignancy ICD-10 C21.2 Malignant neoplasm: Cloacogenic zone 
Malignancy ICD-10 C21.8 
Malignant neoplasm: Overlapping lesion of rectum, anus and anal 
canal 
Malignancy ICD-10 C22 Malignant neoplasm of liver and intrahepatic bile ducts 
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Malignancy ICD-10 C22.0 Malignant neoplasm: Liver cell carcinoma 
Malignancy ICD-10 C22.1 Malignant neoplasm: Intrahepatic bile duct carcinoma 
Malignancy ICD-10 C22.2 Malignant neoplasm: Hepatoblastoma 
Malignancy ICD-10 C22.3 Malignant neoplasm: Angiosarcoma of liver 
Malignancy ICD-10 C22.4 Malignant neoplasm: Other sarcomas of liver 
Malignancy ICD-10 C22.7 Malignant neoplasm: Other specified carcinomas of liver 
Malignancy ICD-10 C22.9 Malignant neoplasm: Liver, unspecified 
Malignancy ICD-10 C23 Malignant neoplasm of gallbladder 
Malignancy ICD-10 C24 Malignant neoplasm of other and unspecified parts of biliary tract 
Malignancy ICD-10 C24.0 Malignant neoplasm: Extrahepatic bile duct 
Malignancy ICD-10 C24.1 Malignant neoplasm: Ampulla of Vater 
Malignancy ICD-10 C24.8 Malignant neoplasm: Overlapping lesion of biliary tract 
Malignancy ICD-10 C24.9 Malignant neoplasm: Biliary tract, unspecified 
Malignancy ICD-10 C25 Malignant neoplasm of pancreas 
Malignancy ICD-10 C25.0 Malignant neoplasm: Head of pancreas 
Malignancy ICD-10 C25.1 Malignant neoplasm: Body of pancreas 
Malignancy ICD-10 C25.2 Malignant neoplasm: Tail of pancreas 
Malignancy ICD-10 C25.3 Malignant neoplasm: Pancreatic duct 
Malignancy ICD-10 C25.4 Malignant neoplasm: Endocrine pancreas 
Malignancy ICD-10 C25.7 Malignant neoplasm: Other parts of pancreas 
Malignancy ICD-10 C25.8 Malignant neoplasm: Overlapping lesion of pancreas 
Malignancy ICD-10 C25.9 Malignant neoplasm: Pancreas, unspecified 
Malignancy ICD-10 C26 Malignant neoplasm of other and ill-defined digestive organs 
Malignancy ICD-10 C26.0 Malignant neoplasm: Intestinal tract, part unspecified 
Malignancy ICD-10 C26.1 Malignant neoplasm: Spleen 
Malignancy ICD-10 C26.8 Malignant neoplasm: Overlapping lesion of digestive system 
Malignancy ICD-10 C26.9 Malignant neoplasm: Ill-defined sites within the digestive system 
Malignancy ICD-10 C30 Malignant neoplasm of nasal cavity and middle ear 
Malignancy ICD-10 C30.0 Malignant neoplasm: Nasal cavity 
Malignancy ICD-10 C30.1 Malignant neoplasm: Middle ear 
Malignancy ICD-10 C31 Malignant neoplasm of accessory sinuses 
Malignancy ICD-10 C31.0 Malignant neoplasm: Maxillary sinus 
Malignancy ICD-10 C31.1 Malignant neoplasm: Ethmoidal sinus 
Malignancy ICD-10 C31.2 Malignant neoplasm: Frontal sinus 
Malignancy ICD-10 C31.3 Malignant neoplasm: Sphenoidal sinus 
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Malignancy ICD-10 C31.8 Malignant neoplasm: Overlapping lesion of accessory sinuses 
Malignancy ICD-10 C31.9 Malignant neoplasm: Accessory sinus, unspecified 
Malignancy ICD-10 C32 Malignant neoplasm of larynx 
Malignancy ICD-10 C32.0 Malignant neoplasm: Glottis 
Malignancy ICD-10 C32.1 Malignant neoplasm: Supraglottis 
Malignancy ICD-10 C32.2 Malignant neoplasm: Subglottis 
Malignancy ICD-10 C32.3 Malignant neoplasm: Laryngeal cartilage 
Malignancy ICD-10 C32.8 Malignant neoplasm: Overlapping lesion of larynx 
Malignancy ICD-10 C32.9 Malignant neoplasm: Larynx, unspecified 
Malignancy ICD-10 C33 Malignant neoplasm of trachea 
Malignancy ICD-10 C34 Malignant neoplasm of bronchus and lung 
Malignancy ICD-10 C34.0 Malignant neoplasm: Main bronchus 
Malignancy ICD-10 C34.1 Malignant neoplasm: Upper lobe, bronchus or lung 
Malignancy ICD-10 C34.2 Malignant neoplasm: Middle lobe, bronchus or lung 
Malignancy ICD-10 C34.3 Malignant neoplasm: Lower lobe, bronchus or lung 
Malignancy ICD-10 C34.8 Malignant neoplasm: Overlapping lesion of bronchus and lung 
Malignancy ICD-10 C34.9 Malignant neoplasm: Bronchus or lung, unspecified 
Malignancy ICD-10 C37 Malignant neoplasm of thymus 
Malignancy ICD-10 C38 Malignant neoplasm of heart, mediastinum and pleura 
Malignancy ICD-10 C38.0 Malignant neoplasm: Heart 
Malignancy ICD-10 C38.1 Malignant neoplasm: Anterior mediastinum 
Malignancy ICD-10 C38.2 Malignant neoplasm: Posterior mediastinum 
Malignancy ICD-10 C38.3 Malignant neoplasm: Mediastinum, part unspecified 
Malignancy ICD-10 C38.4 Malignant neoplasm: Pleura 
Malignancy ICD-10 C38.8 
Malignant neoplasm: Overlapping lesion of heart, mediastinum 
and pleura 
Malignancy ICD-10 C39 
Malignant neoplasm of other and ill-defined sites in the 
respiratory system and intrathoracic organs 
Malignancy ICD-10 C39.0 Malignant neoplasm: Upper respiratory tract, part unspecified 
Malignancy ICD-10 C39.8 
Malignant neoplasm: Overlapping lesion of respiratory and 
intrathoracic organs 
Malignancy ICD-10 C39.9 Malignant neoplasm: Ill-defined sites within the respiratory system 
Malignancy ICD-10 C40 Malignant neoplasm of bone and articular cartilage of limbs 
Malignancy ICD-10 C40.0 Malignant neoplasm: Scapula and long bones of upper limb 
Malignancy ICD-10 C40.1 Malignant neoplasm: Short bones of upper limb 
Malignancy ICD-10 C40.2 Malignant neoplasm: Long bones of lower limb 
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Malignancy ICD-10 C40.3 Malignant neoplasm: Short bones of lower limb 
Malignancy ICD-10 C40.8 
Malignant neoplasm: Overlapping lesion of bone and articular 
cartilage of limbs 
Malignancy ICD-10 C40.9 
Malignant neoplasm: Bone and articular cartilage of limb, 
unspecified 
Malignancy ICD-10 C41 
Malignant neoplasm of bone and articular cartilage of other and 
unspecified sites 
Malignancy ICD-10 C41.0 Malignant neoplasm: Bones of skull and face 
Malignancy ICD-10 C41.1 Malignant neoplasm: Mandible 
Malignancy ICD-10 C41.2 Malignant neoplasm: Vertebral column 
Malignancy ICD-10 C41.3 Malignant neoplasm: Ribs, sternum and clavicle 
Malignancy ICD-10 C41.4 Malignant neoplasm: Pelvic bones, sacrum and coccyx 
Malignancy ICD-10 C41.8 
Malignant neoplasm: Overlapping lesion of bone and articular 
cartilage 
Malignancy ICD-10 C41.9 Malignant neoplasm: Bone and articular cartilage, unspecified 
Malignancy ICD-10 C43 Malignant melanoma of skin 
Malignancy ICD-10 C43.0 Malignant neoplasm: Malignant melanoma of lip 
Malignancy ICD-10 C43.1 
Malignant neoplasm: Malignant melanoma of eyelid, including 
canthus 
Malignancy ICD-10 C43.2 
Malignant neoplasm: Malignant melanoma of ear and external 
auricular canal 
Malignancy ICD-10 C43.3 
Malignant neoplasm: Malignant melanoma of other and 
unspecified parts of face 
Malignancy ICD-10 C43.4 Malignant neoplasm: Malignant melanoma of scalp and neck 
Malignancy ICD-10 C43.5 Malignant neoplasm: Malignant melanoma of trunk 
Malignancy ICD-10 C43.6 
Malignant neoplasm: Malignant melanoma of upper limb, 
including shoulder 
Malignancy ICD-10 C43.7 
Malignant neoplasm: Malignant melanoma of lower limb, 
including hip 
Malignancy ICD-10 C43.8 Malignant neoplasm: Overlapping malignant melanoma of skin 
Malignancy ICD-10 C43.9 Malignant neoplasm: Malignant melanoma of skin, unspecified 
Malignancy ICD-10 C44 Other malignant neoplasms of skin 
Malignancy ICD-10 C44.0 Malignant neoplasm: Skin of lip 
Malignancy ICD-10 C44.1 Malignant neoplasm: Skin of eyelid, including canthus 
Malignancy ICD-10 C44.2 Malignant neoplasm: Skin of ear and external auricular canal 
Malignancy ICD-10 C44.3 Malignant neoplasm: Skin of other and unspecified parts of face 
Malignancy ICD-10 C44.4 Malignant neoplasm: Skin of scalp and neck 
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Malignancy ICD-10 C44.5 Malignant neoplasm: Skin of trunk 
Malignancy ICD-10 C44.6 Malignant neoplasm: Skin of upper limb, including shoulder 
Malignancy ICD-10 C44.7 Malignant neoplasm: Skin of lower limb, including hip 
Malignancy ICD-10 C44.8 Malignant neoplasm: Overlapping lesion of skin 
Malignancy ICD-10 C44.9 Malignant neoplasm: Malignant neoplasm of skin, unspecified 
Malignancy ICD-10 C45 Mesothelioma 
Malignancy ICD-10 C46 Kaposi sarcoma 
Malignancy ICD-10 C47 
Malignant neoplasm of peripheral nerves and autonomic nervous 
system 
Malignancy ICD-10 C47.0 Malignant neoplasm: Peripheral nerves of head, face and neck 
Malignancy ICD-10 C47.1 
Malignant neoplasm: Peripheral nerves of upper limb, including 
shoulder 
Malignancy ICD-10 C47.2 
Malignant neoplasm: Peripheral nerves of lower limb, including 
hip 
Malignancy ICD-10 C47.3 Malignant neoplasm: Peripheral nerves of thorax 
Malignancy ICD-10 C47.4 Malignant neoplasm: Peripheral nerves of abdomen 
Malignancy ICD-10 C47.5 Malignant neoplasm: Peripheral nerves of pelvis 
Malignancy ICD-10 C47.6 Malignant neoplasm: Peripheral nerves of trunk, unspecified 
Malignancy ICD-10 C47.8 
Malignant neoplasm: Overlapping lesion of peripheral nerves and 
autonomic nervous system 
Malignancy ICD-10 C47.9 
Malignant neoplasm: Peripheral nerves and autonomic nervous 
system, unspecified 
Malignancy ICD-10 C48 Malignant neoplasm of retroperitoneum and peritoneum 
Malignancy ICD-10 C48.0 Malignant neoplasm: Retroperitoneum 
Malignancy ICD-10 C48.1 Malignant neoplasm: Specified parts of peritoneum 
Malignancy ICD-10 C48.2 Malignant neoplasm: Peritoneum, unspecified 
Malignancy ICD-10 C48.8 
Malignant neoplasm: Overlapping lesion of retroperitoneum and 
peritoneum 
Malignancy ICD-10 C49 Malignant neoplasm of other connective and soft tissue 
Malignancy ICD-10 C49.0 
Malignant neoplasm: Connective and soft tissue of head, face 
and neck 
Malignancy ICD-10 C49.1 
Malignant neoplasm: Connective and soft tissue of upper limb, 
including shoulder 
Malignancy ICD-10 C49.2 
Malignant neoplasm: Connective and soft tissue of lower limb, 
including hip 
Malignancy ICD-10 C49.3 Malignant neoplasm: Connective and soft tissue of thorax 
Malignancy ICD-10 C49.4 Malignant neoplasm: Connective and soft tissue of abdomen 
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Malignancy ICD-10 C49.5 Malignant neoplasm: Connective and soft tissue of pelvis 
Malignancy ICD-10 C49.6 
Malignant neoplasm: Connective and soft tissue of trunk, 
unspecified 
Malignancy ICD-10 C49.8 
Malignant neoplasm: Overlapping lesion of connective and soft 
tissue 
Malignancy ICD-10 C49.9 Malignant neoplasm: Connective and soft tissue, unspecified 
Malignancy ICD-10 C50 Malignant neoplasm of breast 
Malignancy ICD-10 C50.0 Malignant neoplasm: Nipple and areola 
Malignancy ICD-10 C50.1 Malignant neoplasm: Central portion of breast 
Malignancy ICD-10 C50.2 Malignant neoplasm: Upper-inner quadrant of breast 
Malignancy ICD-10 C50.3 Malignant neoplasm: Lower-inner quadrant of breast 
Malignancy ICD-10 C50.4 Malignant neoplasm: Upper-outer quadrant of breast 
Malignancy ICD-10 C50.5 Malignant neoplasm: Lower-outer quadrant of breast 
Malignancy ICD-10 C50.6 Malignant neoplasm: Axillary tail of breast 
Malignancy ICD-10 C50.8 Malignant neoplasm: Overlapping lesion of breast 
Malignancy ICD-10 C50.9 Malignant neoplasm: Breast, unspecified 
Malignancy ICD-10 C51 Malignant neoplasm of vulva 
Malignancy ICD-10 C51.0 Malignant neoplasm: Labium majus 
Malignancy ICD-10 C51.1 Malignant neoplasm: Labium minus 
Malignancy ICD-10 C51.2 Malignant neoplasm: Clitoris 
Malignancy ICD-10 C51.8 Malignant neoplasm: Overlapping lesion of vulva 
Malignancy ICD-10 C51.9 Malignant neoplasm: Vulva, unspecified 
Malignancy ICD-10 C52 Malignant neoplasm of vagina 
Malignancy ICD-10 C53 Malignant neoplasm of cervix uteri 
Malignancy ICD-10 C53.0 Malignant neoplasm: Endocervix 
Malignancy ICD-10 C53.1 Malignant neoplasm: Exocervix 
Malignancy ICD-10 C53.8 Malignant neoplasm: Overlapping lesion of cervix uteri 
Malignancy ICD-10 C53.9 Malignant neoplasm: Cervix uteri, unspecified 
Malignancy ICD-10 C54 Malignant neoplasm of corpus uteri 
Malignancy ICD-10 C54.0 Malignant neoplasm: Isthmus uteri 
Malignancy ICD-10 C54.1 Malignant neoplasm: Endometrium 
Malignancy ICD-10 C54.2 Malignant neoplasm: Myometrium 
Malignancy ICD-10 C54.3 Malignant neoplasm: Fundus uteri 
Malignancy ICD-10 C54.8 Malignant neoplasm: Overlapping lesion of corpus uteri 
Malignancy ICD-10 C54.9 Malignant neoplasm: Corpus uteri, unspecified 
Malignancy ICD-10 C55 Malignant neoplasm of uterus, part unspecified 
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Malignancy ICD-10 C56 Malignant neoplasm of ovary 
Malignancy ICD-10 C57 
Malignant neoplasm of other and unspecified female genital 
organs 
Malignancy ICD-10 C57.0 Malignant neoplasm: Fallopian tube 
Malignancy ICD-10 C57.1 Malignant neoplasm: Broad ligament 
Malignancy ICD-10 C57.2 Malignant neoplasm: Round ligament 
Malignancy ICD-10 C57.3 Malignant neoplasm: Parametrium 
Malignancy ICD-10 C57.4 Malignant neoplasm: Uterine adnexa, unspecified 
Malignancy ICD-10 C57.7 Malignant neoplasm: Other specified female genital organs 
Malignancy ICD-10 C57.8 Malignant neoplasm: Overlapping lesion of female genital organs 
Malignancy ICD-10 C57.9 Malignant neoplasm: Female genital organ, unspecified 
Malignancy ICD-10 C58 Malignant neoplasm of placenta 
Malignancy ICD-10 C60 Malignant neoplasm of penis 
Malignancy ICD-10 C60.0 Malignant neoplasm: Prepuce 
Malignancy ICD-10 C60.1 Malignant neoplasm: Glans penis 
Malignancy ICD-10 C60.2 Malignant neoplasm: Body of penis 
Malignancy ICD-10 C60.8 Malignant neoplasm: Overlapping lesion of penis 
Malignancy ICD-10 C60.9 Malignant neoplasm: Penis, unspecified 
Malignancy ICD-10 C61 Malignant neoplasm of prostate 
Malignancy ICD-10 C62 Malignant neoplasm of testis 
Malignancy ICD-10 C62.0 Malignant neoplasm: Undescended testis 
Malignancy ICD-10 C62.1 Malignant neoplasm: Descended testis 
Malignancy ICD-10 C62.9 Malignant neoplasm: Testis, unspecified 
Malignancy ICD-10 C63 Malignant neoplasm of other and unspecified male genital organs 
Malignancy ICD-10 C63.0 Malignant neoplasm: Epididymis 
Malignancy ICD-10 C63.1 Malignant neoplasm: Spermatic cord 
Malignancy ICD-10 C63.2 Malignant neoplasm: Scrotum 
Malignancy ICD-10 C63.7 Malignant neoplasm: Other specified male genital organs 
Malignancy ICD-10 C63.8 Malignant neoplasm: Overlapping lesion of male genital organs 
Malignancy ICD-10 C63.9 Malignant neoplasm: Male genital organ, unspecified 
Malignancy ICD-10 C64 Malignant neoplasm of kidney, except renal pelvis 
Malignancy ICD-10 C65 Malignant neoplasm of renal pelvis 
Malignancy ICD-10 C66 Malignant neoplasm of ureter 
Malignancy ICD-10 C67 Malignant neoplasm of bladder 
Malignancy ICD-10 C67.0 Malignant neoplasm: Trigone of bladder 
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Malignancy ICD-10 C67.1 Malignant neoplasm: Dome of bladder 
Malignancy ICD-10 C67.2 Malignant neoplasm: Lateral wall of bladder 
Malignancy ICD-10 C67.3 Malignant neoplasm: Anterior wall of bladder 
Malignancy ICD-10 C67.4 Malignant neoplasm: Posterior wall of bladder 
Malignancy ICD-10 C67.5 Malignant neoplasm: Bladder neck 
Malignancy ICD-10 C67.6 Malignant neoplasm: Ureteric orifice 
Malignancy ICD-10 C67.7 Malignant neoplasm: Urachus 
Malignancy ICD-10 C67.8 Malignant neoplasm: Overlapping lesion of bladder 
Malignancy ICD-10 C67.9 Malignant neoplasm: Bladder, unspecified 
Malignancy ICD-10 C68 Malignant neoplasm of other and unspecified urinary organs 
Malignancy ICD-10 C68.0 Malignant neoplasm: Urethra 
Malignancy ICD-10 C68.1 Malignant neoplasm: Paraurethral gland 
Malignancy ICD-10 C68.8 Malignant neoplasm: Overlapping lesion of urinary organs 
Malignancy ICD-10 C68.9 Malignant neoplasm: Urinary organ, unspecified 
Malignancy ICD-10 C69 Malignant neoplasm of eye and adnexa 
Malignancy ICD-10 C69.0 Malignant neoplasm: Conjunctiva 
Malignancy ICD-10 C69.1 Malignant neoplasm: Cornea 
Malignancy ICD-10 C69.2 Malignant neoplasm: Retina 
Malignancy ICD-10 C69.3 Malignant neoplasm: Choroid 
Malignancy ICD-10 C69.4 Malignant neoplasm: Ciliary body 
Malignancy ICD-10 C69.5 Malignant neoplasm: Lacrimal gland and duct 
Malignancy ICD-10 C69.6 Malignant neoplasm: Orbit 
Malignancy ICD-10 C69.8 Malignant neoplasm: Overlapping lesion of eye and adnexa 
Malignancy ICD-10 C69.9 Malignant neoplasm: Eye, unspecified 
Malignancy ICD-10 C70 Malignant neoplasm of meninges 
Malignancy ICD-10 C70.0 Malignant neoplasm: Cerebral meninges 
Malignancy ICD-10 C70.1 Malignant neoplasm: Spinal meninges 
Malignancy ICD-10 C70.9 Malignant neoplasm: Meninges, unspecified 
Malignancy ICD-10 C71 Malignant neoplasm of brain 
Malignancy ICD-10 C71.0 Malignant neoplasm: Cerebrum, except lobes and ventricles 
Malignancy ICD-10 C71.1 Malignant neoplasm: Frontal lobe 
Malignancy ICD-10 C71.2 Malignant neoplasm: Temporal lobe 
Malignancy ICD-10 C71.3 Malignant neoplasm: Parietal lobe 
Malignancy ICD-10 C71.4 Malignant neoplasm: Occipital lobe 
Malignancy ICD-10 C71.5 Malignant neoplasm: Cerebral ventricle 
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Malignancy ICD-10 C71.6 Malignant neoplasm: Cerebellum 
Malignancy ICD-10 C71.7 Malignant neoplasm: Brain stem 
Malignancy ICD-10 C71.8 Malignant neoplasm: Overlapping lesion of brain 
Malignancy ICD-10 C71.9 Malignant neoplasm: Brain, unspecified 
Malignancy ICD-10 C72 
Malignant neoplasm of spinal cord, cranial nerves and other parts 
of central nervous system 
Malignancy ICD-10 C72.0 Malignant neoplasm: Spinal cord 
Malignancy ICD-10 C72.1 Malignant neoplasm: Cauda equina 
Malignancy ICD-10 C72.2 Malignant neoplasm: Olfactory nerve 
Malignancy ICD-10 C72.3 Malignant neoplasm: Optic nerve 
Malignancy ICD-10 C72.4 Malignant neoplasm: Acoustic nerve 
Malignancy ICD-10 C72.5 Malignant neoplasm: Other and unspecified cranial nerves 
Malignancy ICD-10 C72.8 
Malignant neoplasm: Overlapping lesion of brain and other parts 
of central nervous system 
Malignancy ICD-10 C72.9 Malignant neoplasm: Central nervous system, unspecified 
Malignancy ICD-10 C73 Malignant neoplasm of thyroid gland 
Malignancy ICD-10 C74 Malignant neoplasm of adrenal gland 
Malignancy ICD-10 C74.0 Malignant neoplasm: Cortex of adrenal gland 
Malignancy ICD-10 C74.1 Malignant neoplasm: Medulla of adrenal gland 
Malignancy ICD-10 C74.9 Malignant neoplasm: Adrenal gland, unspecified 
Malignancy ICD-10 C75 
Malignant neoplasm of other endocrine glands and related 
structures 
Malignancy ICD-10 C75.0 Malignant neoplasm: Parathyroid gland 
Malignancy ICD-10 C75.1 Malignant neoplasm: Pituitary gland 
Malignancy ICD-10 C75.2 Malignant neoplasm: Craniopharyngeal duct 
Malignancy ICD-10 C75.3 Malignant neoplasm: Pineal gland 
Malignancy ICD-10 C75.4 Malignant neoplasm: Carotid body 
Malignancy ICD-10 C75.5 Malignant neoplasm: Aortic body and other paraganglia 
Malignancy ICD-10 C75.8 Malignant neoplasm: Pluriglandular involvement, unspecified 
Malignancy ICD-10 C75.9 Malignant neoplasm: Endocrine gland, unspecified 
Malignancy ICD-10 C76 Malignant neoplasm of other and ill-defined sites 
Malignancy ICD-10 C76.0 
Malignant neoplasm of other and ill-defined sites: Head, face and 
neck 
Malignancy ICD-10 C76.1 Malignant neoplasm of other and ill-defined sites: Thorax 
Malignancy ICD-10 C76.2 Malignant neoplasm of other and ill-defined sites: Abdomen 
Malignancy ICD-10 C76.3 Malignant neoplasm of other and ill-defined sites: Pelvis 
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Malignancy ICD-10 C76.4 Malignant neoplasm of other and ill-defined sites: Upper limb 
Malignancy ICD-10 C76.5 Malignant neoplasm of other and ill-defined sites: Lower limb 
Malignancy ICD-10 C76.7 
Malignant neoplasm of other and ill-defined sites: Other ill-defined 
sites 
Malignancy ICD-10 C76.8 
Malignant neoplasm of other and ill-defined sites: Overlapping 
lesion of other and ill-defined sites 
Malignancy ICD-10 C77 Secondary and unspecified malignant neoplasm of lymph nodes 
Malignancy ICD-10 C77.0 
Secondary and unspecified malignant neoplasm: Lymph nodes of 
head, face and neck 
Malignancy ICD-10 C77.1 
Secondary and unspecified malignant neoplasm: Intrathoracic 
lymph nodes 
Malignancy ICD-10 C77.2 
Secondary and unspecified malignant neoplasm: Intra-abdominal 
lymph nodes 
Malignancy ICD-10 C77.3 
Secondary and unspecified malignant neoplasm: Axillary and 
upper limb lymph nodes 
Malignancy ICD-10 C77.4 
Secondary and unspecified malignant neoplasm: Inguinal and 
lower limb lymph nodes 
Malignancy ICD-10 C77.5 
Secondary and unspecified malignant neoplasm: Intrapelvic 
lymph nodes 
Malignancy ICD-10 C77.8 
Secondary and unspecified malignant neoplasm: Lymph nodes of 
multiple regions 
Malignancy ICD-10 C77.9 
Secondary and unspecified malignant neoplasm: Lymph node, 
unspecified 
Malignancy ICD-10 C78 
Secondary malignant neoplasm of respiratory and digestive 
organs 
Malignancy ICD-10 C79 Secondary malignant neoplasm of other and unspecified sites 
Malignancy ICD-10 C80 Malignant neoplasm, without specification of site 
Malignancy ICD-10 C81 Hodgkin lymphoma 
Malignancy ICD-10 C81.0 Nodular lymphocyte predominant Hodgkin lymphoma 
Malignancy ICD-10 C81.1 Nodular sclerosis classical Hodgkin lymphoma 
Malignancy ICD-10 C81.2 Mixed cellularity classical Hodgkin lymphoma 
Malignancy ICD-10 C81.3 Lymphocyte depleted classical Hodgkin lymphoma 
Malignancy ICD-10 C81.7 Other classical Hodgkin lymphoma 
Malignancy ICD-10 C81.9 Hodgkin lymphoma, unspecified 
Malignancy ICD-10 C82 Follicular lymphoma 
Malignancy ICD-10 C82.0 Follicular lymphoma grade I 
Malignancy ICD-10 C82.1 Follicular lymphoma grade II 
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Malignancy ICD-10 C82.2 Follicular lymphoma grade III, unspecified 
Malignancy ICD-10 C83 Non-follicular lymphoma 
Malignancy ICD-10 C83.0 Small cell B-cell lymphoma 
Malignancy ICD-10 C83.1 Mantle cell lymphoma 
Malignancy ICD-10 C83.5 Lymphoblastic (diffuse) lymphoma 
Malignancy ICD-10 C84 Mature T/NK-cell lymphomas 
Malignancy ICD-10 C85 Other and unspecified types of non-Hodgkin lymphoma 
Malignancy ICD-10 C86 Other specified types of T/NK-cell lymphoma 
Malignancy ICD-10 C88 Malignant immunoproliferative diseases 
Malignancy ICD-10 C90 Multiple myeloma and malignant plasma cell neoplasms 
Malignancy ICD-10 C91 Lymphoid leukaemia 
Malignancy ICD-10 C92 Myeloid leukaemia 
Malignancy ICD-10 C93 Monocytic leukaemia 
Malignancy ICD-10 C94 Other leukaemias of specified cell type 
Malignancy ICD-10 C95 Leukaemia of unspecified cell type 
Malignancy ICD-10 C96 
Other and unspecified malignant neoplasms of lymphoid, 
haematopoietic and related tissue 
Malignancy ICD-10 C97 Malignant neoplasms of independent (primary) multiple sites 
Malignancy Read B0...00 Malignant neoplasm of lip, oral cavity and pharynx 
Malignancy Read B0...11 Carcinoma of lip, oral cavity and pharynx 
Malignancy Read B00..00 Malignant neoplasm of lip 
Malignancy Read B00..11 Carcinoma of lip 
Malignancy Read B000.00 Malignant neoplasm of upper lip, vermilion border 
Malignancy Read B000000 Malignant neoplasm of upper lip, external 
Malignancy Read B000100 Malignant neoplasm of upper lip, lipstick area 
Malignancy Read B000z00 Malignant neoplasm of upper lip, vermilion border NOS 
Malignancy Read B001.00 Malignant neoplasm of lower lip, vermilion border 
Malignancy Read B001000 Malignant neoplasm of lower lip, external 
Malignancy Read B001100 Malignant neoplasm of lower lip, lipstick area 
Malignancy Read B001z00 Malignant neoplasm of lower lip, vermilion border NOS 
Malignancy Read B002.00 Malignant neoplasm of upper lip, inner aspect 
Malignancy Read B002100 Malignant neoplasm of upper lip, frenulum 
Malignancy Read B002200 Malignant neoplasm of upper lip, mucosa 
Malignancy Read B002300 Malignant neoplasm of upper lip, oral aspect 
Malignancy Read B002z00 Malignant neoplasm of upper lip, inner aspect NOS 
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Malignancy Read B003.00 Malignant neoplasm of lower lip, inner aspect 
Malignancy Read B003000 Malignant neoplasm of lower lip, buccal aspect 
Malignancy Read B003100 Malignant neoplasm of lower lip, frenulum 
Malignancy Read B003200 Malignant neoplasm of lower lip, mucosa 
Malignancy Read B003300 Malignant neoplasm of lower lip, oral aspect 
Malignancy Read B003z00 Malignant neoplasm of lower lip, inner aspect NOS 
Malignancy Read B004.00 Malignant neoplasm of lip unspecified, inner aspect 
Malignancy Read B004000 Malignant neoplasm of lip unspecified, buccal aspect 
Malignancy Read B004200 Malignant neoplasm of lip unspecified, mucosa 
Malignancy Read B004300 Malignant neoplasm of lip, oral aspect 
Malignancy Read B005.00 Malignant neoplasm of commissure of lip 
Malignancy Read B006.00 Malignant neoplasm of overlapping lesion of lip 
Malignancy Read B007.00 Malignant neoplasm of lip, unspecified 
Malignancy Read B00z000 Malignant neoplasm of lip, unspecified, external 
Malignancy Read B00z100 Malignant neoplasm of lip, unspecified, lipstick area 
Malignancy Read B00zz00 Malignant neoplasm of lip, vermilion border NOS 
Malignancy Read B01..00 Malignant neoplasm of tongue 
Malignancy Read B010.00 Malignant neoplasm of base of tongue 
Malignancy Read B010.11 Malignant neoplasm of posterior third of tongue 
Malignancy Read B010000 Malignant neoplasm of base of tongue dorsal surface 
Malignancy Read B010z00 Malignant neoplasm of fixed part of tongue NOS 
Malignancy Read B011.00 Malignant neoplasm of dorsal surface of tongue 
Malignancy Read B011z00 Malignant neoplasm of dorsum of tongue NOS 
Malignancy Read B012.00 Malignant neoplasm of tongue, tip and lateral border 
Malignancy Read B013.00 Malignant neoplasm of ventral surface of tongue 
Malignancy Read B013000 Malignant neoplasm of anterior 2/3 of tongue ventral surface 
Malignancy Read B013100 Malignant neoplasm of frenulum linguae 
Malignancy Read B013z00 Malignant neoplasm of ventral tongue surface NOS 
Malignancy Read B014.00 Malignant neoplasm of anterior 2/3 of tongue unspecified 
Malignancy Read B015.00 Malignant neoplasm of tongue, junctional zone 
Malignancy Read B016.00 Malignant neoplasm of lingual tonsil 
Malignancy Read B017.00 Malignant overlapping lesion of tongue 
Malignancy Read B01y.00 Malignant neoplasm of other sites of tongue 
Malignancy Read B01z.00 Malignant neoplasm of tongue NOS 
Malignancy Read B02..00 Malignant neoplasm of major salivary glands 
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Malignancy Read B020.00 Malignant neoplasm of parotid gland 
Malignancy Read B021.00 Malignant neoplasm of submandibular gland 
Malignancy Read B022.00 Malignant neoplasm of sublingual gland 
Malignancy Read B02y.00 Malignant neoplasm of other major salivary glands 
Malignancy Read B02z.00 Malignant neoplasm of major salivary gland NOS 
Malignancy Read B03..00 Malignant neoplasm of gum 
Malignancy Read B030.00 Malignant neoplasm of upper gum 
Malignancy Read B031.00 Malignant neoplasm of lower gum 
Malignancy Read B03y.00 Malignant neoplasm of other sites of gum 
Malignancy Read B03z.00 Malignant neoplasm of gum NOS 
Malignancy Read B04..00 Malignant neoplasm of floor of mouth 
Malignancy Read B040.00 Malignant neoplasm of anterior portion of floor of mouth 
Malignancy Read B041.00 Malignant neoplasm of lateral portion of floor of mouth 
Malignancy Read B042.00 Malignant neoplasm, overlapping lesion of floor of mouth 
Malignancy Read B04y.00 Malignant neoplasm of other sites of floor of mouth 
Malignancy Read B04z.00 Malignant neoplasm of floor of mouth NOS 
Malignancy Read B05..00 Malignant neoplasm of other and unspecified parts of mouth 
Malignancy Read B050.00 Malignant neoplasm of cheek mucosa 
Malignancy Read B050.11 Malignant neoplasm of buccal mucosa 
Malignancy Read B051.00 Malignant neoplasm of vestibule of mouth 
Malignancy Read B051000 Malignant neoplasm of upper buccal sulcus 
Malignancy Read B051100 Malignant neoplasm of lower buccal sulcus 
Malignancy Read B052.00 Malignant neoplasm of hard palate 
Malignancy Read B053.00 Malignant neoplasm of soft palate 
Malignancy Read B054.00 Malignant neoplasm of uvula 
Malignancy Read B055.00 Malignant neoplasm of palate unspecified 
Malignancy Read B055000 Malignant neoplasm of junction of hard and soft palate 
Malignancy Read B055100 Malignant neoplasm of roof of mouth 
Malignancy Read B055z00 Malignant neoplasm of palate NOS 
Malignancy Read B056.00 Malignant neoplasm of retromolar area 
Malignancy Read B057.00 Overlapping lesion of other and unspecified parts of mouth 
Malignancy Read B05y.00 Malignant neoplasm of other specified mouth parts 
Malignancy Read B05z.00 Malignant neoplasm of mouth NOS 
Malignancy Read B05z000 Kaposi's sarcoma of palate 
Malignancy Read B06..00 Malignant neoplasm of oropharynx 
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Malignancy Read B060.00 Malignant neoplasm of tonsil 
Malignancy Read B060000 Malignant neoplasm of faucial tonsil 
Malignancy Read B060100 Malignant neoplasm of palatine tonsil 
Malignancy Read B060200 Malignant neoplasm of overlapping lesion of tonsil 
Malignancy Read B060z00 Malignant neoplasm tonsil NOS 
Malignancy Read B061.00 Malignant neoplasm of tonsillar fossa 
Malignancy Read B062.00 Malignant neoplasm of tonsillar pillar 
Malignancy Read B062000 Malignant neoplasm of faucial pillar 
Malignancy Read B062100 Malignant neoplasm of glossopalatine fold 
Malignancy Read B062200 Malignant neoplasm of palatoglossal arch 
Malignancy Read B062300 Malignant neoplasm of palatopharyngeal arch 
Malignancy Read B062z00 Malignant neoplasm of tonsillar fossa NOS 
Malignancy Read B063.00 Malignant neoplasm of vallecula 
Malignancy Read B064.00 Malignant neoplasm of anterior epiglottis 
Malignancy Read B064000 Malignant neoplasm of epiglottis, free border 
Malignancy Read B064100 Malignant neoplasm of glossoepiglottic fold 
Malignancy Read B064z00 Malignant neoplasm of anterior epiglottis NOS 
Malignancy Read B065.00 Malignant neoplasm of junctional region of epiglottis 
Malignancy Read B066.00 Malignant neoplasm of lateral wall of oropharynx 
Malignancy Read B067.00 Malignant neoplasm of posterior wall of oropharynx 
Malignancy Read B06y.00 Malignant neoplasm of oropharynx, other specified sites 
Malignancy Read B06yz00 Malignant neoplasm of other specified site of oropharynx NOS 
Malignancy Read B06z.00 Malignant neoplasm of oropharynx NOS 
Malignancy Read B07..00 Malignant neoplasm of nasopharynx 
Malignancy Read B070.00 Malignant neoplasm of roof of nasopharynx 
Malignancy Read B071.00 Malignant neoplasm of posterior wall of nasopharynx 
Malignancy Read B071000 Malignant neoplasm of adenoid 
Malignancy Read B071100 Malignant neoplasm of pharyngeal tonsil 
Malignancy Read B071z00 Malignant neoplasm of posterior wall of nasopharynx NOS 
Malignancy Read B072.00 Malignant neoplasm of lateral wall of nasopharynx 
Malignancy Read B072000 Malignant neoplasm of pharyngeal recess 
Malignancy Read B072z00 Malignant neoplasm of lateral wall of nasopharynx NOS 
Malignancy Read B073.00 Malignant neoplasm of anterior wall of nasopharynx 
Malignancy Read B073100 Malignant neoplasm of nasopharyngeal soft palate surface 
Malignancy Read B073200 Malignant neoplasm posterior margin nasal septum and choanae 
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Malignancy Read B073z00 Malignant neoplasm of anterior wall of nasopharynx NOS 
Malignancy Read B074.00 Malignant neoplasm, overlapping lesion of nasopharynx 
Malignancy Read B07y.00 Malignant neoplasm of other specified site of nasopharynx 
Malignancy Read B07z.00 Malignant neoplasm of nasopharynx NOS 
Malignancy Read B08..00 Malignant neoplasm of hypopharynx 
Malignancy Read B080.00 Malignant neoplasm of postcricoid region 
Malignancy Read B081.00 Malignant neoplasm of pyriform sinus 
Malignancy Read B082.00 Malignant neoplasm aryepiglottic fold, hypopharyngeal aspect 
Malignancy Read B083.00 Malignant neoplasm of posterior pharynx 
Malignancy Read B08y.00 Malignant neoplasm of other specified hypopharyngeal site 
Malignancy Read B08z.00 Malignant neoplasm of hypopharynx NOS 
Malignancy Read B0z..00 Malig neop other/ill-defined sites lip, oral cavity, pharynx 
Malignancy Read B0z0.00 Malignant neoplasm of pharynx unspecified 
Malignancy Read B0z1.00 Malignant neoplasm of Waldeyer's ring 
Malignancy Read B0z2.00 Malignant neoplasm of laryngopharynx 
Malignancy Read B0zy.00 Malignant neoplasm of other sites lip, oral cavity, pharynx 
Malignancy Read B0zz.00 Malignant neoplasm of lip, oral cavity and pharynx NOS 
Malignancy Read B1...00 Malignant neoplasm of digestive organs and peritoneum 
Malignancy Read B1...11 Carcinoma of digestive organs and peritoneum 
Malignancy Read B10..00 Malignant neoplasm of oesophagus 
Malignancy Read B100.00 Malignant neoplasm of cervical oesophagus 
Malignancy Read B101.00 Malignant neoplasm of thoracic oesophagus 
Malignancy Read B102.00 Malignant neoplasm of abdominal oesophagus 
Malignancy Read B103.00 Malignant neoplasm of upper third of oesophagus 
Malignancy Read B104.00 Malignant neoplasm of middle third of oesophagus 
Malignancy Read B105.00 Malignant neoplasm of lower third of oesophagus 
Malignancy Read B106.00 Malignant neoplasm, overlapping lesion of oesophagus 
Malignancy Read B107.00 Siewert type I adenocarcinoma 
Malignancy Read B10y.00 Malignant neoplasm of other specified part of oesophagus 
Malignancy Read B10z.00 Malignant neoplasm of oesophagus NOS 
Malignancy Read B10z.11 Oesophageal cancer 
Malignancy Read B11..00 Malignant neoplasm of stomach 
Malignancy Read B11..11 Gastric neoplasm 
Malignancy Read B110.00 Malignant neoplasm of cardia of stomach 
Malignancy Read B110000 Malignant neoplasm of cardiac orifice of stomach 
  
 
1
8
2
 
Condition / Diagnosis Coding System Code Description 
Malignancy Read B110100 Malignant neoplasm of cardio-oesophageal junction of stomach 
Malignancy Read B110111 Malignant neoplasm of gastro-oesophageal junction 
Malignancy Read B110z00 Malignant neoplasm of cardia of stomach NOS 
Malignancy Read B111.00 Malignant neoplasm of pylorus of stomach 
Malignancy Read B111000 Malignant neoplasm of prepylorus of stomach 
Malignancy Read B111100 Malignant neoplasm of pyloric canal of stomach 
Malignancy Read B111z00 Malignant neoplasm of pylorus of stomach NOS 
Malignancy Read B112.00 Malignant neoplasm of pyloric antrum of stomach 
Malignancy Read B113.00 Malignant neoplasm of fundus of stomach 
Malignancy Read B114.00 Malignant neoplasm of body of stomach 
Malignancy Read B115.00 Malignant neoplasm of lesser curve of stomach unspecified 
Malignancy Read B116.00 Malignant neoplasm of greater curve of stomach unspecified 
Malignancy Read B117.00 Malignant neoplasm, overlapping lesion of stomach 
Malignancy Read B118.00 Siewert type II adenocarcinoma 
Malignancy Read B119.00 Siewert type III adenocarcinoma 
Malignancy Read B11y.00 Malignant neoplasm of other specified site of stomach 
Malignancy Read B11y000 Malignant neoplasm of anterior wall of stomach NEC 
Malignancy Read B11y100 Malignant neoplasm of posterior wall of stomach NEC 
Malignancy Read B11yz00 Malignant neoplasm of other specified site of stomach NOS 
Malignancy Read B11z.00 Malignant neoplasm of stomach NOS 
Malignancy Read B12..00 Malignant neoplasm of small intestine and duodenum 
Malignancy Read B120.00 Malignant neoplasm of duodenum 
Malignancy Read B121.00 Malignant neoplasm of jejunum 
Malignancy Read B122.00 Malignant neoplasm of ileum 
Malignancy Read B123.00 Malignant neoplasm of Meckel's diverticulum 
Malignancy Read B124.00 Malignant neoplasm, overlapping lesion of small intestine 
Malignancy Read B12y.00 Malignant neoplasm of other specified site small intestine 
Malignancy Read B12z.00 Malignant neoplasm of small intestine NOS 
Malignancy Read B13..00 Malignant neoplasm of colon 
Malignancy Read B130.00 Malignant neoplasm of hepatic flexure of colon 
Malignancy Read B131.00 Malignant neoplasm of transverse colon 
Malignancy Read B132.00 Malignant neoplasm of descending colon 
Malignancy Read B133.00 Malignant neoplasm of sigmoid colon 
Malignancy Read B134.00 Malignant neoplasm of caecum 
Malignancy Read B134.11 Carcinoma of caecum 
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Malignancy Read B135.00 Malignant neoplasm of appendix 
Malignancy Read B136.00 Malignant neoplasm of ascending colon 
Malignancy Read B137.00 Malignant neoplasm of splenic flexure of colon 
Malignancy Read B138.00 Malignant neoplasm, overlapping lesion of colon 
Malignancy Read B139.00 Hereditary nonpolyposis colon cancer 
Malignancy Read B13y.00 Malignant neoplasm of other specified sites of colon 
Malignancy Read B13z.00 Malignant neoplasm of colon NOS 
Malignancy Read B13z.11 Colonic cancer 
Malignancy Read B14..00 Malignant neoplasm of rectum, rectosigmoid junction and anus 
Malignancy Read B140.00 Malignant neoplasm of rectosigmoid junction 
Malignancy Read B141.00 Malignant neoplasm of rectum 
Malignancy Read B141.11 Carcinoma of rectum 
Malignancy Read B141.12 Rectal carcinoma 
Malignancy Read B142.00 Malignant neoplasm of anal canal 
Malignancy Read B142.11 Anal carcinoma 
Malignancy Read B142000 Malignant neoplasm of cloacogenic zone 
Malignancy Read B143.00 Malignant neoplasm of anus unspecified 
Malignancy Read B14y.00 Malig neop other site rectum, rectosigmoid junction and anus 
Malignancy Read B14z.00 Malignant neoplasm rectum,rectosigmoid junction and anus NOS 
Malignancy Read B15..00 Malignant neoplasm of liver and intrahepatic bile ducts 
Malignancy Read B150.00 Primary malignant neoplasm of liver 
Malignancy Read B150000 Primary carcinoma of liver 
Malignancy Read B150100 Hepatoblastoma of liver 
Malignancy Read B150200 Primary angiosarcoma of liver 
Malignancy Read B150300 Hepatocellular carcinoma 
Malignancy Read B150z00 Primary malignant neoplasm of liver NOS 
Malignancy Read B151.00 Malignant neoplasm of intrahepatic bile ducts 
Malignancy Read B151000 Malignant neoplasm of interlobular bile ducts 
Malignancy Read B151200 Malignant neoplasm of intrahepatic biliary passages 
Malignancy Read B151400 Malignant neoplasm of intrahepatic gall duct 
Malignancy Read B151z00 Malignant neoplasm of intrahepatic bile ducts NOS 
Malignancy Read B152.00 Malignant neoplasm of liver unspecified 
Malignancy Read B153.00 Secondary malignant neoplasm of liver 
Malignancy Read B15z.00 Malignant neoplasm of liver and intrahepatic bile ducts NOS 
Malignancy Read B16..00 Malignant neoplasm gallbladder and extrahepatic bile ducts 
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Malignancy Read B160.00 Malignant neoplasm of gallbladder 
Malignancy Read B160.11 Carcinoma gallbladder 
Malignancy Read B161.00 Malignant neoplasm of extrahepatic bile ducts 
Malignancy Read B161000 Malignant neoplasm of cystic duct 
Malignancy Read B161100 Malignant neoplasm of hepatic duct 
Malignancy Read B161200 Malignant neoplasm of common bile duct 
Malignancy Read B161211 Carcinoma common bile duct 
Malignancy Read B161300 Malignant neoplasm of sphincter of Oddi 
Malignancy Read B161z00 Malignant neoplasm of extrahepatic bile ducts NOS 
Malignancy Read B162.00 Malignant neoplasm of ampulla of Vater 
Malignancy Read B163.00 Malignant neoplasm, overlapping lesion of biliary tract 
Malignancy Read B16y.00 Malignant neoplasm other gallbladder/extrahepatic bile duct 
Malignancy Read B16z.00 Malignant neoplasm gallbladder/extrahepatic bile ducts NOS 
Malignancy Read B17..00 Malignant neoplasm of pancreas 
Malignancy Read B170.00 Malignant neoplasm of head of pancreas 
Malignancy Read B171.00 Malignant neoplasm of body of pancreas 
Malignancy Read B172.00 Malignant neoplasm of tail of pancreas 
Malignancy Read B173.00 Malignant neoplasm of pancreatic duct 
Malignancy Read B174.00 Malignant neoplasm of Islets of Langerhans 
Malignancy Read B175.00 Malignant neoplasm, overlapping lesion of pancreas 
Malignancy Read B17y.00 Malignant neoplasm of other specified sites of pancreas 
Malignancy Read B17y000 Malignant neoplasm of ectopic pancreatic tissue 
Malignancy Read B17yz00 Malignant neoplasm of specified site of pancreas NOS 
Malignancy Read B17z.00 Malignant neoplasm of pancreas NOS 
Malignancy Read B18..00 Malignant neoplasm of retroperitoneum and peritoneum 
Malignancy Read B180.00 Malignant neoplasm of retroperitoneum 
Malignancy Read B180100 Malignant neoplasm of perinephric tissue 
Malignancy Read B180200 Malignant neoplasm of retrocaecal tissue 
Malignancy Read B180z00 Malignant neoplasm of retroperitoneum NOS 
Malignancy Read B181.00 Mesothelioma of peritoneum 
Malignancy Read B182.00 Overlapping malign lesion of retroperitoneum and peritoneum 
Malignancy Read B18y.00 Malignant neoplasm of specified parts of peritoneum 
Malignancy Read B18y100 Malignant neoplasm of mesocaecum 
Malignancy Read B18y200 Malignant neoplasm of mesorectum 
Malignancy Read B18y300 Malignant neoplasm of omentum 
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Malignancy Read B18y400 Malignant neoplasm of parietal peritoneum 
Malignancy Read B18y500 Malignant neoplasm of pelvic peritoneum 
Malignancy Read B18y600 Malignant neoplasm of the pouch of Douglas 
Malignancy Read B18y700 Malignant neoplasm of mesentery 
Malignancy Read B18yz00 Malignant neoplasm of specified parts of peritoneum NOS 
Malignancy Read B18z.00 Malignant neoplasm of retroperitoneum and peritoneum NOS 
Malignancy Read B1z..00 Malig neop oth/ill-defined sites digestive tract/peritoneum 
Malignancy Read B1z0.00 Malignant neoplasm of intestinal tract, part unspecified 
Malignancy Read B1z0.11 Cancer of bowel 
Malignancy Read B1z1.00 Malignant neoplasm of spleen NEC 
Malignancy Read B1z1100 Fibrosarcoma of spleen 
Malignancy Read B1z1z00 Malignant neoplasm of spleen NOS 
Malignancy Read B1z2.00 Malignant neoplasm, overlapping lesion of digestive system 
Malignancy Read B1zy.00 Malignant neoplasm other spec digestive tract and peritoneum 
Malignancy Read B1zz.00 Malignant neoplasm of digestive tract and peritoneum NOS 
Malignancy Read B2...00 Malig neop of respiratory tract and intrathoracic organs 
Malignancy Read B2...11 Carcinoma of respiratory tract and intrathoracic organs 
Malignancy Read B20..00 Malig neop nasal cavities, middle ear and accessory sinuses 
Malignancy Read B200.00 Malignant neoplasm of nasal cavities 
Malignancy Read B200000 Malignant neoplasm of cartilage of nose 
Malignancy Read B200100 Malignant neoplasm of nasal conchae 
Malignancy Read B200200 Malignant neoplasm of septum of nose 
Malignancy Read B200300 Malignant neoplasm of vestibule of nose 
Malignancy Read B200z00 Malignant neoplasm of nasal cavities NOS 
Malignancy Read B201.00 Malig neop auditory tube, middle ear and mastoid air cells 
Malignancy Read B201100 Malignant neoplasm of tympanic cavity 
Malignancy Read B201200 Malignant neoplasm of tympanic antrum 
Malignancy Read B201300 Malignant neoplasm of mastoid air cells 
Malignancy Read B201z00 Malig neop auditory tube, middle ear, mastoid air cells NOS 
Malignancy Read B202.00 Malignant neoplasm of maxillary sinus 
Malignancy Read B203.00 Malignant neoplasm of ethmoid sinus 
Malignancy Read B204.00 Malignant neoplasm of frontal sinus 
Malignancy Read B205.00 Malignant neoplasm of sphenoidal sinus 
Malignancy Read B206.00 Malignant neoplasm, overlapping lesion of accessory sinuses 
Malignancy Read B20y.00 Malig neop other site nasal cavity, middle ear and sinuses 
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Malignancy Read B20z.00 Malignant neoplasm of accessory sinus NOS 
Malignancy Read B21..00 Malignant neoplasm of larynx 
Malignancy Read B210.00 Malignant neoplasm of glottis 
Malignancy Read B211.00 Malignant neoplasm of supraglottis 
Malignancy Read B212.00 Malignant neoplasm of subglottis 
Malignancy Read B213.00 Malignant neoplasm of laryngeal cartilage 
Malignancy Read B213000 Malignant neoplasm of arytenoid cartilage 
Malignancy Read B213100 Malignant neoplasm of cricoid cartilage 
Malignancy Read B213300 Malignant neoplasm of thyroid cartilage 
Malignancy Read B213z00 Malignant neoplasm of laryngeal cartilage NOS 
Malignancy Read B214.00 Malignant neoplasm, overlapping lesion of larynx 
Malignancy Read B215.00 Malignant neoplasm of epiglottis NOS 
Malignancy Read B21y.00 Malignant neoplasm of larynx, other specified site 
Malignancy Read B21z.00 Malignant neoplasm of larynx NOS 
Malignancy Read B22..00 Malignant neoplasm of trachea, bronchus and lung 
Malignancy Read B220.00 Malignant neoplasm of trachea 
Malignancy Read B220100 Malignant neoplasm of mucosa of trachea 
Malignancy Read B220z00 Malignant neoplasm of trachea NOS 
Malignancy Read B221.00 Malignant neoplasm of main bronchus 
Malignancy Read B221000 Malignant neoplasm of carina of bronchus 
Malignancy Read B221100 Malignant neoplasm of hilus of lung 
Malignancy Read B221z00 Malignant neoplasm of main bronchus NOS 
Malignancy Read B222.00 Malignant neoplasm of upper lobe, bronchus or lung 
Malignancy Read B222.11 Pancoast's syndrome 
Malignancy Read B222000 Malignant neoplasm of upper lobe bronchus 
Malignancy Read B222100 Malignant neoplasm of upper lobe of lung 
Malignancy Read B222z00 Malignant neoplasm of upper lobe, bronchus or lung NOS 
Malignancy Read B223.00 Malignant neoplasm of middle lobe, bronchus or lung 
Malignancy Read B223000 Malignant neoplasm of middle lobe bronchus 
Malignancy Read B223100 Malignant neoplasm of middle lobe of lung 
Malignancy Read B223z00 Malignant neoplasm of middle lobe, bronchus or lung NOS 
Malignancy Read B224.00 Malignant neoplasm of lower lobe, bronchus or lung 
Malignancy Read B224000 Malignant neoplasm of lower lobe bronchus 
Malignancy Read B224100 Malignant neoplasm of lower lobe of lung 
Malignancy Read B224z00 Malignant neoplasm of lower lobe, bronchus or lung NOS 
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Malignancy Read B225.00 Malignant neoplasm of overlapping lesion of bronchus & lung 
Malignancy Read B226.00 Mesothelioma 
Malignancy Read B22y.00 Malignant neoplasm of other sites of bronchus or lung 
Malignancy Read B22z.00 Malignant neoplasm of bronchus or lung NOS 
Malignancy Read B22z.11 Lung cancer 
Malignancy Read B23..00 Malignant neoplasm of pleura 
Malignancy Read B230.00 Malignant neoplasm of parietal pleura 
Malignancy Read B231.00 Malignant neoplasm of visceral pleura 
Malignancy Read B232.00 Mesothelioma of pleura 
Malignancy Read B23y.00 Malignant neoplasm of other specified pleura 
Malignancy Read B23z.00 Malignant neoplasm of pleura NOS 
Malignancy Read B24..00 Malignant neoplasm of thymus, heart and mediastinum 
Malignancy Read B240.00 Malignant neoplasm of thymus 
Malignancy Read B241.00 Malignant neoplasm of heart 
Malignancy Read B241000 Malignant neoplasm of endocardium 
Malignancy Read B241200 Malignant neoplasm of myocardium 
Malignancy Read B241300 Malignant neoplasm of pericardium 
Malignancy Read B241400 Mesothelioma of pericardium 
Malignancy Read B241z00 Malignant neoplasm of heart NOS 
Malignancy Read B242.00 Malignant neoplasm of anterior mediastinum 
Malignancy Read B243.00 Malignant neoplasm of posterior mediastinum 
Malignancy Read B24X.00 Malignant neoplasm of mediastinum, part unspecified 
Malignancy Read B24y.00 Malig neop of other site of heart, thymus and mediastinum 
Malignancy Read B24z.00 Malignant neoplasm of heart, thymus and mediastinum NOS 
Malignancy Read B25..00 Malig neo, overlapping lesion of heart, mediastinum & pleura 
Malignancy Read B26..00 Malignant neoplasm, overlap lesion of resp & intrathor orgs 
Malignancy Read B2z..00 Malig neop other/ill-defined sites resp/intrathoracic organs 
Malignancy Read B2z0.00 Malig neop of upper respiratory tract, part unspecified 
Malignancy Read B2zy.00 Malignant neoplasm of other site of respiratory tract 
Malignancy Read B2zz.00 Malignant neoplasm of respiratory tract NOS 
Malignancy Read B3...00 Malig neop of bone, connective tissue, skin and breast 
Malignancy Read B3...11 Carcinoma of bone, connective tissue, skin and breast 
Malignancy Read B3...12 Sarcoma of bone and connective tissue 
Malignancy Read B30..00 Malignant neoplasm of bone and articular cartilage 
Malignancy Read B30..11 Chondroma 
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Malignancy Read B30..12 Osteoma 
Malignancy Read B300.00 Malignant neoplasm of bones of skull and face 
Malignancy Read B300000 Malignant neoplasm of ethmoid bone 
Malignancy Read B300100 Malignant neoplasm of frontal bone 
Malignancy Read B300200 Malignant neoplasm of malar bone 
Malignancy Read B300300 Malignant neoplasm of nasal bone 
Malignancy Read B300400 Malignant neoplasm of occipital bone 
Malignancy Read B300500 Malignant neoplasm of orbital bone 
Malignancy Read B300600 Malignant neoplasm of parietal bone 
Malignancy Read B300700 Malignant neoplasm of sphenoid bone 
Malignancy Read B300800 Malignant neoplasm of temporal bone 
Malignancy Read B300900 Malignant neoplasm of zygomatic bone 
Malignancy Read B300A00 Malignant neoplasm of maxilla 
Malignancy Read B300B00 Malignant neoplasm of turbinate 
Malignancy Read B300C00 Malignant neoplasm of vomer 
Malignancy Read B300z00 Malignant neoplasm of bones of skull and face NOS 
Malignancy Read B301.00 Malignant neoplasm of mandible 
Malignancy Read B302.00 Malignant neoplasm of vertebral column 
Malignancy Read B302000 Malignant neoplasm of cervical vertebra 
Malignancy Read B302100 Malignant neoplasm of thoracic vertebra 
Malignancy Read B302200 Malignant neoplasm of lumbar vertebra 
Malignancy Read B302z00 Malignant neoplasm of vertebral column NOS 
Malignancy Read B303.00 Malignant neoplasm of ribs, sternum and clavicle 
Malignancy Read B303000 Malignant neoplasm of rib 
Malignancy Read B303100 Malignant neoplasm of sternum 
Malignancy Read B303200 Malignant neoplasm of clavicle 
Malignancy Read B303300 Malignant neoplasm of costal cartilage 
Malignancy Read B303400 Malignant neoplasm of costo-vertebral joint 
Malignancy Read B303500 Malignant neoplasm of xiphoid process 
Malignancy Read B303z00 Malignant neoplasm of rib, sternum and clavicle NOS 
Malignancy Read B304.00 Malignant neoplasm of scapula and long bones of upper arm 
Malignancy Read B304000 Malignant neoplasm of scapula 
Malignancy Read B304100 Malignant neoplasm of acromion 
Malignancy Read B304200 Malignant neoplasm of humerus 
Malignancy Read B304300 Malignant neoplasm of radius 
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Malignancy Read B304400 Malignant neoplasm of ulna 
Malignancy Read B304z00 Malig neop of scapula and long bones of upper arm NOS 
Malignancy Read B305.00 Malignant neoplasm of hand bones 
Malignancy Read B305.11 Malignant neoplasm of carpal bones 
Malignancy Read B305.12 Malignant neoplasm of metacarpal bones 
Malignancy Read B305000 Malignant neoplasm of carpal bone - scaphoid 
Malignancy Read B305100 Malignant neoplasm of carpal bone - lunate 
Malignancy Read B305C00 Malignant neoplasm of fifth metacarpal bone 
Malignancy Read B305D00 Malignant neoplasm of phalanges of hand 
Malignancy Read B305z00 Malignant neoplasm of hand bones NOS 
Malignancy Read B306.00 Malignant neoplasm of pelvic bones, sacrum and coccyx 
Malignancy Read B306000 Malignant neoplasm of ilium 
Malignancy Read B306100 Malignant neoplasm of ischium 
Malignancy Read B306200 Malignant neoplasm of pubis 
Malignancy Read B306300 Malignant neoplasm of sacral vertebra 
Malignancy Read B306400 Malignant neoplasm of coccygeal vertebra 
Malignancy Read B306500 Malignant sacral teratoma 
Malignancy Read B306z00 Malignant neoplasm of pelvis, sacrum or coccyx NOS 
Malignancy Read B307.00 Malignant neoplasm of long bones of leg 
Malignancy Read B307000 Malignant neoplasm of femur 
Malignancy Read B307100 Malignant neoplasm of fibula 
Malignancy Read B307200 Malignant neoplasm of tibia 
Malignancy Read B307z00 Malignant neoplasm of long bones of leg NOS 
Malignancy Read B308.00 Malignant neoplasm of short bones of leg 
Malignancy Read B308100 Malignant neoplasm of talus 
Malignancy Read B308200 Malignant neoplasm of calcaneum 
Malignancy Read B308300 Malignant neoplasm of medial cuneiform 
Malignancy Read B308800 Malignant neoplasm of first metatarsal bone 
Malignancy Read B308B00 Malignant neoplasm of fourth metatarsal bone 
Malignancy Read B308D00 Malignant neoplasm of phalanges of foot 
Malignancy Read B308z00 Malignant neoplasm of short bones of leg NOS 
Malignancy Read B30W.00 Malignant neoplasm/overlap lesion/bone+articulr cartilage 
Malignancy Read B30X.00 Malignant neoplasm/bones+articular cartilage/limb,unspfd 
Malignancy Read B30z.00 Malignant neoplasm of bone and articular cartilage NOS 
Malignancy Read B30z000 Osteosarcoma 
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Malignancy Read B31..00 Malignant neoplasm of connective and other soft tissue 
Malignancy Read B310.00 Malig neop of connective and soft tissue head, face and neck 
Malignancy Read B310000 Malignant neoplasm of soft tissue of head 
Malignancy Read B310100 Malignant neoplasm of soft tissue of face 
Malignancy Read B310200 Malignant neoplasm of soft tissue of neck 
Malignancy Read B310300 Malignant neoplasm of cartilage of ear 
Malignancy Read B310400 Malignant neoplasm of tarsus of eyelid 
Malignancy Read B310z00 Malig neop connective and soft tissue head, face, neck NOS 
Malignancy Read B311.00 Malig neop connective and soft tissue upper limb/shoulder 
Malignancy Read B311000 Malignant neoplasm of connective and soft tissue of shoulder 
Malignancy Read B311100 Malignant neoplasm of connective and soft tissue, upper arm 
Malignancy Read B311200 Malignant neoplasm of connective and soft tissue of fore-arm 
Malignancy Read B311300 Malignant neoplasm of connective and soft tissue of hand 
Malignancy Read B311400 Malignant neoplasm of connective and soft tissue of finger 
Malignancy Read B311500 Malignant neoplasm of connective and soft tissue of thumb 
Malignancy Read B311z00 Malig neop connective soft tissue upper limb/shoulder NOS 
Malignancy Read B312.00 Malig neop of connective and soft tissue of hip and leg 
Malignancy Read B312000 Malignant neoplasm of connective and soft tissue of hip 
Malignancy Read B312100 Malig neop of connective and soft tissue thigh and upper leg 
Malignancy Read B312200 Malig neop connective and soft tissue of popliteal space 
Malignancy Read B312300 Malig neop of connective and soft tissue of lower leg 
Malignancy Read B312400 Malignant neoplasm of connective and soft tissue of foot 
Malignancy Read B312500 Malignant neoplasm of connective and soft tissue of toe 
Malignancy Read B312z00 Malig neop connective and soft tissue hip and leg NOS 
Malignancy Read B313.00 Malignant neoplasm of connective and soft tissue of thorax 
Malignancy Read B313000 Malignant neoplasm of connective and soft tissue of axilla 
Malignancy Read B313100 Malignant neoplasm of diaphragm 
Malignancy Read B313200 Malignant neoplasm of great vessels 
Malignancy Read B313300 Malig neoplasm of connective and soft tissues of thor spine 
Malignancy Read B313z00 Malig neop of connective and soft tissue of thorax NOS 
Malignancy Read B314.00 Malignant neoplasm of connective and soft tissue of abdomen 
Malignancy Read B314000 Malig neop of connective and soft tissue of abdominal wall 
Malignancy Read B314100 Malig neoplasm of connective and soft tissues of lumb spine 
Malignancy Read B314z00 Malig neop of connective and soft tissue of abdomen NOS 
Malignancy Read B315.00 Malignant neoplasm of connective and soft tissue of pelvis 
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Malignancy Read B315000 Malignant neoplasm of connective and soft tissue of buttock 
Malignancy Read B315100 Malig neop of connective and soft tissue of inguinal region 
Malignancy Read B315200 Malignant neoplasm of connective and soft tissue of perineum 
Malignancy Read B315z00 Malig neop of connective and soft tissue of pelvis NOS 
Malignancy Read B316.00 Malig neop of connective and soft tissue trunk unspecified 
Malignancy Read B31y.00 Malig neop connective and soft tissue other specified site 
Malignancy Read B31z.00 Malignant neoplasm of connective and soft tissue, site NOS 
Malignancy Read B31z000 Kaposi's sarcoma of soft tissue 
Malignancy Read B32..00 Malignant melanoma of skin 
Malignancy Read B320.00 Malignant melanoma of lip 
Malignancy Read B321.00 Malignant melanoma of eyelid including canthus 
Malignancy Read B322.00 Malignant melanoma of ear and external auricular canal 
Malignancy Read B322000 Malignant melanoma of auricle (ear) 
Malignancy Read B322100 Malignant melanoma of external auditory meatus 
Malignancy Read B322z00 Malignant melanoma of ear and external auricular canal NOS 
Malignancy Read B323.00 Malignant melanoma of other and unspecified parts of face 
Malignancy Read B323000 Malignant melanoma of external surface of cheek 
Malignancy Read B323100 Malignant melanoma of chin 
Malignancy Read B323200 Malignant melanoma of eyebrow 
Malignancy Read B323300 Malignant melanoma of forehead 
Malignancy Read B323400 Malignant melanoma of external surface of nose 
Malignancy Read B323500 Malignant melanoma of temple 
Malignancy Read B323z00 Malignant melanoma of face NOS 
Malignancy Read B324.00 Malignant melanoma of scalp and neck 
Malignancy Read B324000 Malignant melanoma of scalp 
Malignancy Read B324100 Malignant melanoma of neck 
Malignancy Read B324z00 Malignant melanoma of scalp and neck NOS 
Malignancy Read B325.00 Malignant melanoma of trunk (excluding scrotum) 
Malignancy Read B325000 Malignant melanoma of axilla 
Malignancy Read B325100 Malignant melanoma of breast 
Malignancy Read B325200 Malignant melanoma of buttock 
Malignancy Read B325300 Malignant melanoma of groin 
Malignancy Read B325500 Malignant melanoma of perineum 
Malignancy Read B325600 Malignant melanoma of umbilicus 
Malignancy Read B325700 Malignant melanoma of back 
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Malignancy Read B325800 Malignant melanoma of chest wall 
Malignancy Read B325z00 Malignant melanoma of trunk, excluding scrotum, NOS 
Malignancy Read B326.00 Malignant melanoma of upper limb and shoulder 
Malignancy Read B326000 Malignant melanoma of shoulder 
Malignancy Read B326100 Malignant melanoma of upper arm 
Malignancy Read B326200 Malignant melanoma of fore-arm 
Malignancy Read B326300 Malignant melanoma of hand 
Malignancy Read B326400 Malignant melanoma of finger 
Malignancy Read B326500 Malignant melanoma of thumb 
Malignancy Read B326z00 Malignant melanoma of upper limb or shoulder NOS 
Malignancy Read B327.00 Malignant melanoma of lower limb and hip 
Malignancy Read B327000 Malignant melanoma of hip 
Malignancy Read B327100 Malignant melanoma of thigh 
Malignancy Read B327200 Malignant melanoma of knee 
Malignancy Read B327300 Malignant melanoma of popliteal fossa area 
Malignancy Read B327400 Malignant melanoma of lower leg 
Malignancy Read B327500 Malignant melanoma of ankle 
Malignancy Read B327600 Malignant melanoma of heel 
Malignancy Read B327700 Malignant melanoma of foot 
Malignancy Read B327800 Malignant melanoma of toe 
Malignancy Read B327900 Malignant melanoma of great toe 
Malignancy Read B327z00 Malignant melanoma of lower limb or hip NOS 
Malignancy Read B32y.00 Malignant melanoma of other specified skin site 
Malignancy Read B32y000 Overlapping malignant melanoma of skin 
Malignancy Read B32z.00 Malignant melanoma of skin NOS 
Malignancy Read B33..00 Other malignant neoplasm of skin 
Malignancy Read B33..11 Basal cell carcinoma 
Malignancy Read B33..12 Epithelioma 
Malignancy Read B33..13 Rodent ulcer 
Malignancy Read B33..14 Malignant neoplasm of sebaceous gland 
Malignancy Read B33..15 Malignant neoplasm of sweat gland 
Malignancy Read B33..16 Epithelioma basal cell 
Malignancy Read B330.00 Malignant neoplasm of skin of lip 
Malignancy Read B331.00 Malignant neoplasm of eyelid including canthus 
Malignancy Read B331000 Malignant neoplasm of canthus 
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Malignancy Read B331100 Malignant neoplasm of upper eyelid 
Malignancy Read B331200 Malignant neoplasm of lower eyelid 
Malignancy Read B332.00 Malignant neoplasm skin of ear and external auricular canal 
Malignancy Read B332000 Malignant neoplasm of skin of auricle (ear) 
Malignancy Read B332100 Malignant neoplasm of skin of external auditory meatus 
Malignancy Read B332200 Malignant neoplasm of pinna NEC 
Malignancy Read B332z00 Malig neop skin of ear and external auricular canal NOS 
Malignancy Read B333.00 Malignant neoplasm skin of other and unspecified parts face 
Malignancy Read B333000 Malignant neoplasm of skin of cheek, external 
Malignancy Read B333100 Malignant neoplasm of skin of chin 
Malignancy Read B333200 Malignant neoplasm of skin of eyebrow 
Malignancy Read B333300 Malignant neoplasm of skin of forehead 
Malignancy Read B333400 Malignant neoplasm of skin of nose (external) 
Malignancy Read B333500 Malignant neoplasm of skin of temple 
Malignancy Read B333z00 Malignant neoplasm skin other and unspec part of face NOS 
Malignancy Read B334.00 Malignant neoplasm of scalp and skin of neck 
Malignancy Read B334000 Malignant neoplasm of scalp 
Malignancy Read B334100 Malignant neoplasm of skin of neck 
Malignancy Read B334z00 Malignant neoplasm of scalp or skin of neck NOS 
Malignancy Read B335.00 Malignant neoplasm of skin of trunk, excluding scrotum 
Malignancy Read B335000 Malignant neoplasm of skin of axillary fold 
Malignancy Read B335100 Malignant neoplasm of skin of chest, excluding breast 
Malignancy Read B335200 Malignant neoplasm of skin of breast 
Malignancy Read B335300 Malignant neoplasm of skin of abdominal wall 
Malignancy Read B335400 Malignant neoplasm of skin of umbilicus 
Malignancy Read B335500 Malignant neoplasm of skin of groin 
Malignancy Read B335600 Malignant neoplasm of skin of perineum 
Malignancy Read B335700 Malignant neoplasm of skin of back 
Malignancy Read B335800 Malignant neoplasm of skin of buttock 
Malignancy Read B335900 Malignant neoplasm of perianal skin 
Malignancy Read B335A00 Malignant neoplasm of skin of scapular region 
Malignancy Read B335z00 Malignant neoplasm of skin of trunk, excluding scrotum, NOS 
Malignancy Read B336.00 Malignant neoplasm of skin of upper limb and shoulder 
Malignancy Read B336000 Malignant neoplasm of skin of shoulder 
Malignancy Read B336100 Malignant neoplasm of skin of upper arm 
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Malignancy Read B336200 Malignant neoplasm of skin of fore-arm 
Malignancy Read B336300 Malignant neoplasm of skin of hand 
Malignancy Read B336400 Malignant neoplasm of skin of finger 
Malignancy Read B336500 Malignant neoplasm of skin of thumb 
Malignancy Read B336z00 Malignant neoplasm of skin of upper limb or shoulder NOS 
Malignancy Read B337.00 Malignant neoplasm of skin of lower limb and hip 
Malignancy Read B337000 Malignant neoplasm of skin of hip 
Malignancy Read B337100 Malignant neoplasm of skin of thigh 
Malignancy Read B337200 Malignant neoplasm of skin of knee 
Malignancy Read B337300 Malignant neoplasm of skin of popliteal fossa area 
Malignancy Read B337400 Malignant neoplasm of skin of lower leg 
Malignancy Read B337500 Malignant neoplasm of skin of ankle 
Malignancy Read B337600 Malignant neoplasm of skin of heel 
Malignancy Read B337700 Malignant neoplasm of skin of foot 
Malignancy Read B337800 Malignant neoplasm of skin of toe 
Malignancy Read B337900 Malignant neoplasm of skin of great toe 
Malignancy Read B337z00 Malignant neoplasm of skin of lower limb or hip NOS 
Malignancy Read B338.00 Squamous cell carcinoma of skin 
Malignancy Read B339.00 Dermatofibrosarcoma protuberans 
Malignancy Read B33X.00 Malignant neoplasm overlapping lesion of skin 
Malignancy Read B33y.00 Malignant neoplasm of other specified skin sites 
Malignancy Read B33z.00 Malignant neoplasm of skin NOS 
Malignancy Read B33z.11 Squamous cell carcinoma of skin NOS 
Malignancy Read B33z000 Kaposi's sarcoma of skin 
Malignancy Read B33z100 Naevoid basal cell carcinoma syndrome 
Malignancy Read B33z111 Basal cell naevus syndrome 
Malignancy Read B34..00 Malignant neoplasm of female breast 
Malignancy Read B34..11 Ca female breast 
Malignancy Read B340.00 Malignant neoplasm of nipple and areola of female breast 
Malignancy Read B340000 Malignant neoplasm of nipple of female breast 
Malignancy Read B340100 Malignant neoplasm of areola of female breast 
Malignancy Read B340z00 Malignant neoplasm of nipple or areola of female breast NOS 
Malignancy Read B341.00 Malignant neoplasm of central part of female breast 
Malignancy Read B342.00 Malignant neoplasm of upper-inner quadrant of female breast 
Malignancy Read B343.00 Malignant neoplasm of lower-inner quadrant of female breast 
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Malignancy Read B344.00 Malignant neoplasm of upper-outer quadrant of female breast 
Malignancy Read B345.00 Malignant neoplasm of lower-outer quadrant of female breast 
Malignancy Read B346.00 Malignant neoplasm of axillary tail of female breast 
Malignancy Read B347.00 Malignant neoplasm, overlapping lesion of breast 
Malignancy Read B34y.00 Malignant neoplasm of other site of female breast 
Malignancy Read B34y000 Malignant neoplasm of ectopic site of female breast 
Malignancy Read B34yz00 Malignant neoplasm of other site of female breast NOS 
Malignancy Read B34z.00 Malignant neoplasm of female breast NOS 
Malignancy Read B35..00 Malignant neoplasm of male breast 
Malignancy Read B350.00 Malignant neoplasm of nipple and areola of male breast 
Malignancy Read B350000 Malignant neoplasm of nipple of male breast 
Malignancy Read B350100 Malignant neoplasm of areola of male breast 
Malignancy Read B35z.00 Malignant neoplasm of other site of male breast 
Malignancy Read B35z000 Malignant neoplasm of ectopic site of male breast 
Malignancy Read B35zz00 Malignant neoplasm of male breast NOS 
Malignancy Read B36..00 Local recurrence of malignant tumour of breast 
Malignancy Read B3y..00 Malig neop of bone, connective tissue, skin and breast OS 
Malignancy Read B3z..00 Malig neop of bone, connective tissue, skin and breast NOS 
Malignancy Read B4...00 Malignant neoplasm of genitourinary organ 
Malignancy Read B4...11 Carcinoma of genitourinary organ 
Malignancy Read B40..00 Malignant neoplasm of uterus, part unspecified 
Malignancy Read B41..00 Malignant neoplasm of cervix uteri 
Malignancy Read B41..11 Cervical carcinoma (uterus) 
Malignancy Read B410.00 Malignant neoplasm of endocervix 
Malignancy Read B410000 Malignant neoplasm of endocervical canal 
Malignancy Read B410100 Malignant neoplasm of endocervical gland 
Malignancy Read B410z00 Malignant neoplasm of endocervix NOS 
Malignancy Read B411.00 Malignant neoplasm of exocervix 
Malignancy Read B412.00 Malignant neoplasm, overlapping lesion of cervix uteri 
Malignancy Read B41y.00 Malignant neoplasm of other site of cervix 
Malignancy Read B41y000 Malignant neoplasm of cervical stump 
Malignancy Read B41y100 Malignant neoplasm of squamocolumnar junction of cervix 
Malignancy Read B41yz00 Malignant neoplasm of other site of cervix NOS 
Malignancy Read B41z.00 Malignant neoplasm of cervix uteri NOS 
Malignancy Read B42..00 Malignant neoplasm of placenta 
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Malignancy Read B420.00 Choriocarcinoma 
Malignancy Read B43..00 Malignant neoplasm of body of uterus 
Malignancy Read B430.00 Malignant neoplasm of corpus uteri, excluding isthmus 
Malignancy Read B430000 Malignant neoplasm of cornu of corpus uteri 
Malignancy Read B430100 Malignant neoplasm of fundus of corpus uteri 
Malignancy Read B430200 Malignant neoplasm of endometrium of corpus uteri 
Malignancy Read B430211 Malignant neoplasm of endometrium 
Malignancy Read B430300 Malignant neoplasm of myometrium of corpus uteri 
Malignancy Read B430z00 Malignant neoplasm of corpus uteri NOS 
Malignancy Read B431.00 Malignant neoplasm of isthmus of uterine body 
Malignancy Read B431000 Malignant neoplasm of lower uterine segment 
Malignancy Read B431z00 Malignant neoplasm of isthmus of uterine body NOS 
Malignancy Read B432.00 Malignant neoplasm of overlapping lesion of corpus uteri 
Malignancy Read B43y.00 Malignant neoplasm of other site of uterine body 
Malignancy Read B43z.00 Malignant neoplasm of body of uterus NOS 
Malignancy Read B44..00 Malignant neoplasm of ovary and other uterine adnexa 
Malignancy Read B440.00 Malignant neoplasm of ovary 
Malignancy Read B440.11 Cancer of ovary 
Malignancy Read B441.00 Malignant neoplasm of fallopian tube 
Malignancy Read B442.00 Malignant neoplasm of broad ligament 
Malignancy Read B443.00 Malignant neoplasm of parametrium 
Malignancy Read B44y.00 Malignant neoplasm of other site of uterine adnexa 
Malignancy Read B44z.00 Malignant neoplasm of uterine adnexa NOS 
Malignancy Read B45..00 Malig neop of other and unspecified female genital organs 
Malignancy Read B450.00 Malignant neoplasm of vagina 
Malignancy Read B450100 Malignant neoplasm of vaginal vault 
Malignancy Read B450z00 Malignant neoplasm of vagina NOS 
Malignancy Read B451.00 Malignant neoplasm of labia majora 
Malignancy Read B451000 Malignant neoplasm of greater vestibular (Bartholin's) gland 
Malignancy Read B451z00 Malignant neoplasm of labia majora NOS 
Malignancy Read B452.00 Malignant neoplasm of labia minora 
Malignancy Read B453.00 Malignant neoplasm of clitoris 
Malignancy Read B454.00 Malignant neoplasm of vulva unspecified 
Malignancy Read B454.11 Primary vulval cancer 
Malignancy Read B45X.00 Malignant neoplasm/overlapping lesion/feml genital organs 
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Malignancy Read B45y.00 Malignant neoplasm of other specified female genital organ 
Malignancy Read B45y000 Malignant neoplasm of overlapping lesion of vulva 
Malignancy Read B45z.00 Malignant neoplasm of female genital organ NOS 
Malignancy Read B46..00 Malignant neoplasm of prostate 
Malignancy Read B47..00 Malignant neoplasm of testis 
Malignancy Read B470.00 Malignant neoplasm of undescended testis 
Malignancy Read B470200 Seminoma of undescended testis 
Malignancy Read B470300 Teratoma of undescended testis 
Malignancy Read B470z00 Malignant neoplasm of undescended testis NOS 
Malignancy Read B471.00 Malignant neoplasm of descended testis 
Malignancy Read B471000 Seminoma of descended testis 
Malignancy Read B471100 Teratoma of descended testis 
Malignancy Read B471z00 Malignant neoplasm of descended testis NOS 
Malignancy Read B47z.00 Malignant neoplasm of testis NOS 
Malignancy Read B47z.11 Seminoma of testis 
Malignancy Read B47z.12 Teratoma of testis 
Malignancy Read B48..00 Malignant neoplasm of penis and other male genital organs 
Malignancy Read B480.00 Malignant neoplasm of prepuce (foreskin) 
Malignancy Read B481.00 Malignant neoplasm of glans penis 
Malignancy Read B482.00 Malignant neoplasm of body of penis 
Malignancy Read B483.00 Malignant neoplasm of penis, part unspecified 
Malignancy Read B484.00 Malignant neoplasm of epididymis 
Malignancy Read B485.00 Malignant neoplasm of spermatic cord 
Malignancy Read B486.00 Malignant neoplasm of scrotum 
Malignancy Read B487.00 Malignant neoplasm, overlapping lesion of penis 
Malignancy Read B48y.00 Malignant neoplasm of other male genital organ 
Malignancy Read B48y000 Malignant neoplasm of seminal vesicle 
Malignancy Read B48y100 Malignant neoplasm of tunica vaginalis 
Malignancy Read B48y200 Malignant neoplasm, overlapping lesion male genital orgs 
Malignancy Read B48yz00 Malignant neoplasm of other male genital organ NOS 
Malignancy Read B48z.00 Malignant neoplasm of penis and other male genital organ NOS 
Malignancy Read B49..00 Malignant neoplasm of urinary bladder 
Malignancy Read B490.00 Malignant neoplasm of trigone of urinary bladder 
Malignancy Read B491.00 Malignant neoplasm of dome of urinary bladder 
Malignancy Read B492.00 Malignant neoplasm of lateral wall of urinary bladder 
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Malignancy Read B493.00 Malignant neoplasm of anterior wall of urinary bladder 
Malignancy Read B494.00 Malignant neoplasm of posterior wall of urinary bladder 
Malignancy Read B495.00 Malignant neoplasm of bladder neck 
Malignancy Read B496.00 Malignant neoplasm of ureteric orifice 
Malignancy Read B497.00 Malignant neoplasm of urachus 
Malignancy Read B498.00 Local recurrence of malignant tumour of urinary bladder 
Malignancy Read B49y.00 Malignant neoplasm of other site of urinary bladder 
Malignancy Read B49y000 Malignant neoplasm, overlapping lesion of bladder 
Malignancy Read B49z.00 Malignant neoplasm of urinary bladder NOS 
Malignancy Read B4A..00 Malig neop of kidney and other unspecified urinary organs 
Malignancy Read B4A..11 Renal malignant neoplasm 
Malignancy Read B4A0.00 Malignant neoplasm of kidney parenchyma 
Malignancy Read B4A0000 Hypernephroma 
Malignancy Read B4A1.00 Malignant neoplasm of renal pelvis 
Malignancy Read B4A1000 Malignant neoplasm of renal calyces 
Malignancy Read B4A1100 Malignant neoplasm of ureteropelvic junction 
Malignancy Read B4A1z00 Malignant neoplasm of renal pelvis NOS 
Malignancy Read B4A2.00 Malignant neoplasm of ureter 
Malignancy Read B4A3.00 Malignant neoplasm of urethra 
Malignancy Read B4A4.00 Malignant neoplasm of paraurethral glands 
Malignancy Read B4Ay.00 Malignant neoplasm of other urinary organs 
Malignancy Read B4Ay000 Malignant neoplasm of overlapping lesion of urinary organs 
Malignancy Read B4Az.00 Malignant neoplasm of kidney or urinary organs NOS 
Malignancy Read B4y..00 Malignant neoplasm of genitourinary organ OS 
Malignancy Read B4z..00 Malignant neoplasm of genitourinary organ NOS 
Malignancy Read B5...00 Malignant neoplasm of other and unspecified sites 
Malignancy Read B5...11 Carcinoma of other and unspecified sites 
Malignancy Read B50..00 Malignant neoplasm of eye 
Malignancy Read B500.00 Malig neop eyeball excl conjunctiva, cornea, retina, choroid 
Malignancy Read B500000 Malignant neoplasm of ciliary body 
Malignancy Read B500100 Malignant neoplasm of iris 
Malignancy Read B500200 Malignant neoplasm of crystalline lens 
Malignancy Read B500z00 Malignant neoplasm of eyeball NOS 
Malignancy Read B501.00 Malignant neoplasm of orbit 
Malignancy Read B501000 Malignant neoplasm of connective tissue of orbit 
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Malignancy Read B501z00 Malignant neoplasm of orbit NOS 
Malignancy Read B502.00 Malignant neoplasm of lacrimal gland 
Malignancy Read B503.00 Malignant neoplasm of conjunctiva 
Malignancy Read B504.00 Malignant neoplasm of cornea 
Malignancy Read B505.00 Malignant neoplasm of retina 
Malignancy Read B506.00 Malignant neoplasm of choroid 
Malignancy Read B507.00 Malignant neoplasm of lacrimal duct 
Malignancy Read B507000 Malignant neoplasm of lacrimal sac 
Malignancy Read B507100 Malignant neoplasm of nasolacrimal duct 
Malignancy Read B508.00 Malignant neoplasm, overlapping lesion of eye and adnexa 
Malignancy Read B50y.00 Malignant neoplasm of other specified site of eye 
Malignancy Read B50z.00 Malignant neoplasm of eye NOS 
Malignancy Read B51..00 Malignant neoplasm of brain 
Malignancy Read B51..11 Cerebral tumour - malignant 
Malignancy Read B510.00 Malignant neoplasm cerebrum (excluding lobes and ventricles) 
Malignancy Read B510000 Malignant neoplasm of basal ganglia 
Malignancy Read B510100 Malignant neoplasm of cerebral cortex 
Malignancy Read B510300 Malignant neoplasm of globus pallidus 
Malignancy Read B510400 Malignant neoplasm of hypothalamus 
Malignancy Read B510500 Malignant neoplasm of thalamus 
Malignancy Read B510z00 Malignant neoplasm of cerebrum NOS 
Malignancy Read B511.00 Malignant neoplasm of frontal lobe 
Malignancy Read B512.00 Malignant neoplasm of temporal lobe 
Malignancy Read B512000 Malignant neoplasm of hippocampus 
Malignancy Read B512z00 Malignant neoplasm of temporal lobe NOS 
Malignancy Read B513.00 Malignant neoplasm of parietal lobe 
Malignancy Read B514.00 Malignant neoplasm of occipital lobe 
Malignancy Read B515.00 Malignant neoplasm of cerebral ventricles 
Malignancy Read B515000 Malignant neoplasm of choroid plexus 
Malignancy Read B516.00 Malignant neoplasm of cerebellum 
Malignancy Read B517.00 Malignant neoplasm of brain stem 
Malignancy Read B517000 Malignant neoplasm of cerebral peduncle 
Malignancy Read B517100 Malignant neoplasm of medulla oblongata 
Malignancy Read B517200 Malignant neoplasm of midbrain 
Malignancy Read B517300 Malignant neoplasm of pons 
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Malignancy Read B517z00 Malignant neoplasm of brain stem NOS 
Malignancy Read B51y.00 Malignant neoplasm of other parts of brain 
Malignancy Read B51y000 Malignant neoplasm of corpus callosum 
Malignancy Read B51y200 Malignant neoplasm, overlapping lesion of brain 
Malignancy Read B51yz00 Malignant neoplasm of other part of brain NOS 
Malignancy Read B51z.00 Malignant neoplasm of brain NOS 
Malignancy Read B52..00 Malig neop of other and unspecified parts of nervous system 
Malignancy Read B520.00 Malignant neoplasm of cranial nerves 
Malignancy Read B520000 Malignant neoplasm of olfactory bulb 
Malignancy Read B520100 Malignant neoplasm of optic nerve 
Malignancy Read B520200 Malignant neoplasm of acoustic nerve 
Malignancy Read B520z00 Malignant neoplasm of cranial nerves NOS 
Malignancy Read B521.00 Malignant neoplasm of cerebral meninges 
Malignancy Read B521z00 Malignant neoplasm of cerebral meninges NOS 
Malignancy Read B522.00 Malignant neoplasm of spinal cord 
Malignancy Read B523.00 Malignant neoplasm of spinal meninges 
Malignancy Read B523z00 Malignant neoplasm of spinal meninges NOS 
Malignancy Read B524.00 Malig neopl peripheral nerves and autonomic nervous system 
Malignancy Read B524000 Malignant neoplasm of peripheral nerves of head, face & neck 
Malignancy Read B524100 Malignant neoplasm of peripheral nerve,upp limb,incl should 
Malignancy Read B524200 Malignant neoplasm of peripheral nerve of low limb, incl hip 
Malignancy Read B524300 Malignant neoplasm of peripheral nerve of thorax 
Malignancy Read B524400 Malignant neoplasm of peripheral nerve of abdomen 
Malignancy Read B524500 Malignant neoplasm of peripheral nerve of pelvis 
Malignancy Read B524600 Malignant neoplasm,overlap lesion periph nerve & auton ns 
Malignancy Read B524W00 Mal neoplasm/periph nerves+autonomic nervous system,unspc 
Malignancy Read B525.00 Malignant neoplasm of cauda equina 
Malignancy Read B52W.00 Malig neopl, overlap lesion brain & other part of CNS 
Malignancy Read B52X.00 Malignant neoplasm of meninges, unspecified 
Malignancy Read B52y.00 Malignant neoplasm of other specified part of nervous system 
Malignancy Read B52z.00 Malignant neoplasm of nervous system NOS 
Malignancy Read B53..00 Malignant neoplasm of thyroid gland 
Malignancy Read B54..00 Malig neop of other endocrine glands and related structures 
Malignancy Read B540.00 Malignant neoplasm of adrenal gland 
Malignancy Read B540.11 Phaeochromocytoma 
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Malignancy Read B540000 Malignant neoplasm of adrenal cortex 
Malignancy Read B540100 Malignant neoplasm of adrenal medulla 
Malignancy Read B540z00 Malignant neoplasm of adrenal gland NOS 
Malignancy Read B541.00 Malignant neoplasm of parathyroid gland 
Malignancy Read B542.00 Malignant neoplasm pituitary gland and craniopharyngeal duct 
Malignancy Read B542000 Malignant neoplasm of pituitary gland 
Malignancy Read B542100 Malignant neoplasm of craniopharyngeal duct 
Malignancy Read B542z00 Malig neop pituitary gland or craniopharyngeal duct NOS 
Malignancy Read B543.00 Malignant neoplasm of pineal gland 
Malignancy Read B544.00 Malignant neoplasm of carotid body 
Malignancy Read B545.00 Malignant neoplasm of aortic body and other paraganglia 
Malignancy Read B545000 Malignant neoplasm of glomus jugulare 
Malignancy Read B545100 Malignant neoplasm of aortic body 
Malignancy Read B545200 Malignant neoplasm of coccygeal body 
Malignancy Read B545z00 Malignant neoplasm of aortic body or paraganglia NOS 
Malignancy Read B546.00 Neuroblastoma 
Malignancy Read B54X.00 Malignant neoplasm-pluriglandular involvement,unspecified 
Malignancy Read B54y.00 Malignant neoplasm of other specified endocrine gland 
Malignancy Read B54z.00 Malig neop of endocrine gland or related structure NOS 
Malignancy Read B55..00 Malignant neoplasm of other and ill-defined sites 
Malignancy Read B550.00 Malignant neoplasm of head, neck and face 
Malignancy Read B550000 Malignant neoplasm of head NOS 
Malignancy Read B550100 Malignant neoplasm of cheek NOS 
Malignancy Read B550200 Malignant neoplasm of nose NOS 
Malignancy Read B550300 Malignant neoplasm of jaw NOS 
Malignancy Read B550400 Malignant neoplasm of neck NOS 
Malignancy Read B550500 Malignant neoplasm of supraclavicular fossa NOS 
Malignancy Read B550z00 Malignant neoplasm of head, neck and face NOS 
Malignancy Read B551.00 Malignant neoplasm of thorax 
Malignancy Read B551000 Malignant neoplasm of axilla NOS 
Malignancy Read B551100 Malignant neoplasm of chest wall NOS 
Malignancy Read B551200 Malignant neoplasm of intrathoracic site NOS 
Malignancy Read B551z00 Malignant neoplasm of thorax NOS 
Malignancy Read B552.00 Malignant neoplasm of abdomen 
Malignancy Read B553.00 Malignant neoplasm of pelvis 
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Malignancy Read B553000 Malignant neoplasm of inguinal region NOS 
Malignancy Read B553100 Malignant neoplasm of presacral region 
Malignancy Read B553z00 Malignant neoplasm of pelvis NOS 
Malignancy Read B554.00 Malignant neoplasm of upper limb NOS 
Malignancy Read B555.00 Malignant neoplasm of lower limb NOS 
Malignancy Read B55y.00 Malignant neoplasm of other specified sites 
Malignancy Read B55y000 Malignant neoplasm of back NOS 
Malignancy Read B55y100 Malignant neoplasm of trunk NOS 
Malignancy Read B55y200 Malignant neoplasm of flank NOS 
Malignancy Read B55yz00 Malignant neoplasm of specified site NOS 
Malignancy Read B55z.00 Malignant neoplasm of other and ill defined site NOS 
Malignancy Read B56..00 Secondary and unspecified malignant neoplasm of lymph nodes 
Malignancy Read B56..11 Lymph node metastases 
Malignancy Read B560.00 Secondary and unspec malig neop lymph nodes head/face/neck 
Malignancy Read B560000 Secondary and unspec malig neop of superficial parotid LN 
Malignancy Read B560100 
Secondary and unspec malignant neoplasm mastoid lymph 
nodes 
Malignancy Read B560200 Secondary and unspec malig neop superficial cervical LN 
Malignancy Read B560300 Secondary and unspec malignant neoplasm occipital lymph node 
Malignancy Read B560400 Secondary and unspec malig neop deep parotid lymph nodes 
Malignancy Read B560500 Secondary and unspec malig neop submandibular lymph nodes 
Malignancy Read B560600 Secondary and unspec malig neop of facial lymph nodes 
Malignancy Read B560700 Secondary and unspec malig neop submental lymph nodes 
Malignancy Read B560800 Secondary and unspec malig neop anterior cervical LN 
Malignancy Read B560900 Secondary and unspec malig neop deep cervical LN 
Malignancy Read B560z00 Secondary unspec malig neop lymph nodes head/face/neck NOS 
Malignancy Read B561.00 Secondary and unspec malig neop intrathoracic lymph nodes 
Malignancy Read B561000 
Secondary and unspec malig neop internal mammary lymph 
nodes 
Malignancy Read B561100 Secondary and unspec malig neop intercostal lymph nodes 
Malignancy Read B561200 Secondary and unspec malig neop diaphragmatic lymph nodes 
Malignancy Read B561300 Secondary and unspec malig neop ant mediastinal lymph nodes 
Malignancy Read B561400 Secondary and unspec malig neop post mediastinal lymph nodes 
Malignancy Read B561500 Secondary and unspec malig neop paratracheal lymph nodes 
Malignancy Read B561600 Secondary and unspec malig neop superfic tracheobronchial LN 
Malignancy Read B561700 Secondary and unspec malig neop inferior tracheobronchial LN 
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Malignancy Read B561800 
Secondary and unspec malig neop bronchopulmonary lymph 
nodes 
Malignancy Read B561900 Secondary and unspec malig neop pulmonary lymph nodes 
Malignancy Read B561z00 Secondary and unspec malig neop intrathoracic LN NOS 
Malignancy Read B562.00 Secondary and unspec malig neop intra-abdominal lymph nodes 
Malignancy Read B562000 Secondary and unspec malig neop coeliac lymph nodes 
Malignancy Read B562100 Secondary and unspec malig neop superficial mesenteric LN 
Malignancy Read B562200 Secondary and unspec malig neop inferior mesenteric LN 
Malignancy Read B562300 Secondary and unspec malig neop common iliac lymph nodes 
Malignancy Read B562400 Secondary and unspec malig neop external iliac lymph nodes 
Malignancy Read B562z00 Secondary and unspec malig neop intra-abdominal LN NOS 
Malignancy Read B563.00 Secondary and unspec malig neop axilla and upper limb LN 
Malignancy Read B563000 Secondary and unspec malig neop axillary lymph nodes 
Malignancy Read B563100 Secondary and unspec malig neop supratrochlear lymph nodes 
Malignancy Read B563200 Secondary and unspec malig neop infraclavicular lymph nodes 
Malignancy Read B563300 Secondary and unspec malig neop pectoral lymph nodes 
Malignancy Read B563z00 Secondary and unspec malig neop axilla and upper limb LN NOS 
Malignancy Read B564.00 Secondary and unspec malig neop inguinal and lower limb LN 
Malignancy Read B564000 Secondary and unspec malig neop superficial inguinal LN 
Malignancy Read B564100 Secondary and unspec malig neop deep inguinal lymph nodes 
Malignancy Read B564z00 Secondary and unspec malig neop of inguinal and leg LN NOS 
Malignancy Read B565.00 Secondary and unspec malig neop intrapelvic lymph nodes 
Malignancy Read B565000 Secondary and unspec malig neop internal iliac lymph nodes 
Malignancy Read B565200 Secondary and unspec malig neop circumflex iliac LN 
Malignancy Read B565300 Secondary and unspec malig neop sacral lymph nodes 
Malignancy Read B565z00 Secondary and unspec malig neop intrapelvic LN NOS 
Malignancy Read B56y.00 Secondary and unspec malig neop lymph nodes multiple sites 
Malignancy Read B56z.00 Secondary and unspec malig neop lymph nodes NOS 
Malignancy Read B57..00 Secondary malig neop of respiratory and digestive systems 
Malignancy Read B57..11 Metastases of respiratory and/or digestive systems 
Malignancy Read B57..12 Secondary carcinoma of respiratory and/or digestive systems 
Malignancy Read B570.00 Secondary malignant neoplasm of lung 
Malignancy Read B571.00 Secondary malignant neoplasm of mediastinum 
Malignancy Read B572.00 Secondary malignant neoplasm of pleura 
Malignancy Read B573.00 Secondary malignant neoplasm of other respiratory organs 
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Malignancy Read B574.00 Secondary malignant neoplasm of small intestine and duodenum 
Malignancy Read B574000 Secondary malignant neoplasm of duodenum 
Malignancy Read B574200 Secondary malignant neoplasm of ileum 
Malignancy Read B574z00 Secondary malig neop of small intestine or duodenum NOS 
Malignancy Read B575.00 Secondary malignant neoplasm of large intestine and rectum 
Malignancy Read B575000 Secondary malignant neoplasm of colon 
Malignancy Read B575100 Secondary malignant neoplasm of rectum 
Malignancy Read B575z00 Secondary malig neop of large intestine or rectum NOS 
Malignancy Read B576.00 Secondary malig neop of retroperitoneum and peritoneum 
Malignancy Read B576000 Secondary malignant neoplasm of retroperitoneum 
Malignancy Read B576100 Secondary malignant neoplasm of peritoneum 
Malignancy Read B576200 Malignant ascites 
Malignancy Read B576z00 Secondary malig neop of retroperitoneum or peritoneum NOS 
Malignancy Read B577.00 Secondary malignant neoplasm of liver 
Malignancy Read B577.11 Liver metastases 
Malignancy Read B57y.00 Secondary malignant neoplasm of other digestive organ 
Malignancy Read B57z.00 Secondary malig neop of respiratory or digestive system NOS 
Malignancy Read B58..00 Secondary malignant neoplasm of other specified sites 
Malignancy Read B58..11 Secondary carcinoma of other specified sites 
Malignancy Read B580.00 Secondary malignant neoplasm of kidney 
Malignancy Read B581.00 Secondary malignant neoplasm of other urinary organs 
Malignancy Read B581000 Secondary malignant neoplasm of ureter 
Malignancy Read B581100 Secondary malignant neoplasm of bladder 
Malignancy Read B581200 Secondary malignant neoplasm of urethra 
Malignancy Read B581z00 Secondary malignant neoplasm of other urinary organ NOS 
Malignancy Read B582.00 Secondary malignant neoplasm of skin 
Malignancy Read B582000 Secondary malignant neoplasm of skin of head 
Malignancy Read B582100 Secondary malignant neoplasm of skin of face 
Malignancy Read B582200 Secondary malignant neoplasm of skin of neck 
Malignancy Read B582300 Secondary malignant neoplasm of skin of trunk 
Malignancy Read B582400 Secondary malignant neoplasm of skin of shoulder and arm 
Malignancy Read B582500 Secondary malignant neoplasm of skin of hip and leg 
Malignancy Read B582600 Secondary malignant neoplasm of skin of breast 
Malignancy Read B582z00 Secondary malignant neoplasm of skin NOS 
Malignancy Read B583.00 Secondary malignant neoplasm of brain and spinal cord 
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Malignancy Read B583000 Secondary malignant neoplasm of brain 
Malignancy Read B583100 Secondary malignant neoplasm of spinal cord 
Malignancy Read B583200 Cerebral metastasis 
Malignancy Read B583z00 Secondary malignant neoplasm of brain or spinal cord NOS 
Malignancy Read B584.00 Secondary malignant neoplasm of other part of nervous system 
Malignancy Read B585.00 Secondary malignant neoplasm of bone and bone marrow 
Malignancy Read B585000 Pathological fracture due to metastatic bone disease 
Malignancy Read B586.00 Secondary malignant neoplasm of ovary 
Malignancy Read B587.00 Secondary malignant neoplasm of adrenal gland 
Malignancy Read B58y.00 Secondary malignant neoplasm of other specified sites 
Malignancy Read B58y000 Secondary malignant neoplasm of breast 
Malignancy Read B58y100 Secondary malignant neoplasm of uterus 
Malignancy Read B58y200 Secondary malignant neoplasm of cervix uteri 
Malignancy Read B58y211 Secondary cancer of the cervix 
Malignancy Read B58y300 Secondary malignant neoplasm of vagina 
Malignancy Read B58y400 Secondary malignant neoplasm of vulva 
Malignancy Read B58y411 Secondary cancer of the vulva 
Malignancy Read B58y500 Secondary malignant neoplasm of prostate 
Malignancy Read B58y600 Secondary malignant neoplasm of testis 
Malignancy Read B58y700 Secondary malignant neoplasm of penis 
Malignancy Read B58y800 Secondary malignant neoplasm of epididymis and vas deferens 
Malignancy Read B58y900 Secondary malignant neoplasm of tongue 
Malignancy Read B58yz00 Secondary malignant neoplasm of other specified site NOS 
Malignancy Read B58z.00 Secondary malignant neoplasm of other specified site NOS 
Malignancy Read B59..00 Malignant neoplasm of unspecified site 
Malignancy Read B590.00 Disseminated malignancy NOS 
Malignancy Read B590.11 Carcinomatosis 
Malignancy Read B591.00 Other malignant neoplasm NOS 
Malignancy Read B592.00 Malignant neoplasms of independent (primary) multiple sites 
Malignancy Read B592X00 Kaposi's sarcoma of multiple organs 
Malignancy Read B593.00 Primary malignant neoplasm of unknown site 
Malignancy Read B594.00 Secondary malignant neoplasm of unknown site 
Malignancy Read B595.00 Malignant tumour of unknown origin 
Malignancy Read B59z.00 Malignant neoplasm of unspecified site NOS 
Malignancy Read B59zX00 Kaposi's sarcoma, unspecified 
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Malignancy Read B5y..00 Malignant neoplasm of other and unspecified site OS 
Malignancy Read B5z..00 Malignant neoplasm of other and unspecified site NOS 
Malignancy Read B6...00 Malignant neoplasm of lymphatic and haemopoietic tissue 
Malignancy Read B6...11 Malignant neoplasm of histiocytic tissue 
Malignancy Read B60..00 Lymphosarcoma and reticulosarcoma 
Malignancy Read B600.00 Reticulosarcoma 
Malignancy Read B600000 Reticulosarcoma of unspecified site 
Malignancy Read B600100 Reticulosarcoma of lymph nodes of head, face and neck 
Malignancy Read B600300 Reticulosarcoma of intra-abdominal lymph nodes 
Malignancy Read B600700 Reticulosarcoma of spleen 
Malignancy Read B600z00 Reticulosarcoma NOS 
Malignancy Read B601.00 Lymphosarcoma 
Malignancy Read B601000 Lymphosarcoma of unspecified site 
Malignancy Read B601100 Lymphosarcoma of lymph nodes of head, face and neck 
Malignancy Read B601200 Lymphosarcoma of intrathoracic lymph nodes 
Malignancy Read B601300 Lymphosarcoma of intra-abdominal lymph nodes 
Malignancy Read B601500 Lymphosarcoma of lymph nodes of inguinal region and leg 
Malignancy Read B601700 Lymphosarcoma of spleen 
Malignancy Read B601800 Lymphosarcoma of lymph nodes of multiple sites 
Malignancy Read B601z00 Lymphosarcoma NOS 
Malignancy Read B602.00 Burkitt's lymphoma 
Malignancy Read B602100 Burkitt's lymphoma of lymph nodes of head, face and neck 
Malignancy Read B602200 Burkitt's lymphoma of intrathoracic lymph nodes 
Malignancy Read B602300 Burkitt's lymphoma of intra-abdominal lymph nodes 
Malignancy Read B602500 Burkitt's lymphoma of lymph nodes of inguinal region and leg 
Malignancy Read B602z00 Burkitt's lymphoma NOS 
Malignancy Read B60y.00 Other specified reticulosarcoma or lymphosarcoma 
Malignancy Read B60z.00 Reticulosarcoma or lymphosarcoma NOS 
Malignancy Read B61..00 Hodgkin's disease 
Malignancy Read B61..11 Hodgkin lymphoma 
Malignancy Read B610.00 Hodgkin's paragranuloma 
Malignancy Read B610100 Hodgkin's paragranuloma of lymph nodes of head, face, neck 
Malignancy Read B610300 Hodgkin's paragranuloma of intra-abdominal lymph nodes 
Malignancy Read B611.00 Hodgkin's granuloma 
Malignancy Read B611100 Hodgkin's granuloma of lymph nodes of head, face and neck 
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Malignancy Read B612.00 Hodgkin's sarcoma 
Malignancy Read B612400 Hodgkin's sarcoma of lymph nodes of axilla and upper limb 
Malignancy Read B613.00 Hodgkin's disease, lymphocytic-histiocytic predominance 
Malignancy Read B613000 Hodgkin's, lymphocytic-histiocytic predominance unspec site 
Malignancy Read B613100 Hodgkin's, lymphocytic-histiocytic pred of head, face, neck 
Malignancy Read B613200 Hodgkin's, lymphocytic-histiocytic pred intrathoracic nodes 
Malignancy Read B613300 Hodgkin's, lymphocytic-histiocytic pred intra-abdominal node 
Malignancy Read B613500 Hodgkin's, lymphocytic-histiocytic pred inguinal and leg 
Malignancy Read B613600 Hodgkin's, lymphocytic-histiocytic pred intrapelvic nodes 
Malignancy Read B613700 Hodgkin's, lymphocytic-histiocytic predominance of spleen 
Malignancy Read B613800 Hodgkin's, lymphocytic-histiocytic pred of multiple sites 
Malignancy Read B613z00 Hodgkin's, lymphocytic-histiocytic predominance NOS 
Malignancy Read B614.00 Hodgkin's disease, nodular sclerosis 
Malignancy Read B614000 Hodgkin's disease, nodular sclerosis of unspecified site 
Malignancy Read B614100 Hodgkin's nodular sclerosis of head, face and neck 
Malignancy Read B614200 Hodgkin's nodular sclerosis of intrathoracic lymph nodes 
Malignancy Read B614300 Hodgkin's nodular sclerosis of intra-abdominal lymph nodes 
Malignancy Read B614400 Hodgkin's nodular sclerosis of lymph nodes of axilla and arm 
Malignancy Read B614700 Hodgkin's disease, nodular sclerosis of spleen 
Malignancy Read B614800 Hodgkin's nodular sclerosis of lymph nodes of multiple sites 
Malignancy Read B614z00 Hodgkin's disease, nodular sclerosis NOS 
Malignancy Read B615.00 Hodgkin's disease, mixed cellularity 
Malignancy Read B615000 Hodgkin's disease, mixed cellularity of unspecified site 
Malignancy Read B615100 Hodgkin's mixed cellularity of lymph nodes head, face, neck 
Malignancy Read B615200 Hodgkin's mixed cellularity of intrathoracic lymph nodes 
Malignancy Read B615z00 Hodgkin's disease, mixed cellularity NOS 
Malignancy Read B616.00 Hodgkin's disease, lymphocytic depletion 
Malignancy Read B616000 Hodgkin's lymphocytic depletion of unspecified site 
Malignancy Read B616400 Hodgkin's lymphocytic depletion lymph nodes axilla and arm 
Malignancy Read B616700 Hodgkin's disease, lymphocytic depletion of spleen 
Malignancy Read B616800 Hodgkin's lymphocytic depletion lymph nodes multiple sites 
Malignancy Read B616z00 Hodgkin's disease, lymphocytic depletion NOS 
Malignancy Read B617.00 Nodular lymphocyte predominant Hodgkin lymphoma 
Malignancy Read B618.00 Nodular sclerosis classical Hodgkin lymphoma 
Malignancy Read B61B.00 Lymphocyte-rich classical Hodgkin lymphoma 
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Malignancy Read B61C.00 Other classical Hodgkin lymphoma 
Malignancy Read B61z.00 Hodgkin's disease NOS 
Malignancy Read B61z.11 Hodgkin lymphoma NOS 
Malignancy Read B61z000 Hodgkin's disease NOS, unspecified site 
Malignancy Read B61z100 Hodgkin's disease NOS of lymph nodes of head, face and neck 
Malignancy Read B61z200 Hodgkin's disease NOS of intrathoracic lymph nodes 
Malignancy Read B61z400 Hodgkin's disease NOS of lymph nodes of axilla and arm 
Malignancy Read B61z500 Hodgkin's disease NOS of lymph nodes inguinal region and leg 
Malignancy Read B61z700 Hodgkin's disease NOS of spleen 
Malignancy Read B61z800 Hodgkin's disease NOS of lymph nodes of multiple sites 
Malignancy Read B61zz00 Hodgkin's disease NOS 
Malignancy Read B62..00 Other malignant neoplasm of lymphoid and histiocytic tissue 
Malignancy Read B620.00 Nodular lymphoma (Brill - Symmers disease) 
Malignancy Read B620000 Nodular lymphoma of unspecified site 
Malignancy Read B620100 Nodular lymphoma of lymph nodes of head, face and neck 
Malignancy Read B620200 Nodular lymphoma of intrathoracic lymph nodes 
Malignancy Read B620300 Nodular lymphoma of intra-abdominal lymph nodes 
Malignancy Read B620500 Nodular lymphoma of lymph nodes of inguinal region and leg 
Malignancy Read B620800 Nodular lymphoma of lymph nodes of multiple sites 
Malignancy Read B620z00 Nodular lymphoma NOS 
Malignancy Read B621.00 Mycosis fungoides 
Malignancy Read B621000 Mycosis fungoides of unspecified site 
Malignancy Read B621300 Mycosis fungoides of intra-abdominal lymph nodes 
Malignancy Read B621400 Mycosis fungoides of lymph nodes of axilla and upper limb 
Malignancy Read B621500 Mycosis fungoides of lymph nodes of inguinal region and leg 
Malignancy Read B621800 Mycosis fungoides of lymph nodes of multiple sites 
Malignancy Read B621z00 Mycosis fungoides NOS 
Malignancy Read B622.00 Sezary's disease 
Malignancy Read B622z00 Sezary's disease NOS 
Malignancy Read B623.00 Malignant histiocytosis 
Malignancy Read B623000 Malignant histiocytosis of unspecified site 
Malignancy Read B623100 Malignant histiocytosis of lymph nodes head, face and neck 
Malignancy Read B623300 Malignant histiocytosis of intra-abdominal lymph nodes 
Malignancy Read B623z00 Malignant histiocytosis NOS 
Malignancy Read B624.00 Leukaemic reticuloendotheliosis 
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Malignancy Read B624.11 Leukaemic reticuloendotheliosis 
Malignancy Read B624.12 Hairy cell leukaemia 
Malignancy Read B624000 Leukaemic reticuloendotheliosis of unspecified sites 
Malignancy Read B624300 Leukaemic reticuloend of intra-abdominal lymph nodes 
Malignancy Read B624z00 Leukaemic reticuloendotheliosis NOS 
Malignancy Read B625.00 Letterer-Siwe disease 
Malignancy Read B625.11 Histiocytosis X (acute, progressive) 
Malignancy Read B625000 Letterer-Siwe disease of unspecified sites 
Malignancy Read B625200 Letterer-Siwe disease of intrathoracic lymph nodes 
Malignancy Read B625800 Letterer-Siwe disease of lymph nodes of multiple sites 
Malignancy Read B625z00 Letterer-Siwe disease NOS 
Malignancy Read B626.00 Malignant mast cell tumours 
Malignancy Read B626000 Mast cell malignancy of unspecified site 
Malignancy Read B626500 Mast cell malignancy of lymph nodes inguinal region and leg 
Malignancy Read B626800 Mast cell malignancy of lymph nodes of multiple sites 
Malignancy Read B626z00 Malignant mast cell tumour NOS 
Malignancy Read B627.00 Non - Hodgkin's lymphoma 
Malignancy Read B627.11 Non-Hodgkin lymphoma 
Malignancy Read B627000 Follicular non-Hodgkin's small cleaved cell lymphoma 
Malignancy Read B627100 Follicular non-Hodg mixed sml cleavd & lge cell lymphoma 
Malignancy Read B627200 Follicular non-Hodgkin's large cell lymphoma 
Malignancy Read B627300 Diffuse non-Hodgkin's small cell (diffuse) lymphoma 
Malignancy Read B627500 Diffuse non-Hodgkin mixed sml & lge cell (diffuse) lymphoma 
Malignancy Read B627600 Diffuse non-Hodgkin's immunoblastic (diffuse) lymphoma 
Malignancy Read B627700 Diffuse non-Hodgkin's lymphoblastic (diffuse) lymphoma 
Malignancy Read B627800 Diffuse non-Hodgkin's lymphoma undifferentiated (diffuse) 
Malignancy Read B627900 Mucosa-associated lymphoma 
Malignancy Read B627911 Maltoma 
Malignancy Read B627A00 Diffuse non-Hodgkin's large cell lymphoma 
Malignancy Read B627B00 Other types of follicular non-Hodgkin's lymphoma 
Malignancy Read B627C00 Follicular non-Hodgkin's lymphoma 
Malignancy Read B627C11 Follicular lymphoma NOS 
Malignancy Read B627D00 Diffuse non-Hodgkin's centroblastic lymphoma 
Malignancy Read B627E00 Diffuse large B-cell lymphoma 
Malignancy Read B627F00 Extranod marg zone B-cell lymphom mucosa-assoc lymphoid tiss 
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Malignancy Read B627G00 Mediastinal (thymic) large B-cell lymphoma 
Malignancy Read B627W00 Unspecified B-cell non-Hodgkin's lymphoma 
Malignancy Read B627X00 Diffuse non-Hodgkin's lymphoma, unspecified 
Malignancy Read B628.00 Follicular lymphoma 
Malignancy Read B628000 Follicular lymphoma grade 1 
Malignancy Read B628100 Follicular lymphoma grade 2 
Malignancy Read B628300 Follicular lymphoma grade 3a 
Malignancy Read B628500 Diffuse follicle centre lymphoma 
Malignancy Read B628700 Other types of follicular lymphoma 
Malignancy Read B629.00 Multifocal multisystemic dissem Langerhans-cell histiocytosi 
Malignancy Read B62A.00 Sarcoma of dendritic cells 
Malignancy Read B62C.00 Unifocal Langerhans-cell histiocytosis 
Malignancy Read B62D.00 Histiocytic sarcoma 
Malignancy Read B62E.00 T/NK-cell lymphoma 
Malignancy Read B62E100 Anaplastic large cell lymphoma, ALK-positive 
Malignancy Read B62E200 Anaplastic large cell lymphoma, ALK-negative 
Malignancy Read B62E300 Cutaneous T-cell lymphoma 
Malignancy Read B62E600 Enteropathy-associated T-cell lymphoma 
Malignancy Read B62E700 Subcutaneous panniculitic T-cell lymphoma 
Malignancy Read B62E800 Blastic NK-cell lymphoma 
Malignancy Read B62E900 Angioimmunoblastic T-cell lymphoma 
Malignancy Read B62EA00 Primary cutaneous CD30-positive T-cell proliferations 
Malignancy Read B62Ew00 Other mature T/NK-cell lymphoma 
Malignancy Read B62F.00 Nonfollicular lymphoma 
Malignancy Read B62F.11 Non-follicular lymphoma 
Malignancy Read B62F000 Small cell B-cell lymphoma 
Malignancy Read B62F100 Mantle cell lymphoma 
Malignancy Read B62F200 Lymphoblastic (diffuse) lymphoma 
Malignancy Read B62x.00 Malignant lymphoma otherwise specified 
Malignancy Read B62x000 T-zone lymphoma 
Malignancy Read B62x100 Lymphoepithelioid lymphoma 
Malignancy Read B62x200 Peripheral T-cell lymphoma 
Malignancy Read B62x400 Malignant reticulosis 
Malignancy Read B62x500 Malignant immunoproliferative small intestinal disease 
Malignancy Read B62x600 True histiocytic lymphoma 
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Malignancy Read B62xX00 Oth and unspecif peripheral & cutaneous T-cell lymphomas 
Malignancy Read B62y.00 Malignant lymphoma NOS 
Malignancy Read B62y000 Malignant lymphoma NOS of unspecified site 
Malignancy Read B62y100 Malignant lymphoma NOS of lymph nodes of head, face and neck 
Malignancy Read B62y200 Malignant lymphoma NOS of intrathoracic lymph nodes 
Malignancy Read B62y300 Malignant lymphoma NOS of intra-abdominal lymph nodes 
Malignancy Read B62y400 Malignant lymphoma NOS of lymph nodes of axilla and arm 
Malignancy Read B62y500 Malignant lymphoma NOS of lymph node inguinal region and leg 
Malignancy Read B62y600 Malignant lymphoma NOS of intrapelvic lymph nodes 
Malignancy Read B62y700 Malignant lymphoma NOS of spleen 
Malignancy Read B62y800 Malignant lymphoma NOS of lymph nodes of multiple sites 
Malignancy Read B62yz00 Malignant lymphoma NOS 
Malignancy Read B62z.00 Malignant neoplasms of lymphoid and histiocytic tissue NOS 
Malignancy Read B62z100 Unspec malig neop lymphoid/histiocytic lymph node head/neck 
Malignancy Read B62z200 Unspec malig neop lymphoid/histiocytic of intrathoracic node 
Malignancy Read B62z300 Unspec malig neop lymphoid/histiocytic intra-abdominal nodes 
Malignancy Read B62z500 Unspec malig neop lymphoid/histiocytic nodes inguinal/leg 
Malignancy Read B62z800 Unspec malig neop lymphoid/histiocytic of multiple sites 
Malignancy Read B62zz00 Lymphoid and histiocytic malignancy NOS 
Malignancy Read B62zz11 Immunoproliferative neoplasm 
Malignancy Read B63..00 Multiple myeloma and immunoproliferative neoplasms 
Malignancy Read B630.00 Multiple myeloma 
Malignancy Read B630.11 Kahler's disease 
Malignancy Read B630.12 Myelomatosis 
Malignancy Read B630000 Malignant plasma cell neoplasm, extramedullary plasmacytoma 
Malignancy Read B630100 Solitary myeloma 
Malignancy Read B630200 Plasmacytoma NOS 
Malignancy Read B630300 Lambda light chain myeloma 
Malignancy Read B630400 Solitary plasmacytoma 
Malignancy Read B631.00 Plasma cell leukaemia 
Malignancy Read B63y.00 Other immunoproliferative neoplasms 
Malignancy Read B63z.00 Immunoproliferative neoplasm or myeloma NOS 
Malignancy Read B64..00 Lymphoid leukaemia 
Malignancy Read B64..11 Lymphatic leukaemia 
Malignancy Read B640.00 Acute lymphoid leukaemia 
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Malignancy Read B640000 B-cell acute lymphoblastic leukaemia 
Malignancy Read B641.00 Chronic lymphoid leukaemia 
Malignancy Read B641.11 Chronic lymphatic leukaemia 
Malignancy Read B641000 B-cell chronic lymphocytic leukaemia 
Malignancy Read B641011 Chronic lymphocytic leukaemia of B-cell type 
Malignancy Read B641200 
 Malignancy Read B642.00 Subacute lymphoid leukaemia 
Malignancy Read B64y.00 Other lymphoid leukaemia 
Malignancy Read B64y100 Prolymphocytic leukaemia 
Malignancy Read B64y200 Adult T-cell leukaemia 
Malignancy Read B64y500 Adult T-cell lymphoma/leukaemia (HTLV-1-associated) 
Malignancy Read B64yz00 Other lymphoid leukaemia NOS 
Malignancy Read B64z.00 Lymphoid leukaemia NOS 
Malignancy Read B65..00 Myeloid leukaemia 
Malignancy Read B650.00 Acute myeloid leukaemia 
Malignancy Read B651.00 Chronic myeloid leukaemia 
Malignancy Read B651.11 Chronic granulocytic leukaemia 
Malignancy Read B651000 Chronic eosinophilic leukaemia 
Malignancy Read B651100 Chronic myeloid leukaemia, BCR/ABL positive 
Malignancy Read B651200 Chronic neutrophilic leukaemia 
Malignancy Read B651z00 Chronic myeloid leukaemia NOS 
Malignancy Read B652.00 Subacute myeloid leukaemia 
Malignancy Read B653.00 Myeloid sarcoma 
Malignancy Read B653000 Chloroma 
Malignancy Read B653100 Granulocytic sarcoma 
Malignancy Read B654.00 Acute myeloblastic leukaemia 
Malignancy Read B65y100 Acute promyelocytic leukaemia 
Malignancy Read B65yz00 Other myeloid leukaemia NOS 
Malignancy Read B65z.00 Myeloid leukaemia NOS 
Malignancy Read B66..00 Monocytic leukaemia 
Malignancy Read B66..12 Monoblastic leukaemia 
Malignancy Read B660.00 Acute monocytic leukaemia 
Malignancy Read B661.00 Chronic monocytic leukaemia 
Malignancy Read B662.00 Subacute monocytic leukaemia 
Malignancy Read B66y.00 Other monocytic leukaemia 
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Malignancy Read B66yz00 Other monocytic leukaemia NOS 
Malignancy Read B66z.00 Monocytic leukaemia NOS 
Malignancy Read B67..00 Other specified leukaemia 
Malignancy Read B670.00 Acute erythraemia and erythroleukaemia 
Malignancy Read B670.11 Di Guglielmo's disease 
Malignancy Read B671.00 Chronic erythraemia 
Malignancy Read B671.11 Heilmeyer - Schoner disease 
Malignancy Read B672.00 Megakaryocytic leukaemia 
Malignancy Read B672.11 Thrombocytic leukaemia 
Malignancy Read B673.00 Mast cell leukaemia 
Malignancy Read B674.00 Acute panmyelosis 
Malignancy Read B675.00 Acute myelofibrosis 
Malignancy Read B677.00 Myelodysplastic and myeloproliferative disease 
Malignancy Read B67y.00 Other and unspecified leukaemia 
Malignancy Read B67y000 Lymphosarcoma cell leukaemia 
Malignancy Read B67yz00 Other and unspecified leukaemia NOS 
Malignancy Read B67z.00 Other specified leukaemia NOS 
Malignancy Read B68..00 Leukaemia of unspecified cell type 
Malignancy Read B680.00 Acute leukaemia NOS 
Malignancy Read B681.00 Chronic leukaemia NOS 
Malignancy Read B682.00 Subacute leukaemia NOS 
Malignancy Read B68y.00 Other leukaemia of unspecified cell type 
Malignancy Read B68z.00 Leukaemia NOS 
Malignancy Read B69..00 Myelomonocytic leukaemia 
Malignancy Read B690.00 Acute myelomonocytic leukaemia 
Malignancy Read B691.00 Chronic myelomonocytic leukaemia 
Malignancy Read B692.00 Subacute myelomonocytic leukaemia 
Malignancy Read B693.00 Juvenile myelomonocytic leukaemia 
Malignancy Read B6y..00 Malignant neoplasm lymphatic or haematopoietic tissue OS 
Malignancy Read B6y0.00 Myeloproliferative disorder 
Malignancy Read B6y0.11 Myeloproliferative disease 
Malignancy Read B6y1.00 Myelosclerosis with myeloid metaplasia 
Malignancy Read B6z..00 Malignant neoplasm lymphatic or haematopoietic tissue NOS 
Malignancy Read B6z0.00 Kaposi's sarcoma of lymph nodes 
Malignancy Read BBb3.12 [M]Subependymal astrocytoma NOS 
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Malignancy Read BBb4.00 [M]Subependymal giant cell astrocytoma 
Malignancy Read BBbG.00 [M]Pilocytic astrocytoma 
Malignancy Read BBbG.12 [M]Piloid astrocytoma 
Malignancy Read BBc7.11 [M]Neuroastrocytoma 
Malignancy Read Byu0.00 [X]Malignant neoplasm of lip, oral cavity and pharynx 
Malignancy Read Byu1.00 [X]Malignant neoplasm of digestive organs 
Malignancy Read Byu1100 [X]Other specified carcinomas of liver 
Malignancy Read Byu1200 [X]Malignant neoplasm of intestinal tract, part unspecified 
Malignancy Read Byu1300 [X]Malignant neoplsm/ill-defin sites within digestive system 
Malignancy Read Byu2.00 [X]Malignant neoplasm of respiratory and intrathoracic orga 
Malignancy Read Byu2000 [X]Malignant neoplasm of bronchus or lung, unspecified 
Malignancy Read Byu2100 [X]Malignant neoplasm/overlap lesion/heart,mediastinm+pleura 
Malignancy Read Byu2300 [X]Malignant neopl/overlapping les/resp+intrathoracic organs 
Malignancy Read Byu2400 [X]Malignant neoplasm/ill-defined sites within resp system 
Malignancy Read Byu2500 [X]Malignant neoplasm of mediastinum, part unspecified 
Malignancy Read Byu3.00 [X]Malignant neoplasm of bone and articular cartilage 
Malignancy Read Byu3100 [X]Malignant neoplasm/bones+articular cartilage/limb,unspfd 
Malignancy Read Byu3200 [X]Malignant neoplasm/overlap lesion/bone+articulr cartilage 
Malignancy Read Byu3300 [X]Malignant neoplasm/bone+articular cartilage, unspecified 
Malignancy Read Byu4.00 [X]Melanoma and other malignant neoplasms of skin 
Malignancy Read Byu4000 [X]Malignant melanoma of other+unspecified parts of face 
Malignancy Read Byu4100 [X]Malignant melanoma of skin, unspecified 
Malignancy Read Byu4200 [X]Oth malignant neoplasm/skin of oth+unspecfd parts of face 
Malignancy Read Byu4300 [X]Malignant neoplasm of skin, unspecified 
Malignancy Read Byu5.00 [X]Malignant neoplasm of mesothelial and soft tissue 
Malignancy Read Byu5000 [X]Mesothelioma of other sites 
Malignancy Read Byu5011 [X]Mesothelioma of lung 
Malignancy Read Byu5100 [X]Mesothelioma, unspecified 
Malignancy Read Byu5300 [X]Kaposi's sarcoma, unspecified 
Malignancy Read Byu5400 [X]Malignant neoplasm/peripheral nerves of trunk,unspecified 
Malignancy Read Byu5500 [X]Mal neoplasm/overlap les/periph nerv+autonomic nerv systm 
Malignancy Read Byu5700 [X]Malignant neoplasm of peritoneum, unspecified 
Malignancy Read Byu5800 [X]Mal neoplasm/connective+soft tissue of trunk,unspecified 
Malignancy Read Byu5900 [X]Malignant neoplasm/connective + soft tissue,unspecified 
Malignancy Read Byu5A00 [X]Malignant neoplasm overlapping lesion of skin 
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Malignancy Read Byu5B00 [X]Kaposi's sarcoma of other sites 
Malignancy Read Byu6.00 [X]Malignant neoplasm of breast 
Malignancy Read Byu7.00 [X]Malignant neoplasm of female genital organs 
Malignancy Read Byu7000 [X]Malignant neoplasm of uterine adnexa, unspecified 
Malignancy Read Byu7100 [X]Malignant neoplasm/other specified female genital organs 
Malignancy Read Byu7300 [X]Malignant neoplasm of female genital organ, unspecified 
Malignancy Read Byu8.00 [X]Malignant neoplasm of male genital organs 
Malignancy Read Byu8000 [X]Malignant neoplasm/other specified male genital organs 
Malignancy Read Byu8200 [X]Malignant neoplasm of male genital organ, unspecified 
Malignancy Read Byu9.00 [X]Malignant neoplasm of urinary tract 
Malignancy Read Byu9000 [X]Malignant neoplasm of urinary organ, unspecified 
Malignancy Read ByuA.00 [X]Malignant neoplasm of eye, brain and other parts of cent 
Malignancy Read ByuA000 [X]Malignant neoplasm/other and unspecified cranial nerves 
Malignancy Read ByuA100 [X]Malignant neoplasm/central nervous system, unspecified 
Malignancy Read ByuA200 [X]Malignant neoplasm of meninges, unspecified 
Malignancy Read ByuA300 [X]Malig neopl, overlap lesion brain & other part of CNS 
Malignancy Read ByuB.00 [X]Malignant neoplasm of thyroid and other endocrine glands 
Malignancy Read ByuB100 [X]Malignant neoplasm of endocrine gland, unspecified 
Malignancy Read ByuC.00 [X]Malignant neoplasm of ill-defined, secondary and unspeci 
Malignancy Read ByuC000 [X]Malignant neoplasm of other specified sites 
Malignancy Read ByuC100 [X]Malignant neoplasm/overlap lesion/other+ill-defined sites 
Malignancy Read ByuC200 [X]2ndry+unspcf malignant neoplasm lymph nodes/multi regions 
Malignancy Read ByuC300 [X]Secondary malignant neoplasm/oth+unspc respiratory organs 
Malignancy Read ByuC400 [X]Secondary malignant neoplasm/oth+unspcfd digestive organs 
Malignancy Read ByuC500 [X]2ndry malignant neoplasm/bladder+oth+unsp urinary organs 
Malignancy Read ByuC600 [X]2ndry malignant neoplasm/oth+unspec parts/nervous system 
Malignancy Read ByuC700 [X]Secondary malignant neoplasm of other specified sites 
Malignancy Read ByuC800 [X]Malignant neoplasm without specification of site 
Malignancy Read ByuD.00 [X]Malignant neoplasms of lymphoid, haematopoietic and rela 
Malignancy Read ByuD000 [X]Other Hodgkin's disease 
Malignancy Read ByuD100 [X]Other types of follicular non-Hodgkin's lymphoma 
Malignancy Read ByuD200 [X]Other types of diffuse non-Hodgkin's lymphoma 
Malignancy Read ByuD300 [X]Other specified types of non-Hodgkin's lymphoma 
Malignancy Read ByuD400 [X]Other malignant immunoproliferative diseases 
Malignancy Read ByuD500 [X]Other lymphoid leukaemia 
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Malignancy Read ByuD600 [X]Other myeloid leukaemia 
Malignancy Read ByuD700 [X]Other monocytic leukaemia 
Malignancy Read ByuD800 [X]Other specified leukaemias 
Malignancy Read ByuD900 [X]Other leukaemia of unspecified cell type 
Malignancy Read ByuDA00 [X]Oth spcf mal neoplsm/lymphoid,haematopoietic+rltd tissue 
Malignancy Read ByuDB00 [X]Mal neoplasm/lymphoid,haematopoietic+related tissu,unspcf 
Malignancy Read ByuDC00 [X]Diffuse non-Hodgkin's lymphoma, unspecified 
Malignancy Read ByuDE00 [X]Unspecified B-cell non-Hodgkin's lymphoma 
Malignancy Read ByuDF00 [X]Non-Hodgkin's lymphoma, unspecified type 
Malignancy Read ByuDF11 [X]Non-Hodgkin's lymphoma NOS 
Malignancy Read ByuE.00 [X]Malignant neoplasms/independent (primary) multiple sites 
Malignancy Read ByuE000 [X]Malignant neoplasms/independent(primary)multiple sites 
Ophthalmic surgery Read 7200 Excision of eye 
Ophthalmic surgery Read 7201 Extirpation of lesion of orbit 
Ophthalmic surgery Read 7202 Insertion of prosthesis of eye 
Ophthalmic surgery Read 7203 Attention to prosthesis of eye 
Ophthalmic surgery Read 7204 Plastic repair of orbit 
Ophthalmic surgery Read 7204 Correction vertical orbital dystopia c orbital osteotomies 
Ophthalmic surgery Read 7204.11 Reconstruction of orbit 
Ophthalmic surgery Read 7204.12 Correction of deformity of orbit with orbital osteotomy 
Ophthalmic surgery Read 7204.13 Plastic repair of cavity of orbit 
Ophthalmic surgery Read 7205 Incision of orbit 
Ophthalmic surgery Read 7205.11 Orbitotomy 
Ophthalmic surgery Read 7206 Other operations on orbit 
Ophthalmic surgery Read 7210 Operations on eyebrow 
Ophthalmic surgery Read 7211 Operations on canthus 
Ophthalmic surgery Read 7211 Canthoplasty 
Ophthalmic surgery Read 7212 Extirpation of lesion of eyelid 
Ophthalmic surgery Read 7213 Excision of redundant skin of eyelid 
Ophthalmic surgery Read 7213.11 Blepharoplasty 
Ophthalmic surgery Read 7214 Reconstruction of eyelid 
Ophthalmic surgery Read 7215 Correction of deformity of eyelid 
Ophthalmic surgery Read 7216 Other plastic repair of eyelid 
Ophthalmic surgery Read 7216.11 Tarsorrhaphy 
Ophthalmic surgery Read 7217 Other repair of eyelid 
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Ophthalmic surgery Read 7218 Correction of ptosis of eyelid 
Ophthalmic surgery Read 7219 Incision of eyelid 
Ophthalmic surgery Read 7220 Operations on lacrimal gland 
Ophthalmic surgery Read 7221 Connection between lacrimal apparatus and nose 
Ophthalmic surgery Read 7222 Other operations on lacrimal sac 
Ophthalmic surgery Read 7223 Operations on nasolacrimal duct 
Ophthalmic surgery Read 7223.11 Instrumentation of nasolacrimal duct 
Ophthalmic surgery Read 7224 Other operations on lacrimal apparatus 
Ophthalmic surgery Read 7230 Combined operations on muscles of eye 
Ophthalmic surgery Read 7231 Recession of muscle of eye 
Ophthalmic surgery Read 7232 Resection of muscle of eye 
Ophthalmic surgery Read 7232.12 Plication of eye muscle 
Ophthalmic surgery Read 7232.13 Tucking of eye muscle 
Ophthalmic surgery Read 7233 Partial division of tendon of muscle of eye 
Ophthalmic surgery Read 7233.11 Partial tenotomy of eye muscle 
Ophthalmic surgery Read 7234 Other adjustment to muscle of eye 
Ophthalmic surgery Read 7235 Other operations on muscle of eye 
Ophthalmic surgery Read 7236 Advancement of eye muscle 
Ophthalmic surgery Read 7240 Extirpation of lesion of conjunctiva 
Ophthalmic surgery Read 7241 Repair of conjunctiva 
Ophthalmic surgery Read 7242 Incision of conjunctiva 
Ophthalmic surgery Read 7243 Other operations on conjunctiva 
Ophthalmic surgery Read 7244 Extirpation of lesion of cornea 
Ophthalmic surgery Read 7245 Plastic operations on cornea 
Ophthalmic surgery Read 7246 Closure of cornea 
Ophthalmic surgery Read 7247 Removal of foreign body from cornea 
Ophthalmic surgery Read 7248 Incision of cornea 
Ophthalmic surgery Read 7249 Other operations on cornea 
Ophthalmic surgery Read 7250 Extirpation of lesion of sclera 
Ophthalmic surgery Read 7251 Buckling operations for attachment of retina 
Ophthalmic surgery Read 7251.11 Scleral buckling for attachment of retina 
Ophthalmic surgery Read 7252 Incision of sclera 
Ophthalmic surgery Read 7252.11 Sclerotomy 
Ophthalmic surgery Read 7253 Other operations on sclera 
Ophthalmic surgery Read 7254 Excision of iris 
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Ophthalmic surgery Read 7255 Filtering operations on iris 
Ophthalmic surgery Read 7256 Other operations on trabecular meshwork of eye 
Ophthalmic surgery Read 7257 Incision of iris 
Ophthalmic surgery Read 7258 Other operations on iris 
Ophthalmic surgery Read 7259 Operations following glaucoma surgery 
Ophthalmic surgery Read 7260 Extirpation of ciliary body 
Ophthalmic surgery Read 7261 Other operations on ciliary body 
Ophthalmic surgery Read 7262 Other operations on anterior chamber of eye 
Ophthalmic surgery Read 7263 Extracapsular extraction of lens 
Ophthalmic surgery Read 7263.12 Extracapsular extraction of cataract 
Ophthalmic surgery Read 7264 Intracapsular extraction of lens 
Ophthalmic surgery Read 7264.11 Intracapsular extraction of cataract 
Ophthalmic surgery Read 7265 Incision of capsule of lens 
Ophthalmic surgery Read 7265.11 Capsulotomy of eye lens 
Ophthalmic surgery Read 7266 Other extraction of lens 
Ophthalmic surgery Read 7266.11 Other extraction of cataract 
Ophthalmic surgery Read 7267 Prosthesis of lens 
Ophthalmic surgery Read 7268 Other operations on lens 
Ophthalmic surgery Read 7270 Operations on vitreous body 
Ophthalmic surgery Read 7271 Photocoagulation of retina for detachment 
Ophthalmic surgery Read 7272 Destruction of lesion of retina 
Ophthalmic surgery Read 7272.11 Other destruction of retina 
Ophthalmic surgery Read 7273 Other operations on retina 
Ophthalmic surgery Read 7274 Other operations on eye 
Ophthalmic surgery Read 7275 Pan retinal photocoagulation for glaucoma 
Ophthalmic surgery Read 7276 Pan retinal photocoagulation for diabetes 
Ophthalmic surgery Read 7277 Operations on retinal membrane 
Ophthalmic surgery Read 7278 Translocation of retina 
Ophthalmic surgery Read 7279 Fixation of retina 
Ophthalmic surgery Read 7200000 Exenteration of orbit 
Ophthalmic surgery Read 7200100 Enucleation of eyeball 
Ophthalmic surgery Read 7200111 Enucleation of eye 
Ophthalmic surgery Read 7200200 Evisceration of contents of eyeball 
Ophthalmic surgery Read 7200211 Evisceration of eye 
Ophthalmic surgery Read 7200300 Partial excision of bony orbit 
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Ophthalmic surgery Read 7201000 Excision of lesion of orbit 
Ophthalmic surgery Read 7201100 Destruction of lesion of orbit 
Ophthalmic surgery Read 7201200 Cryotherapy to lesion of orbit 
Ophthalmic surgery Read 7201300 Cauterisation of lesion of orbit 
Ophthalmic surgery Read 7202000 Insertion of prosthetic replacement for orbit 
Ophthalmic surgery Read 7202100 Insertion of prosthetic replacement for eyeball 
Ophthalmic surgery Read 7202111 Insertion of Castroviejo orbital implant 
Ophthalmic surgery Read 7203000 Revision of prosthetic replacement for orbit 
Ophthalmic surgery Read 7203100 Revision of prosthetic replacement for eyeball 
Ophthalmic surgery Read 7203200 Removal of prosthetic replacement for orbit 
Ophthalmic surgery Read 7203300 Removal of prosthetic replacement for eyeball 
Ophthalmic surgery Read 7204000 Reconstruction of cavity of orbit, unspecified 
Ophthalmic surgery Read 7204100 Plastic repair of cavity of orbit, unspecified 
Ophthalmic surgery Read 7204200 Enlargement of cavity of orbit 
Ophthalmic surgery Read 7204300 Reconstruction of cavity of orbit with skin graft 
Ophthalmic surgery Read 7204500 Reconstruction of cavity of orbit with local skin flap 
Ophthalmic surgery Read 7204700 Reconstruction cavity orbit with microvascular transfer flap 
Ophthalmic surgery Read 7204800 Suture of orbit 
Ophthalmic surgery Read 7204900 Reconstruction of cavity of orbit with bone graft 
Ophthalmic surgery Read 7205000 Biopsy of lesion of orbit 
Ophthalmic surgery Read 7205100 Drainage of orbit 
Ophthalmic surgery Read 7205200 Decompression of orbit 
Ophthalmic surgery Read 7205300 Removal of foreign body from orbit 
Ophthalmic surgery Read 7205400 Exploration of orbit 
Ophthalmic surgery Read 7205500 Lateral orbitotomy 
Ophthalmic surgery Read 7205600 Anterior orbitotomy 
Ophthalmic surgery Read 7206000 Transposition of ligament of orbit 
Ophthalmic surgery Read 7206100 Open reduction of fracture of orbit 
Ophthalmic surgery Read 7206200 Removal of fixation from fracture of orbit 
Ophthalmic surgery Read 7206300 Retroocular injection into orbit 
Ophthalmic surgery Read 7206311 Retrobulbar injection into orbit 
Ophthalmic surgery Read 7206400 Open reduction of fracture of orbit and internal fixation 
Ophthalmic surgery Read 7206500 Insertion of orbital floor implant 
Ophthalmic surgery Read 7206600 Removal of orbital floor implant 
Ophthalmic surgery Read 7206700 Packing of maxilla to correct blow-out fracture of orbit 
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Ophthalmic surgery Read 7206800 Internal fixation of fracture of orbit 
Ophthalmic surgery Read 7210000 Excision of lesion of eyebrow 
Ophthalmic surgery Read 7210100 Hair bearing flap to eyebrow 
Ophthalmic surgery Read 7210200 Hair bearing graft to eyebrow 
Ophthalmic surgery Read 7210300 Suture of eyebrow 
Ophthalmic surgery Read 7210400 Incision of lesion of eyebrow 
Ophthalmic surgery Read 7210500 Biopsy of lesion of eyebrow 
Ophthalmic surgery Read 7211000 Excision of lesion of canthus 
Ophthalmic surgery Read 7211100 Destruction of lesion of canthus 
Ophthalmic surgery Read 7211200 Correction of epicanthus 
Ophthalmic surgery Read 7211211 Mustarde canthoplasty 
Ophthalmic surgery Read 7211300 Correction of telecanthus, unspecified 
Ophthalmic surgery Read 7211400 Repair of canthus with skin graft incl full thickness graft 
Ophthalmic surgery Read 7211500 Canthotomy 
Ophthalmic surgery Read 7211600 Cryosurgical destruction of lesion of canthus 
Ophthalmic surgery Read 7211611 Cryotherapy of lesion of canthus 
Ophthalmic surgery Read 7211700 Cauterisation of lesion of canthus 
Ophthalmic surgery Read 7211711 Retropunctal cautery of lesion of canthus 
Ophthalmic surgery Read 7211800 Curettage of lesion of canthus 
Ophthalmic surgery Read 7211900 Repair of canthus with local skin flap 
Ophthalmic surgery Read 7212000 Excision of lesion of eyelid 
Ophthalmic surgery Read 7212100 Cauterisation of lesion of eyelid 
Ophthalmic surgery Read 7212200 Cryotherapy to lesion of eyelid 
Ophthalmic surgery Read 7212300 Destruction of lesion of eyelid NEC 
Ophthalmic surgery Read 7212400 Curettage of lesion of eyelid 
Ophthalmic surgery Read 7212500 Total excision of eyelid 
Ophthalmic surgery Read 7212600 Incision and curettage of meibomian cyst 
Ophthalmic surgery Read 7212700 Incision and curettage of lesion of eyelid 
Ophthalmic surgery Read 7212800 Debulking of cartilage graft of eyelid 
Ophthalmic surgery Read 7212900 Wedge excision of lesion of eyelid 
Ophthalmic surgery Read 7213000 Blepharoplasty of both eyelids 
Ophthalmic surgery Read 7213100 Blepharoplasty of upper eyelid 
Ophthalmic surgery Read 7213200 Blepharoplasty of lower eyelid 
Ophthalmic surgery Read 7213300 Blepharoplasty NEC 
Ophthalmic surgery Read 7214000 Reconstruction of eyelid with local skin flap 
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Ophthalmic surgery Read 7214100 Reconstruction of eyelid with skin graft 
Ophthalmic surgery Read 7214200 Reconstruction of eyelid with tarsoconjunctival flap 
Ophthalmic surgery Read 7214300 Reconstruction of eyelid with chondromucosal graft 
Ophthalmic surgery Read 7214400 Reconstruction of upper eyelid with lower eyelid skin flap 
Ophthalmic surgery Read 7214600 Reconstruction of eyelid with Tripier skin flap 
Ophthalmic surgery Read 7214700 Graft of cartilage to eyelid 
Ophthalmic surgery Read 7214800 Graft of skin and fat to eyelid 
Ophthalmic surgery Read 7214900 Graft of fascia to eyelid 
Ophthalmic surgery Read 7215000 Correction of ectropion 
Ophthalmic surgery Read 7215011 Kuhnt repair of ectropion 
Ophthalmic surgery Read 7215012 Szymanowski repair of ectropion 
Ophthalmic surgery Read 7215100 Correction of entropion 
Ophthalmic surgery Read 7215111 Wheeler repair of entropion 
Ophthalmic surgery Read 7215112 Weiss repair of entropion 
Ophthalmic surgery Read 7215200 Correction of trichiasis 
Ophthalmic surgery Read 7215300 Retropunctal cautery 
Ophthalmic surgery Read 7215400 Correction of cicatricial ectropion 
Ophthalmic surgery Read 7215500 Correction of cicatricial entropion 
Ophthalmic surgery Read 7215600 Correction of ectropion NEC 
Ophthalmic surgery Read 7215700 Correction of entropion NEC 
Ophthalmic surgery Read 7216000 Central tarsorrhaphy 
Ophthalmic surgery Read 7216100 Lateral tarsorrhaphy 
Ophthalmic surgery Read 7216200 Medial tarsorrhaphy 
Ophthalmic surgery Read 7216300 Tarsorrhaphy NEC 
Ophthalmic surgery Read 7216400 Revision of tarsorrhaphy 
Ophthalmic surgery Read 7216500 Repair of ruptured palpebral ligament 
Ophthalmic surgery Read 7217000 Suture of eyelid 
Ophthalmic surgery Read 7218000 Correction of eyelid ptosis using levator muscle technique 
Ophthalmic surgery Read 7218011 Blascovics resection of levator muscle of eyelid 
Ophthalmic surgery Read 7218012 Everbusch resection of levator muscle of eyelid 
Ophthalmic surgery Read 7218100 Correction of eyelid ptosis using frontalis muscle technique 
Ophthalmic surgery Read 7218200 Correction of ptosis of eyelid using sling of fascia 
Ophthalmic surgery Read 7218211 Crawford tarsofrontalis sling of eyelid using fascia 
Ophthalmic surgery Read 7218300 Correction of eyelid ptosis using superior rectus technique 
Ophthalmic surgery Read 7218400 Tarsomullerectomy 
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Ophthalmic surgery Read 7218411 Fasanella tarsomullerectomy 
Ophthalmic surgery Read 7218412 Servat tarsomullerectomy 
Ophthalmic surgery Read 7218500 Correction of eyelid ptosis using aponeurosis technique 
Ophthalmic surgery Read 7219000 Drainage of lesion of eyelid 
Ophthalmic surgery Read 7220000 Excision of lacrimal gland 
Ophthalmic surgery Read 7220100 Radiotherapy to lacrimal gland 
Ophthalmic surgery Read 7220200 Destruction of lacrimal gland NEC 
Ophthalmic surgery Read 7220300 Biopsy of lesion of lacrimal gland 
Ophthalmic surgery Read 7220400 Incision of lacrimal gland 
Ophthalmic surgery Read 7220500 Removal of calculus from lacrimal gland 
Ophthalmic surgery Read 7221000 Canaliculodacryocystorhinostomy 
Ophthalmic surgery Read 7221011 Jones canaliculodacrocystorhinostomy 
Ophthalmic surgery Read 7221100 Conjunctivodacryocystorhinostomy 
Ophthalmic surgery Read 7221200 Dacryocystorhinostomy and insertion of tube HFQ 
Ophthalmic surgery Read 7221211 Insertion of Jones dacryocystorhinostomy tube 
Ophthalmic surgery Read 7221212 Insertion of Lester dacryocystorhinostomy tube 
Ophthalmic surgery Read 7221300 Dacryocystorhinostomy NEC 
Ophthalmic surgery Read 7221400 Revision of anastomosis between lacrimal gland and nose 
Ophthalmic surgery Read 7222000 Excision of lacrimal sac 
Ophthalmic surgery Read 7222011 Dacryocystectomy 
Ophthalmic surgery Read 7222100 Destruction of lesion of lacrimal sac 
Ophthalmic surgery Read 7222200 Biopsy of lesion of lacrimal sac 
Ophthalmic surgery Read 7222300 Incision of lacrimal sac 
Ophthalmic surgery Read 7223000 Drainage of nasolacrimal duct 
Ophthalmic surgery Read 7223011 Insertion of tube into nasolachrimal duct 
Ophthalmic surgery Read 7223100 Dilation of nasolacrimal duct 
Ophthalmic surgery Read 7223200 Irrigation of nasolacrimal duct 
Ophthalmic surgery Read 7223211 Syringing of nasolacrimal duct 
Ophthalmic surgery Read 7223300 Removal of tube from nasolacrimal duct 
Ophthalmic surgery Read 7223400 Probing of nasolacrimal duct NEC 
Ophthalmic surgery Read 7224000 Repair of canaliculus 
Ophthalmic surgery Read 7224100 Enlargement of lacrimal punctum 
Ophthalmic surgery Read 7224200 Occlusion of lacrimal punctum 
Ophthalmic surgery Read 7224300 Three snip procedure to eyelid 
Ophthalmic surgery Read 7224400 Retropunctal cautery of lacrimal punctum 
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Ophthalmic surgery Read 7224500 Insertion of silicon plug into lacrimal canaliculus 
Ophthalmic surgery Read 7224600 Marsupialisation of canaliculus 
Ophthalmic surgery Read 7224700 Canaliculotomy 
Ophthalmic surgery Read 7230000 Eye muscle medial rectus recession+lateral rectus resection 
Ophthalmic surgery Read 7230100 Bilateral recession of medial recti muscles of eye 
Ophthalmic surgery Read 7230200 Bilateral resection of medial recti muscles of eye 
Ophthalmic surgery Read 7230300 Bilateral recession of lateral recti muscles of eye 
Ophthalmic surgery Read 7230400 Bilateral resection of lateral recti muscles of eye 
Ophthalmic surgery Read 7230500 Recession of lateral rectus and resection of medial rectus 
Ophthalmic surgery Read 7230511 Recess lateral rectus mus and resect medial rectus mus eye 
Ophthalmic surgery Read 7231000 Recession of medial rectus muscle of eye NEC 
Ophthalmic surgery Read 7231100 Recession of lateral rectus muscle of eye NEC 
Ophthalmic surgery Read 7231200 Recession of superior rectus muscle of eye 
Ophthalmic surgery Read 7231300 Recession of inferior rectus muscle of eye 
Ophthalmic surgery Read 7231400 Recession of superior oblique muscle of eye 
Ophthalmic surgery Read 7231500 Recession of inferior oblique muscle of eye 
Ophthalmic surgery Read 7231600 Recession of combination of muscles of eye 
Ophthalmic surgery Read 7231700 Recession of levator muscle of eyelid 
Ophthalmic surgery Read 7232000 Resection of medial rectus muscle of eye NEC 
Ophthalmic surgery Read 7232011 Advancement of medial rectus muscle of eye 
Ophthalmic surgery Read 7232100 Resection of lateral rectus muscle of eye NEC 
Ophthalmic surgery Read 7232200 Resection of superior rectus muscle of eye 
Ophthalmic surgery Read 7232300 Resection of inferior rectus muscle of eye 
Ophthalmic surgery Read 7232400 Resection of superior oblique muscle of eye 
Ophthalmic surgery Read 7232500 Resection of inferior oblique muscle of eye 
Ophthalmic surgery Read 7232511 Myectomy of inferior oblique muscle of eye 
Ophthalmic surgery Read 7232600 Resection of combination of muscles of eye 
Ophthalmic surgery Read 7233000 Tenotomy of medial rectus muscle of eye 
Ophthalmic surgery Read 7233200 Tenotomy of superior rectus muscle of eye 
Ophthalmic surgery Read 7233400 Tenotomy of superior oblique muscle of eye 
Ophthalmic surgery Read 7233500 Tenotomy of inferior oblique muscle of eye 
Ophthalmic surgery Read 7233700 Tenotomy of muscle of eye NEC 
Ophthalmic surgery Read 7234000 Transposition of muscle of eye NEC 
Ophthalmic surgery Read 7234100 Lengthening of muscle of eye by muscle slide 
Ophthalmic surgery Read 7234200 Insertion of adjustable suture into muscle of eye 
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Ophthalmic surgery Read 7235000 Excision of lesion of muscle of eye 
Ophthalmic surgery Read 7235100 Freeing of adhesions of muscle of eye 
Ophthalmic surgery Read 7235200 Biopsy of lesion of muscle of eye 
Ophthalmic surgery Read 7235300 Repair of muscle of eye NEC 
Ophthalmic surgery Read 7235400 Botulinum toxin injection into eye muscle 
Ophthalmic surgery Read 7236000 Advancement of medial rectus 
Ophthalmic surgery Read 7236100 Advancement of lateral rectus 
Ophthalmic surgery Read 7236200 Advancement of superior rectus 
Ophthalmic surgery Read 7236300 Advancement of inferior rectus 
Ophthalmic surgery Read 7236400 Advancement of superior oblique 
Ophthalmic surgery Read 7236500 Advancement of inferior oblique 
Ophthalmic surgery Read 7240000 Excision of lesion of conjunctiva 
Ophthalmic surgery Read 7240100 Cauterisation of lesion of conjunctiva 
Ophthalmic surgery Read 7240200 Cryotherapy to lesion of conjunctiva 
Ophthalmic surgery Read 7240300 Curettage of lesion of conjunctiva 
Ophthalmic surgery Read 7241000 Mucosal graft to conjunctiva 
Ophthalmic surgery Read 7241100 Amniotic graft to conjunctiva 
Ophthalmic surgery Read 7241200 Sliding graft to conjunctiva 
Ophthalmic surgery Read 7241300 Prosthetic replacement of conjunctiva 
Ophthalmic surgery Read 7241400 Suture of conjunctiva 
Ophthalmic surgery Read 7241500 Graft to conjunctiva NEC 
Ophthalmic surgery Read 7242000 Peritomy 
Ophthalmic surgery Read 7243000 Division of adhesions of conjunctiva 
Ophthalmic surgery Read 7243100 Biopsy of lesion of conjunctiva 
Ophthalmic surgery Read 7243200 Removal of foreign body from conjunctiva 
Ophthalmic surgery Read 7243300 Subconjunctival injection 
Ophthalmic surgery Read 7243400 Exploration of conjunctiva 
Ophthalmic surgery Read 7243500 Creation of hood of conjunctiva 
Ophthalmic surgery Read 7243600 Transplantation of conjunctiva 
Ophthalmic surgery Read 7244000 Superficial keratectomy 
Ophthalmic surgery Read 7244100 Excision of lesion of cornea NEC 
Ophthalmic surgery Read 7244200 Cauterisation of lesion of cornea 
Ophthalmic surgery Read 7244300 Cryotherapy to lesion of cornea 
Ophthalmic surgery Read 7244400 Radiotherapy to lesion of cornea 
Ophthalmic surgery Read 7244500 Destruction of lesion of cornea NEC 
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Ophthalmic surgery Read 7244600 Debridement of lesion of cornea 
Ophthalmic surgery Read 7244700 Excision of pterygium of cornea 
Ophthalmic surgery Read 7244800 Excision of pterygium of cornea and corneal graft 
Ophthalmic surgery Read 7244811 D'Ombrain excision of pterygium of cornea and corneal graft 
Ophthalmic surgery Read 7244900 Laser keratectomy 
Ophthalmic surgery Read 7244911 Excimer photorefractive keratectomy 
Ophthalmic surgery Read 7245000 Refractive keratoplasty 
Ophthalmic surgery Read 7245100 Lamellar graft to cornea 
Ophthalmic surgery Read 7245200 Penetrating graft to cornea 
Ophthalmic surgery Read 7245300 Insertion of prosthesis into cornea 
Ophthalmic surgery Read 7245400 Laser assisted in situ keratomileusis 
Ophthalmic surgery Read 7245500 Second stage Dacron mesh keratoprosthesis 
Ophthalmic surgery Read 7245600 Deep lamellar graft to cornea 
Ophthalmic surgery Read 7245700 Amniotic membrane graft to cornea 
Ophthalmic surgery Read 7245800 Transplant of corneal limbal cells 
Ophthalmic surgery Read 7245900 Lamellar graft to cornea NEC 
Ophthalmic surgery Read 7246000 Suture of cornea 
Ophthalmic surgery Read 7246100 Adjustment to suture of cornea 
Ophthalmic surgery Read 7246200 Removal of suture from cornea 
Ophthalmic surgery Read 7246300 Glueing of cornea 
Ophthalmic surgery Read 7247000 Surgical removal of foreign body from cornea 
Ophthalmic surgery Read 7247100 Magnetic extraction of foreign body from cornea 
Ophthalmic surgery Read 7248000 Section of cornea 
Ophthalmic surgery Read 7248100 Trephine of cornea 
Ophthalmic surgery Read 7248200 Radial keratotomy 
Ophthalmic surgery Read 7248300 Astigmatic keratotomy 
Ophthalmic surgery Read 7249000 Biopsy of lesion of cornea 
Ophthalmic surgery Read 7249100 Chelation of cornea 
Ophthalmic surgery Read 7249200 Exploration of cornea 
Ophthalmic surgery Read 7249300 Tattooing of cornea 
Ophthalmic surgery Read 7249400 Placement of therapeutic contact lens on to cornea 
Ophthalmic surgery Read 7250000 Punch resection of sclera 
Ophthalmic surgery Read 7250100 Excision of lesion of sclera NEC 
Ophthalmic surgery Read 7250200 Cauterisation of lesion of sclera 
Ophthalmic surgery Read 7251000 Overlay scleroplasty 
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Ophthalmic surgery Read 7251100 Imbrication of sclera 
Ophthalmic surgery Read 7251200 Buckling of sclera and implant however further qualified 
Ophthalmic surgery Read 7251300 Buckling of sclera and local or encircling explant HFQ 
Ophthalmic surgery Read 7251311 Arruga string operation for detached retina 
Ophthalmic surgery Read 7251400 Buckling of sclera NEC 
Ophthalmic surgery Read 7251500 Removal of implant or explant from sclera 
Ophthalmic surgery Read 7251600 Maintenance of implant or explant in sclera 
Ophthalmic surgery Read 7252000 Drainage of lesion of sclera 
Ophthalmic surgery Read 7252100 Corneoscleral trephine 
Ophthalmic surgery Read 7252200 Drainage of subretinal fluid through sclera 
Ophthalmic surgery Read 7252300 Trephining of sclera and iridectomy 
Ophthalmic surgery Read 7252311 Elliot trephining of sclera and iridectomy 
Ophthalmic surgery Read 7252400 Sclerotomy NEC 
Ophthalmic surgery Read 7253000 Biopsy of lesion of sclera 
Ophthalmic surgery Read 7253100 Repair of sclera 
Ophthalmic surgery Read 7253200 Graft to sclera 
Ophthalmic surgery Read 7253300 Suture of sclera 
Ophthalmic surgery Read 7254000 Iridocyclectomy 
Ophthalmic surgery Read 7254100 Surgical iridectomy 
Ophthalmic surgery Read 7254111 Iridectomy NEC 
Ophthalmic surgery Read 7255000 Trabeculectomy 
Ophthalmic surgery Read 7255100 Inclusion of iris 
Ophthalmic surgery Read 7255200 Fixation of iris 
Ophthalmic surgery Read 7255300 Iridoplasty NEC 
Ophthalmic surgery Read 7255311 Pupilloplasty 
Ophthalmic surgery Read 7255400 Insert tube in ant chamber- assist aqueous humour drainage 
Ophthalmic surgery Read 7255411 Insertion Molteno implantation tube in anterior chamber eye 
Ophthalmic surgery Read 7255500 Viscocanulostomy 
Ophthalmic surgery Read 7255600 Revision of trabeculectomy 
Ophthalmic surgery Read 7255700 Viscocanalostomy 
Ophthalmic surgery Read 7256000 Laser trabeculoplasty 
Ophthalmic surgery Read 7256100 Trabeculotomy 
Ophthalmic surgery Read 7256200 Goniotomy 
Ophthalmic surgery Read 7256211 Barkan goniotomy 
Ophthalmic surgery Read 7256300 Goniopuncture 
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Ophthalmic surgery Read 7256400 Viscogonioplasty 
Ophthalmic surgery Read 7257000 Iridosclerotomy 
Ophthalmic surgery Read 7257100 Surgical iridotomy 
Ophthalmic surgery Read 7257111 Iridotomy NEC 
Ophthalmic surgery Read 7257200 Laser iridotomy 
Ophthalmic surgery Read 7257300 Correction iridodialysis NEC 
Ophthalmic surgery Read 7258000 Excision of prolapsed iris 
Ophthalmic surgery Read 7258100 Excision of lesion of iris 
Ophthalmic surgery Read 7258200 Destruction of lesion of iris 
Ophthalmic surgery Read 7258300 Biopsy of lesion of iris 
Ophthalmic surgery Read 7258400 Removal of foreign body from iris 
Ophthalmic surgery Read 7258500 Stretching of iris 
Ophthalmic surgery Read 7258600 Excision of pupillary membrane 
Ophthalmic surgery Read 7258700 Resuturing of trabeculectomy 
Ophthalmic surgery Read 7258800 Repositioning of iris 
Ophthalmic surgery Read 7258900 Insertion of iris hooks 
Ophthalmic surgery Read 7259000 Needling of bleb following glaucoma surgery 
Ophthalmic surgery Read 7259100 Injection of bleb following glaucoma surgery 
Ophthalmic surgery Read 7259200 Revision of bleb NEC following glaucoma surgery 
Ophthalmic surgery Read 7259300 Removal of releasable suture following glaucoma surgery 
Ophthalmic surgery Read 7259400 Laser suture lysis following glaucoma surgery 
Ophthalmic surgery Read 7260000 Cauterisation of ciliary body 
Ophthalmic surgery Read 7260100 Cryotherapy to ciliary body 
Ophthalmic surgery Read 7260200 Excision of ciliary body 
Ophthalmic surgery Read 7260300 Laser photocoagulation of ciliary body 
Ophthalmic surgery Read 7260400 Destruction of ciliary body NEC 
Ophthalmic surgery Read 7260500 Transcleral diode laser cycloablation 
Ophthalmic surgery Read 7261000 Separation of ciliary body 
Ophthalmic surgery Read 7261011 Cyclodialysis 
Ophthalmic surgery Read 7262000 Reformation of anterior chamber of eye 
Ophthalmic surgery Read 7262100 Paracentesis of anterior chamber of eye 
Ophthalmic surgery Read 7262200 Injection into anterior chamber of eye 
Ophthalmic surgery Read 7262300 Irrigation of anterior chamber of eye 
Ophthalmic surgery Read 7262311 Washout of anterior chamber of eye 
Ophthalmic surgery Read 7263000 Simple linear extraction of lens 
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Ophthalmic surgery Read 7263011 Needling of lens for cataract 
Ophthalmic surgery Read 7263100 Phakoemulsification of lens 
Ophthalmic surgery Read 7263111 Phacoemulsification of lens 
Ophthalmic surgery Read 7263200 Aspiration of lens 
Ophthalmic surgery Read 7264000 Forceps extraction of lens 
Ophthalmic surgery Read 7264100 Suction extraction of lens 
Ophthalmic surgery Read 7264200 Cryoextraction of lens 
Ophthalmic surgery Read 7265000 Membranectomy of lens 
Ophthalmic surgery Read 7265100 Capsulotomy of anterior lens capsule 
Ophthalmic surgery Read 7265200 Capsulotomy of posterior lens capsule 
Ophthalmic surgery Read 7265300 Capsulotomy of lens NEC 
Ophthalmic surgery Read 7265400 YAG laser capsulotomy of lens 
Ophthalmic surgery Read 7265500 Laser capsulotomy of lens 
Ophthalmic surgery Read 7266000 Curettage of lens 
Ophthalmic surgery Read 7266100 Discission of cataract 
Ophthalmic surgery Read 7266200 Mechanical lensectomy 
Ophthalmic surgery Read 7267000 Insertion of prosthetic replacement for lens 
Ophthalmic surgery Read 7267100 Revision of prosthetic replacement for lens 
Ophthalmic surgery Read 7267200 Removal of prosthetic replacement for lens 
Ophthalmic surgery Read 7267300 Phakoemulsification lens insertion prosthetic replacement 
Ophthalmic surgery Read 7267311 Phacoemulsification lens insertion prosthetic replacement 
Ophthalmic surgery Read 7267400 Insertion prosthetic replacement lens using suture fixation 
Ophthalmic surgery Read 7267500 Insertion of prosthetic replacement for lens NEC 
Ophthalmic surgery Read 7267600 Cataract extraction and insertion of intraocular lens 
Ophthalmic surgery Read 7268000 Capsulectomy 
Ophthalmic surgery Read 7268100 Couching of lens 
Ophthalmic surgery Read 7268200 Biopsy of lesion of lens 
Ophthalmic surgery Read 7268300 Surgical removal of foreign body from lens 
Ophthalmic surgery Read 7268400 Magnetic extraction of foreign body from lens 
Ophthalmic surgery Read 7268500 Reposition lens 
Ophthalmic surgery Read 7268600 Insertion of lens capsule tension ring 
Ophthalmic surgery Read 7270000 Extirpation of vitreous body using anterior approach 
Ophthalmic surgery Read 7270011 Anterior vitrectomy 
Ophthalmic surgery Read 7270100 Extirpation of vitreous body NEC 
Ophthalmic surgery Read 7270200 Injection of vitreous substitute into vitreous body 
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Ophthalmic surgery Read 7270300 Injection into vitreous body NEC 
Ophthalmic surgery Read 7270400 Pars plana vitrectomy 
Ophthalmic surgery Read 7270411 Vitrectomy using pars plana approach 
Ophthalmic surgery Read 7270500 Air/gas exchange of vitreous 
Ophthalmic surgery Read 7270600 Internal tamponade of retina using gas 
Ophthalmic surgery Read 7270700 Internal tamponade of retina using air 
Ophthalmic surgery Read 7270800 Internal tamponade of retina using liquid 
Ophthalmic surgery Read 7270900 Internal tamponade of retina using oil 
Ophthalmic surgery Read 7271000 Xenon photocoagulation of retina for detachment 
Ophthalmic surgery Read 7271100 Laser photocoagulation of retina for detachment 
Ophthalmic surgery Read 7272000 Cauterisation of lesion of retina 
Ophthalmic surgery Read 7272011 Electrocoagulation of lesion of retina NEC 
Ophthalmic surgery Read 7272012 Photocoagulation of lesion of retina NEC 
Ophthalmic surgery Read 7272013 Laser therapy lesion of retina 
Ophthalmic surgery Read 7272100 Cryotherapy to lesion of retina 
Ophthalmic surgery Read 7272200 Radiotherapy to lesion of retina 
Ophthalmic surgery Read 7272300 Laser destruction of lesion of retina 
Ophthalmic surgery Read 7272400 Plaque radiotherapy to lesion of retina 
Ophthalmic surgery Read 7272500 Panretinal laser photocoagulation to lesion of retina NEC 
Ophthalmic surgery Read 7272600 Laser photocoagulation to lesion of retina NEC 
Ophthalmic surgery Read 7272700 External beam radiotherapy to lesion of retina 
Ophthalmic surgery Read 7272800 Panretinal laser photocoagulation to lesion of retina 
Ophthalmic surgery Read 7272900 Focal laser photocoagulation of retina 
Ophthalmic surgery Read 7273000 Epiretinal dissection 
Ophthalmic surgery Read 7273100 Excision of lesion of retina 
Ophthalmic surgery Read 7273200 Biopsy of lesion of retina 
Ophthalmic surgery Read 7273300 Reposition plombage for detachment 
Ophthalmic surgery Read 7273400 Retinal vascular sheathotomy 
Ophthalmic surgery Read 7273500 Drainage of subretinal fluid through retina 
Ophthalmic surgery Read 7273600 Retinotomy NEC 
Ophthalmic surgery Read 7274000 Biopsy of lesion of eye NEC 
Ophthalmic surgery Read 7274100 Repair of globe 
Ophthalmic surgery Read 7274200 Suture of eye NEC 
Ophthalmic surgery Read 7274300 Removal of foreign body from eye NEC 
Ophthalmic surgery Read 7274311 Removal of foreign body from eye 
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Ophthalmic surgery Read 7274400 Fluorescein angiography of eye 
Ophthalmic surgery Read 7274500 Examination of eye under anaesthetic 
Ophthalmic surgery Read 7274600 Drainage of suprachoroidal fluid 
Ophthalmic surgery Read 7274611 Aspiration of choroidal fluid 
Ophthalmic surgery Read 7274700 Refraction under general anaesthetic 
Ophthalmic surgery Read 7274800 Injection of therapeutic substance around the eye 
Ophthalmic surgery Read 7277000 Peel of epiretinal (fibroglial) membrane 
Ophthalmic surgery Read 7277100 Peel of internal limiting membrane 
Ophthalmic surgery Read 7277200 Delamination of epiretinal fibrovascular membrane 
Ophthalmic surgery Read 7277300 Segmentation of epiretinal fibrovascular membrane 
Ophthalmic surgery Read 7277400 Removal of subretinal vascular membrane 
Ophthalmic surgery Read 7277500 Removal of subretinal membrane NEC 
Ophthalmic surgery Read 7277600 Injection of therapeutic substance into macula 
Ophthalmic surgery Read 7278000 Pigment epithelium translocation of retina 
Ophthalmic surgery Read 7278100 Macular translocation three hundred and sixty degrees 
Ophthalmic surgery Read 7278200 Limited macular translocation 
Ophthalmic surgery Read 7279000 Retinopexy using cryotherapy 
Ophthalmic surgery Read 7279100 Retinopexy using diathermy 
Ophthalmic surgery Read 7279200 Retinopexy using mechanical tacks 
Ophthalmic surgery Read 7279300 Retinopexy using tissue adhesive 
Ophthalmic surgery Read 7279400 Retinopexy NEC 
Ophthalmic surgery Read 72...00 Eye operations 
Ophthalmic surgery Read 720..00 Orbit operations 
Ophthalmic surgery Read 7200y00 Other specified excision of eye 
Ophthalmic surgery Read 7200z00 Excision of eye NOS 
Ophthalmic surgery Read 7201y00 Other specified extirpation of lesion of orbit 
Ophthalmic surgery Read 7202y00 Other specified insertion of prosthesis of eye 
Ophthalmic surgery Read 7202z00 Insertion of prosthesis of eye NOS 
Ophthalmic surgery Read 7203y00 Other specified attention to prosthesis of eye 
Ophthalmic surgery Read 7203z00 Attention to prosthesis of eye NOS 
Ophthalmic surgery Read 7204A00 Correction of hypertelorism with orbital osteotomies 
Ophthalmic surgery Read 7204C00 Corr hypertelorism c orbital osteotomies+nasal reconstruct 
Ophthalmic surgery Read 7204D00 Correction of hypotelorism with orbital osteotomies 
Ophthalmic surgery Read 7204F00 Correct rotational orbital dystopia with orbital osteotomies 
Ophthalmic surgery Read 7204y00 Other specified plastic repair of orbit 
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Ophthalmic surgery Read 7204z00 Plastic repair of orbit NOS 
Ophthalmic surgery Read 7205z00 Incision of orbit NOS 
Ophthalmic surgery Read 7205z11 Orbitotomy NEC 
Ophthalmic surgery Read 7206y00 Other specified other operation on orbit 
Ophthalmic surgery Read 7206z00 Other operation on orbit NOS 
Ophthalmic surgery Read 720y.00 Other specified operations on orbit 
Ophthalmic surgery Read 720z.00 Orbit operations NOS 
Ophthalmic surgery Read 721..00 Eyebrow and eyelid operations 
Ophthalmic surgery Read 721..11 Eyelid operations 
Ophthalmic surgery Read 7210y00 Other specified operation on eyebrow 
Ophthalmic surgery Read 7210z00 Operation on eyebrow NOS 
Ophthalmic surgery Read 7211B00 Medial canthopexy 
Ophthalmic surgery Read 7211C00 Lateral canthopexy 
Ophthalmic surgery Read 7211D00 Lateral canthoplasty 
Ophthalmic surgery Read 7211F00 Biopsy of lesion of canthus 
Ophthalmic surgery Read 7211y00 Other specified operation on canthus 
Ophthalmic surgery Read 7211z00 Operation on canthus NOS 
Ophthalmic surgery Read 7212A00 Excision of lesion of eyelid NEC 
Ophthalmic surgery Read 7212y00 Other specified extirpation of lesion of eyelid 
Ophthalmic surgery Read 7212z00 Extirpation of lesion of eyelid NOS 
Ophthalmic surgery Read 7213y00 Other specified excision of redundant skin of eyelid 
Ophthalmic surgery Read 7213z00 Excision of redundant skin of eyelid NOS 
Ophthalmic surgery Read 7214y00 Other specified reconstruction of eyelid 
Ophthalmic surgery Read 7214z00 Reconstruction of eyelid NOS 
Ophthalmic surgery Read 7215y00 Other specified correction of deformity of eyelid 
Ophthalmic surgery Read 7215z00 Correction of deformity of eyelid NOS 
Ophthalmic surgery Read 7216y00 Other specified other plastic repair of eyelid 
Ophthalmic surgery Read 7216z00 Other plastic repair of eyelid NOS 
Ophthalmic surgery Read 7217y00 Other specified other repair of eyelid 
Ophthalmic surgery Read 7217z00 Other repair of eyelid NOS 
Ophthalmic surgery Read 7218y00 Other specified correction of ptosis of eyelid 
Ophthalmic surgery Read 7218z00 Correction of ptosis of eyelid NOS 
Ophthalmic surgery Read 7219y00 Other specified incision of eyelid 
Ophthalmic surgery Read 7219y11 Henderson incision of muller muscle of eyelid 
Ophthalmic surgery Read 7219z00 Incision of eyelid NOS 
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Ophthalmic surgery Read 721A.00 Protective suture of eyelid 
Ophthalmic surgery Read 721A000 Complete protective suture of eyelid 
Ophthalmic surgery Read 721A300 Medial protective suture of eyelid 
Ophthalmic surgery Read 721A400 Removal of protective suture from eyelid 
Ophthalmic surgery Read 721A500 Tissue glue protective tarsorrhaphy 
Ophthalmic surgery Read 721A600 Insertion of everting sutures to lower eyelid 
Ophthalmic surgery Read 721Ay00 Other specified protective suture of eyelid 
Ophthalmic surgery Read 721B.00 Other operations on eyelid 
Ophthalmic surgery Read 721B000 Avulsion of nerve of eyelid 
Ophthalmic surgery Read 721B100 Biopsy of lesion of eyelid 
Ophthalmic surgery Read 721B200 Removal of foreign body from eyelid 
Ophthalmic surgery Read 721B300 Injection into eyelid 
Ophthalmic surgery Read 721B400 Exploration of eyelid 
Ophthalmic surgery Read 721B500 Epilation of eyelash 
Ophthalmic surgery Read 721B511 Retro-punctal cautery 
Ophthalmic surgery Read 721B512 Electrolysis of eyelash 
Ophthalmic surgery Read 721B600 Insertion of gold weight to upper eyelid 
Ophthalmic surgery Read 721B700 Denervation of nerve of eyelid 
Ophthalmic surgery Read 721By00 Other specified other operation on eyelid 
Ophthalmic surgery Read 721Bz00 Other operation on eyelid NOS 
Ophthalmic surgery Read 721C.00 Replacement of canthal tendon 
Ophthalmic surgery Read 721C000 Replacement of lateral canthal tendon using tarsal strip 
Ophthalmic surgery Read 721C100 Replacement of lateral canthal tendon using periosteal strip 
Ophthalmic surgery Read 721C200 Replacement of medial canthal tendon using periosteal strip 
Ophthalmic surgery Read 721Cy00 Other specified replacement of canthal tendon 
Ophthalmic surgery Read 721Cz00 Replacement of canthal tendon NOS 
Ophthalmic surgery Read 721y.00 Other specified operations on eyelid or eyebrow 
Ophthalmic surgery Read 721z.00 Eyelid and eyebrow operations NOS 
Ophthalmic surgery Read 722..00 Lacrimal apparatus operations 
Ophthalmic surgery Read 7220y00 Other specified operation on lacrimal gland 
Ophthalmic surgery Read 7220z00 Operation on lacrimal gland NOS 
Ophthalmic surgery Read 7221y00 Other specified connection between lacrimal gland and nose 
Ophthalmic surgery Read 7221z00 Connection between lacrimal gland and nose NOS 
Ophthalmic surgery Read 7222y00 Other specified other operation on lacrimal sac 
Ophthalmic surgery Read 7222z00 Other operation on lacrimal sac NOS 
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Ophthalmic surgery Read 7223y00 Other specified operation on nasolacrimal duct 
Ophthalmic surgery Read 7223z00 Operation on nasolacrimal duct NOS 
Ophthalmic surgery Read 7224y00 Other specified other operation on lacrimal apparatus 
Ophthalmic surgery Read 7224z00 Other operation on lacrimal apparatus NOS 
Ophthalmic surgery Read 722y.00 Other specified operations on lacrimal apparatus 
Ophthalmic surgery Read 722z.00 Lacrimal apparatus operations NOS 
Ophthalmic surgery Read 723..00 Eye muscle operations 
Ophthalmic surgery Read 723..11 Oblique eye muscle operations 
Ophthalmic surgery Read 723..12 Operations for squint 
Ophthalmic surgery Read 723..13 Rectus eye muscle operations 
Ophthalmic surgery Read 7230y00 Other specified combined operation on muscles of eye 
Ophthalmic surgery Read 7230z00 Combined operation on muscles of eye NOS 
Ophthalmic surgery Read 7231y00 Other specified recession of muscle of eye 
Ophthalmic surgery Read 7231z00 Recession of muscle of eye NOS 
Ophthalmic surgery Read 7232y00 Other specified resection of muscle of eye 
Ophthalmic surgery Read 7232z00 Resection of muscle of eye NOS 
Ophthalmic surgery Read 7233z00 Partial division of tendon of muscle of eye NOS 
Ophthalmic surgery Read 7234y00 Other specified other adjustment to muscle of eye 
Ophthalmic surgery Read 7234z00 Other adjustment to muscle of eye NOS 
Ophthalmic surgery Read 7235y00 Other specified other operation on muscle of eye 
Ophthalmic surgery Read 7235z00 Other operation on muscle of eye NOS 
Ophthalmic surgery Read 723y.00 Other specified operations on muscle of the eye 
Ophthalmic surgery Read 723z.00 Operations on muscle of the eye NOS 
Ophthalmic surgery Read 724..00 Conjunctiva and cornea operations 
Ophthalmic surgery Read 724..11 Conjunctiva operations 
Ophthalmic surgery Read 724..12 Cornea operations 
Ophthalmic surgery Read 7240y00 Other specified extirpation of lesion of conjunctiva 
Ophthalmic surgery Read 7240z00 Extirpation of lesion of conjunctiva NOS 
Ophthalmic surgery Read 7241y00 Other specified repair of conjunctiva 
Ophthalmic surgery Read 7241z00 Repair of conjunctiva NOS 
Ophthalmic surgery Read 7242y00 Other specified incision of conjunctiva 
Ophthalmic surgery Read 7242z00 Incision of conjunctiva NOS 
Ophthalmic surgery Read 7243y00 Other specified other operation on conjunctiva 
Ophthalmic surgery Read 7243z00 Other operation on conjunctiva NOS 
Ophthalmic surgery Read 7244y00 Other specified extirpation of lesion of cornea 
  
 
2
3
4
 
Condition / Diagnosis Coding System Code Description 
Ophthalmic surgery Read 7244z00 Extirpation of lesion of cornea NOS 
Ophthalmic surgery Read 7245A00 Laser assisted subepithelial keratomileusis 
Ophthalmic surgery Read 7245y00 Other specified plastic operation on cornea 
Ophthalmic surgery Read 7245z00 Plastic operation on cornea NOS 
Ophthalmic surgery Read 7246y00 Other specified closure of cornea 
Ophthalmic surgery Read 7246z00 Closure of cornea NOS 
Ophthalmic surgery Read 7247y00 Other specified removal of foreign body from cornea 
Ophthalmic surgery Read 7247z00 Removal of foreign body from cornea NOS 
Ophthalmic surgery Read 7248y00 Other specified incision of cornea 
Ophthalmic surgery Read 7248z00 Incision of cornea NOS 
Ophthalmic surgery Read 7249y00 Other specified other operation on cornea 
Ophthalmic surgery Read 7249z00 Other operation on cornea NOS 
Ophthalmic surgery Read 724A.00 Excision of sclera 
Ophthalmic surgery Read 724A000 Deep sclerectomy with spacer 
Ophthalmic surgery Read 724A100 Deep sclerectomy without spacer 
Ophthalmic surgery Read 724Ay00 Other specified excision of sclera 
Ophthalmic surgery Read 724Az00 Excision of sclera NOS 
Ophthalmic surgery Read 724B.00 Other plastic operations on cornea 
Ophthalmic surgery Read 724B000 Hydrogel prosthetic keratoplasty 
Ophthalmic surgery Read 724B100 Laser in situ keratomileusis 
Ophthalmic surgery Read 724B200 Endothelial graft to cornea 
Ophthalmic surgery Read 724B300 Photorefractive keratectomy 
Ophthalmic surgery Read 724B400 Laser subepithelial keratomileusis 
Ophthalmic surgery Read 724By00 Other specified other plastic operations on cornea 
Ophthalmic surgery Read 724Bz00 Other plastic operations on cornea NOS 
Ophthalmic surgery Read 724y.00 Other specified operations on conjunctiva or cornea 
Ophthalmic surgery Read 724z.00 Conjunctiva and cornea operations NOS 
Ophthalmic surgery Read 725..00 Sclera and iris operations 
Ophthalmic surgery Read 725..11 Iris operations 
Ophthalmic surgery Read 725..12 Sclera operations 
Ophthalmic surgery Read 7251y00 Other specified buckling operation for attachment of retina 
Ophthalmic surgery Read 7251z00 Buckling operation for attachment of retina NOS 
Ophthalmic surgery Read 7252y00 Other specified incision of sclera 
Ophthalmic surgery Read 7252y11 Scheie cautery incision of sclera 
Ophthalmic surgery Read 7253y00 Other specified other operation on sclera 
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Ophthalmic surgery Read 7253z00 Other operation on sclera NOS 
Ophthalmic surgery Read 7254y00 Other specified excision of iris 
Ophthalmic surgery Read 7254z00 Excision of iris NOS 
Ophthalmic surgery Read 7255y00 Other specified filtering operation on iris 
Ophthalmic surgery Read 7255z00 Filtering operation on iris NOS 
Ophthalmic surgery Read 7256y00 Other operation on trabecular meshwork of eye OS 
Ophthalmic surgery Read 7256z00 Other operation on trabecular meshwork of eye NOS 
Ophthalmic surgery Read 7257y00 Other specified incision of iris 
Ophthalmic surgery Read 7257z00 Incision of iris NOS 
Ophthalmic surgery Read 7258y00 Other specified other operation on iris 
Ophthalmic surgery Read 7258z00 Other operation on iris NOS 
Ophthalmic surgery Read 7259y00 Other specified operations following glaucoma surgery 
Ophthalmic surgery Read 7259z00 Operations following glaucoma surgery NOS 
Ophthalmic surgery Read 725y.00 Other specified operations on sclera or iris 
Ophthalmic surgery Read 725z.00 Sclera and iris operations NOS 
Ophthalmic surgery Read 726..00 Anterior chamber of eye and lens operations 
Ophthalmic surgery Read 7261y00 Other specified other operation on ciliary body 
Ophthalmic surgery Read 7261z00 Other operation on ciliary body NOS 
Ophthalmic surgery Read 7262y00 Other specified other operation on anterior chamber of eye 
Ophthalmic surgery Read 7262z00 Other operation on anterior chamber of eye NOS 
Ophthalmic surgery Read 7263y00 Other specified extracapsular extraction of lens 
Ophthalmic surgery Read 7263z00 Extracapsular extraction of lens NOS 
Ophthalmic surgery Read 7264y00 Other specified intracapsular extraction of lens 
Ophthalmic surgery Read 7264z00 Intracapsular extraction of lens NOS 
Ophthalmic surgery Read 7265y00 Other specified incision of capsule of lens 
Ophthalmic surgery Read 7265z00 Incision of capsule of lens NOS 
Ophthalmic surgery Read 7266y00 Other specified other extraction of lens 
Ophthalmic surgery Read 7266z00 Other extraction of lens NOS 
Ophthalmic surgery Read 7267y00 Other specified prosthesis of lens 
Ophthalmic surgery Read 7267z00 Prosthesis of lens NOS 
Ophthalmic surgery Read 7268y00 Other specified other operation on lens 
Ophthalmic surgery Read 7268z00 Other operation on lens NOS 
Ophthalmic surgery Read 726y.00 Anterior chamber of eye or lens operations OS 
Ophthalmic surgery Read 726z.00 Anterior chamber of eye and lens operations NOS 
Ophthalmic surgery Read 727..00 Retina and other parts of eye operations 
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Ophthalmic surgery Read 7270A00 Removal of internal tamponade agent from vitreous body 
Ophthalmic surgery Read 7270B00 Vitrectomy using anterior approach 
Ophthalmic surgery Read 7270B11 Anterior vitrectomy 
Ophthalmic surgery Read 7270C00 Injection of vitreous substitute into vitreous body NEC 
Ophthalmic surgery Read 7270D00 Injection of Ranibizumab into vitreous body 
Ophthalmic surgery Read 7270y00 Other specified operation on vitreous body 
Ophthalmic surgery Read 7270z00 Operation on vitreous body NOS 
Ophthalmic surgery Read 7271y00 Other specified photocoagulation of retina for detachment 
Ophthalmic surgery Read 7271z00 Photocoagulation of retina for detachment NOS 
Ophthalmic surgery Read 7272y00 Other specified destruction of lesion of retina 
Ophthalmic surgery Read 7272z00 Destruction of lesion of retina NOS 
Ophthalmic surgery Read 7273y00 Other specified other operation on retina 
Ophthalmic surgery Read 7273z00 Other operation on retina NOS 
Ophthalmic surgery Read 7274y00 Other specified other operation on eye 
Ophthalmic surgery Read 7274z00 Other operation on eye NOS 
Ophthalmic surgery Read 7277y00 Other specified operations on retinal membrane 
Ophthalmic surgery Read 7277z00 Operations on retinal membrane NOS 
Ophthalmic surgery Read 7278z00 Translocation of retina NOS 
Ophthalmic surgery Read 7279y00 Other specified fixation of retina 
Ophthalmic surgery Read 7279z00 Fixation of retina NOS 
Ophthalmic surgery Read 727A.00 Evaluation of retina 
Ophthalmic surgery Read 727A000 Digital imaging of retina 
Ophthalmic surgery Read 727A100 Indocyanine angiography evaluation of retina 
Ophthalmic surgery Read 727A200 Tomography evaluation of retina 
Ophthalmic surgery Read 727A300 Ultrasonic evaluation of retina 
Ophthalmic surgery Read 727A400 Scanning laser ophthalmoscopy evaluation of retina 
Ophthalmic surgery Read 727Ay00 Other specified evaluation of retina 
Ophthalmic surgery Read 727Az00 Evaluation of retina NOS 
Ophthalmic surgery Read 727B.00 Destruction of subretinal lesion 
Ophthalmic surgery Read 727B000 Transpupillary thermotherapy to subretinal lesion 
Ophthalmic surgery Read 727B100 Photodynamic therapy to subretinal lesion 
Ophthalmic surgery Read 727B200 Photodynamic therapy to choroidal neovascular membrane 
Ophthalmic surgery Read 727By00 Other specified destruction of subretinal lesion 
Ophthalmic surgery Read 727Bz00 Destruction of subretinal lesion NOS 
Ophthalmic surgery Read 727C.00 Operations on posterior segment of eye 
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Ophthalmic surgery Read 727C000 Insertion sustained release device posterior segment of eye 
Ophthalmic surgery Read 727C100 Injection of steroid into posterior segment of eye 
Ophthalmic surgery Read 727C200 Injection therapeutic substance posterior segment of eye NEC 
Ophthalmic surgery Read 727Cy00 Other specified operations on posterior segment of eye 
Ophthalmic surgery Read 727Cz00 Operations on posterior segment of eye NOS 
Ophthalmic surgery Read 727D.00 Local anaesthetics for ophthalmology procedures 
Ophthalmic surgery Read 727D000 Topical anaesthetic for ophthalmology procedure 
Ophthalmic surgery Read 727D100 Subconjunctival anaesthetic 
Ophthalmic surgery Read 727D200 Subtenons anaesthetic 
Ophthalmic surgery Read 727D300 Peribulbar anaesthetic 
Ophthalmic surgery Read 727Dy00 Other specified local anaesthetics ophthalmology procedures 
Ophthalmic surgery Read 727Dz00 Local anaesthetics for ophthalmology procedures NOS 
Ophthalmic surgery Read 727y.00 Other specified operations on retina or other parts of eye 
Ophthalmic surgery Read 727z.00 Retina and other parts of eye operations NOS 
Ophthalmic surgery Read 72y..00 Other specified operations on eye 
Ophthalmic surgery Read 72z..00 Eye operations NOS 
Parkinson disease ICD-10  G20 Parkinson disease 
Parkinson disease ICD-10  G21 Secondary parkisonism 
Parkinson disease ICD-10  G21.0 Malignant neuroleptic syndrome 
Parkinson disease ICD-10  G21.1 Other drug-induced secondary parkinsonism 
Parkinson disease ICD-10  G21.2 Secondary parkinsonism due to other external agents 
Parkinson disease ICD-10  G21.3 Postencephalitic parkinsonism 
Parkinson disease ICD-10  G21.4 Vascular parkinsonism 
Parkinson disease ICD-10  G21.8 Other secondary parkinsonism 
Parkinson disease ICD-10  G21.9 Secondary parkinsonism, unspecified 
Parkinson disease ICD-10  G22 Parkinsonism in diseases classified elsewhere 
Parkinson disease Read 2987 O/E -Parkinson flexion posture 
Parkinson disease Read 2987.11 O/E - Parkinson posture 
Parkinson disease Read 2994 O/E-festination-Parkinson gait 
Parkinson disease Read 2994.11 O/E - Parkinson gait 
Parkinson disease Read 147F.00 History of Parkinson's disease 
Parkinson disease Read 297A.00 O/E - Parkinsonian tremor 
Parkinson disease Read A94y100 Syphilitic parkinsonism 
Parkinson disease Read Eu02300 [X]Dementia in Parkinson's disease 
Parkinson disease Read F11x900 Cerebral degeneration in Parkinson's disease 
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Parkinson disease Read F12..00 Parkinson's disease 
Parkinson disease Read F121.00 Parkinsonism secondary to drugs 
Parkinson disease Read F121.11 Drug induced parkinsonism 
Parkinson disease Read F123.00 Postencephalitic parkinsonism 
Parkinson disease Read F124.00 Vascular parkinsonism 
Parkinson disease Read F12W.00 Secondary parkinsonism due to other external agents 
Parkinson disease Read F12X.00 Secondary parkinsonism, unspecified 
Parkinson disease Read F12z.00 Parkinson's disease NOS 
Parkinson disease Read F130300 Parkinsonism with orthostatic hypotension 
Parkinson disease Read Fyu2000 [X]Other drug-induced secondary parkinsonism 
Parkinson disease Read Fyu2100 [X]Other secondary parkinsonism 
Parkinson disease Read Fyu2200 [X]Parkinsonism in diseases classified elsewhere 
Parkinson disease Read Fyu2900 [X]Secondary parkinsonism, unspecified 
Parkinson disease Read G567400 Wolff-Parkinson-White syndrome 
Parkinson disease Read SL6..00 Anticonvulsant and antiParkinsonian drug poisoning 
Parkinson disease Read SL6y.00 Antiparkinsonism drug poisoning 
Parkinson disease Read SL6yz00 Antiparkinsonian drug poisoning NOS 
Parkinson disease Read SL6z.00 Anticonvulsant or antiparkinsonian drug poisoning NOS 
Parkinson disease Read T850.00 Accidental poisoning by anticonvulsant + anti-parkinson drug 
Parkinson disease Read T850.12 Accidental poisoning by anti-parkinsonism drug 
Parkinson disease Read TJ6..00 Adverse reaction to anticonvulsants/anti-parkinsonism drugs 
Parkinson disease Read TJ64.00 Adverse reaction to antiparkinsonism drugs 
Parkinson disease Read TJ64z00 Adverse reaction to antiparkinsonism drugs NOS 
Parkinson disease Read TJ6z.00 Adverse reaction to anticonvulsant/antiparkinsonism drug NOS 
Parkinson disease Read U1A3.00 [X]Accident poisoning/exposure to antiparkinson drug 
Parkinson disease Read U606.11 [X] Adverse react to anticonvulsants & anti-parkinsons drugs 
Parkinson disease Read U606700 [X]Antiparkinsonism drugs caus advers effects in therap use 
Parkinson disease Read U606711 [X] Adverse reaction to antiparkinsonism drug 
Parkinson disease Read U606718 [X] Adverse reaction to antiparkinsonism drugs NOS 
Parkinson disease Read U606719 [X] Adverse react to anticonvuls or antiparkinson drug NOS 
Prior stroke or TIA ICD 10 G45 Transient cerebral ischaemic attacks and related syndromes 
Prior stroke or TIA ICD 10 G45.0 Vertebro-basilar artery syndrome 
Prior stroke or TIA ICD 10 G45.1 Carotid artery syndrome (hemispheric) 
Prior stroke or TIA ICD 10 G45.2 Multiple and bilateral precerebral artery syndromes 
Prior stroke or TIA ICD 10 G45.3 Amaurosis fugax 
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Prior stroke or TIA ICD 10 G45.4 Transient global amnesia 
Prior stroke or TIA ICD 10 G45.8 Other transient cerebral ischaemic attacks and related syndromes 
Prior stroke or TIA ICD 10 G45.9 Transient cerebral ischaemic attack, unspecified 
Prior stroke or TIA ICD 10 G95.1 Vascular myelopathies 
Prior stroke or TIA ICD 10 H34.1 Central retinal artery occlusion 
Prior stroke or TIA ICD 10 H34.2 Other retinal artery occlusions 
Prior stroke or TIA ICD 10 I63 Cerebral infarction 
Prior stroke or TIA ICD 10 I63.0 Cerebral infarct due to thrombosis of precerebral arteries 
Prior stroke or TIA ICD 10 I63.1 Cerebral infarction due to embolism of precerebral arteries 
Prior stroke or TIA ICD 10 I63.2 Cereb infarct due unsp occlusion or stenos precerebrl arts 
Prior stroke or TIA ICD 10 I63.3 Cerebral infarction due to thrombosis of cerebral arteries 
Prior stroke or TIA ICD 10 I63.4 Cerebral infarction due to embolism of cerebral arteries 
Prior stroke or TIA ICD 10 I63.5 Cerebrl infarct due unspec occlusion or stenos cerebrl arts 
Prior stroke or TIA ICD 10 I63.6 Cereb infarct due cerebral venous thrombosis, nonpyogenic 
Prior stroke or TIA ICD 10 I63.8 Other cerebral infarction 
Prior stroke or TIA ICD 10 I63.9 Cerebral infarction, unspecified 
Prior stroke or TIA ICD 10 I64 Stroke, not specified as haemorrhage or infarction 
Prior stroke or TIA ICD 10 I64.0 Stroke, not specified as haemorrhage or infarction 
Prior stroke or TIA ICD 10 I69.3 Sequelae of cerebral infarction 
Prior stroke or TIA ICD 10 I69.4 Sequelae of stroke, not specified as haemorrhage or infarction 
Prior stroke or TIA Read 14A7.00 H/O: CVA/stroke 
Prior stroke or TIA Read 14A7.11 H/O: CVA 
Prior stroke or TIA Read 14A7.12 H/O: stroke 
Prior stroke or TIA Read 14AK.00 H/O: Stroke in last year 
Prior stroke or TIA Read 662e.00 Stroke/CVA annual review 
Prior stroke or TIA Read 662M100 Stroke 6 month review 
Prior stroke or TIA Read 662M200 Stroke initial post discharge review 
Prior stroke or TIA Read 7P24200 Delivery of rehabilitation for stroke 
Prior stroke or TIA Read 9Om..00 Stroke/transient ischaemic attack monitoring administration 
Prior stroke or TIA Read 9Om0.00 Stroke/transient ischaemic attack monitoring first letter 
Prior stroke or TIA Read 9Om1.00 Stroke/transient ischaemic attack monitoring second letter 
Prior stroke or TIA Read 9Om2.00 Stroke/transient ischaemic attack monitoring third letter 
Prior stroke or TIA Read 9Om3.00 Stroke/transient ischaemic attack monitoring verbal invitati 
Prior stroke or TIA Read 9Om4.00 Stroke/transient ischaemic attack monitoring telephone invte 
Prior stroke or TIA Read Fyu5500 [X]Other transnt cerebral ischaemic attacks+related syndroms 
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Prior stroke or TIA Read G63y000 Cerebral infarct due to thrombosis of precerebral arteries 
Prior stroke or TIA Read G63y100 Cerebral infarction due to embolism of precerebral arteries 
Prior stroke or TIA Read G64..11 CVA - cerebral artery occlusion 
Prior stroke or TIA Read G64..13 Stroke due to cerebral arterial occlusion 
Prior stroke or TIA Read G640000 Cerebral infarction due to thrombosis of cerebral arteries 
Prior stroke or TIA Read G641000 Cerebral infarction due to embolism of cerebral arteries 
Prior stroke or TIA Read G64z.00 Cerebral infarction NOS 
Prior stroke or TIA Read G64z200 Left sided cerebral infarction 
Prior stroke or TIA Read G64z300 Right sided cerebral infarction 
Prior stroke or TIA Read G65..00 Transient cerebral ischaemia 
Prior stroke or TIA Read G65..12 Transient ischaemic attack 
Prior stroke or TIA Read G657.00 Carotid territory transient ischaemic attack 
Prior stroke or TIA Read G65y.00 Other transient cerebral ischaemia 
Prior stroke or TIA Read G65z.00 Transient cerebral ischaemia NOS 
Prior stroke or TIA Read G65z000 Impending cerebral ischaemia 
Prior stroke or TIA Read G65z100 Intermittent cerebral ischaemia 
Prior stroke or TIA Read G65zz00 Transient cerebral ischaemia NOS 
Prior stroke or TIA Read G66..00 Stroke and cerebrovascular accident unspecified 
Prior stroke or TIA Read G66..11 CVA unspecified 
Prior stroke or TIA Read G66..12 Stroke unspecified 
Prior stroke or TIA Read G66..13 CVA - Cerebrovascular accident unspecified 
Prior stroke or TIA Read G664.00 Cerebellar stroke syndrome 
Prior stroke or TIA Read G667.00 Left sided CVA 
Prior stroke or TIA Read G668.00 Right sided CVA 
Prior stroke or TIA Read G671.00 Generalised ischaemic cerebrovascular disease NOS 
Prior stroke or TIA Read G671z00 Generalised ischaemic cerebrovascular disease NOS 
Prior stroke or TIA Read G683.00 Sequelae of cerebral infarction 
Prior stroke or TIA Read G68X.00 Sequelae of stroke,not specfd as h'morrhage or infarction 
Prior stroke or TIA Read Gyu6400 [X]Other cerebral infarction 
Prior stroke or TIA Read L440.11 CVA - cerebrovascular accident in the puerperium 
Prior stroke or TIA Read L440.12 Stroke in the puerperium 
Prior stroke or TIA Read ZV12511 [V]Personal history of stroke 
Prior stroke or TIA Read ZV12512 [V]Personal history of cerebrovascular accident (CVA) 
Prosthetic valve Read 7910.00 Plastic repair of mitral valve 
Prosthetic valve Read 7910.11 Mitral valvuloplasty 
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Prosthetic valve Read 7910.12 Replacement of mitral valve 
Prosthetic valve Read 7911.00 Plastic repair of aortic valve 
Prosthetic valve Read 7911.12 Replacement of aortic valve 
Prosthetic valve Read 7912.11 Replacement of tricuspid valve 
Prosthetic valve Read 7913.12 Replacement of pulmonary valve 
Prosthetic valve Read 7914.11 Replacement of unspecified valve of heart 
Prosthetic valve Read 7910000 Allograft replacement of mitral valve 
Prosthetic valve Read 7910100 Xenograft replacement of mitral valve 
Prosthetic valve Read 7910200 Prosthetic replacement of mitral valve 
Prosthetic valve Read 7910211 Bjork-Shiley prosthetic replacement of mitral valve 
Prosthetic valve Read 7910212 Bjork-Shiley prosthetic replacement of mitral valve 
Prosthetic valve Read 7910213 Carpentier prosthetic replacement of mitral valve 
Prosthetic valve Read 7910214 Edwards prosthetic replacement of mitral valve 
Prosthetic valve Read 7910300 Replacement of mitral valve NEC 
Prosthetic valve Read 7910400 Mitral valvuloplasty NEC 
Prosthetic valve Read 7910411 Mitral valve repair NEC 
Prosthetic valve Read 7911000 Allograft replacement of aortic valve 
Prosthetic valve Read 7911100 Xenograft replacement of aortic valve 
Prosthetic valve Read 7911200 Prosthetic replacement of aortic valve 
Prosthetic valve Read 7911300 Replacement of aortic valve NEC 
Prosthetic valve Read 7911411 Aortic valve repair NEC 
Prosthetic valve Read 7911500 Transapical aortic valve implantation 
Prosthetic valve Read 7911600 Transluminal aortic valve implantation 
Prosthetic valve Read 7912000 Allograft replacement of tricuspid valve 
Prosthetic valve Read 7912100 Xenograft replacement of tricuspid valve 
Prosthetic valve Read 7912200 Prosthetic replacement of tricuspid valve 
Prosthetic valve Read 7912300 Replacement of tricuspid valve NEC 
Prosthetic valve Read 7913000 Allograft replacement of pulmonary valve 
Prosthetic valve Read 7913100 Xenograft replacement of pulmonary valve 
Prosthetic valve Read 7913200 Prosthetic replacement of pulmonary valve 
Prosthetic valve Read 7913300 Replacement of pulmonary valve NEC 
Prosthetic valve Read 7914000 Allograft replacement of valve of heart NEC 
Prosthetic valve Read 7914100 Xenograft replacement of valve of heart NEC 
Prosthetic valve Read 7914200 Prosthetic replacement of valve of heart NEC 
Prosthetic valve Read 7914211 Edwards prosthetic replacement of valve of heart 
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Prosthetic valve Read 7914212 Starr prosthetic replacement of valve of heart 
Prosthetic valve Read 7914300 Replacement of valve of heart NEC 
Prosthetic valve Read 7914600 Replacement of truncal valve 
Prosthetic valve Read 7915000 Revision of plastic repair of mitral valve 
Prosthetic valve Read 7915100 Revision of plastic repair of aortic valve 
Prosthetic valve Read 7916000 Open mitral valvotomy 
Prosthetic valve Read 7917000 Closed mitral valvotomy 
Prosthetic valve Read 7918000 Annuloplasty of mitral valve 
Prosthetic valve Read 7919000 Percutaneous transluminal mitral valvotomy 
Prosthetic valve Read 7919600 Percutaneous transluminal pulmonary valve replacement 
Prosthetic valve Read 790D700 Replacement of valved cardiac conduit 
Prosthetic valve Read 7910y00 Other specified plastic repair of mitral valve 
Prosthetic valve Read 7910z00 Plastic repair of mitral valve NOS 
Prosthetic valve Read 7911y00 Other specified plastic repair of aortic valve 
Prosthetic valve Read 7911z00 Plastic repair of aortic valve NOS 
Prosthetic valve Read P641.00 Bicuspid aortic valve 
Prosthetic valve Read SP00200 Mechanical complication of heart valve prosthesis 
Prosthetic valve Read SyuK611 [X] Embolism from prosthetic heart valve 
Prosthetic valve Read TB01200 Implant of heart valve prosthesis + complication, no blame 
Prosthetic valve Read ZV43300 [V]Has artificial heart valve 
Prosthetic valve Read ZV45H00 [V]Presence of prosthetic heart valve 
Prosthetic valve Read ZVu6e00 [X]Presence of other heart valve replacement 
Proteinuria ICD-10 D51.1 
Vitamin B12 deficiency anemia due to selective vitamin B12 
malabsorption with proteinuria 
Proteinuria ICD-10 N06.0 Isolated proteinuria with minor glomerular abnormality 
Proteinuria ICD-10 N06.1 Isolated proteinuria with focal and segmental glomerular lesions 
Proteinuria ICD-10 N06.2 Isolated proteinuria with diffuse membranous glomerulonephritis 
Proteinuria ICD-10 N06.3 
Isolated proteinuria with diffuse mesangial proliferative 
glomerulonephritis 
Proteinuria ICD-10 N06.4 
Isolated proteinuria with diffuse endocapillary proliferative 
glomerulonephritis 
Proteinuria ICD-10 N06.5 
Isolated proteinuria with diffuse mesangiocapillary 
glomerulonephritis 
Proteinuria ICD-10 N06.6 Isolated proteinuria with dense deposit disease 
Proteinuria ICD-10 N06.7 Isolated proteinuria with diffuse crescentic glomerulonephritis 
Proteinuria ICD-10 N06.8 Isolated proteinuria with other morphologic lesion 
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Proteinuria ICD-10 N06.9 Isolated proteinuria with unspecified morphologic lesion 
Proteinuria ICD-10 O12.1 Gestational proteinuria 
Proteinuria ICD-10 O12.2 Gestational oedema with proteinuria 
Proteinuria ICD-10 R80 Isolated proteinuria 
Proteinuria Read 4678 Proteinuria 
Proteinuria Read 1Z17.00 Chronic kidney disease stage 1 with proteinuria 
Proteinuria Read 1Z17.11 CKD stage 1 with proteinuria 
Proteinuria Read 1Z19.00 Chronic kidney disease stage 2 with proteinuria 
Proteinuria Read 1Z19.11 CKD stage 2 with proteinuria 
Proteinuria Read 1Z1B.00 Chronic kidney disease stage 3 with proteinuria 
Proteinuria Read 1Z1B.11 CKD stage 3 with proteinuria 
Proteinuria Read 1Z1D.00 Chronic kidney disease stage 3A with proteinuria 
Proteinuria Read 1Z1D.11 CKD stage 3A with proteinuria 
Proteinuria Read 1Z1F.00 Chronic kidney disease stage 3B with proteinuria 
Proteinuria Read 1Z1F.11 CKD stage 3B with proteinuria 
Proteinuria Read 1Z1H.00 Chronic kidney disease stage 4 with proteinuria 
Proteinuria Read 1Z1H.11 CKD stage 4 with proteinuria 
Proteinuria Read 1Z1K.00 Chronic kidney disease stage 5 with proteinuria 
Proteinuria Read 1Z1K.11 CKD stage 5 with proteinuria 
Proteinuria Read C10EK00 Type 1 diabetes mellitus with persistent proteinuria 
Proteinuria Read C10FL00 Type 2 diabetes mellitus with persistent proteinuria 
Proteinuria Read C10FL11 Type II diabetes mellitus with persistent proteinuria 
Proteinuria Read D011100 Vit B12 defic anaemia due to malabsorption with proteinuria 
Proteinuria Read K0A4.00 Isolated proteinuria with specified morphological lesion 
Proteinuria Read K0A4W00 Isolated proteinuria, with unspecified morpholog changes 
Proteinuria Read K0A4X00 Isolated proteinuria, with oth specif morpholog changes 
Proteinuria Read K136.00 Benign postural proteinuria 
Proteinuria Read K136.11 Orthostatic proteinuria 
Proteinuria Read K190X00 Persistent proteinuria, unspecified 
Proteinuria Read Kyu5G00 [X]Persistent proteinuria, unspecified 
Proteinuria Read L16C.00 Pregnancy induced oedema+proteinuria without hypertension 
Proteinuria Read L16C000 Gestational proteinuria 
Proteinuria Read L16C100 Gestational oedema with proteinuria 
Proteinuria Read Lyu1.00 [X]Oedema,proteinuria+hypertens in pregnancy,childbrth,puerp 
Proteinuria Read R110.00 [D]Proteinuria 
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Condition / Diagnosis Coding System Code Description 
Proteinuria Read R110100 [D]Bence-Jones proteinuria 
Proteinuria Read R110200 [D]Exercise proteinuria 
Proteinuria Read R110z00 [D]Proteinuria NOS 
Psychosis Read E0...00 Organic psychotic conditions 
Psychosis Read E00..00 Senile and presenile organic psychotic conditions 
Psychosis Read E00y.00 Other senile and presenile organic psychoses 
Psychosis Read E00y.11 Presbyophrenic psychosis 
Psychosis Read E00z.00 Senile or presenile psychoses NOS 
Psychosis Read E01..00 Alcoholic psychoses 
Psychosis Read E011000 Korsakov's alcoholic psychosis 
Psychosis Read E011100 Korsakov's alcoholic psychosis with peripheral neuritis 
Psychosis Read E013.00 Alcohol withdrawal hallucinosis 
Psychosis Read E015.00 Alcoholic paranoia 
Psychosis Read E01y.00 Other alcoholic psychosis 
Psychosis Read E01yz00 Other alcoholic psychosis NOS 
Psychosis Read E01z.00 Alcoholic psychosis NOS 
Psychosis Read E02..00 Drug psychoses 
Psychosis Read E021.00 Drug-induced paranoia or hallucinatory states 
Psychosis Read E021000 Drug-induced paranoid state 
Psychosis Read E021100 Drug-induced hallucinosis 
Psychosis Read E021z00 Drug-induced paranoia or hallucinatory state NOS 
Psychosis Read E02y.00 Other drug psychoses 
Psychosis Read E02yz00 Other drug psychoses NOS 
Psychosis Read E02z.00 Drug psychosis NOS 
Psychosis Read E03..00 Transient organic psychoses 
Psychosis Read E03y.00 Other transient organic psychoses 
Psychosis Read E03y100 Organic hallucinosis syndrome 
Psychosis Read E03y300 Unspecified puerperal psychosis 
Psychosis Read E03yz00 Other transient organic psychoses NOS 
Psychosis Read E03z.00 Transient organic psychoses NOS 
Psychosis Read E04..00 Other chronic organic psychoses 
Psychosis Read E040.11 Korsakoff's non-alcoholic psychosis 
Psychosis Read E04y.00 Other specified chronic organic psychoses 
Psychosis Read E04z.00 Chronic organic psychosis NOS 
Psychosis Read E0y..00 Other specified organic psychoses 
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Condition / Diagnosis Coding System Code Description 
Psychosis Read E0z..00 Organic psychoses NOS 
Psychosis Read E1...00 Non-organic psychoses 
Psychosis Read E10..00 Schizophrenic disorders 
Psychosis Read E100.00 Simple schizophrenia 
Psychosis Read E100.11 Schizophrenia simplex 
Psychosis Read E100000 Unspecified schizophrenia 
Psychosis Read E100100 Subchronic schizophrenia 
Psychosis Read E100200 Chronic schizophrenic 
Psychosis Read E100300 Acute exacerbation of subchronic schizophrenia 
Psychosis Read E100400 Acute exacerbation of chronic schizophrenia 
Psychosis Read E100500 Schizophrenia in remission 
Psychosis Read E100z00 Simple schizophrenia NOS 
Psychosis Read E101.00 Hebephrenic schizophrenia 
Psychosis Read E101000 Unspecified hebephrenic schizophrenia 
Psychosis Read E101400 Acute exacerbation of chronic hebephrenic schizophrenia 
Psychosis Read E101500 Hebephrenic schizophrenia in remission 
Psychosis Read E101z00 Hebephrenic schizophrenia NOS 
Psychosis Read E102.00 Catatonic schizophrenia 
Psychosis Read E102000 Unspecified catatonic schizophrenia 
Psychosis Read E102100 Subchronic catatonic schizophrenia 
Psychosis Read E102500 Catatonic schizophrenia in remission 
Psychosis Read E102z00 Catatonic schizophrenia NOS 
Psychosis Read E103.00 Paranoid schizophrenia 
Psychosis Read E103000 Unspecified paranoid schizophrenia 
Psychosis Read E103100 Subchronic paranoid schizophrenia 
Psychosis Read E103200 Chronic paranoid schizophrenia 
Psychosis Read E103300 Acute exacerbation of subchronic paranoid schizophrenia 
Psychosis Read E103400 Acute exacerbation of chronic paranoid schizophrenia 
Psychosis Read E103500 Paranoid schizophrenia in remission 
Psychosis Read E103z00 Paranoid schizophrenia NOS 
Psychosis Read E104.00 Acute schizophrenic episode 
Psychosis Read E104.11 Oneirophrenia 
Psychosis Read E105.00 Latent schizophrenia 
Psychosis Read E105000 Unspecified latent schizophrenia 
Psychosis Read E105200 Chronic latent schizophrenia 
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Condition / Diagnosis Coding System Code Description 
Psychosis Read E105500 Latent schizophrenia in remission 
Psychosis Read E105z00 Latent schizophrenia NOS 
Psychosis Read E106.00 Residual schizophrenia 
Psychosis Read E107.00 Schizo-affective schizophrenia 
Psychosis Read E107.11 Cyclic schizophrenia 
Psychosis Read E107000 Unspecified schizo-affective schizophrenia 
Psychosis Read E107100 Subchronic schizo-affective schizophrenia 
Psychosis Read E107200 Chronic schizo-affective schizophrenia 
Psychosis Read E107300 Acute exacerbation subchronic schizo-affective schizophrenia 
Psychosis Read E107400 Acute exacerbation of chronic schizo-affective schizophrenia 
Psychosis Read E107500 Schizo-affective schizophrenia in remission 
Psychosis Read E107z00 Schizo-affective schizophrenia NOS 
Psychosis Read E10y.00 Other schizophrenia 
Psychosis Read E10y.11 Cenesthopathic schizophrenia 
Psychosis Read E10y000 Atypical schizophrenia 
Psychosis Read E10y100 Coenesthopathic schizophrenia 
Psychosis Read E10yz00 Other schizophrenia NOS 
Psychosis Read E10z.00 Schizophrenia NOS 
Psychosis Read E11..00 Affective psychoses 
Psychosis Read E11..11 Bipolar psychoses 
Psychosis Read E11..12 Depressive psychoses 
Psychosis Read E11..13 Manic psychoses 
Psychosis Read E110.11 Hypomanic psychoses 
Psychosis Read E110400 Single manic episode, severe, with psychosis 
Psychosis Read E111400 Recurrent manic episodes, severe, with psychosis 
Psychosis Read E112400 Single major depressive episode, severe, with psychosis 
Psychosis Read E113400 Recurrent major depressive episodes, severe, with psychosis 
Psychosis Read E114400 Bipolar affect disord, currently manic,severe with psychosis 
Psychosis Read E115400 Bipolar affect disord, now depressed, severe with psychosis 
Psychosis Read E116400 Mixed bipolar affective disorder, severe, with psychosis 
Psychosis Read E117400 Unspecified bipolar affective disorder,severe with psychosis 
Psychosis Read E11y.00 Other and unspecified manic-depressive psychoses 
Psychosis Read E11y000 Unspecified manic-depressive psychoses 
Psychosis Read E11y300 Other mixed manic-depressive psychoses 
Psychosis Read E11yz00 Other and unspecified manic-depressive psychoses NOS 
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Condition / Diagnosis Coding System Code Description 
Psychosis Read E11z.00 Other and unspecified affective psychoses 
Psychosis Read E11z000 Unspecified affective psychoses NOS 
Psychosis Read E11zz00 Other affective psychosis NOS 
Psychosis Read E12..00 Paranoid states 
Psychosis Read E120.00 Simple paranoid state 
Psychosis Read E121.00 Chronic paranoid psychosis 
Psychosis Read E122.00 Paraphrenia 
Psychosis Read E123.00 Shared paranoid disorder 
Psychosis Read E12y.00 Other paranoid states 
Psychosis Read E12y000 Paranoia querulans 
Psychosis Read E12yz00 Other paranoid states NOS 
Psychosis Read E12z.00 Paranoid psychosis NOS 
Psychosis Read E13..00 Other nonorganic psychoses 
Psychosis Read E13..11 Reactive psychoses 
Psychosis Read E130.00 Reactive depressive psychosis 
Psychosis Read E130.11 Psychotic reactive depression 
Psychosis Read E131.00 Acute hysterical psychosis 
Psychosis Read E133.00 Acute paranoid reaction 
Psychosis Read E134.00 Psychogenic paranoid psychosis 
Psychosis Read E13y.00 Other reactive psychoses 
Psychosis Read E13y000 Psychogenic stupor 
Psychosis Read E13y100 Brief reactive psychosis 
Psychosis Read E13yz00 Other reactive psychoses NOS 
Psychosis Read E13z.00 Nonorganic psychosis NOS 
Psychosis Read E13z.11 Psychotic episode NOS 
Psychosis Read E14..00 Psychoses with origin in childhood 
Psychosis Read E141.00 Disintegrative psychosis 
Psychosis Read E141100 Residual disintegrative psychoses 
Psychosis Read E14y.00 Other childhood psychoses 
Psychosis Read E14y000 Atypical childhood psychoses 
Psychosis Read E14y100 Borderline psychosis of childhood 
Psychosis Read E14yz00 Other childhood psychoses NOS 
Psychosis Read E14z.00 Child psychosis NOS 
Psychosis Read E14z.11 Childhood schizophrenia NOS 
Psychosis Read E1y..00 Other specified non-organic psychoses 
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Psychosis Read E1z..00 Non-organic psychosis NOS 
Rheumatoid arthritis ICD-10 M05 Seropositive rheumatoid arthritis 
Rheumatoid arthritis ICD-10 M05.0 Felty syndrome 
Rheumatoid arthritis ICD-10 M05.1 Rheumatoid lung disease 
Rheumatoid arthritis ICD-10 M05.2 Rheumatoid vasculitis 
Rheumatoid arthritis ICD-10 M05.3 
Rheumatoid arthritis with involvement of other organs and 
systems 
Rheumatoid arthritis ICD-10 M05.8 Other seropositive rheumatoid arthritis 
Rheumatoid arthritis ICD-10 M05.9 Seropositive rheumatoid arthritis, unspecified 
Rheumatoid arthritis ICD-10 M06 Other rheumatoid arthritis 
Rheumatoid arthritis ICD-10 M06.0 Seronegative rheumatoid arthritis 
Rheumatoid arthritis ICD-10 M06.1 Adult-onset Still disease 
Rheumatoid arthritis ICD-10 M06.2 Rheumatoid bursitis 
Rheumatoid arthritis ICD-10 M06.3 Rheumatoid nodule 
Rheumatoid arthritis ICD-10 M06.4 Inflammatory polyarthropathy 
Rheumatoid arthritis ICD-10 M06.8 Other specified rheumatoid arthritis 
Rheumatoid arthritis ICD-10 M06.9 Rheumatoid arthritis, unspecified 
Rheumatoid arthritis Read 14G1.00 H/O: rheumatoid arthritis 
Rheumatoid arthritis Read 2G27.00 O/E-hands-rheumatoid spindling 
Rheumatoid arthritis Read 43F1.00 Rheumatoid factor positive 
Rheumatoid arthritis Read 66H..13 Rheumatoid arthrit. monitoring 
Rheumatoid arthritis Read 66HB000 Rheumatoid arthritis annual review 
Rheumatoid arthritis Read 7P20300 Delivery of rehabilitation for rheumatoid arthritis 
Rheumatoid arthritis Read F371200 Polyneuropathy in rheumatoid arthritis 
Rheumatoid arthritis Read F396400 Myopathy due to rheumatoid arthritis 
Rheumatoid arthritis Read N04..00 Rheumatoid arthritis and other inflammatory polyarthropathy 
Rheumatoid arthritis Read N040.00 Rheumatoid arthritis 
Rheumatoid arthritis Read N040000 Rheumatoid arthritis of cervical spine 
Rheumatoid arthritis Read N040100 Other rheumatoid arthritis of spine 
Rheumatoid arthritis Read N040200 Rheumatoid arthritis of shoulder 
Rheumatoid arthritis Read N040400 Rheumatoid arthritis of acromioclavicular joint 
Rheumatoid arthritis Read N040500 Rheumatoid arthritis of elbow 
Rheumatoid arthritis Read N040600 Rheumatoid arthritis of distal radio-ulnar joint 
Rheumatoid arthritis Read N040700 Rheumatoid arthritis of wrist 
Rheumatoid arthritis Read N040800 Rheumatoid arthritis of MCP joint 
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Rheumatoid arthritis Read N040900 Rheumatoid arthritis of PIP joint of finger 
Rheumatoid arthritis Read N040A00 Rheumatoid arthritis of DIP joint of finger 
Rheumatoid arthritis Read N040B00 Rheumatoid arthritis of hip 
Rheumatoid arthritis Read N040C00 Rheumatoid arthritis of sacro-iliac joint 
Rheumatoid arthritis Read N040D00 Rheumatoid arthritis of knee 
Rheumatoid arthritis Read N040F00 Rheumatoid arthritis of ankle 
Rheumatoid arthritis Read N040G00 Rheumatoid arthritis of subtalar joint 
Rheumatoid arthritis Read N040H00 Rheumatoid arthritis of talonavicular joint 
Rheumatoid arthritis Read N040J00 Rheumatoid arthritis of other tarsal joint 
Rheumatoid arthritis Read N040K00 Rheumatoid arthritis of 1st MTP joint 
Rheumatoid arthritis Read N040L00 Rheumatoid arthritis of lesser MTP joint 
Rheumatoid arthritis Read N040Q00 Rheumatoid bursitis 
Rheumatoid arthritis Read N040R00 Rheumatoid nodule 
Rheumatoid arthritis Read N040S00 Rheumatoid arthritis - multiple joint 
Rheumatoid arthritis Read N040T00 Flare of rheumatoid arthritis 
Rheumatoid arthritis Read N042.00 Other rheumatoid arthropathy + visceral/systemic involvement 
Rheumatoid arthritis Read N042200 Rheumatoid nodule 
Rheumatoid arthritis Read N042z00 Rheumatoid arthropathy + visceral/systemic involvement NOS 
Rheumatoid arthritis Read N043.00 Juvenile rheumatoid arthritis - Still's disease 
Rheumatoid arthritis Read N043000 Juvenile rheumatoid arthropathy unspecified 
Rheumatoid arthritis Read N043100 Acute polyarticular juvenile rheumatoid arthritis 
Rheumatoid arthritis Read N043200 Pauciarticular juvenile rheumatoid arthritis 
Rheumatoid arthritis Read N043300 Monarticular juvenile rheumatoid arthritis 
Rheumatoid arthritis Read N043z00 Juvenile rheumatoid arthritis NOS 
Rheumatoid arthritis Read N045500 Juvenile rheumatoid arthritis 
Rheumatoid arthritis Read N047.00 Seropositive errosive rheumatoid arthritis 
Rheumatoid arthritis Read N04X.00 Seropositive rheumatoid arthritis, unspecified 
Rheumatoid arthritis Read N04y012 Fibrosing alveolitis associated with rheumatoid arthritis 
Rheumatoid arthritis Read Nyu1000 [X]Rheumatoid arthritis+involvement/other organs or systems 
Rheumatoid arthritis Read Nyu1100 [X]Other seropositive rheumatoid arthritis 
Rheumatoid arthritis Read Nyu1200 [X]Other specified rheumatoid arthritis 
Rheumatoid arthritis Read Nyu1G00 [X]Seropositive rheumatoid arthritis, unspecified 
Smoking status Read 1371 Never smoked tobacco 
Smoking status Read 1371.11 Non-smoker 
Smoking status Read 1372 Trivial smoker - < 1 cig/day 
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Smoking status Read 1372.11 Occasional smoker 
Smoking status Read 1373 Light smoker - 1-9 cigs/day 
Smoking status Read 1374 Moderate smoker - 10-19 cigs/d 
Smoking status Read 1375 Heavy smoker - 20-39 cigs/day 
Smoking status Read 1376 Very heavy smoker - 40+cigs/d 
Smoking status Read 1377 Ex-trivial smoker (<1/day) 
Smoking status Read 1378 Ex-light smoker (1-9/day) 
Smoking status Read 1379 Ex-moderate smoker (10-19/day) 
Smoking status Read 137..11 Smoker - amount smoked 
Smoking status Read 137A.00 Ex-heavy smoker (20-39/day) 
Smoking status Read 137B.00 Ex-very heavy smoker (40+/day) 
Smoking status Read 137F.00 Ex-smoker - amount unknown 
Smoking status Read 137H.00 Pipe smoker 
Smoking status Read 137I.00 Passive smoker 
Smoking status Read 137I000 Exposed to tobacco smoke at home 
Smoking status Read 137J.00 Cigar smoker 
Smoking status Read 137j.00 Ex-cigarette smoker 
Smoking status Read 137l.00 Ex roll-up cigarette smoker 
Smoking status Read 137L.00 Current non-smoker 
Smoking status Read 137N.00 Ex pipe smoker 
Smoking status Read 137n.00 Total time smoked 
Smoking status Read 137O.00 Ex cigar smoker 
Smoking status Read 137P.00 Cigarette smoker 
Smoking status Read 137P.11 Smoker 
Smoking status Read 137R.00 Current smoker 
Smoking status Read 137S.00 Ex smoker 
Smoking status Read 137U.00 Not a passive smoker 
Smoking status Read 13cA.00 Smokes drugs 
Smoking status Read 13WF.11 Smoker in the family 
Smoking status Read 13WK.00 No smokers in the household 
Smoking status Read 1V08.00 Smokes drugs in cigarette form 
Smoking status Read 9km..00 Ex-smoker annual review - enhanced services administration 
Smoking status Read 9km..11 Ex-smoker annual review 
Smoking status Read 9kn..00 Non-smoker annual review - enhanced services administration 
Smoking status Read 9kn..11 Non-smoker annual review 
  
 
2
5
1
 
Condition / Diagnosis Coding System Code Description 
Smoking status Read 9ko..00 Current smoker annual review - enhanced services admin 
Smoking status Read 9ko..11 Current smoker annual review 
Smoking status Read H310100 Smokers' cough 
Terminal illness ICD-10 C15 Malignant neoplasm of oesophagus 
Terminal illness ICD-10 C15.0 Malignant neoplasm: Cervical part of oesophagus 
Terminal illness ICD-10 C15.1 Malignant neoplasm: Thoracic part of oesophagus 
Terminal illness ICD-10 C15.2 Malignant neoplasm: Abdominal part of oesophagus 
Terminal illness ICD-10 C15.3 Malignant neoplasm: Upper third of oesophagus 
Terminal illness ICD-10 C15.4 Malignant neoplasm: Middle third of oesophagus 
Terminal illness ICD-10 C15.5 Malignant neoplasm: Lower third of oesophagus 
Terminal illness ICD-10 C15.8 Malignant neoplasm: Overlapping lesion of oesophagus 
Terminal illness ICD-10 C15.9 Malignant neoplasm: Oesophagus, unspecified 
Terminal illness ICD-10 C16.0 Malignant neoplasm: Cardia 
Terminal illness ICD-10 C16.1 Malignant neoplasm: Fundus of stomach 
Terminal illness ICD-10 C16.2 Malignant neoplasm: Body of stomach 
Terminal illness ICD-10 C16.3 Malignant neoplasm: Pyloric antrum 
Terminal illness ICD-10 C16.4 Malignant neoplasm: Pylorus 
Terminal illness ICD-10 C16.5 Malignant neoplasm: Lesser curvature of stomach, unspecified 
Terminal illness ICD-10 C16.6 Malignant neoplasm: Greater curvature of stomach, unspecified 
Terminal illness ICD-10 C16.8 Malignant neoplasm: Overlapping lesion of stomach 
Terminal illness ICD-10 C16.9 Malignant neoplasm: Stomach, unspecified 
Terminal illness ICD-10 C22 Malignant neoplasm of liver and intrahepatic bile ducts 
Terminal illness ICD-10 C22.0 Malignant neoplasm: Liver cell carcinoma 
Terminal illness ICD-10 C22.1 Malignant neoplasm: Intrahepatic bile duct carcinoma 
Terminal illness ICD-10 C22.2 Malignant neoplasm: Hepatoblastoma 
Terminal illness ICD-10 C22.3 Malignant neoplasm: Angiosarcoma of liver 
Terminal illness ICD-10 C22.4 Malignant neoplasm: Other sarcomas of liver 
Terminal illness ICD-10 C22.7 Malignant neoplasm: Other specified carcinomas of liver 
Terminal illness ICD-10 C22.9 Malignant neoplasm: Liver, unspecified 
Terminal illness ICD-10 C25 Malignant neoplasm of pancreas 
Terminal illness ICD-10 C25.0 Malignant neoplasm: Head of pancreas 
Terminal illness ICD-10 C25.1 Malignant neoplasm: Body of pancreas 
Terminal illness ICD-10 C25.2 Malignant neoplasm: Tail of pancreas 
Terminal illness ICD-10 C25.3 Malignant neoplasm: Pancreatic duct 
Terminal illness ICD-10 C25.4 Malignant neoplasm: Endocrine pancreas 
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Terminal illness ICD-10 C25.7 Malignant neoplasm: Other parts of pancreas 
Terminal illness ICD-10 C25.8 Malignant neoplasm: Overlapping lesion of pancreas 
Terminal illness ICD-10 C25.9 Malignant neoplasm: Pancreas, unspecified 
Terminal illness ICD-10 C34 Malignant neoplasm of bronchus and lung 
Terminal illness ICD-10 C34.0 Malignant neoplasm: Main bronchus 
Terminal illness ICD-10 C34.1 Malignant neoplasm: Upper lobe, bronchus or lung 
Terminal illness ICD-10 C34.2 Malignant neoplasm: Middle lobe, bronchus or lung 
Terminal illness ICD-10 C34.3 Malignant neoplasm: Lower lobe, bronchus or lung 
Terminal illness ICD-10 C34.8 Malignant neoplasm: Overlapping lesion of bronchus and lung 
Terminal illness ICD-10 C34.9 Malignant neoplasm: Bronchus or lung, unspecified 
Terminal illness ICD-10 C56 Malignant neoplasm of ovary 
Terminal illness ICD-10 C56.1 Malignant neoplasm of right ovary 
Terminal illness ICD-10 C56.2 Malignant neoplasm of left ovary 
Terminal illness ICD-10 C56.9 Malignant neoplasm of unspecified ovary 
Terminal illness ICD-10 C71 Malignant neoplasm of brain 
Terminal illness ICD-10 C71.0 Malignant neoplasm: Cerebrum, except lobes and ventricles 
Terminal illness ICD-10 C71.0 Malignant neoplasm of cerebrum, except lobes and ventricles 
Terminal illness ICD-10 C71.1 Malignant neoplasm: Frontal lobe 
Terminal illness ICD-10 C71.1 Malignant neoplasm of frontal lobe 
Terminal illness ICD-10 C71.2 Malignant neoplasm: Temporal lobe 
Terminal illness ICD-10 C71.2 Malignant neoplasm of temporal lobe 
Terminal illness ICD-10 C71.3 Malignant neoplasm: Parietal lobe 
Terminal illness ICD-10 C71.3 Malignant neoplasm of parietal lobe 
Terminal illness ICD-10 C71.4 Malignant neoplasm: Occipital lobe 
Terminal illness ICD-10 C71.4 Malignant neoplasm of occipital lobe 
Terminal illness ICD-10 C71.5 Malignant neoplasm: Cerebral ventricle 
Terminal illness ICD-10 C71.5 Malignant neoplasm of cerebral ventricle 
Terminal illness ICD-10 C71.6 Malignant neoplasm: Cerebellum 
Terminal illness ICD-10 C71.6 Malignant neoplasm of cerebellum 
Terminal illness ICD-10 C71.7 Malignant neoplasm: Brain stem 
Terminal illness ICD-10 C71.7 Malignant neoplasm of brain stem 
Terminal illness ICD-10 C71.8 Malignant neoplasm: Overlapping lesion of brain 
Terminal illness ICD-10 C71.8 Malignant neoplasm of overlapping sites of brain 
Terminal illness ICD-10 C71.9 Malignant neoplasm: Brain, unspecified 
Terminal illness ICD-10 C71.9 Malignant neoplasm of brain, unspecified 
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Terminal illness ICD-10 C72 
Malignant neoplasm of spinal cord, cranial nerves and other parts 
of central nervous system 
Terminal illness ICD-10 C72.0 Malignant neoplasm: Spinal cord 
Terminal illness ICD-10 C72.1 Malignant neoplasm: Cauda equina 
Terminal illness ICD-10 C72.2 Malignant neoplasm: Olfactory nerve 
Terminal illness ICD-10 C72.3 Malignant neoplasm: Optic nerve 
Terminal illness ICD-10 C72.4 Malignant neoplasm: Acoustic nerve 
Terminal illness ICD-10 C72.5 Malignant neoplasm: Other and unspecified cranial nerves 
Terminal illness ICD-10 C72.8 
Malignant neoplasm: Overlapping lesion of brain and other parts 
of central nervous system 
Terminal illness ICD-10 C72.9 Malignant neoplasm: Central nervous system, unspecified 
Terminal illness ICD-10 Z51.5 Encounter for palliative care 
Terminal illness Read 9367 Patient held palliative care record 
Terminal illness Read 1Z0..00 Terminal illness 
Terminal illness Read 1Z00.00 Terminal illness - early stage 
Terminal illness Read 1Z01.00 Terminal illness - late stage 
Terminal illness Read 8BAe.00 Anticipatory palliative care 
Terminal illness Read 8BAN.00 Community specialist palliative care 
Terminal illness Read 8BAP.00 Specialist palliative care 
Terminal illness Read 8BAR.00 Specialist palliative care treatment - inpatient 
Terminal illness Read 8BAS.00 Specialist palliative care treatment - daycare 
Terminal illness Read 8BAT.00 Specialist palliative care treatment - outpatient 
Terminal illness Read 8BJ1.00 Palliative treatment 
Terminal illness Read 8Cc4.00 Management of multiple sclerosis in palliative phase 
Terminal illness Read 8CM3.00 Palliative care plan review 
Terminal illness Read 8H7g.00 Referral to palliative care service 
Terminal illness Read 8Hg0.00 Discharged from community specialist palliative care team 
Terminal illness Read 8HH7.00 Referred to community specialist palliative care team 
Terminal illness Read 8IEE.00 Referral to community palliative care team declined 
Terminal illness Read 9b9B.00 Palliative medicine 
Terminal illness Read 9c0L000 Planned palliative oncology treatment 
Terminal illness Read 9c0P.00 Current palliative oncology treatment 
Terminal illness Read 9K9..00 Palliative care handover form completed 
Terminal illness Read 9ke..00 Palliative care - enhanced services administration 
Terminal illness Read 9NgD.00 Under care of palliative care service 
Terminal illness Read 9Nh0.00 Under the care of community palliative care team 
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Terminal illness Read 9NlJ.00 Seen by palliative care service 
Terminal illness Read 9NNd.00 Under care of palliative care specialist nurse 
Terminal illness Read B1...00 Malignant neoplasm of digestive organs and peritoneum 
Terminal illness Read B1...11 Carcinoma of digestive organs and peritoneum 
Terminal illness Read B10..00 Malignant neoplasm of oesophagus 
Terminal illness Read B100.00 Malignant neoplasm of cervical oesophagus 
Terminal illness Read B101.00 Malignant neoplasm of thoracic oesophagus 
Terminal illness Read B102.00 Malignant neoplasm of abdominal oesophagus 
Terminal illness Read B103.00 Malignant neoplasm of upper third of oesophagus 
Terminal illness Read B104.00 Malignant neoplasm of middle third of oesophagus 
Terminal illness Read B105.00 Malignant neoplasm of lower third of oesophagus 
Terminal illness Read B106.00 Malignant neoplasm, overlapping lesion of oesophagus 
Terminal illness Read B107.00 Siewert type I adenocarcinoma 
Terminal illness Read B10y.00 Malignant neoplasm of other specified part of oesophagus 
Terminal illness Read B10z.00 Malignant neoplasm of oesophagus NOS 
Terminal illness Read B10z.11 Oesophageal cancer 
Terminal illness Read B11..00 Malignant neoplasm of stomach 
Terminal illness Read B11..11 Gastric neoplasm 
Terminal illness Read B110.00 Malignant neoplasm of cardia of stomach 
Terminal illness Read B110000 Malignant neoplasm of cardiac orifice of stomach 
Terminal illness Read B110100 Malignant neoplasm of cardio-oesophageal junction of stomach 
Terminal illness Read B110111 Malignant neoplasm of gastro-oesophageal junction 
Terminal illness Read B110z00 Malignant neoplasm of cardia of stomach NOS 
Terminal illness Read B111.00 Malignant neoplasm of pylorus of stomach 
Terminal illness Read B111000 Malignant neoplasm of prepylorus of stomach 
Terminal illness Read B111100 Malignant neoplasm of pyloric canal of stomach 
Terminal illness Read B111z00 Malignant neoplasm of pylorus of stomach NOS 
Terminal illness Read B112.00 Malignant neoplasm of pyloric antrum of stomach 
Terminal illness Read B113.00 Malignant neoplasm of fundus of stomach 
Terminal illness Read B114.00 Malignant neoplasm of body of stomach 
Terminal illness Read B115.00 Malignant neoplasm of lesser curve of stomach unspecified 
Terminal illness Read B116.00 Malignant neoplasm of greater curve of stomach unspecified 
Terminal illness Read B117.00 Malignant neoplasm, overlapping lesion of stomach 
Terminal illness Read B118.00 Siewert type II adenocarcinoma 
Terminal illness Read B119.00 Siewert type III adenocarcinoma 
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Terminal illness Read B11y.00 Malignant neoplasm of other specified site of stomach 
Terminal illness Read B11y000 Malignant neoplasm of anterior wall of stomach NEC 
Terminal illness Read B11y100 Malignant neoplasm of posterior wall of stomach NEC 
Terminal illness Read B11yz00 Malignant neoplasm of other specified site of stomach NOS 
Terminal illness Read B11z.00 Malignant neoplasm of stomach NOS 
Terminal illness Read B15..00 Malignant neoplasm of liver and intrahepatic bile ducts 
Terminal illness Read B150.00 Primary malignant neoplasm of liver 
Terminal illness Read B150000 Primary carcinoma of liver 
Terminal illness Read B150100 Hepatoblastoma of liver 
Terminal illness Read B150200 Primary angiosarcoma of liver 
Terminal illness Read B150300 Hepatocellular carcinoma 
Terminal illness Read B150z00 Primary malignant neoplasm of liver NOS 
Terminal illness Read B151.00 Malignant neoplasm of intrahepatic bile ducts 
Terminal illness Read B151000 Malignant neoplasm of interlobular bile ducts 
Terminal illness Read B151200 Malignant neoplasm of intrahepatic biliary passages 
Terminal illness Read B151400 Malignant neoplasm of intrahepatic gall duct 
Terminal illness Read B151z00 Malignant neoplasm of intrahepatic bile ducts NOS 
Terminal illness Read B152.00 Malignant neoplasm of liver unspecified 
Terminal illness Read B153.00 Secondary malignant neoplasm of liver 
Terminal illness Read B15z.00 Malignant neoplasm of liver and intrahepatic bile ducts NOS 
Terminal illness Read B16..00 Malignant neoplasm gallbladder and extrahepatic bile ducts 
Terminal illness Read B17..00 Malignant neoplasm of pancreas 
Terminal illness Read B170.00 Malignant neoplasm of head of pancreas 
Terminal illness Read B171.00 Malignant neoplasm of body of pancreas 
Terminal illness Read B172.00 Malignant neoplasm of tail of pancreas 
Terminal illness Read B173.00 Malignant neoplasm of pancreatic duct 
Terminal illness Read B174.00 Malignant neoplasm of Islets of Langerhans 
Terminal illness Read B175.00 Malignant neoplasm, overlapping lesion of pancreas 
Terminal illness Read B17y.00 Malignant neoplasm of other specified sites of pancreas 
Terminal illness Read B17y000 Malignant neoplasm of ectopic pancreatic tissue 
Terminal illness Read B17yz00 Malignant neoplasm of specified site of pancreas NOS 
Terminal illness Read B17z.00 Malignant neoplasm of pancreas NOS 
Terminal illness Read B221.00 Malignant neoplasm of main bronchus 
Terminal illness Read B221000 Malignant neoplasm of carina of bronchus 
Terminal illness Read B221100 Malignant neoplasm of hilus of lung 
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Terminal illness Read B221z00 Malignant neoplasm of main bronchus NOS 
Terminal illness Read B222.00 Malignant neoplasm of upper lobe, bronchus or lung 
Terminal illness Read B222.11 Pancoast's syndrome 
Terminal illness Read B222000 Malignant neoplasm of upper lobe bronchus 
Terminal illness Read B222100 Malignant neoplasm of upper lobe of lung 
Terminal illness Read B222z00 Malignant neoplasm of upper lobe, bronchus or lung NOS 
Terminal illness Read B223.00 Malignant neoplasm of middle lobe, bronchus or lung 
Terminal illness Read B223000 Malignant neoplasm of middle lobe bronchus 
Terminal illness Read B223100 Malignant neoplasm of middle lobe of lung 
Terminal illness Read B223z00 Malignant neoplasm of middle lobe, bronchus or lung NOS 
Terminal illness Read B224.00 Malignant neoplasm of lower lobe, bronchus or lung 
Terminal illness Read B224000 Malignant neoplasm of lower lobe bronchus 
Terminal illness Read B224100 Malignant neoplasm of lower lobe of lung 
Terminal illness Read B224z00 Malignant neoplasm of lower lobe, bronchus or lung NOS 
Terminal illness Read B225.00 Malignant neoplasm of overlapping lesion of bronchus & lung 
Terminal illness Read B226.00 Mesothelioma 
Terminal illness Read B22y.00 Malignant neoplasm of other sites of bronchus or lung 
Terminal illness Read B22z.00 Malignant neoplasm of bronchus or lung NOS 
Terminal illness Read B22z.11 Lung cancer 
Terminal illness Read B23..00 Malignant neoplasm of pleura 
Terminal illness Read B230.00 Malignant neoplasm of parietal pleura 
Terminal illness Read B231.00 Malignant neoplasm of visceral pleura 
Terminal illness Read B232.00 Mesothelioma of pleura 
Terminal illness Read B23y.00 Malignant neoplasm of other specified pleura 
Terminal illness Read B23z.00 Malignant neoplasm of pleura NOS 
Terminal illness Read B44..00 Malignant neoplasm of ovary and other uterine adnexa 
Terminal illness Read B440.00 Malignant neoplasm of ovary 
Terminal illness Read B440.11 Cancer of ovary 
Terminal illness Read B51..00 Malignant neoplasm of brain 
Terminal illness Read B51..11 Cerebral tumour - malignant 
Terminal illness Read B510.00 Malignant neoplasm cerebrum (excluding lobes and ventricles) 
Terminal illness Read B510000 Malignant neoplasm of basal ganglia 
Terminal illness Read B510100 Malignant neoplasm of cerebral cortex 
Terminal illness Read B510300 Malignant neoplasm of globus pallidus 
Terminal illness Read B510400 Malignant neoplasm of hypothalamus 
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Terminal illness Read B510500 Malignant neoplasm of thalamus 
Terminal illness Read B510z00 Malignant neoplasm of cerebrum NOS 
Terminal illness Read B511.00 Malignant neoplasm of frontal lobe 
Terminal illness Read B512.00 Malignant neoplasm of temporal lobe 
Terminal illness Read B512000 Malignant neoplasm of hippocampus 
Terminal illness Read B512z00 Malignant neoplasm of temporal lobe NOS 
Terminal illness Read B513.00 Malignant neoplasm of parietal lobe 
Terminal illness Read B514.00 Malignant neoplasm of occipital lobe 
Terminal illness Read B515.00 Malignant neoplasm of cerebral ventricles 
Terminal illness Read B515000 Malignant neoplasm of choroid plexus 
Terminal illness Read B516.00 Malignant neoplasm of cerebellum 
Terminal illness Read B517.00 Malignant neoplasm of brain stem 
Terminal illness Read B517000 Malignant neoplasm of cerebral peduncle 
Terminal illness Read B517100 Malignant neoplasm of medulla oblongata 
Terminal illness Read B517200 Malignant neoplasm of midbrain 
Terminal illness Read B517300 Malignant neoplasm of pons 
Terminal illness Read B517z00 Malignant neoplasm of brain stem NOS 
Terminal illness Read B51y.00 Malignant neoplasm of other parts of brain 
Terminal illness Read B51y000 Malignant neoplasm of corpus callosum 
Terminal illness Read B51y200 Malignant neoplasm, overlapping lesion of brain 
Terminal illness Read B51yz00 Malignant neoplasm of other part of brain NOS 
Terminal illness Read B51z.00 Malignant neoplasm of brain NOS 
Terminal illness Read B520.00 Malignant neoplasm of cranial nerves 
Terminal illness Read B520000 Malignant neoplasm of olfactory bulb 
Terminal illness Read B520100 Malignant neoplasm of optic nerve 
Terminal illness Read B520200 Malignant neoplasm of acoustic nerve 
Terminal illness Read B520z00 Malignant neoplasm of cranial nerves NOS 
Terminal illness Read B521.00 Malignant neoplasm of cerebral meninges 
Terminal illness Read B521z00 Malignant neoplasm of cerebral meninges NOS 
Terminal illness Read B52W.00 Malig neopl, overlap lesion brain & other part of CNS 
Terminal illness Read B52X.00 Malignant neoplasm of meninges, unspecified 
Terminal illness Read B542.00 Malignant neoplasm pituitary gland and craniopharyngeal duct 
Terminal illness Read B542000 Malignant neoplasm of pituitary gland 
Terminal illness Read B542100 Malignant neoplasm of craniopharyngeal duct 
Terminal illness Read B543.00 Malignant neoplasm of pineal gland 
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Terminal illness Read B545000 Malignant neoplasm of glomus jugulare 
Terminal illness Read B560400 Secondary and unspec malig neop deep parotid lymph nodes 
Terminal illness Read B583.00 Secondary malignant neoplasm of brain and spinal cord 
Terminal illness Read B583000 Secondary malignant neoplasm of brain 
Terminal illness Read B583200 Cerebral metastasis 
Terminal illness Read BBb3.12 [M]Subependymal astrocytoma NOS 
Terminal illness Read BBb4.00 [M]Subependymal giant cell astrocytoma 
Terminal illness Read BBbG.00 [M]Pilocytic astrocytoma 
Terminal illness Read BBbG.12 [M]Piloid astrocytoma 
Terminal illness Read BBc7.11 [M]Neuroastrocytoma 
Terminal illness Read Z172.00 Palliative care 
Terminal illness Read ZL18R00 Under care of palliative care physician 
Terminal illness Read ZL5AP00 Referral to palliative care physician 
Terminal illness Read ZL9AR00 Seen by palliative care physician 
Terminal illness Read ZLD3R00 Discharge by palliative care physician 
Terminal illness Read ZLE6P00 Discharge from palliative care service 
Terminal illness Read ZV57C00 [V]Palliative care 
Thrombocytopenia ICD-10 D69.3 Immune thrombocytopenic purpura 
Thrombocytopenia ICD-10 D69.4 Other primary thrombocytopenia 
Thrombocytopenia ICD-10 D69.5 Other secondary thrombocytopenia 
Thrombocytopenia ICD-10 D69.6 Thrombocytopenia, unspecified 
Thrombocytopenia Read 42P2.00 Thrombocytopenia 
Thrombocytopenia Read 42P2.11 Auto-immune thrombocytopenia 
Thrombocytopenia Read C391211 Thrombocytopenic eczema with immunodeficiency 
Thrombocytopenia Read D313.00 Primary thrombocytopenia 
Thrombocytopenia Read D313.12 Idiopathic thrombocytopenic purpura 
Thrombocytopenia Read D313.15 Thrombocytopenic purpura 
Thrombocytopenia Read D313000 Idiopathic thrombocytopenic purpura 
Thrombocytopenia Read D313012 ITP - idiopathic thrombocytopenic purpura 
Thrombocytopenia Read D313100 Congenital thrombocytopenic purpura 
Thrombocytopenia Read D313111 Hereditary thrombocytopenia NEC 
Thrombocytopenia Read D313200 Thrombocytopenic purpura with absent radius 
Thrombocytopenia Read D313300 [X]Essential thrombocytopenia NOS 
Thrombocytopenia Read D313y00 Other specified primary thrombocytopenia 
Thrombocytopenia Read D313z00 Primary thrombocytopenia NOS 
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Thrombocytopenia Read D313z11 Essential thrombocytopenia NOS 
Thrombocytopenia Read D314.00 Secondary thrombocytopenia 
Thrombocytopenia Read D314100 Thrombocytopenia due to drugs 
Thrombocytopenia Read D314y00 Other specified secondary thrombocytopenia 
Thrombocytopenia Read D314z00 Secondary thrombocytopenia NOS 
Thrombocytopenia Read D315.00 Thrombocytopenia NOS 
Thrombocytopenia Read Dyu3200 [X]Other primary thrombocytopenia 
Thrombocytopenia Read G756100 Thrombotic thrombocytopenic purpura 
Thrombocytopenia Read Q451100 Trans neonatal thrombocyto due to idopath matern thrombocyto 
Valvular disease Read G11..00 Mitral valve diseases 
Valvular disease Read G110.00 Mitral stenosis 
Valvular disease Read G112.00 Mitral stenosis with insufficiency 
Valvular disease Read G112.12 Mitral stenosis with incompetence 
Valvular disease Read G112.13 Mitral stenosis with regurgitation 
Valvular disease Read G113.00 Nonrheumatic mitral valve stenosis 
Valvular disease Read G11z.00 Mitral valve disease NOS 
Valvular disease Read G13..00 Diseases of mitral and aortic valves 
Valvular disease Read G130.00 Mitral and aortic stenosis 
Valvular disease Read G131.00 Mitral stenosis and aortic insufficiency 
Valvular disease Read G131.13 Mitral stenosis and aortic incompetence 
Valvular disease Read G131.14 Mitral stenosis and aortic regurgitation 
Valvular disease Read G13y.00 Multiple mitral and aortic valve involvement 
Valvular disease Read G13z.00 Mitral and aortic valve disease NOS 
Valvular disease Read G540z00 Mitral valve disorders NOS 
Valvular disease Read G544.00 Multiple valve diseases 
Valvular disease Read G544100 Disorders of both mitral and tricuspid valves 
Valvular disease Read G544200 Combined disorders of mitral, aortic and tricuspid valves 
Valvular disease Read G544X00 Multiple valve disease, unspecified 
Valvular disease Read P65..00 Congenital mitral stenosis 
Valvular disease Read P650.00 Congenital mitral stenosis, unspecified 
Valvular disease Read P65z.00 Congenital mitral stenosis NOS 
Vascular disease ICD-10 G08 Intracranial and intraspinal phlebitis and thrombophlebitis 
Vascular disease ICD-10 I20 Angina pectoris 
Vascular disease ICD-10 I20.0 Unstable angina 
Vascular disease ICD-10 I20.1 Angina pectoris with documented spasm 
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Vascular disease ICD-10 I20.8 Other forms of angina pectoris 
Vascular disease ICD-10 I20.9 Angina pectoris, unspecified 
Vascular disease ICD-10 I74 Arterial embolism and thrombosis 
Vascular disease ICD-10 I74.0 Embolism and thrombosis of abdominal aorta 
Vascular disease ICD-10 I74.1 Embolism and thrombosis of other and unspecified parts of aorta 
Vascular disease ICD-10 I74.2 Embolism and thrombosis of arteries of the upper extremities 
Vascular disease ICD-10 I74.3 Embolism and thrombosis of arteries of the lower extremities 
Vascular disease ICD-10 I74.4 Embolism and thrombosis of arteries of extremities, unspecified 
Vascular disease ICD-10 I74.5 Embolism and thrombosis of iliac artery 
Vascular disease ICD-10 I74.8 Embolism and thrombosis of other arteries 
Vascular disease ICD-10 I74.9 Embolism and thrombosis of unspecified artery 
Vascular disease ICD-10 I80 Phlebitis and thrombophlebitis 
Vascular disease ICD-10 I80.0 
Phlebitis and thrombophlebitis of superficial vessels of lower 
extremities 
Vascular disease ICD-10 I80.1 Phlebitis and thrombophlebitis of femoral vein 
Vascular disease ICD-10 I80.2 
Phlebitis and thrombophlebitis of other deep vessels of lower 
extremities 
Vascular disease ICD-10 I80.3 Phlebitis and thrombophlebitis of lower extremities, unspecified 
Vascular disease ICD-10 I80.8 Phlebitis and thrombophlebitis of other sites 
Vascular disease ICD-10 I80.9 Phlebitis and thrombophlebitis of unspecified site 
Vascular disease ICD-10 I82.2 Embolism and thrombosis of vena cava 
Vascular disease ICD-10 I82.3 Embolism and thrombosis of renal vein 
Vascular disease ICD-10 I82.8 Embolism and thrombosis of other specified veins 
Vascular disease ICD-10 I82.9 Embolism and thrombosis of unspecified vein 
Vascular disease ICD-10 K75.1 Phlebitis of portal vein 
Vascular disease ICD-10  I21 Acute myocardial infarction 
Vascular disease ICD-10  I21.0 Acute transmural myocardial infarction of anterior wall 
Vascular disease ICD-10  I21.1 Acute transmural myocardial infarction of inferior wall 
Vascular disease ICD-10  I21.2 Acute transmural myocardial infarction of other sites 
Vascular disease ICD-10  I21.3 Acute transmural myocardial infarction of unspecified site 
Vascular disease ICD-10  I21.4 Acute subendocardial myocardial infarction 
Vascular disease ICD-10  I21.9 Acute myocardial infarction, unspecified 
Vascular disease ICD-10  I22 Subsequent myocardial infarction 
Vascular disease ICD-10  I22.0 Subsequent myocardial infarction of anterior wall 
Vascular disease ICD-10  I22.1 Subsequent myocardial infarction of inferior wall 
Vascular disease ICD-10  I22.8 Subsequent myocardial infarction of other sites 
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Vascular disease ICD-10  I22.9 Subsequent myocardial infarction of unspecified site 
Vascular disease ICD-10  I23 
Certain current complications following acute myocardial 
infarction 
Vascular disease ICD-10  I23.0 
Haemopericardium as current complication following acute 
myocardial infarction 
Vascular disease ICD-10  I23.1 
Atrial septal defect as current complication following acute 
myocardial infarction 
Vascular disease ICD-10  I23.2 
Ventricular septal defect as current complication following acute 
myocardial infarction 
Vascular disease ICD-10  I23.3 
Rupture of cardiac wall without haemopericardium as current 
complication following acute myocardial infarction 
Vascular disease ICD-10  I23.4 
Rupture of chordae tendineae as current complication following 
acute myocardial infarction 
Vascular disease ICD-10  I23.5 
Rupture of papillary muscle as current complication following 
acute myocardial infarction 
Vascular disease ICD-10  I23.6 
Thrombosis of atrium, auricular appendage, and ventricle as 
current complications following acute myocardial infarction 
Vascular disease ICD-10  I23.8 Other current complications following acute myocardial infarction 
Vascular disease ICD-10  I25.1 Atherosclerotic heart disease 
Vascular disease ICD-10  I25.3 Aneurysm of heart 
Vascular disease ICD-10  I25.5 Ischaemic cardiomyopathy 
Vascular disease ICD-10  I25.8 Other forms of chronic ischaemic heart disease 
Vascular disease ICD-10  I25.9 Chronic ischaemic heart disease, unspecified 
Vascular disease ICD-10  I70 Atherosclerosis 
Vascular disease ICD-10  I70.0 Atherosclerosis of aorta 
Vascular disease ICD-10  I70.1 Atherosclerosis of renal artery 
Vascular disease ICD-10  I70.2 Atherosclerosis of arteries of extremities 
Vascular disease ICD-10  I70.8 Atherosclerosis of other arteries 
Vascular disease ICD-10  I70.9 Generalized and unspecified atherosclerosis 
Vascular disease ICD-10  I73.9 Peripheral vascular disease, unspecified 
Vascular disease ICD-10  Z95.1 Presence of aortocoronary bypass graft 
Vascular disease Read 3232 ECG: old myocardial infarction 
Vascular disease Read 7920 Saphenous vein graft replacement of coronary artery 
Vascular disease Read 7920.11 Saphenous vein graft bypass of coronary artery 
Vascular disease Read 7921 Other autograft replacement of coronary artery 
Vascular disease Read 7921.11 Other autograft bypass of coronary artery 
Vascular disease Read 7922 Allograft replacement of coronary artery 
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Vascular disease Read 7922.11 Allograft bypass of coronary artery 
Vascular disease Read 7923 Prosthetic replacement of coronary artery 
Vascular disease Read 7923.11 Prosthetic bypass of coronary artery 
Vascular disease Read 7924 Revision of bypass for coronary artery 
Vascular disease Read 7925 Connection of mammary artery to coronary artery 
Vascular disease Read 7925.11 Creation of bypass from mammary artery to coronary artery 
Vascular disease Read 7926 Connection of other thoracic artery to coronary artery 
Vascular disease Read 7928 Transluminal balloon angioplasty of coronary artery 
Vascular disease Read 7928.11 Percutaneous balloon coronary angioplasty 
Vascular disease Read 7920000 Saphenous vein graft replacement of one coronary artery 
Vascular disease Read 7920100 Saphenous vein graft replacement of two coronary arteries 
Vascular disease Read 7920200 Saphenous vein graft replacement of three coronary arteries 
Vascular disease Read 7920300 Saphenous vein graft replacement of four+ coronary arteries 
Vascular disease Read 7921000 Autograft replacement of one coronary artery NEC 
Vascular disease Read 7921100 Autograft replacement of two coronary arteries NEC 
Vascular disease Read 7921200 Autograft replacement of three coronary arteries NEC 
Vascular disease Read 7921300 Autograft replacement of four of more coronary arteries NEC 
Vascular disease Read 7922000 Allograft replacement of one coronary artery 
Vascular disease Read 7922100 Allograft replacement of two coronary arteries 
Vascular disease Read 7922200 Allograft replacement of three coronary arteries 
Vascular disease Read 7922300 Allograft replacement of four or more coronary arteries 
Vascular disease Read 7923000 Prosthetic replacement of one coronary artery 
Vascular disease Read 7923100 Prosthetic replacement of two coronary arteries 
Vascular disease Read 7923200 Prosthetic replacement of three coronary arteries 
Vascular disease Read 7923300 Prosthetic replacement of four or more coronary arteries 
Vascular disease Read 7924000 Revision of bypass for one coronary artery 
Vascular disease Read 7924100 Revision of bypass for two coronary arteries 
Vascular disease Read 7924200 Revision of bypass for three coronary arteries 
Vascular disease Read 7924300 Revision of bypass for four or more coronary arteries 
Vascular disease Read 7925000 Double anastomosis of mammary arteries to coronary arteries 
Vascular disease Read 7925011 LIMA sequential anastomosis 
Vascular disease Read 7925012 RIMA sequential anastomosis 
Vascular disease Read 7925100 Double implant of mammary arteries into coronary arteries 
Vascular disease Read 7925200 Single anast mammary art to left ant descend coronary art 
Vascular disease Read 7925300 Single anastomosis of mammary artery to coronary artery NEC 
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Vascular disease Read 7925311 LIMA single anastomosis 
Vascular disease Read 7925312 RIMA single anastomosis 
Vascular disease Read 7925400 Single implantation of mammary artery into coronary artery 
Vascular disease Read 7926000 Double anastom thoracic arteries to coronary arteries NEC 
Vascular disease Read 7926200 Single anastomosis of thoracic artery to coronary artery NEC 
Vascular disease Read 7926300 Single implantation thoracic artery into coronary artery NEC 
Vascular disease Read 7927500 Open angioplasty of coronary artery 
Vascular disease Read 7928000 Percut transluminal balloon angioplasty one coronary artery 
Vascular disease Read 7928100 Percut translum balloon angioplasty mult coronary arteries 
Vascular disease Read 7928200 Percut translum balloon angioplasty bypass graft coronary a 
Vascular disease Read 7928300 Percut translum cutting balloon angioplasty coronary artery 
Vascular disease Read 7929000 Percutaneous transluminal laser coronary angioplasty 
Vascular disease Read 7929300 Rotary blade coronary angioplasty 
Vascular disease Read 7929400 Insertion of coronary artery stent 
Vascular disease Read 7929500 Insertion of drug-eluting coronary artery stent 
Vascular disease Read 7929600 Percutaneous transluminal atherectomy of coronary artery 
Vascular disease Read 7932200 Open removal of cardiac thrombus 
Vascular disease Read 14A3.00 H/O: myocardial infarct <60 
Vascular disease Read 14A4.00 H/O: myocardial infarct >60 
Vascular disease Read 14A5.00 H/O: angina pectoris 
Vascular disease Read 14AH.00 H/O: Myocardial infarction in last year 
Vascular disease Read 14AJ.00 H/O: Angina in last year 
Vascular disease Read 14AT.00 History of myocardial infarction 
Vascular disease Read 14AW.00 H/O acute coronary syndrome 
Vascular disease Read 323..00 ECG: myocardial infarction 
Vascular disease Read 323Z.00 ECG: myocardial infarct NOS 
Vascular disease Read 790H300 Revascularisation of wall of heart 
Vascular disease Read 792..11 Coronary artery bypass graft operations 
Vascular disease Read 7920y00 Saphenous vein graft replacement of coronary artery OS 
Vascular disease Read 7920z00 Saphenous vein graft replacement coronary artery NOS 
Vascular disease Read 7921y00 Other autograft replacement of coronary artery OS 
Vascular disease Read 7921z00 Other autograft replacement of coronary artery NOS 
Vascular disease Read 7922y00 Other specified allograft replacement of coronary artery 
Vascular disease Read 7922z00 Allograft replacement of coronary artery NOS 
Vascular disease Read 7923z00 Prosthetic replacement of coronary artery NOS 
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Vascular disease Read 7924y00 Other specified revision of bypass for coronary artery 
Vascular disease Read 7924z00 Revision of bypass for coronary artery NOS 
Vascular disease Read 7925y00 Connection of mammary artery to coronary artery OS 
Vascular disease Read 7925z00 Connection of mammary artery to coronary artery NOS 
Vascular disease Read 7926z00 Connection of other thoracic artery to coronary artery NOS 
Vascular disease Read 7928y00 Transluminal balloon angioplasty of coronary artery OS 
Vascular disease Read 7928z00 Transluminal balloon angioplasty of coronary artery NOS 
Vascular disease Read 792B.00 Repair of coronary artery NEC 
Vascular disease Read 792C.00 Other replacement of coronary artery 
Vascular disease Read 792C000 Replacement of coronary arteries using multiple methods 
Vascular disease Read 792Cy00 Other specified replacement of coronary artery 
Vascular disease Read 792Cz00 Replacement of coronary artery NOS 
Vascular disease Read 792D.00 Other bypass of coronary artery 
Vascular disease Read 792Dy00 Other specified other bypass of coronary artery 
Vascular disease Read 792Dz00 Other bypass of coronary artery NOS 
Vascular disease Read 792E.00 Percutaneous coronary intervention 
Vascular disease Read 793Ey00 Other specified other operation on heart 
Vascular disease Read 793G.00 Perc translumin balloon angioplasty stenting coronary artery 
Vascular disease Read 793G000 Perc translum ball angio insert 1-2 drug elut stents cor art 
Vascular disease Read 793G100 Perc tran ball angio ins 3 or more drug elut stents cor art 
Vascular disease Read 793G200 Perc translum balloon angioplasty insert 1-2 stents cor art 
Vascular disease Read 793G300 Percutaneous cor balloon angiop 3 more stents cor art NEC 
Vascular disease Read 793Gz00 Perc translum balloon angioplasty stenting coronary art NOS 
Vascular disease Read 7A4A211 Open thrombectomy of femoral artery 
Vascular disease Read 7A4A311 Open thrombectomy of popliteal artery 
Vascular disease Read 7A54700 Percutaneous transluminal thrombolysis of artery 
Vascular disease Read 7A56000 Percutaneous transluminal arterial thrombolysis reconstruct 
Vascular disease Read 889A.00 Diab mellit insulin-glucose infus acute myocardial infarct 
Vascular disease Read 9kg..00 Deep vein thrombosis - enhanced services administration 
Vascular disease Read F161500 Anterior spinal artery thrombosis 
Vascular disease Read G3...00 Ischaemic heart disease 
Vascular disease Read G3...13 IHD - Ischaemic heart disease 
Vascular disease Read G30..00 Acute myocardial infarction 
Vascular disease Read G30..13 Cardiac rupture following myocardial infarction (MI) 
Vascular disease Read G30..15 MI - acute myocardial infarction 
  
 
2
6
5
 
Condition / Diagnosis Coding System Code Description 
Vascular disease Read G30..17 Silent myocardial infarction 
Vascular disease Read G301.00 Other specified anterior myocardial infarction 
Vascular disease Read G301z00 Anterior myocardial infarction NOS 
Vascular disease Read G304.00 Posterior myocardial infarction NOS 
Vascular disease Read G305.00 Lateral myocardial infarction NOS 
Vascular disease Read G306.00 True posterior myocardial infarction 
Vascular disease Read G307100 Acute non-ST segment elevation myocardial infarction 
Vascular disease Read G308.00 Inferior myocardial infarction NOS 
Vascular disease Read G30B.00 Acute posterolateral myocardial infarction 
Vascular disease Read G30X.00 Acute transmural myocardial infarction of unspecif site 
Vascular disease Read G30X000 Acute ST segment elevation myocardial infarction 
Vascular disease Read G30y.00 Other acute myocardial infarction 
Vascular disease Read G30yz00 Other acute myocardial infarction NOS 
Vascular disease Read G30z.00 Acute myocardial infarction NOS 
Vascular disease Read G31..00 Other acute and subacute ischaemic heart disease 
Vascular disease Read G310.00 Postmyocardial infarction syndrome 
Vascular disease Read G311.13 Unstable angina 
Vascular disease Read G311000 Myocardial infarction aborted 
Vascular disease Read G311011 MI - myocardial infarction aborted 
Vascular disease Read G311100 Unstable angina 
Vascular disease Read G311300 Refractory angina 
Vascular disease Read G311500 Acute coronary syndrome 
Vascular disease Read G31y.00 Other acute and subacute ischaemic heart disease 
Vascular disease Read G31y000 Acute coronary insufficiency 
Vascular disease Read G31yz00 Other acute and subacute ischaemic heart disease NOS 
Vascular disease Read G32..00 Old myocardial infarction 
Vascular disease Read G32..11 Healed myocardial infarction 
Vascular disease Read G32..12 Personal history of myocardial infarction 
Vascular disease Read G33..00 Angina pectoris 
Vascular disease Read G331.00 Prinzmetal's angina 
Vascular disease Read G331.11 Variant angina pectoris 
Vascular disease Read G33z.00 Angina pectoris NOS 
Vascular disease Read G33z300 Angina on effort 
Vascular disease Read G33z500 Post infarct angina 
Vascular disease Read G33z700 Stable angina 
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Vascular disease Read G33zz00 Angina pectoris NOS 
Vascular disease Read G34..00 Other chronic ischaemic heart disease 
Vascular disease Read G340.00 Coronary atherosclerosis 
Vascular disease Read G34y.00 Other specified chronic ischaemic heart disease 
Vascular disease Read G34yz00 Other specified chronic ischaemic heart disease NOS 
Vascular disease Read G34z.00 Other chronic ischaemic heart disease NOS 
Vascular disease Read G35..00 Subsequent myocardial infarction 
Vascular disease Read G350.00 Subsequent myocardial infarction of anterior wall 
Vascular disease Read G351.00 Subsequent myocardial infarction of inferior wall 
Vascular disease Read G353.00 Subsequent myocardial infarction of other sites 
Vascular disease Read G35X.00 Subsequent myocardial infarction of unspecified site 
Vascular disease Read G36..00 Certain current complication follow acute myocardial infarct 
Vascular disease Read G38..00 Postoperative myocardial infarction 
Vascular disease Read G380.00 Postoperative transmural myocardial infarction anterior wall 
Vascular disease Read G381.00 Postoperative transmural myocardial infarction inferior wall 
Vascular disease Read G383.00 Postoperative transmural myocardial infarction unspec site 
Vascular disease Read G384.00 Postoperative subendocardial myocardial infarction 
Vascular disease Read G38z.00 Postoperative myocardial infarction, unspecified 
Vascular disease Read G3y..00 Other specified ischaemic heart disease 
Vascular disease Read G3z..00 Ischaemic heart disease NOS 
Vascular disease Read G401.00 Pulmonary embolism 
Vascular disease Read G401.12 Pulmonary embolus 
Vascular disease Read G401000 Post operative pulmonary embolus 
Vascular disease Read G401100 Recurrent pulmonary embolism 
Vascular disease Read G631.12 Thrombosis, carotid artery 
Vascular disease Read G700.00 Aortic atherosclerosis 
Vascular disease Read G73z000 Intermittent claudication 
Vascular disease Read G74..00 Arterial embolism and thrombosis 
Vascular disease Read G74..11 Arterial embolus and thrombosis 
Vascular disease Read G74..12 Thrombosis - arterial 
Vascular disease Read G74..13 Arterial embolic and thrombotic occlusion 
Vascular disease Read G742.00 Embolism and thrombosis of an arm or leg artery 
Vascular disease Read G742000 Embolism and thrombosis of the brachial artery 
Vascular disease Read G742100 Embolism and thrombosis of the radial artery 
Vascular disease Read G742200 Embolism and thrombosis of the ulnar artery 
  
 
2
6
7
 
Condition / Diagnosis Coding System Code Description 
Vascular disease Read G742300 Embolism and thrombosis of an arm artery NOS 
Vascular disease Read G742400 Embolism and thrombosis of the femoral artery 
Vascular disease Read G742500 Embolism and thrombosis of the popliteal artery 
Vascular disease Read G742600 Embolism and thrombosis of the anterior tibial artery 
Vascular disease Read G742700 Embolism and thrombosis of the dorsalis pedis artery 
Vascular disease Read G742800 Embolism and thrombosis of the posterior tibial artery 
Vascular disease Read G742900 Embolism and thrombosis of a leg artery NOS 
Vascular disease Read G742z00 Peripheral arterial embolism and thrombosis NOS 
Vascular disease Read G74y.00 Embolism and thrombosis of other specified artery 
Vascular disease Read G74y000 Embolism and/or thrombosis of the common iliac artery 
Vascular disease Read G74y100 Embolism and/or thrombosis of the internal iliac artery 
Vascular disease Read G74y200 Embolism and/or thrombosis of the external iliac artery 
Vascular disease Read G74y300 Embolism and thrombosis of the iliac artery unspecified 
Vascular disease Read G74y500 Embolism and thrombosis of the subclavian artery 
Vascular disease Read G74y600 Embolism and thrombosis of the splenic artery 
Vascular disease Read G74y700 Embolism and thrombosis of the axillary artery 
Vascular disease Read G74y800 Embolism and thrombosis of the coeliac artery 
Vascular disease Read G74y900 Embolism and thrombosis of the hepatic artery 
Vascular disease Read G74z.00 Arterial embolism and thrombosis NOS 
Vascular disease Read G801.00 Deep vein phlebitis and thrombophlebitis of the leg 
Vascular disease Read G801.11 Deep vein thrombosis 
Vascular disease Read G801.12 Deep vein thrombosis, leg 
Vascular disease Read G801.13 DVT - Deep vein thrombosis 
Vascular disease Read G801000 Phlebitis of the femoral vein 
Vascular disease Read G801100 Phlebitis of the popliteal vein 
Vascular disease Read G801200 Phlebitis of the anterior tibial vein 
Vascular disease Read G801400 Phlebitis of the posterior tibial vein 
Vascular disease Read G801500 Deep vein phlebitis of the leg unspecified 
Vascular disease Read G801600 Thrombophlebitis of the femoral vein 
Vascular disease Read G801700 Thrombophlebitis of the popliteal vein 
Vascular disease Read G801800 Thrombophlebitis of the anterior tibial vein 
Vascular disease Read G801A00 Thrombophlebitis of the posterior tibial vein 
Vascular disease Read G801B00 Deep vein thrombophlebitis of the leg unspecified 
Vascular disease Read G801C00 Deep vein thrombosis of leg related to air travel 
Vascular disease Read G801D00 Deep vein thrombosis of lower limb 
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Vascular disease Read G801F00 Deep vein thrombosis of peroneal vein 
Vascular disease Read G801G00 Recurrent deep vein thrombosis 
Vascular disease Read G801z00 Deep vein phlebitis and thrombophlebitis of the leg NOS 
Vascular disease Read G80y.11 Phlebitis and/or thrombophlebitis of iliac vein 
Vascular disease Read G80y000 Phlebitis of the common iliac vein 
Vascular disease Read G80y200 Phlebitis of the external iliac vein 
Vascular disease Read G80y300 Phlebitis of the iliac vein unspecified 
Vascular disease Read G80y400 Thrombophlebitis of the common iliac vein 
Vascular disease Read G80y500 Thrombophlebitis of the internal iliac vein 
Vascular disease Read G80y600 Thrombophlebitis of the external iliac vein 
Vascular disease Read G80y700 Thrombophlebitis of the iliac vein unspecified 
Vascular disease Read G80y800 Phlebitis and thrombophlebitis of the iliac vein NOS 
Vascular disease Read G824.00 Axillary vein thrombosis 
Vascular disease Read G825.00 Thrombosis of subclavian vein 
Vascular disease Read Gyu3.00 [X]Ischaemic heart diseases 
Vascular disease Read Gyu3000 [X]Other forms of angina pectoris 
Vascular disease Read Gyu3200 [X]Other forms of acute ischaemic heart disease 
Vascular disease Read Gyu3300 [X]Other forms of chronic ischaemic heart disease 
Vascular disease Read Gyu3400 [X]Acute transmural myocardial infarction of unspecif site 
Vascular disease Read Gyu3600 [X]Subsequent myocardial infarction of unspecified site 
Vascular disease Read Gyu8000 [X]Phlebitis+thrombophlebitis/oth deep vessls/low extremites 
Vascular disease Read J420100 Thrombus of the superior mesenteric artery 
Vascular disease Read K138000 Renal artery embolism 
Vascular disease Read K138200 Renal artery thrombosis 
Vascular disease Read L413.00 Antenatal deep vein thrombosis 
Vascular disease Read L413.11 DVT - deep venous thrombosis, antenatal 
Vascular disease Read L413000 Antenatal deep vein thrombosis unspecified 
Vascular disease Read L413100 Antenatal deep vein thrombosis - delivered 
Vascular disease Read L413200 Antenatal deep vein thrombosis with antenatal complication 
Vascular disease Read L413z00 Antenatal deep vein thrombosis NOS 
Vascular disease Read L414.00 Postnatal deep vein thrombosis 
Vascular disease Read L414.11 DVT - deep venous thrombosis, postnatal 
Vascular disease Read L414000 Postnatal deep vein thrombosis unspecified 
Vascular disease Read L414200 Postnatal deep vein thrombosis with postnatal complication 
Vascular disease Read L414z00 Postnatal deep vein thrombosis NOS 
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Vascular disease Read SP12200 Post operative deep vein thrombosis 
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Medication Product 
Code 
Product Name BNF Header 
Antidepressants 3349 Nardil 15mg tablets (Archimedes Pharma UK Ltd) Monoamine-oxidase Inhibitors 
Antidepressants 3783 Tranylcypromine 10mg tablets Monoamine-oxidase Inhibitors 
Antidepressants 4321 Phenelzine 15mg tablets Monoamine-oxidase Inhibitors 
Antidepressants 10787 Parnate 10mg Tablet (Goldshield Pharmaceuticals 
Ltd) 
Monoamine-oxidase Inhibitors 
Antidepressants 12207 Isocarboxazid 10mg tablets Monoamine-oxidase Inhibitors 
Antidepressants 12503 Marplan 10mg Tablet (Cambridge Laboratories Ltd) Monoamine-oxidase Inhibitors 
Antidepressants 18290 Marsilid 25mg Tablet (Roche Products Ltd) Monoamine-oxidase Inhibitors 
Antidepressants 25945 Iproniazid 25mg Monoamine-oxidase Inhibitors 
Antidepressants 41654 Tranylcypromine 10mg tablets (Mercury Pharma 
Group Ltd) 
Monoamine-oxidase Inhibitors 
Antidepressants 41731 Isocarboxazid 10mg Tablet (Cambridge Laboratories 
Ltd) 
Monoamine-oxidase Inhibitors 
Antidepressants 301 Venlafaxine 37.5mg tablets Other Antidepressant Drugs 
Antidepressants 470 Venlafaxine 75mg modified-release capsules Other Antidepressant Drugs 
Antidepressants 600 Flupentixol 1mg tablets Other Antidepressant Drugs 
Antidepressants 623 Efexor 37.5mg tablets (Wyeth Pharmaceuticals) Other Antidepressant Drugs 
Antidepressants 742 Mirtazapine 30mg tablets Other Antidepressant Drugs 
Antidepressants 1222 Venlafaxine 75mg tablets Other Antidepressant Drugs 
Antidepressants 1474 Efexor XL 75mg capsules (Pfizer Ltd) Other Antidepressant Drugs 
Antidepressants 2275 Flupentixol 500microgram tablets Other Antidepressant Drugs 
Antidepressants 2356 Reboxetine 4mg tablets Other Antidepressant Drugs 
Antidepressants 2654 Venlafaxine 150mg modified-release capsules Other Antidepressant Drugs 
Antidepressants 3951 Fluanxol 1mg tablets (Lundbeck Ltd) Other Antidepressant Drugs 
Antidepressants 3953 Fluanxol 500microgram tablets (Lundbeck Ltd) Other Antidepressant Drugs 
Antidepressants 4422 Tryptophan 500mg tablets Other Antidepressant Drugs 
Antidepressants 4726 Zispin 30mg tablets (Organon Laboratories Ltd) Other Antidepressant Drugs 
Antidepressants 5611 Optimax 500mg tablets (Merck Serono Ltd) Other Antidepressant Drugs 
Antidepressants 5710 Efexor XL 150mg capsules (Pfizer Ltd) Other Antidepressant Drugs 
Antidepressants 6421 Mirtazapine 15mg orodispersible tablets Other Antidepressant Drugs 
Antidepressants 6481 Mirtazapine 45mg orodispersible tablets Other Antidepressant Drugs 
Antidepressants 6488 Mirtazapine 30mg orodispersible tablets Other Antidepressant Drugs 
Antidepressants 6795 Mirtazapine 15mg tablets Other Antidepressant Drugs 
Antidepressants 6846 Zispin SolTab 15mg orodispersible tablets (Merck 
Sharp & Dohme Ltd) 
Other Antidepressant Drugs 
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Antidepressants 6854 Mirtazapine 45mg tablets Other Antidepressant Drugs 
Antidepressants 8844 Tryptophan with ascorbic acid and pyridoxine powder Other Antidepressant Drugs 
Antidepressants 9182 Efexor 75mg tablets (Wyeth Pharmaceuticals) Other Antidepressant Drugs 
Antidepressants 9534 Nefazodone Starter pack Other Antidepressant Drugs 
Antidepressants 10083 Zispin SolTab 30mg orodispersible tablets (Merck 
Sharp & Dohme Ltd) 
Other Antidepressant Drugs 
Antidepressants 12221 Pacitron 500mg Tablet (Rorer Pharmaceuticals Ltd) Other Antidepressant Drugs 
Antidepressants 13237 Venlafaxine 37.5mg/5ml oral suspension Other Antidepressant Drugs 
Antidepressants 15163 Edronax 4mg tablets (Pfizer Ltd) Other Antidepressant Drugs 
Antidepressants 15268 Zispin SolTab 45mg orodispersible tablets (Merck 
Sharp & Dohme Ltd) 
Other Antidepressant Drugs 
Antidepressants 16154 Mirtazapine 15mg/ml oral solution sugar free Other Antidepressant Drugs 
Antidepressants 20504 Optimax wv Tablet (E. Merck) Other Antidepressant Drugs 
Antidepressants 33337 Mirtazapine 45mg tablets (A A H Pharmaceuticals Ltd) Other Antidepressant Drugs 
Antidepressants 39359 Venlafaxine 75mg modified-release tablets Other Antidepressant Drugs 
Antidepressants 39360 Venlafaxine 150mg modified-release tablets Other Antidepressant Drugs 
Antidepressants 39770 Tifaxin XL 75mg capsules (Genus Pharmaceuticals 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 39809 Tifaxin XL 150mg capsules (Genus Pharmaceuticals 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40048 ViePax XL 75mg tablets (Dexcel-Pharma Ltd) Other Antidepressant Drugs 
Antidepressants 40049 ViePax XL 150mg tablets (Dexcel-Pharma Ltd) Other Antidepressant Drugs 
Antidepressants 40054 Venlafaxine 225mg modified-release tablets Other Antidepressant Drugs 
Antidepressants 40059 Venlalic XL 75mg tablets (Dallas Burston Ashbourne 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40062 Venlalic XL 150mg tablets (Dallas Burston Ashbourne 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40092 Vensir XL 150mg capsules (Morningside Healthcare 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40160 Mirtazapine 30mg tablets (Actavis UK Ltd) Other Antidepressant Drugs 
Antidepressants 40277 Vensir XL 75mg capsules (Morningside Healthcare 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40295 Valdoxan 25mg tablets (Servier Laboratories Ltd) Other Antidepressant Drugs 
Antidepressants 40407 Venlalic XL 225mg tablets (Dallas Burston Ashbourne 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40494 Agomelatine 25mg tablets Other Antidepressant Drugs 
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Antidepressants 40514 Venaxx XL 150mg capsules (Mercury Pharma Group 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40515 Venaxx XL 75mg capsules (Mercury Pharma Group 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 40517 Vexarin XL 150mg capsules (Generics (UK) Ltd) Other Antidepressant Drugs 
Antidepressants 40764 ViePax 37.5mg tablets (Dexcel-Pharma Ltd) Other Antidepressant Drugs 
Antidepressants 40815 Tardcaps XL 75mg capsules (IXL Pharma Ltd) Other Antidepressant Drugs 
Antidepressants 40817 Tardcaps XL 150mg capsules (IXL Pharma Ltd) Other Antidepressant Drugs 
Antidepressants 40917 ViePax 75mg tablets (Dexcel-Pharma Ltd) Other Antidepressant Drugs 
Antidepressants 41033 Rodomel XL 75mg capsules (Teva UK Ltd) Other Antidepressant Drugs 
Antidepressants 41299 Politid XL 75mg capsules (Actavis UK Ltd) Other Antidepressant Drugs 
Antidepressants 41314 Rodomel XL 150mg capsules (Teva UK Ltd) Other Antidepressant Drugs 
Antidepressants 42600 Vexarin XL 75mg capsules (Generics (UK) Ltd) Other Antidepressant Drugs 
Antidepressants 43203 Venlafaxine 75mg modified-release capsules (Sandoz 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 43234 Mirtazapine 45mg orodispersible tablets (Teva UK 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 43235 Mirtazapine 45mg orodispersible tablets (A A H 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 43236 Mirtazapine 45mg orodispersible tablets (Actavis UK 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 43237 Mirtazapine 15mg orodispersible tablets (Teva UK 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 43239 Mirtazapine 15mg tablets (A A H Pharmaceuticals Ltd) Other Antidepressant Drugs 
Antidepressants 43241 Mirtazapine 15mg orodispersible tablets (Aurobindo 
Pharma Ltd) 
Other Antidepressant Drugs 
Antidepressants 43242 Mirtazapine 15mg tablets (Genus Pharmaceuticals 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 43246 Mirtazapine 15mg orodispersible tablets (Genus 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 43247 Mirtazapine 45mg orodispersible tablets (Genus 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 43248 Mirtazapine 15mg orodispersible tablets (Focus 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 43250 Mirtazapine 30mg orodispersible tablets (A A H 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 43253 Mirtazapine 15mg orodispersible tablets (A A H Other Antidepressant Drugs 
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Pharmaceuticals Ltd) 
Antidepressants 43256 Mirtazapine 45mg orodispersible tablets (Focus 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 43257 Mirtazapine 15mg tablets (Teva UK Ltd) Other Antidepressant Drugs 
Antidepressants 43334 Venlafaxine 150mg modified-release capsules 
(Sandoz Ltd) 
Other Antidepressant Drugs 
Antidepressants 43673 Politid XL 150mg capsules (Actavis UK Ltd) Other Antidepressant Drugs 
Antidepressants 43968 Foraven XL 75mg capsules (Forum Products Ltd) Other Antidepressant Drugs 
Antidepressants 44936 Venlaneo XL 150mg capsules (Kent Pharmaceuticals 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 44937 Venlaneo XL 75mg capsules (Kent Pharmaceuticals 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 45664 Depefex XL 150mg capsules (Chiesi Ltd) Other Antidepressant Drugs 
Antidepressants 45806 Venlafaxine 37.5mg modified-release tablets Other Antidepressant Drugs 
Antidepressants 45818 Venlalic XL 37.5mg tablets (Dallas Burston Ashbourne 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 45959 Depefex XL 75mg capsules (Chiesi Ltd) Other Antidepressant Drugs 
Antidepressants 46668 Mirtazapine 15mg tablets (Arrow Generics Ltd) Other Antidepressant Drugs 
Antidepressants 47945 Mirtazapine 30mg tablets (A A H Pharmaceuticals Ltd) Other Antidepressant Drugs 
Antidepressants 47966 Mirtazapine 15mg/ml oral solution sugar free 
(Rosemont Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 48199 Ranfaxine XL 75mg capsules (Ranbaxy (UK) Ltd) Other Antidepressant Drugs 
Antidepressants 48698 Mirtazapine 15mg orodispersible tablets sugar free Other Antidepressant Drugs 
Antidepressants 49511 Venlablue XL 75mg capsules (Bluefish 
Pharmaceuticals AB) 
Other Antidepressant Drugs 
Antidepressants 49820 Mirtazapine 45mg orodispersible tablets sugar free Other Antidepressant Drugs 
Antidepressants 50081 Venlablue XL 150mg capsules (Bluefish 
Pharmaceuticals AB) 
Other Antidepressant Drugs 
Antidepressants 50592 Fluanxol 1mg tablets (Sigma Pharmaceuticals Plc) Other Antidepressant Drugs 
Antidepressants 50892 Zispin SolTab 15mg orodispersible tablets (Necessity 
Supplies Ltd) 
Other Antidepressant Drugs 
Antidepressants 50934 Venlafaxine 150mg/5ml oral solution Other Antidepressant Drugs 
Antidepressants 51280 Efexor XL 150mg capsules (Waymade Healthcare 
Plc) 
Other Antidepressant Drugs 
Antidepressants 51361 Venlafaxine 37.5mg tablets (Ranbaxy (UK) Ltd) Other Antidepressant Drugs 
Antidepressants 51699 Venlafaxine 37.5mg/5ml oral solution Other Antidepressant Drugs 
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Antidepressants 52074 Alventa XL 75mg capsules (Consilient Health Ltd) Other Antidepressant Drugs 
Antidepressants 52516 Alventa XL 150mg capsules (Consilient Health Ltd) Other Antidepressant Drugs 
Antidepressants 52716 Tonpular XL 75mg capsules (Wockhardt UK Ltd) Other Antidepressant Drugs 
Antidepressants 53321 Mirtazapine 15mg/ml oral solution sugar free (A A H 
Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 53326 Venlafaxine 75mg/5ml oral solution Other Antidepressant Drugs 
Antidepressants 53543 Zispin SolTab 30mg orodispersible tablets (Necessity 
Supplies Ltd) 
Other Antidepressant Drugs 
Antidepressants 53648 Mirtazapine 30mg orodispersible tablets (Actavis UK 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 53699 Mirtazapine 15mg tablets (Actavis UK Ltd) Other Antidepressant Drugs 
Antidepressants 54012 Mirtazapine 15mg orodispersible tablets sugar free 
(Sandoz Ltd) 
Other Antidepressant Drugs 
Antidepressants 54342 Mirtazapine 15mg tablets (Medreich Plc) Other Antidepressant Drugs 
Antidepressants 54644 Mirtazapine 15mg tablets (Pfizer Ltd) Other Antidepressant Drugs 
Antidepressants 54686 Tryptophan 500mg capsules Other Antidepressant Drugs 
Antidepressants 54747 Optimax 500mg capsules (Merck Serono Ltd) Other Antidepressant Drugs 
Antidepressants 54792 Mirtazapine 30mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Other Antidepressant Drugs 
Antidepressants 55424 Venlafaxine Other Antidepressant Drugs 
Antidepressants 55482 Mirtazapine 15mg orodispersible tablets (Generics 
(UK) Ltd) 
Other Antidepressant Drugs 
Antidepressants 55501 Venlafaxine 150mg Modified-release capsule 
(Hillcross Pharmaceuticals Ltd) 
Other Antidepressant Drugs 
Antidepressants 56209 Mirtazapine 30mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Other Antidepressant Drugs 
Antidepressants 56457 Venlafaxine 75mg tablets (Teva UK Ltd) Other Antidepressant Drugs 
Antidepressants 56662 Venlafaxine 37.5mg tablets (A A H Pharmaceuticals 
Ltd) 
Other Antidepressant Drugs 
Antidepressants 2883 Moclobemide 150mg tablets Reversible Monoamine-oxidase Inhibitors 
Antidepressants 5187 Moclobemide 300mg tablets Reversible Monoamine-oxidase Inhibitors 
Antidepressants 5832 Manerix 300mg tablets (Meda Pharmaceuticals Ltd) Reversible Monoamine-oxidase Inhibitors 
Antidepressants 9206 Manerix 150mg tablets (Meda Pharmaceuticals Ltd) Reversible Monoamine-oxidase Inhibitors 
Antidepressants 41747 Moclobemide 150mg tablets (Teva UK Ltd) Reversible Monoamine-oxidase Inhibitors 
Antidepressants 22 Fluoxetine 20mg capsules Selective Serotonin Re-uptake Inhibitors 
Antidepressants 50 Paroxetine 20mg tablets Selective Serotonin Re-uptake Inhibitors 
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Antidepressants 67 Citalopram 20mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 252 Prozac 20mg/5ml liquid (Eli Lilly and Company Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 418 Prozac 20mg capsules (Eli Lilly and Company Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 476 Citalopram 10mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 488 Sertraline 50mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 513 Citalopram 40mg/ml oral drops sugar free Selective Serotonin Re-uptake Inhibitors 
Antidepressants 527 Paroxetine 10mg/5ml oral suspension sugar free Selective Serotonin Re-uptake Inhibitors 
Antidepressants 603 Escitalopram 10mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 648 Cipralex 10mg tablets (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 727 Sertraline 100mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 785 Cipralex 5mg tablets (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 815 Cipramil 40mg/ml drops (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 841 Seroxat 20mg tablets (GlaxoSmithKline UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 1397 Paroxetine 30mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 1575 Seroxat 30mg tablets (GlaxoSmithKline UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 1612 Lustral 50mg tablets (Pfizer Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 1712 Cipramil 20mg tablets (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 2290 Fluvoxamine 100mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 2408 Cipramil 40mg tablets (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 2548 Fluoxetine 20mg/5ml oral solution Selective Serotonin Re-uptake Inhibitors 
Antidepressants 2880 Fluvoxamine 50mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 2897 Faverin 50mg tablets (Abbott Healthcare Products 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 3391 Dutonin 100mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 3601 Seroxat 20mg/10ml liquid (GlaxoSmithKline UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 3861 Cipramil 10mg tablets (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4011 Nefazodone 200mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4075 Fluoxetine 60mg capsules Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4297 Dutonin 200mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4352 Lustral 100mg tablets (Pfizer Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4554 Nefazodone 100mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4770 Citalopram 40mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 4907 Prozac 60mg capsules (Eli Lilly and Company Ltd) Selective Serotonin Re-uptake Inhibitors 
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Antidepressants 6218 Escitalopram 20mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 6360 Cipralex 20mg tablets (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 6405 Escitalopram 5mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 7328 Sertraline 50mg/5ml oral suspension Selective Serotonin Re-uptake Inhibitors 
Antidepressants 12123 Faverin 100mg tablets (Abbott Healthcare Products 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 14740 Oxactin 20mg capsules (Discovery Pharmaceuticals 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 19183 Fluoxetine 20mg capsules (A A H Pharmaceuticals 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 19470 Fluoxetine 20mg capsules (Ranbaxy (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 20152 Escitalopram 10mg/ml oral drops sugar free Selective Serotonin Re-uptake Inhibitors 
Antidepressants 26016 Citalopram 20mg tablets (Sandoz Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 26056 Cipralex 10mg/ml oral drops (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 29756 Paxoran 20mg Tablet (Ranbaxy (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 29786 Ranflutin 20mg capsules (Ranbaxy (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 30258 Fluoxetine 20mg/5ml oral solution (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 32401 Sertraline 50mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 32546 Paxoran 10mg Tablet (Ranbaxy (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 32848 Citalopram 10mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 32899 Paroxetine 20mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 33071 Felicium 20mg capsules (Opus Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 33410 Fluoxetine 20mg capsules (Zentiva) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 33720 Citalopram 10mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 33779 Prozit 20mg/5ml oral solution (Pinewood Healthcare) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 33978 Paroxetine 20mg tablets (Generics (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34202 Fluoxetine 20mg capsules (Genus Pharmaceuticals 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34216 Fluoxetine 20mg/5ml oral solution (A A H 
Pharmaceuticals Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34288 Fluoxetine 20mg capsules (Generics (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34294 Fluoxetine 20mg capsules (IVAX Pharmaceuticals UK 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34351 Paroxetine 20mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
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Antidepressants 34356 Citalopram 20mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34413 Citalopram 10mg tablets (Zentiva) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34415 Citalopram 20mg tablets (Generics (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34419 Paroxetine 20mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34436 Citalopram 10mg tablets (Generics (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34456 Fluoxetine 20mg capsules (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34466 Citalopram 40mg tablets (Sandoz Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34498 Citalopram 10mg Tablet (Neo Laboratories Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34499 Citalopram 10mg tablets (Sandoz Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34586 Citalopram 10mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34587 Paroxetine 30mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34603 Citalopram 40mg tablets (Generics (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34722 Citalopram 20mg Tablet (Neo Laboratories Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34822 Citalopram 20mg tablets (Zentiva) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34849 Fluoxetine 20mg capsules (Tillomed Laboratories Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34856 Fluoxetine 60mg capsules (Generics (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34871 Citalopram 20mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34966 Citalopram 20mg tablets (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 34970 Citalopram 20mg tablets (Niche Generics Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 35021 Paroxetine 10mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 35112 Seroxat 10mg tablets (GlaxoSmithKline UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 36746 Citalopram 40mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 36893 Fluoxetine 20mg/5ml oral solution sugar free Selective Serotonin Re-uptake Inhibitors 
Antidepressants 37256 Prozep 20mg/5ml oral solution (Chemidex Pharma 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 38890 Fluoxetine 20mg Capsule (Milpharm Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 40165 Paroxetine 30mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 40726 Escitalopram 20mg/ml oral drops sugar free Selective Serotonin Re-uptake Inhibitors 
Antidepressants 40892 Paroxetine 20mg tablets (Genus Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 41062 Cipralex 20mg/ml oral drops (Lundbeck Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 41528 Citalopram 10mg tablets (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 42107 Fluoxetine 20mg capsules (Niche Generics Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 42387 Sertraline 50mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 42499 Fluoxetine 10mg tablets Selective Serotonin Re-uptake Inhibitors 
Antidepressants 42660 Citalopram 10mg tablets (Almus Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
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Antidepressants 42803 Fluoxetine 20mg/5ml oral solution (IVAX 
Pharmaceuticals UK Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 43518 Fluvoxamine 100mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 43519 Citalopram 40mg Tablet (Neo Laboratories Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 44861 Fluvoxamine 100mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 44944 Sertraline 100mg tablets (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45223 Citalopram 40mg tablets (Niche Generics Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45224 Fluoxetine 20mg capsules (Sandoz Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45247 Fluoxetine 20mg capsules (Kent Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45286 Citalopram 10mg tablets (Niche Generics Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45304 Citalopram 40mg tablets (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45316 Fluoxetine 20mg capsules (Wockhardt UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45329 Fluoxetine 20mg capsules (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 45915 Sertraline 50mg tablets (Almus Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 46926 Citalopram 40mg tablets (Zentiva) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 46977 Citalopram 40mg tablets (Actavis UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 48026 Citalopram 20mg tablets (Almus Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 48045 Fluvoxamine 100mg tablets (A A H Pharmaceuticals 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 48220 Prozac 20mg capsules (Lexon (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 49165 Citalopram 10mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 49519 Sertraline 100mg/5ml oral suspension Selective Serotonin Re-uptake Inhibitors 
Antidepressants 52100 Citalopram 10mg tablets (Arrow Generics Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 52354 Citalopram 20mg tablets (Doncaster Pharmaceuticals 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 52408 Citalopram 10mg tablets (Kent Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 52607 Citalopram 20mg tablets (Bristol Laboratories Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 52824 Citalopram 10mg tablets (PLIVA Pharma Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 53394 Citalopram 20mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 53787 Citalopram 10mg tablets (Bristol Laboratories Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 54081 Sertraline 25mg/5ml oral suspension Selective Serotonin Re-uptake Inhibitors 
Antidepressants 54826 Sertraline 150mg/5ml oral suspension Selective Serotonin Re-uptake Inhibitors 
Antidepressants 54827 Citalopram 10mg/5ml oral suspension Selective Serotonin Re-uptake Inhibitors 
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Code 
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Antidepressants 54933 Sertraline 100mg tablets (PLIVA Pharma Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 55023 Paroxetine 20mg tablets (Medreich Plc) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 55033 Citalopram 40mg tablets (Doncaster Pharmaceuticals 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 55146 Sertraline 100mg tablets (A A H Pharmaceuticals Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 55488 Sertraline 50mg tablets (Teva UK Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 55537 Seroxat 30mg tablets (Lexon (UK) Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 56009 Citalopram 20mg tablets (Arrow Generics Ltd) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 56292 Citalopram 40mg/ml oral drops sugar free (Actavis UK 
Ltd) 
Selective Serotonin Re-uptake Inhibitors 
Antidepressants 56355 Citalopram 10mg tablets (Waymade Healthcare Plc) Selective Serotonin Re-uptake Inhibitors 
Antidepressants 74 Dosulepin 75mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 84 Dosulepin 25mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 114 Lofepramine 70mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 182 Tryptizol 10mg/ml Injection (Merck Sharp & Dohme 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 595 Amitriptyline 25mg / Perphenazine 2mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 1169 Prothiaden 25mg capsules (Teofarma) Tricyclic And Related Antidepressant Drugs 
Antidepressants 1208 Triptafen tablets (Mercury Pharma Group Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 1730 Trazodone 100mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 1940 Dothapax 25 capsules (Ashbourne Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 2039 Trimipramine 25mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 2093 Gamanil 70mg tablets (Merck Serono Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 2320 Prothiaden 75mg tablets (Teofarma) Tricyclic And Related Antidepressant Drugs 
Antidepressants 2531 Surmontil 50mg capsules (Sanofi) Tricyclic And Related Antidepressant Drugs 
Antidepressants 2532 Surmontil 25mg tablets (Sanofi) Tricyclic And Related Antidepressant Drugs 
Antidepressants 3083 Mianserin 10mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 3183 Nortriptyline 10mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 3194 Clomipramine 10mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 3196 Trimipramine 50mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 3355 Trazodone 50mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 3554 Doxepin 25mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 3657 Anafranil 25mg capsules (Novartis Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
  
 
2
8
0
 
Medication Product 
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Antidepressants 3670 Clomipramine 25mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 3842 Doxepin 10mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 3903 Nortriptyline 25mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 3925 Clomipramine 50mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 4003 Molipaxin 150mg tablets (Zentiva) Tricyclic And Related Antidepressant Drugs 
Antidepressants 4020 Trazodone 150mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 4194 Molipaxin 100mg capsules (Zentiva) Tricyclic And Related Antidepressant Drugs 
Antidepressants 4218 Lofepramine 70mg/5ml oral suspension sugar free Tricyclic And Related Antidepressant Drugs 
Antidepressants 4310 Trimipramine 10mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 4411 Amoxapine 150mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 4874 Molipaxin 50mg capsules (Zentiva) Tricyclic And Related Antidepressant Drugs 
Antidepressants 5073 Doxepin 50mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 6054 Dosulepin 25mg/5ml oral solution sugar free Tricyclic And Related Antidepressant Drugs 
Antidepressants 6255 Mianserin 30mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 6442 Trazodone 50mg/5ml oral solution sugar free Tricyclic And Related Antidepressant Drugs 
Antidepressants 7059 Doxepin 75mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 7468 Bolvidon 10mg Tablet (Organon Laboratories Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 7515 Anafranil 10mg capsules (Novartis Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 7677 Allegron 10mg tablets (King Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 7693 Anafranil 50mg capsules (Novartis Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 7894 Anafranil SR 75mg tablets (Novartis Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 7910 Tofranil 25mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 8144 Bolvidon 20mg Tablet (Organon Laboratories Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 8174 Molipaxin 50mg/5ml oral liquid (Sanofi) Tricyclic And Related Antidepressant Drugs 
Antidepressants 8585 Bolvidon 30mg Tablet (Organon Laboratories Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 8640 Allegron 25mg tablets (King Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 8661 Clomipramine 75mg modified-release tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 8719 Anafranil 25mg/5ml syrup (Novartis Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 8720 Clomipramine 25mg/5ml oral solution Tricyclic And Related Antidepressant Drugs 
Antidepressants 8928 Surmontil 10mg tablets (Sanofi) Tricyclic And Related Antidepressant Drugs 
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Antidepressants 10413 Sinequan 10mg capsules (Pfizer Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 10948 Dosulepin 75mg/5ml oral solution sugar free Tricyclic And Related Antidepressant Drugs 
Antidepressants 11956 Norval 20mg Tablet (Bencard) Tricyclic And Related Antidepressant Drugs 
Antidepressants 11963 Limbitrol 10 Capsule (Roche Products Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 12111 Vivalan 50mg Tablet (AstraZeneca UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 12125 Sinequan 50mg capsules (Pfizer Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 12129 Sinequan 25mg capsules (Pfizer Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 12192 Norval 30mg Tablet (Bencard) Tricyclic And Related Antidepressant Drugs 
Antidepressants 12227 Butriptyline 25mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 12309 Viloxazine hcl 50mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 12368 Norval 10mg Tablet (Bencard) Tricyclic And Related Antidepressant Drugs 
Antidepressants 14398 Asendis 50mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 14519 Sinequan 75mg capsules (Pfizer Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 14534 Limbitrol 5 Capsule (Roche Products Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 15380 Asendis 25mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 15632 Dothapax 75 tablets (Ashbourne Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 17319 Amoxapine 25mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 18342 Amitriptyline 25mg / Chlordiazepoxide 10mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 18932 Evadyne 25mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 19168 Dosulepin 25mg/5ml mixture Tricyclic And Related Antidepressant Drugs 
Antidepressants 19181 Trazodone 100mg capsules (Generics (UK) Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 19186 Dosulepin 75mg tablets (Actavis UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 19779 Amitriptyline 10mg/ml injection Tricyclic And Related Antidepressant Drugs 
Antidepressants 20571 Fluphenazine with nortriptyline 
500microgramswith10mg Tablet 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 21081 Amitriptyline 12.5mg / Chlordiazepoxide 5mg capsules Tricyclic And Related Antidepressant Drugs 
Antidepressants 21157 Thaden 75mg tablets (Opus Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 21357 Asendis 100mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 21819 Prepadine 75mg tablets (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 21820 Prepadine 25mg capsules (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 23426 Dosulepin 25mg capsules (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 24700 Prondol 15mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 24723 Asendis 150mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 25444 Lomont 70mg/5ml oral suspension (Rosemont Tricyclic And Related Antidepressant Drugs 
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Pharmaceuticals Ltd) 
Antidepressants 27476 Iprindole hc 15mg Tricyclic And Related Antidepressant Drugs 
Antidepressants 27733 Iprindole hc 30mg Tricyclic And Related Antidepressant Drugs 
Antidepressants 29339 Trazodone 50mg capsules (Generics (UK) Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 29857 Trazodone 150mg tablets (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 29875 Dosulepin 25mg capsules (Generics (UK) Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 30376 Thaden 25mg capsules (Opus Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 30983 Trazodone 150mg tablets (Generics (UK) Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 31672 Prondol 30mg Tablet (Wyeth Pharmaceuticals) Tricyclic And Related Antidepressant Drugs 
Antidepressants 31824 Dosulepin 25mg capsules (IVAX Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 31826 Dosulepin 75mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 32121 Dosulepin 75mg tablets (A A H Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 32457 Butriptyline 50mg tablets Tricyclic And Related Antidepressant Drugs 
Antidepressants 33164 Dosulepin 25mg capsules (Sandoz Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34003 Trazodone 50mg capsules (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34046 Lofepramine 70mg tablets (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34058 Dosulepin 75mg tablets (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34223 Dosulepin 25mg capsules (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34245 Clomipramine 25mg capsules (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34421 Trazodone 50mg capsules (Zentiva) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34470 Trazodone 150mg tablets (Zentiva) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34503 Amitriptyline 25mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34525 Dosulepin 75mg tablets (Generics (UK) Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34578 Lofepramine 70mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34580 Trazodone 100mg capsules (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34641 Dosulepin 25mg capsules (Sovereign Medical Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34643 Dosulepin 25mg capsules (Almus Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
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Antidepressants 34672 Lofepramine 70mg tablets (Sterwin Medicines) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34745 Dosulepin 25mg capsules (Actavis UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 34866 Clomipramine 10mg capsules (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 34950 Lofepramine 70mg tablets (Actavis UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 35258 Sinepin 25mg capsules (Marlborough 
Pharmaceuticals Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 35493 Sinepin 50mg capsules (Marlborough 
Pharmaceuticals Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 38274 Clomipramine 50mg/5ml oral suspension Tricyclic And Related Antidepressant Drugs 
Antidepressants 40777 Doxepin 25mg/5ml oral suspension Tricyclic And Related Antidepressant Drugs 
Antidepressants 41563 Clomipramine 25mg capsules (IVAX Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 41597 Clomipramine 50mg capsules (IVAX Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 41609 Trazodone 50mg capsules (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 41627 Lofepramine 70mg Tablet (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 41628 Clomipramine 10mg capsules (IVAX Pharmaceuticals 
UK Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 41709 Trazodone 100mg capsules (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 41710 Trazodone 100mg capsules (Zentiva) Tricyclic And Related Antidepressant Drugs 
Antidepressants 42228 Trimipramine 10mg tablets (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 42734 Dosulepin 75mg tablets (Almus Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 43024 Dosulepin 100mg/5ml oral solution Tricyclic And Related Antidepressant Drugs 
Antidepressants 43534 Lofepramine 70mg/5ml Oral suspension (Rosemont 
Pharmaceuticals Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 43561 Clomipramine 10mg capsules (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 44853 Dosulepin 25mg capsules (Kent Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 45226 Trimipramine 25mg tablets (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 45233 Amitriptyline 10mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 45318 Clomipramine 50mg capsules (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 45350 Clomipramine 25mg capsules (Teva UK Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 45737 Dosulepin 25mg/5ml Oral solution (Rosemont Tricyclic And Related Antidepressant Drugs 
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Pharmaceuticals Ltd) 
Antidepressants 46970 Amitriptyline 50mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 47363 Mianserin 20mg Tablet (Berk Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 48216 Nortriptyline 25mg tablets (A A H Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 50722 Dosulepin 25mg/5ml oral solution Tricyclic And Related Antidepressant Drugs 
Antidepressants 51758 Prothiaden 25mg capsules (Stephar (U.K.) Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 53161 Clomipramine 50mg/5ml oral solution Tricyclic And Related Antidepressant Drugs 
Antidepressants 53187 Clomipramine 50mg capsules (Kent Pharmaceuticals 
Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 53808 Trimipramine 10mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Tricyclic And Related Antidepressant Drugs 
Antidepressants 55137 Trazodone 150mg/5ml oral suspension Tricyclic And Related Antidepressant Drugs 
Antidepressants 55138 Trazodone 250mg/5ml oral solution Tricyclic And Related Antidepressant Drugs 
Antidepressants 55970 Nortriptyline 10mg tablets (King Pharmaceuticals Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 56229 Lofepramine 70mg/5ml oral solution Tricyclic And Related Antidepressant Drugs 
Antidepressants 56703 Lofepramine 70mg tablets (Sandoz Ltd) Tricyclic And Related Antidepressant Drugs 
Antidepressants 57226 Trazodone 25mg/5ml oral suspension Tricyclic And Related Antidepressant Drugs 
Antiplatelet drugs 3 Aspirin 75mg dispersible tablets Antiplatelet Drugs 
Antiplatelet drugs 16 Aspirin 75mg tablets Antiplatelet Drugs 
Antiplatelet drugs 34 Aspirin 75mg gastro-resistant tablets Antiplatelet Drugs 
Antiplatelet drugs 489 Clopidogrel 75mg tablets Antiplatelet Drugs 
Antiplatelet drugs 572 Ticlopidine 250mg tablets Antiplatelet Drugs 
Antiplatelet drugs 689 Persantin 25mg tablets (Boehringer Ingelheim Ltd) Antiplatelet Drugs 
Antiplatelet drugs 714 Dipyridamole 200mg modified-release capsules Antiplatelet Drugs 
Antiplatelet drugs 771 Dipyridamole 25mg tablets Antiplatelet Drugs 
Antiplatelet drugs 836 Plavix 75mg tablets (Sanofi) Antiplatelet Drugs 
Antiplatelet drugs 1814 Dipyridamole 100mg tablets Antiplatelet Drugs 
Antiplatelet drugs 2106 Persantin 100mg tablets (Boehringer Ingelheim Ltd) Antiplatelet Drugs 
Antiplatelet drugs 2628 Nu-seals aspirin ec 75mg Gastro-resistant tablet (Eli 
Lilly and Company Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 3832 Persantin Retard 200mg capsules (Boehringer 
Ingelheim Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 4679 Asasantin Retard capsules (Boehringer Ingelheim Ltd) Antiplatelet Drugs 
Antiplatelet drugs 5882 Dipyridamole 50mg/5ml oral suspension sugar free Antiplatelet Drugs 
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Antiplatelet drugs 6666 Dipyridamole 200mg modified-release / Aspirin 25mg 
capsules 
Antiplatelet Drugs 
Antiplatelet drugs 9301 Aspirin 100mg modified-release tablets Antiplatelet Drugs 
Antiplatelet drugs 10031 Aspirin 25mg with Dipyridamole 200mg modified-
release capsules 
Antiplatelet Drugs 
Antiplatelet drugs 17449 Ticlid 250mg tablets (Sanofi-Synthelabo Ltd) Antiplatelet Drugs 
Antiplatelet drugs 17704 Platet 100mg Effervescent tablet (Roche Products 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 17920 Disprin cv 100mg Modified-release tablet (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 19189 Micropirin 75mg Gastro-resistant tablet (Ratiopharm 
UK Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 21019 ReoPro 10mg/5ml solution for injection vials (Eli Lilly 
and Company Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 21989 Cerebrovase 100mg Tablet (Ashbourne 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 22138 Aspirin 324mg modified-release tablets Antiplatelet Drugs 
Antiplatelet drugs 22618 Solprin 75mg Tablet (Reckitt Benckiser Healthcare 
(UK) Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 23878 Nu-seals cardio ec 75mg Gastro-resistant tablet 
(Genus Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 25232 Vasyrol cold sore 100mg Tablet (Shire 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 25284 Cerebrovase 25mg Tablet (Ashbourne 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 30554 Abciximab 10mg/5ml solution for injection vials Antiplatelet Drugs 
Antiplatelet drugs 30975 Modaplate 25mg Tablet (Berk Pharmaceuticals Ltd) Antiplatelet Drugs 
Antiplatelet drugs 30976 Modaplate 100mg Tablet (Berk Pharmaceuticals Ltd) Antiplatelet Drugs 
Antiplatelet drugs 31192 Vasyrol cold sore 25mg Tablet (Shire 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 31211 Aspirin 75mg Dispersible tablet (A A H 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 31938 Aspirin 75mg gastro-resistant tablets (Sandoz Ltd) Antiplatelet Drugs 
Antiplatelet drugs 31953 Aspirin 75mg dispersible tablets (IVAX 
Pharmaceuticals UK Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 31954 Aspirin 75mg dispersible tablets (Teva UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 31956 Aspirin 75mg gastro-resistant tablets (Kent Antiplatelet Drugs 
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Pharmaceuticals Ltd) 
Antiplatelet drugs 32036 Aspirin 75mg dispersible tablets (Actavis UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 32992 Aspirin 75mg gastro-resistant tablets (Generics (UK) 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 33293 Aspirin 75mg gastro-resistant tablets (Sterwin 
Medicines) 
Antiplatelet Drugs 
Antiplatelet drugs 33320 Aspirin 75mg Dispersible tablet (Sovereign Medical 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 33656 Aspirin 75mg dispersible tablets (A A H 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 33676 Aspirin 75mg dispersible tablets (Kent 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 33877 Aggrastat 12.5mg/250ml infusion bags (Correvio 
GmbH) 
Antiplatelet Drugs 
Antiplatelet drugs 34385 Aspirin 75mg Soluble tablet (Co-operative) Antiplatelet Drugs 
Antiplatelet drugs 34434 Aspirin 75mg dispersible tablets (Thornton & Ross 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 34485 Aspirin 75mg gastro-resistant tablets (IVAX 
Pharmaceuticals UK Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 34611 Aspirin 75mg gastro-resistant tablets (C P 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 34709 Dipyridamole 100mg tablets (A A H Pharmaceuticals 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 34796 Aspirin 75mg Gastro-resistant tablet (Galen Ltd) Antiplatelet Drugs 
Antiplatelet drugs 34797 Aspirin 75mg gastro-resistant tablets (Actavis UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 34942 Aspirin 75mg Dispersible tablet (Nucare Plc) Antiplatelet Drugs 
Antiplatelet drugs 35108 Dipyridamole 100mg/5ml oral suspension Antiplatelet Drugs 
Antiplatelet drugs 35809 Tirofiban hydrochloride 12.5mg/250ml infusion bags Antiplatelet Drugs 
Antiplatelet drugs 36543 Aspirin 100mg effervescent tablets Antiplatelet Drugs 
Antiplatelet drugs 38349 Clopidogrel 300mg tablets Antiplatelet Drugs 
Antiplatelet drugs 38998 Plavix 300mg tablets (Sanofi) Antiplatelet Drugs 
Antiplatelet drugs 39738 Aspirin 162.5mg modified-release capsules Antiplatelet Drugs 
Antiplatelet drugs 39932 Prasugrel 10mg tablets Antiplatelet Drugs 
Antiplatelet drugs 40114 Prasugrel 5mg tablets Antiplatelet Drugs 
Antiplatelet drugs 40381 Aspirin 75mg Soluble tablet (C P Pharmaceuticals 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 40591 Efient 5mg tablets (Eli Lilly and Company Ltd) Antiplatelet Drugs 
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Antiplatelet drugs 40913 Grepid 75mg tablets (Beacon Pharmaceuticals Ltd) Antiplatelet Drugs 
Antiplatelet drugs 41229 Efient 10mg tablets (Eli Lilly and Company Ltd) Antiplatelet Drugs 
Antiplatelet drugs 41512 Aspirin 75mg gastro-resistant tablets (Teva UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 42750 Clopidogrel 75mg tablets (Actavis UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 43530 Dipyridamole 100mg tablets (Actavis UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 43679 Flamasacard 162.5mg Modified-release capsule 
(Abbey Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 43709 Aspirin 75mg gastro-resistant tablets (Almus 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 45576 Ticagrelor 90mg tablets Antiplatelet Drugs 
Antiplatelet drugs 45643 Aspirin 75mg Soluble tablet (Celltech Pharma Europe 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 45905 Clopidogrel 1mg/ml oral suspension Antiplatelet Drugs 
Antiplatelet drugs 46891 Clopidogrel 75mg/5ml oral suspension Antiplatelet Drugs 
Antiplatelet drugs 46976 Dipyridamole 100mg tablets (Kent Pharmaceuticals 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 47895 Brilique 90mg tablets (AstraZeneca UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 47992 Aspirin 75mg gastro-resistant tablets (A A H 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 48021 Aspirin 75mg Tablet (Hillcross Pharmaceuticals Ltd) Antiplatelet Drugs 
Antiplatelet drugs 48974 Aspirin 75mg tablets (Phoenix Healthcare Distribution 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 49060 Aspirin 75mg dispersible tablets (Alliance Healthcare 
(Distribution) Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 49685 Aspirin 75mg dispersible tablets (Sigma 
Pharmaceuticals Plc) 
Antiplatelet Drugs 
Antiplatelet drugs 50926 Aspirin 75mg dispersible tablets (The Boots Company 
Plc) 
Antiplatelet Drugs 
Antiplatelet drugs 50949 Aspirin 75mg tablets (A A H Pharmaceuticals Ltd) Antiplatelet Drugs 
Antiplatelet drugs 51358 Dipyridamole 100mg tablets (Generics (UK) Ltd) Antiplatelet Drugs 
Antiplatelet drugs 51561 Aspirin 75mg gastro-resistant tablets (Zanza 
Laboratories Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 52618 Aspirin 75mg dispersible tablets (Bristol Laboratories 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 52761 Clopidogrel 75mg tablets (Dr Reddy's Laboratories 
(UK) Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 53178 Aspirin 75mg gastro-resistant tablets (Wockhardt UK Antiplatelet Drugs 
  
 
2
8
8
 
Medication Product 
Code 
Product Name BNF Header 
Ltd) 
Antiplatelet drugs 53751 Clopidogrel 75mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 54284 Aspirin 75mg dispersible tablets (Almus 
Pharmaceuticals Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 54430 Aspirin 75mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 54565 Aspirin 75mg dispersible tablets (Lloyds Pharmacy 
Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 54700 Clopidogrel 75mg tablets (A A H Pharmaceuticals Ltd) Antiplatelet Drugs 
Antiplatelet drugs 54997 Aspirin 75mg dispersible tablets (Dowelhurst Ltd) Antiplatelet Drugs 
Antiplatelet drugs 55161 Clopidogrel 75mg tablets (Wockhardt UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 56503 Asasantin Retard capsules (Mawdsley-Brooks & 
Company Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 56807 Clopidogrel 75mg tablets (Teva UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 56883 Aspirin 75mg tablets (Waymade Healthcare Plc) Antiplatelet Drugs 
Antiplatelet drugs 56995 Aspirin 75mg dispersible tablets (Phoenix Healthcare 
Distribution Ltd) 
Antiplatelet Drugs 
Antiplatelet drugs 56996 Aspirin 75mg dispersible tablets (Waymade 
Healthcare Plc) 
Antiplatelet Drugs 
Antiplatelet drugs 57036 Clopidogrel 75mg tablets (Generics (UK) Ltd) Antiplatelet Drugs 
Antiplatelet drugs 57057 Aspirin 75mg dispersible tablets (Wockhardt UK Ltd) Antiplatelet Drugs 
Antiplatelet drugs 10310 Aspirin powder Antiplatelet Drugs/Extemporaneous Item/Non-
opioid Analgesics 
Antiplatelet drugs 254 Aspirin 300mg tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 377 Aspirin 300mg dispersible tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 434 Aspirin 300mg gastro-resistant tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 645 Aspirin 300mg suppositories Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 1049 Nu-seals aspirin 600mg Tablet (Eli Lilly and Company 
Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 1137 Nu-seals aspirin ec 300mg Gastro-resistant tablet (Eli 
Lilly and Company Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 6006 Nu-Seals 75 gastro-resistant tablets (Alliance 
Pharmaceuticals Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 6696 Micropirin 75mg gastro-resistant tablets (Dexcel-
Pharma Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 8186 Aspirin 300mg modified-release tablets Antiplatelet Drugs/Non-opioid Analgesics 
  
 
2
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Medication Product 
Code 
Product Name BNF Header 
Antiplatelet drugs 8645 Aspirin 300mg effervescent tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 9144 Caprin 75mg gastro-resistant tablets (Wockhardt UK 
Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 9939 Aspirin 500mg effervescent tablets sugar free Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 10305 Aspirin 162.5mg capsules Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 21921 Postmi ec 300mg Gastro-resistant tablet (Ashbourne 
Pharmaceuticals Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 23488 Claradin 300mg Tablet (Nicholas Laboratories Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 28810 Aspirin 300mg with Glycine 133mg soluble tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 29759 Aspro Tablet (Roche Consumer Health) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 30920 Aspirin 300mg Dispersible tablet (M & A Pharmachem 
Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 31870 Aspirin 320mg tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 32210 Aspirin 300mg dispersible tablets (Actavis UK Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 34309 Aspirin 300mg dispersible tablets (A A H 
Pharmaceuticals Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 34386 Aspirin 300mg tablets (Actavis UK Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 34666 Aspirin ec 300mg Gastro-resistant tablet (A A H 
Pharmaceuticals Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 36521 Aspirin 500mg modified-release tablets Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 37541 Aspirin 227mg medicated chewing-gum Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 45851 Aspirin 300mg Soluble tablet (Ranbaxy (UK) Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 48000 Aspirin 300mg tablets (Sigma Pharmaceuticals Plc) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 48165 Aspirin 300mg tablets (Aspar Pharmaceuticals Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 49220 Aspirin 300mg tablets (Kent Pharmaceuticals Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 49799 Aspirin 150mg suppositories (A A H Pharmaceuticals 
Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 50555 Aspirin 300mg dispersible tablets (Doncaster 
Pharmaceuticals Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 52044 Aspirin 300mg caplets (The Boots Company Plc) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 52280 Aspirin 300mg Tablet (Wockhardt UK Ltd) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 53804 Aspirin 300mg gastro-resistant tablets (Alliance 
Healthcare (Distribution) Ltd) 
Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 56736 Aspirin 300mg tablets (Waymade Healthcare Plc) Antiplatelet Drugs/Non-opioid Analgesics 
Antiplatelet drugs 393 Disprin 300mg dispersible tablets (Reckitt Benckiser 
Healthcare (UK) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
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Medication Product 
Code 
Product Name BNF Header 
Antiplatelet drugs 657 Aspirin 500mg granules sachets sugar free Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 1902 Aspirn 600mg gastro-resistant tablets Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 2105 Solprin 300mg Tablet (Reckitt Benckiser Healthcare 
(UK) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 2607 Paynocil Tablet (Beecham Research Laboratories) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 6007 Nu-Seals 300 gastro-resistant tablets (Alliance 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 7516 Aspirin 300mg effervescent tablets sugar free Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 8185 Disprin CV 300mg modified-release tablets (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 11977 Aspro clear maximum strength tablets Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 15364 Aspirin 150mg suppositories Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 18217 Aspirin 300mg orodispersible tablets sugar free Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 18329 Enprin 75mg gastro-resistant tablets (Galpharm 
International Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 22232 Disprin Direct 300mg orodispersible tablets (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 23593 PostMI 75 dispersible tablets (Ashbourne 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 23932 Aspro Clear 300mg effervescent tablets (Bayer Plc) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 24025 Caprin 300mg gastro-resistant tablets (Pinewood 
Healthcare) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 24960 Aspirin 300mg tablets (Vantage) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 25335 PostMI 75 EC tablets (Ashbourne Pharmaceuticals 
Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 25718 Angettes 75 tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 29848 Aspirin 300mg with Glycine 150mg chewable tablets Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 31210 Aspirin 300mg Tablet (Co-operative) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 31858 Caspac xl 162.5mg Capsule (Pharmacia Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 33662 Aspirin 300mg Dispersible tablet (A A H 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 33668 Aspirin 300mg Dispersible tablet (Rusco Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 34762 Aspirin 300mg Gastro-resistant tablet (Galen Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 40144 Aspirin 300mg Dispersible tablet (Thornton & Ross 
Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 41569 Aspirin 300mg tablets (A A H Pharmaceuticals Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
  
 
2
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Medication Product 
Code 
Product Name BNF Header 
Antiplatelet drugs 41594 Aspirin 300mg Dispersible tablet (Teva UK Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 41766 Maximum Strength Aspro Clear 500mg effervescent 
tablets (Bayer Plc) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 43060 Aspirin 300mg Soluble tablet (Celltech Pharma 
Europe Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 43434 Aspirin 300mg gastro-resistant tablets (A A H 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 43806 Aspirin 300mg gastro-resistant tablets (Sandoz Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 44639 Aspirin 300mg Dispersible tablet (Nucare Plc) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 45840 Aspirin 300mg Dispersible tablet (Numark 
Management Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 51474 Aspirin 150mg suppositories (Martindale 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 52905 Aspirin 300mg tablets (Lloyds Pharmacy Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 53622 Aspirin 300mg Tablet (M & A Pharmachem Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 53711 Aspirin 300mg Tablet (Nucare Plc) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 53791 Aspirin 150mg suppositories (Alliance Healthcare 
(Distribution) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 53816 Aspirin 300mg dispersible tablets (Alliance Healthcare 
(Distribution) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 54526 Aspirin 300mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 54734 Aspirin 300mg tablets (Wockhardt UK Ltd) Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 55230 Aspirin 300mg dispersible tablets (Kent 
Pharmaceuticals Ltd) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antiplatelet drugs 56007 Aspirin 300mg dispersible tablets (Sigma 
Pharmaceuticals Plc) 
Non-opioid Analgesics/Antiplatelet Drugs 
Antipsychotics 228 Fentazin 5mg/ml Injection (Goldshield 
Pharmaceuticals Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 500 Buccastem 3mg Tablet (Reckitt Benckiser Healthcare 
(UK) Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 512 Stemetil 5mg Tablet (Castlemead Healthcare Ltd) -/Antipsychotic Drugs 
Antipsychotics 2620 Haloperidol 1mg/ml Oral solution -/Antipsychotic Drugs 
Antipsychotics 3772 Largactil 50mg Tablet (Hawgreen Ltd) -/Antipsychotic Drugs 
Antipsychotics 6523 Haldol 5mg/ml Injection (Janssen-Cilag Ltd) -/Antipsychotic Drugs 
Antipsychotics 7593 Stemetil 5mg/5ml Oral solution (Castlemead 
Healthcare Ltd) 
-/Antipsychotic Drugs 
  
 
2
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Medication Product 
Code 
Product Name BNF Header 
Antipsychotics 8506 Chlorpromazine 100mg suppository -/Antipsychotic Drugs 
Antipsychotics 8771 Largactil 10mg Tablet (Hawgreen Ltd) -/Antipsychotic Drugs 
Antipsychotics 9975 Haloperidol 1mg/ml sugar free Oral solution -/Antipsychotic Drugs 
Antipsychotics 10435 Haloperidol 10mg/ml Oral solution -/Antipsychotic Drugs 
Antipsychotics 15438 Prochlorperazine maleate 15mg modified release 
capsul 
-/Antipsychotic Drugs 
Antipsychotics 17087 Perphenazine 5mg/ml injection -/Antipsychotic Drugs 
Antipsychotics 18289 Stelazine 10mg/ml Concentrate (Goldshield 
Pharmaceuticals Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 18668 Trifluoperazine 10mg/ml concentrate -/Antipsychotic Drugs 
Antipsychotics 24494 Haldol 10mg/ml Liquid (Janssen-Cilag Ltd) -/Antipsychotic Drugs 
Antipsychotics 28679 Dozic 2mg/ml Oral solution (Rosemont 
Pharmaceuticals Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 28862 Chloractil 100mg Tablet (DDSA Pharmaceuticals Ltd) -/Antipsychotic Drugs 
Antipsychotics 32051 Haloperidol 5mg Tablet (Generics (UK) Ltd) -/Antipsychotic Drugs 
Antipsychotics 34039 Haloperidol 1mg/ml Liquid (Rosemont 
Pharmaceuticals Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 37871 Chlorpromazine 25mg/5ml Oral solution (Rosemont 
Pharmaceuticals Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 41546 Haloperidol 1mg/ml Liquid (Hillcross Pharmaceuticals 
Ltd) 
-/Antipsychotic Drugs 
Antipsychotics 41645 Chlorpromazine 25mg/ml Injection (Antigen 
Pharmaceuticals) 
-/Antipsychotic Drugs 
Antipsychotics 43020 Haloperidol Oral solution -/Antipsychotic Drugs 
Antipsychotics 1733 Flupentixol decanoate 20mg/ml Injection Antipsychotic Depot Injections 
Antipsychotics 2136 Depixol 20mg/ml Injection (Lundbeck Ltd) Antipsychotic Depot Injections 
Antipsychotics 2155 Depixol -conc 100mg/ml Injection (Lundbeck Ltd) Antipsychotic Depot Injections 
Antipsychotics 2156 Depixol 40mg/2ml solution for injection ampoules 
(Lundbeck Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 2276 Flupentixol 40mg/2ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 3926 Modecate 25mg/ml Injection (Sanofi-Synthelabo Ltd) Antipsychotic Depot Injections 
Antipsychotics 8044 Redeptin 2mg/ml Injection (Janssen-Cilag Ltd) Antipsychotic Depot Injections 
Antipsychotics 8712 Flupentixol decanoate 100mg/ml Injection Antipsychotic Depot Injections 
Antipsychotics 9022 Fluphenazine decanoate 25mg/ml Injection Antipsychotic Depot Injections 
Antipsychotics 10514 Fluphenazine decanoate 100mg/ml Injection Antipsychotic Depot Injections 
Antipsychotics 10827 Fluspirilene 2mg/ml Injection Antipsychotic Depot Injections 
  
 
2
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Medication Product 
Code 
Product Name BNF Header 
Antipsychotics 10944 Pipotiazine palmitate 50mg/ml depot injection Antipsychotic Depot Injections 
Antipsychotics 12128 Modecate concentrate 100mg/ml Injection (Sanofi-
Synthelabo Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 12340 Piportil 50mg/ml Depot injection (JHC Healthcare Ltd) Antipsychotic Depot Injections 
Antipsychotics 14130 Depixol Low Volume 200mg/1ml solution for injection 
ampoules (Lundbeck Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 14839 Flupentixol 200mg/1ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 14889 Depixol Conc 100mg/1ml solution for injection 
ampoules (Lundbeck Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 14966 Flupentixol 20mg/1ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 17190 Fluphenazine enanthate 25mg/ml Injection Antipsychotic Depot Injections 
Antipsychotics 18155 Flupentixol 50mg/0.5ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 18175 Flupentixol 100mg/1ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 18197 Depixol Conc 50mg/0.5ml solution for injection 
ampoules (Lundbeck Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 19283 Depixol 20mg/1ml solution for injection ampoules 
(Lundbeck Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 25835 Moditen enanthate 25mg/ml Injection (Sanofi-
Synthelabo Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 33780 Modecate 25mg/1ml solution for injection ampoules 
(Sanofi) 
Antipsychotic Depot Injections 
Antipsychotics 35065 Fluphenazine decanoate 25mg/1ml solution for 
injection ampoules 
Antipsychotic Depot Injections 
Antipsychotics 35122 Modecate 12.5mg/0.5ml solution for injection 
ampoules (Sanofi) 
Antipsychotic Depot Injections 
Antipsychotics 35176 Fluphenazine decanoate 100mg/1ml solution for 
injection ampoules 
Antipsychotic Depot Injections 
Antipsychotics 35235 Piportil Depot 50mg/1ml solution for injection 
ampoules (Sanofi) 
Antipsychotic Depot Injections 
Antipsychotics 35391 Fluphenazine decanoate 50mg/0.5ml solution for 
injection ampoules 
Antipsychotic Depot Injections 
Antipsychotics 35445 Modecate 50mg/2ml solution for injection ampoules 
(Sanofi) 
Antipsychotic Depot Injections 
Antipsychotics 35455 Modecate Concentrate 100mg/1ml solution for 
injection ampoules (Sanofi) 
Antipsychotic Depot Injections 
Antipsychotics 35487 Modecate Concentrate 50mg/0.5ml solution for 
injection ampoules (Sanofi) 
Antipsychotic Depot Injections 
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Medication Product 
Code 
Product Name BNF Header 
Antipsychotics 35488 Piportil Depot 100mg/2ml solution for injection 
ampoules (Sanofi) 
Antipsychotic Depot Injections 
Antipsychotics 35530 Fluphenazine decanoate 12.5mg/0.5ml solution for 
injection ampoules 
Antipsychotic Depot Injections 
Antipsychotics 35684 Pipotiazine 50mg/1ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 35723 Fluphenazine decanoate 50mg/2ml solution for 
injection ampoules 
Antipsychotic Depot Injections 
Antipsychotics 36394 Pipotiazine 100mg/2ml solution for injection ampoules Antipsychotic Depot Injections 
Antipsychotics 41970 Fluphenazine decanoate 25mg/1ml solution for 
injection ampoules (Hospira UK Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 41971 Fluphenazine decanoate 25mg/ml Injection (Antigen 
Pharmaceuticals) 
Antipsychotic Depot Injections 
Antipsychotics 46224 Paliperidone 50mg/0.5ml suspension for injection pre-
filled syringes 
Antipsychotic Depot Injections 
Antipsychotics 46351 Paliperidone 150mg/1.5ml suspension for injection 
pre-filled syringes 
Antipsychotic Depot Injections 
Antipsychotics 46434 Xeplion 100mg/1ml suspension for injection pre-filled 
syringes (Janssen-Cilag Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 46435 Xeplion 150mg/1.5ml suspension for injection pre-
filled syringes (Janssen-Cilag Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 46436 Xeplion 75mg/0.75ml suspension for injection pre-
filled syringes (Janssen-Cilag Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 46447 Paliperidone 100mg/1ml suspension for injection pre-
filled syringes 
Antipsychotic Depot Injections 
Antipsychotics 46556 Paliperidone 75mg/0.75ml suspension for injection 
pre-filled syringes 
Antipsychotic Depot Injections 
Antipsychotics 47162 Xeplion 50mg/0.5ml suspension for injection pre-filled 
syringes (Janssen-Cilag Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 57170 Psytixol 100mg/1ml solution for injection ampoules 
(Generics (UK) Ltd) 
Antipsychotic Depot Injections 
Antipsychotics 46422 Olanzapine embonate 300mg powder and solvent for 
suspension for injection vials 
Antipsychotic Depot Injections/Antipsychotic 
Drugs 
Antipsychotics 55268 Zypadhera 300mg powder and solvent for suspension 
for injection vials (Eli Lilly and Company Ltd) 
Antipsychotic Depot Injections/Antipsychotic 
Drugs 
Antipsychotics 302 Risperidone 1mg/ml oral solution sugar free Antipsychotic Drugs 
Antipsychotics 329 Haloperidol 1.5mg tablets Antipsychotic Drugs 
Antipsychotics 475 Haloperidol 10mg tablets Antipsychotic Drugs 
Antipsychotics 588 Chlorpromazine 25mg tablets Antipsychotic Drugs 
  
 
2
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Medication Product 
Code 
Product Name BNF Header 
Antipsychotics 609 Perphenazine 2mg tablets Antipsychotic Drugs 
Antipsychotics 631 Risperdal 500microgram tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 667 Risperidone 500microgram tablets Antipsychotic Drugs 
Antipsychotics 840 Fentazin 2mg tablets (Mercury Pharma Group Ltd) Antipsychotic Drugs 
Antipsychotics 1192 Thioridazine 10mg tablets Antipsychotic Drugs 
Antipsychotics 1218 Thioridazine 25mg tablets Antipsychotic Drugs 
Antipsychotics 1314 Thioridazine 50mg tablets Antipsychotic Drugs 
Antipsychotics 1319 Clopixol 10mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 1320 Risperidone 1mg tablets Antipsychotic Drugs 
Antipsychotics 1321 Risperidone 2mg tablets Antipsychotic Drugs 
Antipsychotics 2094 Haldol decanoate 50mg/1ml solution for injection 
ampoules (Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 2135 Sulpiride 200mg tablets Antipsychotic Drugs 
Antipsychotics 2154 Chlorpromazine 100mg tablets Antipsychotic Drugs 
Antipsychotics 2157 Perphenazine 4mg tablets Antipsychotic Drugs 
Antipsychotics 2419 Haloperidol 500microgram capsules Antipsychotic Drugs 
Antipsychotics 2621 Haloperidol 5mg tablets Antipsychotic Drugs 
Antipsychotics 2786 Risperidone 6mg tablets Antipsychotic Drugs 
Antipsychotics 2787 Risperidone 4mg tablets Antipsychotic Drugs 
Antipsychotics 2801 Thioridazine 10mg/5ml Oral solution Antipsychotic Drugs 
Antipsychotics 2972 Promazine 25mg tablets Antipsychotic Drugs 
Antipsychotics 3021 Thioridazine 100mg tablets Antipsychotic Drugs 
Antipsychotics 3197 Promazine 100mg tablet Antipsychotic Drugs 
Antipsychotics 3226 Sparine 50mg Tablet (Wyeth Pharmaceuticals) Antipsychotic Drugs 
Antipsychotics 3227 Sparine 50mg/5ml Liquid (Wyeth Pharmaceuticals) Antipsychotic Drugs 
Antipsychotics 3228 Promazine 50mg tablets Antipsychotic Drugs 
Antipsychotics 3348 Chlorpromazine 50mg tablets Antipsychotic Drugs 
Antipsychotics 3605 Thioridazine 25mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 3952 Chlorpromazine 25mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 4232 Nozinan 25mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 4434 Chlorpromazine 50mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 4442 Nozinan 25mg/1ml solution for injection ampoules 
(Sanofi) 
Antipsychotic Drugs 
Antipsychotics 4820 Risperdal 1mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 5014 Levomepromazine 25mg tablets Antipsychotic Drugs 
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Medication Product 
Code 
Product Name BNF Header 
Antipsychotics 5039 Quetiapine 100mg tablets Antipsychotic Drugs 
Antipsychotics 5040 Quetiapine 150mg tablets Antipsychotic Drugs 
Antipsychotics 5212 Fluphenazine 1mg tablets Antipsychotic Drugs 
Antipsychotics 5219 Risperidone 3mg tablets Antipsychotic Drugs 
Antipsychotics 5262 Risperdal 1mg/ml liquid (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 5283 Quetiapine 25mg tablets Antipsychotic Drugs 
Antipsychotics 5545 Serenace 500microgram capsules (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 5597 Moditen 1mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 5707 Flupentixol 3mg tablets Antipsychotic Drugs 
Antipsychotics 5712 Depixol 3mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 5762 Clopixol acuphase 50mg/ml Oily injection (Lundbeck 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 5821 Pimozide 4mg tablets Antipsychotic Drugs 
Antipsychotics 6023 Olanzapine 10mg Orodispersible tablet Antipsychotic Drugs 
Antipsychotics 6064 Levomepromazine 25mg/1ml solution for injection 
ampoules 
Antipsychotic Drugs 
Antipsychotics 6134 Dozic 5mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 6373 Risperidone 1mg orodispersible tablets sugar free Antipsychotic Drugs 
Antipsychotics 6412 Olanzapine 5mg Orodispersible tablet Antipsychotic Drugs 
Antipsychotics 6443 Promazine 25mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 6561 Aripiprazole 10mg tablets Antipsychotic Drugs 
Antipsychotics 6573 Aripiprazole 15mg tablets Antipsychotic Drugs 
Antipsychotics 6838 Olanzapine 15mg Orodispersible tablet Antipsychotic Drugs 
Antipsychotics 6864 Seroquel 200mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 7039 Quetiapine 300mg tablets Antipsychotic Drugs 
Antipsychotics 7382 Risperidone 500microgram orodispersible tablets 
sugar free 
Antipsychotic Drugs 
Antipsychotics 7390 Levomepromazine 6mg tablets Antipsychotic Drugs 
Antipsychotics 7436 Serenace 5mg/1ml solution for injection ampoules 
(IVAX Pharmaceuticals UK Ltd) 
Antipsychotic Drugs 
Antipsychotics 7514 Largactil 50mg/2ml solution for injection ampoules 
(Sanofi) 
Antipsychotic Drugs 
Antipsychotics 7833 Neulactil 2.5mg Tablet (JHC Healthcare Ltd) Antipsychotic Drugs 
Antipsychotics 7834 Pericyazine 2.5mg tablets Antipsychotic Drugs 
Antipsychotics 7919 Fentazin 4mg tablets (Mercury Pharma Group Ltd) Antipsychotic Drugs 
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Antipsychotics 8031 Neulactil 10mg Tablet (JHC Healthcare Ltd) Antipsychotic Drugs 
Antipsychotics 8032 Pericyazine 10mg tablets Antipsychotic Drugs 
Antipsychotics 8046 Clozapine 25mg tablets Antipsychotic Drugs 
Antipsychotics 8047 Clozapine 100mg tablets Antipsychotic Drugs 
Antipsychotics 8153 Serenace 2mg/ml liquid (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 8519 Chlorpromazine 100mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 8637 Pimozide 10mg tablet Antipsychotic Drugs 
Antipsychotics 8881 Remoxipride 150mg capsule Antipsychotic Drugs 
Antipsychotics 8903 Sulpiride 200mg/5ml oral solution sugar free Antipsychotic Drugs 
Antipsychotics 8921 Integrin 10mg Capsule (Sanofi-Synthelabo Ltd) Antipsychotic Drugs 
Antipsychotics 8979 Serenace 1.5mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 9190 Chlorpromazine 25mg/5ml oral solution sugar free Antipsychotic Drugs 
Antipsychotics 9247 Sulpiride 400mg tablets Antipsychotic Drugs 
Antipsychotics 9340 Risperdal 3mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 9347 Clopixol 25mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 9475 Risperdal 4mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 9515 Zoleptil 50 tablets (Movianto UK Ltd) Antipsychotic Drugs 
Antipsychotics 9659 Risperdal 2mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 9686 Zuclopenthixol 10mg tablets Antipsychotic Drugs 
Antipsychotics 9794 Quetiapine 200mg tablets Antipsychotic Drugs 
Antipsychotics 10107 Quetiapine Starter Pack Antipsychotic Drugs 
Antipsychotics 10405 Thioridazine 25mg/5ml sugar free Oral solution Antipsychotic Drugs 
Antipsychotics 10565 Haloperidol decanoate 50mg/1ml solution for injection 
ampoules 
Antipsychotic Drugs 
Antipsychotics 10666 Dolmatil 200mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 10780 Promazine 50mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 11799 Risperdal 6mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 11821 Risperdal Quicklet 500microgram orodispersible 
tablets (Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 11828 Risperidone 2mg orodispersible tablets sugar free Antipsychotic Drugs 
Antipsychotics 12073 Clopixol Conc 500mg/1ml solution for injection 
ampoules (Lundbeck Ltd) 
Antipsychotic Drugs 
Antipsychotics 12193 Sparine 25mg Tablet (Wyeth Pharmaceuticals) Antipsychotic Drugs 
Antipsychotics 12195 Pericyazine 10mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 12224 Zuclopenthixol decanoate 500mg/1ml solution for Antipsychotic Drugs 
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injection ampoules 
Antipsychotics 12386 Haldol decanoate 100mg/1ml solution for injection 
ampoules (Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 12387 Haloperidol 20mg tablets Antipsychotic Drugs 
Antipsychotics 12445 Remoxipride 300mg capsule Antipsychotic Drugs 
Antipsychotics 12666 Sertindole 4mg tablets Antipsychotic Drugs 
Antipsychotics 12707 Zuclopenthixol 2mg tablets Antipsychotic Drugs 
Antipsychotics 12921 Haldol 2mg/ml oral solution (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 13311 Sparine 50mg/ml Injection (Wyeth Pharmaceuticals) Antipsychotic Drugs 
Antipsychotics 13338 Serenace 5mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 13368 Clopixol 2mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 13483 Serenace 20mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 13484 Serenace 10mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 13600 Zuclopenthixol 25mg tablets Antipsychotic Drugs 
Antipsychotics 13902 Neulactil Forte syrup (Sanofi) Antipsychotic Drugs 
Antipsychotics 14112 Clozaril 100mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 14344 Aripiprazole 5mg tablets Antipsychotic Drugs 
Antipsychotics 14576 Zuclopenthixol acetate 50mg/ml oily injection Antipsychotic Drugs 
Antipsychotics 14610 Promazine 50mg/5ml oral solution sugar free Antipsychotic Drugs 
Antipsychotics 14767 Risperdal Consta 50mg powder and solvent for 
suspension for injection vials (Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 14789 Risperdal Consta 37.5mg powder and solvent for 
suspension for injection vials (Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 14813 Seroquel 150mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 14858 Abilify 15mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 14859 Seroquel 25mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 15047 Orap 4mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 15161 Promazine 50mg/ml injection Antipsychotic Drugs 
Antipsychotics 15395 Promazine 12.5mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 15472 Pericyazine 25mg tablet Antipsychotic Drugs 
Antipsychotics 15598 Thioridazine 100mg/5ml sugar free Oral solution Antipsychotic Drugs 
Antipsychotics 15814 Haloperidol decanoate 100mg/1ml solution for 
injection ampoules 
Antipsychotic Drugs 
Antipsychotics 16006 Risperdal Quicklet 2mg orodispersible tablets Antipsychotic Drugs 
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(Janssen-Cilag Ltd) 
Antipsychotics 16103 Olanzapine 20mg Orodispersible tablet Antipsychotic Drugs 
Antipsychotics 16223 Roxiam 300mg Capsule (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 16425 Risperidone 37.5mg powder and solvent for 
suspension for injection vials 
Antipsychotic Drugs 
Antipsychotics 16434 Risperidone 25mg powder and solvent for suspension 
for injection vials 
Antipsychotic Drugs 
Antipsychotics 16489 Risperidone 50mg powder and solvent for suspension 
for injection vials 
Antipsychotic Drugs 
Antipsychotics 16561 Aripiprazole 30mg tablets Antipsychotic Drugs 
Antipsychotics 16575 Aripiprazole 1mg/ml oral solution Antipsychotic Drugs 
Antipsychotics 16768 Solian 50 tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 16908 Risperdal Consta 25mg powder and solvent for 
suspension for injection vials (Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 16986 Risperdal Quicklet 1mg orodispersible tablets 
(Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 16998 Sertindole 12mg tablets Antipsychotic Drugs 
Antipsychotics 17050 Sertindole 20mg tablets Antipsychotic Drugs 
Antipsychotics 17399 Thioridazine 50mg/5ml Oral solution Antipsychotic Drugs 
Antipsychotics 17504 Zotepine 25mg tablets Antipsychotic Drugs 
Antipsychotics 17634 Promazine 50mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 17958 Clozaril 25mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 18013 Seroquel 100mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 18132 Abilify 5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 18181 Sulpor 200mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 18352 Sulpitil 200mg tablets (Pfizer Ltd) Antipsychotic Drugs 
Antipsychotics 19016 Roxiam 150mg Capsule (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 19900 Sertindole 16mg tablets Antipsychotic Drugs 
Antipsychotics 21027 Triperidol 1mg Tablet (Lagap) Antipsychotic Drugs 
Antipsychotics 21047 Triperidol 0.5mg Tablet (Lagap) Antipsychotic Drugs 
Antipsychotics 21064 Neulactil 25mg Tablet (JHC Healthcare Ltd) Antipsychotic Drugs 
Antipsychotics 21199 Denzapine 100mg tablets (Genus Pharmaceuticals 
Ltd) 
Antipsychotic Drugs 
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Antipsychotics 21339 Veractil 25mg Tablet (Rhone-Poulenc Rorer Ltd) Antipsychotic Drugs 
Antipsychotics 21709 Seroquel 300mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 21744 Anquil 250microgram Tablet (Concord 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 22049 Clopixol 200mg/1ml solution for injection ampoules 
(Lundbeck Ltd) 
Antipsychotic Drugs 
Antipsychotics 22606 Chlorpromazine 25mg/1ml solution for injection 
ampoules 
Antipsychotic Drugs 
Antipsychotics 22660 Haldol 5mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 22814 Trifluperidol 1mg Tablet Antipsychotic Drugs 
Antipsychotics 23034 Remoxipride 75mg capsule Antipsychotic Drugs 
Antipsychotics 23162 Serdolect 16mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 23659 Trifluperidol 0.5mg Tablet Antipsychotic Drugs 
Antipsychotics 23678 Haldol 10mg tablets (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 24069 Dolmatil 400mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 24270 Zuclopenthixol acetate 50mg/1ml solution for injection 
ampoules 
Antipsychotic Drugs 
Antipsychotics 24358 Abilify 10mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 25336 Zotepine 50mg tablets Antipsychotic Drugs 
Antipsychotics 25966 Serdolect 4mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 27148 Orap 10mg Tablet (Janssen-Cilag Ltd) Antipsychotic Drugs 
Antipsychotics 27211 Integrin 40mg Tablet (Sanofi-Synthelabo Ltd) Antipsychotic Drugs 
Antipsychotics 28147 Taractan 15mg Tablet (Roche Products Ltd) Antipsychotic Drugs 
Antipsychotics 28231 Levinan 6mg Tablet (Link Pharmaceuticals Ltd) Antipsychotic Drugs 
Antipsychotics 28355 Zuclopenthixol decanoate 200mg/1ml solution for 
injection ampoules 
Antipsychotic Drugs 
Antipsychotics 28759 Zotepine 100mg tablets Antipsychotic Drugs 
Antipsychotics 29879 Abilify 30mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 30088 Zoleptil 25 tablets (Movianto UK Ltd) Antipsychotic Drugs 
Antipsychotics 30111 Chlorprothixene 50mg tablets Antipsychotic Drugs 
Antipsychotics 30487 Denzapine 25mg tablets (Genus Pharmaceuticals Ltd) Antipsychotic Drugs 
Antipsychotics 31063 Serdolect 12mg tablets (Lundbeck Ltd) Antipsychotic Drugs 
Antipsychotics 31098 Aripiprazole 15mg orodispersible tablets sugar free Antipsychotic Drugs 
Antipsychotics 31171 Chlorpromazine 50mg tablets (A A H Pharmaceuticals Antipsychotic Drugs 
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Antipsychotics 31172 Chlorpromazine 50mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 31175 Chlorpromazine 25mg tablets (A A H Pharmaceuticals 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 31184 Chlorpromazine 25mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Antipsychotic Drugs 
Antipsychotics 31537 Zuclopenthixol acetate 100mg/2ml solution for 
injection ampoules 
Antipsychotic Drugs 
Antipsychotics 31538 Clopixol Acuphase 100mg/2ml solution for injection 
ampoules (Lundbeck Ltd) 
Antipsychotic Drugs 
Antipsychotics 31576 Solian 100mg/ml oral solution (Sanofi) Antipsychotic Drugs 
Antipsychotics 31796 Benquil 250microgram tablets (Concord 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 32076 Aripiprazole 10mg orodispersible tablets sugar free Antipsychotic Drugs 
Antipsychotics 32838 Haloperidol 1.5mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 33493 Sparine 100mg Tablet (Wyeth Pharmaceuticals) Antipsychotic Drugs 
Antipsychotics 34339 Haloperidol 1.5mg tablets (A A H Pharmaceuticals 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 34630 Chlorpromazine 50mg tablets (Genus 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 34668 Chlorpromazine 25mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 34693 Chlorpromazine 25mg tablets (Genus 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 34736 Chlorpromazine 100mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 34810 Sulpiride 200mg tablets (Wockhardt UK Ltd) Antipsychotic Drugs 
Antipsychotics 34903 Haloperidol 5mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 34905 Thioridazine 25mg Tablet (IVAX Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 35141 Risperidone 3mg orodispersible tablets sugar free Antipsychotic Drugs 
Antipsychotics 35548 Risperdal Quicklet 3mg orodispersible tablets 
(Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 35589 Risperidone 4mg orodispersible tablets sugar free Antipsychotic Drugs 
Antipsychotics 35787 Thioridazine 50mg Tablet (IVAX Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 35929 Chlorpromazine 50mg/2ml solution for injection Antipsychotic Drugs 
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ampoules 
Antipsychotics 35953 Risperdal Quicklet 4mg orodispersible tablets 
(Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 36101 Clopixol Acuphase 50mg/1ml solution for injection 
ampoules (Lundbeck Ltd) 
Antipsychotic Drugs 
Antipsychotics 36116 Paliperidone 6mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 36771 Haloperidol 250micrograms/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 36954 Invega 6mg modified-release tablets (Janssen-Cilag 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 37501 Paliperidone 9mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 37606 Abilify 10mg orodispersible tablets (Bristol-Myers 
Squibb Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 37717 Paliperidone 3mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 38010 Abilify 15mg orodispersible tablets (Bristol-Myers 
Squibb Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 38080 Abilify 1mg/ml oral solution (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 38089 Promazine 50mg/5ml syrup (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 38262 Haloperidol 5mg/1ml solution for injection ampoules Antipsychotic Drugs 
Antipsychotics 38375 Aripiprazole 9.75mg/1.3ml solution for injection vials Antipsychotic Drugs 
Antipsychotics 38540 Haldol 5mg/1ml solution for injection ampoules 
(Janssen-Cilag Ltd) 
Antipsychotic Drugs 
Antipsychotics 38840 Quetiapine 400mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 38885 Quetiapine 50mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 38906 Quetiapine 300mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 38912 Quetiapine 200mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 38913 Seroquel XL 50mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 38914 Seroquel XL 200mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 38937 Seroquel XL 300mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 39237 Seroquel XL 400mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 39830 Neulactil 2.5mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 40390 Promazine 25mg/5ml syrup (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 40586 Clozapine 50mg tablets Antipsychotic Drugs 
Antipsychotics 40587 Clozapine 200mg tablets Antipsychotic Drugs 
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Antipsychotics 40779 Quetiapine 100mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 40782 Levomepromazine 6mg Tablet Antipsychotic Drugs 
Antipsychotics 40881 Neulactil 10mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 40932 Quetiapine 100mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 41070 Denzapine 50mg tablets (Genus Pharmaceuticals Ltd) Antipsychotic Drugs 
Antipsychotics 41428 Denzapine 200mg tablets (Genus Pharmaceuticals 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 41675 Sulpiride 200mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 41732 Promazine 50mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 41995 Promazine 50mg/ml Injection (Genus 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 42242 Clozapine 50mg/ml oral suspension sugar free Antipsychotic Drugs 
Antipsychotics 42816 Thioridazine 50mg/5ml Oral solution (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 42895 Haloperidol 5mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 43423 Sulpiride 200mg tablets (A A H Pharmaceuticals Ltd) Antipsychotic Drugs 
Antipsychotics 43520 Haloperidol 1.5mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 43522 Sulpiride 200mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 43654 Promazine 50mg/ml injection Antipsychotic Drugs 
Antipsychotics 44024 Quetiapine 150mg modified-release tablets Antipsychotic Drugs 
Antipsychotics 44186 Chlorpromazine 25mg/5ml oral solution (A A H 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 44326 Seroquel XL 150mg tablets (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 45281 Chlorpromazine 100mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 45444 Denzapine 50mg/ml oral suspension (Genus 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 45810 Haloperidol 10mg/5ml oral solution sugar free Antipsychotic Drugs 
Antipsychotics 45839 Quetiapine 25mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 45860 Thioridazine 100mg Tablet (IVAX Pharmaceuticals UK 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 45880 Haloperidol 5mg/5ml oral solution sugar free Antipsychotic Drugs 
Antipsychotics 46677 Risperidone 500microgram tablets (Actavis UK Ltd) Antipsychotic Drugs 
Antipsychotics 46705 Abilify 9.75mg/1.3ml solution for injection vials 
(Bristol-Myers Squibb Pharmaceuticals Ltd) 
Antipsychotic Drugs 
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Antipsychotics 46764 Quetiapine 12.5mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 46871 Quetiapine 12.5mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 46945 Promazine 25mg Tablet (Biorex Laboratories Ltd) Antipsychotic Drugs 
Antipsychotics 46960 Chlorpromazine 100mg tablets (IVAX 
Pharmaceuticals UK Ltd) 
Antipsychotic Drugs 
Antipsychotics 47013 Haloperidol 1mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 47149 Haloperidol 1mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 47233 Zaponex 25mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 47302 Zaponex 100mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 47361 Thioridazine 10mg/5ml Oral solution (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 47808 Haloperidol 10mg/5ml oral solution sugar free (A A H 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 47832 Risperidone 500microgram tablets (A A H 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 48077 Roxiam ir 75mg Capsule (AstraZeneca UK Ltd) Antipsychotic Drugs 
Antipsychotics 49207 Haloperidol 2mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 49606 Levinan 6mg tablets (Archimedes Pharma UK Ltd) Antipsychotic Drugs 
Antipsychotics 49696 Quetiapine 25mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 49699 Abilify 5mg tablets (Sigma Pharmaceuticals Plc) Antipsychotic Drugs 
Antipsychotics 51178 Quetiapine 50mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 51240 Risperidone 125micrograms/5ml oral solution Antipsychotic Drugs 
Antipsychotics 51444 Risperdal Consta 50mg powder and solvent for 
suspension for injection vials (Waymade Healthcare 
Plc) 
Antipsychotic Drugs 
Antipsychotics 52050 Haloperidol 1.5mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 52846 Nozinan 25mg/1ml solution for injection ampoules 
(Lexon (UK) Ltd) 
Antipsychotic Drugs 
Antipsychotics 52940 Sondate XL 50mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 53552 Quetiapine 25mg tablets (Zentiva) Antipsychotic Drugs 
Antipsychotics 53649 Haloperidol 2mg/5ml oral suspension Antipsychotic Drugs 
Antipsychotics 53951 Levomepromazine 6.25mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 54346 Risperidone 1mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 54483 Sondate XL 300mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 55011 Largactil 25mg tablets (Sanofi) Antipsychotic Drugs 
Antipsychotics 55661 Risperidone 1mg tablets (Kent Pharmaceuticals Ltd) Antipsychotic Drugs 
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Antipsychotics 55848 Haloperidol 5mg/1ml solution for injection ampoules 
(Mercury Pharma Group Ltd) 
Antipsychotic Drugs 
Antipsychotics 55870 Quetiapine oral liquid Antipsychotic Drugs 
Antipsychotics 55890 Promazine 50mg/5ml Liquid (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 56215 Quetiapine 50mg/5ml oral solution Antipsychotic Drugs 
Antipsychotics 56387 Risperidone 1mg/ml oral solution sugar free (Alliance 
Healthcare (Distribution) Ltd) 
Antipsychotic Drugs 
Antipsychotics 56647 Quetiapine 300mg tablets (Arrow Generics Ltd) Antipsychotic Drugs 
Antipsychotics 56862 Chlorpromazine 25mg/5ml syrup (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs 
Antipsychotics 57034 Sondate XL 200mg tablets (Teva UK Ltd) Antipsychotic Drugs 
Antipsychotics 57114 Abilify 5mg tablets (Mawdsley-Brooks & Company 
Ltd) 
Antipsychotic Drugs 
Antipsychotics 57217 Risperidone 1mg tablets (Generics (UK) Ltd) Antipsychotic Drugs 
Antipsychotics 2814 Largactil 25mg Tablet (Hawgreen Ltd) Antipsychotic Drugs/- 
Antipsychotics 3233 Haloperidol 2mg/ml sugar free Liquid Antipsychotic Drugs/- 
Antipsychotics 3246 Stemetil 12.5mg/ml Injection (Castlemead Healthcare 
Ltd) 
Antipsychotic Drugs/- 
Antipsychotics 4234 Haloperidol 5mg/ml Injection Antipsychotic Drugs/- 
Antipsychotics 4401 Prochlorperazine maleate 10mg modified release 
capsule 
Antipsychotic Drugs/- 
Antipsychotics 5192 Haloperidol 1mg/5ml sugar free Oral solution Antipsychotic Drugs/- 
Antipsychotics 5510 Prochlorperazine mesilate 12.5mg/ml injection Antipsychotic Drugs/- 
Antipsychotics 7479 Stelazine 1mg/ml Injection (Goldshield 
Pharmaceuticals Ltd) 
Antipsychotic Drugs/- 
Antipsychotics 7493 Largactil 100mg Tablet (Hawgreen Ltd) Antipsychotic Drugs/- 
Antipsychotics 8311 Chlorpromazine 25mg/ml injection Antipsychotic Drugs/- 
Antipsychotics 8537 Trifluoperazine 1mg/ml Injection Antipsychotic Drugs/- 
Antipsychotics 8689 Vertigon spansule 10 10mg Spansule 
(GlaxoSmithKline Consumer Healthcare) 
Antipsychotic Drugs/- 
Antipsychotics 10434 Largactil 25mg/5ml Oral solution (Hawgreen Ltd) Antipsychotic Drugs/- 
Antipsychotics 11213 Haloperidol 2mg/5ml sugar free Oral solution Antipsychotic Drugs/- 
Antipsychotics 13105 Haloperidol 2mg/ml Oral solution Antipsychotic Drugs/- 
Antipsychotics 14987 Perphenazine 2mg/5ml oral solution sugar free Antipsychotic Drugs/- 
Antipsychotics 15418 Largactil forte 100mg/5ml Oral suspension (Hawgreen Antipsychotic Drugs/- 
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Antipsychotics 17227 Chloractil 25mg Tablet (DDSA Pharmaceuticals Ltd) Antipsychotic Drugs/- 
Antipsychotics 17379 Haloperidol 1.5mg/5ml sugar free Oral solution Antipsychotic Drugs/- 
Antipsychotics 17849 Vertigon spansule 15 15mg Spansule 
(GlaxoSmithKline Consumer Healthcare) 
Antipsychotic Drugs/- 
Antipsychotics 19002 Largactil 100mg Suppository (Rhone-Poulenc Rorer 
Ltd) 
Antipsychotic Drugs/- 
Antipsychotics 25653 Chloractil 50mg Tablet (DDSA Pharmaceuticals Ltd) Antipsychotic Drugs/- 
Antipsychotics 25909 Perphenazine 4mg/5ml Oral solution sugar free Antipsychotic Drugs/- 
Antipsychotics 34272 Haloperidol 5mg/ml Injection (Antigen 
Pharmaceuticals) 
Antipsychotic Drugs/- 
Antipsychotics 37705 Chlorpromazine 100mg/5ml suspension Antipsychotic Drugs/- 
Antipsychotics 42000 Haloperidol 2mg/ml Liquid (Rosemont 
Pharmaceuticals Ltd) 
Antipsychotic Drugs/- 
Antipsychotics 42807 Haloperidol 500microgram Tablet (Lagap) Antipsychotic Drugs/- 
Antipsychotics 54458 Prochlorperazine 5mg Tablet (Teva UK Ltd) Antipsychotic Drugs/- 
Antipsychotics 55871 Haloperidol 2mg/ml Liquid (Hillcross Pharmaceuticals 
Ltd) 
Antipsychotic Drugs/- 
Antipsychotics 3774 Clopixol 200mg/ml Oily injection (Lundbeck Ltd) Antipsychotic Drugs/Antipsychotic Depot 
Injections 
Antipsychotics 3775 Zuclopenthixol decanoate 200mg/ml oily injection Antipsychotic Drugs/Antipsychotic Depot 
Injections 
Antipsychotics 43914 Olanzapine embonate 210mg powder and solvent for 
suspension for injection vials 
Antipsychotic Drugs/Antipsychotic Depot 
Injections 
Antipsychotics 3773 Droperidol 10mg tablets Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Antipsychotics 13369 Droleptan 1mg/ml Oral solution (Janssen-Cilag Ltd) Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Antipsychotics 15128 Droperidol 1mg/ml liquid Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Antipsychotics 21125 Droleptan 5mg/ml Injection (Janssen-Cilag Ltd) Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Antipsychotics 53634 Droperidol capsules Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Antipsychotics 1234 Stemetil 25mg suppositories (Sanofi) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
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Antipsychotics 1316 Stelazine 5mg tablets (Mercury Pharma Group Ltd) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 1318 Stelazine 1mg tablets (Mercury Pharma Group Ltd) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 1434 Prochlorperazine 5mg suppositories Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 1990 Prochlorperazine 25mg suppositories Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 11531 Trifluoperazine 5mg/5ml oral solution sugar free Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 13145 Trifluoperazine 1mg/5ml oral solution sugar free Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 13607 Proziere 5mg tablets (Ashbourne Pharmaceuticals 
Ltd) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 14356 Stemetil 12.5mg/1ml solution for injection ampoules 
(Sanofi) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 14364 Prochlorperazine 12.5mg/1ml solution for injection 
ampoules 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 32064 Prochlorperazine 5mg tablets (Actavis UK Ltd) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 32772 Prochlorperazine 5mg tablets (Generics (UK) Ltd) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 32876 Prochlorperazine 5mg tablets (Teva UK Ltd) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 40162 Trifluoperazine 1mg tablets (A A H Pharmaceuticals 
Ltd) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
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Antipsychotics 43420 Prochlorperazine 5mg tablets (Dr Reddy's 
Laboratories (UK) Ltd) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 49170 Stemetil 5mg tablets (Lexon (UK) Ltd) Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 51551 Stemetil 5mg tablets (Mawdsley-Brooks & Company 
Ltd) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 55038 Prochlorperazine 5mg tablets (Sigma 
Pharmaceuticals Plc) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 55382 Trifluoperazine 1mg/5ml oral solution sugar free 
(Mercury Pharma Group Ltd) 
Antipsychotic Drugs/Drug Used In Nausea And 
Vertigo - Antihistamines, Phenothiazines & 
Related Drugs 
Antipsychotics 24053 Sulparex 200mg Tablet (E R Squibb and Sons Ltd) Antipsychotic Drugs/Drugs For Essential 
Tremor, Chorea, Tics, And Related Disorders 
Antipsychotics 1249 Olanzapine 10mg tablets Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 5653 Olanzapine 7.5mg tablets Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 13820 Zyprexa 10mg tablets (Eli Lilly and Company Ltd) Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 13888 Zyprexa 10mg Velotabs (Eli Lilly and Company Ltd) Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 18024 Zyprexa 5mg tablets (Eli Lilly and Company Ltd) Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 18453 Zyprexa 2.5mg tablets (Eli Lilly and Company Ltd) Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 29540 Olanzapine 20mg tablets Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 33883 Zyprexa 20mg Velotabs (Eli Lilly and Company Ltd) Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 45953 Zyprexa 10mg powder for solution for injection vials 
(Eli Lilly and Company Ltd) 
Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 47063 Olanzapine 10mg orodispersible tablets sugar free Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
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Antipsychotics 47098 Olanzapine 5mg orodispersible tablets sugar free Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 47103 Olanzapine 15mg orodispersible tablets sugar free Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 50214 Olanzapine 5mg orodispersible tablets Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 52001 Olanzapine 2.5mg tablets (Aspire Pharma Ltd) Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 53556 Olanzapine 10mg oral lyophilisates sugar free Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 53848 Zalasta 5mg orodispersible tablets (Consilient Health 
Ltd) 
Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 56072 Olanzapine 20mg orodispersible tablets Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 56193 Olanzapine 5mg oral lyophilisates sugar free Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 56577 Olanzapine 15mg oral lyophilisates sugar free Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 57270 Olanzapine 2.5mg/5ml oral suspension Antipsychotic Drugs/Drugs Used For Mania And 
Hypomania 
Antipsychotics 3356 Parstelin Tablet (GlaxoSmithKline Consumer 
Healthcare) 
Antipsychotic Drugs/Monoamine-oxidase 
Inhibitors 
Antipsychotics 3955 Tranylcypromine with trifluoperazine Tablet Antipsychotic Drugs/Monoamine-oxidase 
Inhibitors 
Antipsychotics 24890 Trifluoperazine with tranylcypromine 1mg + 10mg 
Tablet 
Antipsychotic Drugs/Monoamine-oxidase 
Inhibitors 
Antipsychotics 55620 Flupentixol Liquid Antipsychotic Drugs/Other Antidepressant 
Drugs 
Antipsychotics 1453 Triptafen m 2mg+10mg Tablet (Goldshield 
Pharmaceuticals Ltd) 
Antipsychotic Drugs/Tricyclic And Related 
Antidepressant Drugs 
Antipsychotics 15171 Droleptan 10mg Tablet (Janssen-Cilag Ltd) Benzodiazepines (peri-operative)/Antipsychotic 
Drugs 
Antipsychotics 22609 Droperidol 5mg/ml injection Benzodiazepines (peri-operative)/Antipsychotic 
Drugs 
Antipsychotics 42229 Droperidol oral liquid Benzodiazepines (peri-operative)/Antipsychotic 
Drugs 
Antipsychotics 85 Prochlorperazine 5mg tablets Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
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Drugs/Antipsychotic Drugs 
Antipsychotics 227 Stemetil 5mg suppositories (Sanofi) Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 1245 Trifluoperazine 5mg tablets Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 1857 Trifluoperazine 1mg tablets Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 6036 Prochlorperazine 5mg/5ml oral solution Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 8985 Stelazine 1mg/5ml syrup (Mercury Pharma Group Ltd) Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 29948 Stelazine Forte 1mg/ml oral solution (Mercury Pharma 
Group Ltd) 
Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 32122 Prochlorperazine 12.5mg/1ml solution for injection 
ampoules (Mercury Pharma Group Ltd) 
Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 32551 Prochlorperazine 5mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 34344 Prochlorperazine 5mg tablets (A A H Pharmaceuticals 
Ltd) 
Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 39887 Stemetil 5mg tablets (Sanofi) Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 40001 Stemetil 5mg/5ml syrup (Sanofi) Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 41663 Trifluoperazine 5mg tablets (A A H Pharmaceuticals 
Ltd) 
Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 50462 Stemetil 5mg tablets (Doncaster Pharmaceuticals Ltd) Drug Used In Nausea And Vertigo - 
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Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 51579 Stemetil 5mg tablets (Sigma Pharmaceuticals Plc) Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 54429 Stemetil 5mg tablets (Waymade Healthcare Plc) Drug Used In Nausea And Vertigo - 
Antihistamines, Phenothiazines & Related 
Drugs/Antipsychotic Drugs 
Antipsychotics 2656 Olanzapine 2.5mg tablets Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 3281 Olanzapine 5mg tablets Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 6850 Olanzapine 15mg tablets Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 14717 Zyprexa 5mg Velotabs (Eli Lilly and Company Ltd) Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 16407 Zyprexa 15mg Velotabs (Eli Lilly and Company Ltd) Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 19976 Zyprexa 15mg tablets (Eli Lilly and Company Ltd) Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 21964 Zyprexa 7.5mg tablets (Eli Lilly and Company Ltd) Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 23431 Olanzapine 10mg powder for solution for injection 
vials 
Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 36163 Zyprexa 20mg tablets (Eli Lilly and Company Ltd) Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 47093 Olanzapine 20mg orodispersible tablets sugar free Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 55622 Olanzapine 10mg orodispersible tablets Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 55667 Olanzapine 15mg tablets (Actavis UK Ltd) Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 56143 Olanzapine 15mg orodispersible tablets Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 56265 Olanzapine 20mg oral lyophilisates sugar free Drugs Used For Mania And 
Hypomania/Antipsychotic Drugs 
Antipsychotics 2540 Benperidol 250microgram tablets First-generation Antipsychotic Drugs 
Antipsychotics 47365 Anquil 250microgram tablets (Archimedes Pharma UK First-generation Antipsychotic Drugs 
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Antipsychotics 4876 Amisulpride 50mg tablets Second-generation Antipsychotic Drugs 
Antipsychotics 4992 Solian 200 tablets (Sanofi) Second-generation Antipsychotic Drugs 
Antipsychotics 5071 Amisulpride 200mg tablets Second-generation Antipsychotic Drugs 
Antipsychotics 5927 Amisulpride 400mg tablets Second-generation Antipsychotic Drugs 
Antipsychotics 6109 Solian 400 tablets (Sanofi) Second-generation Antipsychotic Drugs 
Antipsychotics 6482 Amisulpride 100mg/ml oral solution sugar free Second-generation Antipsychotic Drugs 
Antipsychotics 6524 Amisulpride 100mg tablets Second-generation Antipsychotic Drugs 
Antipsychotics 11938 Amisulpride 25mg/5ml oral suspension Second-generation Antipsychotic Drugs 
Antipsychotics 26544 Solian 100 tablets (Sanofi) Second-generation Antipsychotic Drugs 
Antipsychotics 34927 Amisulpride 200mg tablets (Zentiva) Second-generation Antipsychotic Drugs 
Antipsychotics 41702 Amisulpride 100mg tablets (Zentiva) Second-generation Antipsychotic Drugs 
Antipsychotics 41714 Amisulpride 50mg tablets (Zentiva) Second-generation Antipsychotic Drugs 
Antipsychotics 46889 Amisulpride 25mg/5ml oral solution Second-generation Antipsychotic Drugs 
Antipsychotics 46969 Amisulpride 200mg tablets (A A H Pharmaceuticals 
Ltd) 
Second-generation Antipsychotic Drugs 
Antipsychotics 51558 Amisulpride 12.5mg/5ml oral suspension Second-generation Antipsychotic Drugs 
Antipsychotics 52076 Amisulpride 12.5mg/5ml oral solution Second-generation Antipsychotic Drugs 
Antipsychotics 55625 Amisulpride 50mg/5ml oral suspension Second-generation Antipsychotic Drugs 
Apixaban 47566 Apixaban 2.5mg tablets  
Apixaban 53740 Eliquis 2.5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
 
Apixaban 54066 Apixaban 5mg tablets  
ASA 254 Aspirin 300mg tablets  
ASA 377 Aspirin 300mg dispersible tablets  
ASA 434 Aspirin 300mg gastro-resistant tablets  
ASA 7516 Aspirin 300mg effervescent tablets sugar free  
ASA 8186 Aspirin 300mg modified-release tablets  
ASA 8645 Aspirin 300mg effervescent tablets  
ASA 18217 Aspirin 300mg orodispersible tablets sugar free  
ASA 22138 Aspirin 324mg modified-release tablets  
ASA 24960 Aspirin 300mg tablets (Vantage)  
ASA 28810 Aspirin 300mg with Glycine 133mg soluble tablets  
ASA 29848 Aspirin 300mg with Glycine 150mg chewable tablets  
ASA 30920 Aspirin 300mg Dispersible tablet (M & A Pharmachem  
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ASA 31210 Aspirin 300mg Tablet (Co-operative)  
ASA 31870 Aspirin 320mg tablets  
ASA 32210 Aspirin 300mg dispersible tablets (Actavis UK Ltd)  
ASA 33662 Aspirin 300mg Dispersible tablet (A A H 
Pharmaceuticals Ltd) 
 
ASA 33668 Aspirin 300mg Dispersible tablet (Rusco Ltd)  
ASA 34309 Aspirin 300mg dispersible tablets (A A H 
Pharmaceuticals Ltd) 
 
ASA 34386 Aspirin 300mg tablets (Actavis UK Ltd)  
ASA 34762 Aspirin 300mg Gastro-resistant tablet (Galen Ltd)  
ASA 40144 Aspirin 300mg Dispersible tablet (Thornton & Ross 
Ltd) 
 
ASA 41569 Aspirin 300mg tablets (A A H Pharmaceuticals Ltd)  
ASA 41594 Aspirin 300mg Dispersible tablet (Teva UK Ltd)  
ASA 43060 Aspirin 300mg Soluble tablet (Celltech Pharma 
Europe Ltd) 
 
ASA 43434 Aspirin 300mg gastro-resistant tablets (A A H 
Pharmaceuticals Ltd) 
 
ASA 43806 Aspirin 300mg gastro-resistant tablets (Sandoz Ltd)  
ASA 44639 Aspirin 300mg Dispersible tablet (Nucare Plc)  
ASA 45840 Aspirin 300mg Dispersible tablet (Numark 
Management Ltd) 
 
ASA 45851 Aspirin 300mg Soluble tablet (Ranbaxy (UK) Ltd)  
ASA 48000 Aspirin 300mg tablets (Sigma Pharmaceuticals Plc)  
ASA 48165 Aspirin 300mg tablets (Aspar Pharmaceuticals Ltd)  
ASA 49220 Aspirin 300mg tablets (Kent Pharmaceuticals Ltd)  
ASA 50555 Aspirin 300mg dispersible tablets (Doncaster 
Pharmaceuticals Ltd) 
 
ASA 52044 Aspirin 300mg caplets (The Boots Company Plc)  
ASA 52280 Aspirin 300mg Tablet (Wockhardt UK Ltd)  
ASA 52905 Aspirin 300mg tablets (Lloyds Pharmacy Ltd)  
ASA 53622 Aspirin 300mg Tablet (M & A Pharmachem Ltd)  
ASA 53711 Aspirin 300mg Tablet (Nucare Plc)  
ASA 53804 Aspirin 300mg gastro-resistant tablets (Alliance 
Healthcare (Distribution) Ltd) 
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ASA 53816 Aspirin 300mg dispersible tablets (Alliance Healthcare 
(Distribution) Ltd) 
 
ASA 54526 Aspirin 300mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
 
ASA 54734 Aspirin 300mg tablets (Wockhardt UK Ltd)  
ASA 55230 Aspirin 300mg dispersible tablets (Kent 
Pharmaceuticals Ltd) 
 
ASA 55579 Aspirin 300mg tablets (Almus Pharmaceuticals Ltd)  
ASA 56007 Aspirin 300mg dispersible tablets (Sigma 
Pharmaceuticals Plc) 
 
ASA 56736 Aspirin 300mg tablets (Waymade Healthcare Plc)  
Benzodiazepines 3773 Droperidol 10mg tablets Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Benzodiazepines 13369 Droleptan 1mg/ml Oral solution (Janssen-Cilag Ltd) Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Benzodiazepines 15128 Droperidol 1mg/ml liquid Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Benzodiazepines 21125 Droleptan 5mg/ml Injection (Janssen-Cilag Ltd) Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Benzodiazepines 53634 Droperidol capsules Antipsychotic Drugs/Benzodiazepines (peri-
operative) 
Benzodiazepines 4141 Oxazepam 15mg tablets Benzodiazepines 
Benzodiazepines 4566 Oxazepam 10mg tablets Benzodiazepines 
Benzodiazepines 9696 Alprazolam 250microgram tablets Benzodiazepines 
Benzodiazepines 10274 Diazepam 2mg/5ml oral solution sugar free Benzodiazepines 
Benzodiazepines 10802 Xanax 250microgram tablets (Pfizer Ltd) Benzodiazepines 
Benzodiazepines 11486 Alprazolam 500microgram tablets Benzodiazepines 
Benzodiazepines 12598 Xanax 500microgram tablets (Pfizer Ltd) Benzodiazepines 
Benzodiazepines 20968 Diazepam 2mg/5ml oral solution sugar free (Actavis 
UK Ltd) 
Benzodiazepines 
Benzodiazepines 36604 Oxazepam 10mg tablets (A A H Pharmaceuticals Ltd) Benzodiazepines 
Benzodiazepines 41411 Oxazepam 15mg tablets (A A H Pharmaceuticals Ltd) Benzodiazepines 
Benzodiazepines 41531 Oxazepam 10mg tablets (Actavis UK Ltd) Benzodiazepines 
Benzodiazepines 41553 Oxazepam 10mg tablets (Genus Pharmaceuticals Ltd) Benzodiazepines 
Benzodiazepines 41602 Oxazepam 15mg tablets (Actavis UK Ltd) Benzodiazepines 
Benzodiazepines 46946 Oxazepam 15mg tablets (Genus Pharmaceuticals Ltd) Benzodiazepines 
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Benzodiazepines 51985 Diazepam 2mg/5ml oral suspension Benzodiazepines 
Benzodiazepines 53461 Diazepam 2mg/5ml oral solution sugar free (A A H 
Pharmaceuticals Ltd) 
Benzodiazepines 
Benzodiazepines 3234 Midazolam 5mg/ml Injection Benzodiazepines (peri-operative) 
Benzodiazepines 5856 Hypnovel 10mg/5ml solution for injection ampoules 
(Roche Products Ltd) 
Benzodiazepines (peri-operative) 
Benzodiazepines 5872 Midazolam 2mg/ml Injection Benzodiazepines (peri-operative) 
Benzodiazepines 6020 Midazolam 1mg/ml Injection Benzodiazepines (peri-operative) 
Benzodiazepines 7392 Midazolam 10mg/5ml solution for injection ampoules Benzodiazepines (peri-operative) 
Benzodiazepines 13304 Midazolam 5mg/5ml solution for injection ampoules Benzodiazepines (peri-operative) 
Benzodiazepines 24457 Fentanyl with droperidol 500microgramwith2.5mg/ml 
Injection 
Benzodiazepines (peri-operative) 
Benzodiazepines 26961 Midazolam 50mg/10ml solution for injection ampoules Benzodiazepines (peri-operative) 
Benzodiazepines 45695 Midazolam 2.5mg/ml oral solution Benzodiazepines (peri-operative) 
Benzodiazepines 48715 Midazolam 10mg/2ml oromucosal solution pre-filled 
syringes (Special Order) 
Benzodiazepines (peri-operative) 
Benzodiazepines 48807 Midazolam 5mg/1ml oromucosal solution pre-filled 
syringes (Special Order) 
Benzodiazepines (peri-operative) 
Benzodiazepines 48817 Midazolam 2.5mg/0.5ml oromucosal solution pre-filled 
syringes (Special Order) 
Benzodiazepines (peri-operative) 
Benzodiazepines 49095 Midazolam 10mg/ml oromucosal solution Benzodiazepines (peri-operative) 
Benzodiazepines 49595 Midazolam 10mg/ml oral solution Benzodiazepines (peri-operative) 
Benzodiazepines 50618 Midazolam 7.5mg/1.5ml oromucosal solution pre-filled 
syringes (Special Order) 
Benzodiazepines (peri-operative) 
Benzodiazepines 52845 Midazolam 12.5mg/5ml oral suspension Benzodiazepines (peri-operative) 
Benzodiazepines 52954 Midazolam 7.5mg tablets Benzodiazepines (peri-operative) 
Benzodiazepines 55931 Midazolam 10mg/1ml oromucosal solution pre-filled 
oral syringes 
Benzodiazepines (peri-operative) 
Benzodiazepines 56988 Midazolam 5mg/2ml solution for injection ampoules Benzodiazepines (peri-operative) 
Benzodiazepines 15171 Droleptan 10mg Tablet (Janssen-Cilag Ltd) Benzodiazepines (peri-operative)/Antipsychotic 
Drugs 
Benzodiazepines 22609 Droperidol 5mg/ml injection Benzodiazepines (peri-operative)/Antipsychotic 
Drugs 
Benzodiazepines 42229 Droperidol oral liquid Benzodiazepines (peri-operative)/Antipsychotic 
Drugs 
Benzodiazepines 10954 Ativan 1mg Tablet (Wyeth Pharmaceuticals) Benzodiazepines (peri-operative)/Anxiolytics 
Benzodiazepines 17830 Ativan 2.5mg Tablet (Wyeth Pharmaceuticals) Benzodiazepines (peri-operative)/Anxiolytics 
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Benzodiazepines 1088 Lorazepam 1mg tablets Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 10581 Hypnovel 10mg/2ml solution for injection ampoules 
(Roche Products Ltd) 
Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 13305 Midazolam 2mg/2ml solution for injection ampoules Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 32911 Midazolam 10mg/2ml solution for injection ampoules 
(Mercury Pharma Group Ltd) 
Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 34735 Midazolam 10mg/2ml solution for injection ampoules 
(Wockhardt UK Ltd) 
Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 35932 Lorazepam 2.5mg tablets (Teva UK Ltd) Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 36200 Lorazepam 1mg tablets (Generics (UK) Ltd) Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 37566 Lorazepam 1mg/5ml oral suspension Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 39284 Lorazepam 1mg tablets (Genus Pharmaceuticals Ltd) Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 45829 Lorazepam 1mg tablets (Sandoz Ltd) Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 46896 Lorazepam 500micrograms/5ml oral solution Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 57268 Lorazepam 2.5mg tablets (Sandoz Ltd) Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 1400 Diazepam 10mg tablets Benzodiazepines (peri-
operative)/Benzodiazepines/Drugs Used In 
Status Epilepticus/Skeletal Muscle 
Relaxants/Febrile Convulsions 
Benzodiazepines 34293 Diazepam 10mg tablets (Generics (UK) Ltd) Benzodiazepines (peri-
operative)/Benzodiazepines/Skeletal Muscle 
Relaxants/Febrile Convulsions/Drugs Used In 
Status Epilepticus 
Benzodiazepines 43450 Midazolam Oral solution Benzodiazepines (peri-operative)/Drugs Used 
In Status Epilepticus 
Benzodiazepines 9430 Diazepam 2.5mg/5ml oral suspension Benzodiazepines (peri-operative)/Drugs Used 
In Status Epilepticus/Benzodiazepines/Skeletal 
Muscle Relaxants/Therapy Of Convulsions Due 
To Poisoning 
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Benzodiazepines 51335 Diazepam 10mg/5ml oral solution Benzodiazepines (peri-operative)/Drugs Used 
In Status Epilepticus/Therapy Of Convulsions 
Due To Poisoning/Skeletal Muscle 
Relaxants/Benzodiazepines 
Benzodiazepines 46 Diazepam 2mg tablets Benzodiazepines (peri-operative)/Febrile 
Convulsions/Benzodiazepines/Skeletal Muscle 
Relaxants/Drugs Used In Status Epilepticus 
Benzodiazepines 34335 Diazepam 2mg tablets (Teva UK Ltd) Benzodiazepines (peri-operative)/Febrile 
Convulsions/Drugs Used In Status 
Epilepticus/Skeletal Muscle 
Relaxants/Benzodiazepines 
Benzodiazepines 7567 Temazepam planpak Capsule (Manufacturer 
unknown) 
Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 7569 Temazepam 15mg capsules Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 8798 Temazepam gelthix 10mg Capsule (Pharmacia Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 10430 Temazepam 30mg capsules Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 12293 Normison 10mg Capsule (Wyeth Pharmaceuticals) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 15110 Temazepam 10mg/5ml Oral solution (Generics (UK) 
Ltd) 
Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 20245 Temazepam 10mg gel-fill capsules Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 21454 Normison 20mg Capsule (Wyeth Pharmaceuticals) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 29441 Euhypnos forte 20mg Capsule (Pharmacia Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 33648 Temazepam 10mg Tablet (Wyeth Pharmaceuticals) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 34508 Temazepam 10mg tablets (Generics (UK) Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 36602 Temazepam 20mg Tablet (Pharmacia Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 41516 Temazepam 10mg Tablet (IVAX Pharmaceuticals UK 
Ltd) 
Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 41562 Temazepam 10mg Tablet (Pharmacia Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 41717 Temazepam 20mg tablets (A A H Pharmaceuticals 
Ltd) 
Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 41718 Temazepam 10mg Capsule (Hillcross 
Pharmaceuticals Ltd) 
Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 46939 Temazepam 20mg tablets (Teva UK Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 46964 Temazepam 20mg tablets (Actavis UK Ltd) Benzodiazepines (peri-operative)/Hypnotics 
Benzodiazepines 56236 Diazepam 2mg tablets (Wockhardt UK Ltd) Benzodiazepines (peri-operative)/Skeletal 
Muscle Relaxants/Drugs Used In Status 
Epilepticus/Benzodiazepines/Febrile 
  
 
3
1
8
 
Medication Product 
Code 
Product Name BNF Header 
Convulsions 
Benzodiazepines 12849 Diazepam 10mg/5ml oral suspension Benzodiazepines (peri-operative)/Skeletal 
Muscle Relaxants/Therapy Of Convulsions Due 
To Poisoning/Drugs Used In Status 
Epilepticus/Benzodiazepines 
Benzodiazepines 5842 Diazepam 2.5mg/1.25ml rectal solution tube Benzodiazepines (peri-operative)/Therapy Of 
Convulsions Due To Poisoning/Skeletal Muscle 
Relaxants/Benzodiazepines/Drugs Used In 
Status Epilepticus 
Benzodiazepines 18488 Diazepam 2.5mg RecTubes (Wockhardt UK Ltd) Benzodiazepines (peri-operative)/Therapy Of 
Convulsions Due To Poisoning/Skeletal Muscle 
Relaxants/Benzodiazepines/Drugs Used In 
Status Epilepticus 
Benzodiazepines 2091 Lorazepam 2.5mg tablets Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 7391 Midazolam 10mg/2ml solution for injection ampoules Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 13279 Lorazepam 500micrograms/5ml oral suspension Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 33086 Lorazepam 1mg tablets (Teva UK Ltd) Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 35373 Midazolam 50mg/50ml solution for infusion vials Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 37745 Lorazepam 1mg/5ml oral solution Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 38193 Midazolam 100mg/50ml solution for infusion vials Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 41391 Lorazepam 1mg tablets (Arrow Generics Ltd) Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 42814 Lorazepam 2.5mg tablets (Genus Pharmaceuticals 
Ltd) 
Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 56551 Lorazepam 5mg/5ml oral solution Benzodiazepines/Benzodiazepines (peri-
operative) 
Benzodiazepines 29945 Diazepam 2mg tablets (Ranbaxy (UK) Ltd) Benzodiazepines/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Drugs 
Used In Status Epilepticus/Febrile Convulsions 
Benzodiazepines 34524 Diazepam 2mg tablets (Actavis UK Ltd) Benzodiazepines/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Drugs 
  
 
3
1
9
 
Medication Product 
Code 
Product Name BNF Header 
Used In Status Epilepticus/Febrile Convulsions 
Benzodiazepines 41632 Diazepam 10mg tablets (A A H Pharmaceuticals Ltd) Benzodiazepines/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Febrile 
Convulsions/Drugs Used In Status Epilepticus 
Benzodiazepines 55481 Clobazam 10mg/5ml oral suspension sugar free Benzodiazepines/Control Of Epilepsy 
Benzodiazepines 56781 Tapclob 10mg/5ml oral suspension (Martindale 
Pharmaceuticals Ltd) 
Benzodiazepines/Control Of Epilepsy 
Benzodiazepines 41607 Diazepam 10mg tablets (Teva UK Ltd) Benzodiazepines/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Febrile Convulsions/Skeletal Muscle 
Relaxants 
Benzodiazepines 47 Diazepam 5mg tablets Benzodiazepines/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Febrile 
Convulsions 
Benzodiazepines 3973 Tensium 10mg tablets (DDSA Pharmaceuticals Ltd) Benzodiazepines/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Febrile 
Convulsions 
Benzodiazepines 33776 Diazepam 10mg/2ml solution for injection ampoules 
(Hameln Pharmaceuticals Ltd) 
Benzodiazepines/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Therapy Of Convulsions Due To 
Poisoning/Skeletal Muscle Relaxants 
Benzodiazepines 34677 Diazepam 2mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Benzodiazepines/Febrile 
Convulsions/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Drugs 
Used In Status Epilepticus 
Benzodiazepines 34635 Diazepam 5mg tablets (A A H Pharmaceuticals Ltd) Benzodiazepines/Febrile Convulsions/Drugs 
Used In Status Epilepticus/Skeletal Muscle 
Relaxants/Benzodiazepines (peri-operative) 
Benzodiazepines 1463 Chlordiazepoxide 10mg capsules Benzodiazepines/Skeletal Muscle Relaxants 
Benzodiazepines 2122 Chlordiazepoxide 5mg capsules Benzodiazepines/Skeletal Muscle Relaxants 
Benzodiazepines 18125 Librium 5mg capsules (Meda Pharmaceuticals Ltd) Benzodiazepines/Skeletal Muscle Relaxants 
Benzodiazepines 24599 Librium 10mg capsules (Meda Pharmaceuticals Ltd) Benzodiazepines/Skeletal Muscle Relaxants 
Benzodiazepines 27880 Tropium 5mg capsules (Dr Reddy's Laboratories (UK) 
Ltd) 
Benzodiazepines/Skeletal Muscle Relaxants 
Benzodiazepines 35936 Chlordiazepoxide 5mg capsules (A A H 
Pharmaceuticals Ltd) 
Benzodiazepines/Skeletal Muscle Relaxants 
  
 
3
2
0
 
Medication Product 
Code 
Product Name BNF Header 
Benzodiazepines 45241 Chlordiazepoxide 10mg capsules (A A H 
Pharmaceuticals Ltd) 
Benzodiazepines/Skeletal Muscle Relaxants 
Benzodiazepines 46913 Diazepam 10mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Benzodiazepines/Skeletal Muscle 
Relaxants/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Febrile Convulsions 
Benzodiazepines 32853 Diazepam 2mg/5ml oral solution (Sandoz Ltd) Benzodiazepines/Skeletal Muscle 
Relaxants/Therapy Of Convulsions Due To 
Poisoning/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-operative) 
Benzodiazepines 8345 Stesolid 10mg rectal tube (Actavis UK Ltd) Benzodiazepines/Therapy Of Convulsions Due 
To Poisoning/Skeletal Muscle Relaxants/Drugs 
Used In Status Epilepticus/Benzodiazepines 
(peri-operative) 
Benzodiazepines 54759 Clobazam 5mg/5ml oral suspension sugar free Control Of Epilepsy/Benzodiazepines 
Benzodiazepines 54934 Tapclob 5mg/5ml oral suspension (Martindale 
Pharmaceuticals Ltd) 
Control Of Epilepsy/Benzodiazepines 
Benzodiazepines 7301 Midazolam 10mg/ml buccal solution Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-operative) 
Benzodiazepines 10278 Epistatus 10mg/ml Oromucosal solution (Special 
Products Ltd) 
Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-operative) 
Benzodiazepines 44764 Midazolam maleate buccal solution Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-operative) 
Benzodiazepines 42503 Diazepam 5mg/5ml oral solution (A A H 
Pharmaceuticals Ltd) 
Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Febrile 
Convulsions/Benzodiazepines/Skeletal Muscle 
Relaxants 
Benzodiazepines 12237 Diazepam 10mg/2ml emulsion for injection ampoules Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants/Therapy 
Of Convulsions Due To 
Poisoning/Benzodiazepines 
Benzodiazepines 664 Lorazepam 4mg/1ml solution for injection ampoules Drugs Used In Status 
Epilepticus/Benzodiazepines/Benzodiazepines 
(peri-operative) 
Benzodiazepines 7444 Ativan 4mg/1ml solution for injection ampoules (Pfizer 
Ltd) 
Drugs Used In Status 
Epilepticus/Benzodiazepines/Benzodiazepines 
  
 
3
2
1
 
Medication Product 
Code 
Product Name BNF Header 
(peri-operative) 
Benzodiazepines 4395 Stesolid 5mg rectal tube (Actavis UK Ltd) Drugs Used In Status 
Epilepticus/Benzodiazepines/Benzodiazepines 
(peri-operative)/Therapy Of Convulsions Due 
To Poisoning/Skeletal Muscle Relaxants 
Benzodiazepines 34340 Diazepam 10mg tablets (Ranbaxy (UK) Ltd) Drugs Used In Status 
Epilepticus/Benzodiazepines/Febrile 
Convulsions/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants 
Benzodiazepines 32417 Diazepam 10mg/2ml solution for injection ampoules 
(Wockhardt UK Ltd) 
Drugs Used In Status 
Epilepticus/Benzodiazepines/Febrile 
Convulsions/Skeletal Muscle 
Relaxants/Benzodiazepines (peri-operative) 
Benzodiazepines 53566 Diazepam 2.5mg/5ml oral solution Drugs Used In Status 
Epilepticus/Benzodiazepines/Therapy Of 
Convulsions Due To Poisoning/Skeletal Muscle 
Relaxants/Benzodiazepines (peri-operative) 
Benzodiazepines 12124 Diazepam 10mg/2ml solution for injection ampoules Drugs Used In Status Epilepticus/Febrile 
Convulsions/Skeletal Muscle 
Relaxants/Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 34615 Diazepam 5mg tablets (Generics (UK) Ltd) Drugs Used In Status Epilepticus/Febrile 
Convulsions/Skeletal Muscle 
Relaxants/Benzodiazepines/Benzodiazepines 
(peri-operative) 
Benzodiazepines 45244 Diazepam 5mg tablets (Sandoz Ltd) Drugs Used In Status Epilepticus/Skeletal 
Muscle Relaxants/Benzodiazepines (peri-
operative)/Benzodiazepines/Febrile 
Convulsions 
Benzodiazepines 2078 Diazepam 5mg RecTubes (Wockhardt UK Ltd) Drugs Used In Status Epilepticus/Therapy Of 
Convulsions Due To 
Poisoning/Benzodiazepines/Skeletal Muscle 
Relaxants/Benzodiazepines (peri-operative) 
Benzodiazepines 45218 Diazepam 5mg tablets (Ranbaxy (UK) Ltd) Febrile 
Convulsions/Benzodiazepines/Benzodiazepines 
(peri-operative)/Skeletal Muscle 
Relaxants/Drugs Used In Status Epilepticus 
Benzodiazepines 51754 Diazepam 10mg/2ml solution for injection ampoules Febrile Convulsions/Skeletal Muscle 
  
 
3
2
2
 
Medication Product 
Code 
Product Name BNF Header 
(A A H Pharmaceuticals Ltd) Relaxants/Benzodiazepines/Benzodiazepines 
(peri-operative)/Drugs Used In Status 
Epilepticus 
Benzodiazepines 46966 Diazepam 5mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Febrile Convulsions/Skeletal Muscle 
Relaxants/Drugs Used In Status 
Epilepticus/Benzodiazepines/Benzodiazepines 
(peri-operative) 
Benzodiazepines 20 Temazepam 10mg tablets Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 780 Temazepam 10mg/5ml oral solution sugar free Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 921 Temazepam 10mg capsules Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 1729 Temazepam 20mg tablets Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 2403 Temazepam 20mg capsules Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 12462 Temazepam gelthix 20mg Capsule (Pharmacia Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 20801 Temazepam gelthix 30mg Capsule (Pharmacia Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 23120 Temazepam gelthix 15mg Capsule (Pharmacia Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 27367 Temazepam 10mg/5ml oral solution sugar free 
(Rosemont Pharmaceuticals Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 30779 Temazepam 20mg Tablet (Wyeth Pharmaceuticals) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 30985 Temazepam 20mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 32320 Temazepam 20mg gel-fill capsules Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 32847 Temazepam 10mg/5ml oral solution sugar free (A A H 
Pharmaceuticals Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 34002 Temazepam 10mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 34331 Temazepam 10mg tablets (A A H Pharmaceuticals 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 34406 Temazepam 10mg tablets (Teva UK Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 34572 Temazepam 20mg tablets (Generics (UK) Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 36611 Euhypnos 10mg/5ml Oral solution (Pharmacia Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 38418 Temazepam 10mg Capsule (Berk Pharmaceuticals 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 38424 Temazepam 20mg Capsule (Berk Pharmaceuticals 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 41653 Temazepam 20mg Capsule (Hillcross 
Pharmaceuticals Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 45254 Temazepam 10mg tablets (Actavis UK Ltd) Hypnotics/Benzodiazepines (peri-operative) 
  
 
3
2
3
 
Medication Product 
Code 
Product Name BNF Header 
Benzodiazepines 45283 Temazepam 10mg tablets (Genus Pharmaceuticals 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 46078 Temazepam 20mg tablets (Genus Pharmaceuticals 
Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 49589 Temazepam 10mg tablets (Sandoz Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 55836 Temazepam 10mg/5ml oral solution sugar free (Focus 
Pharmaceuticals Ltd) 
Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 56811 Temazepam 10mg tablets (F.Maltby & Sons Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 56927 Temazepam 10mg tablets (Ethigen Ltd) Hypnotics/Benzodiazepines (peri-operative) 
Benzodiazepines 952 Vallergan 7.5mg/5ml Oral solution (Castlemead 
Healthcare Ltd) 
Sedating Antihistamines/Benzodiazepines (peri-
operative) 
Benzodiazepines 1723 Vallergan forte 30mg/5ml Oral solution (Castlemead 
Healthcare Ltd) 
Sedating Antihistamines/Benzodiazepines (peri-
operative) 
Benzodiazepines 2405 Vallergan 10mg Tablet (Castlemead Healthcare Ltd) Sedating Antihistamines/Benzodiazepines (peri-
operative) 
Benzodiazepines 5294 Chlordiazepoxide 10mg tablets Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 6025 Chlordiazepoxide 5mg tablets Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 30273 Tropium 5mg tablets (Dr Reddy's Laboratories (UK) 
Ltd) 
Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 41582 Chlordiazepoxide 5mg capsules (Actavis UK Ltd) Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 41583 Chlordiazepoxide 10mg capsules (Actavis UK Ltd) Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 43438 Chlordiazepoxide 5mg tablets (A A H Pharmaceuticals 
Ltd) 
Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 44302 Tropium 10mg tablets (Dr Reddy's Laboratories (UK) 
Ltd) 
Skeletal Muscle Relaxants/Benzodiazepines 
Benzodiazepines 2083 Diazepam 10mg RecTubes (Wockhardt UK Ltd) Skeletal Muscle Relaxants/Benzodiazepines 
(peri-operative)/Drugs Used In Status 
Epilepticus/Therapy Of Convulsions Due To 
Poisoning/Benzodiazepines 
Benzodiazepines 34482 Diazepam 5mg tablets (Teva UK Ltd) Skeletal Muscle 
Relaxants/Benzodiazepines/Benzodiazepines 
(peri-operative)/Drugs Used In Status 
Epilepticus/Febrile Convulsions 
Benzodiazepines 33672 Diazepam 2mg tablets (A A H Pharmaceuticals Ltd) Skeletal Muscle 
Relaxants/Benzodiazepines/Benzodiazepines 
(peri-operative)/Febrile Convulsions/Drugs 
Used In Status Epilepticus 
  
 
3
2
4
 
Medication Product 
Code 
Product Name BNF Header 
Benzodiazepines 13756 Diazemuls 10mg/2ml emulsion for injection ampoules 
(Actavis UK Ltd) 
Skeletal Muscle 
Relaxants/Benzodiazepines/Drugs Used In 
Status Epilepticus/Benzodiazepines (peri-
operative)/Therapy Of Convulsions Due To 
Poisoning 
Benzodiazepines 9065 Diazepam 5mg/5ml oral solution Skeletal Muscle 
Relaxants/Benzodiazepines/Febrile 
Convulsions/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-operative) 
Benzodiazepines 34338 Diazepam 2mg tablets (Generics (UK) Ltd) Skeletal Muscle Relaxants/Drugs Used In 
Status Epilepticus/Febrile 
Convulsions/Benzodiazepines (peri-
operative)/Benzodiazepines 
Benzodiazepines 45313 Diazepam 2mg tablets (Almus Pharmaceuticals Ltd) Skeletal Muscle Relaxants/Febrile 
Convulsions/Benzodiazepines (peri-
operative)/Benzodiazepines/Drugs Used In 
Status Epilepticus 
Benzodiazepines 32296 Diazepam 5mg tablets (Actavis UK Ltd) Skeletal Muscle Relaxants/Febrile 
Convulsions/Benzodiazepines (peri-
operative)/Drugs Used In Status 
Epilepticus/Benzodiazepines 
Benzodiazepines 34807 Diazepam 10mg tablets (Actavis UK Ltd) Skeletal Muscle Relaxants/Febrile 
Convulsions/Benzodiazepines (peri-
operative)/Drugs Used In Status 
Epilepticus/Benzodiazepines 
Benzodiazepines 2352 Diazepam 2mg/5ml oral solution Skeletal Muscle Relaxants/Therapy Of 
Convulsions Due To 
Poisoning/Benzodiazepines/Benzodiazepines 
(peri-operative)/Drugs Used In Status 
Epilepticus 
Benzodiazepines 4176 Diazepam 10mg/2.5ml rectal solution tube Skeletal Muscle Relaxants/Therapy Of 
Convulsions Due To 
Poisoning/Benzodiazepines/Drugs Used In 
Status Epilepticus/Benzodiazepines (peri-
operative) 
Benzodiazepines 6747 Diazepam 5mg/2.5ml rectal solution tube Skeletal Muscle Relaxants/Therapy Of 
Convulsions Due To 
Poisoning/Benzodiazepines/Drugs Used In 
  
 
3
2
5
 
Medication Product 
Code 
Product Name BNF Header 
Status Epilepticus/Benzodiazepines (peri-
operative) 
Benzodiazepines 34614 Diazepam 10mg/2.5ml rectal solution tube (Sandoz 
Ltd) 
Therapy Of Convulsions Due To 
Poisoning/Benzodiazepines/Drugs Used In 
Status Epilepticus/Benzodiazepines (peri-
operative)/Skeletal Muscle Relaxants 
Benzodiazepines 34045 Diazepam 5mg/5ml oral solution (Sandoz Ltd) Therapy Of Convulsions Due To 
Poisoning/Benzodiazepines/Skeletal Muscle 
Relaxants/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-operative) 
Benzodiazepines 34033 Diazepam 5mg/2.5ml rectal solution tube (Sandoz 
Ltd) 
Therapy Of Convulsions Due To 
Poisoning/Drugs Used In Status 
Epilepticus/Benzodiazepines (peri-
operative)/Benzodiazepines/Skeletal Muscle 
Relaxants 
Carbamazepine 432 Carbamazepine 100mg tablets Control Of Epilepsy 
Carbamazepine 596 Carbamazepine 100mg/5ml oral suspension sugar 
free 
Control Of Epilepsy 
Carbamazepine 652 Carbamazepine 400mg tablets Control Of Epilepsy 
Carbamazepine 1158 Carbamazepine 200mg tablets Control Of Epilepsy 
Carbamazepine 2085 Tegretol 200mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Control Of Epilepsy 
Carbamazepine 2388 Carbamazepine 200mg modified-release tablets Control Of Epilepsy 
Carbamazepine 3569 Carbamazepine 400mg modified-release tablets Control Of Epilepsy 
Carbamazepine 4066 Tegretol 400mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Control Of Epilepsy 
Carbamazepine 4913 Tegretol 100mg/5ml liquid (Novartis Pharmaceuticals 
UK Ltd) 
Control Of Epilepsy 
Carbamazepine 4982 Carbamazepine 100mg chewable tablets sugar free Control Of Epilepsy 
Carbamazepine 5977 Tegretol 100mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Control Of Epilepsy 
Carbamazepine 11696 Carbamazepine 200mg chewable tablets sugar free Control Of Epilepsy 
Carbamazepine 12880 Tegretol 200mg Chewtabs (Novartis Pharmaceuticals 
UK Ltd) 
Control Of Epilepsy 
Carbamazepine 12931 Epimaz Retard 200mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Control Of Epilepsy 
Carbamazepine 12932 Epimaz 100mg tablets (IVAX Pharmaceuticals UK Control Of Epilepsy 
  
 
3
2
6
 
Medication Product 
Code 
Product Name BNF Header 
Ltd) 
Carbamazepine 13112 Carbagen SR 200mg tablets (Generics (UK) Ltd) Control Of Epilepsy 
Carbamazepine 13524 Tegretol 100mg Chewtabs (Novartis Pharmaceuticals 
UK Ltd) 
Control Of Epilepsy 
Carbamazepine 15082 Tegretol 250mg suppositories (Novartis 
Pharmaceuticals UK Ltd) 
Control Of Epilepsy 
Carbamazepine 17428 Carbamazepine 250mg suppositories Control Of Epilepsy 
Carbamazepine 17429 Carbamazepine 125mg suppositories Control Of Epilepsy 
Carbamazepine 17978 Teril Retard 200mg tablets (Taro Pharmaceuticals 
(UK) Ltd) 
Control Of Epilepsy 
Carbamazepine 18011 Teril Retard 400mg tablets (Taro Pharmaceuticals 
(UK) Ltd) 
Control Of Epilepsy 
Carbamazepine 18762 Epimaz 200mg tablets (Teva UK Ltd) Control Of Epilepsy 
Carbamazepine 18763 Epimaz 400mg tablets (Teva UK Ltd) Control Of Epilepsy 
Carbamazepine 21441 Tegretol 125mg suppositories (Novartis 
Pharmaceuticals UK Ltd) 
Control Of Epilepsy 
Carbamazepine 26012 Carbagen SR 400mg tablets (Generics (UK) Ltd) Control Of Epilepsy 
Carbamazepine 28345 Carbamazepine 100mg tablets (Teva UK Ltd) Control Of Epilepsy 
Carbamazepine 30763 Carbamazepine 100mg tablets (A A H 
Pharmaceuticals Ltd) 
Control Of Epilepsy 
Carbamazepine 32931 Carbamazepine 400mg tablets (Teva UK Ltd) Control Of Epilepsy 
Carbamazepine 34370 Carbamazepine 200mg modified-release tablets (A A 
H Pharmaceuticals Ltd) 
Control Of Epilepsy 
Carbamazepine 34904 Carbamazepine 200mg tablets (A A H 
Pharmaceuticals Ltd) 
Control Of Epilepsy 
Carbamazepine 37058 Carbamazepine 500mg/5ml oral suspension Control Of Epilepsy 
Carbamazepine 40404 Carbamazepine 400mg modified-release tablets (A A 
H Pharmaceuticals Ltd) 
Control Of Epilepsy 
Carbamazepine 43417 Carbamazepine 400mg tablets (A A H 
Pharmaceuticals Ltd) 
Control Of Epilepsy 
Carbamazepine 45903 Tegretol Prolonged Release 400mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Control Of Epilepsy 
Carbamazepine 45941 Tegretol Prolonged Release 200mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Control Of Epilepsy 
Carbamazepine 48397 Tegretol Prolonged Release 200mg tablets 
(Doncaster Pharmaceuticals Ltd) 
Control Of Epilepsy 
Carbamazepine 49833 Tegretol 200mg tablets (Lexon (UK) Ltd) Control Of Epilepsy 
  
 
3
2
7
 
Medication Product 
Code 
Product Name BNF Header 
Carbamazepine 51760 Tegretol 400mg tablets (Lexon (UK) Ltd) Control Of Epilepsy 
Carbamazepine 52840 Tegretol Prolonged Release 400mg tablets (Necessity 
Supplies Ltd) 
Control Of Epilepsy 
Carbamazepine 53492 Tegretol Prolonged Release 200mg tablets (Sigma 
Pharmaceuticals Plc) 
Control Of Epilepsy 
Carbamazepine 53893 Tegretol Prolonged Release 400mg tablets (Stephar 
(U.K.) Ltd) 
Control Of Epilepsy 
Carbamazepine 54445 Carbamazepine 400mg tablets (Sigma 
Pharmaceuticals Plc) 
Control Of Epilepsy 
Carbamazepine 55904 Carbamazepine 100mg tablets (Generics (UK) Ltd) Control Of Epilepsy 
Carbamazepine 56734 Carbamazepine 100mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Control Of Epilepsy 
Carbamazepine 2823 Tegretol retard 200mg Modified-release tablet 
(Novartis Pharmaceuticals UK Ltd) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 2824 Tegretol retard 400mg Modified-release tablet 
(Novartis Pharmaceuticals UK Ltd) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 30509 Timonil retard 400mg Modified-release tablet (C P 
Pharmaceuticals Ltd) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 32900 Carbamazepine sr 200mg Tablet (IVAX 
Pharmaceuticals UK Ltd) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 37800 Carbamazepine 200mg Modified-release tablet 
(Lagap) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 41726 Carbamazepine 100mg Tablet (IVAX Pharmaceuticals 
UK Ltd) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 46972 Carbamazepine 200mg Tablet (IVAX Pharmaceuticals 
UK Ltd) 
Control Of Epilepsy/Drugs Used For Mania And 
Hypomania 
Carbamazepine 34958 Carbamazepine 100mg Tablet (Berk Pharmaceuticals 
Ltd) 
Drugs Used For Mania And Hypomania/Control 
Of Epilepsy 
Carbamazepine 40403 Carbamazepine 400mg Modified-release tablet 
(Lagap) 
Drugs Used For Mania And Hypomania/Control 
Of Epilepsy 
Carbamazepine 43451 Carbamazepine 400mg Modified-release tablet 
(Generics (UK) Ltd) 
Drugs Used For Mania And Hypomania/Control 
Of Epilepsy 
Carbamazepine 46888 Carbamazepine 200mg Modified-release tablet 
(Generics (UK) Ltd) 
Drugs Used For Mania And Hypomania/Control 
Of Epilepsy 
Carbamazepine 47294 Carbamazepine sr 400mg Tablet (IVAX 
Pharmaceuticals UK Ltd) 
Drugs Used For Mania And Hypomania/Control 
Of Epilepsy 
Carbamazepine 53188 Carbamazepine 500mg/5ml Oral suspension 
(Martindale Pharmaceuticals Ltd) 
Drugs Used For Mania And Hypomania/Control 
Of Epilepsy 
  
 
3
2
8
 
Medication Product 
Code 
Product Name BNF Header 
Cyclosporine (IV and PO) 38056 Ciclosporin 50mg/1ml solution for infusion ampoules Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 42924 Ciclosporin 250mg/5ml solution for infusion ampoules Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 19370 Ciclosporin 50mg/ml concentrate solution infusion Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response (in Chronic Bowel 
Disorders) 
Cyclosporine (IV and PO) 26790 Sandimmun 50mg/ml Concentrate for solution for 
infusion (Novartis Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response (in Chronic Bowel 
Disorders) 
Cyclosporine (IV and PO) 47377 Ciclosporin 25mg Capsule (Hillcross Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response (in Chronic Bowel 
Disorders) 
Cyclosporine (IV and PO) 972 Neoral 25mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 1626 Ciclosporin 100mg/ml oral solution sugar free Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 2837 Ciclosporin 50mg capsules Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 13494 Sandimmun 100mg/ml oral solution (Novartis 
Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 13556 Sandimmun 100mg capsules (Novartis 
Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
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Medication Product 
Code 
Product Name BNF Header 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 16035 Ciclosporin 10mg capsules Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 47102 Capimune 50mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 52615 Neoral 100mg capsules (Sigma Pharmaceuticals Plc) Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 54134 Ciclosporin 100mg capsules (Sigma Pharmaceuticals 
Plc) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Cyclosporine (IV and PO) 16137 Neoral 10mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 46395 Capimune 100mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 48798 Ciclosporin 50mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
  
 
3
3
0
 
Medication Product 
Code 
Product Name BNF Header 
Cyclosporine (IV and PO) 54975 Ciclosporin 100mg capsules (Cubic Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 55116 Ciclosporin 25mg capsules (Cubic Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 47042 Ciclosporin 100mg Capsule (Hillcross 
Pharmaceuticals Ltd) 
Drugs Affecting The Immune Response (in 
Chronic Bowel Disorders)/Corticosteroids And 
Other Immunosuppressants 
Cyclosporine (IV and PO) 1905 Neoral 100mg/ml oral solution (Novartis 
Pharmaceuticals UK Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 2838 Ciclosporin 25mg capsules Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 15596 Sandimmun 50mg capsules (Novartis 
Pharmaceuticals UK Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 42637 Deximune 25mg capsules (Dexcel-Pharma Ltd) Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 48763 Ciclosporin 25mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 49958 Neoral 25mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 53175 Neoral 25mg capsules (Mawdsley-Brooks & Company Drugs Affecting The Immune Response For 
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Medication Product 
Code 
Product Name BNF Header 
Ltd) Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 53176 Neoral 50mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 54867 Ciclosporin 50mg capsules (Sigma Pharmaceuticals 
Plc) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 54974 Ciclosporin 50mg capsules (Cubic Pharmaceuticals 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 3920 Sandimmun 25mg capsules (Novartis 
Pharmaceuticals UK Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 46637 Capimune 25mg capsules (Generics (UK) Ltd) Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 52743 Ciclosporin 25mg capsules (Sigma Pharmaceuticals 
Plc) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 47192 Capsorin 100mg capsules (Morningside Healthcare 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs That Suppress 
The Rheumatic Disease 
Process/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic Disease 
Cyclosporine (IV and PO) 3896 Ciclosporin 100mg capsules Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
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Medication Product 
Code 
Product Name BNF Header 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 4231 Neoral 50mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 48556 Ciclosporin 100mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And Psoriasis 
Cyclosporine (IV and PO) 47047 Capsorin 50mg capsules (Morningside Healthcare 
Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
Immunosuppressants/Drugs That Suppress 
The Rheumatic Disease Process/Drugs 
Affecting The Immune Response For Eczema 
And Psoriasis 
Cyclosporine (IV and PO) 973 Neoral 100mg capsules (Novartis Pharmaceuticals 
UK Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 42448 Deximune 50mg capsules (Dexcel-Pharma Ltd) Drugs Affecting The Immune Response In 
Rheumatic Disease/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 42449 Deximune 100mg capsules (Dexcel-Pharma Ltd) Drugs Affecting The Immune Response In 
Rheumatic Disease/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Corticosteroids And Other 
Immunosuppressants 
Cyclosporine (IV and PO) 47471 Capsorin 25mg capsules (Morningside Healthcare 
Ltd) 
Drugs That Suppress The Rheumatic Disease 
Process/Drugs Affecting The Immune 
Response For Eczema And Psoriasis/Drugs 
Affecting The Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Dabigatran 39444 Dabigatran etexilate 110mg capsules  
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Medication Product 
Code 
Product Name BNF Header 
Dabigatran 39503 Dabigatran etexilate 75mg capsules  
Dabigatran 39755 Pradaxa 110mg capsules (Boehringer Ingelheim Ltd)  
Dabigatran 42474 Pradaxa 75mg capsules (Boehringer Ingelheim Ltd)  
Dabigatran 46632 Dabigatran etexilate 150mg capsules  
Dabigatran 46678 Pradaxa 150mg capsules (Boehringer Ingelheim Ltd)  
Diabetes medications 37875 Vildagliptin 50mg tablets Antidiabetic Drugs 
Diabetes medications 39149 Galvus 50mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Antidiabetic Drugs 
Diabetes medications 23 Metformin 500mg tablets Biguanides 
Diabetes medications 93 Metformin 850mg tablets Biguanides 
Diabetes medications 735 Metformin 100mg/ml Oral solution Biguanides 
Diabetes medications 7048 Metformin 500mg modified-release tablets Biguanides 
Diabetes medications 7166 Glucophage 500mg tablets (Merck Serono Ltd) Biguanides 
Diabetes medications 7610 Glucophage 850mg tablets (Merck Serono Ltd) Biguanides 
Diabetes medications 11990 Metformin 500mg/5ml oral solution sugar free Biguanides 
Diabetes medications 16044 Glucophage SR 500mg tablets (Merck Serono Ltd) Biguanides 
Diabetes medications 25678 Glucamet 500mg Tablet (Opus Pharmaceuticals Ltd) Biguanides 
Diabetes medications 26258 Glucamet 850mg Tablet (Opus Pharmaceuticals Ltd) Biguanides 
Diabetes medications 27501 Orabet 500mg Tablet (Lagap) Biguanides 
Diabetes medications 31146 Metsol 500mg/5ml oral solution (Kappin Ltd) Biguanides 
Diabetes medications 33087 Metformin 500mg tablets (Actavis UK Ltd) Biguanides 
Diabetes medications 33674 Metformin 850mg tablets (A A H Pharmaceuticals Ltd) Biguanides 
Diabetes medications 34004 Metformin 500mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Biguanides 
Diabetes medications 34020 Metformin 850mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Biguanides 
Diabetes medications 34135 Metformin 500mg Tablet (M & A Pharmachem Ltd) Biguanides 
Diabetes medications 34323 Metformin 500mg tablets (A A H Pharmaceuticals Ltd) Biguanides 
Diabetes medications 34504 Metformin 500mg tablets (Wockhardt UK Ltd) Biguanides 
Diabetes medications 34598 Metformin 500mg tablets (Generics (UK) Ltd) Biguanides 
Diabetes medications 34697 Metformin 850mg tablets (Wockhardt UK Ltd) Biguanides 
Diabetes medications 34742 Metformin 850mg tablets (Teva UK Ltd) Biguanides 
Diabetes medications 34836 Metformin 850mg tablets (Actavis UK Ltd) Biguanides 
Diabetes medications 34917 Metformin 500mg tablets (Teva UK Ltd) Biguanides 
Diabetes medications 38355 Metformin 750mg modified-release tablets Biguanides 
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Code 
Product Name BNF Header 
Diabetes medications 38400 Glucophage SR 750mg tablets (Merck Serono Ltd) Biguanides 
Diabetes medications 39560 Bolamyn SR 500mg tablets (Teva UK Ltd) Biguanides 
Diabetes medications 39598 Metformin 1g modified-release tablets Biguanides 
Diabetes medications 39729 Glucophage SR 1000mg tablets (Merck Serono Ltd) Biguanides 
Diabetes medications 39988 Metformin 500mg oral powder sachets sugar free Biguanides 
Diabetes medications 40007 Glucophage 1000mg oral powder sachets (Merck 
Serono Ltd) 
Biguanides 
Diabetes medications 40110 Glucophage 500mg oral powder sachets (Merck 
Serono Ltd) 
Biguanides 
Diabetes medications 40233 Metformin 1g oral powder sachets sugar free Biguanides 
Diabetes medications 42161 Orabet 500mg Tablet (Sandoz Ltd) Biguanides 
Diabetes medications 43270 Metformin 500mg/5ml oral solution sugar free 
(Rosemont Pharmaceuticals Ltd) 
Biguanides 
Diabetes medications 44250 Metformin 500mg/5ml Oral solution (Hillcross 
Pharmaceuticals Ltd) 
Biguanides 
Diabetes medications 45581 Metabet SR 500mg tablets (Morningside Healthcare 
Ltd) 
Biguanides 
Diabetes medications 46989 Metabet SR 1000mg tablets (Morningside Healthcare 
Ltd) 
Biguanides 
Diabetes medications 47939 Glucient SR 500mg tablets (Consilient Health Ltd) Biguanides 
Diabetes medications 48149 Metformin 500mg tablets (Almus Pharmaceuticals Ltd) Biguanides 
Diabetes medications 49502 Glucophage SR 500mg tablets (Mawdsley-Brooks & 
Company Ltd) 
Biguanides 
Diabetes medications 49738 Metformin 1g modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Biguanides 
Diabetes medications 50570 Glucophage SR 500mg tablets (Lexon (UK) Ltd) Biguanides 
Diabetes medications 50821 Metformin 850mg tablets (Pfizer Ltd) Biguanides 
Diabetes medications 50970 Metformin 500mg tablets (Bristol Laboratories Ltd) Biguanides 
Diabetes medications 51080 Metabet SR 1000mg tablets (Actavis UK Ltd) Biguanides 
Diabetes medications 51135 Metformin 500mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Biguanides 
Diabetes medications 51527 Metformin 500mg tablets (Boston Healthcare Ltd) Biguanides 
Diabetes medications 52221 Diagemet XL 500mg tablets (Genus Pharmaceuticals 
Ltd) 
Biguanides 
Diabetes medications 52442 Metformin 500mg tablets (Pfizer Ltd) Biguanides 
Diabetes medications 52634 Glucophage SR 500mg tablets (Doncaster 
Pharmaceuticals Ltd) 
Biguanides 
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Diabetes medications 53478 Metformin 500mg modified-release tablets (Kent 
Pharmaceuticals Ltd) 
Biguanides 
Diabetes medications 53774 Metabet SR 500mg tablets (Actavis UK Ltd) Biguanides 
Diabetes medications 53867 Metformin 500mg tablets (Zentiva) Biguanides 
Diabetes medications 54442 Metformin (roi) 1000mg Tablet Biguanides 
Diabetes medications 54898 Metformin 850mg tablets (Almus Pharmaceuticals Ltd) Biguanides 
Diabetes medications 55270 Duformin 500mg Tablet (Dumex Ltd) Biguanides 
Diabetes medications 55711 Metformin 500mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Biguanides 
Diabetes medications 55739 Metformin 500mg tablets (Tillomed Laboratories Ltd) Biguanides 
Diabetes medications 57147 Bolamyn SR 1000mg tablets (Teva UK Ltd) Biguanides 
Diabetes medications 5845 Mixtard 30 InnoLet 100units/ml suspension for 
injection 3ml pre-filled pen (Novo Nordisk Ltd) 
Biphasic Insulins 
Diabetes medications 7228 NovoMix 30 FlexPen 100units/ml suspension for 
injection 3ml pre-filled pen (Novo Nordisk Ltd) 
Biphasic Insulins 
Diabetes medications 7231 Mixtard 30 Penfill 100units/ml suspension for injection 
3ml cartridges (Novo Nordisk Ltd) 
Biphasic Insulins 
Diabetes medications 7267 NovoMix 30 Penfill 100units/ml suspension for 
injection 3ml cartridges (Novo Nordisk Ltd) 
Biphasic Insulins 
Diabetes medications 7300 Mixtard 30 100units/ml suspension for injection 10ml 
vials (Novo Nordisk Ltd) 
Biphasic Insulins 
Diabetes medications 10277 Humulin M3 100units/ml suspension for injection 3ml 
cartridges (Eli Lilly and Company Ltd) 
Biphasic Insulins 
Diabetes medications 16152 Insulin isophane biphasic human 30/70 100units/ml 
suspension for injection 3ml cartridges 
Biphasic Insulins 
Diabetes medications 19513 Humulin M3 100units/ml suspension for injection 10ml 
vials (Eli Lilly and Company Ltd) 
Biphasic Insulins 
Diabetes medications 19878 Insulin isophane biphasic human 30/70 100units/ml 
suspension for injection 3ml pre-filled disposable 
devices 
Biphasic Insulins 
Diabetes medications 20995 Hypurin Porcine 30/70 Mix 100units/ml suspension for 
injection 3ml cartridges (Wockhardt UK Ltd) 
Biphasic Insulins 
Diabetes medications 21232 Insulin isophane biphasic human 30/70 100units/ml 
suspension for injection 10ml vials 
Biphasic Insulins 
Diabetes medications 23099 Insulin aspart biphasic 30/70 100units/ml suspension 
for injection 3ml pre-filled disposable devices 
Biphasic Insulins 
Diabetes medications 24002 Insuman Comb 25 100units/ml suspension for Biphasic Insulins 
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injection 5ml vials (Sanofi) 
Diabetes medications 24795 Insulin aspart biphasic 30/70 100units/ml suspension 
for injection 3ml cartridges 
Biphasic Insulins 
Diabetes medications 24800 Hypurin Porcine 30/70 Mix 100units/ml suspension for 
injection 10ml vials (Wockhardt UK Ltd) 
Biphasic Insulins 
Diabetes medications 24993 Insuman Comb 25 100units/ml suspension for 
injection 3ml cartridges (Sanofi) 
Biphasic Insulins 
Diabetes medications 25133 Insuman Comb 25 100units/ml suspension for 
injection 3ml pre-filled OptiSet pen (Sanofi) 
Biphasic Insulins 
Diabetes medications 27280 Insulin isophane biphasic porcine 30/70 100units/ml 
suspension for injection 10ml vials 
Biphasic Insulins 
Diabetes medications 28096 Insulin isophane biphasic human 50/50 100units/ml 
suspension for injection 3ml cartridges 
Biphasic Insulins 
Diabetes medications 30819 Insuman Comb 15 100units/ml suspension for 
injection 3ml pre-filled OptiSet pen (Sanofi) 
Biphasic Insulins 
Diabetes medications 31205 Insuman Comb 50 100units/ml suspension for 
injection 3ml pre-filled OptiSet pen (Sanofi) 
Biphasic Insulins 
Diabetes medications 35253 Insuman Comb 50 100units/ml suspension for 
injection 3ml cartridges (Sanofi) 
Biphasic Insulins 
Diabetes medications 36031 Insulin isophane biphasic porcine 30/70 100units/ml 
suspension for injection 3ml cartridges 
Biphasic Insulins 
Diabetes medications 36194 Insulin isophane biphasic human 25/75 100units/ml 
suspension for injection 3ml cartridges 
Biphasic Insulins 
Diabetes medications 41120 Insulin isophane biphasic human 50/50 100units/ml 
suspension for injection 3ml pre-filled disposable 
devices 
Biphasic Insulins 
Diabetes medications 42954 Insulin isophane biphasic human 25/75 100units/ml 
suspension for injection 5ml vials 
Biphasic Insulins 
Diabetes medications 43991 Humulin M3 KwikPen 100units/ml suspension for 
injection 3ml pre-filled pen (Eli Lilly and Company Ltd) 
Biphasic Insulins 
Diabetes medications 44378 Insulin isophane biphasic human 25/75 100units/ml 
suspension for injection 3ml pre-filled disposable 
devices 
Biphasic Insulins 
Diabetes medications 44480 Insuman Comb 25 100units/ml suspension for 
injection 3ml pre-filled SoloStar pen (Sanofi) 
Biphasic Insulins 
Diabetes medications 45158 Insuman Comb 15 100units/ml suspension for 
injection 3ml cartridges (Sanofi) 
Biphasic Insulins 
Diabetes medications 56489 NovoMix 30 Penfill 100units/ml suspension for Biphasic Insulins 
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injection 3ml cartridges (Waymade Healthcare Plc) 
Diabetes medications 56857 Insulin isophane biphasic human 15/85 100units/ml 
suspension for injection 3ml cartridges 
Biphasic Insulins 
Diabetes medications 53710 Insulin human 500units/ml solution for injection 20ml 
vials 
Insulins 
Diabetes medications 1593 Insulatard penfill 100 100iu/ml Penfill (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 1595 Insulatard NovoLet 100units/ml suspension for 
injection (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 1649 Human actraphane 100iu/ml Injection (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 1805 Mixtard 30/70 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 1806 Penmix 30/70 100iu/ml Penfill (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 1886 Insulatard 100iu/ml GE injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 2220 Penmix 20/80 Pen (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 2454 Mixtard 30 penfill 100 100iu/ml Penfill (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 2929 Mixtard 30 100iu/ml GE injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 3396 Penmix 10/90 Penfill (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 3439 Penmix 10/90 Pen (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 3550 Mixtard 40 penfill 100 100iu/ml Penfill (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 3551 Mixtard 20 penfill 100 100iu/ml Penfill (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 4163 Rapitard MC 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 4198 Humulin m3 100unit/ml M3 injection (Eli Lilly and 
Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 4199 Humulin m1 100unit/ml M1 injection (Eli Lilly and 
Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 4715 Humalog mix 25 25/75 100units/ml Injection (Eli Lilly 
and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 4760 Humulin i 100unit/ml Injection (Eli Lilly and Company 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 4784 Lentard mc 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 4790 Mixtard 50 penfill 100 100iu/ml Penfill (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 5250 Insulin biphasic lispro human prb 25:75; 100 units/ml Intermediate- And Long-acting Insulins 
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Injection 
Diabetes medications 5255 Mixtard 10 penfill 100 100iu/ml Penfill (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 5501 Insuman basal 100iu/ml Injection (Aventis Pharma) Intermediate- And Long-acting Insulins 
Diabetes medications 5891 Insulatard FlexPen 100units/ml suspension for 
injection (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 5953 Insulin glargine 100iu/ml Injection Intermediate- And Long-acting Insulins 
Diabetes medications 6057 Lantus 100iu/ml Injection (Aventis Pharma) Intermediate- And Long-acting Insulins 
Diabetes medications 6061 Novomix 30 30/70 100units/ml Injection (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 6958 Levemir FlexPen 100units/ml solution for injection 3ml 
pre-filled pen (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 6965 Levemir Penfill 100units/ml solution for injection 3ml 
cartridges (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 7237 Lantus 100units/ml solution for injection 3ml pre-filled 
OptiSet pen (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 7266 Lantus 100units/ml solution for injection 3ml cartridges 
(Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 7350 Insulin isophane porcine 100units/ml suspension for 
injection 10ml vials 
Intermediate- And Long-acting Insulins 
Diabetes medications 7393 Insulin glargine 100units/ml solution for injection 3ml 
cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 7400 Insulin glargine 100units/ml solution for injection 3ml 
pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
Diabetes medications 7402 Lantus 100units/ml solution for injection 10ml vials 
(Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 7771 Human protaphane penfill 100 100unit/ml Penfill 
(Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 7772 Human protaphane 100unit/ml Injection (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 8118 Humaject i 100iu/ml Pen (Eli Lilly and Company Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 8203 Penmix 50/50 100iu/ml Penfill (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 8322 Insulin zinc suspension mixed human pyr 100unit/ml 
Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 8895 Initard 50/50 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 9341 Insulin biphasic isophane human prb 30:70; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
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Medication Product 
Code 
Product Name BNF Header 
Diabetes medications 9376 Insulin zinc suspension crystalline human pyr 
100unit/ml long acting Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 9503 Hypurin Bovine Protamine Zinc 100units/ml 
suspension for injection 10ml vials (Wockhardt UK 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 9737 Insulatard innolet 100iu/ml Injection (Novo Nordisk 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10001 Humalog Mix50 Pen 100units/ml suspension for 
injection 3ml pre-filled pen (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10067 Insulin biphasic aspart human pyr 30:70; 100 units/ml 
Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 10184 Insulin detemir 100 iu/ml Solution for injection Intermediate- And Long-acting Insulins 
Diabetes medications 10207 Insulin isophane human 100units/ml suspension for 
injection 3ml cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 10208 Insulatard InnoLet 100units/ml suspension for 
injection 3ml pre-filled pen (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10225 Lantus 100units/ml solution for injection 3ml OptiClik 
cartridges (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10229 Humulin I Pen 100units/ml suspension for injection 
3ml pre-filled pen (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10243 Humalog Mix25 100units/ml suspension for injection 
3ml cartridges (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10259 Insulin glargine 100units/ml solution for injection 10ml 
vials 
Intermediate- And Long-acting Insulins 
Diabetes medications 10484 Penmix 20/80 Penfill (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 10887 Penmix 40/60 100iu/ml Penfill (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 10910 Humaject m2 100iu/ml M2 pen (Eli Lilly and Company 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 10915 Humaject m1 100iu/ml M1 pen (Eli Lilly and Company 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 11055 Insulin biphasic isophane human pyr 20:80; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 11056 Insulin biphasic isophane human pyr 30:70; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 11080 Insulin isophane human prb 100iu/ml Injection Intermediate- And Long-acting Insulins 
Diabetes medications 11107 Humulin m4 100unit/ml M4 injection (Eli Lilly and 
Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 12035 Insulin zinc mixed bovine 100units/ml suspension for Intermediate- And Long-acting Insulins 
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injection 10ml vials 
Diabetes medications 12299 Semitard mc 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 13416 Insulin biphasic 100 units/ml Injection Intermediate- And Long-acting Insulins 
Diabetes medications 13516 Hypurin bovine isophane 100unit/ml Injection (C P 
Pharmaceuticals Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 13729 Insulin isophane human emp 100unit/ml Injection Intermediate- And Long-acting Insulins 
Diabetes medications 13837 Insulin biphasic isophane human prb 10:90; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 14270 Humalog Mix25 Pen 100units/ml suspension for 
injection 3ml pre-filled pen (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 14290 Insulatard Penfill 100units/ml suspension for injection 
3ml cartridges (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 14301 Insulin detemir 100units/ml solution for injection 3ml 
cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 14330 Insulin detemir 100units/ml solution for injection 3ml 
pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
Diabetes medications 14340 Hypurin Bovine Isophane 100units/ml suspension for 
injection 10ml vials (Wockhardt UK Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 14357 Humulin I 100units/ml suspension for injection 3ml 
cartridges (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 14505 Insulin protamine zinc bovine 100units/ml suspension 
for injection 10ml vials 
Intermediate- And Long-acting Insulins 
Diabetes medications 14644 Insulin biphasic isophane human prb 20:80; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 14649 Insulin biphasic isophane human pyr 10:90; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 14918 Humulin I 100units/ml suspension for injection 10ml 
vials (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 14925 Insulin isophane human vial 100unit/ml Sterile 
suspension injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 14928 Insulatard 100units/ml suspension for injection 10ml 
vials (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 14933 Hypurin Porcine Isophane 100units/ml suspension for 
injection 3ml cartridges (Wockhardt UK Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 15199 Insuman comb 25 100iu/ml Injection (Aventis Pharma) Intermediate- And Long-acting Insulins 
Diabetes medications 15961 Insulin isophane human crb 100iu/ml Injection Intermediate- And Long-acting Insulins 
Diabetes medications 16682 Tempulin 100unit/ml Injection (Knoll Ltd) Intermediate- And Long-acting Insulins 
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Diabetes medications 16700 Insulin zinc mixed bovine vial 100unit/ml Sterile 
suspension injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 17712 Hypurin Bovine Lente 100units/ml suspension for 
injection 10ml vials (Wockhardt UK Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 17731 Penmix 50/50 100iu/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 17809 Humaject m4 100iu/ml M4 pen (Eli Lilly and Company 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 18590 Insulin isophane bovine 100units/ml suspension for 
injection 10ml vials 
Intermediate- And Long-acting Insulins 
Diabetes medications 18593 Humalog Mix50 100units/ml suspension for injection 
3ml cartridges (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 20422 Insuman comb 15 100iu/ml Injection (Aventis Pharma) Intermediate- And Long-acting Insulins 
Diabetes medications 21110 Insulin biphasic isophane human prb 50:50; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 21347 Penmix 40/60 100iu/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 21374 Insulin biphasic isophane human prb 40:60; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 21395 Insulin biphasic isophane human pyr 40:60; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 21554 Insuman comb 50 100iu/ml Injection (Aventis Pharma) Intermediate- And Long-acting Insulins 
Diabetes medications 22058 Pur-in mix 15/85 Injection (C P Pharmaceuticals Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 22155 Humaject m5 100iu/ml M5 pen (Eli Lilly and Company 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 23992 Insuman Basal 100units/ml suspension for injection 
3ml pre-filled OptiSet pen (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 25812 Insulin isophane human 100units/ml suspension for 
injection 3ml pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
Diabetes medications 26403 Pur-in mix 25/75 Injection (C P Pharmaceuticals Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 26498 Insulin zinc suspension mixed bovine and porcine 
100unit/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 27177 Insulin biphasic lispro human prb 50:50; 100 units/ml 
Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 27461 Insuman Basal 100units/ml suspension for injection 
3ml cartridges (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 27614 Penmix 30/70 100iu/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 28183 Hypurin Porcine Isophane 100units/ml suspension for 
injection 10ml vials (Wockhardt UK Ltd) 
Intermediate- And Long-acting Insulins 
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Diabetes medications 28185 Insulin lispro biphasic 25/75 100units/ml suspension 
for injection 3ml cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 28588 Hypurin Bovine Isophane 100units/ml suspension for 
injection 3ml cartridges (Wockhardt UK Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 29837 Insulin biphasic isophane human prb 25:75; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 30236 Isophane insulin 100iu/ml Injection Intermediate- And Long-acting Insulins 
Diabetes medications 30686 Insulin isophane porcine 100units/ml suspension for 
injection 3ml cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 31258 Insulin lispro biphasic 25/75 100units/ml suspension 
for injection 3ml pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
Diabetes medications 33167 Insulin biphasic isophane human crb 25:75; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 33966 Insulatard 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 34031 Monotard mc 100unit/ml Injection (Novo Nordisk Ltd) Intermediate- And Long-acting Insulins 
Diabetes medications 34097 Human initard 50/50 100unit/ml Injection (Novo 
Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 35260 Levemir InnoLet 100units/ml solution for injection 3ml 
pre-filled pen (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 35468 Insuman Basal 100units/ml suspension for injection 
5ml vials (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 35701 Insulin lispro biphasic 50/50 100units/ml suspension 
for injection 3ml pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
Diabetes medications 36066 Insulin isophane bovine 100units/ml suspension for 
injection 3ml cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 36146 Insulin lispro biphasic 50/50 100units/ml suspension 
for injection 3ml cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 36853 Lantus 100units/ml solution for injection 3ml pre-filled 
SoloStar pen (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 38422 Isophane 100iu/ml Injection (Celltech Pharma Europe 
Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 39006 Humalog Mix25 KwikPen 100units/ml suspension for 
injection 3ml pre-filled pen (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 39086 Humalog Mix50 KwikPen 100units/ml suspension for 
injection 3ml pre-filled pen (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 41834 Insulin zinc suspension lente 100iu/ml Injection 
(Celltech Pharma Europe Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 42395 Humalog Mix25 100units/ml suspension for injection Intermediate- And Long-acting Insulins 
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10ml vials (Eli Lilly and Company Ltd) 
Diabetes medications 43950 Humulin I KwikPen 100units/ml suspension for 
injection 3ml pre-filled pen (Eli Lilly and Company Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 43953 Insulin lispro biphasic 25/75 100units/ml suspension 
for injection 10ml vials 
Intermediate- And Long-acting Insulins 
Diabetes medications 44251 Insulin zinc suspension mixed porcine 100unit/ml 
Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 46001 Insuman Basal 100units/ml suspension for injection 
3ml pre-filled SoloStar pen (Sanofi) 
Intermediate- And Long-acting Insulins 
Diabetes medications 47856 Neuphane 100unit/ml Injection (Wellcome Medical 
Division) 
Intermediate- And Long-acting Insulins 
Diabetes medications 49831 Lantus 100units/ml solution for injection 3ml pre-filled 
SoloStar pen (Necessity Supplies Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 50633 Lantus 100units/ml solution for injection 3ml cartridges 
(Necessity Supplies Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 52522 Humalog Mix50 KwikPen 100units/ml suspension for 
injection 3ml pre-filled pen (Doncaster 
Pharmaceuticals Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 52748 Insulatard Penfill 100units/ml suspension for injection 
3ml cartridges (Waymade Healthcare Plc) 
Intermediate- And Long-acting Insulins 
Diabetes medications 54462 Insulin biphasic isophane human emp 25:75; 100 
units/ml Injection 
Intermediate- And Long-acting Insulins 
Diabetes medications 55234 Tresiba FlexTouch 200units/ml solution for injection 
3ml pre-filled pen (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 55462 Tresiba FlexTouch 100units/ml solution for injection 
3ml pre-filled pen (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 55517 Insulin isophane human 100units/ml suspension for 
injection 10ml vials 
Intermediate- And Long-acting Insulins 
Diabetes medications 55618 Levemir FlexPen 100units/ml solution for injection 3ml 
pre-filled pen (Waymade Healthcare Plc) 
Intermediate- And Long-acting Insulins 
Diabetes medications 55687 Insulin degludec 100units/ml solution for injection 3ml 
pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
Diabetes medications 55907 Insulin degludec 100units/ml solution for injection 3ml 
cartridges 
Intermediate- And Long-acting Insulins 
Diabetes medications 55910 Tresiba Penfill 100units/ml solution for injection 3ml 
cartridges (Novo Nordisk Ltd) 
Intermediate- And Long-acting Insulins 
Diabetes medications 56691 Insulin degludec 200units/ml solution for injection 3ml 
pre-filled disposable devices 
Intermediate- And Long-acting Insulins 
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Diabetes medications 479 Acarbose 50mg tablets Other Antidiabetic Drugs 
Diabetes medications 548 Pioglitazone 15mg tablets Other Antidiabetic Drugs 
Diabetes medications 3740 Guar gum 90% granules Other Antidiabetic Drugs 
Diabetes medications 4307 Guarina Sachets (Norgine Pharmaceuticals Ltd) Other Antidiabetic Drugs 
Diabetes medications 5174 Acarbose 100mg tablets Other Antidiabetic Drugs 
Diabetes medications 5621 Glucobay 50mg tablets (Bayer Plc) Other Antidiabetic Drugs 
Diabetes medications 5678 Nateglinide 120mg tablets Other Antidiabetic Drugs 
Diabetes medications 5989 Nateglinide 180mg tablets Other Antidiabetic Drugs 
Diabetes medications 7695 Guarem Sachets (Shire Pharmaceuticals Ltd) Other Antidiabetic Drugs 
Diabetes medications 9105 Glucobay 100mg tablets (Bayer Plc) Other Antidiabetic Drugs 
Diabetes medications 9699 Pioglitazone 30mg tablets Other Antidiabetic Drugs 
Diabetes medications 9707 Repaglinide 1mg tablets Other Antidiabetic Drugs 
Diabetes medications 9748 Repaglinide 2mg tablets Other Antidiabetic Drugs 
Diabetes medications 9865 Repaglinide 500microgram tablets Other Antidiabetic Drugs 
Diabetes medications 10051 Pioglitazone 45mg tablets Other Antidiabetic Drugs 
Diabetes medications 11316 NovoNorm 500microgram tablets (Novo Nordisk Ltd) Other Antidiabetic Drugs 
Diabetes medications 11321 NovoNorm 1mg tablets (Novo Nordisk Ltd) Other Antidiabetic Drugs 
Diabetes medications 11366 NovoNorm 2mg tablets (Novo Nordisk Ltd) Other Antidiabetic Drugs 
Diabetes medications 11483 Nateglinide 60mg tablets Other Antidiabetic Drugs 
Diabetes medications 13628 Romozin 400mg Tablet (Glaxo Wellcome UK Ltd) Other Antidiabetic Drugs 
Diabetes medications 15955 Starlix 120mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 18220 Pioglitazone 15mg / Metformin 850mg tablets Other Antidiabetic Drugs 
Diabetes medications 19472 Actos 45mg tablets (Takeda UK Ltd) Other Antidiabetic Drugs 
Diabetes medications 20287 Actos 15mg tablets (Takeda UK Ltd) Other Antidiabetic Drugs 
Diabetes medications 20889 Actos 30mg tablets (Takeda UK Ltd) Other Antidiabetic Drugs 
Diabetes medications 23945 Starlix 60mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 27125 Starlix 180mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 31077 Competact 15mg/850mg tablets (Takeda UK Ltd) Other Antidiabetic Drugs 
Diabetes medications 35022 Sitagliptin 100mg tablets Other Antidiabetic Drugs 
Diabetes medications 35144 Byetta 5micrograms/0.02ml solution for injection 1.2ml 
pre-filled disposable devices (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
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Diabetes medications 35149 Exenatide 10micrograms/0.04ml solution for injection 
2.4ml pre-filled disposable devices 
Other Antidiabetic Drugs 
Diabetes medications 35150 Byetta 10micrograms/0.04ml solution for injection 
2.4ml pre-filled disposable devices (Bristol-Myers 
Squibb Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 35251 Exenatide 5micrograms/0.02ml solution for injection 
1.2ml pre-filled disposable devices 
Other Antidiabetic Drugs 
Diabetes medications 35462 Januvia 100mg tablets (Merck Sharp & Dohme Ltd) Other Antidiabetic Drugs 
Diabetes medications 35561 Prandin 2mg tablets (Novo Nordisk Ltd) Other Antidiabetic Drugs 
Diabetes medications 36774 Prandin 1mg tablets (Novo Nordisk Ltd) Other Antidiabetic Drugs 
Diabetes medications 36948 Prandin 0.5mg tablets (Novo Nordisk Ltd) Other Antidiabetic Drugs 
Diabetes medications 37617 Rosiglitazone 2mg tablet Other Antidiabetic Drugs 
Diabetes medications 37874 Vildagliptin 50mg / Metformin 850mg tablets Other Antidiabetic Drugs 
Diabetes medications 39203 Eucreas 50mg/850mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 40642 Victoza 6mg/ml solution for injection 3ml pre-filled pen 
(Novo Nordisk Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 40693 Liraglutide 6mg/ml solution for injection 3ml pre-filled 
disposable devices 
Other Antidiabetic Drugs 
Diabetes medications 41204 Saxagliptin 5mg tablets Other Antidiabetic Drugs 
Diabetes medications 41431 Onglyza 5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 43619 Metformin 1g / Sitagliptin 50mg tablets Other Antidiabetic Drugs 
Diabetes medications 43684 Janumet 50mg/1000mg tablets (Merck Sharp & 
Dohme Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 45775 Saxagliptin 2.5mg tablets Other Antidiabetic Drugs 
Diabetes medications 45821 Onglyza 2.5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 46458 Exenatide 2mg powder and solvent for suspension for 
injection vials 
Other Antidiabetic Drugs 
Diabetes medications 46469 Bydureon 2mg powder and solvent for suspension for 
injection vials (Bristol-Myers Squibb Pharmaceuticals 
Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 46665 Linagliptin 5mg tablets Other Antidiabetic Drugs 
Diabetes medications 46716 Trajenta 5mg tablets (Boehringer Ingelheim Ltd) Other Antidiabetic Drugs 
Diabetes medications 48120 Avandia 2mg Tablet (GlaxoSmithKline UK Ltd) Other Antidiabetic Drugs 
Diabetes medications 48139 Pioglitazone 30mg tablets (A A H Pharmaceuticals Other Antidiabetic Drugs 
  
 
3
4
6
 
Medication Product 
Code 
Product Name BNF Header 
Ltd) 
Diabetes medications 48401 Sitagliptin 50mg tablets Other Antidiabetic Drugs 
Diabetes medications 48533 Sitagliptin 25mg tablets Other Antidiabetic Drugs 
Diabetes medications 50087 Januvia 50mg tablets (Merck Sharp & Dohme Ltd) Other Antidiabetic Drugs 
Diabetes medications 50124 Januvia 25mg tablets (Merck Sharp & Dohme Ltd) Other Antidiabetic Drugs 
Diabetes medications 52203 Enyglid 0.5mg tablets (Consilient Health Ltd) Other Antidiabetic Drugs 
Diabetes medications 54182 Dapagliflozin 10mg tablets Other Antidiabetic Drugs 
Diabetes medications 54203 Forxiga 10mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 54265 Dapagliflozin 5mg tablets Other Antidiabetic Drugs 
Diabetes medications 54480 Forxiga 5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 54891 Saxagliptin 2.5mg / Metformin 1g tablets Other Antidiabetic Drugs 
Diabetes medications 54973 Saxagliptin 2.5mg / Metformin 850mg tablets Other Antidiabetic Drugs 
Diabetes medications 55413 Lixisenatide 20micrograms/0.2ml solution for injection 
3ml pre-filled disposable devices 
Other Antidiabetic Drugs 
Diabetes medications 55459 Lixisenatide 10micrograms/0.2ml solution for injection 
3ml pre-filled disposable devices 
Other Antidiabetic Drugs 
Diabetes medications 55723 Lixisenatide 10micrograms/0.2ml solution for injection 
3ml pre-filled disposable devices and Lixisenatide 
20micrograms/0.2ml solution for injection 3ml pre-
filled disposable devices 
Other Antidiabetic Drugs 
Diabetes medications 55728 Lyxumia 10micrograms/0.2ml solution for injection 3ml 
pre-filled pen (Sanofi) 
Other Antidiabetic Drugs 
Diabetes medications 55729 Lyxumia 20micrograms/0.2ml solution for injection 3ml 
pre-filled pen (Sanofi) 
Other Antidiabetic Drugs 
Diabetes medications 55767 Lyxumia 10micrograms/0.2ml solution for injection 3ml 
pre-filled pen and Lyxumia 20micrograms/0.2ml 
solution for injection 3ml pre-filled pen (Sanofi) 
Other Antidiabetic Drugs 
Diabetes medications 56208 Pioglitazone 15mg tablets (A A H Pharmaceuticals 
Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 56831 Troglitazone 200mg Tablet Other Antidiabetic Drugs 
Diabetes medications 56965 Komboglyze 2.5mg/1000mg tablets (Bristol-Myers 
Squibb Pharmaceuticals Ltd) 
Other Antidiabetic Drugs 
Diabetes medications 5021 NovoRapid Penfill 100units/ml solution for injection 
3ml cartridges (Novo Nordisk Ltd) 
Short-acting Insulins 
Diabetes medications 5892 NovoRapid FlexPen 100units/ml solution for injection Short-acting Insulins 
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3ml pre-filled pen (Novo Nordisk Ltd) 
Diabetes medications 6209 NovoRapid 100units/ml solution for injection 10ml 
vials (Novo Nordisk Ltd) 
Short-acting Insulins 
Diabetes medications 6447 Insulin aspart human pyr 100 iu/ml Injection Short-acting Insulins 
Diabetes medications 7318 Humalog 100units/ml solution for injection 3ml 
cartridges (Eli Lilly and Company Ltd) 
Short-acting Insulins 
Diabetes medications 7349 Actrapid 100units/ml solution for injection 10ml vials 
(Novo Nordisk Ltd) 
Short-acting Insulins 
Diabetes medications 9521 Pork Actrapid 100units/ml solution for injection 10ml 
vials (Novo Nordisk Ltd) 
Short-acting Insulins 
Diabetes medications 10264 Humalog Pen 100units/ml solution for injection 3ml 
pre-filled pen (Eli Lilly and Company Ltd) 
Short-acting Insulins 
Diabetes medications 14299 Insulin glulisine 100units/ml solution for injection 3ml 
cartridges 
Short-acting Insulins 
Diabetes medications 14313 Insulin lispro 100units/ml solution for injection 3ml 
cartridges 
Short-acting Insulins 
Diabetes medications 14339 Hypurin Bovine Neutral 100units/ml solution for 
injection 10ml vials (Wockhardt UK Ltd) 
Short-acting Insulins 
Diabetes medications 14345 Apidra 100units/ml solution for injection 3ml cartridges 
(Sanofi) 
Short-acting Insulins 
Diabetes medications 14362 Insulin lispro 100units/ml solution for injection 3ml pre-
filled disposable devices 
Short-acting Insulins 
Diabetes medications 14930 Hypurin Porcine Neutral 100units/ml solution for 
injection 3ml cartridges (Wockhardt UK Ltd) 
Short-acting Insulins 
Diabetes medications 14944 Humulin S 100units/ml solution for injection 3ml 
cartridges (Eli Lilly and Company Ltd) 
Short-acting Insulins 
Diabetes medications 16129 Insulin soluble human 100units/ml solution for 
injection 3ml cartridges 
Short-acting Insulins 
Diabetes medications 16142 Insulin aspart 100units/ml solution for injection 3ml 
cartridges 
Short-acting Insulins 
Diabetes medications 18224 Humalog 100units/ml solution for injection 10ml vials 
(Eli Lilly and Company Ltd) 
Short-acting Insulins 
Diabetes medications 18592 Insulin soluble bovine 100units/ml solution for injection 
10ml vials 
Short-acting Insulins 
Diabetes medications 19491 Apidra 100units/ml solution for injection 10ml vials 
(Sanofi) 
Short-acting Insulins 
Diabetes medications 19877 Insulin aspart 100units/ml solution for injection 3ml 
pre-filled disposable devices 
Short-acting Insulins 
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Diabetes medications 21235 Humulin S 100units/ml solution for injection 10ml vials 
(Eli Lilly and Company Ltd) 
Short-acting Insulins 
Diabetes medications 21583 Apidra 100units/ml solution for injection 3ml pre-filled 
OptiSet pen (Sanofi) 
Short-acting Insulins 
Diabetes medications 21590 Insulin glulisine 100units/ml solution for injection 3ml 
pre-filled disposable devices 
Short-acting Insulins 
Diabetes medications 22983 Insuman Rapid 100units/ml solution for injection 3ml 
cartridges (Sanofi) 
Short-acting Insulins 
Diabetes medications 23231 Hypurin Bovine Neutral 100units/ml solution for 
injection 3ml cartridges (Wockhardt UK Ltd) 
Short-acting Insulins 
Diabetes medications 23993 Insuman Rapid 100units/ml solution for injection 3ml 
pre-filled OptiSet pen (Sanofi) 
Short-acting Insulins 
Diabetes medications 25479 Insulin soluble porcine 100units/ml solution for 
injection 3ml cartridges 
Short-acting Insulins 
Diabetes medications 26060 Insulin lispro 100units/ml solution for injection 10ml 
vials 
Short-acting Insulins 
Diabetes medications 26098 Hypurin Porcine Neutral 100units/ml solution for 
injection 10ml vials (Wockhardt UK Ltd) 
Short-acting Insulins 
Diabetes medications 27396 Insulin soluble porcine 100units/ml solution for 
injection 10ml vials 
Short-acting Insulins 
Diabetes medications 27402 Insulin soluble human 100units/ml solution for 
injection 10ml vials 
Short-acting Insulins 
Diabetes medications 28101 Insulin glulisine 100units/ml solution for injection 10ml 
vials 
Short-acting Insulins 
Diabetes medications 28442 Insulin glulisine 100unit/ml Solution for injection Short-acting Insulins 
Diabetes medications 29567 Insulin aspart 100units/ml solution for injection 10ml 
vials 
Short-acting Insulins 
Diabetes medications 29953 Apidra 100units/ml solution for injection 3ml OptiClik 
cartridges (Sanofi) 
Short-acting Insulins 
Diabetes medications 36430 Insulin soluble human 100units/ml solution for 
injection 3ml pre-filled disposable devices 
Short-acting Insulins 
Diabetes medications 36920 Apidra 100units/ml solution for injection 3ml pre-filled 
SoloStar pen (Sanofi) 
Short-acting Insulins 
Diabetes medications 38986 Humalog KwikPen 100units/ml solution for injection 
3ml pre-filled pen (Eli Lilly and Company Ltd) 
Short-acting Insulins 
Diabetes medications 46666 NovoRapid FlexTouch 100units/ml solution for 
injection 3ml pre-filled pen (Novo Nordisk Ltd) 
Short-acting Insulins 
Diabetes medications 49108 NovoRapid Penfill 100units/ml solution for injection Short-acting Insulins 
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3ml cartridges (Necessity Supplies Ltd) 
Diabetes medications 51743 NovoRapid Penfill 100units/ml solution for injection 
3ml cartridges (Sigma Pharmaceuticals Plc) 
Short-acting Insulins 
Diabetes medications 53118 NovoRapid FlexPen 100units/ml solution for injection 
3ml pre-filled pen (Mawdsley-Brooks & Company Ltd) 
Short-acting Insulins 
Diabetes medications 53251 NovoRapid Penfill 100units/ml solution for injection 
3ml cartridges (Doncaster Pharmaceuticals Ltd) 
Short-acting Insulins 
Diabetes medications 55603 Humalog KwikPen 100units/ml solution for injection 
3ml pre-filled pen (Doncaster Pharmaceuticals Ltd) 
Short-acting Insulins 
Diabetes medications 32 Gliclazide 80mg tablets Sulphonylureas 
Diabetes medications 1253 Chlorpropamide 100mg tablets Sulphonylureas 
Diabetes medications 1254 Glibenclamide 5mg tablets Sulphonylureas 
Diabetes medications 1847 Chlorpropamide 250mg tablets Sulphonylureas 
Diabetes medications 1964 Diamicron 80mg tablets (Servier Laboratories Ltd) Sulphonylureas 
Diabetes medications 1965 Tolbutamide 500mg tablets Sulphonylureas 
Diabetes medications 2219 Glibenclamide 2.5mg tablets Sulphonylureas 
Diabetes medications 4862 Diabetamide 2.5mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Sulphonylureas 
Diabetes medications 5276 Glimepiride 1mg tablets Sulphonylureas 
Diabetes medications 5316 Glimepiride 4mg tablets Sulphonylureas 
Diabetes medications 5353 Glimepiride 2mg tablets Sulphonylureas 
Diabetes medications 5627 Gliclazide 30mg modified-release tablets Sulphonylureas 
Diabetes medications 5636 Glipizide 5mg tablets Sulphonylureas 
Diabetes medications 6337 Glimepiride 3mg tablets Sulphonylureas 
Diabetes medications 7284 Amaryl 2mg tablets (Zentiva) Sulphonylureas 
Diabetes medications 7332 Amaryl 1mg tablets (Zentiva) Sulphonylureas 
Diabetes medications 7409 Amaryl 3mg tablets (Zentiva) Sulphonylureas 
Diabetes medications 7744 Daonil 5mg tablets (Sanofi) Sulphonylureas 
Diabetes medications 7912 Semi-Daonil 2.5mg tablets (Sanofi) Sulphonylureas 
Diabetes medications 8034 Diabinese 100mg Tablet (Pfizer Ltd) Sulphonylureas 
Diabetes medications 8168 Diabinese 250mg Tablet (Pfizer Ltd) Sulphonylureas 
Diabetes medications 8976 Euglucon 2.5mg tablets (Aventis Pharma) Sulphonylureas 
Diabetes medications 10427 Tolazamide 250mg Tablet Sulphonylureas 
Diabetes medications 11284 Amaryl 4mg tablets (Zentiva) Sulphonylureas 
Diabetes medications 11695 Diamicron 30mg MR tablets (Servier Laboratories Ltd) Sulphonylureas 
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Code 
Product Name BNF Header 
Diabetes medications 11946 Tolbutamide 50mg/ml Injection Sulphonylureas 
Diabetes medications 12245 Glutril 25mg Tablet (Roche Products Ltd) Sulphonylureas 
Diabetes medications 12259 Glibornuride 25mg Tablet Sulphonylureas 
Diabetes medications 12455 Rastinon 500mg Tablet (Hoechst Marion Roussel) Sulphonylureas 
Diabetes medications 12513 Glibenese 5mg tablets (Pfizer Ltd) Sulphonylureas 
Diabetes medications 13331 Euglucon 5mg tablets (Sanofi) Sulphonylureas 
Diabetes medications 15374 Gliclazide 40mg/5ml oral suspension Sulphonylureas 
Diabetes medications 16602 Calabren 2.5mg Tablet (Berk Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 17343 Gliclazide 80mg tablets (A A H Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 17698 Minodiab 5mg tablets (Pfizer Ltd) Sulphonylureas 
Diabetes medications 19336 Tolazamide 100mg Tablet Sulphonylureas 
Diabetes medications 21424 Glibenclamide 5mg/5ml oral suspension Sulphonylureas 
Diabetes medications 21489 Tolanase 250mg Tablet (Pharmacia Ltd) Sulphonylureas 
Diabetes medications 21564 Gliclazide 80mg tablets (Wockhardt UK Ltd) Sulphonylureas 
Diabetes medications 21832 Diabetamide 5mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Sulphonylureas 
Diabetes medications 21892 Diaglyk 80mg tablets (Ashbourne Pharmaceuticals 
Ltd) 
Sulphonylureas 
Diabetes medications 22145 Tolanase 100mg Tablet (Pharmacia Ltd) Sulphonylureas 
Diabetes medications 22858 Acetohexamide 500mg tablets Sulphonylureas 
Diabetes medications 24848 Glymidine sodium 500mg Tablet Sulphonylureas 
Diabetes medications 25636 Libanil 2.5mg Tablet (Approved Prescription Services 
Ltd) 
Sulphonylureas 
Diabetes medications 26118 Dimelor 500mg Tablet (Eli Lilly and Company Ltd) Sulphonylureas 
Diabetes medications 26218 Calabren 5mg Tablet (Berk Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 27969 Glymese 250mg Tablet (DDSA Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 28708 Malix 2.5mg Tablet (Lagap) Sulphonylureas 
Diabetes medications 29326 Glipizide 5mg tablets (Generics (UK) Ltd) Sulphonylureas 
Diabetes medications 29939 Gliclazide 80mg tablets (Generics (UK) Ltd) Sulphonylureas 
Diabetes medications 30460 Malix 5mg Tablet (Lagap) Sulphonylureas 
Diabetes medications 31212 Gliclazide 80mg tablets (Actavis UK Ltd) Sulphonylureas 
Diabetes medications 31474 Libanil 5mg Tablet (Approved Prescription Services 
Ltd) 
Sulphonylureas 
Diabetes medications 33562 Duclazide 80mg Tablet (Dumex Ltd) Sulphonylureas 
Diabetes medications 33673 Tolbutamide 500mg tablets (Actavis UK Ltd) Sulphonylureas 
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Code 
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Diabetes medications 34399 Gliclazide 80mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Sulphonylureas 
Diabetes medications 34507 Glibenclamide 2.5mg tablets (Wockhardt UK Ltd) Sulphonylureas 
Diabetes medications 34563 Glibenclamide 5mg tablets (Wockhardt UK Ltd) Sulphonylureas 
Diabetes medications 34676 Glibenclamide 2.5mg tablets (A A H Pharmaceuticals 
Ltd) 
Sulphonylureas 
Diabetes medications 34706 Glibenclamide 2.5mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Sulphonylureas 
Diabetes medications 34802 Glipizide 5mg tablets (IVAX Pharmaceuticals UK Ltd) Sulphonylureas 
Diabetes medications 34932 Gliclazide 80mg tablets (Genus Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 34957 Tolbutamide 500mg tablets (A A H Pharmaceuticals 
Ltd) 
Sulphonylureas 
Diabetes medications 36856 Gliclazide 80mg tablets (Sandoz Ltd) Sulphonylureas 
Diabetes medications 40365 Glimepiride 1mg tablets (Actavis UK Ltd) Sulphonylureas 
Diabetes medications 40425 Nazdol MR 30mg tablets (Teva UK Ltd) Sulphonylureas 
Diabetes medications 41558 Glibenclamide 5mg tablets (Teva UK Ltd) Sulphonylureas 
Diabetes medications 41559 Glibenclamide 5mg tablets (A A H Pharmaceuticals 
Ltd) 
Sulphonylureas 
Diabetes medications 41593 Glibenclamide 2.5mg tablets (Teva UK Ltd) Sulphonylureas 
Diabetes medications 42790 Gliclazide 80mg Tablet (Merck Generics (UK) Ltd) Sulphonylureas 
Diabetes medications 43065 Gliclazide 40mg tablets Sulphonylureas 
Diabetes medications 43465 Zicron 40mg tablets (Bristol Laboratories Ltd) Sulphonylureas 
Diabetes medications 44304 Glyconon 500mg Tablet (DDSA Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 44473 Edicil MR 30mg tablets (Ratiopharm UK Ltd) Sulphonylureas 
Diabetes medications 44738 Niddaryl 1mg tablets (Dee Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 45215 Gliclazide 80mg Tablet (Neo Laboratories Ltd) Sulphonylureas 
Diabetes medications 45831 Dacadis MR 30mg tablets (Generics (UK) Ltd) Sulphonylureas 
Diabetes medications 46927 Tolbutamide 500mg tablets (Teva UK Ltd) Sulphonylureas 
Diabetes medications 47074 Gliclazide 80mg/5ml oral suspension Sulphonylureas 
Diabetes medications 47894 Nazdol MR 30mg tablets (Consilient Health Ltd) Sulphonylureas 
Diabetes medications 48056 Gliclazide 80mg tablets (Sovereign Medical Ltd) Sulphonylureas 
Diabetes medications 51955 Gliclazide 80mg tablets (Accord Healthcare Ltd) Sulphonylureas 
Diabetes medications 53288 Gliclazide 30mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Sulphonylureas 
Diabetes medications 54764 Gliclazide 80mg tablets (Arrow Generics Ltd) Sulphonylureas 
Diabetes medications 55862 Gliclazide Oral solution Sulphonylureas 
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Diabetes medications 56008 Gliclazide 80mg tablets (Almus Pharmaceuticals Ltd) Sulphonylureas 
Diabetes medications 56437 Gliclazide 60mg modified-release tablets Sulphonylureas 
Dronedarone 43112 Dronedarone 400mg tablets Drugs For Arrhythmias 
Dronedarone 44437 Multaq 400mg tablets (Sanofi) Drugs For Arrhythmias 
Hypertension medications 65 Lisinopril 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 69 Lisinopril 20mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 78 Lisinopril 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 80 Ramipril 5mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 82 Ramipril 10mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 97 Perindopril erbumine 4mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 147 Ramipril 1.25mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 196 Enalapril 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 277 Lisinopril 2.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 448 Enalapril 2.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 593 Perindopril erbumine 2mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 633 Fosinopril 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 654 Ramipril 2.5/5mg/10mg capsule Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 709 Ramipril 2.5mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 756 Ramipril 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 761 Ramipril 1.25mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1121 Captopril 12.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1143 Captopril 25mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1144 Capoten 25mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1299 Enalapril 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1520 Capozide 25mg/50mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1807 Captopril 50mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 1904 Enalapril 20mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 3069 Acepril 25mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 3310 Capoten 12.5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 3720 Zestril 2.5mg tablets (AstraZeneca UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 3839 Capoten 50mg tablets (Bristol-Myers Squibb Angiotensin-converting Enzyme Inhibitors 
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Pharmaceuticals Ltd) 
Hypertension medications 3929 Quinapril 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 4103 Trandolapril 1mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 4571 Staril 10mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5047 Trandolapril 2mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5159 Quinapril 20mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5275 Tritace 2.5mg capsules (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5612 Coversyl 2mg tablets (Servier Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5735 Tritace 5mg capsules (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5800 Coversyl 4mg tablets (Servier Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 5861 Fosinopril 20mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6078 Perindopril erbumine 8mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6261 Tritace 1.25mg tablets (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6288 Ramipril 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6314 Ramipril 2.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6362 Tritace 5mg tablets (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6364 Tritace 2.5mg tablets (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6408 Tanatril 5mg tablets (Chiesi Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6468 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6765 Quinapril 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6786 Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6806 Zestril 10mg tablets (AstraZeneca UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 6807 Zestril 5mg tablets (AstraZeneca UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 7314 Accupro 5mg tablets (Pfizer Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 7419 Trandolapril 500microgram capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8025 Gopten 1mg capsules (Abbott Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8026 Gopten 2mg capsules (Abbott Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8105 Innovace 20mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8106 Innovace 2.5mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8268 Zestril 20mg tablets (AstraZeneca UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8800 Innovace 5mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 8830 Innovace 10mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 9646 Tritace 1.25mg capsules (Aventis Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 9693 Tritace 10mg capsules (Sanofi) Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 9731 Quinapril 40mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 9915 Tritace 10mg tablets (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 9948 Trandolapril 4mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 10882 Carace 2.5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 11197 Innovace melt 5mg Wafer (Merck Sharp & Dohme 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 11351 Co-zidocapt 25mg/50mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 11561 Co-zidocapt 12.5mg/25mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 11937 Ramipril 2.5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 11983 Perindopril erbumine 4mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 11987 Lisinopril 5mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 12313 Carace 20mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 12411 Cilazapril 500microgram tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 12412 Cilazapril 2.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 12574 Cilazapril 1mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 12815 Tanatril 10mg tablets (Chiesi Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 12858 Imidapril 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 13026 Cilazapril 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 13589 Staril 20mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 13755 Enalapril 10mg wafer Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 14387 Carace 5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 14477 Accupro 10mg tablets (Pfizer Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 14478 Accupro 20mg tablets (Pfizer Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 14960 Coversyl 8mg tablets (Servier Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15031 Accuretic 12.5mg/10mg tablets (Pfizer Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15085 Innovace Titration pack (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15096 Accupro 40mg tablets (Pfizer Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15108 Quinapril 10mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15121 Moexipril 7.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15605 Cilazapril 250micrograms tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 15958 Captopril 2mg tablets Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 16196 Vascace 5mg tablets (Roche Products Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 16197 Vascace 2.5mg tablets (Roche Products Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 16212 Vascace 1mg tablets (Roche Products Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 16701 Carace 10mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 16708 Enalapril titration pack Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 16710 Gopten 500microgram capsules (Abbott Laboratories 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 16924 Imidapril 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 17120 Moexipril 15mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 17624 Captopril 5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 17633 Captopril 3mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 18219 Imidapril 20mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 18263 Acezide 25mg/50mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 18269 Acepril 12.5mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 18325 Acepril 50mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 19198 Lisinopril 20mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 19204 Lisinopril 5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 19208 Enalapril 10mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 19223 Lisinopril 10mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 20188 Enalapril 2.5mg wafer Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 20849 Tensopril 12.5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 20975 Lisinopril 7.5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 21053 Vascace 500microgram tablets (Roche Products Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 21231 Caralpha 20mg/12.5mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 21943 Kaplon 12.5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 22439 Ednyt 20mg Tablet (Dominion Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 22708 Enalapril 5mg wafer Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 23252 Pralenal 10 tablets (Opus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 23478 Tensopril 50mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 23642 Vascace 0.25mg Tablet (Roche Products Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 24041 Enalapril 20mg wafer Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 24482 Captomex 50mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 25998 Captomex 12.5mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 26995 Kaplon 25mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 27871 Innovace melt 10mg Wafer (Merck Sharp & Dohme 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28127 Enalapril 2.5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28486 Captopril 6.25mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28586 Lopace 5mg capsules (Discovery Pharmaceuticals 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28724 Perdix 7.5mg tablets (UCB Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28725 Perdix 15mg tablets (UCB Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28820 Captomex 25mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 28902 Odrik 2mg capsules (Aventis Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 29130 Gopten 4mg capsules (Abbott Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 29530 Innovace melt 2.5mg Wafer (Merck Sharp & Dohme 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 29627 Lopace 2.5mg capsules (Discovery Pharmaceuticals 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 30039 Tensopril 25mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 30921 Lisinopril 2.5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 31307 Odrik 500microgram capsules (Aventis Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 31587 Innovace melt 20mg Wafer (Merck Sharp & Dohme 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 31716 Enalapril 20mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 31810 Odrik 1mg capsules (Aventis Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32048 Kaplon 50mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32241 Enalapril 10mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32514 Ecopace 25mg tablets (Mercury Pharma Group Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32560 Tanatril 20mg tablets (Chiesi Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32597 Lisinopril 10mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32857 Ramipril 1.25mg capsules (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 32934 Lopace 10mg capsules (Discovery Pharmaceuticals 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33057 Ednyt 5mg Tablet (Dominion Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33078 Enalapril 20mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33095 Perindopril erbumine 4mg tablets (A A H Angiotensin-converting Enzyme Inhibitors 
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Pharmaceuticals Ltd) 
Hypertension medications 33336 Captopril 5mg/5ml Oral suspension (Eldon 
Laboratories) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33353 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 
(Teva UK Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33646 Captopril 12.5mg Tablet (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33811 Ramipril 2.5mg capsules (Ranbaxy (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33894 Ramipril 10mg capsules (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 33977 Lisinopril 10mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34357 Ramipril 10mg capsules (Genus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34382 Ramipril 5mg capsules (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34390 Ramipril 5mg capsules (Genus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34400 Enalapril 5mg Tablet (Dowelhurst Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34412 Ramipril 5mg capsules (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34429 Ramipril 5mg capsules (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34431 Ramipril 2.5mg capsules (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34432 Ramipril 2.5mg capsules (Genus Pharmaceuticals 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34453 Enalapril 20mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34471 Lisinopril 5mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34490 Ramipril 2.5mg capsules (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34505 Ramipril 2.5mg capsules (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34528 Ramipril 2.5mg capsules (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34539 Ramipril 5mg capsules (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34540 Ramipril 5mg capsules (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34544 Captopril 12.5mg Tablet (IVAX Pharmaceuticals UK 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34562 Captopril 25mg Tablet (IVAX Pharmaceuticals UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34567 Ramipril 2.5mg capsules (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34583 Ramipril 10mg Capsule (Dexcel-Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34589 Ramipril 5mg Capsule (Dexcel-Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34651 Ramipril 10mg capsules (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34652 Ramipril 5mg Capsule (Sovereign Medical Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34657 Ramipril 10mg capsules (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34696 Lisinopril 20mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 34698 Ramipril 1.25mg capsules (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34710 Ramipril 10mg capsules (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34712 Enalapril 20mg tablets (Kent Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34719 Captopril 50mg Tablet (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34732 Ramipril 2.5mg Capsule (Dexcel-Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34768 Enalapril 20mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34798 Enalapril 20mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34799 Lisinopril 20mg tablets (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34877 Ramipril 10mg Capsule (Sovereign Medical Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34893 Ramipril 10mg Capsule (IVAX Pharmaceuticals UK 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34936 Captopril 25mg Tablet (Lagap) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34937 Captopril 50mg Tablet (IVAX Pharmaceuticals UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34943 Ramipril 10mg capsules (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34952 Enalapril 10mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 34953 Enalapril 20mg tablets (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 35007 Ramipril 10mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 35302 Captopril 12.5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 35731 Perindopril erbumine 8mg tablets (A A H 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 35794 Enalapril 5mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 36742 Captopril 2mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 36753 Ednyt 10mg Tablet (Dominion Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37080 Enalapril 5mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37087 Enalapril 5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37655 Captopril 25mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37710 Lisinopril 10mg / Hydrochlorothiazide 12.5mg tablets 
(Teva UK Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37778 Lisinopril 5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37930 Perindopril arginine 5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37964 Perindopril arginine 2.5mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37965 Coversyl Arginine 5mg tablets (Servier Laboratories 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 37971 Perindopril arginine 10mg tablets Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 38026 Coversyl Arginine 10mg tablets (Servier Laboratories 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38034 Coversyl Arginine 2.5mg tablets (Servier Laboratories 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38285 Perindopril erbumine 4mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38308 Ramipril 2.5/5mg/10mg tablet Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38510 Perindopril erbumine 4mg tablets (Apotex UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38854 Quinapril 20mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38899 Quinil 10mg tablets (Tillomed Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 38995 Zestoretic 20 tablets (AstraZeneca UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39137 Zestoretic 10 tablets (AstraZeneca UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39147 Carace 20 Plus tablets (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39227 Capozide LS 12.5mg/25mg tablets (Bristol-Myers 
Squibb Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39242 Carace 10 Plus tablets (Merck Sharp & Dohme Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39355 Tritace 10mg Tablet (Sterwin Medicines) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39421 Tritace titration pack tablets (Sanofi) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 39512 Captopril 25mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 40355 Quinil 5mg tablets (Tillomed Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 40384 Ramipril 10mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41417 Enalapril 2.5mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41522 Lisopress 20mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41532 Lisopress 5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41538 Lisopress 2.5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41573 Lisopress 10mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41617 Captopril 25mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41633 Captopril 12.5mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41694 Enalapril 2.5mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41743 Captopril 50mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 41746 Enalapril 10mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 42081 Tritace 1.25mg Tablet (Sterwin Medicines) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 42285 Quinil 40mg tablets (Tillomed Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 42723 Pralenal 5 tablets (Opus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 42894 Enalapril 10mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 42901 Enalapril 5mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 42902 Enalapril 20mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 42908 Enalapril 5mg tablets (IVAX Pharmaceuticals UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43012 Perindopril erbumine oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43411 Enalapril 5mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43412 Lisinopril 2.5mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43413 Lisinopril 20mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43416 Lisinopril 10mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43418 Lisinopril 5mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43432 Captopril 6.25mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43507 Captopril 25mg Tablet (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43563 Enalapril 2.5mg tablets (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43566 Lisinopril 2.5mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43649 Captopril 25mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 43813 Perindopril erbumine 2mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 44527 Captopril 5mg/ml oral solution sugar free Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 44657 Ednyt 2.5mg Tablet (Dominion Pharma) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45217 Enalapril 5mg tablets (Kent Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45228 Captopril capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45264 Ramipril 1.25mg capsules (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45300 Lisinopril 10mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45319 Perindopril erbumine 2mg tablets (A A H 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45324 Lisinopril 20mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45337 Lisinopril 5mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45340 Ramipril 10mg Capsule (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45554 Ramipril 5mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45816 Lisinopril 5mg tablets (Almus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 45938 Perindopril erbumine 8mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46365 Quinil 20mg tablets (Tillomed Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46851 Captopril 5mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46890 Ramipril 5mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46951 Captopril 12.5mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46957 Captopril 12.5mg tablets (Tillomed Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46974 Enalapril 5mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 46975 Lisinopril 5mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 46979 Lisinopril 20mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 47021 Ramipril 2.5mg/5ml oral solution sugar free Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 47159 Lisinopril 10mg tablets (Almus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 47998 Ramipril 2.5mg capsules (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 48008 Ramipril 5mg capsules (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 48049 Perindopril erbumine 2mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 48053 Ramipril 2.5mg capsules (Almus Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 48180 Perindopril erbumine 4mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 48214 Perindopril erbumine 4mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 49164 Ramipril 10mg capsules (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 49491 Perindopril erbumine 2mg tablets (Consilient Health 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 50334 Enalapril 4mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 50347 Coversyl Arginine 5mg tablets (Waymade Healthcare 
Plc) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 50402 Perindopril 2mg Tablet (Servier Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 50509 Ramipril 10mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 50780 Enalapril 2mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 50863 Enalapril 5mg/5ml oral solution (Drug Tariff Special 
Order) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 51433 Lisinopril 20mg tablets (Tillomed Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 51701 Ramipril 5mg capsules (Bristol Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 51714 Ramipril 2.5mg capsules (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 51807 Coversyl Arginine 5mg tablets (Doncaster 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52010 Enalapril 10mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52088 Lisinopril 5mg tablets (Phoenix Healthcare Distribution 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52197 Ramipril 5mg capsules (Sigma Pharmaceuticals Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52293 Captopril 2mg capsules Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52399 Ramipril 1.25mg capsules (Kent Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52407 Ramipril 10mg capsules (Kent Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 52499 Captopril 25mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 52882 Enalapril 5mg/5ml oral suspension sugar free Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53058 Perindopril erbumine 8mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53271 Lisinopril 10mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53551 Lisinopril 20mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53612 Ramipril 10mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53621 Ramipril 2.5mg capsules (Bristol Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53719 Enalapril 20mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53820 Lisinopril 5mg tablets (Arrow Generics Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 53915 Enalapril 5mg tablets (Dexcel-Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54037 Lisinopril 10mg tablets (Relonchem Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54201 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 
(Almus Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54283 Lisinopril 5mg/5ml oral suspension (Drug Tariff 
Special Order) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54288 Lisinopril 10mg tablets (Arrow Generics Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54298 Ramipril 2.5mg capsules (Arrow Generics Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54345 Trandolapril 4mg capsules (Arrow Generics Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54512 Lisinopril Oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54544 Captopril 25mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54620 Ramipril 2.5mg capsules (Sigma Pharmaceuticals Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54733 Perindopril erbumine 8mg tablets (Consilient Health 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54899 Perindopril erbumine 2mg tablets (Teva UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54928 Lisinopril 10mg tablets (Bristol Laboratories Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54941 Ramipril 5mg capsules (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54942 Perindopril erbumine 8mg tablets (Generics (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 54986 Perindopril erbumine 8mg/5ml oral suspension Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55002 Lisinopril 20mg tablets (Accord Healthcare Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55299 Ramipril 1.25mg capsules (A A H Pharmaceuticals 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55399 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-converting Enzyme Inhibitors 
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(A A H Pharmaceuticals Ltd) 
Hypertension medications 55456 Lisinopril 5mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55588 Lisinopril 20mg tablets (Sigma Pharmaceuticals Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55639 Lisinopril 10mg tablets (Accord Healthcare Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55798 Ramipril 5mg capsules (Waymade Healthcare Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55896 Lisinopril 2.5mg tablets (Actavis UK Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 55903 Enalapril 10mg tablets (Dexcel-Pharma Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56013 Ramipril 2.5mg capsules (Waymade Healthcare Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56038 Ramipril 10mg tablets (Pfizer Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56079 Perindopril tosilate 10mg tablets Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56129 Ramipril 5mg capsules (Kent Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56148 Ramipril 1.25mg tablets (Kent Pharmaceuticals Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56162 Perindopril erbumine 4mg tablets (Consilient Health 
Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56169 Ramipril 10mg capsules (Arrow Generics Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56244 Lisinopril 20mg / Hydrochlorothiazide 12.5mg tablets 
(Tillomed Laboratories Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56279 Lisinopril 2.5mg/5ml oral solution Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56356 Ramipril 10mg capsules (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56472 Perindopril erbumine 4mg tablets (Kent 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56473 Perindopril erbumine 2mg tablets (Sigma 
Pharmaceuticals Plc) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56505 Zestril 5mg tablets (Lexon (UK) Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56506 Coversyl 2mg tablets (Dowelhurst Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56508 Coversyl 4mg tablets (Dowelhurst Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56509 Capoten 12.5mg tablets (Dowelhurst Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56510 Zestril 20mg tablets (Sigma Pharmaceuticals Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56516 Perindopril erbumine 2mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56704 Ramipril 1.25mg capsules (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56763 Ramipril 10mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 56850 Ecopace 12.5mg tablets (Mercury Pharma Group Ltd) Angiotensin-converting Enzyme Inhibitors 
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Hypertension medications 56855 Ramipril 10mg capsules (Sigma Pharmaceuticals Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 57048 Lisinopril 10mg tablets (Zentiva) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 57073 Ramipril 1.25mg capsules (Waymade Healthcare Plc) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 57235 Ramipril 1.25mg tablets (Sandoz Ltd) Angiotensin-converting Enzyme Inhibitors 
Hypertension medications 18223 Trandolapril with verapamil 2mg + 180mg Modified-
release capsule 
Angiotensin-converting Enzyme 
Inhibitors/Calcium-channel Blockers 
Hypertension medications 19690 Verapamil 180mg modified-release / Trandolapril 2mg 
capsules 
Angiotensin-converting Enzyme 
Inhibitors/Calcium-channel Blockers 
Hypertension medications 20579 Tarka modified-release capsules (Abbott Laboratories 
Ltd) 
Angiotensin-converting Enzyme 
Inhibitors/Calcium-channel Blockers 
Hypertension medications 3203 Capozide LS Tablet (E R Squibb and Sons Ltd) Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 6359 Zestoretic 10- 10mg+12.5mg Tablet (AstraZeneca UK 
Ltd) 
Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 9764 Carace 20 Tablet (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 15135 Hydrochlorothiazide with captopril 12.5mg with 25mg 
Tablet 
Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 37978 Perindopril arginine 5mg / Indapamide 1.25mg tablets Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 48098 Perindopril arginine 4mg with Indapamide 1.25mg 
tablet 
Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 50607 Perindopril arginine 2mg with Indapamide 625 
micrograms tablet 
Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 56157 Perindopril tosilate 5mg / Indapamide 1.25mg tablets Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 520 Losartan 25mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 529 Candesartan 2mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 531 Candesartan 4mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 575 Valsartan 40mg capsules Angiotensin-ii Receptor Antagonists 
Hypertension medications 624 Losartan 100mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 828 Irbesartan 75mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 1293 Irbesartan 150mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 1780 Losartan 50mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 2971 Irbesartan 300mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 3222 Valsartan 80mg capsules Angiotensin-ii Receptor Antagonists 
Hypertension medications 4155 Amias 2mg tablets (Takeda UK Ltd) Angiotensin-ii Receptor Antagonists 
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Hypertension medications 4226 Cozaar 25mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 4540 Cozaar-Comp 50mg/12.5mg tablets (Merck Sharp & 
Dohme Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 4645 Valsartan 160mg capsules Angiotensin-ii Receptor Antagonists 
Hypertension medications 4685 Amias 4mg tablets (Takeda UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 4741 Candesartan 16mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 4818 Candesartan 8mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 5013 Amias 8mg tablets (Takeda UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 5117 Amias 16mg tablets (Takeda UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 5723 Cozaar 50mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 5988 Telmisartan 40mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 6217 Olmesartan medoxomil 10mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 6243 Telmisartan 20mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 6285 Olmesartan medoxomil 20mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 6351 Olmesartan medoxomil 40mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 6437 Losartan 50mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 6518 Diovan 160mg capsules (Novartis Pharmaceuticals 
UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 6939 Eprosartan 300mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 7043 Candesartan 32mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 7338 Aprovel 75mg tablets (Sanofi) Angiotensin-ii Receptor Antagonists 
Hypertension medications 9196 Aprovel 150mg tablets (Sanofi) Angiotensin-ii Receptor Antagonists 
Hypertension medications 9745 Teveten 300mg tablets (Abbott Healthcare Products 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 10323 Losartan 100mg / Hydrochlorothiazide 25mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 11251 Diovan 40mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 11252 Diovan 80mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 11348 Aprovel 300mg tablets (Sanofi) Angiotensin-ii Receptor Antagonists 
Hypertension medications 11448 Irbesartan 150mg / Hydrochlorothiazide 12.5mg 
tablets 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 11469 Irbesartan 300mg / Hydrochlorothiazide 12.5mg 
tablets 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 12836 Eprosartan 600mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 12874 Telmisartan 80mg tablets Angiotensin-ii Receptor Antagonists 
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Hypertension medications 13123 Eprosartan 400mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 13821 Micardis 40mg tablets (Boehringer Ingelheim Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 14870 Telmisartan 40mg / Hydrochlorothiazide 12.5mg 
tablets 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 14943 Valsartan 40mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 14965 Cozaar 100mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 14983 Olmetec 10mg tablets (Daiichi Sankyo UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 16161 Telmisartan 80mg / Hydrochlorothiazide 12.5mg 
tablets 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 16285 Teveten 400mg tablets (Abbott Healthcare Products 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 16371 Teveten 600mg tablets (Abbott Healthcare Products 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 17545 Micardis 80mg tablets (Boehringer Ingelheim Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 17686 Micardis 20mg tablets (Boehringer Ingelheim Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 17689 MicardisPlus 80mg/12.5mg tablets (Boehringer 
Ingelheim Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 18202 MicardisPlus 40mg/12.5mg tablets (Boehringer 
Ingelheim Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 18910 Olmetec 20mg tablets (Daiichi Sankyo UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 20117 Olmetec 40mg tablets (Daiichi Sankyo UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 21423 Cozaar-Comp 100mg/25mg tablets (Merck Sharp & 
Dohme Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 24359 Diovan 40mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 31072 Amias 32mg tablets (Takeda UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 35481 Irbesartan 300mg / Hydrochlorothiazide 25mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 36939 Irbesartan 300mg/5ml oral suspension Angiotensin-ii Receptor Antagonists 
Hypertension medications 37573 Valsartan 320mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 37650 Losartan 100mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 37747 Cozaar-Comp 100mg/12.5mg tablets (Merck Sharp & 
Dohme Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 38395 Valsartan 80mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 38459 Telmisartan 80mg / Hydrochlorothiazide 25mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 38889 MicardisPlus 80mg/25mg tablets (Boehringer 
Ingelheim Ltd) 
Angiotensin-ii Receptor Antagonists 
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Hypertension medications 39199 Diovan 320mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 39786 Olmesartan medoxomil 10mg/5ml oral suspension Angiotensin-ii Receptor Antagonists 
Hypertension medications 39944 Losartan 12.5mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 40571 Cozaar 12.5mg tablets (Merck Sharp & Dohme Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 40711 Losartan 2.5mg/ml oral suspension sugar free Angiotensin-ii Receptor Antagonists 
Hypertension medications 41232 Cozaar 2.5mg/ml oral suspension (Merck Sharp & 
Dohme Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 44778 Valsartan 160mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 45600 Diovan 160mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 46355 Sevikar HCT 20mg/5mg/12.5mg tablets (Daiichi 
Sankyo UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 47006 Losartan 100mg tablets (Teva UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 47573 Sevikar HCT 40mg/5mg/12.5mg tablets (Daiichi 
Sankyo UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 47616 Sevikar HCT 40mg/10mg/12.5mg tablets (Daiichi 
Sankyo UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 47727 Sevikar HCT 40mg/5mg/25mg tablets (Daiichi Sankyo 
UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 48039 Losartan 100mg / Hydrochlorothiazide 12.5mg tablets 
(Teva UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 48398 Losartan 25mg tablets (Dexcel-Pharma Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 49492 Losartan 25mg tablets (Generics (UK) Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 49588 Losartan 100mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 50185 Candesartan 8mg tablets (Teva UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 50971 Losartan 25mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 51117 Candesartan 8mg tablets (Doncaster Pharmaceuticals 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 51186 Losartan 25mg tablets (Arrow Generics Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 51368 Azilsartan medoxomil 80mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 51519 Candesartan 8mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 51601 Losartan 50mg tablets (Actavis UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 51647 Candesartan 4mg tablets (Mawdsley-Brooks & 
Company Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 51897 Edarbi 20mg tablets (Takeda UK Ltd) Angiotensin-ii Receptor Antagonists 
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Hypertension medications 52189 Losartan 100mg / Hydrochlorothiazide 25mg tablets 
(A A H Pharmaceuticals Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 52208 Candesartan 16mg tablets (A A H Pharmaceuticals 
Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 52427 Cozaar 100mg tablets (Necessity Supplies Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 52559 Candesartan 8mg tablets (Zentiva) Angiotensin-ii Receptor Antagonists 
Hypertension medications 52658 Losartan 100mg/5ml oral suspension Angiotensin-ii Receptor Antagonists 
Hypertension medications 52659 Losartan 50mg/5ml oral solution Angiotensin-ii Receptor Antagonists 
Hypertension medications 52886 Losartan 12.5mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 52972 Irbesartan 300mg tablets (Sigma Pharmaceuticals 
Plc) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 53220 Sevikar HCT 40mg/10mg/25mg tablets (Daiichi 
Sankyo UK Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 53680 Candesartan 16mg tablets (Teva UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 53755 Candesartan 4mg tablets (Teva UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 53833 Valsartan 160mg capsules (Generics (UK) Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54049 Losartan 50mg tablets (Accord Healthcare Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54057 Losartan 50mg tablets (Teva UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54326 Candesartan 32mg tablets (Teva UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54404 Losartan 100mg tablets (Actavis UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54414 Candesartan 16mg tablets (Consilient Health Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54735 Losartan 50mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 54740 Losartan 25mg tablets (Actavis UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 54843 Losartan 50mg tablets (Dexcel-Pharma Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 55017 Irbesartan 300mg tablets (Accord Healthcare Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 55160 Cozaar-Comp 50mg/12.5mg tablets (Sigma 
Pharmaceuticals Plc) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 55187 Valsartan 160mg capsules (Arrow Generics Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 55296 Losartan 50mg tablets (Generics (UK) Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 55446 Losartan 100mg tablets (Bristol Laboratories Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 55718 Losartan 25mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 56104 Losartan 50mg tablets (A A H Pharmaceuticals Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 56204 Losartan 50mg / Hydrochlorothiazide 12.5mg tablets 
(Actavis UK Ltd) 
Angiotensin-ii Receptor Antagonists 
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Hypertension medications 56606 Azilsartan medoxomil 40mg tablets Angiotensin-ii Receptor Antagonists 
Hypertension medications 56970 Losartan 100mg tablets (Pfizer Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 56975 Losartan 50mg / Hydrochlorothiazide 12.5mg tablets 
(A A H Pharmaceuticals Ltd) 
Angiotensin-ii Receptor Antagonists 
Hypertension medications 57026 Candesartan 8mg tablets (Waymade Healthcare Plc) Angiotensin-ii Receptor Antagonists 
Hypertension medications 57028 Losartan 100mg tablets (Generics (UK) Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 57266 Candesartan 2mg tablets (Actavis UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 57273 Candesartan 8mg tablets (Actavis UK Ltd) Angiotensin-ii Receptor Antagonists 
Hypertension medications 6877 Co-Diovan 160mg/12.5mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Angiotensin-ii Receptor Antagonists With 
Diuretic 
Hypertension medications 11864 Valsartan 160mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-ii Receptor Antagonists With 
Diuretic 
Hypertension medications 14283 Valsartan 160mg / Hydrochlorothiazide 25mg tablets Angiotensin-ii Receptor Antagonists With 
Diuretic 
Hypertension medications 25382 Co-Diovan 160mg/25mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Angiotensin-ii Receptor Antagonists With 
Diuretic 
Hypertension medications 764 Co-Diovan 80mg/12.5mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Angiotensin-ii Receptor 
Antagonists/Angiotensin-ii Receptor 
Antagonists With Diuretic 
Hypertension medications 16060 Valsartan 80mg / Hydrochlorothiazide 12.5mg tablets Angiotensin-ii Receptor 
Antagonists/Angiotensin-ii Receptor 
Antagonists With Diuretic 
Hypertension medications 52858 Co-Diovan 80mg/12.5mg tablets (Sigma 
Pharmaceuticals Plc) 
Angiotensin-ii Receptor 
Antagonists/Angiotensin-ii Receptor 
Antagonists With Diuretic 
Hypertension medications 35173 Valsartan 160mg with amlodipine 5mg tablets Angiotensin-ii Receptor Antagonists/Calcium-
channel Blockers 
Hypertension medications 35304 Valsartan 160mg with amlodipine 10mg tablets Angiotensin-ii Receptor Antagonists/Calcium-
channel Blockers 
Hypertension medications 18200 Olmesartan medoxomil 20mg / Hydrochlorothiazide 
12.5mg tablets 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 18903 Olmesartan medoxomil 20mg / Hydrochlorothiazide 
25mg tablets 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 24484 Hydrochlorothiazide with valsartan 12.5mg with 
160mg Tablet 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 24632 Hydrochlorothiazide with losartan 25mg with 100mg 
Tablet 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
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Hypertension medications 27520 Olmetec Plus 20mg/25mg tablets (Daiichi Sankyo UK 
Ltd) 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 38367 Hydrochlorothiazide with losartan 12.5mg with 100mg 
Tablet 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 46687 Olmesartan medoxomil with amlodipine and 
hydrochlorothiazide 20mg + 5mg + 12.5mg Tablet 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 46792 Olmesartan medoxomil with amlodipine and 
hydrochlorothiazide 40mg + 5mg + 12.5mg Tablet 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 55358 Olmesartan medoxomil with amlodipine and 
hydrochlorothiazide 40mg + 10mg + 25mg Tablet 
Angiotensin-ii Receptor Antagonists/Thiazides 
And Related Diuretics 
Hypertension medications 769 Propranolol 80mg modified-release capsules Antithyroid Drugs/Beta-adrenoceptor Blocking 
Drugs/Drugs For Essential Tremor, Chorea, 
Tics, And Related Disorders/Prophylaxis Of 
Migraine 
Hypertension medications 34378 Propranolol 10mg tablets (A A H Pharmaceuticals Ltd) Antithyroid Drugs/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 45765 Syprol 40mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Antithyroid Drugs/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 49863 Propranolol 5mg/5ml oral solution sugar free Antithyroid Drugs/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 55949 Propranolol 40mg/5ml oral solution Antithyroid Drugs/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 5478 Propranolol 10mg/5ml oral solution sugar free Antithyroid Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related Disorders/Beta-
adrenoceptor Blocking Drugs/Prophylaxis Of 
Migraine 
Hypertension medications 45494 Propranolol 10mg tablets (Almus Pharmaceuticals 
Ltd) 
Antithyroid Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related Disorders/Beta-
adrenoceptor Blocking Drugs/Prophylaxis Of 
Migraine 
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Hypertension medications 55849 Propranolol 160mg tablets (Generics (UK) Ltd) Antithyroid Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related Disorders/Beta-
adrenoceptor Blocking Drugs/Prophylaxis Of 
Migraine 
Hypertension medications 55416 Propranolol 40mg tablets (Almus Pharmaceuticals 
Ltd) 
Antithyroid Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Prophylaxis Of Migraine/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 25359 Rapranol SR 160mg capsules (Ranbaxy (UK) Ltd) Antithyroid Drugs/Prophylaxis Of Migraine/Beta-
adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 8303 Tenavoid Tablet (Edwin Burgess Ltd) Anxiolytics/Thiazides And Related Diuretics 
Hypertension medications 8464 Meprobamate with bendroflumethiazide Tablet Anxiolytics/Thiazides And Related Diuretics 
Hypertension medications 5 Atenolol 50mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 24 Atenolol 100mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 26 Atenolol 25mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 197 Atenolol 5mg/10ml solution for injection ampoules Beta-adrenoceptor Blocking Drugs 
Hypertension medications 751 Nebivolol 5mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 817 Carvedilol 3.125mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 822 Bisoprolol 1.5mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs 
Hypertension medications 1295 Labetalol 400mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 1333 Oxprenolol 40mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 1334 Oxprenolol 160mg modified-release tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 1597 Labetalol 100mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 1684 Beta-Adalat modified-release capsules (Bayer Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2361 Trasicor 80mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2432 Tenormin LS 50mg tablets (AstraZeneca UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2499 Nadolol 80mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2587 Tenormin 100mg tablets (AstraZeneca UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2590 Tenormin 25mg tablets (AstraZeneca UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2629 Carvedilol 12.5mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2775 Labetalol 200mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 2780 Oxprenolol 80mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 3516 Oxprenolol 20mg tablets Beta-adrenoceptor Blocking Drugs 
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Hypertension medications 3691 Sotalol 160mg with hydrochlorothiazide 25mg tablet Beta-adrenoceptor Blocking Drugs 
Hypertension medications 3748 Oxprenolol 160mg Tablet Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4025 Slow-Trasicor 160mg tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4265 Celectol 200mg Tablet (Pantheon Healthcare Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4410 Carvedilol 6.25mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4429 Trasidrex modified-release tablets (Mercury Pharma 
Group Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4542 Atenolol 50mg / Nifedipine 20mg modified-release 
capsules 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4588 Visken 5mg Tablet (Sovereign Medical Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 4725 Labetalol 50mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 5284 Pindolol 5mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 6066 Atenolol 25mg/5ml oral solution sugar free Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7049 Carvedilol 25mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7429 Tenormin 5mg/10ml solution for injection ampoules 
(AstraZeneca UK Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7474 Trasicor 20mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7528 Nebilet 5mg tablets (A. Menarini Farmaceutica 
Internazionale SRL) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7620 Acebutolol 400mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7974 Celiprolol 400mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8023 Sectral 400mg tablets (Sanofi) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8061 Sotalol 80mg with hydrochlorothiazide 12.5mg tablet Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8113 Acebutolol 200mg capsules Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8172 Acebutolol 100mg capsules Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8262 Celiprolol 200mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8290 Trasicor 40mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8555 Sectral 200mg capsules (Sanofi) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8642 Tenif 50mg/20mg modified-release capsules 
(AstraZeneca UK Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8707 Trandate 200mg tablets (Focus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 8807 Trandate 400mg tablets (Focus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 9016 Trandate 100mg tablets (Focus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 9273 Trandate 50mg tablets (Focus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
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Hypertension medications 10191 Atenix 50 tablets (Ashbourne Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 10429 Lopresor 50mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 10716 Corgard 80mg tablets (Sanofi) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 10777 Trasicor 160mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 12296 Sectral 100mg capsules (Sanofi) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 12456 Sotazide Tablet (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 13394 Tenormin 25mg/5ml syrup (AstraZeneca UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 13499 Lopresor 100mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 13871 Co-prenozide 160mg/0.25mg modified-release tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 14117 Eucardic 3.125mg tablets (Roche Products Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 14146 Eucardic 6.25mg tablets (Roche Products Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 14502 Metoprolol 5mg/5ml solution for injection ampoules Beta-adrenoceptor Blocking Drugs 
Hypertension medications 14673 Pindolol 15mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 15042 Tolerzide Tablet (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 15176 Totamol 50mg Tablet (C P Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 15730 Totamol 100mg Tablet (C P Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 16645 Labrocol 400mg Tablet (Lagap) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 16776 Celectol 400mg Tablet (Pantheon Healthcare Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 17122 Isoprenaline 200micrograms/1ml solution for injection 
ampoules 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 17322 Atenix 25 tablets (Ashbourne Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 17783 Spiroprop Tablet (Pharmacia Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 18414 Eucardic 12.5mg tablets (Roche Products Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 18950 Totamol 25mg Tablet (C P Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 19172 Atenolol 25mg tablets (IVAX Pharmaceuticals UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 19182 Atenolol 50mg tablets (IVAX Pharmaceuticals UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 19191 Atenolol 100mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 19202 Carvedilol 6.25mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 19437 Eucardic 25mg tablets (Roche Products Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 19998 Trandate 100mg/20ml solution for injection ampoules 
(Focus Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs 
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Hypertension medications 20012 Visken 15mg Tablet (Sovereign Medical Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 20169 Practolol 2mg/ml injection Beta-adrenoceptor Blocking Drugs 
Hypertension medications 20502 Atenix 100 tablets (Ashbourne Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 20728 Atenamin 25mg Tablet (OPD Pharm) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 21133 Atenamin 50mg Tablet (OPD Pharm) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 21885 Oxyprenix SR 160mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 22793 Labrocol 200mg Tablet (Lagap) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 24094 Trasicor 40mg tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 24191 Antipressan 50mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 24195 Antipressan 100mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 24461 Betaloc I.V. 5mg/5ml solution for injection ampoules 
(AstraZeneca UK Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 25462 Clopamide 5mg with Pindolol 10mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 25644 Apsolox 80mg Tablet (Approved Prescription Services 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 26211 Antipressan 25mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 26922 Brevibloc Premixed 100mg/10ml solution for injection 
vials (Baxter Healthcare Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 27357 Oxprenolol 40mg Tablet (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 27719 Metoros ls 95mg Tablet (Geigy Pharmaceuticals) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 28700 Cartrol 10mg Tablet (Novartis Consumer Health UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29180 Trasicor 80mg tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29230 Slow-pren 160mg Tablet (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29368 Atenolol 25mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29398 Atenamin 100mg Tablet (OPD Pharm) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29762 Mepranix 50mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29827 Carteolol HCl 10mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 29998 Metoros 190mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 30400 Mepranix 100mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 30541 Esmolol HCl 250mg/ml concentrate solution for 
infusion 
Beta-adrenoceptor Blocking Drugs 
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Product Name BNF Header 
Hypertension medications 30636 Vasaten 50mg Tablet (Shire Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 30770 Labetalol 200mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 31536 Atenolol 25mg tablets (Kent Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 31934 Atenolol 100mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 32787 Visken 15mg tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33079 Atenolol 100mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33085 Atenolol 100mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33092 Atenolol 50mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33184 Atenolol 100mg tablets (Wockhardt UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33374 Carvedilol 12.5mg tablets (Genus Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33569 Oxprenolol sr 160mg Modified-release tablet (Hillcross 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33650 Atenolol 50mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33657 Atenolol 25mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 33850 Atenolol 50mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34171 Labetalol 100mg Tablet (C P Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34177 Labetalol 100mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34188 Labetalol 200mg Tablet (Celltech Pharma Europe Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34265 Atenolol 50mg tablets (Sandoz Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34365 Atenolol 50mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34443 Atenolol 50mg tablets (Wockhardt UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34492 Atenolol 25mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34501 Carvedilol 12.5mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34575 Atenolol 25mg tablets (Wockhardt UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34585 Atenolol 25mg tablets (Sandoz Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34695 Atenolol 50mg tablets (Kent Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34740 Carvedilol 6.25mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34741 Carvedilol 3.125mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34754 Atenolol 100mg tablets (Sandoz Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34882 Atenolol 50mg Tablet (Berk Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34890 Metoprolol 50mg Tablet (Berk Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 34976 Atenolol 25mg tablets (Tillomed Laboratories Ltd) Beta-adrenoceptor Blocking Drugs 
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Hypertension medications 35054 Celectol 200mg tablets (Zentiva) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 35062 Trasicor 20mg tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 35695 Visken 5mg tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 35778 Labrocol 100mg Tablet (Lagap) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 35940 Celectol 400mg tablets (Zentiva) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 36261 Atenolol 50mg tablets (Tillomed Laboratories Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 37837 Bisoprolol 2.5mg Tablet (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 38370 Labetalol 100mg/20ml solution for injection ampoules Beta-adrenoceptor Blocking Drugs 
Hypertension medications 39646 Bisoprolol 0.625mg/5ml oral solution Beta-adrenoceptor Blocking Drugs 
Hypertension medications 39819 Esmolol 2.5g/250ml infusion bags Beta-adrenoceptor Blocking Drugs 
Hypertension medications 40240 Labetalol 400mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 40761 Nebivolol 2.5mg tablets Beta-adrenoceptor Blocking Drugs 
Hypertension medications 41740 Celiprolol 200mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 41827 Labetalol 100mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 42795 Celiprolol 200mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 43564 Bisoprolol 5mg Tablet (PLIVA Pharma Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 44083 Labetalol 200mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 44808 Nebivolol 2.5mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 44858 Atenolol 25mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 45250 Labetalol 400mg tablets (Sandoz Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 45289 Metoprolol tartrate Oral solution Beta-adrenoceptor Blocking Drugs 
Hypertension medications 45309 Acebutolol 400mg tablets (A A H Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 46908 Atenolol 100mg tablets (Kent Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 46931 Atenolol 100mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 46935 Carvedilol 3.125mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 46936 Carvedilol 3.125mg tablets (A A H Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 47107 Carvedilol 5mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs 
Hypertension medications 47300 Nebivolol 2.5mg tablets (Glenmark Generics (Europe) 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 47536 Metoprolol tartrate 12.5mg/5ml Oral suspension Beta-adrenoceptor Blocking Drugs 
Hypertension medications 47673 Labetalol 400mg Tablet (Approved Prescription 
Services Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 47674 Labetalol 200mg Tablet (C P Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
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Hypertension medications 47870 Atenolol 25mg tablets (Almus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 49142 Carvedilol 3.125mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs 
Hypertension medications 49953 Atenolol 25mg tablets (Bristol Laboratories Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 50403 Bisoprolol 1.25mg Tablet (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 50702 Atenolol 25mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 51643 Atenolol 25mg/5ml oral solution sugar free (Alliance 
Healthcare (Distribution) Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 51998 Atenolol 25mg tablets (Co-Pharma Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 52310 Atenolol 25mg tablets (Crescent Pharma Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 52500 Atenolol 50mg tablets (Almus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 52728 Beta-Adalat modified-release capsules (Lexon (UK) 
Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 53204 Atenolol 50mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 53215 Atenolol 50mg tablets (Bristol Laboratories Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 53414 Atenolol 50mg tablets (Accord Healthcare Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 53802 Atenolol 25mg tablets (Sigma Pharmaceuticals Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 53826 Atenolol 25mg tablets (Boston Healthcare Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 54106 Carvedilol 1.5mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs 
Hypertension medications 54487 Nebivolol 2.5mg tablets (Sigma Pharmaceuticals Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 54542 Atenolol 25mg tablets (Zanza Laboratories Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 54752 Atenolol 50mg tablets (Co-Pharma Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 55778 Atenolol 50mg tablets (Phoenix Healthcare 
Distribution Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 55853 Pindolol 15mg Tablet (Hillcross Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 56445 Atenolol 25mg/5ml oral solution sugar free (A A H 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs 
Hypertension medications 56485 Celectol 200mg tablets (Waymade Healthcare Plc) Beta-adrenoceptor Blocking Drugs 
Hypertension medications 7543 Kalten capsules (M & A Pharmachem Ltd) Beta-adrenoceptor Blocking Drugs With Diuretic 
Hypertension medications 9143 Viskaldix tablets (Amdipharm Plc) Beta-adrenoceptor Blocking Drugs With Diuretic 
Hypertension medications 12651 Timolol 10mg / Bendroflumethiazide 2.5mg tablets Beta-adrenoceptor Blocking Drugs With Diuretic 
Hypertension medications 14057 Pindolol 10mg / Clopamide 5mg tablets Beta-adrenoceptor Blocking Drugs With Diuretic 
Hypertension medications 25363 Prestim tablets (Meda Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs With Diuretic 
Hypertension medications 48745 Timolol 10mg / Amiloride 2.5mg / Hydrochlorothiazide 
25mg tablets 
Beta-adrenoceptor Blocking Drugs With Diuretic 
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Code 
Product Name BNF Header 
Hypertension medications 3167 Propranolol 160mg tablets Beta-adrenoceptor Blocking Drugs/Antithyroid 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 33644 Propranolol 80mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs/Antithyroid 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 35938 Propranolol 80mg modified-release capsules (A A H 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs/Antithyroid 
Drugs/Prophylaxis Of Migraine/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 786 Sotalol 40mg tablets Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 9292 Sotalol 160mg tablets Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 11380 Sotacor 160mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 13051 Sotalol 200mg tablets Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 34371 Sotalol 40mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 34690 Sotalol 80mg tablets (Sandoz Ltd) Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 35710 Sotalol 25mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 39423 Sotalol 80mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs/Drugs For 
Arrhythmias 
Hypertension medications 20468 Half Beta-Prograne 80mg modified-release capsules 
(Tillomed Laboratories Ltd) 
Beta-adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 31776 Propranolol 40mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 56764 Propranolol 40mg tablets (Waymade Healthcare Plc) Beta-adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
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Medication Product 
Code 
Product Name BNF Header 
Disorders/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 7091 Bisoprolol 3.75mg tablets Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 14030 Cardicor 2.5mg tablets (Merck Serono Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 18185 Cardicor 7.5mg tablets (Merck Serono Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 33909 Congescor 1.25mg tablets (Tillomed Laboratories Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 37118 Bisoprolol 2.5mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 38991 Bisoprolol 7.5mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 47041 Bisoprolol 2.5mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 50514 Bisoprolol 2.5mg tablets (Chanelle Medical UK Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 53885 Bisoprolol 1.25mg tablets (A A H Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 55791 Bisoprolol 3.75mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 56459 Bisoprolol 2.5mg tablets (Accord Healthcare Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 57023 Bisoprolol 2.5mg tablets (Almus Pharmaceuticals Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart Failure 
Hypertension medications 24083 Bisoprolol 5mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart 
Failure/Management Of Myocardial Infarction 
Hypertension medications 39846 Vivacor 5mg tablets (Lexon (UK) Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart 
Failure/Management Of Myocardial Infarction 
Hypertension medications 55298 Bisoprolol 10mg tablets (Sigma Pharmaceuticals Plc) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart 
Failure/Management Of Myocardial Infarction 
Hypertension medications 56486 Monocor 10mg tablets (Dowelhurst Ltd) Beta-adrenoceptor Blocking 
Drugs/Hypertension And Heart 
Failure/Management Of Myocardial Infarction 
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Medication Product 
Code 
Product Name BNF Header 
Hypertension medications 24832 Lasipressin Tablet (Hoechst UK Ltd) Beta-adrenoceptor Blocking Drugs/Loop 
Diuretics 
Hypertension medications 26529 Furosemide with penbutolol Tablet Beta-adrenoceptor Blocking Drugs/Loop 
Diuretics 
Hypertension medications 10892 Emcor 10mg tablets (Merck Serono Ltd) Beta-adrenoceptor Blocking 
Drugs/Management Of Myocardial 
Infarction/Hypertension And Heart Failure 
Hypertension medications 19178 Bisoprolol 10mg tablets (Ranbaxy (UK) Ltd) Beta-adrenoceptor Blocking 
Drugs/Management Of Myocardial 
Infarction/Hypertension And Heart Failure 
Hypertension medications 19858 Cardicor 10mg tablets (Merck Serono Ltd) Beta-adrenoceptor Blocking 
Drugs/Management Of Myocardial 
Infarction/Hypertension And Heart Failure 
Hypertension medications 34963 Bisoprolol 5mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking 
Drugs/Management Of Myocardial 
Infarction/Hypertension And Heart Failure 
Hypertension medications 7852 Blocadren 10mg Tablet (Merck Sharp & Dohme Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 7853 Timolol 10mg tablets Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 8071 Betaloc 50mg tablets (AstraZeneca UK Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 11793 Metoprolol 50mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 23587 Sloprolol 160mg Capsule (C P Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 28128 Propranolol 80mg Modified-release capsule (Actavis 
UK Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 29610 Betim 10mg tablets (Meda Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 32162 Propranolol 80mg Modified-release capsule (Lagap) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 33376 Probeta LA 160mg Capsule (Trinity Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34094 Metoprolol 50mg tablets (A A H Pharmaceuticals Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34185 Propranolol LA 80mg Modified-release capsule 
(Approved Prescription Services Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
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Hypertension medications 34509 Metoprolol 100mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34584 Metoprolol 50mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34854 Metoprolol 100mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34867 Propranolol 80mg Capsule (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34884 Propranolol 160mg Modified-release capsule (Sandoz 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 34945 Propranolol 160mg Modified-release capsule (Lagap) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 36603 Propranolol SR 160mg Modified-release capsule 
(Hillcross Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 40167 Metoprolol 100mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 46614 Lopresor 50mg tablets (Recordati Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 52136 Bedranol sr 160mg Capsule (Lagap) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 55979 Metoprolol 25mg/5ml oral suspension Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine 
Hypertension medications 25367 Rapranol SR 80mg capsules (Ranbaxy (UK) Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 26229 Beta-Prograne 160mg modified-release capsules 
(Tillomed Laboratories Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 34783 Propranolol 10mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 34868 Propranolol 40mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
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Hypertension medications 34214 Propranolol 160mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 45297 Propranolol 40mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 56173 Half Beta-Prograne 80mg modified-release capsules 
(Actavis UK Ltd) 
Beta-adrenoceptor Blocking Drugs/Prophylaxis 
Of Migraine/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 17679 Sotalol 10mg/ml injection Beta-adrenoceptor Blocking 
Drugs/Supraventricular & Ventricular 
Arrhythmias 
Hypertension medications 24635 Sotacor 10mg/ml Injection (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking 
Drugs/Supraventricular & Ventricular 
Arrhythmias 
Hypertension medications 34640 Sotalol 40mg Tablet (Tillomed Laboratories Ltd) Beta-adrenoceptor Blocking 
Drugs/Supraventricular & Ventricular 
Arrhythmias 
Hypertension medications 3827 Propanix 40mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 9185 Propranolol 80mg/5ml oral solution Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 12495 Berkolol 10mg Tablet (Berk Pharmaceuticals Ltd) Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 21838 Propanix 80mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 21839 Berkolol 80mg Tablet (Berk Pharmaceuticals Ltd) Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 24218 Berkolol 160mg Tablet (Berk Pharmaceuticals Ltd) Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 27964 Apsolol 40mg Tablet (Approved Prescription Services 
Ltd) 
Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 33836 Apsolol 160mg Tablet (Approved Prescription 
Services Ltd) 
Beta-adrenoceptor Blocking 
Drugs/Supraventricular Arrhythmias 
Hypertension medications 38433 Propranolol 50mg/5ml Oral solution (Rosemont Beta-adrenoceptor Blocking 
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Pharmaceuticals Ltd) Drugs/Supraventricular Arrhythmias 
Hypertension medications 1124 Tenoretic 100mg/25mg tablets (AstraZeneca UK Ltd) Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 1788 Atenolol 100mg with Chlortalidone 25mg tablets Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 3526 Amiloride with atenolol with hydrochlorothiazide 
capsules 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 8147 Lopresoretic Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 9783 Co-tenidone 50mg/12.5mg tablets Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 11338 Bendroflumethiazide 5mg with Nadolol 40mg tablets Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 13526 Atenix Co 100 tablets (Ashbourne Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 15488 Metoprolol tartrate with chlortalidone Tablet Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 16786 Chlortalidone 25mg with Atenolol 100mg tablets Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 19055 Chlortalidone 12.5mg with Atenolol 50mg tablets Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 19142 Bendroflumethiazide 2.5mg with Timolol maleate 
10mg tablets 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 22912 Bendroflumethiazide 2.5mg with Propanolol 80mg 
capsules 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 24280 Totaretic 100mg+25mg Tablet (C P Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 26248 Tenchlor 100mg/25mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 26741 Totaretic 50mg+12.5mg Tablet (C P Pharmaceuticals 
Ltd) 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 29427 Hydrochlorothiazide with metoprolol tartrate 12.5mg 
with 100mg tablet 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 30519 Amiloride with timolol with hydrochlorothiazide tablets Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 31470 Tenchlor 50mg/12.5mg tablets (Teva UK Ltd) Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 34012 Co-tenidone 100mg/25mg tablets (IVAX Beta-adrenoceptor Blocking Drugs/Thiazides 
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Pharmaceuticals UK Ltd) And Related Diuretics 
Hypertension medications 34034 Co-tenidone 50mg/12.5mg tablets (IVAX 
Pharmaceuticals UK Ltd) 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 34449 Co-tenidone 50mg/12.5mg tablets (Generics (UK) Ltd) Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 34899 Co-tenidone 100mg/25mg tablets (A A H 
Pharmaceuticals Ltd) 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 46952 Co-tenidone 100mg/25mg tablets (Actavis UK Ltd) Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 52145 Cyclopenthiazide 0.25mg with oxprenolol 160mg 
modified-release tablets 
Beta-adrenoceptor Blocking Drugs/Thiazides 
And Related Diuretics 
Hypertension medications 29 Amlodipine besilate 5mg tablets Calcium-channel Blockers 
Hypertension medications 71 Amlodipine besilate 10mg tablets Calcium-channel Blockers 
Hypertension medications 219 Diltiazem 120mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 269 Nifedipine 5mg capsules Calcium-channel Blockers 
Hypertension medications 410 Nifedipine 10mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 452 Nifedipine 10mg capsules Calcium-channel Blockers 
Hypertension medications 491 Felodipine 2.5mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 501 Felodipine 5mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 517 Adizem sr 120mg Modified-release capsule (Napp 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 536 Tildiem la 200mg Modified-release capsule (Sanofi) Calcium-channel Blockers 
Hypertension medications 541 Adalat LA 20 tablets (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 568 Felodipine 10mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 636 Diltiazem 60mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 662 Adalat 5mg capsules (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 700 Vera-Til SR 120mg tablets (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 729 Amlodipine maleate 5mg tablets Calcium-channel Blockers 
Hypertension medications 737 Nifedipine 20mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 749 Amlodipine 5mg tablets Calcium-channel Blockers 
Hypertension medications 793 Adizem xl 240mg Capsule (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 939 Tildiem Retard 90mg tablets (Sanofi) Calcium-channel Blockers 
Hypertension medications 1118 Verapamil 40mg tablets Calcium-channel Blockers 
Hypertension medications 1120 Verapamil 80mg tablets Calcium-channel Blockers 
Hypertension medications 1130 Viazem XL 300mg capsules (Genus Pharmaceuticals Calcium-channel Blockers 
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Hypertension medications 1262 Nifedipine 12 20mg Modified-release tablet Calcium-channel Blockers 
Hypertension medications 1289 Tildiem Retard 120mg tablets (Sanofi) Calcium-channel Blockers 
Hypertension medications 1298 Verapamil 240mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 1300 Nifensar xl 20mg Modified-release tablet (Rhone-
Poulenc Rorer Ltd) 
Calcium-channel Blockers 
Hypertension medications 1449 Nifedipine 24 30mg Modified-release tablet Calcium-channel Blockers 
Hypertension medications 1529 Posicor 50mg Tablet (Roche Products Ltd) Calcium-channel Blockers 
Hypertension medications 1538 Diltiazem 60mg tablets Calcium-channel Blockers 
Hypertension medications 1574 Verapamil 120mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 1686 Diltiazem 90mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 1747 Verapamil 120mg tablets Calcium-channel Blockers 
Hypertension medications 1748 Cordilox 120mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 1836 Diltiazem 60mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 1854 Adalat la 30mg Tablet (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 1995 Diltiazem 12hr 120mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 2280 Adalat retard 10mg tablets (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 2343 Adalat retard 20mg tablets (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 2453 Diltiazem 60mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 2521 Adalat 10mg capsules (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 2528 Slozem 120mg capsules (Merck Serono Ltd) Calcium-channel Blockers 
Hypertension medications 2592 Viazem XL 120mg capsules (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 2605 Nifedipine 10mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 2663 Diltiazem 240mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 2686 Dilzem xl mr 240mg Modified-release capsule (Elan 
Pharma) 
Calcium-channel Blockers 
Hypertension medications 2746 Coracten SR 10mg capsules (UCB Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 2811 Adizem sr 180mg Modified-release capsule (Napp 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 2888 Tildiem 60mg modified-release tablets (Sanofi) Calcium-channel Blockers 
Hypertension medications 2926 Nicardipine 20mg capsules Calcium-channel Blockers 
Hypertension medications 3057 Securon 120mg tablets (Abbott Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 3061 Diltiazem 12hr 180mg modified-release capsules Calcium-channel Blockers 
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Hypertension medications 3118 Adizem sr 90mg Modified-release capsule (Napp 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 3221 Lacidipine 4mg tablets Calcium-channel Blockers 
Hypertension medications 3302 Cardene SR 30mg capsules (Astellas Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 3342 Securon SR 240mg tablets (Abbott Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 3343 Half Securon SR 120mg tablets (Abbott Laboratories 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 3370 Dilzem xl mr 120mg Modified-release capsule (Elan 
Pharma) 
Calcium-channel Blockers 
Hypertension medications 3676 Dilzem xl mr 180mg Modified-release capsule (Elan 
Pharma) 
Calcium-channel Blockers 
Hypertension medications 3711 Adipine MR 20 tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 3712 Coracten XL 30mg capsules (UCB Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 3917 Istin 5mg tablets (Pfizer Ltd) Calcium-channel Blockers 
Hypertension medications 3930 Nifedipine 60mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 3931 Posicor 100mg Tablet (Roche Products Ltd) Calcium-channel Blockers 
Hypertension medications 3943 Verapamil 240mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 4227 Adalat la 60mg Tablet (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 4239 Adipine MR 10 tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 4308 Dilzem sr 90mg Capsule (Elan Pharma) Calcium-channel Blockers 
Hypertension medications 4408 Slozem 240mg capsules (Merck Serono Ltd) Calcium-channel Blockers 
Hypertension medications 4635 Diltiazem 200mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 4732 Diltiazem 90mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 4808 Diltiazem 240mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 4852 Adizem sr 120mg Modified-release tablet (Napp 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 4856 Coracten SR 20mg capsules (UCB Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 4923 Diltiazem 24hr 180mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 4939 Coracten XL 60mg capsules (UCB Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 5054 Angitil SR 180 capsules (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 5158 Lacidipine 2mg tablets Calcium-channel Blockers 
Hypertension medications 5162 Nifedipine 30mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 5181 Angiopine MR 20mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 5194 Dilzem sr 120mg Capsule (Elan Pharma) Calcium-channel Blockers 
Hypertension medications 5234 Slozem 180mg capsules (Merck Serono Ltd) Calcium-channel Blockers 
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Hypertension medications 5277 Fortipine LA 40 tablets (Mercury Pharma Group Ltd) Calcium-channel Blockers 
Hypertension medications 5296 Tildiem la 300mg Modified-release capsule (Sanofi) Calcium-channel Blockers 
Hypertension medications 5326 Diltiazem 24hr 300mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 5348 Diltiazem 300mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 5477 Nicardipine 30mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 5513 Dilzem sr 60mg Capsule (Elan Pharma) Calcium-channel Blockers 
Hypertension medications 5570 Zanidip 10mg tablets (Recordati Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 5593 Lercanidipine 10mg tablets Calcium-channel Blockers 
Hypertension medications 5806 Tensipine MR 20 tablets (Genus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 5914 Istin 10mg tablets (Pfizer Ltd) Calcium-channel Blockers 
Hypertension medications 6309 Adizem xl 300mg Capsule (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 6477 Amlodipine maleate 10mg tablets Calcium-channel Blockers 
Hypertension medications 6510 Univer 120mg modified-release capsules (Teva UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 6856 Amlodipine 10mg tablets Calcium-channel Blockers 
Hypertension medications 7280 Plendil 10mg modified-release tablets (AstraZeneca 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 7398 Viazem XL 360mg capsules (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 7541 Nifopress Retard 20mg tablets (Mercury Pharma 
Group Ltd) 
Calcium-channel Blockers 
Hypertension medications 7562 Cardene 30mg capsules (Astellas Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 7681 Synadrin 60mg Tablet (Hoechst UK Ltd) Calcium-channel Blockers 
Hypertension medications 8201 Nicardipine 30mg capsules Calcium-channel Blockers 
Hypertension medications 8213 Nifedipine 24 20mg Modified-release tablet Calcium-channel Blockers 
Hypertension medications 8257 Prescal 2.5mg tablets (Novartis Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 8310 Isradipine 2.5mg tablets Calcium-channel Blockers 
Hypertension medications 8558 Adizem xl 120mg Capsule (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 8884 Cordilox 40mg tablets (IVAX Pharmaceuticals UK Ltd) Calcium-channel Blockers 
Hypertension medications 8945 Univer 240mg modified-release capsules (Teva UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 8975 Verapamil 180mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 9240 Adizem xl 180mg Capsule (Napp Pharmaceuticals Calcium-channel Blockers 
  
 
3
8
8
 
Medication Product 
Code 
Product Name BNF Header 
Ltd) 
Hypertension medications 9269 Nifedipine 40mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 9334 Plendil 2.5mg modified-release tablets (AstraZeneca 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 9374 Adizem 60mg Modified-release tablet (Napp 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 9386 Nicardipine 45mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 9410 Angitil SR 120 capsules (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 9437 Plendil 5mg modified-release tablets (AstraZeneca UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 9485 Hypolar Retard 20 tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 9553 Slofedipine XL 60 tablets (Zentiva) Calcium-channel Blockers 
Hypertension medications 9569 Verapamil 120mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 9573 Slofedipine XL 30mg tablets (Zentiva) Calcium-channel Blockers 
Hypertension medications 9670 Motens 4mg tablets (Boehringer Ingelheim Ltd) Calcium-channel Blockers 
Hypertension medications 9708 Diltiazem 24hr 120mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 9723 Calcicard CR 90mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 9750 Nifedipine 60mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 10135 Nifedipress mr 10mg Modified-release tablet (Sandoz 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 10136 Nifedipress MR 20 tablets (Dexcel-Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 10153 Felendil xl 5mg Modified-release tablet (Ratiopharm 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 10246 Adipine XL 60mg tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 10267 Adizem-XL 200mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 10595 Nimotop 30mg tablets (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 10688 Verapamil 160mg tablets Calcium-channel Blockers 
Hypertension medications 11223 Angitil SR 90 capsules (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 11512 Nifedipress MR 10 tablets (Dexcel-Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 11547 Nimodipine 30mg tablets Calcium-channel Blockers 
Hypertension medications 11769 Calchan MR 20 tablets (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 11770 Dilzem SR 60 capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 11777 Verapamil 40mg/5ml oral solution sugar free Calcium-channel Blockers 
Hypertension medications 11922 Diltiazem 60mg/5ml oral suspension Calcium-channel Blockers 
Hypertension medications 11943 Cardene 20mg capsules (Astellas Pharma Ltd) Calcium-channel Blockers 
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Hypertension medications 11966 Motens 2mg tablets (Boehringer Ingelheim Ltd) Calcium-channel Blockers 
Hypertension medications 11972 Vertab SR 240 tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 11973 Calcicard CR 120mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 12104 Cordilox 160mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 12392 Univer 180mg modified-release capsules (Teva UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 12606 Nifelease 20mg Modified-release tablet (Eastern 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 12613 Unipine xl 30mg Modified-release tablet (Genus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 12639 Diltiazem HCl 90mg Modified-release tablet (Actavis 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 12705 Angiozem CR 90mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 12875 Cardene SR 45mg capsules (Astellas Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 13027 Viazem XL 240mg capsules (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 13033 Angitil XL 240 capsules (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 13075 Dilzem XL 180 capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 13127 Dilzem XL 240 capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 13139 Adipine XL 30mg tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 13240 Dilzem XL 120 capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 13243 Lercanidipine 20mg tablets Calcium-channel Blockers 
Hypertension medications 13251 Vera-Til SR 240mg tablets (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 13302 Dilzem SR 90 capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 13410 Angiozem 60mg modified-release tablets (Ashbourne 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 13672 Angiopine MR 10mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 13699 Angiopine la 40mg Tablet (Ashbourne 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 13856 Verapress MR 240mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 13926 Diltiazem 360mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 13965 Cordilox MR 240mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 14300 Zanidip 20mg tablets (Recordati Pharmaceuticals Ltd) Calcium-channel Blockers 
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Hypertension medications 14305 Vascalpha 10mg modified-release tablets (Actavis UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 14861 Calchan MR 10 tablets (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 15221 Dilcardia xl 180mg Modified-release capsule 
(Generics (UK) Ltd) 
Calcium-channel Blockers 
Hypertension medications 15288 Angitil XL 300 capsules (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 15652 Mibefradil 50mg Tablet Calcium-channel Blockers 
Hypertension medications 15715 Genalat retard 20mg Modified-release tablet (Wyeth 
Pharmaceuticals) 
Calcium-channel Blockers 
Hypertension medications 16038 Dilzem SR 120 capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 16073 Nifedipress MR 10 tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 16162 Amlodipine 5mg/5ml oral suspension Calcium-channel Blockers 
Hypertension medications 16328 Verapress MR 240mg tablets (Dexcel-Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 16677 Cordilox 80mg tablets (IVAX Pharmaceuticals UK Ltd) Calcium-channel Blockers 
Hypertension medications 16850 Angiozem CR 120mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 17325 Cardilate MR 10mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 17338 Nifedotard 20 mr 20mg Modified-release tablet (Galen 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 17342 Nivaten retard 10mg Modified-release tablet (Actavis 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 17406 Zemtard 180 XL capsules (Galen Ltd) Calcium-channel Blockers 
Hypertension medications 17425 Zemtard 120 XL capsules (Galen Ltd) Calcium-channel Blockers 
Hypertension medications 17448 Nifedipress mr 10mg Modified-release tablet (Sterwin 
Medicines) 
Calcium-channel Blockers 
Hypertension medications 17492 Zemtard 300 XL capsules (Galen Ltd) Calcium-channel Blockers 
Hypertension medications 17557 Felotens XL 5mg tablets (Genus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 17566 Felotens XL 10mg tablets (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 17586 Slozem 300mg capsules (Merck Serono Ltd) Calcium-channel Blockers 
Hypertension medications 17599 Verapress MR 240mg tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 17640 Amlostin 5mg tablets (Discovery Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 17666 Viazem XL 180mg capsules (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 18038 Nisoldipine 20mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 18379 Dilcardia SR 90mg capsules (Generics (UK) Ltd) Calcium-channel Blockers 
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Hypertension medications 18403 Diltiazem HCl 180mg Modified-release capsule 
(Hillcross Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 18404 Diltiazem 60mg modified-release capsules (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 18830 Disogram SR 90mg capsules (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 18834 Disogram SR 60mg capsules (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 18852 Disogram SR 120mg capsules (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 18874 Disogram SR 180mg capsules (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 18975 Calcicard 60mg Tablet (3M Health Care Ltd) Calcium-channel Blockers 
Hypertension medications 19013 Clinium 120mg Tablet (LEO Pharma) Calcium-channel Blockers 
Hypertension medications 19129 Syscor MR 10 tablets (Forest Laboratories UK Ltd) Calcium-channel Blockers 
Hypertension medications 19170 Tensipine MR 10 tablets (Genus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 19175 Verapamil 40mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 19426 Disogram SR 240mg capsules (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 19440 Disogram SR 300mg capsules (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 19457 Ranvera MR 240mg tablets (Ranbaxy (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 19459 Verapamil 240mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 20257 Cardilate MR 20mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 20311 Nifedipress mr 20mg Modified-release tablet 
(Generics (UK) Ltd) 
Calcium-channel Blockers 
Hypertension medications 20459 Felendil xl 10mg Modified-release tablet (Ratiopharm 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 20591 Nifedipress MR 20 tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 20642 Bi-carzem sr 60mg Modified-release capsule 
(Tillomed Laboratories Ltd) 
Calcium-channel Blockers 
Hypertension medications 20878 Angiopine 10 capsules (Ashbourne Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 20890 Zemtard 240 XL capsules (Galen Ltd) Calcium-channel Blockers 
Hypertension medications 21145 Dilcardia SR 60mg capsules (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 21216 Hypolar Retard 10mg tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 21245 Nifedipress mr 10mg Modified-release tablet (Actavis 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 21763 Diltiazem 60mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
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Hypertension medications 21773 Diltiazem HCl 60mg Tablet (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 21778 Diltiazem 60mg modified-release tablets (Teva UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 21795 Retalzem 60 modified-release tablets (Kent 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 21872 Angiopine 5mg Capsule (Ashbourne Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 21886 Nifedipress MR 20 tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 21918 Optil 60mg modified-release tablets (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 22019 Calanif 10mg Capsule (Berk Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 22142 Calcilat 10mg Capsule (Eastern Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 22217 Nimodrel 10mg modified-release tablet (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 22241 Mibefradil 100mg Tablet Calcium-channel Blockers 
Hypertension medications 22619 Britiazim 60mg Modified-release tablet (Thames 
Laboratories Ltd) 
Calcium-channel Blockers 
Hypertension medications 22696 Slofedipine 20mg tablets (Sterwin Medicines) Calcium-channel Blockers 
Hypertension medications 23233 Bi-carzem sr 90mg Modified-release capsule 
(Tillomed Laboratories Ltd) 
Calcium-channel Blockers 
Hypertension medications 23733 Optil sr 90mg Modified-release capsule (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 23736 Hypolar XL 30 tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 23805 Nisoldipine 10mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 23823 Nisoldipine 30mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 24228 Nimodrel 20mg modified-release tablet (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 24365 Cardioplen XL 5mg tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 24366 Cardioplen XL 10mg tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 25132 Nifopress MR 20mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 25572 Felogen XL 5mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 25646 Nivaten retard 20mg Modified-release tablet (Actavis 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 25777 Dilcardia SR 120mg capsules (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 25919 Nifedipine 20mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 26265 Calanif 5mg Capsule (Berk Pharmaceuticals Ltd) Calcium-channel Blockers 
  
 
3
9
3
 
Medication Product 
Code 
Product Name BNF Header 
Hypertension medications 26267 Optil sr 120mg Modified-release capsule (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 26269 Optil sr 180mg Modified-release capsule (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 26270 Optil xl 300mg Modified-release capsule (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 26309 Optil xl 240mg Modified-release capsule (Opus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 26337 Cabren 10mg modified-release tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 26460 Dilcardia xl 240mg Modified-release capsule 
(Generics (UK) Ltd) 
Calcium-channel Blockers 
Hypertension medications 26463 Zemret xl 240mg Capsule (Neo Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 26674 Verapamil 5mg/2ml solution for injection ampoules Calcium-channel Blockers 
Hypertension medications 26759 Zildil SR 60mg capsules (Chanelle Medical UK Ltd) Calcium-channel Blockers 
Hypertension medications 26774 Nifedipine 10mg/5ml Oral suspension Calcium-channel Blockers 
Hypertension medications 27135 Diltiazem sr 90mg Capsule (Hillcross Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 27136 Diltiazem 90mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 27295 Securon IV 5mg/2ml solution for injection ampoules 
(Abbott Laboratories Ltd) 
Calcium-channel Blockers 
Hypertension medications 27401 Kenzem SR 90mg capsules (Kent Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 27685 Diltiazem HCl 300mg Capsule (PLIVA Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 28688 Nifedipine 10mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 28721 Neofel XL 5mg tablets (Kent Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 28949 Bi-carzem sr 120mg Modified-release capsule 
(Tillomed Laboratories Ltd) 
Calcium-channel Blockers 
Hypertension medications 29044 Neofel XL 10mg tablets (Kent Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 29145 Felendil xl 2.5mg Modified-release tablet (Ratiopharm 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 29637 Verapress MR 240mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 29676 Calazem 60mg Modified-release tablet (Berk 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 30197 Diltiazem 120mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 30199 Nifedipine 30mg modified-release tablets Calcium-channel Blockers 
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Hypertension medications 30242 Diltiazem 180mg modified-release capsules Calcium-channel Blockers 
Hypertension medications 30462 Ethimil MR 240mg tablets (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 30473 Coroday MR 20mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 30557 Felogen XL 10mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 30758 Lidoflazine 120mg Tablet Calcium-channel Blockers 
Hypertension medications 30915 Cabren 2.5mg modified-release tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 30991 Cabren 5mg modified-release tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 31336 Syscor MR 30 tablets (Forest Laboratories UK Ltd) Calcium-channel Blockers 
Hypertension medications 31337 Syscor MR 20 tablets (Forest Laboratories UK Ltd) Calcium-channel Blockers 
Hypertension medications 31489 Bi-carzem xl 240mg Capsule (Tillomed Laboratories 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 31490 Zolvera 40mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 31676 Diltiazem HCl 120mg Modified-release tablet (Actavis 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 31711 Verapamil 80mg tablets (A A H Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 31737 Zildil SR 120mg capsules (Chanelle Medical UK Ltd) Calcium-channel Blockers 
Hypertension medications 31761 Amlostin 10mg tablets (Discovery Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 32089 Diltiazem HCl 120mg Modified-release capsule 
(Hillcross Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 32262 Diltiazem HCl 60mg Tablet (C P Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 32590 Verapamil 40mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 32595 Amlodipine 5mg tablets (A A H Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 32658 Dilcardia xl 120mg Modified-release capsule 
(Generics (UK) Ltd) 
Calcium-channel Blockers 
Hypertension medications 32870 Diltiazem 60mg modified-release tablets (Sterwin 
Medicines) 
Calcium-channel Blockers 
Hypertension medications 32917 Amlodipine 5mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 32922 Felodipine 10mg Modified-release tablet (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 33025 Nimodrel XL 30mg tablets (Zurich Pharmaceuticals) Calcium-channel Blockers 
Hypertension medications 33091 Felodipine 10mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 33471 Verapamil 40mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
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Hypertension medications 33932 Parmid XL 5mg tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 34093 Amlodipine 10mg tablets (A A H Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 34101 Nifedipine mr 20mg Modified-release tablet (IVAX 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 34115 Nifedipine 60mg Modified-release tablet Calcium-channel Blockers 
Hypertension medications 34146 Nifedipine mr 10mg Modified-release tablet (IVAX 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 34187 Nifedipine 10mg Modified-release tablet (Generics 
(UK) Ltd) 
Calcium-channel Blockers 
Hypertension medications 34247 Nifedipine 10mg Capsule (Berk Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 34377 Diltiazem HCl 90mg Modified-release capsule 
(Hillcross Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 34475 Diltiazem HCl 90mg Modified-release tablet (IVAX 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 34522 Nifedipine 5mg capsules (A A H Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 34581 Diltiazem HCl 60mg Modified-release tablet (Kent 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 34607 Nifedipine 5mg capsules (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 34824 Diltiazem HCl 120mg Modified-release tablet (IVAX 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 34959 Verapamil 40mg tablets (A A H Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 34975 Nifedipine 5mg capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 35084 Vascalpha 5mg modified-release tablets (Actavis UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 35096 Exforge 10mg/160mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 35189 Amlodipine 10mg / Valsartan 160mg tablets Calcium-channel Blockers 
Hypertension medications 35317 Exforge 5mg/80mg tablets (Novartis Pharmaceuticals 
UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 35329 Amlodipine 5mg / Valsartan 80mg tablets Calcium-channel Blockers 
Hypertension medications 35343 Amlodipine 5mg / Valsartan 160mg tablets Calcium-channel Blockers 
Hypertension medications 35592 Cardioplen XL 2.5mg tablets (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 35646 Neozipine XL 60mg tablets (Kent Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 35696 Kenzem SR 120mg capsules (Kent Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
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Hypertension medications 35697 Exforge 5mg/160mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 35729 Verapamil 80mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 36202 Amlodipine 10mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 36583 Zemret xl 180mg Capsule (Neo Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 36620 Parmid XL 10mg tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 36664 Zemret xl 300mg Capsule (Neo Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 37025 Nifedipine 20mg modified-release tablets Calcium-channel Blockers 
Hypertension medications 37184 Valni XL 30mg tablets (Zentiva) Calcium-channel Blockers 
Hypertension medications 37530 Neozipine XL 30mg tablets (Kent Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 37726 Nifedipine 100mg/5ml oral suspension Calcium-channel Blockers 
Hypertension medications 37774 Kenzem SR 60mg capsules (Kent Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 37897 Felotens XL 2.5mg tablets (Genus Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38066 Diltiazem HCl 60mg Modified-release tablet (Lagap) Calcium-channel Blockers 
Hypertension medications 38107 Nifedipine sr 30mg Tablet (Hillcross Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38434 Keloc SR 10mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 38545 Tildiem LA 200 capsules (Sanofi) Calcium-channel Blockers 
Hypertension medications 38632 Adizem-SR 90mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38634 Adizem-XL 300mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38818 Adizem-SR 120mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38831 Adizem-SR 180mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38855 Adizem-XL 180mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38865 Adizem-XL 120mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38876 Tildiem LA 300 capsules (Sanofi) Calcium-channel Blockers 
Hypertension medications 38882 Adizem-XL 240mg capsules (Napp Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 38964 Adizem-SR 120mg tablets (Napp Pharmaceuticals Calcium-channel Blockers 
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Ltd) 
Hypertension medications 39009 Verapamil 40mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 39171 Bi-Carzem SR 60mg capsules (Tillomed Laboratories 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 39298 Bi-Carzem SR 90mg capsules (Tillomed Laboratories 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 39357 Neofel XL 2.5mg tablets (Kent Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 39800 Valni XL 60mg tablets (Zentiva) Calcium-channel Blockers 
Hypertension medications 39804 Amlodipine 5mg tablets (Dr Reddy's Laboratories (UK) 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 39914 Amlodipine 5mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 40074 Nifedipine 20mg Capsule Calcium-channel Blockers 
Hypertension medications 40405 Verapamil 120mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 40633 Vascalpha 5mg modified-release tablets (Almus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 41489 Bi-Carzem SR 120mg capsules (Tillomed 
Laboratories Ltd) 
Calcium-channel Blockers 
Hypertension medications 41586 Verapamil 80mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 41635 Diltiazem 60mg modified-release tablets (IVAX 
Pharmaceuticals UK Ltd) 
Calcium-channel Blockers 
Hypertension medications 41679 Verapamil 80mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 41693 Verapamil 120mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 41979 Adipine la 30mg Modified-release tablet (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 42210 Amlodipine 10mg tablets (Zentiva) Calcium-channel Blockers 
Hypertension medications 42625 Vera-Til SR 120mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 42731 Diltiazem sr 120mg Capsule (Hillcross 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 42804 Diltiazem HCl 180mg Capsule (PLIVA Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 42819 Diltiazem xl 240mg Capsule (Hillcross 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 42912 Nifedipine 10mg capsules (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 43222 Valni 20 Retard tablets (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 43394 Pinefeld XL 10mg tablets (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 43410 Nifedipine extra 60mg Modified-release tablet Calcium-channel Blockers 
Hypertension medications 43430 Diltiazem 120mg modified-release tablets (A A H Calcium-channel Blockers 
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Pharmaceuticals Ltd) 
Hypertension medications 43470 Amlodipine 5mg tablets (Wockhardt UK Ltd) Calcium-channel Blockers 
Hypertension medications 43511 Nifedipine 10mg capsules (A A H Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 43512 Felodipine 5mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 43515 Nifedipine 10mg capsules (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 43753 Adalat LA 30 tablets (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 43790 Vascalpha 10mg modified-release tablets (Almus 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 43818 Adalat LA 60 tablets (Bayer Plc) Calcium-channel Blockers 
Hypertension medications 43879 Vera-Til SR 240mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 43880 Amlodipine 5mg tablets (Almus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 44192 Zemret 240 XL capsules (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 44859 Felodipine sr 5mg Tablet (Approved Prescription 
Services Ltd) 
Calcium-channel Blockers 
Hypertension medications 44887 Bi-carzem xl 300mg Capsule (Tillomed Laboratories 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 45070 Amlodipine 10mg/5ml oral suspension Calcium-channel Blockers 
Hypertension medications 45279 Amlodipine 5mg tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 45292 Nicardipine 30mg capsules (A A H Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 45308 Verapamil 240mg modified-release tablets (Generics 
(UK) Ltd) 
Calcium-channel Blockers 
Hypertension medications 45564 Diltiazem 2% ointment Calcium-channel Blockers 
Hypertension medications 45685 Adanif XL 30mg tablets (Focus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 45759 Diltiazem HCl 240mg Capsule (PLIVA Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 46009 Verapamil 120mg tablets (Kent Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 46233 Amlodipine Oral solution Calcium-channel Blockers 
Hypertension medications 46445 Nifedipine 10mg capsules (IVAX Pharmaceuticals UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 46724 Amlodipine 5mg/5ml oral solution Calcium-channel Blockers 
Hypertension medications 46887 Adanif XL 60mg tablets (Focus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 46937 Diltiazem 60mg modified-release tablets (Actavis UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 46955 Verapamil 80mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
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Hypertension medications 47002 Amlodipine 10mg/5ml sugar free Oral suspension Calcium-channel Blockers 
Hypertension medications 47027 Nifedipine 10mg Modified-release tablet (Kent 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 47217 Adipine la 60mg Modified-release tablet (Chiesi Ltd) Calcium-channel Blockers 
Hypertension medications 47222 Verapamil 120mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 47230 Verapamil 240mg modified-release tablets (Teva UK 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 47285 Nifedipine xl 60mg Tablet (Hillcross Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 47331 Lercanidipine 10mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 47415 Diltiazem sr 60mg Capsule (Hillcross Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 47529 Nifedipine 20mg/ml oral drops Calcium-channel Blockers 
Hypertension medications 47530 Horizem SR 60mg capsules (Horizon lifecare) Calcium-channel Blockers 
Hypertension medications 47608 Zemret 300 XL capsules (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 47614 Nifedipine 30mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 47707 Nifedipine Oral solution Calcium-channel Blockers 
Hypertension medications 47724 Bi-Carzem XL 240mg capsules (Tillomed Laboratories 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 47732 Zemret 180 XL capsules (Tillomed Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 47887 Nimodrel XL 60mg tablets (Zurich Pharmaceuticals) Calcium-channel Blockers 
Hypertension medications 47996 Diltiazem 2% gel Calcium-channel Blockers 
Hypertension medications 48009 Felodipine 5mg Modified-release tablet (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 48272 Diltiazem 60mg modified-release capsules (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 48282 Diltiazem 90mg modified-release capsules (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 48288 Diltiazem 120mg modified-release capsules (A A H 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 48457 Diltiazem 90mg modified-release capsules (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 48870 Adizem-SR 90mg capsules (Doncaster 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 49001 Diltiazem 120mg modified-release tablets (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
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Hypertension medications 49289 Diltiazem 120mg modified-release capsules (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 49338 Nifedipine 20mg modified-release tablets (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 49390 Diltiazem 90mg modified-release tablets (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 49500 Diltiazem 2% ointment (Drug Tariff Special Order) Calcium-channel Blockers 
Hypertension medications 49636 Amlodipine 10mg tablets (Doncaster Pharmaceuticals 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 49762 Nifedipine 10mg modified-release tablets (Alliance 
Healthcare (Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 51261 Tildiem Retard 120mg tablets (Mawdsley-Brooks & 
Company Ltd) 
Calcium-channel Blockers 
Hypertension medications 51461 Securon SR 240mg tablets (Waymade Healthcare 
Plc) 
Calcium-channel Blockers 
Hypertension medications 51917 Adalat LA 60 tablets (Sigma Pharmaceuticals Plc) Calcium-channel Blockers 
Hypertension medications 52017 Adalat LA 30 tablets (Mawdsley-Brooks & Company 
Ltd) 
Calcium-channel Blockers 
Hypertension medications 52276 Adizem-XL 180mg capsules (Doncaster 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 52440 Amlodipine 10mg/5ml oral solution Calcium-channel Blockers 
Hypertension medications 52701 Tildiem LA 200 capsules (Mawdsley-Brooks & 
Company Ltd) 
Calcium-channel Blockers 
Hypertension medications 53278 Adalat LA 30 tablets (Necessity Supplies Ltd) Calcium-channel Blockers 
Hypertension medications 53357 Nifedipine 10mg/5ml oral suspension Calcium-channel Blockers 
Hypertension medications 53500 Adalat LA 30 tablets (Doncaster Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 53629 Adalat retard 20mg tablets (Lexon (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 53868 Amlodipine 5mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 53990 Nifedipine 5mg/5ml oral suspension Calcium-channel Blockers 
Hypertension medications 54515 Amlodipine 10mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Calcium-channel Blockers 
Hypertension medications 54633 Amlodipine 5mg tablets (Bristol Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 54654 Amlodipine 10mg tablets (Almus Pharmaceuticals Ltd) Calcium-channel Blockers 
Hypertension medications 54696 Amlodipine 10mg tablets (Sandoz Ltd) Calcium-channel Blockers 
Hypertension medications 54799 Tildiem LA 300 capsules (Mawdsley-Brooks & 
Company Ltd) 
Calcium-channel Blockers 
Hypertension medications 54983 Amlodipine 2.5mg/5ml oral suspension Calcium-channel Blockers 
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Hypertension medications 55257 Diltiazem 60mg/5ml oral solution Calcium-channel Blockers 
Hypertension medications 55306 Folpik XL 5mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 55455 Nifedipine 10mg capsules (Co-Pharma Ltd) Calcium-channel Blockers 
Hypertension medications 55740 Neofel XL 2.5mg tablets (Actavis UK Ltd) Calcium-channel Blockers 
Hypertension medications 55824 Nifedipine 20mg Modified-release tablet (Berk 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 56147 Amlodipine 10mg tablets (Accord Healthcare Ltd) Calcium-channel Blockers 
Hypertension medications 56334 Amlodipine 10mg tablets (Bristol Laboratories Ltd) Calcium-channel Blockers 
Hypertension medications 56467 Tildiem 60mg modified-release tablets (Doncaster 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 56469 Adalat LA 60 tablets (Necessity Supplies Ltd) Calcium-channel Blockers 
Hypertension medications 56758 Diltiazem 90mg modified-release capsules (Cubic 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 56767 Lercanidipine 20mg tablets (Generics (UK) Ltd) Calcium-channel Blockers 
Hypertension medications 56994 Lacidipine 4mg tablets (Teva UK Ltd) Calcium-channel Blockers 
Hypertension medications 57208 Diltiazem 120mg modified-release capsules (Cubic 
Pharmaceuticals Ltd) 
Calcium-channel Blockers 
Hypertension medications 11567 Ramipril 5mg with felodipine 5mg modified-release 
tablet 
Calcium-channel Blockers/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 11965 Ramipril 2.5mg with felodipine 2.5mg modified-release 
tablet 
Calcium-channel Blockers/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 35174 Valsartan 80mg with amlodipine 5mg tablets Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 39984 Sevikar 20mg/5mg tablets (Daiichi Sankyo UK Ltd) Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 40316 Olmesartan medoxomil 20mg / Amlodipine 5mg 
tablets 
Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 40639 Olmesartan medoxomil 40mg / Amlodipine 5mg 
tablets 
Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 40668 Olmesartan medoxomil 40mg / Amlodipine 10mg 
tablets 
Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 41203 Sevikar 40mg/10mg tablets (Daiichi Sankyo UK Ltd) Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 41205 Sevikar 40mg/5mg tablets (Daiichi Sankyo UK Ltd) Calcium-channel Blockers/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 15117 Nifedipine with atenolol 20mg + 50mg Capsule Calcium-channel Blockers/Beta-adrenoceptor 
Blocking Drugs 
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Hypertension medications 8759 Verapamil hcl 120mg modified release tablets Calcium-channel Blockers/Supraventricular 
Arrhythmias 
Hypertension medications 10832 Securon 80mg Tablet (Abbott Laboratories Ltd) Calcium-channel Blockers/Supraventricular 
Arrhythmias 
Hypertension medications 25059 Berkatens 80mg Tablet (Berk Pharmaceuticals Ltd) Calcium-channel Blockers/Supraventricular 
Arrhythmias 
Hypertension medications 28844 Berkatens 120mg Tablet (Berk Pharmaceuticals Ltd) Calcium-channel Blockers/Supraventricular 
Arrhythmias 
Hypertension medications 45051 Verapamil hc 240mg Modified-release tablet (Actavis 
UK Ltd) 
Calcium-channel Blockers/Supraventricular 
Arrhythmias 
Hypertension medications 1707 Methyldopa 250mg tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 2104 Rauwiloid 2mg Tablet (3M Health Care Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 3049 Methyldopa 125mg tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 3070 Methyldopa 500mg tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 4215 Catapres 100microgram tablets (Boehringer Ingelheim 
Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 4406 Decaserpyl plus Tablet (Roussel Laboratories Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 4993 Moxonidine 200microgram tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 6694 Clonidine 300microgram tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 7174 Moxonidine 400microgram tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 7416 Aldomet 50mg/ml Injection (Merck Sharp & Dohme 
Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 7626 Aldomet 250mg Tablet (Merck Sharp & Dohme Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 7642 Aldomet 500mg Tablet (Merck Sharp & Dohme Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 8033 Aldomet 125mg Tablet (Merck Sharp & Dohme Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 9225 Methyldopa 250mg Capsule Centrally Acting Antihypertensive Drugs 
Hypertension medications 9749 Physiotens 400microgram tablets (Abbott Healthcare 
Products Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 9876 Physiotens 300microgram tablets (Abbott Healthcare 
Products Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 10253 Moxonidine 300microgram tablets Centrally Acting Antihypertensive Drugs 
Hypertension medications 10713 Decaserpyl 5mg Tablet (Roussel Laboratories Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 10714 Methoserpidine 5mg Tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 11177 Physiotens 200microgram tablets (Abbott Healthcare 
Products Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 14390 Aldomet 250mg/5ml Liquid (Merck Sharp & Dohme 
Ltd) 
Centrally Acting Antihypertensive Drugs 
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Hypertension medications 15493 Reserpine with hydrochlorothiazide tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 16248 Clonidine 150micrograms/1ml solution for injection 
ampoules 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 18252 Metalpha 250mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 19892 Serpasil -esidrex Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 20656 Serpasil 250microgram Tablet (Novartis 
Pharmaceuticals UK Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 20690 Reserpine 250micrograms tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 21346 Hydromet Tablet (MSD Thomas Morson 
Pharmaceuticals) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 21502 Serpasil 100microgram Tablet (Novartis 
Pharmaceuticals UK Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 22853 Reserpine 100micrograms tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 23345 Hypercal 2mg Tablet (Carlton Laboratories) Centrally Acting Antihypertensive Drugs 
Hypertension medications 23380 Catapres 300microgram tablets (Boehringer Ingelheim 
Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 23761 Methyldopa 250mg/5ml oral suspension Centrally Acting Antihypertensive Drugs 
Hypertension medications 24196 Dopamet 250mg Tablet (Berk Pharmaceuticals Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 25275 Metalpha 500mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 25289 Dopamet 500mg Tablet (Berk Pharmaceuticals Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 25393 Decaserpyl 10mg Tablet (Roussel Laboratories Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 25645 Seominal Tablet (Sterling-Winthrop) Centrally Acting Antihypertensive Drugs 
Hypertension medications 26919 Methyldopa 50mg/ml Injection Centrally Acting Antihypertensive Drugs 
Hypertension medications 28738 Methyldopa with hydrochlorothiazide Tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 29187 Methoserpidine 10mg Tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 29570 Dopamet 125mg Tablet (Berk Pharmaceuticals Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 29696 Methoserpidine with benzthiazide Tablet Centrally Acting Antihypertensive Drugs 
Hypertension medications 30129 Abicol Tablet (Knoll Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 30293 Catapres 150micrograms/1ml solution for injection 
ampoules (Boehringer Ingelheim Ltd) 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 30691 Hypercal b Tablet (Carlton Laboratories) Centrally Acting Antihypertensive Drugs 
Hypertension medications 32913 Methyldopa 250mg tablets (Actavis UK Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 33322 Moxonidine 200microgram tablets (Sandoz Ltd) Centrally Acting Antihypertensive Drugs 
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Medication Product 
Code 
Product Name BNF Header 
Hypertension medications 40310 Moxonidine 200microgram tablets (Teva UK Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 41661 Methyldopa 250mg Tablet (C P Pharmaceuticals Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 43531 Moxonidine 400microgram tablets (Sandoz Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 43988 Aldomet 250mg tablets (Aspen Pharma Trading Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 43989 Aldomet 500mg tablets (Aspen Pharma Trading Ltd) Centrally Acting Antihypertensive Drugs 
Hypertension medications 49684 Clonidine 100micrograms/24hours transdermal 
patches 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 54467 Clonidine 300micrograms/24hours transdermal 
patches 
Centrally Acting Antihypertensive Drugs 
Hypertension medications 33093 Clonidine 25microgram tablets (Sandoz Ltd) Centrally Acting Antihypertensive 
Drugs/Oestrogens And Hrt/Prophylaxis Of 
Migraine 
Hypertension medications 52555 Clonidine 50micrograms/5ml oral solution Centrally Acting Antihypertensive 
Drugs/Oestrogens And Hrt/Prophylaxis Of 
Migraine 
Hypertension medications 2979 Centyl k Tablet (Edwin Burgess Ltd) Diuretics With Potassium 
Hypertension medications 7734 Diumide-K Continus tablets (Teofarma) Diuretics With Potassium 
Hypertension medications 8102 Furosemide 40mg / Potassium chloride 600mg 
(potassium 8mmol) modified-release tablets 
Diuretics With Potassium 
Hypertension medications 10781 Lasix with k Tablet (Hoechst Marion Roussel) Diuretics With Potassium 
Hypertension medications 18983 Brinaldix k Effervescent tablet (Berk Pharmaceuticals 
Ltd) 
Diuretics With Potassium 
Hypertension medications 20426 Centyl k 2.5mg+7.7mmol Tablet (Edwin Burgess Ltd) Diuretics With Potassium 
Hypertension medications 22839 Clopamide with Potassium effervescent tablets Diuretics With Potassium 
Hypertension medications 36519 Esidrex -k Tablet (Novartis Pharmaceuticals UK Ltd) Diuretics With Potassium 
Hypertension medications 6794 Perindopril erbumine 4mg / Indapamide 1.25mg 
tablets 
Drugs Affecting The Renin-angiotensin 
System/Angiotensin-converting Enzyme 
Inhibitors/Thiazides And Related Diuretics 
Hypertension medications 1572 Sotalol 80mg tablets Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 4004 Sotacor 80mg tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 5858 Beta-Cardone 40mg tablets (Focus Pharmaceuticals 
Ltd) 
Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 6751 Beta-Cardone 80mg tablets (Focus Pharmaceuticals 
Ltd) 
Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 13487 Beta-Cardone 200mg tablets (Focus Pharmaceuticals Drugs For Arrhythmias/Beta-adrenoceptor 
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Code 
Product Name BNF Header 
Ltd) Blocking Drugs 
Hypertension medications 34520 Sotalol 80mg tablets (Generics (UK) Ltd) Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34600 Sotalol 40mg tablets (Teva UK Ltd) Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 43549 Sotalol 40mg tablets (IVAX Pharmaceuticals UK Ltd) Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 51492 Sotalol 25mg/5ml oral solution Drugs For Arrhythmias/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 2414 Inderal 10mg tablets (AstraZeneca UK Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Prophylaxis Of 
Migraine 
Hypertension medications 26895 Syprol 10mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Prophylaxis Of 
Migraine 
Hypertension medications 42152 Syprol 50mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Prophylaxis Of 
Migraine 
Hypertension medications 1006 Half Inderal LA 80mg capsules (AstraZeneca UK Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Antithyroid 
Drugs/Prophylaxis Of Migraine/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 43525 Propranolol 10mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Antithyroid 
Drugs/Prophylaxis Of Migraine/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 17082 Syprol 5mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs/Prophylaxis Of 
Migraine 
Hypertension medications 297 Propranolol 10mg tablets Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 707 Propranolol 40mg tablets Drugs For Essential Tremor, Chorea, Tics, And 
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Code 
Product Name BNF Header 
Related Disorders/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 27700 Propranolol 40mg tablets (Actavis UK Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 33602 Slo-Pro 160mg capsules (Generics (UK) Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Beta-adrenoceptor Blocking 
Drugs/Prophylaxis Of Migraine/Antithyroid 
Drugs 
Hypertension medications 34804 Propranolol 10mg tablets (Teva UK Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Antithyroid Drugs/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 55228 Propranolol 40mg tablets (Boston Healthcare Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Antithyroid Drugs/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 1048 Inderal 80mg tablets (AstraZeneca UK Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 39233 Propranolol 80mg modified-release capsules (Teva 
UK Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 47907 Bedranol SR 160mg capsules (Almus 
Pharmaceuticals Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 52777 Propranolol 40mg tablets (Kent Pharmaceuticals Ltd) Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 54623 Beta-Prograne 160mg modified-release capsules 
(Actavis UK Ltd) 
Drugs For Essential Tremor, Chorea, Tics, And 
Related Disorders/Prophylaxis Of 
Migraine/Beta-adrenoceptor Blocking 
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Medication Product 
Code 
Product Name BNF Header 
Drugs/Antithyroid Drugs 
Hypertension medications 594 Bisoprolol 2.5mg tablets Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 599 Bisoprolol 1.25mg tablets Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 5713 Bisoprolol 7.5mg tablets Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 14058 Cardicor 1.25mg tablets (Merck Serono Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 19853 Cardicor 3.75mg tablets (Merck Serono Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 32552 Congescor 2.5mg tablets (Tillomed Laboratories Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 43251 Bisoprolol 1.25mg tablets (Generics (UK) Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 50224 Congescor 2.5mg tablets (Teva UK Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 50300 Congescor 1.25mg tablets (Teva UK Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 51528 Bisoprolol 1.25mg tablets (Actavis UK Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 53664 Bisoprolol 2.5mg tablets (Sandoz Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 54479 Bisoprolol 1.25mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 56240 Bisoprolol 3.75mg tablets (Sandoz Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 56768 Bisoprolol 2.5mg tablets (Niche Generics Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 4771 Emcor LS 5mg tablets (Merck Serono Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs/Management Of 
Myocardial Infarction 
Hypertension medications 32114 Bisoprolol 5mg tablets (Generics (UK) Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs/Management Of 
Myocardial Infarction 
Hypertension medications 34821 Bisoprolol 10mg tablets (Generics (UK) Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs/Management Of 
Myocardial Infarction 
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Code 
Product Name BNF Header 
Hypertension medications 55929 Bisoprolol 5mg tablets (Accord Healthcare Ltd) Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs/Management Of 
Myocardial Infarction 
Hypertension medications 1290 Bisoprolol 10mg tablets Hypertension And Heart Failure/Management 
Of Myocardial Infarction/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 21966 Bipranix 5mg tablets (Ashbourne Pharmaceuticals 
Ltd) 
Hypertension And Heart Failure/Management 
Of Myocardial Infarction/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 44000 Bisoprolol 2.5mg/5ml oral suspension Hypertension And Heart Failure/Management 
Of Myocardial Infarction/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 52686 Bisoprolol 2.5mg/5ml oral solution Hypertension And Heart Failure/Management 
Of Myocardial Infarction/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 6 Furosemide 40mg tablets Loop Diuretics 
Hypertension medications 55 Furosemide 20mg tablets Loop Diuretics 
Hypertension medications 562 Furosemide 10mg/ml Injection Loop Diuretics 
Hypertension medications 814 Bumetanide 1mg tablets Loop Diuretics 
Hypertension medications 2788 Burinex 1mg tablets (LEO Pharma) Loop Diuretics 
Hypertension medications 3248 Furosemide 500mg tablets Loop Diuretics 
Hypertension medications 3287 Furosemide 1mg/ml Oral solution Loop Diuretics 
Hypertension medications 4182 Lasix 5mg/5ml oral solution (Borg Medicare) Loop Diuretics 
Hypertension medications 4258 Lasix 20mg/2ml solution for injection ampoules 
(Sanofi) 
Loop Diuretics 
Hypertension medications 4705 Furosemide 20mg/2ml Injection Loop Diuretics 
Hypertension medications 5218 Bumetanide 1mg/5ml oral solution sugar free Loop Diuretics 
Hypertension medications 5249 Furosemide 50mg/5ml oral solution sugar free Loop Diuretics 
Hypertension medications 5728 Furosemide 40mg/5ml oral solution sugar free Loop Diuretics 
Hypertension medications 5868 Frusol 20mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 6118 Furosemide 20mg/5ml oral solution sugar free Loop Diuretics 
Hypertension medications 7606 Lasix 40mg tablets (Sanofi) Loop Diuretics 
Hypertension medications 7709 Arelix 6mg Capsule (Hoechst Marion Roussel) Loop Diuretics 
Hypertension medications 7799 Lasix 20mg tablets (Borg Medicare) Loop Diuretics 
Hypertension medications 7806 Bumetanide 5mg tablets Loop Diuretics 
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Code 
Product Name BNF Header 
Hypertension medications 8052 Torasemide 5mg tablets Loop Diuretics 
Hypertension medications 9680 Frusol 40mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 10066 Torem 5mg tablets (Meda Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 10392 Lasix 500mg tablets (Sanofi) Loop Diuretics 
Hypertension medications 10422 Lasix 50mg/5ml Injection (Hoechst UK Ltd) Loop Diuretics 
Hypertension medications 11268 Torem 2.5mg tablets (Meda Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 11487 Torasemide 2.5mg tablets Loop Diuretics 
Hypertension medications 12226 Burinex 1mg/5ml Oral solution (LEO Pharma) Loop Diuretics 
Hypertension medications 12294 Burinex 5mg tablets (LEO Pharma) Loop Diuretics 
Hypertension medications 12318 Lasix 250mg/25ml Injection (Hoechst Marion Roussel) Loop Diuretics 
Hypertension medications 12354 Etacrynic 50mg tablets Loop Diuretics 
Hypertension medications 12367 Piretanide 6mg capsule Loop Diuretics 
Hypertension medications 14761 Frusid 40mg tablets (Dr Reddy's Laboratories (UK) 
Ltd) 
Loop Diuretics 
Hypertension medications 14837 Frusol 50mg/5ml oral solution (Rosemont 
Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 15341 Burinex 0.5mg/ml Injection (LEO Pharma) Loop Diuretics 
Hypertension medications 16206 Froop 40mg tablets (Ashbourne Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 18096 Torasemide 10mg tablets Loop Diuretics 
Hypertension medications 18650 Edecrin 50mg Tablet (Merck Sharp & Dohme Ltd) Loop Diuretics 
Hypertension medications 18716 Dryptal 10mg/ml Injection (Berk Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 19056 Furosemide 50mg/5ml sugar free Oral solution 
(Rosemont Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 19192 Furosemide 40mg Tablet (M & A Pharmachem Ltd) Loop Diuretics 
Hypertension medications 19194 Furosemide 20mg tablets (Teva UK Ltd) Loop Diuretics 
Hypertension medications 19258 Furosemide 50mg/5ml solution for injection ampoules Loop Diuretics 
Hypertension medications 19300 Bumetanide 2mg/4ml solution for injection ampoules Loop Diuretics 
Hypertension medications 20538 Frumax 40mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Loop Diuretics 
Hypertension medications 21849 Dryptal 40mg Tablet (Berk Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 22658 Torem 10mg tablets (Meda Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 24835 Min-i-jet furosemide 10mg/ml Injection (Celltech 
Pharma Europe Ltd) 
Loop Diuretics 
Hypertension medications 25334 Furosemide 500mg tablets (A A H Pharmaceuticals 
Ltd) 
Loop Diuretics 
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Hypertension medications 25717 Furosemide 40mg tablets (Generics (UK) Ltd) Loop Diuretics 
Hypertension medications 26292 Diuresal 40mg Tablet (Lagap) Loop Diuretics 
Hypertension medications 27447 Furosemide 40mg tablets (Wockhardt UK Ltd) Loop Diuretics 
Hypertension medications 27690 Furosemide 40mg tablets (A A H Pharmaceuticals 
Ltd) 
Loop Diuretics 
Hypertension medications 27696 Furosemide 40mg tablets (Kent Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 27926 Furosemide 20mg tablets (Generics (UK) Ltd) Loop Diuretics 
Hypertension medications 29780 Furosemide 20mg Tablet (C P Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 30625 Furosemide 20mg tablets (A A H Pharmaceuticals 
Ltd) 
Loop Diuretics 
Hypertension medications 30875 Furosemide 250mg/25ml solution for injection 
ampoules 
Loop Diuretics 
Hypertension medications 30913 Betinex 1mg Tablet (Berk Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 31548 Furosemide 20mg tablets (Actavis UK Ltd) Loop Diuretics 
Hypertension medications 31932 Bumetanide 1mg tablets (C P Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 32002 Etacrynic 50mg/vial injection Loop Diuretics 
Hypertension medications 32091 Bumetanide 1mg tablets (A A H Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 32277 Furosemide 80mg/8ml solution for injection pre-filled 
syringes 
Loop Diuretics 
Hypertension medications 32896 Furosemide 40mg tablets (Ranbaxy (UK) Ltd) Loop Diuretics 
Hypertension medications 32918 Furosemide 20mg tablets (Sandoz Ltd) Loop Diuretics 
Hypertension medications 34006 Furosemide 40mg tablets (Actavis UK Ltd) Loop Diuretics 
Hypertension medications 34374 Furosemide 40mg tablets (Teva UK Ltd) Loop Diuretics 
Hypertension medications 34557 Furosemide 40mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Loop Diuretics 
Hypertension medications 34613 Bumetanide 5mg tablets (Teva UK Ltd) Loop Diuretics 
Hypertension medications 34934 Bumetanide 1mg tablets (Generics (UK) Ltd) Loop Diuretics 
Hypertension medications 35162 Furosemide 20mg/2ml solution for injection ampoules Loop Diuretics 
Hypertension medications 36190 Furosemide 5mg/5ml oral solution sugar free Loop Diuretics 
Hypertension medications 36767 Bumetanide 1mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Loop Diuretics 
Hypertension medications 39602 Bumetanide 1mg tablets (Actavis UK Ltd) Loop Diuretics 
Hypertension medications 40190 Torasemide iv 20mg/4ml Intravenous injection Loop Diuretics 
Hypertension medications 40247 Furosemide 10mg/ml Injection (Martindale 
Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 40738 Torem iv 10mg/2ml Intravenous injection (Boehringer Loop Diuretics 
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Mannheim UK Ltd) 
Hypertension medications 40898 Torasemide 5mg tablets (A A H Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 41292 Furosemide 20mg tablets (Wockhardt UK Ltd) Loop Diuretics 
Hypertension medications 41405 Furosemide 500mg tablets (Teva UK Ltd) Loop Diuretics 
Hypertension medications 41828 Furosemide 500mg tablets (Actavis UK Ltd) Loop Diuretics 
Hypertension medications 42388 Furosemide 40mg/5ml oral solution sugar free (Focus 
Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 42488 Furosemide 40mg/5ml oral solution sugar free (A A H 
Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 45305 Bumetanide 1mg tablets (Teva UK Ltd) Loop Diuretics 
Hypertension medications 46116 Furosemide 10mg/ml Injection (Antigen 
Pharmaceuticals) 
Loop Diuretics 
Hypertension medications 46525 Torasemide 5mg tablets (Teva UK Ltd) Loop Diuretics 
Hypertension medications 46699 Furosemide 40mg tablets (Almus Pharmaceuticals 
Ltd) 
Loop Diuretics 
Hypertension medications 46948 Furosemide 40mg tablets (Arrow Generics Ltd) Loop Diuretics 
Hypertension medications 47815 Furosemide 20mg Tablet (Celltech Pharma Europe 
Ltd) 
Loop Diuretics 
Hypertension medications 49268 Furosemide 50mg/5ml oral suspension Loop Diuretics 
Hypertension medications 51983 Furosemide 5mg/5ml oral suspension Loop Diuretics 
Hypertension medications 52045 Furosemide 250mg/5ml solution for injection vials Loop Diuretics 
Hypertension medications 52887 Furosemide 20mg/2ml solution for injection ampoules 
(A A H Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 52900 Furosemide 80mg/8ml solution for injection Minijet 
pre-filled syringes (UCB Pharma Ltd) 
Loop Diuretics 
Hypertension medications 53967 Furosemide 20mg tablets (Bristol Laboratories Ltd) Loop Diuretics 
Hypertension medications 54825 Furosemide 20mg tablets (Sigma Pharmaceuticals 
Plc) 
Loop Diuretics 
Hypertension medications 55548 Bumetanide 1mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Loop Diuretics 
Hypertension medications 55738 Furosemide 50mg/5ml solution for injection ampoules 
(Hameln Pharmaceuticals Ltd) 
Loop Diuretics 
Hypertension medications 56051 Furosemide 20mg tablets (Kent Pharmaceuticals Ltd) Loop Diuretics 
Hypertension medications 56375 Furosemide 40mg tablets (Accord Healthcare Ltd) Loop Diuretics 
Hypertension medications 47647 Co-amilofruse oral liquid Loop Diuretics/Potassium-sparing Diuretics And 
Aldosterone Antagonists 
Hypertension medications 211 Frumil 40mg+5mg Tablet (Helios Healthcare Ltd) Loop Diuretics/Potassium-sparing Diuretics 
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With Other Diuretics 
Hypertension medications 1301 Frumil ls 20mg+2.5mg Tablet (Helios Healthcare Ltd) Loop Diuretics/Potassium-sparing Diuretics 
With Other Diuretics 
Hypertension medications 4211 Furosemide with amiloride 20mg+2.5mg Tablet Loop Diuretics/Potassium-sparing Diuretics 
With Other Diuretics 
Hypertension medications 9431 Frusemek 40mg+5mg Tablet (Approved Prescription 
Services Ltd) 
Loop Diuretics/Potassium-sparing Diuretics 
With Other Diuretics 
Hypertension medications 9456 Amiloride 5mg / furosemide 40mg tablets Loop Diuretics/Potassium-sparing Diuretics 
With Other Diuretics 
Hypertension medications 18497 Amiloride 10mg / furosemide 80mg tablets Loop Diuretics/Potassium-sparing Diuretics 
With Other Diuretics 
Hypertension medications 30773 Co-amilofruse 5mg+40mg Tablet (Berk 
Pharmaceuticals Ltd) 
Loop Diuretics/Potassium-sparing Diuretics 
With Other Diuretics 
Hypertension medications 7553 Bisoprolol 5mg/5ml oral suspension Management Of Myocardial Infarction/Beta-
adrenoceptor Blocking Drugs/Hypertension And 
Heart Failure 
Hypertension medications 17615 Cardicor 5mg tablets (Merck Serono Ltd) Management Of Myocardial Infarction/Beta-
adrenoceptor Blocking Drugs/Hypertension And 
Heart Failure 
Hypertension medications 19200 Bisoprolol 5mg tablets (IVAX Pharmaceuticals UK Ltd) Management Of Myocardial Infarction/Beta-
adrenoceptor Blocking Drugs/Hypertension And 
Heart Failure 
Hypertension medications 21905 Bipranix 10mg tablets (Ashbourne Pharmaceuticals 
Ltd) 
Management Of Myocardial Infarction/Beta-
adrenoceptor Blocking Drugs/Hypertension And 
Heart Failure 
Hypertension medications 52611 Bisoprolol 10mg/5ml oral solution Management Of Myocardial Infarction/Beta-
adrenoceptor Blocking Drugs/Hypertension And 
Heart Failure 
Hypertension medications 53334 Bisoprolol 10mg tablets (A A H Pharmaceuticals Ltd) Management Of Myocardial Infarction/Beta-
adrenoceptor Blocking Drugs/Hypertension And 
Heart Failure 
Hypertension medications 472 Bisoprolol 5mg tablets Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 3588 Monocor 5mg tablets (Wyeth Pharmaceuticals) Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 5968 Monocor 10mg tablets (Wyeth Pharmaceuticals) Management Of Myocardial 
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Product Name BNF Header 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 32630 Vivacor 10mg tablets (Lexon (UK) Ltd) Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 33839 Bisoprolol 10mg tablets (Actavis UK Ltd) Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 41591 Bisoprolol 10mg tablets (Teva UK Ltd) Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 52635 Bisoprolol 5mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 57176 Bisoprolol 10mg tablets (Accord Healthcare Ltd) Management Of Myocardial 
Infarction/Hypertension And Heart Failure/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 31013 Mersalyl 50mg/ml Injection Mercurial Diuretics 
Hypertension medications 45578 Clonidine 25microgram tablets (A A H 
Pharmaceuticals Ltd) 
Oestrogens And Hrt/Centrally Acting 
Antihypertensive Drugs/Prophylaxis Of Migraine 
Hypertension medications 53142 Clonidine 50micrograms/5ml oral suspension Oestrogens And Hrt/Prophylaxis Of 
Migraine/Centrally Acting Antihypertensive 
Drugs 
Hypertension medications 20652 Mannitol 10% Infusion Osmotic Diuretics 
Hypertension medications 30965 Mannitol 20% Infusion Osmotic Diuretics 
Hypertension medications 52937 Mannitol 50g/500ml infusion polyethylene bottles Osmotic Diuretics 
Hypertension medications 3054 Hygroton 100mg Tablet (Alliance Pharmaceuticals 
Ltd) 
Posterior Pituitary Hormones And 
Antagonists/Thiazides And Related Diuretics 
Hypertension medications 3548 Chlortalidone 100mg tablets Posterior Pituitary Hormones And 
Antagonists/Thiazides And Related Diuretics 
Hypertension medications 692 Spironolactone 25mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 708 Spironolactone 50mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 787 Spironolactone 100mg capsule Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 1060 Amiloride 5mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
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Medication Product 
Code 
Product Name BNF Header 
Hypertension medications 2142 Spironolactone 100mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 2179 Triamterene 50mg capsules Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 2389 Aldactone 25mg tablets (Pfizer Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 4068 Dytac 50mg capsules (Mercury Pharma Group Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 4161 Spiroctan 25mg Tablet (Roche Products Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 4960 Aldactone 50mg tablets (Pfizer Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 6815 Spironolactone 50mg/5ml oral suspension sugar free Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 7952 Aldactone 100mg tablets (Pfizer Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 7991 Spiroctan 100mg Capsule (Roche Products Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 9935 Amiloride 5mg/5ml oral solution sugar free Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 10214 Spironolactone 5mg/5ml oral suspension sugar free Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 10251 Eplerenone 25mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 11156 Spirolone 25mg Tablet (Berk Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 11519 Spironolactone 25mg/5ml oral suspension sugar free Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 12946 Spironolactone 10mg/5ml oral suspension sugar free Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 13264 Spironolactone 15mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 13352 Midamor 5mg Tablet (MSD Thomas Morson 
Pharmaceuticals) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 14109 Spironolactone 100mg/5ml oral solution sugar free Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 14144 Inspra 25mg tablets (Pfizer Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
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Hypertension medications 15052 Spiroctan 50mg Tablet (Roche Products Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 16531 Eplerenone 50mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 17902 Spirolone 100mg Tablet (Berk Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 17950 Spirolone 50mg Tablet (Berk Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 19195 Spironolactone 50mg Tablet (Wyeth Pharmaceuticals) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 21911 Spirospare 25mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 23091 Spirospare 100 tablets (Ashbourne Pharmaceuticals 
Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 24893 Amilospare Tablet (Ashbourne Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 25494 Diatensec 50mg Tablet (Pharmacia Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 26217 Berkamil 5mg Tablet (Berk Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 29397 Spiretic 100mg Tablet (DDSA Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 29694 Inspra 50mg tablets (Pfizer Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 31219 Spironolactone 100mg tablets (A A H 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 31375 Amilamont 5mg/5ml oral solution sugar free 
(Rosemont Pharmaceuticals Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 31529 Spironolactone 25mg tablets (Teva UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 32837 Spironolactone 50mg tablets (Teva UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 33837 Amiloride 5mg tablets (A A H Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 34296 Spironolactone 25mg tablets (A A H Pharmaceuticals 
Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 34324 Amiloride 5mg tablets (Teva UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
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Hypertension medications 34347 Spironolactone 25mg tablets (Actavis UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 34750 Amiloride 5mg tablets (Actavis UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 34908 Spironolactone 25mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 35789 Spironolactone 25mg Tablet (Celltech Pharma Europe 
Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 41074 Spironolactone 25mg tablets (Almus Pharmaceuticals 
Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 41592 Spironolactone 100mg tablets (Actavis UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 41630 Amiloride 5mg Tablet (IVAX Pharmaceuticals UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 41660 Spironolactone 100mg tablets (Teva UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 41706 Spironolactone 50mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 43514 Spironolactone 50mg tablets (A A H Pharmaceuticals 
Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 43523 Amiloride 5mg tablets (Generics (UK) Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 44254 Amiloride 5.67mg tablets Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 45078 Spironolactone 25mg/5ml Oral solution sugar free 
(Rosemont Pharmaceuticals Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 46674 Spironolactone 50mg/5ml Oral suspension sugar free 
(Rosemont Pharmaceuticals Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 46930 Amiloride 5mg tablets (Wockhardt UK Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 46990 Spironolactone 50mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 47018 Spironolactone 25mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 47687 Spiretic 25mg Tablet (DDSA Pharmaceuticals Ltd) Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 49388 Spironolactone 100mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
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Hypertension medications 50079 Spironolactone 10mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 50370 Spironolactone 5mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 51652 Spironolactone 25mg tablets (Doncaster 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 51720 Spironolactone 25mg/5ml oral solution Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 51933 Spironolactone 50mg/5ml oral solution Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 52366 Spironolactone 5mg/5ml oral solution Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 52970 Spironolactone 10mg/5ml oral solution Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 53253 Spironolactone 50mg/5ml oral suspension (Drug Tariff 
Special Order) 
Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 54120 Spironolactone 4mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 56067 Spironolactone 4mg/5ml oral solution Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 56274 Spironolactone 4.5mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 56536 Spironolactone 100mg/5ml oral solution Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 57104 Spironolactone 200mg/5ml oral suspension Potassium-sparing Diuretics And Aldosterone 
Antagonists 
Hypertension medications 56 Co-amilofruse 5mg/40mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 193 Co-amilofruse 2.5mg/20mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 923 Co-amilozide 5mg/50mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 924 Co-amilozide 2.5mg/25mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 1251 Moduret 25 tablets (Merck Sharp & Dohme Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 1297 Aldactide 50 tablets (Pfizer Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
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Hypertension medications 1721 Dyazide 50mg/25mg tablets (Mercury Pharma Group 
Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 2001 Aldactide 25 tablets (Pfizer Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 2255 Navispare 2.5mg/250microgram tablets (Mercury 
Pharma Group Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 2493 Burinex A 5mg/1mg tablets (LEO Pharma) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 2772 Lasoride 5mg/40mg tablets (Sanofi) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 2961 Frusene 50mg/40mg tablets (Orion Pharma (UK) Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 3793 Co-amilofruse 10mg/80mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 4661 Spironolactone 50mg / Furosemide 20mg capsules Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 4873 Fru-Co 5mg/40mg tablets (Teva UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 5416 Co-triamterzide 50mg/25mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 5727 Amiloride 2.5mg / Cyclopenthiazide 250microgram 
tablets 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 7441 Lasilactone 20mg/50mg capsules (Sanofi) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 8897 Triam-Co 50mg/25mg tablets (IVAX Pharmaceuticals 
UK Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 11265 Triamterene 50mg / Furosemide 40mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 11384 Co-flumactone 50mg/50mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 12547 Triamterene 50mg / Chlortalidone 50mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 13435 Frumil Forte 10mg/80mg tablets (Sanofi) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 14587 Amiloride 5mg / Bumetanide 1mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 15811 Co-flumactone 25mg/25mg tablets Potassium-sparing Diuretics With Other 
Diuretics 
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Hypertension medications 16498 Kalspare tablets (DHP Healthcare Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 18361 Amilmaxco 5mg/50mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 18726 Triamaxco 50mg/25mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 20066 Amil-Co 5mg/50mg tablets (IVAX Pharmaceuticals UK 
Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 21938 Froop Co 5mg/40mg tablets (Ashbourne 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 25965 Co-amilofruse 2.5mg/20mg tablets (Wockhardt UK 
Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 28129 Co-amilofruse 5mg/40mg tablets (Teva UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 31150 Co-amilozide 5mg/50mg tablets (IVAX 
Pharmaceuticals UK Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 31773 Co-amilofruse 5mg/40mg tablets (Wockhardt UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 33527 Co-amilofruse 5mg/40mg tablets (Generics (UK) Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 33658 Co-amilofruse 5mg/40mg tablets (A A H 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 34280 Co-amilofruse 2.5mg/20mg tablets (Sandoz Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 34367 Co-amilozide 2.5mg/25mg tablets (Wockhardt UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 34622 Co-amilofruse 10mg/80mg tablets (Wockhardt UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 38901 Frumil LS 20mg/2.5mg tablets (Sanofi) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 39807 Frumil 40mg/5mg tablets (Sanofi) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 41533 Co-amilofruse 2.5mg/20mg tablets (Teva UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 41556 Co-amilozide 5mg/50mg tablets (Teva UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 41719 Co-amilofruse 5mg/40mg tablets (Actavis UK Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
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Hypertension medications 42142 Moduretic 5mg/50mg tablets (Merck Sharp & Dohme 
Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 43508 Co-amilofruse 5mg/40mg tablets (Sandoz Ltd) Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 46916 Co-amilozide 5mg/50mg tablets (A A H 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 47804 Co-triamterzide 50mg/25mg tablets (A A H 
Pharmaceuticals Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 53508 Spironolactone 5mg/5ml / Chlorothiazide 50mg/5ml 
oral suspension 
Potassium-sparing Diuretics With Other 
Diuretics 
Hypertension medications 1369 Furosemide with amiloride 40mg+5mg Tablet Potassium-sparing Diuretics With Other 
Diuretics/Loop Diuretics 
Hypertension medications 2495 Bumetanide with Amiloride tablets Potassium-sparing Diuretics With Other 
Diuretics/Loop Diuretics 
Hypertension medications 3050 Furosemide with triamterene 40mgwith50mg Tablet Potassium-sparing Diuretics With Other 
Diuretics/Loop Diuretics 
Hypertension medications 5220 Furosemide with amiloride 80mg+10mg Tablet Potassium-sparing Diuretics With Other 
Diuretics/Loop Diuretics 
Hypertension medications 15874 Amiloride 2.5mg / furosemide 20mg tablets Potassium-sparing Diuretics With Other 
Diuretics/Loop Diuretics 
Hypertension medications 18332 Aridil 20mg+2.5mg Tablet (C P Pharmaceuticals Ltd) Potassium-sparing Diuretics With Other 
Diuretics/Loop Diuretics 
Hypertension medications 4034 Amiloride 5mg / hydrochlorothiazide 50mg/5ml 
solution 
Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 8058 Normetic Tablet (Abbott Laboratories Ltd) Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 8521 Spironolactone 25mg with hydroflumethiazide 25mg 
tablet 
Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 15127 Hydrochlorothiazide with triamterene 25mgwith50mg 
Tablet 
Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 19890 Hydrochlorothiazide with amiloride 25mgwith2.5mg 
Tablet 
Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 24008 Vasetic Tablet (Shire Pharmaceuticals Ltd) Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 25505 Spiro-co 50mg+50mg Tablet (IVAX Pharmaceuticals 
UK Ltd) 
Potassium-sparing Diuretics With Other 
Diuretics/Thiazides And Related Diuretics 
Hypertension medications 940 Propranolol 80mg tablets Prophylaxis Of Migraine/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Drugs For 
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Product Name BNF Header 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 1448 Propranolol 160mg modified-release capsules Prophylaxis Of Migraine/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 46363 Half Beta-Prograne 80mg modified-release capsules 
(Teva UK Ltd) 
Prophylaxis Of Migraine/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 54297 Propranolol 50mg/5ml oral solution Prophylaxis Of Migraine/Antithyroid Drugs/Beta-
adrenoceptor Blocking Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 3005 Inderal LA 160mg capsules (AstraZeneca UK Ltd) Prophylaxis Of Migraine/Antithyroid 
Drugs/Drugs For Essential Tremor, Chorea, 
Tics, And Related Disorders/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 739 Metoprolol 50mg tablets Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 753 Metoprolol 100mg tablets Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 3344 Betaloc 100mg tablets (AstraZeneca UK Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 3474 Betaloc-SA 200mg tablets (AstraZeneca UK Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 8068 Metoprolol 200mg modified-release tablets Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 8978 Propanix 160mg Modified-release capsule 
(Ashbourne Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 12037 Betim 10mg Tablet (ICN Pharmaceuticals France 
S.A.) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 15619 Half-betadur cr 80mg Capsule (Monmouth 
Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 20082 Lopresor SR 200mg tablets (Recordati 
Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 22208 Half propanix la 80mg Modified-release capsule 
(Ashbourne Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
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Hypertension medications 23326 Betadur cr 160mg Modified-release capsule 
(Monmouth Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 26228 Propanix LA 160mg Modified-release capsule 
(Ashbourne Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 26255 Lopranol la 160mg Capsule (Opus Pharmaceuticals 
Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 28788 Half propatard la 80mg Modified-release capsule 
(Galen Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 32836 Metoprolol 50mg tablets (Generics (UK) Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34092 Metoprolol 100mg tablets (Teva UK Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34125 Metoprolol 100mg tablets (A A H Pharmaceuticals 
Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34208 Propranolol SR 160mg Modified-release capsule (C P 
Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34407 Metoprolol 50mg tablets (Teva UK Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34430 Metoprolol 50mg tablets (Actavis UK Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34925 Metoprolol 50mg tablets (Sandoz Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 34949 Propranolol 160mg Modified-release capsule (Actavis 
UK Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 40241 Propranolol LA 160mg Capsule (Approved 
Prescription Services Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 45343 Propranolol SR 80mg Modified-release capsule (C P 
Pharmaceuticals Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 46740 Lopresor 100mg tablets (Recordati Pharmaceuticals 
Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 51447 Metoprolol 12.5mg/5ml oral suspension Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 57240 Metoprolol 50mg/5ml oral suspension (Special Order) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs 
Hypertension medications 1050 Inderal 40mg tablets (AstraZeneca UK Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
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Hypertension medications 3087 Propranolol 40mg/5ml oral solution sugar free Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 52609 Inderal LA 160mg capsules (Sigma Pharmaceuticals 
Plc) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Antithyroid Drugs/Drugs For 
Essential Tremor, Chorea, Tics, And Related 
Disorders 
Hypertension medications 14808 Bedranol SR 80mg capsules (Sandoz Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 28996 Bedranol SR 160mg capsules (Sandoz Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 36576 Propranolol 10mg tablets (Generics (UK) Ltd) Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 57063 Bedranol SR 80mg capsules (Almus Pharmaceuticals 
Ltd) 
Prophylaxis Of Migraine/Beta-adrenoceptor 
Blocking Drugs/Drugs For Essential Tremor, 
Chorea, Tics, And Related 
Disorders/Antithyroid Drugs 
Hypertension medications 338 Clonidine 25microgram tablets Prophylaxis Of Migraine/Centrally Acting 
Antihypertensive Drugs/Oestrogens And Hrt 
Hypertension medications 31214 Propranolol 80mg tablets (Generics (UK) Ltd) Prophylaxis Of Migraine/Drugs For Essential 
Tremor, Chorea, Tics, And Related 
Disorders/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 41555 Propranolol 40mg tablets (A A H Pharmaceuticals Ltd) Prophylaxis Of Migraine/Drugs For Essential 
Tremor, Chorea, Tics, And Related 
Disorders/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 45877 Beta-Prograne 160mg modified-release capsules 
(Teva UK Ltd) 
Prophylaxis Of Migraine/Drugs For Essential 
Tremor, Chorea, Tics, And Related 
Disorders/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
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Medication Product 
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Hypertension medications 48682 Propranolol 50mg/5ml oral solution sugar free Prophylaxis Of Migraine/Drugs For Essential 
Tremor, Chorea, Tics, And Related 
Disorders/Beta-adrenoceptor Blocking 
Drugs/Antithyroid Drugs 
Hypertension medications 2878 Clonidine 100microgram tablets Prophylaxis Of Migraine/Oestrogens And 
Hrt/Centrally Acting Antihypertensive Drugs 
Hypertension medications 55797 Clonidine 25micrograms/5ml oral solution Prophylaxis Of Migraine/Oestrogens And 
Hrt/Centrally Acting Antihypertensive Drugs 
Hypertension medications 27727 Sotalol 2mg/ml injection Supraventricular & Ventricular 
Arrhythmias/Beta-adrenoceptor Blocking Drugs 
Hypertension medications 220 Propranolol 5mg/5ml oral solution Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 8331 Inderal 160mg Tablet (AstraZeneca UK Ltd) Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 11711 Propranolol 50mg/5ml oral solution Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 14552 Propanix 10mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 21866 Berkolol 40mg Tablet (Berk Pharmaceuticals Ltd) Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 28048 Angilol 10mg Tablet (DDSA Pharmaceuticals Ltd) Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 29763 Propanix 160mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 31833 Angilol 80mg Tablet (DDSA Pharmaceuticals Ltd) Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 53177 Propranolol oral solution Supraventricular Arrhythmias/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 8524 Securon 40mg Tablet (Abbott Laboratories Ltd) Supraventricular Arrhythmias/Calcium-channel 
Blockers 
Hypertension medications 19325 Cordilox 2.5mg/ml Injection (IVAX Pharmaceuticals 
UK Ltd) 
Supraventricular Arrhythmias/Calcium-channel 
Blockers 
Hypertension medications 22826 Securon 160mg Tablet (Abbott Laboratories Ltd) Supraventricular Arrhythmias/Calcium-channel 
Blockers 
Hypertension medications 23872 Berkatens 40mg Tablet (Berk Pharmaceuticals Ltd) Supraventricular Arrhythmias/Calcium-channel 
Blockers 
Hypertension medications 26252 Berkatens 160mg Tablet (Berk Pharmaceuticals Ltd) Supraventricular Arrhythmias/Calcium-channel 
Blockers 
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Hypertension medications 28843 Verapamil hc 80mg Tablet (Celltech Pharma Europe 
Ltd) 
Supraventricular Arrhythmias/Calcium-channel 
Blockers 
Hypertension medications 46884 Verapamil hc 240mg Modified-release tablet (Sandoz 
Ltd) 
Supraventricular Arrhythmias/Calcium-channel 
Blockers 
Hypertension medications 2 Bendroflumethiazide 2.5mg tablets Thiazides And Related Diuretics 
Hypertension medications 58 Bendroflumethiazide 5mg tablets Thiazides And Related Diuretics 
Hypertension medications 542 Hydrochlorothiazide 25mg tablets Thiazides And Related Diuretics 
Hypertension medications 605 Chlortalidone 50mg tablets Thiazides And Related Diuretics 
Hypertension medications 1125 Navidrex -k Tablet (Novartis Pharmaceuticals UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 1170 Cyclopenthiazide 500microgram tablets Thiazides And Related Diuretics 
Hypertension medications 1209 Neo-Naclex 5mg tablets (Mercury Pharma Group Ltd) Thiazides And Related Diuretics 
Hypertension medications 1211 Bendroflumethiazide 2.5mg / Potassium chloride 
630mg (potassium 8.4mmol) modified-release tablets 
Thiazides And Related Diuretics 
Hypertension medications 1213 Neo-Naclex-K modified-release tablets (Mercury 
Pharma Group Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 2046 Navidrex 500microgram tablets (Mercury Pharma 
Group Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 2612 Indapamide 2.5mg tablets Thiazides And Related Diuretics 
Hypertension medications 2833 CYCLOPENTHIAZIDE -K tablets Thiazides And Related Diuretics 
Hypertension medications 3056 Natrilix SR 1.5mg tablets (Servier Laboratories Ltd) Thiazides And Related Diuretics 
Hypertension medications 3517 Hydrochlorothiazide 50mg tablets Thiazides And Related Diuretics 
Hypertension medications 3997 Hygroton 50mg tablets (Alliance Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 4044 Diurexan 20mg tablets (Meda Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 4332 Metolazone 5mg tablets Thiazides And Related Diuretics 
Hypertension medications 4334 Metolazone 500microgram low dose Tablet Thiazides And Related Diuretics 
Hypertension medications 5112 Indapamide 1.5mg modified-release tablets Thiazides And Related Diuretics 
Hypertension medications 6816 Chlorothiazide 250mg/5ml oral suspension Thiazides And Related Diuretics 
Hypertension medications 7351 Bendroflumethiazide 2.5mg/5ml oral suspension Thiazides And Related Diuretics 
Hypertension medications 7618 Xipamide 20mg tablets Thiazides And Related Diuretics 
Hypertension medications 7641 Natrilix 2.5mg tablets (Servier Laboratories Ltd) Thiazides And Related Diuretics 
Hypertension medications 7698 Aprinox 5mg tablets (Amdipharm Plc) Thiazides And Related Diuretics 
Hypertension medications 8526 Aprinox 2.5mg tablets (Amdipharm Plc) Thiazides And Related Diuretics 
Hypertension medications 8602 Metenix 5mg tablets (Sanofi) Thiazides And Related Diuretics 
Hypertension medications 8836 Chlorothiazide 500mg tablets Thiazides And Related Diuretics 
Hypertension medications 8891 Hygroton -k Tablet (Novartis Pharmaceuticals UK Ltd) Thiazides And Related Diuretics 
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Hypertension medications 12110 Hydroflumethiazide 50mg Tablet Thiazides And Related Diuretics 
Hypertension medications 12360 Nephril 1mg Tablet (Pfizer Ltd) Thiazides And Related Diuretics 
Hypertension medications 13246 Chlorothiazide 150mg/5ml oral suspension Thiazides And Related Diuretics 
Hypertension medications 13363 Esidrex 50mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 13525 Hydrenox 50mg Tablet (Knoll Ltd) Thiazides And Related Diuretics 
Hypertension medications 15457 Baycaron 25mg Tablet (Bayer Plc) Thiazides And Related Diuretics 
Hypertension medications 17143 Mefruside 25mg Tablet Thiazides And Related Diuretics 
Hypertension medications 17252 Esidrex 25mg Tablet (Novartis Pharmaceuticals UK 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 17720 Saluric 500mg Tablet (Merck Sharp & Dohme Ltd) Thiazides And Related Diuretics 
Hypertension medications 18267 Enduron 5mg Tablet (Abbott Laboratories Ltd) Thiazides And Related Diuretics 
Hypertension medications 18973 Centyl 2.5mg Tablet (Edwin Burgess Ltd) Thiazides And Related Diuretics 
Hypertension medications 19352 Xuret 0.5mg Tablet (Galen Ltd) Thiazides And Related Diuretics 
Hypertension medications 20057 Methyclothiazide 5mg Tablet Thiazides And Related Diuretics 
Hypertension medications 21803 Berkozide 2.5mg Tablet (Berk Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 21867 Berkozide 5mg Tablet (Berk Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 23427 Bendroflumethiazide 5mg tablets (A A H 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 24189 Neo-bendromax 2.5mg Tablet (Ashbourne 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 24190 Neo-bendromax 5mg Tablet (Ashbourne 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 26256 Opumide 2.5mg Tablet (Opus Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 26275 Nindaxa 2.5 tablets (Ashbourne Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 27256 Bendroflumethiazide 2.5mg tablets (Wockhardt UK 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 27689 Bendroflumethiazide 2.5mg tablets (IVAX 
Pharmaceuticals UK Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 27957 Natramid 2.5mg Tablet (Trinity Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 29991 Centyl 5mg Tablet (Edwin Burgess Ltd) Thiazides And Related Diuretics 
Hypertension medications 31670 Bendroflumethiazide 2.5mg tablets (Teva UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 31820 Bendroflumethiazide 5mg tablets (Wockhardt UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 33083 Indapamide 2.5mg tablets (Teva UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 33415 Bendroflumethiazide 2.5mg tablets (Generics (UK) 
Ltd) 
Thiazides And Related Diuretics 
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Hypertension medications 33651 Bendroflumethiazide 2.5mg tablets (A A H 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 33724 Diuril 250mg/5ml oral suspension (Imported (United 
States)) 
Thiazides And Related Diuretics 
Hypertension medications 34059 Bendroflumethiazide 2.5mg tablets (Actavis UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 34124 Bendroflumethiazide 5mg tablets (Actavis UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 34551 Indapamide 2.5mg tablets (Generics (UK) Ltd) Thiazides And Related Diuretics 
Hypertension medications 34602 Bendroflumethiazide 2.5mg tablets (Sovereign 
Medical Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 34803 Bendroflumethiazide 2.5mg Tablet (Regent 
Laboratories Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 39447 Varbim XL 1.5mg tablets (Teva UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 40149 Bendroflumethiazide 5mg tablets (IVAX 
Pharmaceuticals UK Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 40886 Bendroflumethiazide 2.5mg tablets (Almus 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 40907 Indapamide 2.5mg tablets (Genus Pharmaceuticals 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 41517 Bendroflumethiazide 5mg tablets (Teva UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 41861 Tensaid XL 1.5mg tablets (Generics (UK) Ltd) Thiazides And Related Diuretics 
Hypertension medications 41885 Ethibide XL 1.5mg tablets (Genus Pharmaceuticals 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 42906 Indapamide 2.5mg tablets (Niche Generics Ltd) Thiazides And Related Diuretics 
Hypertension medications 43184 Mapemid XL 1.5mg tablets (Teva UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 43516 Indapamide 2.5mg tablets (Actavis UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 44168 Indipam XL 1.5mg tablets (Actavis UK Ltd) Thiazides And Related Diuretics 
Hypertension medications 46302 Neo-Naclex 2.5mg tablets (Mercury Pharma Group 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 46675 Indapamide 1.5mg modified-release tablets (A A H 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 47844 Bendroflumethiazide 2.5mg tablets (Kent 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 48079 Indapamide 2.5mg tablets (Zentiva) Thiazides And Related Diuretics 
Hypertension medications 48099 Indapamide 2.5mg tablets (A A H Pharmaceuticals 
Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 48132 Hydrochlorothiazide Capsule Thiazides And Related Diuretics 
Hypertension medications 49529 Indapamide 2.5mg tablets (Phoenix Healthcare Thiazides And Related Diuretics 
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Distribution Ltd) 
Hypertension medications 49752 Metolazone 2.5mg/5ml oral solution Thiazides And Related Diuretics 
Hypertension medications 53674 Metolazone 2.5mg tablets Thiazides And Related Diuretics 
Hypertension medications 53812 Bendroflumethiazide oral solution Thiazides And Related Diuretics 
Hypertension medications 54316 Indapamide 2.5mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Thiazides And Related Diuretics 
Hypertension medications 54329 Metolazone 5mg/5ml oral suspension Thiazides And Related Diuretics 
Hypertension medications 54341 Chlorothiazide 5mg/5ml oral suspension Thiazides And Related Diuretics 
Hypertension medications 54643 Metolazone Oral solution Thiazides And Related Diuretics 
Hypertension medications 54679 Chlorothiazide 250mg tablets Thiazides And Related Diuretics 
Hypertension medications 55259 Indapamide 2.5mg tablets (Kent Pharmaceuticals Ltd) Thiazides And Related Diuretics 
Hypertension medications 55777 Metolazone 5mg/5ml oral solution Thiazides And Related Diuretics 
Hypertension medications 55889 Chlorothiazide oral solution Thiazides And Related Diuretics 
Hypertension medications 56296 Indapamide 2.5mg tablets (Boston Healthcare Ltd) Thiazides And Related Diuretics 
Hypertension medications 56760 Indapamide 2.5mg tablets (Co-Pharma Ltd) Thiazides And Related Diuretics 
Hypertension medications 56804 Chlorothiazide 25mg/5ml oral suspension Thiazides And Related Diuretics 
Hypertension medications 1021 Innozide 20mg/12.5mg tablets (Merck Sharp & 
Dohme Ltd) 
Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 2982 Zestoretic 20- 20mg+12.5mg Tablet (AstraZeneca UK 
Ltd) 
Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 5189 Enalapril 20mg / Hydrochlorothiazide 12.5mg tablets Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 10902 Captopril 50mg with Hydrochlorothiazide 25mg tablets Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 11133 Hydrochlorothiazide with captopril 25mg with 50mg 
Tablet 
Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 11641 Captopril 25mg with Hydrochlorothiazide 12.5mg 
tablets 
Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 17655 Carace 10 Tablet (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 32166 Capto-co 25mg+50mg Tablet (IVAX Pharmaceuticals 
UK Ltd) 
Thiazides And Related Diuretics/Angiotensin-
converting Enzyme Inhibitors 
Hypertension medications 10316 CoAprovel 150mg/12.5mg tablets (Sanofi) Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 11526 CoAprovel 300mg/12.5mg tablets (Sanofi) Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 14738 Hydrochlorothiazide with losartan 12.5mg with 50mg Thiazides And Related Diuretics/Angiotensin-ii 
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Tablet Receptor Antagonists 
Hypertension medications 23456 Hydrochlorothiazide with valsartan 25mg with 160mg 
Tablet 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 24268 Hydrochlorothiazide with valsartan 12.5mg with 80mg 
Tablet 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 29634 Olmetec Plus 20mg/12.5mg tablets (Daiichi Sankyo 
UK Ltd) 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 35196 CoAprovel 300mg/25mg tablets (Sanofi) Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 35380 Hydrochlorothiazide with olmesartan medoxomil 
12.5mg with 20mg tablet 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 39021 Hydrochlorothiazide with olmesartan medoxomil 25mg 
with 20mg tablet 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 43322 Olmesartan medoxomil 40mg / Hydrochlorothiazide 
12.5mg tablets 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 43915 Olmetec Plus 40mg/12.5mg tablets (Daiichi Sankyo 
UK Ltd) 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 46715 Olmesartan medoxomil with amlodipine and 
hydrochlorothiazide 40mg + 10mg + 12.5mg Tablet 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 47467 Olmesartan medoxomil with amlodipine and 
hydrochlorothiazide 40mg + 5mg + 25mg Tablet 
Thiazides And Related Diuretics/Angiotensin-ii 
Receptor Antagonists 
Hypertension medications 581 Atenolol 50mg with Chlortalidone 12.5mg tablets Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 1288 Tenoret 50mg/12.5mg tablets (AstraZeneca UK Ltd) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 4983 Atenolol with amiloride and hydrochlorothiazide 
capsules 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 5721 Co-tenidone 100mg/25mg tablets Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 8623 Prestim Tablet (ICN Pharmaceuticals France S.A.) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 8673 Oxprenolol with cyclopenthiazide 160mg+0.25mg 
Modified-release tablet 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 12517 Timolol maleate with bendroflumethiazide 20mg + 
5mg Tablet 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 21025 Prestim forte Tablet (LEO Pharma) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 21182 Hydrochlorothiazide with timolol and amiloride 25mg Thiazides And Related Diuretics/Beta-
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with 10mg with 2.5mg Tablet adrenoceptor Blocking Drugs 
Hypertension medications 21873 Atenix Co 50 tablets (Ashbourne Pharmaceuticals Ltd) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 23131 Bendroflumethiazide 5mg with Propanolol 160mg 
modified-release capsules 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 25730 Timolol maleate with amiloride and 
hydrochlorothiazide Tablet 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 28177 Hydrochlorothiazide with atenolol and amiloride 
Capsule 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 31708 Co-tenidone 50mg/12.5mg tablets (Actavis UK Ltd) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 32094 Co-tenidone 50mg/12.5mg tablets (A A H 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 33659 Hydrochlorothiazide with metoprolol tartrate 25mg 
with 200mg Modified-release tablet 
Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 34825 Co-tenidone 50mg/12.5mg tablets (Teva UK Ltd) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 37725 Co-tenidone 100mg/25mg tablets (Generics (UK) Ltd) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 41572 Co-tenidone 100mg/25mg tablets (Teva UK Ltd) Thiazides And Related Diuretics/Beta-
adrenoceptor Blocking Drugs 
Hypertension medications 18606 Diltiazem and hydrochlorothiazide 150mg+12.5mg 
modified-release capsules 
Thiazides And Related Diuretics/Calcium-
channel Blockers 
Hypertension medications 23505 Adizem xl plus 150mg+12.5mg Modified-release 
capsule (Napp Pharmaceuticals Ltd) 
Thiazides And Related Diuretics/Calcium-
channel Blockers 
Hypertension medications 37908 Coversyl Arginine Plus 5mg/1.25mg tablets (Servier 
Laboratories Ltd) 
Thiazides And Related Diuretics/Drugs 
Affecting The Renin-angiotensin 
System/Angiotensin-converting Enzyme 
Inhibitors 
Hypertension medications 51258 Coversyl Arginine Plus 5mg/1.25mg tablets 
(Doncaster Pharmaceuticals Ltd) 
Thiazides And Related Diuretics/Drugs 
Affecting The Renin-angiotensin 
System/Angiotensin-converting Enzyme 
Inhibitors 
Hypertension medications 348 Moduretic Tablet (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 2002 Amiloride 5mg / hydrochlorothiazide 50mg tablets Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 3293 Moduretic Oral solution (Bristol-Myers Squibb Thiazides And Related Diuretics/Potassium-
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Pharmaceuticals Ltd) sparing Diuretics With Other Diuretics 
Hypertension medications 3701 Amiloride 2.5mg / hydrochlorothiazide 25mg tablets Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 7961 Spironolactone 50mg with hydroflumethiazide 50mg 
tablet 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 9223 Triamterene with hydrochlorothiazide 50mg + 25mg 
Tablet 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 12546 Kalspare Tablet (Dominion Pharma) Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 18733 Co-amilozide 5mg with 50mg/ml oral solution Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 22923 Hydrochlorothiazide with amiloride 50mg with 5mg 
Tablet 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 25500 Hypertane 50 Tablet (Schwarz Pharma Ltd) Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 26219 Zida-co 5mg+50mg Tablet (Opus Pharmaceuticals 
Ltd) 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 26220 Delvas Tablet (Berk Pharmaceuticals Ltd) Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 28157 Kalspare ls Tablet (Dominion Pharma) Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 29529 Hydroflumethiazide with spironolactone 25mg+25mg 
Tablet 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 30272 Benthiazide with Triamterene capsules Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 31131 Spiro-co 25mg+25mg Tablet (IVAX Pharmaceuticals 
UK Ltd) 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 37294 Triamterene with chlortalidone 50mg + 25mg Tablet Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
Hypertension medications 45916 Hydroflumethiazide with spironolactone 50mg+50mg 
Tablet 
Thiazides And Related Diuretics/Potassium-
sparing Diuretics With Other Diuretics 
NSAIDs 15 Ibuprofen 400mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40 Diclofenac sodium 50mg gastro-resistant tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 120 Indocid 25mg capsules (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 126 Ponstan 250mg capsules (Chemidex Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 129 Naprosyn 500mg suppositories (Roche Products Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 140 Naproxen 500mg suppositories Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 141 Piroxicam 10mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 162 Arthrotec 50 gastro-resistant tablets (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 177 Indometacin 25mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 259 Mefenamic acid 250mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 296 Ponstan Forte 500mg tablets (Chemidex Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 341 Feldene 10mg capsules (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 344 Acemetacin 60mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 360 Brufen 100mg/5ml syrup (Abbott Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 389 Ketoprofen 50mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 392 Ibuprofen 200mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 402 Nurofen 200mg Tablet (Crookes Healthcare Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 407 Brufen 600mg effervescent granules sachets (Abbott 
Laboratories Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 417 Diclofenac 50mg dispersible tablets sugar free Non-steroidal Anti-inflammatory Drugs 
NSAIDs 447 Diclofenac sodium 75mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 474 Celecoxib 100mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 497 Voltarol 25mg gastro-resistant tablets (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 499 Diclofenac 50mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 526 Aceclofenac 100mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 580 Diclofenac sodium 75mg modified-release tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 586 Ibuprofen 200mg Capsule Non-steroidal Anti-inflammatory Drugs 
NSAIDs 589 Voltarol 50mg dispersible tablets (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 597 Diclofenac potassium 50mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 612 Dicloflex 25mg gastro-resistant tablets (Dexcel-
Pharma Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 628 Diclofenac potassium 25mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 647 Ibuprofen 100mg/5ml oral suspension Non-steroidal Anti-inflammatory Drugs 
NSAIDs 649 Diclofenac sodium 25mg gastro-resistant tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 650 Etoricoxib 60mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 676 Diclofenac 75mg/3ml solution for injection ampoules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 736 Indometacin 50mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 754 Mobic 7.5mg suppositories (Boehringer Ingelheim Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 784 Ibuprofen 300mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 849 Ibumed 400mg Tablet (Medipharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 850 Mobic 7.5mg tablets (Boehringer Ingelheim Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 919 Indometacin 100mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 920 Indocid 100mg suppositories (Merck Sharp & Dohme 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1030 Junifen 100mg/5ml Oral suspension (Crookes 
Healthcare Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1073 Mefenamic acid 500mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1086 Ibuprofen 600mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1115 Diclofenac sodium 100mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1116 Diclofenac 100mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1210 Indometacin 75mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1231 Ketoprofen 100mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1246 Ponstan 250mg Dispersible tablet (Chemidex Pharma 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1392 Ibuprofen 800mg modified-release tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1468 Ibuprofen 200mg Soluble tablet Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1469 Meloxicam 15mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1470 Mobic 15mg tablets (Boehringer Ingelheim Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1496 Indocid R 75mg capsules (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1544 Piroxicam 0.5% gel Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1571 Ketoprofen 100mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1688 Indocid 50mg capsules (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1692 Diclofenac sodium 50mg gastro-resistant / Misoprostol 
200microgram tablets 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1739 Brufen 400mg tablets (Abbott Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1755 Piroxicam 20mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1757 Choline Mg trisalicylate 500mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1778 Surgam 300mg Tablet (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 1983 Mefenamic acid 250mg Dispersible tablet Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2129 Brufen retard tabs 800mg Modified-release tablet 
(Abbott Laboratories Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2234 Nabumetone 500mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2235 Relifex 500mg tablets (Meda Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2243 Meloxicam 7.5mg tablets Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 2258 Emflex 60mg capsules (Merck Serono Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2366 Flurbiprofen 100mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2386 Voltarol Retard 100mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2387 Arthrotec 75 gastro-resistant tablets (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2606 Ketoprofen 2.5% gel Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2858 Feldene 0.5% gel (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2863 Tiaprofenic acid 300mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2904 Diclofenac sodium 75mg gastro-resistant modified-
release capsules 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 2938 Ibuprofen 100mg/5ml Oral suspension Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3043 Ketoprofen 200mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3077 Oruvail 2.5% gel (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3170 Meloxicam 15mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3182 Froben 50mg tablets (Abbott Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3266 Flurbiprofen 50mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3409 Feldene 20mg Orodispersible tablet (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3416 Diclofenac sodium 100mg modified-release tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3597 Nurofen 200mg Soluble tablet (Crookes Healthcare 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3599 Ibuprofen 600mg effervescent granules sachets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3710 Piroxicam 20mg dispersible tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3897 Sulindac 100mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3935 Feldene 20 capsules (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3958 Diclofenac 25mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 3974 Tenoxicam 20mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4043 Froben sr 200mg Modified-release capsule (Abbott 
Laboratories Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4216 Brufen 600mg tablets (Abbott Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4298 Nurofen 200mg Tablet (Crookes Healthcare Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4309 Ibuprofen lysine 200mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4368 Lodine 200mg Capsule (Shire Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4469 Fenoprofen 300mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4506 Volsaid Retard 75 tablets (Chiesi Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4564 Fenoprofen 200mg Tablet Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 4625 Voltarol 75mg SR tablets (Novartis Pharmaceuticals 
UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4631 Voltarol 50mg gastro-resistant tablets (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4692 Dicloflex 50mg gastro-resistant tablets (Dexcel-
Pharma Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4710 Mefenamic acid 250mg Capsule (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4713 Voltarol 75mg/3ml solution for injection ampoules 
(Novartis Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4731 Nurofen for children 100mg/5ml Oral suspension 
(Reckitt Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4806 Voltarol 100mg suppositories (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4880 Diclofenac sodium 75mg gastro-resistant / Misoprostol 
200microgram tablets 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4911 Ibuprofen 400mg Granules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 4965 Piroxicam 20mg orodispersible tablets sugar free Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5080 Celebrex 200mg capsules (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5085 Voltarol Rapid 50mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5173 Dexketoprofen 25mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5175 Celebrex 100mg capsules (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5200 Voltarol 50mg suppositories (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5254 Celecoxib 200mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5266 Lodine sr 600mg Modified-release tablet (Shire 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5268 Naproxen 500mg modified-release tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5401 Voltarol Rapid 25mg tablets (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5455 Etodolac 600mg modified-release tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5482 Sulindac 200mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5648 Ibuprofen 200mg orodispersible tablets sugar free Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5812 Etoricoxib 90mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 5938 Etoricoxib 120mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 6249 Froben 100mg tablets (Abbott Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 6464 Arcoxia 60mg tablets (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 6498 Arcoxia 90mg tablets (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7058 Calprofen 100mg/5ml Oral suspension (McNeil 
Products Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7426 Lederfen 300mg Capsule (Wyeth Pharmaceuticals) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7432 Oruvail IM 100mg/2ml solution for injection ampoules 
(Sanofi) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7481 Lederfen 450mg Tablet (Wyeth Pharmaceuticals) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7483 Butazolidin 100mg Tablet (Novartis Pharmaceuticals 
UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7522 Lederfen 300mg Tablet (Wyeth Pharmaceuticals) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7535 Nurofen 200mg Capsule (Crookes Healthcare Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 7667 Diclofenac 12.5mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 8062 Motifene 75mg modified-release capsules (Daiichi 
Sankyo UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 8385 Ketoprofen 150mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 8451 Etodolac 200mg Tablet Non-steroidal Anti-inflammatory Drugs 
NSAIDs 8663 Naprosyn S/R 500mg tablets (Roche Products Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 8969 Lodine 300mg Capsule (Shire Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9222 Dicloflex 75mg SR tablets (Dexcel-Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9421 Powergel 2.5% gel (A. Menarini Farmaceutica 
Internazionale SRL) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9439 Flurbiprofen 200mg modified-release capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9474 Preservex 100mg tablets (Almirall Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9500 Diclotard 75mg modified-release tablets (Galen Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9630 Feldene P 0.5% gel (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9637 Keral 25mg tablets (A. Menarini Farmaceutica 
Internazionale SRL) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9688 Diclovol 75mg SR tablets (Generics (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9736 Mefenamic acid 50mg/5ml oral suspension Non-steroidal Anti-inflammatory Drugs 
NSAIDs 9822 Arcoxia 120mg tablets (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10033 Etodolac 300mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10149 Ibuprofen 200mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10169 Brexidol 20mg tablets (Chiesi Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10209 Ibufem 200mg tablets (Galpharm International Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10295 Relifex 500mg/5ml oral suspension (Meda 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 10325 Dexibuprofen 300mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10336 Ketoprofen 100mg/2ml solution for injection ampoules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10481 Lederfen f 450mg Tablet (Wyeth Pharmaceuticals) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10678 Fenopron 300 tablets (Typharm Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10711 Tolectin 400mg Capsule (Cilag Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10785 Fenbid 300mg Spansules (Mercury Pharma Group 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 10917 Flamrase SR 100mg tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11168 Volsaid Retard 100 tablets (Chiesi Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11215 Voltarol 25mg suppositories (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11466 Nabumetone 500mg/5ml oral suspension sugar free Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11495 Piroxicam betadex 20mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11550 Nurofen Meltlets 200mg tablets (Reckitt Benckiser 
Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11907 Dexibuprofen 400mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11970 Meloxicam 7.5mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 11980 Cuprofen 400mg Tablet (SSL International Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 12000 Ketoprofen 100mg suppositories Non-steroidal Anti-inflammatory Drugs 
NSAIDs 12075 Mobiflex 20mg Tablet (Roche Products Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 12188 Trilisate 500mg Tablet (Napp Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 13459 Dysman 500 tablets (Ashbourne Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 13627 Mobic 15mg suppositories (Boehringer Ingelheim Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 13818 Nabumetone 500mg tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14084 Diclovol 75mg SR tablets (Arun Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14085 Diclovol Retard 100mg tablets (Arun Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14333 Ibuprofen 400mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14385 Cuprofen 200mg Tablet (SSL International Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14422 Fenbufen 450mg Effervescent tablet Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14476 Indolar SR 75mg capsules (Sandoz Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14541 Ponstan 50mg/5ml paediatric Liquid (Chemidex 
Pharma Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14672 Defanac 75mg SR tablets (Ranbaxy (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 14707 Defanac Retard 100mg tablets (Ranbaxy (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 14776 Surgam 300mg tablets (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 15201 Volraman 50mg gastro-resistant tablets (LPC Medical 
(UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 15286 Ketocid 200 modified-release capsules (Chiesi Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 15732 Diclovol 50mg gastro-resistant tablets (Arun 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 16192 Motrin 200mg Tablet (Pharmacia Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 16194 Lodine 200mg Tablet (Shire Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 16221 Diclozip 25mg gastro-resistant tablets (Ashbourne 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 16222 Diclozip 50mg gastro-resistant tablets (Ashbourne 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 16272 Lofensaid Retard 100 tablets (Opus Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 16286 Lofensaid Retard 75 tablets (Opus Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17029 Rhumalgan CR 75 tablets (Sandoz Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17030 Rhumalgan SR 75mg capsules (Sandoz Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17126 Fenactol SR 75mg tablets (Discovery 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17128 Fenactol 50mg gastro-resistant tablets (Discovery 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17525 Fenactol Retard 100mg tablets (Discovery 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17532 Dicloflex Retard 100mg tablets (Kent Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17572 Tenoxicam 20mg powder and solvent for solution for 
injection vials 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17680 Indomax 75 SR capsules (Ashbourne 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17754 Progesic 200mg Tablet (Eli Lilly and Company Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 17818 Ketovail 100mg modified-release capsules (Teva UK 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18196 Orbifen for children 100mg/5ml Oral suspension 
(Orbis Consumer Products Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18234 Rheumacin LA 75mg capsules (Hillcross 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 18364 Ibular 400mg Tablet (Lagap) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18448 Voltarol 12.5mg suppositories (Novartis 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18527 Mandafen 400mg tablets (M & A Pharmachem Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18640 Tolectin 200mg Capsule (Cilag Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18647 Fenoket 200mg modified-release capsules (Opus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18662 Indomod 75mg modified-release capsules (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18798 Lofensaid 50mg gastro-resistant tablets (Opus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18812 Nurofen meltlets lemon 200mg Orodispersible tablet 
(Reckitt Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18820 Fenpaed 100mg/5ml Oral suspension (Pinewood 
Healthcare) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 18921 Fenactol 25mg gastro-resistant tablets (Discovery 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 19046 Ibuprofen 400mg tablets (A A H Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 19320 Piroflam 20mg Capsule (Opus Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 19322 Disalcid 500mg Capsule (3M Health Care Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 19382 Slofenac 75mg SR tablets (Sterwin Medicines) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 19575 Proflex 200mg Tablet (Novartis Consumer Health UK 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20016 Tolmetin 400mg Capsule Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20059 Tiaprofenic acid 300mg sachets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20230 Salsalate 500mg capsules Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20384 Flamatak MR 100mg tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20386 Ramodar 200mg Tablet (Wyeth Pharmaceuticals) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20395 Flamatak MR 75mg tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20442 Nurofen 5% gel (Reckitt Benckiser Healthcare (UK) 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20621 Dicloflex 75mg SR tablets (Kent Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20805 Dicloflex 75mg SR tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 20978 Anadin Ultra liquid capsules (Wyeth Consumer 
Healthcare) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21045 Ibumetin 400mg Tablet (Alfred Benzon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21123 Piroxicam 20mg Capsule (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 21387 Diclofenac sodium 50mg gastro-resistant tablets 
(Generics (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21419 Seractil 300mg tablets (Genus Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21421 Seractil 400mg tablets (Genus Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21444 Volraman 25mg gastro-resistant tablets (LPC Medical 
(UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21610 Rhumalgan CR 100 tablets (Sandoz Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21807 Flamrase 25 EC tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21811 Lidifen 200mg Tablet (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21813 Lidifen 400mg Tablet (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21821 Lidifen f 600mg Tablet (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21824 Flamrase 50 EC tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21831 Dysman 250mg Capsule (Ashbourne Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21846 Pirozip 20 capsules (Ashbourne Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21864 Pirozip 10 capsules (Ashbourne Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 21955 Ketozip 200 XL capsules (Ashbourne 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 22230 Meflam 250mg Capsule (Trinity Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 23204 Pardelprin MR 75mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24121 Diclofenac sodium 25mg gastro-resistant tablets 
(Actavis UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24122 Diclofenac sodium 50mg gastro-resistant tablets 
(Actavis UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24128 Diclofenac sodium 25mg gastro-resistant tablets (A A 
H Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24137 Indometacin 25mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24305 Ibufac 400mg Tablet (DDSA Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24308 Slo-Indo 75mg capsules (Generics (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24356 Eccoxolac 300mg capsules (Meda Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24469 Cuprofen for Children 100mg/5ml oral suspension 
(SSL International Plc) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24531 Mobiflex 20mg Effervescent tablet (Roche Products 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 24617 Tiloket 2.5% gel (Tillomed Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 24682 Tenoxicam 20mg effervescent tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25329 Lofensaid 25mg gastro-resistant tablets (Opus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25358 Defanac 50mg gastro-resistant tablets (Ranbaxy (UK) 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25361 Diclovol 25mg gastro-resistant tablets (Arun 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25362 Defanac 25mg gastro-resistant tablets (Ranbaxy (UK) 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25619 Nurofen 400mg Tablet (Crookes Healthcare Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25643 Surgam 300mg Sachets (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25701 Ketovail 200mg modified-release capsules (Teva UK 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 25794 Isisfen 400mg Tablet (Isis Products Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26165 Diclofenac sodium 50mg gastro-resistant tablets (A A 
H Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26205 Fenbuzip 300mg Capsule (Ashbourne 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26214 Fenbuzip 450mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26234 Flamatrol 10mg Capsule (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26247 Opustan 500mg Tablet (Opus Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26351 Rheumatac Retard 75 tablets (Amdipharm Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26404 Tolmetin 200mg Capsule Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26522 Meflam 500mg Tablet (Trinity Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26631 Rhumalgan XL 100mg capsules (Sandoz Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26970 Ibuprofen 100mg/5ml oral suspension sugar free 
(Teva UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 26994 Fenbuzip 300mg Tablet (Ashbourne Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 27055 Diclofenac sodium 50mg gastro-resistant tablets (Kent 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 27082 Ketpron XL 100mg capsules (Mercury Pharma Group 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 27200 Diclovol Retard 100mg tablets (Generics (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 27723 Phenylbutazone 200mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 27782 Ibuprofen 400mg tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
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Medication Product 
Code 
Product Name BNF Header 
NSAIDs 27968 Apsifen 400mg Tablet (Approved Prescription 
Services Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 28172 Ibuprofen 300mg / Pseudoephedrine 45mg modified-
release capsules 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 28479 Nurofen Back Pain SR 300mg capsules (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 28553 Diclofenac sodium 50mg gastro-resistant tablets 
(Teva UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 28695 Piroflam 10mg Capsule (Opus Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 28888 Galprofen Long Lasting 200mg capsules (Galpharm 
International Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29010 Phenylbutazone 100mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29037 Valdic 100 Retard tablets (Fannin UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29181 Dicloflex 75mg SR tablets (Almus Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29316 Care ibuprofen 400mg Tablet (Thornton & Ross Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29330 Diclofenac sodium 50mg gastro-resistant tablets 
(Sandoz Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29332 Ibuprofen 100mg/5ml oral suspension sugar free 
(Sandoz Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29345 Ibuprofen 100mg/5ml Oral suspension (Hillcross 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29352 Ibuprofen 100mg/5ml oral suspension sugar free 
(Vantage) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29455 Flexotard MR 100mg tablets (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29465 Piroxicam 20mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29524 Ibumetin 600mg Tablet (Alfred Benzon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29587 Ebufac 400mg Tablet (DDSA Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29674 Butazolidin 200mg Tablet (Novartis Pharmaceuticals 
UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29704 Paxofen 200mg Tablet (M A Steinhard Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 29772 Ketotard XL 200mg capsules (Galen Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30122 Lornoxicam 8mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30164 Lemsip Cold and Flu Sinus 12 Hr Ibuprofen + 
Pseudoephedrine modified-release capsules (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30243 Ibuprofen 200mg effervescent tablets Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 30327 Jomethid XL 200mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30382 Ibuprofen 200mg Tablet (C P Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30389 Contraflam 250mg Capsule (Berk Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30391 Contraflam 500mg Tablet (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30811 Proflex 300mg Modified-release capsule (Novartis 
Consumer Health UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30849 Valdic 75 Retard tablets (Fannin UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30892 Mandafen for Children 100mg/5ml oral suspension 
sugar free (M & A Pharmachem Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 30923 Diclofenac 100mg suppositories (A A H 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31064 Mobiflex 20mg Granules (Roche Products Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31178 Ketoprofen 2.5% gel (A A H Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31383 Dexomon 75mg SR tablets (Hillcross Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31469 Apsifen -f 600mg Tablet (Approved Prescription 
Services Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31482 Apsifen 200mg Tablet (Approved Prescription 
Services Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31589 Diclofenac sodium 75mg modified-release tablets (A A 
H Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31787 Econac SR 75mg tablets (Mercury Pharma Group Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31916 Tiloket CR 100mg capsules (Tillomed Laboratories 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31944 Diclofenac sodium 25mg gastro-resistant tablets 
(Generics (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31950 Diclofenac sodium 50mg gastro-resistant tablets 
(Sterwin Medicines) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31959 Indometacin 50mg capsules (A A H Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 31962 Ketpron XL 200mg capsules (Mercury Pharma Group 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32090 Mefenamic acid 500mg tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32100 Ibuprofen 600mg tablets (A A H Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32105 Mefenamic acid 500mg tablets (A A H 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 32108 Diclofenac sodium 25mg gastro-resistant tablets 
(Teva UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32136 Ibular 200mg Tablet (Lagap) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32227 Larafen CR 200mg capsules (Ennogen Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32234 Mefenamic acid 500mg tablets (IVAX 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32366 Relcofen 200mg Tablet (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32509 Anadin Ibuprofen 200mg tablets (Pfizer Consumer 
Healthcare Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32601 Econac 100mg suppositories (Mercury Pharma Group 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32641 Indometacin 25mg capsules (A A H Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32854 Diclofenac sodium 75mg modified-release capsules 
(A A H Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 32862 Ibuprofen 100mg/5ml oral suspension sugar free 
(Thornton & Ross Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 33308 Butazone 100mg Tablet (DDSA Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 33321 Indometacin 50mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 33589 Ibuprofen 400mg tablets (Thornton & Ross Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 33704 Ibuprofen 100mg/5ml oral suspension sugar free (A A 
H Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 33801 Opustan 250mg Capsule (Opus Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 33994 Diclofenac sodium 25mg gastro-resistant tablets 
(IVAX Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34091 Diclofenac sodium 25mg gastro-resistant tablets 
(Sandoz Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34190 Indometacin 75mg modified-release capsules (A A H 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34199 Indometacin 100mg suppositories (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34271 Diclofenac sodium 100mg modified-release tablets (A 
A H Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34359 Ibuprofen 400mg tablets (Vantage) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34425 Ibuprofen 400mg Tablet (Family Health) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34438 Mefenamic acid 250mg capsules (A A H 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34487 Diclofenac sodium 50mg gastro-resistant tablets Non-steroidal Anti-inflammatory Drugs 
  
 
4
4
5
 
Medication Product 
Code 
Product Name BNF Header 
(IVAX Pharmaceuticals UK Ltd) 
NSAIDs 34550 Ibuprofen 400mg tablets film coated (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34595 Mefenamic acid 500mg tablets (Zentiva) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34616 Piroxicam 0.5% gel (A A H Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34621 Ibuprofen 200mg Tablet (Nucare Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34663 Ibuprofen 100mg/5ml Oral suspension (Neo 
Laboratories Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34725 Flurbiprofen 50mg Tablet (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34757 Ibuprofen 400mg Tablet (Unichem) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34793 Mefenamic acid 250mg capsules (Zentiva) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34850 Ibuprofen 600mg tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34889 Ibuprofen 400mg Tablet (Celltech Pharma Europe 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34898 Mefenamic acid 250mg Capsule (Berk 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34910 Mefenamic acid 500mg Tablet (Berk Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34911 Ibuprofen 200mg Tablet (Celltech Pharma Europe 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34924 Mefenamic acid 250mg Capsule (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 34931 Ibuprofen 200mg Tablet (Regent Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 35265 Nurofen for children 3 months to 9 years 100mg/5ml 
Oral suspension (Reckitt Benckiser Healthcare (UK) 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 35292 Nurofen 200mg liquid capsules (Reckitt Benckiser 
Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 35653 Etopan XL 600mg tablets (Taro Pharmaceuticals (UK) 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 35711 Dicloflex 25mg gastro-resistant tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 35893 Dicloflex Retard 100mg tablets (Almus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 35935 Meloxicam 7.5mg tablets (Somex Pharma) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 36260 Mendys 250mg Capsule (Kent Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 36486 Econac XL 100mg tablets (Mercury Pharma Group 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 36597 Hedex Ibuprofen 200mg tablets (Omega Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 36606 Manorfen 400mg tablets (The Manor Drug Company 
(Nottingham) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 36650 Nurofen 200mg tablets (Reckitt Benckiser Healthcare 
(UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37002 Nurofen Express 200mg liquid capsules (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37094 Cuprofen 200mg tablets (SSL International Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37253 Anadin ultra double strength 400mg Capsule (Wyeth 
Consumer Healthcare) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37553 Ibucalm 400mg tablets (Aspar Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37562 Arcoxia 30mg tablets (Merck Sharp & Dohme Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37587 Etoricoxib 30mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37648 Nurofen Express 400mg liquid capsules (Reckitt 
Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37750 Piroxicam 20mg capsules (Generics (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 37763 Diclofenac 75mg/2ml solution for injection vials Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38332 Ibucalm 200mg tablets (Aspar Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38493 Anadin Joint Pain 200mg tablets (Pfizer Consumer 
Healthcare Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38770 Lodine SR 600mg tablets (Almirall Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38817 Diclofenac potassium 12.5mg tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38881 Diclomax SR 75mg capsules (Galen Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38944 Froben SR 200mg capsules (Abbott Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38948 Diclomax Retard 100mg capsules (Galen Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 38992 Flamrase 75mg SR tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39019 Brufen Retard 800mg tablets (Abbott Laboratories 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39109 Feldene Melt 20mg tablets (Pfizer Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39264 Dicloflex Retard 100mg tablets (Dexcel-Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39354 Galpharm ibuprofen for children 100mg/5ml Oral 
suspension (Galpharm International Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39722 Voltarol Pain-eze 12.5mg tablets (Novartis Consumer 
Health UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39823 Dicloflex 50mg gastro-resistant tablets (Almus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 39873 Cuprofen Maximum Strength 400mg tablets (SSL 
International Plc) 
Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 40086 Acoflam 50mg gastro-resistant tablets (Mercury 
Pharma Group Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40141 Ketoprofen 100mg capsules (A A H Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40185 Oruvail 200 modified-release capsules (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40215 Oruvail 100 modified-release capsules (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40253 Ibuprofen 600mg Tablet (Sovereign Medical Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40336 Orudis 50mg capsules (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40394 Advil 400mg Tablet (Wyeth Consumer Healthcare) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40484 Orudis 100mg capsules (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40516 Anadin LiquiFast 200mg capsules (Pfizer Consumer 
Healthcare Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40664 Oruvail 150 modified-release capsules (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 40756 Dicloflex 25mg gastro-resistant tablets (Almus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41450 Orudis 100mg suppositories (Sanofi) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41524 Mefenamic acid 500mg tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41621 Piroxicam 20mg capsules (A A H Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41622 Piroxicam 10mg capsules (A A H Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41623 Piroxicam 20mg capsules (IVAX Pharmaceuticals UK 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41624 Piroxicam 10mg capsules (IVAX Pharmaceuticals UK 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 41677 Mefenamic acid 250mg Capsule (IVAX 
Pharmaceuticals UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 42455 Dicloflex Retard 100mg tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 42604 Mobiflex 20mg tablets (Meda Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 42821 Nabumetone 500mg tablets (A A H Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 43032 Inoven 200mg Tablet (Janssen-Cilag Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 43045 Diclofenac potassium 50mg tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 43456 Anadin LiquiFast 400mg capsules (Pfizer Consumer 
Healthcare Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 43541 Piroxicam 10mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 43616 Celecoxib 400mg capsules Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 43911 Ibuprofen 600mg Tablet (C P Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 44112 Voltarol Joint Pain 12.5mg tablets (Novartis Consumer 
Health UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 44233 Nurofen for children baby 100mg/5ml Oral suspension 
(Reckitt Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 44703 Piroxicam 10mg Capsule (Berk Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 44730 Mentholatum Ibuprofen 5% gel (The Mentholatum 
Company Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 45213 Diclofenac 10mg dispersible tablets Non-steroidal Anti-inflammatory Drugs 
NSAIDs 45216 Ibuprofen 400mg Tablet (C P Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 45331 Ibuprofen 200mg Tablet (Co-Pharma Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 45814 First Resort Double Action Pain Relief 12.5mg tablets 
(Actavis UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 45842 Ibuprofen 600mg Tablet (Celltech Pharma Europe 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 46342 Medifen 3with months 100mg/5ml Oral suspension 
(SSL International Plc) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 46844 Dicloflex 75mg SR tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 46860 Anadin LiquiFast 200mg effervescent tablets (Pfizer 
Consumer Healthcare Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 46940 Ketoprofen 100mg capsules (Generics (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 46967 Mefenamic acid 250mg Capsule (Sandoz Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 46968 Mefenamic acid 250mg capsules (Generics (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 47501 Rhumalgan SR 75mg capsules (Almus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 47816 Tenoxicam 20mg Tablet (Sovereign Medical Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 47820 Voltarol Pain-eze Extra Strength 25mg tablets 
(Novartis Consumer Health UK Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48059 Diclofenac potassium 50mg tablets (A A H 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48062 Ibuprofen 200mg Tablet (Wockhardt UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48084 Ibuprofen 200mg/5ml oral suspension Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48546 Ibuprofen 400mg caplets (Bristol Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48562 Ibuprofen 100mg/5ml oral suspension 5ml sachets 
sugar free 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48568 Boots Rapid Ibuprofen lysine 342mg tablets (The 
Boots Company Plc) 
Non-steroidal Anti-inflammatory Drugs 
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NSAIDs 48644 Ibuprofen 400mg caplets (Lloyds Pharmacy Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48810 Dysman 250 capsules (Ashbourne Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 48871 Diclofenac potassium 25mg tablets (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 49059 Voltarol 50mg dispersible tablets (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 49266 Ibuprofen for Children 100mg/5ml oral suspension 
(Galpharm International Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 49432 Calprofen 100mg/5ml oral suspension (McNeil 
Products Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50058 Voltarol 50mg dispersible tablets (Doncaster 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50059 Celebrex 100mg capsules (Necessity Supplies Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50117 Brufen 100mg/5ml syrup (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50269 Arthrotec 75 gastro-resistant tablets (Mawdsley-
Brooks & Company Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50314 Brufen 600mg effervescent granules sachets 
(Doncaster Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50317 Voltarol 75mg SR tablets (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50343 Feldene 0.5% gel (Doncaster Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50602 Diclofenac potassium 50mg tablets (Alliance 
Healthcare (Distribution) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50628 Ibuprofen 400mg caplets (The Boots Company Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50652 Junior Ibuprofen 100mg/5ml oral suspension (Numark 
Management Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 50785 Diclofenac sodium 50mg gastro-resistant tablets 
(Genesis Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51099 Voltarol Rapid 50mg tablets (Mawdsley-Brooks & 
Company Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51284 Arcoxia 60mg tablets (Sigma Pharmaceuticals Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51293 Diclofenac potassium 50mg tablets (Phoenix 
Healthcare Distribution Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51339 Indometacin 25mg capsules (Genesis 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51343 Voltarol Rapid 25mg tablets (Doncaster 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51808 Diclofenac 12.5mg/5ml oral solution Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51827 Mefenamic acid 500mg tablets (Sigma Non-steroidal Anti-inflammatory Drugs 
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Pharmaceuticals Plc) 
NSAIDs 51828 Ibuprofen 100mg/5ml oral suspension sugar free 
(Kent Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51874 Arcoxia 30mg tablets (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 51943 Orbifen For Children 100mg/5ml oral suspension 
(Orbis Consumer Products Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 52009 Ibuprofen 200mg capsules (Galpharm International 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 52338 Diclofenac potassium 50mg tablets (Focus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 52389 Voltarol 50mg suppositories (Sigma Pharmaceuticals 
Plc) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 52420 Celebrex 100mg capsules (Mawdsley-Brooks & 
Company Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 52617 Ibuprofen 100mg/5ml oral suspension sugar free 
(Sigma Pharmaceuticals Plc) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 52714 Etodolac 600mg modified-release tablets (Alliance 
Healthcare (Distribution) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53164 Diclofenac sodium 25mg gastro-resistant tablets (Kent 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53331 Ibuprofen 100mg/5ml oral suspension sugar free 
(Alliance Healthcare (Distribution) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53345 Voltarol Rapid 50mg tablets (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53384 Voltarol 50mg dispersible tablets (Mawdsley-Brooks & 
Company Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53397 Brufen 100mg/5ml syrup (Mawdsley-Brooks & 
Company Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53576 Arcoxia 120mg tablets (Doncaster Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53604 Ibuprofen 200mg capsules (Numark Management Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 53803 Ibuprofen 200mg capsules (Kent Pharmaceuticals 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 54021 Voltarol Retard 100mg tablets (Sigma 
Pharmaceuticals Plc) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 54075 Voltarol 50mg dispersible tablets (Stephar (U.K.) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 54137 Ibuprofen 400mg tablets (Aspar Pharmaceuticals Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 54514 Ibuprofen lysine 400mg oral powder sachets Non-steroidal Anti-inflammatory Drugs 
  
 
4
5
1
 
Medication Product 
Code 
Product Name BNF Header 
NSAIDs 54518 Diclofenac sodium 50mg gastro-resistant tablets 
(Phoenix Healthcare Distribution Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 54870 Piroxicam 0.5% gel (Alliance Healthcare (Distribution) 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 54906 Diclofenac 50mg/5ml oral suspension Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55009 Brufen 600mg effervescent granules sachets 
(Necessity Supplies Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55099 Acoflam 100mg Retard tablets (Mercury Pharma 
Group Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55153 Nurofen Express Soluble 400mg oral powder sachets 
(Reckitt Benckiser Healthcare (UK) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55233 Ibuprofen 400mg Tablet (Nucare Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55313 Ibuprofen 400mg tablets (Boston Healthcare Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55434 Ibuprofen 400mg tablets (Bristol Laboratories Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55582 Celebrex 200mg capsules (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 55913 Voltarol 50mg suppositories (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56039 Ibuprofen 600mg tablets (Waymade Healthcare Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56078 Rhumalgan XL 100mg capsules (Almus 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56213 Ibuprofen 400mg tablets sugar coated (Kent 
Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56275 Meloxicam 7.5mg tablets (Teva UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56441 Calprofen 100mg/5ml oral suspension 5ml sachets 
(McNeil Products Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56584 Arcoxia 60mg tablets (Lexon (UK) Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56651 Piroxicam 0.5% gel (Sigma Pharmaceuticals Plc) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 56898 Rhumalgan SR 75mg capsules (Actavis UK Ltd) Non-steroidal Anti-inflammatory Drugs 
NSAIDs 57006 Diclofenac sodium 25mg gastro-resistant tablets 
(Phoenix Healthcare Distribution Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 57007 Mefenamic acid 250mg capsules (Essential Generics 
Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 57045 Voltarol 50mg dispersible tablets (Waymade 
Healthcare Plc) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 57112 Ibuprofen 400mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
NSAIDs 57162 Diclofenac 50mg dispersible tablets sugar free 
(Doncaster Pharmaceuticals Ltd) 
Non-steroidal Anti-inflammatory Drugs 
  
 
4
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Medication Product 
Code 
Product Name BNF Header 
NSAIDs 57297 Mefenamic acid 500mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
Non-steroidal Anti-inflammatory Drugs 
Phenytoin 4175 Epanutin 30mg/5ml oral suspension (Pfizer Ltd) Control Of Epilepsy 
Phenytoin 4490 Phenytoin 30mg/5ml oral suspension Control Of Epilepsy 
Phenytoin 14857 Phenytoin 50mg chewable tablets Control Of Epilepsy 
Phenytoin 17177 Epanutin Infatabs 50mg chewable tablets (Pfizer Ltd) Control Of Epilepsy 
Phenytoin 2062 Phenytoin sodium 100mg tablets Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 2782 Phenytoin sodium 50mg tablets Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 3881 Epanutin 50mg capsules (Pfizer Ltd) Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 5587 Phenytoin sodium 50mg capsules Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 10263 Epanutin 300mg capsules (Pfizer Ltd) Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 34144 Phenytoin sodium 100mg tablets (Actavis UK Ltd) Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 47014 Phenytoin 90mg/5ml oral suspension Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 49789 Phenytoin sodium 50mg capsules (Flynn Pharma Ltd) Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 50148 Phenytoin sodium 25mg capsules (Flynn Pharma Ltd) Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 50159 Phenytoin sodium 300mg capsules (Flynn Pharma 
Ltd) 
Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 53749 Phenytoin sodium 100mg capsules (A A H 
Pharmaceuticals Ltd) 
Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 53750 Phenytoin sodium 50mg capsules (A A H 
Pharmaceuticals Ltd) 
Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 56786 Phenytoin sodium 100mg tablets (Milpharm Ltd) Control Of Epilepsy/Drugs Used In Status 
Epilepticus 
Phenytoin 107 Phenytoin 25mg capsule Control Of Epilepsy/Neuropathic Pain 
Phenytoin 3068 Phenytoin 300mg capsule Control Of Epilepsy/Neuropathic Pain 
Phenytoin 9678 Phenytoin 90mg/5ml oral solution sugar free Control Of Epilepsy/Neuropathic Pain 
Phenytoin 30392 Pentran 50mg Tablet (Berk Pharmaceuticals Ltd) Control Of Epilepsy/Neuropathic Pain 
Phenytoin 34699 Phenytoin 90mg/5ml Oral suspension sugar free Control Of Epilepsy/Neuropathic Pain 
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Medication Product 
Code 
Product Name BNF Header 
(Rosemont Pharmaceuticals Ltd) 
Phenytoin 25903 Fosphenytoin 750mg/10ml solution for injection vials Drugs Used In Status Epilepticus 
Phenytoin 27967 Pro-Epanutin 750mg/10ml concentrate for solution for 
injection vials (Pfizer Ltd) 
Drugs Used In Status Epilepticus 
Phenytoin 1398 Epanutin 100mg capsules (Pfizer Ltd) Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 6504 Phenytoin sodium 100mg capsules Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 6594 Phenytoin sodium 300mg capsules Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 6624 Phenytoin sodium 25mg capsules Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 7498 Epanutin 25mg capsules (Pfizer Ltd) Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 12469 Epanutin Ready-Mixed Parenteral 250mg/5ml solution 
for injection ampoules (Pfizer Ltd) 
Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 24637 Phenytoin sodium 250mg/5ml solution for injection 
ampoules 
Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 27113 Phenytoin sodium 100mg tablets (Teva UK Ltd) Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 34592 Phenytoin sodium 100mg tablets (A A H 
Pharmaceuticals Ltd) 
Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 50147 Phenytoin sodium 100mg capsules (Flynn Pharma 
Ltd) 
Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 53846 Phenytoin sodium 300mg capsules (A A H 
Pharmaceuticals Ltd) 
Drugs Used In Status Epilepticus/Control Of 
Epilepsy 
Phenytoin 1370 Phenytoin 100mg capsule Neuropathic Pain/Control Of Epilepsy 
Phenytoin 2128 Phenytoin 50mg capsule Neuropathic Pain/Control Of Epilepsy 
Phenytoin 21854 Pentran 100mg Tablet (Berk Pharmaceuticals Ltd) Neuropathic Pain/Control Of Epilepsy 
Phenytoin 47670 Phenytoin 100mg Capsule (Actavis UK Ltd) Neuropathic Pain/Control Of Epilepsy 
Rifampicin 34130 Rifampicin 300mg Capsule (Approved Prescription 
Services Ltd) 
Antileprotic Drugs/Antituberculosis Drugs 
Rifampicin 42496 Rifampicin 300mg/vial infusion Antileprotic Drugs/Antituberculosis Drugs 
Rifampicin 240 Rifampicin 150mg capsules Antituberculosis Drugs 
Rifampicin 1345 Rifampicin 100mg/5ml oral suspension Antituberculosis Drugs 
Rifampicin 1531 Rifampicin 300mg capsules Antituberculosis Drugs 
Rifampicin 2798 Rimactane 100mg/5ml syrup (Movianto UK Ltd) Antituberculosis Drugs 
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Medication Product 
Code 
Product Name BNF Header 
Rifampicin 3403 Rifinah 150 Tablet (Aventis Pharma) Antituberculosis Drugs 
Rifampicin 4522 Rifinah 300 Tablet (Aventis Pharma) Antituberculosis Drugs 
Rifampicin 7818 Rifater tablets (Sanofi) Antituberculosis Drugs 
Rifampicin 8613 Rifampicin 300mg / Isoniazid 150mg tablets Antituberculosis Drugs 
Rifampicin 9062 Rimactazid 150 tablets (Movianto UK Ltd) Antituberculosis Drugs 
Rifampicin 11226 Rifampicin 600mg powder and solvent for solution for 
infusion vials 
Antituberculosis Drugs 
Rifampicin 12329 Rifampicin 150mg / Isoniazid 100mg tablets Antituberculosis Drugs 
Rifampicin 12437 Rimactazid 300 tablets (Movianto UK Ltd) Antituberculosis Drugs 
Rifampicin 13908 Rifadin 100mg/5ml syrup (Sanofi) Antituberculosis Drugs 
Rifampicin 16639 Rifadin 300mg capsules (Sanofi) Antituberculosis Drugs 
Rifampicin 16802 Isoniazid with rifampicin 150mg + 300mg Tablet Antituberculosis Drugs 
Rifampicin 21367 Rifadin 150mg capsules (Sanofi) Antituberculosis Drugs 
Rifampicin 26776 Isoniazid with rifampicin 100mg + 150mg Tablet Antituberculosis Drugs 
Rifampicin 32407 Rifadin 600mg powder and solvent for solution for 
infusion vials (Sanofi) 
Antituberculosis Drugs 
Rifampicin 34653 Rifampicin 300mg capsules (A A H Pharmaceuticals 
Ltd) 
Antituberculosis Drugs 
Rifampicin 36357 Rimactane 300mg capsules (Sandoz Ltd) Antituberculosis Drugs 
Rifampicin 38661 Rimactane 150mg capsules (Sandoz Ltd) Antituberculosis Drugs 
Rifampicin 39020 Rifinah 300mg/150mg tablets (Sanofi) Antituberculosis Drugs 
Rifampicin 39194 Rifinah 150mg/100mg tablets (Sanofi) Antituberculosis Drugs 
Rifampicin 46917 Rifampicin 300mg capsules (Generics (UK) Ltd) Antituberculosis Drugs 
Rifampicin 1347 Rimactane 150mg Capsule (Novartis Pharmaceuticals 
UK Ltd) 
Antituberculosis Drugs/Antileprotic Drugs 
Rifampicin 25277 Rimactane 300mg Capsule (Novartis Pharmaceuticals 
UK Ltd) 
Antituberculosis Drugs/Antileprotic Drugs 
Rivaroxaban 39119 Rivaroxaban 10mg tablets  
Rivaroxaban 39639 Xarelto 10mg tablets (Bayer Plc)  
Rivaroxaban 48966 Rivaroxaban 15mg tablets  
Rivaroxaban 54451 Rivaroxaban 20mg tablets  
Rivaroxaban 56289 Xarelto 20mg tablets (Bayer Plc)  
Rivaroxaban 56640 Xarelto 15mg tablets (Bayer Plc)  
St. John's wort 23181 Hypericum auro cultum herba 0.1% Liquid Anthroposophical Remedy 
St. John's wort 37496 Hypericum auro cultum herba 0.01 Liquid Anthroposophical Remedy 
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Medication Product 
Code 
Product Name BNF Header 
St. John's wort 16419 St john's wort 333mg tablets Herbal Remedy 
St. John's wort 47794 Kira GoodMood St. John's wort tablets (Ceuta 
Healthcare Ltd) 
Herbal Remedy/Homeopathic Remedy 
St. John's wort 50782 Lloydspharmacy St. John's wort tablets (Lloyds 
Pharmacy Ltd) 
Herbal Remedy/Homeopathic Remedy 
St. John's wort 51588 HealthAid St. John's wort tablets (HealthAid Ltd) Herbal Remedy/Homeopathic Remedy 
St. John's wort 30207 Hypercal cream (Nelsons) Homeopathic Remedy 
St. John's wort 31075 Calendula officinalis 0.45% / Hypericum perforatum 
0.45% cream 
Homeopathic Remedy 
St. John's wort 39535 Hyperiforce St. John's wort tablets (Bioforce (UK) Ltd) Homeopathic Remedy/Herbal Remedy 
St. John's wort 51587 Vega St. John's wort 333-Complex capsules (Vega 
Nutritionals Ltd) 
Homeopathic Remedy/Herbal Remedy 
St. John's wort 51697 Premier St. John's wort 333mg tablets (Premier 
Health Products Ltd) 
Homeopathic Remedy/Herbal Remedy 
St. John's wort 51698 Quest St. John's wort extract 333mg tablets (Quest 
Vitamins Ltd) 
Homeopathic Remedy/Herbal Remedy 
St. John's wort 55834 St. John's wort tablets Homeopathic Remedy/Herbal Remedy 
St. John's wort 56623 Lamberts St. John's wort tablets (Lamberts Healthcare 
Ltd) 
Homeopathic Remedy/Herbal Remedy 
Systemic azole 
antifungals 
29504 Fluconazole 2mg/ml Infusion Antifungal Drugs/Oropharyngeal Anti-infective 
Drugs 
Systemic azole 
antifungals 
44308 Diflucan 2mg/ml Infusion (Pfizer Ltd) Antifungal Drugs/Oropharyngeal Anti-infective 
Drugs 
Systemic azole 
antifungals 
45240 Fluconazole 150mg Capsule (Niche Generics Ltd) Antifungal Drugs/Oropharyngeal Anti-infective 
Drugs 
Systemic azole 
antifungals 
40397 Itraconazole 100mg capsules (Sandoz Ltd) Antifungal Drugs/Triazole Antifungals 
Systemic azole 
antifungals 
48264 Diflucan 150mg capsules (Waymade Healthcare Plc) Antifungal Drugs/Triazole Antifungals 
Systemic azole 
antifungals 
50091 Diflucan 50mg capsules (Lexon (UK) Ltd) Antifungal Drugs/Triazole Antifungals 
Systemic azole 
antifungals 
52720 Sporanox 100mg capsules (Necessity Supplies Ltd) Antifungal Drugs/Triazole Antifungals 
Systemic azole 
antifungals 
52768 Diflucan 150mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Antifungal Drugs/Triazole Antifungals 
Systemic azole 
antifungals 
48481 Fluconazole 150mg capsule and Clotrimazole 1% 
cream 
Antifungal Drugs/Triazole 
Antifungals/Preparations For Vaginal And 
Vulval Candidiasis 
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Medication Product 
Code 
Product Name BNF Header 
Systemic azole 
antifungals 
2721 Ketoconazole 200mg tablets Imidazole Antifungals 
Systemic azole 
antifungals 
4424 Nizoral 200mg tablets (Janssen-Cilag Ltd) Imidazole Antifungals 
Systemic azole 
antifungals 
34817 Fluconazole 50mg Capsule (Niche Generics Ltd) Oropharyngeal Anti-infective Drugs/Antifungal 
Drugs 
Systemic azole 
antifungals 
342 Fluconazole 50mg capsules Triazole Antifungals 
Systemic azole 
antifungals 
788 Diflucan 50mg capsules (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
797 Itraconazole 100mg capsules Triazole Antifungals 
Systemic azole 
antifungals 
1309 Diflucan 150mg capsules (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
1892 Fluconazole 150mg capsules Triazole Antifungals 
Systemic azole 
antifungals 
4071 Diflucan 200mg capsules (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
4229 Fluconazole 200mg capsules Triazole Antifungals 
Systemic azole 
antifungals 
5511 Fluconazole 50mg/5ml oral suspension Triazole Antifungals 
Systemic azole 
antifungals 
5857 Diflucan 50mg/5ml oral suspension (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
5904 Diflucan 200mg/5ml oral suspension (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
6505 Voriconazole 200mg tablets Triazole Antifungals 
Systemic azole 
antifungals 
11810 Fluconazole 200mg/5ml oral suspension Triazole Antifungals 
Systemic azole 
antifungals 
14261 Canesten 150mg capsules (Bayer Plc) Triazole Antifungals 
Systemic azole 
antifungals 
26389 Voriconazole 50mg tablets Triazole Antifungals 
Systemic azole 
antifungals 
32029 Itraconazole 250mg/25ml solution for infusion 
ampoules and diluent 
Triazole Antifungals 
Systemic azole 
antifungals 
33482 Voriconazole 200mg/5ml oral suspension Triazole Antifungals 
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Code 
Product Name BNF Header 
Systemic azole 
antifungals 
34303 Fluconazole 150mg capsules (Teva UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
34307 Fluconazole 50mg capsules (A A H Pharmaceuticals 
Ltd) 
Triazole Antifungals 
Systemic azole 
antifungals 
34320 Fluconazole 150mg capsules (Actavis UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
34457 Fluconazole 50mg capsules (Generics (UK) Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
34514 Fluconazole 150mg capsules (Generics (UK) Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
34763 Fluconazole 50mg capsules (Actavis UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
35635 Fluconazole 50mg/25ml solution for infusion vials Triazole Antifungals 
Systemic azole 
antifungals 
35851 Fluconazole 50mg capsules (Ranbaxy (UK) Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
36182 VFEND 40mg/ml oral suspension (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
36370 Noxafil 40mg/ml oral suspension (Merck Sharp & 
Dohme Ltd) 
Triazole Antifungals 
Systemic azole 
antifungals 
36819 VFEND 200mg tablets (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
38474 Posaconazole 40mg/ml oral suspension Triazole Antifungals 
Systemic azole 
antifungals 
39907 Voriconazole 200mg powder for solution for infusion 
vials 
Triazole Antifungals 
Systemic azole 
antifungals 
42082 VFEND 50mg tablets (Pfizer Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
42087 Fluconazole 200mg capsules (Teva UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
42897 Fluconazole 50mg capsules (Teva UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
43532 Fluconazole 200mg capsules (Actavis UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
43539 Fluconazole 50mg capsules (IVAX Pharmaceuticals 
UK Ltd) 
Triazole Antifungals 
Systemic azole 
antifungals 
43692 Fluconazole 150mg capsules (A A H Pharmaceuticals 
Ltd) 
Triazole Antifungals 
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Systemic azole 
antifungals 
46251 Diflucan 50mg/25ml solution for infusion vials (Pfizer 
Ltd) 
Triazole Antifungals 
Systemic azole 
antifungals 
46923 Fluconazole 50mg capsules (Sandoz Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
47846 Fluconazole 200mg capsules (Zentiva) Triazole Antifungals 
Systemic azole 
antifungals 
49134 Sporanox 100mg capsules (Lexon (UK) Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
53277 Fluconazole 50mg capsules (Alliance Healthcare 
(Distribution) Ltd) 
Triazole Antifungals 
Systemic azole 
antifungals 
54495 Fluconazole 50mg capsules (Wockhardt UK Ltd) Triazole Antifungals 
Systemic azole 
antifungals 
680 Sporanox 100mg capsules (Janssen-Cilag Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
1830 Diflucan One 150mg capsules (McNeil Products Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
4330 Sporanox-Pulse 100mg capsules (Janssen-Cilag Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
14907 Itraconazole 50mg/5ml oral solution sugar free Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
15978 Sporanox 50mg/5ml oral solution (Janssen-Cilag Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
46676 Itraconazole 100mg capsules (Generics (UK) Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
49101 Diflucan 150mg capsules (Necessity Supplies Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic azole 
antifungals 
49138 Diflucan 150mg capsules (Lexon (UK) Ltd) Triazole Antifungals/Antifungal Drugs 
Systemic corticosteroids 51753 Prednisolone 1mg tablets (Co-Pharma Ltd) Antileprotic Drugs/Corticosteroids (in Chronic 
Bowel Disorders)/Glucocorticoid 
Therapy/Systemic Corticosteroids (in 
Musculoskeletal And Joint Conditions)/Drugs 
For Pneumocystis Pneumonia/Corticosteroids 
(for Respiratory Conditions)/Corticosteroids And 
Other Immunosuppressants 
Systemic corticosteroids 578 Prednisolone 1mg tablets Antileprotic Drugs/Corticosteroids And Other 
Immunosuppressants/Drugs For Pneumocystis 
Pneumonia/Glucocorticoid Therapy/Systemic 
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Code 
Product Name BNF Header 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 54434 Prednisolone 2.5mg/5ml oral suspension Antileprotic Drugs/Corticosteroids And Other 
Immunosuppressants/Drugs For Pneumocystis 
Pneumonia/Systemic Corticosteroids (in 
Musculoskeletal And Joint Conditions)/Drugs 
Which Enhance Neuromuscular 
Transmission/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders)/Glucocorticoid Therapy 
Systemic corticosteroids 55024 Prednisolone 5mg/5ml oral solution Antileprotic Drugs/Glucocorticoid 
Therapy/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids And Other 
Immunosuppressants/Drugs Which Enhance 
Neuromuscular Transmission/Drugs For 
Pneumocystis Pneumonia/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions) 
Systemic corticosteroids 55480 Prednisolone 2.5mg gastro-resistant tablets (Alliance 
Pharmaceuticals Ltd) 
Antileprotic Drugs/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Glucocorticoid 
Therapy/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders)/Drugs For Pneumocystis 
Pneumonia/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 32835 Prednisolone 5mg tablets (Wockhardt UK Ltd) Antileprotic Drugs/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Glucocorticoid Therapy/Drugs For 
Pneumocystis Pneumonia/Corticosteroids (for 
Respiratory Conditions)/Corticosteroids (in 
Chronic Bowel Disorders)/Corticosteroids And 
Other Immunosuppressants 
Systemic corticosteroids 21417 Prednisolone 5mg tablets (A A H Pharmaceuticals 
Ltd) 
Corticosteroids (for Respiratory 
Conditions)/Drugs For Pneumocystis 
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Code 
Product Name BNF Header 
Pneumonia/Corticosteroids And Other 
Immunosuppressants/Systemic Corticosteroids 
(in Musculoskeletal And Joint 
Conditions)/Antileprotic Drugs/Corticosteroids 
(in Chronic Bowel Disorders)/Glucocorticoid 
Therapy 
Systemic corticosteroids 34452 Prednisolone 1mg tablets (A A H Pharmaceuticals 
Ltd) 
Corticosteroids (for Respiratory 
Conditions)/Systemic Corticosteroids (in 
Musculoskeletal And Joint Conditions)/Drugs 
For Pneumocystis Pneumonia/Glucocorticoid 
Therapy/Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids And Other 
Immunosuppressants/Antileprotic Drugs 
Systemic corticosteroids 1380 Entocort CR 3mg capsules (AstraZeneca UK Ltd) Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 3898 Budesonide 3mg gastro-resistant modified-release 
capsules 
Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 6095 Budesonide 3mg gastro-resistant capsules Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 16525 Budenofalk 3mg gastro-resistant capsules (Dr. Falk 
Pharma UK Ltd) 
Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 37203 Beclometasone 5mg gastro-resistant modified-release 
tablets 
Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 39067 Clipper 5mg gastro-resistant modified-release tablets 
(Chiesi Ltd) 
Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 51997 Budesonide 9mg gastro-resistant granules sachets Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 56144 Budenofalk 9mg gastro-resistant granules sachets 
(Dr. Falk Pharma UK Ltd) 
Corticosteroids (in Chronic Bowel Disorders) 
Systemic corticosteroids 34660 Prednisolone 1mg tablets (Kent Pharmaceuticals Ltd) Corticosteroids (in Chronic Bowel 
Disorders)/Antileprotic Drugs/Corticosteroids 
And Other 
Immunosuppressants/Corticosteroids (for 
Respiratory Conditions)/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Drugs For Pneumocystis 
Pneumonia/Glucocorticoid Therapy 
Systemic corticosteroids 5913 Deltacortril 2.5mg gastro-resistant tablets (Alliance 
Pharmaceuticals Ltd) 
Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids And Other 
Immunosuppressants/Glucocorticoid 
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Code 
Product Name BNF Header 
Therapy/Drugs For Pneumocystis 
Pneumonia/Antileprotic Drugs/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions) 
Systemic corticosteroids 2704 Prednisolone 25mg tablets Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids (for Respiratory 
Conditions)/Glucocorticoid Therapy/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 53336 Prednisolone 25mg tablets (A A H Pharmaceuticals 
Ltd) 
Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids And Other 
Immunosuppressants/Corticosteroids (for 
Respiratory Conditions)/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Glucocorticoid Therapy 
Systemic corticosteroids 53313 Prednisolone 20mg/5ml oral suspension Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids And Other 
Immunosuppressants/Systemic Corticosteroids 
(in Musculoskeletal And Joint 
Conditions)/Antileprotic Drugs/Drugs Which 
Enhance Neuromuscular 
Transmission/Glucocorticoid Therapy/Drugs For 
Pneumocystis Pneumonia/Corticosteroids (for 
Respiratory Conditions) 
Systemic corticosteroids 56891 Prednisolone 1mg tablets (Waymade Healthcare Plc) Corticosteroids (in Chronic Bowel 
Disorders)/Drugs For Pneumocystis 
Pneumonia/Corticosteroids And Other 
Immunosuppressants/Antileprotic 
Drugs/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Glucocorticoid 
Therapy/Corticosteroids (for Respiratory 
Conditions) 
Systemic corticosteroids 95 Prednisolone 5mg tablets Corticosteroids (in Chronic Bowel 
Disorders)/Drugs For Pneumocystis 
Pneumonia/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
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Conditions)/Antileprotic Drugs/Glucocorticoid 
Therapy/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 3345 Sintisone Tablet (Pharmacia Ltd) Corticosteroids (in Chronic Bowel 
Disorders)/Glucocorticoid Therapy 
Systemic corticosteroids 21833 Decortisyl 5mg Tablet (Roussel Laboratories Ltd) Corticosteroids (in Chronic Bowel 
Disorders)/Glucocorticoid Therapy 
Systemic corticosteroids 31327 Prednisolone steaglate 6.65mg tablet Corticosteroids (in Chronic Bowel 
Disorders)/Glucocorticoid Therapy 
Systemic corticosteroids 43544 Prednisone 5mg Tablet (Knoll Ltd) Corticosteroids (in Chronic Bowel 
Disorders)/Glucocorticoid Therapy 
Systemic corticosteroids 41745 Prednisolone 25mg tablets (Zentiva) Corticosteroids (in Chronic Bowel 
Disorders)/Glucocorticoid 
Therapy/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids And Other 
Immunosuppressants/Systemic Corticosteroids 
(in Musculoskeletal And Joint Conditions) 
Systemic corticosteroids 2839 Tacrolimus 1mg capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 3683 Prograf 1mg capsules (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 5089 Tacrolimus 5mg capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 5870 Prograf 500microgram capsules (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 6484 Sirolimus 2mg tablets Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 6495 Tacrolimus 500microgram capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 6600 Sirolimus 1mg tablets Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 13271 Prograf 5mg capsules (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 20097 Sirolimus 1mg/ml oral solution sugar free Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 23289 Rapamune 1mg tablets (Pfizer Ltd) Corticosteroids And Other 
Immunosuppressants 
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Medication Product 
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Product Name BNF Header 
Systemic corticosteroids 28999 Rapamune 2mg tablets (Pfizer Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 32614 Simulect 20mg powder and solvent for solution for 
injection vials (Novartis Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 33123 Tacrolimus 5mg/1ml solution for infusion ampoules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 33728 Rapamune 1mg/ml oral solution (Pfizer Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 37155 Tacrolimus 1mg/ml suspension Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 37506 Advagraf 1mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 37915 Basiliximab 10mg powder and solvent for solution for 
injection vials 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 37985 Tacrolimus 1mg modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 38056 Ciclosporin 50mg/1ml solution for infusion ampoules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 38113 Tacrolimus 500microgram modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 38919 Advagraf 5mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 38989 Tacrolimus 5mg modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 39633 Advagraf 0.5mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 40632 Basiliximab 20mg powder and solvent for solution for 
injection vials 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 40765 Advagraf 3mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 40964 Tacrolimus 3mg modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 42696 Thymoglobuline 25mg powder and solvent for solution 
for infusion vials (Sanofi) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 42924 Ciclosporin 250mg/5ml solution for infusion ampoules Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 43081 Tacrolimus 1mg granules sachets sugar free Corticosteroids And Other 
Immunosuppressants 
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Medication Product 
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Product Name BNF Header 
Systemic corticosteroids 43082 Tacrolimus 200microgram granules sachets sugar 
free 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 44640 Adoport 0.5mg capsules (Sandoz Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 44641 Adoport 5mg capsules (Sandoz Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 44783 Sirolimus 500microgram tablets Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 44804 Adoport 1mg capsules (Sandoz Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 44926 Tacrolimus 2.5mg/5ml oral suspension Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 46324 Modigraf 0.2mg granules sachets (Astellas Pharma 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 46325 Modigraf 1mg granules sachets (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47239 Vivadex 1mg capsules (Dexcel-Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47240 Vivadex 0.5mg capsules (Dexcel-Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47276 Tacni 1mg capsules (Teva UK Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47416 Tacni 0.5mg capsules (Teva UK Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47432 Tacrolimus 5mg/5ml oral suspension Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47506 Tacni 5mg capsules (Teva UK Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47512 Capexion 1mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47852 Capexion 0.5mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47984 Capexion 5mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 48339 Tacrolimus 1mg capsules (A A H Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 51184 Prograf 1mg capsules (Necessity Supplies Ltd) Corticosteroids And Other 
Immunosuppressants 
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Systemic corticosteroids 51185 Prograf 500microgram capsules (Necessity Supplies 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 51790 Tacrolimus 500microgram capsules (A A H 
Pharmaceuticals Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 52993 Prograf 1mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 54048 Tacrolimus 500micrograms/5ml oral suspension Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 54198 Prograf 1mg capsules (Lexon (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 55010 Vivadex 5mg capsules (Dexcel-Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 55066 Tacrolimus 2.5mg/5ml oral solution Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 19370 Ciclosporin 50mg/ml concentrate solution infusion Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 26790 Sandimmun 50mg/ml Concentrate for solution for 
infusion (Novartis Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 47377 Ciclosporin 25mg Capsule (Hillcross Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 972 Neoral 25mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 1626 Ciclosporin 100mg/ml oral solution sugar free Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 2837 Ciclosporin 50mg capsules Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
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Medication Product 
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Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 13494 Sandimmun 100mg/ml oral solution (Novartis 
Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 13556 Sandimmun 100mg capsules (Novartis 
Pharmaceuticals UK Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 16035 Ciclosporin 10mg capsules Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 47102 Capimune 50mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 52615 Neoral 100mg capsules (Sigma Pharmaceuticals Plc) Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 54134 Ciclosporin 100mg capsules (Sigma Pharmaceuticals 
Plc) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Drugs Affecting The Immune 
Response In Rheumatic Disease 
Systemic corticosteroids 16137 Neoral 10mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
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Systemic corticosteroids 46395 Capimune 100mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Systemic corticosteroids 48798 Ciclosporin 50mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Systemic corticosteroids 54975 Ciclosporin 100mg capsules (Cubic Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Systemic corticosteroids 55116 Ciclosporin 25mg capsules (Cubic Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Drugs Affecting The Immune 
Response For Eczema And Psoriasis 
Systemic corticosteroids 34781 Prednisolone 5mg tablets (Kent Pharmaceuticals Ltd) Corticosteroids And Other 
Immunosuppressants/Drugs For Pneumocystis 
Pneumonia/Antileprotic Drugs/Glucocorticoid 
Therapy/Corticosteroids (for Respiratory 
Conditions)/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 19141 Prednisolone 5mg soluble tablets (Amdipharm Plc) Corticosteroids And Other 
Immunosuppressants/Glucocorticoid 
Therapy/Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids (for Respiratory 
Conditions)/Drugs For Pneumocystis 
Pneumonia/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Antileprotic Drugs 
Systemic corticosteroids 47042 Ciclosporin 100mg Capsule (Hillcross 
Pharmaceuticals Ltd) 
Drugs Affecting The Immune Response (in 
Chronic Bowel Disorders)/Corticosteroids And 
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Other Immunosuppressants 
Systemic corticosteroids 1905 Neoral 100mg/ml oral solution (Novartis 
Pharmaceuticals UK Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 2838 Ciclosporin 25mg capsules Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 15596 Sandimmun 50mg capsules (Novartis 
Pharmaceuticals UK Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 42637 Deximune 25mg capsules (Dexcel-Pharma Ltd) Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 48763 Ciclosporin 25mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 49958 Neoral 25mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 53175 Neoral 25mg capsules (Mawdsley-Brooks & Company 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 53176 Neoral 50mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 54867 Ciclosporin 50mg capsules (Sigma Pharmaceuticals 
Plc) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 54974 Ciclosporin 50mg capsules (Cubic Pharmaceuticals Drugs Affecting The Immune Response For 
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Ltd) Eczema And Psoriasis/Corticosteroids And 
Other Immunosuppressants/Drugs Affecting 
The Immune Response In Rheumatic Disease 
Systemic corticosteroids 3920 Sandimmun 25mg capsules (Novartis 
Pharmaceuticals UK Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 46637 Capimune 25mg capsules (Generics (UK) Ltd) Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 52743 Ciclosporin 25mg capsules (Sigma Pharmaceuticals 
Plc) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs Affecting The 
Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 47192 Capsorin 100mg capsules (Morningside Healthcare 
Ltd) 
Drugs Affecting The Immune Response For 
Eczema And Psoriasis/Drugs That Suppress 
The Rheumatic Disease 
Process/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response In Rheumatic Disease 
Systemic corticosteroids 3896 Ciclosporin 100mg capsules Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And Psoriasis 
Systemic corticosteroids 4231 Neoral 50mg capsules (Novartis Pharmaceuticals UK 
Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And Psoriasis 
Systemic corticosteroids 48556 Ciclosporin 100mg capsules (Phoenix Healthcare 
Distribution Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
Immunosuppressants/Drugs Affecting The 
Immune Response For Eczema And Psoriasis 
Systemic corticosteroids 47047 Capsorin 50mg capsules (Morningside Healthcare 
Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Corticosteroids And Other 
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Product Name BNF Header 
Immunosuppressants/Drugs That Suppress 
The Rheumatic Disease Process/Drugs 
Affecting The Immune Response For Eczema 
And Psoriasis 
Systemic corticosteroids 973 Neoral 100mg capsules (Novartis Pharmaceuticals 
UK Ltd) 
Drugs Affecting The Immune Response In 
Rheumatic Disease/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 42448 Deximune 50mg capsules (Dexcel-Pharma Ltd) Drugs Affecting The Immune Response In 
Rheumatic Disease/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 42449 Deximune 100mg capsules (Dexcel-Pharma Ltd) Drugs Affecting The Immune Response In 
Rheumatic Disease/Drugs Affecting The 
Immune Response For Eczema And 
Psoriasis/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 32803 Prednisolone 5mg gastro-resistant tablets (Actavis UK 
Ltd) 
Drugs For Pneumocystis 
Pneumonia/Antileprotic Drugs/Glucocorticoid 
Therapy/Corticosteroids And Other 
Immunosuppressants/Corticosteroids (for 
Respiratory Conditions)/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 34748 Prednisolone 1mg tablets (Teva UK Ltd) Drugs For Pneumocystis 
Pneumonia/Antileprotic Drugs/Glucocorticoid 
Therapy/Corticosteroids And Other 
Immunosuppressants/Corticosteroids (in 
Chronic Bowel Disorders)/Corticosteroids (for 
Respiratory Conditions)/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions) 
Systemic corticosteroids 34978 Prednisolone 1mg tablets (Wockhardt UK Ltd) Drugs For Pneumocystis 
Pneumonia/Corticosteroids (for Respiratory 
Conditions)/Antileprotic Drugs/Glucocorticoid 
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Therapy/Corticosteroids And Other 
Immunosuppressants/Corticosteroids (in 
Chronic Bowel Disorders)/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions) 
Systemic corticosteroids 34404 Prednisolone 1mg tablets (Actavis UK Ltd) Drugs For Pneumocystis 
Pneumonia/Corticosteroids (in Chronic Bowel 
Disorders)/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Corticosteroids And Other 
Immunosuppressants/Antileprotic 
Drugs/Corticosteroids (for Respiratory 
Conditions)/Glucocorticoid Therapy 
Systemic corticosteroids 47471 Capsorin 25mg capsules (Morningside Healthcare 
Ltd) 
Drugs That Suppress The Rheumatic Disease 
Process/Drugs Affecting The Immune 
Response For Eczema And Psoriasis/Drugs 
Affecting The Immune Response In Rheumatic 
Disease/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 54118 Prednisolone 25mg/5ml oral suspension Drugs Which Enhance Neuromuscular 
Transmission/Corticosteroids And Other 
Immunosuppressants/Glucocorticoid 
Therapy/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders)/Antileprotic Drugs/Corticosteroids 
(for Respiratory Conditions)/Drugs For 
Pneumocystis Pneumonia 
Systemic corticosteroids 41515 Prednisolone 5mg tablets (Teva UK Ltd) Glucocorticoid Therapy/Antileprotic 
Drugs/Corticosteroids (in Chronic Bowel 
Disorders)/Drugs For Pneumocystis 
Pneumonia/Systemic Corticosteroids (in 
Musculoskeletal And Joint 
Conditions)/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 44 Prednisolone 5mg gastro-resistant tablets Glucocorticoid Therapy/Corticosteroids (in 
Chronic Bowel Disorders)/Systemic 
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Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Drugs For Pneumocystis 
Pneumonia/Corticosteroids And Other 
Immunosuppressants/Antileprotic 
Drugs/Corticosteroids (for Respiratory 
Conditions) 
Systemic corticosteroids 20577 Calcort 6mg Tablet (Shire Pharmaceuticals Ltd) Glucocorticoid Therapy/Corticosteroids And 
Other Immunosuppressants 
Systemic corticosteroids 5490 Deltacortril 5mg gastro-resistant tablets (Alliance 
Pharmaceuticals Ltd) 
Glucocorticoid Therapy/Corticosteroids And 
Other Immunosuppressants/Corticosteroids (for 
Respiratory Conditions)/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Corticosteroids (in Chronic Bowel 
Disorders)/Antileprotic Drugs/Drugs For 
Pneumocystis Pneumonia 
Systemic corticosteroids 34393 Prednisolone 5mg gastro-resistant tablets (Teva UK 
Ltd) 
Glucocorticoid Therapy/Drugs For 
Pneumocystis Pneumonia/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Corticosteroids (for Respiratory 
Conditions)/Corticosteroids And Other 
Immunosuppressants/Corticosteroids (in 
Chronic Bowel Disorders)/Antileprotic Drugs 
Systemic corticosteroids 768 Kenalog 40mg/ml Injection (E R Squibb and Sons Ltd) Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 4125 Triamcinolone acetonide 80mg/2ml intramuscular 
injection 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 11334 Dexamethasone sodium phosphate iv 4mg/ml 
injection 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 18266 Methylprednisolone sodium succinate 125mg powder 
and solvent for solution for injection vials 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 21540 Solu-Medrone 500mg powder and solvent for solution 
for injection vials (Pfizer Ltd) 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 24224 Codelsol 16mg/ml Injection (MSD Thomas Morson 
Pharmaceuticals) 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 25839 Solu-Medrone 1g powder and solvent for solution for 
injection vials (Pfizer Ltd) 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 26454 Decadron 4mg/ml Injection (MSD Thomas Morson 
Pharmaceuticals) 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
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Systemic corticosteroids 35688 Methylprednisolone acetate 120mg/3ml suspension 
for injection vials 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 37737 Kenalog 40mg/ml Injection (E R Squibb and Sons Ltd) Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 56940 Dexamethasone 6.6mg/2ml solution for injection 
ampoules 
Glucocorticoid Therapy/Local Corticosteroid 
Injections 
Systemic corticosteroids 2615 Efcortesol 100mg/ml Injection (Sovereign Medical Ltd) Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 3651 Solu-cortef 100mg/vial Injection (Pharmacia Ltd) Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 10574 Cortisone acetate 5mg tablets Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 12400 Cortisyl 25mg Tablet (Aventis Pharma) Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 18637 Cortistab 25mg Tablet (Waymade Healthcare Plc) Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 23210 Cortistab 5mg Tablet (Waymade Healthcare Plc) Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 38054 Hydrocortisone Tablet Glucocorticoid Therapy/Replacement 
Corticosteroids For Endocrine Conditions 
Systemic corticosteroids 28375 Prednisolone 2.5mg gastro-resistant tablets (A A H 
Pharmaceuticals Ltd) 
Glucocorticoid Therapy/Systemic 
Corticosteroids (in Musculoskeletal And Joint 
Conditions)/Corticosteroids (for Respiratory 
Conditions)/Drugs For Pneumocystis 
Pneumonia/Corticosteroids And Other 
Immunosuppressants/Antileprotic 
Drugs/Corticosteroids (in Chronic Bowel 
Disorders) 
Systemic corticosteroids 15717 Betamethasone 4mg/1ml solution for injection 
ampoules 
Local Corticosteroid Injections 
Systemic corticosteroids 22577 Betnesol 4mg/1ml solution for injection ampoules 
(Focus Pharmaceuticals Ltd) 
Local Corticosteroid Injections 
Systemic corticosteroids 3703 Kenalog 80mg/2ml Intramuscular injection (E R 
Squibb and Sons Ltd) 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 12405 Methylprednisolone sodium succinate 2g powder and 
solvent for solution for injection vials 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 13397 Methylprednisolone sodium succinate 1g powder and 
solvent for solution for injection vials 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
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Systemic corticosteroids 13952 Decadron 4mg/ml Injection (MSD Thomas Morson 
Pharmaceuticals) 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 14188 Methylprednisolone sodium succinate 500mg powder 
and solvent for solution for injection vials 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 14906 Dexamethasone 4mg/1ml solution for injection 
ampoules 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 18765 Methylprednisolone sodium succinate 40mg powder 
and solvent for solution for injection vials 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 23511 Solu-Medrone 40mg powder and solvent for solution 
for injection vials (Pfizer Ltd) 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 25226 Solu-Medrone 125mg powder and solvent for solution 
for injection vials (Pfizer Ltd) 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 35040 Depo-Medrone 120mg/3ml suspension for injection 
vials (Pfizer Ltd) 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 35453 Dexamethasone 3.3mg/1ml solution for injection 
ampoules 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 37500 Dexamethasone 6.6mg/2ml solution for injection vials Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 53173 Dexamethasone 4mg/1ml solution for injection 
ampoules (Merck Sharp & Dohme Ltd) 
Local Corticosteroid Injections/Glucocorticoid 
Therapy 
Systemic corticosteroids 2434 Florinef 100microgram tablets (Bristol-Myers Squibb 
Pharmaceuticals Ltd) 
Replacement Corticosteroids For Endocrine 
Conditions 
Systemic corticosteroids 2439 Fludrocortisone 100microgram tablets Replacement Corticosteroids For Endocrine 
Conditions 
Systemic corticosteroids 37622 Fludrocortisone Capsule Replacement Corticosteroids For Endocrine 
Conditions 
Systemic corticosteroids 37870 Fludrocortisone Liquid Replacement Corticosteroids For Endocrine 
Conditions 
Systemic corticosteroids 52472 Fludrocortisone 50micrograms/5ml oral suspension Replacement Corticosteroids For Endocrine 
Conditions 
Systemic corticosteroids 3754 Hydrocortisone na succinate 100mg/vial Injection Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 9574 Hydrocortisone na phosphate 100mg/ml Injection Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 10754 Hydrocortistab 20mg Tablet (Waymade Healthcare 
Plc) 
Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 12398 Cortelan 25mg Tablet (Glaxo Laboratories Ltd) Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
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Medication Product 
Code 
Product Name BNF Header 
Systemic corticosteroids 13350 Hydrocortisone na succinate 500mg/vial Injection Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 14076 Hydrocortisone 5mg/5ml Oral solution Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 34166 Efcortelan soluble 50mg/ml Injection (Glaxo 
Laboratories Ltd) 
Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 53705 Cortisone acetate 5mg Capsule (Martindale 
Pharmaceuticals Ltd) 
Replacement Corticosteroids For Endocrine 
Conditions/Glucocorticoid Therapy 
Systemic corticosteroids 955 Prednisolone 5mg soluble tablets Systemic Corticosteroids (in Musculoskeletal 
And Joint Conditions)/Antileprotic 
Drugs/Corticosteroids (in Chronic Bowel 
Disorders)/Corticosteroids (for Respiratory 
Conditions)/Glucocorticoid 
Therapy/Corticosteroids And Other 
Immunosuppressants/Drugs For Pneumocystis 
Pneumonia 
Systemic corticosteroids 29333 Prednisolone 5mg tablets (Actavis UK Ltd) Systemic Corticosteroids (in Musculoskeletal 
And Joint Conditions)/Antileprotic Drugs/Drugs 
For Pneumocystis Pneumonia/Corticosteroids 
(in Chronic Bowel Disorders)/Corticosteroids 
And Other 
Immunosuppressants/Corticosteroids (for 
Respiratory Conditions)/Glucocorticoid Therapy 
Systemic corticosteroids 31532 Prednisolone 5mg gastro-resistant tablets (A A H 
Pharmaceuticals Ltd) 
Systemic Corticosteroids (in Musculoskeletal 
And Joint Conditions)/Corticosteroids (in 
Chronic Bowel Disorders)/Antileprotic 
Drugs/Corticosteroids (for Respiratory 
Conditions)/Drugs For Pneumocystis 
Pneumonia/Glucocorticoid 
Therapy/Corticosteroids And Other 
Immunosuppressants 
Systemic corticosteroids 557 Prednisolone 2.5mg gastro-resistant tablets Systemic Corticosteroids (in Musculoskeletal 
And Joint Conditions)/Glucocorticoid 
Therapy/Antileprotic Drugs/Corticosteroids (for 
Respiratory Conditions)/Drugs For 
Pneumocystis Pneumonia/Corticosteroids (in 
Chronic Bowel Disorders)/Corticosteroids And 
Other Immunosuppressants 
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Medication Product 
Code 
Product Name BNF Header 
Systemic corticosteroids 34461 Prednisolone 2.5mg gastro-resistant tablets (Actavis 
UK Ltd) 
Systemic Corticosteroids (in Musculoskeletal 
And Joint Conditions)/Glucocorticoid 
Therapy/Antileprotic Drugs/Corticosteroids (for 
Respiratory Conditions)/Drugs For 
Pneumocystis Pneumonia/Corticosteroids And 
Other Immunosuppressants/Corticosteroids (in 
Chronic Bowel Disorders) 
Systemic tacrolimus 2839 Tacrolimus 1mg capsules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 3683 Prograf 1mg capsules (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 5089 Tacrolimus 5mg capsules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 5870 Prograf 500microgram capsules (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 6495 Tacrolimus 500microgram capsules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 13271 Prograf 5mg capsules (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 33123 Tacrolimus 5mg/1ml solution for infusion ampoules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 37155 Tacrolimus 1mg/ml suspension Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 37506 Advagraf 1mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 37985 Tacrolimus 1mg modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 38113 Tacrolimus 500microgram modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 38919 Advagraf 5mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 38989 Tacrolimus 5mg modified-release capsules Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 39633 Advagraf 0.5mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 40765 Advagraf 3mg modified-release capsules (Astellas 
Pharma Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 40964 Tacrolimus 3mg modified-release capsules Corticosteroids And Other 
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Medication Product 
Code 
Product Name BNF Header 
Immunosuppressants 
Systemic tacrolimus 43081 Tacrolimus 1mg granules sachets sugar free Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 43082 Tacrolimus 200microgram granules sachets sugar 
free 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 44640 Adoport 0.5mg capsules (Sandoz Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 44641 Adoport 5mg capsules (Sandoz Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 44804 Adoport 1mg capsules (Sandoz Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 44926 Tacrolimus 2.5mg/5ml oral suspension Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 46324 Modigraf 0.2mg granules sachets (Astellas Pharma 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 46325 Modigraf 1mg granules sachets (Astellas Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47239 Vivadex 1mg capsules (Dexcel-Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47240 Vivadex 0.5mg capsules (Dexcel-Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47276 Tacni 1mg capsules (Teva UK Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47416 Tacni 0.5mg capsules (Teva UK Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47432 Tacrolimus 5mg/5ml oral suspension Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47506 Tacni 5mg capsules (Teva UK Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47512 Capexion 1mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47852 Capexion 0.5mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 47984 Capexion 5mg capsules (Generics (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 48339 Tacrolimus 1mg capsules (A A H Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 51184 Prograf 1mg capsules (Necessity Supplies Ltd) Corticosteroids And Other 
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Medication Product 
Code 
Product Name BNF Header 
Immunosuppressants 
Systemic tacrolimus 51185 Prograf 500microgram capsules (Necessity Supplies 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 51790 Tacrolimus 500microgram capsules (A A H 
Pharmaceuticals Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 52993 Prograf 1mg capsules (Doncaster Pharmaceuticals 
Ltd) 
Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 54048 Tacrolimus 500micrograms/5ml oral suspension Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 54198 Prograf 1mg capsules (Lexon (UK) Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 55010 Vivadex 5mg capsules (Dexcel-Pharma Ltd) Corticosteroids And Other 
Immunosuppressants 
Systemic tacrolimus 55066 Tacrolimus 2.5mg/5ml oral solution Corticosteroids And Other 
Immunosuppressants 
Warfarin (VKA) 45 Warfarin 1mg tablets  
Warfarin (VKA) 61 Warfarin 3mg tablets  
Warfarin (VKA) 833 Warfarin 3mg/5ml oral solution  
Warfarin (VKA) 1781 Warfarin 5mg tablets  
Warfarin (VKA) 4446 Acenocoumarol 1mg tablets  
Warfarin (VKA) 5305 Sinthrome 1mg tablets (Alliance Pharmaceuticals Ltd)  
Warfarin (VKA) 6262 Warfarin 500microgram tablets  
Warfarin (VKA) 8466 Marevan 1mg tablets (Mercury Pharma Group Ltd)  
Warfarin (VKA) 8467 Marevan 3mg tablets (Mercury Pharma Group Ltd)  
Warfarin (VKA) 13348 Marevan 5mg tablets (Mercury Pharma Group Ltd)  
Warfarin (VKA) 13501 Dindevan 50mg Tablet (Goldshield Pharmaceuticals 
Ltd) 
 
Warfarin (VKA) 13502 Dindevan 10mg Tablet (Goldshield Pharmaceuticals 
Ltd) 
 
Warfarin (VKA) 13503 Phenindione 50mg tablets  
Warfarin (VKA) 13504 Phenindione 25mg tablets  
Warfarin (VKA) 13505 Phenindione 10mg tablets  
Warfarin (VKA) 13644 Dindevan 25mg Tablet (Goldshield Pharmaceuticals 
Ltd) 
 
Warfarin (VKA) 15006 Sinthrome 4mg Tablet (Alliance Pharmaceuticals Ltd)  
Warfarin (VKA) 15376 Acenocoumarol 4mg tablets  
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Medication Product 
Code 
Product Name BNF Header 
Warfarin (VKA) 17965 Marevan 500microgram tablets (Mercury Pharma 
Group Ltd) 
 
Warfarin (VKA) 23078 Warfarin 1mg Tablet (WB Pharmaceuticals Ltd)  
Warfarin (VKA) 30202 Warfarin wbp 1mg Tablet (Boehringer Ingelheim Ltd)  
Warfarin (VKA) 30203 Warfarin wbp 3mg Tablet (Boehringer Ingelheim Ltd)  
Warfarin (VKA) 31511 Warfarin 3mg Tablet (WB Pharmaceuticals Ltd)  
Warfarin (VKA) 31937 Warfarin 5mg tablets (Teva UK Ltd)  
Warfarin (VKA) 33711 Warfarin 5mg Tablet (WB Pharmaceuticals Ltd)  
Warfarin (VKA) 34019 Warfarin 1mg tablets (IVAX Pharmaceuticals UK Ltd)  
Warfarin (VKA) 34086 Warfarin 3mg Tablet (Celltech Pharma Europe Ltd)  
Warfarin (VKA) 34087 Warfarin 1mg Tablet (Celltech Pharma Europe Ltd)  
Warfarin (VKA) 34088 Warfarin 5mg Tablet (Celltech Pharma Europe Ltd)  
Warfarin (VKA) 34095 Warfarin wbp 5mg Tablet (Boehringer Ingelheim Ltd)  
Warfarin (VKA) 34299 Warfarin 1mg tablets (Teva UK Ltd)  
Warfarin (VKA) 34416 Warfarin 1mg tablets (Kent Pharmaceuticals Ltd)  
Warfarin (VKA) 34417 Warfarin 3mg tablets (Teva UK Ltd)  
Warfarin (VKA) 34418 Warfarin 5mg tablets (Generics (UK) Ltd)  
Warfarin (VKA) 34517 Warfarin 1mg tablets (Generics (UK) Ltd)  
Warfarin (VKA) 34526 Warfarin 3mg tablets (Generics (UK) Ltd)  
Warfarin (VKA) 34576 Warfarin 1mg Tablet (Lagap)  
Warfarin (VKA) 34691 Warfarin 5mg Tablet (Regent Laboratories Ltd)  
Warfarin (VKA) 34758 Warfarin 3mg tablets (IVAX Pharmaceuticals UK Ltd)  
Warfarin (VKA) 34864 Warfarin 5mg tablets (IVAX Pharmaceuticals UK Ltd)  
Warfarin (VKA) 34918 Warfarin 5mg tablets (Actavis UK Ltd)  
Warfarin (VKA) 36099 Warfarin 1mg/5ml oral suspension  
Warfarin (VKA) 38041 Warfarin sodium 5mg/ml oral suspension  
Warfarin (VKA) 38044 Warfarin 5mg/5ml oral solution  
Warfarin (VKA) 39866 Warfarin 1mg tablets (Almus Pharmaceuticals Ltd)  
Warfarin (VKA) 40143 Warfarin 500microgram tablets (A A H 
Pharmaceuticals Ltd) 
 
Warfarin (VKA) 43407 Warfarin 3mg tablets (A A H Pharmaceuticals Ltd)  
Warfarin (VKA) 43408 Warfarin 1mg tablets (A A H Pharmaceuticals Ltd)  
Warfarin (VKA) 43409 Warfarin 5mg tablets (A A H Pharmaceuticals Ltd)  
Warfarin (VKA) 43655 Warfarin sodium oral solution  
Warfarin (VKA) 44866 Warfarin sodium 1mg/ml oral supension SF  
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Code 
Product Name BNF Header 
Warfarin (VKA) 46924 Phenindione 10mg tablets (Mercury Pharma Group 
Ltd) 
 
Warfarin (VKA) 47944 Warfarin 1mg tablets (Actavis UK Ltd)  
Warfarin (VKA) 48070 Warfarin sodium tablets  
Warfarin (VKA) 48869 Warfarin 1mg/ml oral suspension sugar free  
Warfarin (VKA) 50000 Warfarin 1mg/ml oral suspension sugar free (A A H 
Pharmaceuticals Ltd) 
 
Warfarin (VKA) 51484 Warfarin 1mg tablets (Bristol Laboratories Ltd)  
Warfarin (VKA) 51496 Warfarin 1mg tablets (Phoenix Healthcare Distribution 
Ltd) 
 
Warfarin (VKA) 51509 Warfarin 1mg tablets (APC Pharmaceuticals & 
Chemicals (Europe) Ltd) 
 
Warfarin (VKA) 53745 Warfarin 3mg tablets (Bristol Laboratories Ltd)  
Warfarin (VKA) 53752 Warfarin 1mg tablets (Alliance Healthcare 
(Distribution) Ltd) 
 
Warfarin (VKA) 54892 Warfarin 1mg/ml oral suspension sugar free (Alliance 
Healthcare (Distribution) Ltd) 
 
Warfarin (VKA) 54946 Warfarin 3mg tablets (Actavis UK Ltd)  
Warfarin (VKA) 55316 Warfarin 3mg/5ml oral suspension  
Warfarin (VKA) 55577 Sinthrome 1mg tablets (Lexon (UK) Ltd)  
Warfarin (VKA) 56314 Warfarin 3mg tablets (Kent Pharmaceuticals Ltd)  
Warfarin (VKA) 57032 Warfarin 1mg/ml oral suspension sugar free 
(Rosemont Pharmaceuticals Ltd) 
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APPENDIX C: SUPPLEMENTAL MATERIAL FOR CHAPTER 3 
Supplemental Table 1. Kaplan-Meier estimate of the cumulative incidence of OAC initiation by CHA2DS2-VASc score 
 CHA2DS2-VASc Score 
 0 
(N=980) 
1 
(N=2,132) 
≥2 
(N=19,906) 
    
Kaplan-Meier Estimate (95% CI) of the 
Cumulative Incidence of OAC Initiation by: 
           
    30 days 18.8% 21.3% 30.3% 
 (16.4% to 21.3%) (19.6% to 23.1%) (29.6% to 30.9%) 
    60 days 24.9% 28.9% 40.3% 
 (22.3% to 27.7%) (27.1% to 30.9%) (39.6% to 41.0%) 
    90 days 28.8% 34.1% 45.6% 
 (26.0% to 31.7%) (32.1% to 36.1%) (44.9% to 46.3%) 
   120 days 33.2% 37.8% 49.3% 
 (30.3% to 36.3%) (35.8% to 39.9%) (48.6% to 50.0%) 
   180 days 36.7% 41.9% 53.2% 
 (33.7% to 39.8%) (39.8% to 44.1%) (52.5% to 53.9%) 
   360 days 39.9% 47.2% 57.6% 
 (36.9% to 43.1%) (45.1% to 49.4%) (56.9% to 58.3%) 
OAC = oral anticoagulant; CI = confidence interval 
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Supplemental Table 2. Characteristics of patients with newly diagnosed with NVAF in the years 2013-2014 
 
 First Treatment within 90 Days of Diagnosis  
 
Characteristic 
All 
(N=6,302) 
None 
(N=3,175) 
Warfarin 
(N=2,695) 
Dabigatran 
(N=167) 
Rivaroxaban 
(N=211) 
Apixaban 
(N=54) 
p-value 
All† OAC‡ 
Year of Diagnosis        
   2013 5,107 (81.0%) 2,641 (83.2%) 2,175 (80.7%) 132 (79.0%) 131 (62.1%) 28 (51.9%)   
   2014 1,195 (19.0%) 534 (16.8%) 520 (19.3%) 35 (21.0%) 80 (37.9%) 26 (48.1%)   
Established risk factors for stroke and/or bleeding: 
Female 2,834 (45.0%) 1,473 (46.4%) 1,190 (44.2%) 59 (35.3%) 84 (39.8%) 28 (51.9%) 0.012 0.101 
Age, mean (SD), years 74.3 (12.0) 74.2 (13.5) 74.4 (10.3) 72.3 (11.7) 75.4 (10.5) 74.8 (9.9) 0.079 0.026 
Age category             <0.001 0.105 
   <65 1,177 (18.7%) 693 (21.8%) 404 (15.0%) 43 (25.7%) 30 (14.2%) 7 (13.0%)   
   65-74 1,677 (26.6%) 768 (24.2%) 783 (29.1%) 44 (26.3%) 62 (29.4%) 20 (37.0%)   
   75-84 2,208 (35.0%) 935 (29.4%) 1,119 (41.5%) 55 (32.9%) 80 (37.9%) 19 (35.2%)   
   ≥85 1,240 (19.7%) 779 (24.5%) 389 (14.4%) 25 (15.0%) 39 (18.5%) 8 (14.8%)   
Prior stroke or TIA 943 (15.0%) 398 (12.5%) 450 (16.7%) 38 (22.8%) 42 (19.9%) 15 (27.8%) <0.001 0.442 
Heart failure 904 (14.3%) 428 (13.5%) 437 (16.2%) 17 (10.2%) 19 (9.0%) 3 (5.6%) 0.001 0.596 
Hypertension 5,001 (79.4%) 2,387 (75.2%) 2,264 (84.0%) 129 (77.2%) 177 (83.9%) 44 (81.5%) <0.001 0.265 
Diabetes mellitus 1,083 (17.2%) 466 (14.7%) 537 (19.9%) 28 (16.8%) 41 (19.4%) 11 (20.4%) <0.001 0.750 
Vascular disease 2,005 (31.8%) 958 (30.2%) 923 (34.2%) 46 (27.5%) 66 (31.3%) 12 (22.2%) 0.005 0.390 
CHA2DS2-VASc, mean(SD) 3.5 (1.8) 3.4 (1.8) 3.7 (1.6) 3.3 (1.8) 3.7 (1.6) 3.7 (1.6) <0.001 0.158 
CHA2DS2-VASc, category             <0.001 <0.001 
   0 258 (4.1%) 193 (6.1%) 47 (1.7%) 12 (7.2%) 6 (2.8%) 0          
   1 581 (9.4%) 365 (11.5%) 181 (6.7%) 16 (9.6%) 15 (7.1%) 4 (7.4%)   
   ≥2 5,463 (86.7%) 2,617 (82.4%) 2,467 (91.5%) 139 (83.2%) 190 (90.0%) 50 (92.6%)   
Prior major bleed 1,196 (19.0%) 660 (20.8%) 463 (17.2%) 29 (17.4%) 37 (17.5%) 7 (13.0%) 0.007 0.714 
Abnormal kidney function 207 (3.3%) 116 (3.7%) 82 (3.0%) 3 (1.8%) 4 (1.9%) 2 (3.7%) 0.375 0.682 
Estimated GFR             <0.001 <0.001 
   <15 mL/min 21 (0.3%) 13 (0.4%) 8 (0.3%) 0        0        0          
   15-29 mL/min 99 (1.6%) 58 (1.8%) 38 (1.4%) 0        2 (0.9%) 1 (1.9%)   
   30-49 mL/min 677 (10.7%) 321 (10.1%) 319 (11.8%) 16 (9.6%) 17 (8.1%) 4 (7.4%)   
   50-80 mL/min 2,655 (42.1%) 1,230 (38.7%) 1,222 (45.3%) 79 (47.3%) 99 (46.9%) 25 (46.3%)   
   >80 mL/min 1,529 (24.3%) 789 (24.9%) 628 (23.3%) 39 (23.4%) 61 (28.9%) 12 (22.2%)   
   Missing 1,321 (21.0%) 764 (24.1%) 480 (17.8%) 33 (19.8%) 32 (15.2%) 12 (22.2%)   
† P-values for each independent variable were obtained from a multinomial logistic regression model for 5 treatment options (none and 4 OACs). 
‡ P-values for each independent variable were obtained from a multinomial logistic regression model for 4 OAC treatment options. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = glomerular filtration rate; min = minutes; NSAID 
= nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = coronary heart disease; NE = not estimable.  CHA2DS2-VASc score was calculated by 
summing the points associated with each characteristic: heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 
pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: hypertension; abnormal 
kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or antiplatelet drug use; heavy alcohol use. 
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  First Treatment within 90 Days of Diagnosis  
 
Characteristic 
All 
(N=6,302) 
None 
(N=3,175) 
Warfarin 
(N=2,695) 
Dabigatran 
(N=167) 
Rivaroxaban 
(N=211) 
Apixaban 
(N=54) 
p-value 
All† OAC‡ 
Established risk factors for stroke and/or bleeding: 
Abnormal liver function 30 (0.5%) 21 (0.7%) 8 (0.3%) 0        1 (0.5%) 0        NE NE 
NSAID use 348 (5.5%) 160 (5.0%) 164 (6.1%) 11 (6.6%) 12 (5.7%) 1 (1.9%) 0.324 0.458 
Antiplatelet use 2,976 (47.2%) 1,528 (48.1%) 1,250 (46.4%) 82 (49.1%) 92 (43.6%) 24 (44.4%) 0.507 0.554 
Heavy alcohol use 63 (1.0%) 43 (1.4%) 15 (0.6%) 1 (0.6%) 3 (1.4%) 1 (1.9%) 0.045 0.686 
HAS-BLED, mean (SD) 2.5 (1.2) 2.4 (1.2) 2.5 (1.1) 2.4 (1.2) 2.6 (1.1) 2.6 (1.1) <0.001 0.510 
HAS-BLED, category             <0.001 <0.001 
   0 352 (5.6%) 254 (8.0%) 79 (2.9%) 10 (6.0%) 9 (4.3%) 0          
   1 891 (14.1%) 478 (15.1%) 361 (13.4%) 28 (16.8%) 19 (9.0%) 5 (9.3%)   
   2 1,854 (29.4%) 836 (26.3%) 874 (32.4%) 45 (26.9%) 74 (35.1%) 25 (46.3%)   
   ≥3 3,205 (50.9%) 1,607 (50.6%) 1,381 (51.2%) 84 (50.3%) 109 (51.7%) 24 (44.4%)   
Absolute contraindications for OAC: 
Any absolute contraindication 1,084 (17.2%) 676 (21.3%) 338 (12.5%) 19 (11.4%) 45 (21.3%) 6 (11.1%) <0.001 0.021 
   Major bleeding within 3 months 154 (2.4%) 107 (3.4%) 41 (1.5%) 1 (0.6%) 4 (1.9%) 1 (1.9%) <0.001 0.574 
   Liver failure or cirrhosis 30 (0.5%) 21 (0.7%) 8 (0.3%) 0        1 (0.5%) 0        NE NE 
   ICH, aneurysm, or brain tumor 106 (1.7%) 74 (2.3%) 28 (1.0%) 2 (1.2%) 1 (0.5%) 1 (1.9%) 0.003 0.608 
   Impaired hemostasis 2 (0.0%) 1 (0.0%) 1 (0.0%) 0        0        0        NE NE 
   Severe dementia or psychosis 254 (4.0%) 180 (5.7%) 53 (2.0%) 5 (3.0%) 15 (7.1%) 1 (1.9%) <0.001 0.121 
   Diabetic prolif. retinopathy 61 (1.0%) 30 (0.9%) 24 (0.9%) 3 (1.8%) 4 (1.9%) 0        <0.001 <0.001 
   Malignancy within 6 months 290 (4.6%) 176 (5.5%) 101 (3.7%) 5 (3.0%) 6 (2.8%) 2 (3.7%) 0.010 0.947 
   Recent ophthalmic surgery 73 (1.2%) 27 (0.9%) 41 (1.5%) 1 (0.6%) 4 (1.9%) 0        <0.001 <0.001 
   Terminal condition 149 (2.4%) 104 (3.3%) 38 (1.4%) 3 (1.8%) 4 (1.9%) 0        <0.001 <0.001 
   Accidental fall within 6 months 189 (3.0%) 129 (4.1%) 49 (1.8%) 1 (0.6%) 9 (4.3%) 1 (1.9%) <0.001 0.140 
† P-values for each independent variable were obtained from a multinomial logistic regression model for 5 treatment options (none and 4 OACs). 
‡ P-values for each independent variable were obtained from a multinomial logistic regression model for 4 OAC treatment options. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = glomerular filtration rate; min = minutes; NSAID = 
nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = coronary heart disease; NE = not estimable.  CHA2DS2-VASc score was calculated by 
summing the points associated with each characteristic: heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 
pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: hypertension; abnormal 
kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or antiplatelet drug use; heavy alcohol use. 
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  First Treatment within 90 Days of Diagnosis  
 
Characteristic 
All 
(N=6,302) 
None 
(N=3,175) 
Warfarin 
(N=2,695) 
Dabigatran 
(N=167) 
Rivaroxaban 
(N=211) 
Apixaban 
(N=54) 
p-value 
All† OAC‡ 
Other potential risk factors for stroke and/or bleeding: 
At high risk of falls 615 (9.8%) 366 (11.5%) 210 (7.8%) 12 (7.2%) 25 (11.8%) 2 (3.7%) <0.001 0.116 
Anemia 937 (14.9%) 522 (16.4%) 366 (13.6%) 20 (12.0%) 24 (11.4%) 5 (9.3%) 0.007 0.862 
Thrombocytopenia 47 (0.7%) 33 (1.0%) 13 (0.5%) 0        1 (0.5%) 0        NE NE 
Hyperthyroidism 154 (2.4%) 69 (2.2%) 76 (2.8%) 2 (1.2%) 4 (1.9%) 3 (5.6%) 0.207 0.186 
Proteinuria 140 (2.2%) 62 (2.0%) 65 (2.4%) 7 (4.2%) 6 (2.8%) 0        <0.001 <0.001 
BMI, mean (SD), kg/m2 28.8 (6.5) 28.5 (6.6) 29.2 (6.3) 29.6 (6.4) 28.4 (6.8) 27.7 (5.4) 0.011 0.301 
BMI, category, kg/m2             <0.001 0.588 
   Underweight (<18.5) 151 (2.4%) 85 (2.7%) 53 (2.0%) 4 (2.4%) 8 (3.8%) 1 (1.9%)   
   Normal (18.5-24.9) 720 (11.4%) 374 (11.8%) 290 (10.8%) 20 (12.0%) 27 (12.8%) 9 (16.7%)   
   Overweight (25.0-29.9) 1,148 (18.2%) 500 (15.7%) 568 (21.1%) 25 (15.0%) 44 (20.9%) 11 (20.4%)   
   Obese (≥30.0) 1,156 (18.3%) 497 (15.7%) 572 (21.2%) 37 (22.2%) 44 (20.9%) 6 (11.1%)   
   Missing 3,127 (49.6%) 1,719 (54.1%) 1,212 (45.0%) 81 (48.5%) 88 (41.7%) 27 (50.0%)   
Smoking             <0.001 0.060 
   Current 472 (7.5%) 244 (7.7%) 185 (6.9%) 17 (10.2%) 24 (11.4%) 2 (3.7%)   
   Former 1,894 (30.1%) 912 (28.7%) 858 (31.8%) 45 (26.9%) 64 (30.3%) 15 (27.8%)   
   Never 1,704 (27.0%) 821 (25.9%) 747 (27.7%) 49 (29.3%) 74 (35.1%) 13 (24.1%)   
   Missing 2,232 (35.4%) 1,198 (37.7%) 905 (33.6%) 56 (33.5%) 49 (23.2%) 24 (44.4%)   
Rheumatoid arthritis 122 (1.9%) 63 (2.0%) 53 (2.0%) 0        6 (2.8%) 0        NE NE 
† P-values for each independent variable were obtained from a multinomial logistic regression model for 5 treatment options (none and 4 OACs). 
‡ P-values for each independent variable were obtained from a multinomial logistic regression model for 4 OAC treatment options. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = glomerular filtration rate; min = minutes; NSAID = 
nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = coronary heart disease; NE = not estimable.  CHA2DS2-VASc score was calculated by 
summing the points associated with each characteristic: heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 
pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: hypertension; abnormal 
kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or antiplatelet drug use; heavy alcohol use. 
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  First Treatment within 90 Days of Diagnosis  
 
Characteristic 
All 
(N=6,302) 
None 
(N=3,175) 
Warfarin 
(N=2,695) 
Dabigatran 
(N=167) 
Rivaroxaban 
(N=211) 
Apixaban 
(N=54) 
p-value 
All† OAC‡ 
Drugs that may interact with one or more OAC 
   Psychotropics 873 (13.9%) 463 (14.6%) 357 (13.2%) 17 (10.2%) 31 (14.7%) 5 (9.3%) 0.270 0.325 
   Antidepressants 585 (9.3%) 318 (10.0%) 230 (8.5%) 10 (6.0%) 23 (10.9%) 4 (7.4%) 0.147 0.235 
   Corticosteroids 591 (9.4%) 290 (9.1%) 265 (9.8%) 10 (6.0%) 23 (10.9%) 3 (5.6%) 0.335 0.178 
   Carbamazepine 36 (0.6%) 23 (0.7%) 11 (0.4%) 1 (0.6%) 0        1 (1.9%) <0.001 <0.001 
   Systemic azole antifungals 29 (0.5%) 16 (0.5%) 13 (0.5%) 0        0        0        NE NE 
   Phenytoin 8 (0.1%) 5 (0.2%) 3 (0.1%) 0        0        0        NE NE 
   Cyclosporine 0         0         0         0         0         0         NE NE 
   Tacrolimus 4 (0.1%) 2 (0.1%) 2 (0.1%) 0        0        0        NE NE 
   Dronedarone 0         0         0         0         0         0         NE NE 
   Rifampicin 1 (0.0%) 1 (0.0%) 0        0        0        0        NE NE 
   St. John's wort 0         0         0         0         0         0         NE NE 
† P-values for each independent variable were obtained from a multinomial logistic regression model for 5 treatment options (none and 4 OACs). 
‡ P-values for each independent variable were obtained from a multinomial logistic regression model for 4 OAC treatment options. 
OAC = oral anticoagulant; AF = atrial fibrillation; SD = standard deviation; TIA = transient ischemic attack; GFR = glomerular filtration rate; min = minutes; NSAID = 
nonsteroidal anti-inflammatory drug; BMI = body mass index; CHD = coronary heart disease; NE = not estimable.  CHA2DS2-VASc score was calculated by 
summing the points associated with each characteristic: heart failure / LVEF≤35% (1 pt); hypertension (1 pt); age ≥75 (2 pts); diabetes (1 pt); prior stroke/TIA (2 
pts); vascular disease (1 pt); age 65-74 (1 pt); female (1 pt). HAS-BLED score was calculated by summing 1 point for each characteristic: hypertension; abnormal 
kidney function; abnormal liver function; prior stroke or TIA; prior bleeding; age >65; NSAID or antiplatelet drug use; heavy alcohol use. 
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Supplemental Table 3. Kaplan-Meier estimate of the cumulative incidence of OAC switch 
 First OAC Prescribed 
 Warfarin 
(N=2,683) 
Dabigatran 
(N=171) 
Rivaroxaban 
(N=247) 
Apixaban 
(N=65) 
     
Kaplan-Meier Estimate (95% CI) of the 
Cumulative Incidence of a Switch by: 
            
    30 days 0.7% 4.2% 0.8% 1.5% 
 (0.4% to 1.1%) (2.0% to 8.5%) (0.2% to 3.3%) (0.2% to 10.4%) 
    60 days 1.1% 7.2% 2.1% 3.1% 
 (0.8% to 1.6%) (4.1% to 12.3%) (0.9% to 5.0%) (0.8% to 11.8%) 
    90 days 1.7% 10.3% 4.7% 4.8% 
 (1.2% to 2.2%) (6.5% to 16.0%) (2.6% to 8.4%) (1.6% to 14.3%) 
   120 days 2.3% 13.4% 5.2% 4.8% 
 (1.7% to 2.9%) (9.1% to 19.7%) (3.0% to 8.9%) (1.6% to 14.3%) 
   180 days 3.6% 17.5% 6.1% 4.8% 
 (2.9% to 4.4%) (12.4% to 24.3%) (3.7% to 10.1%) (1.6% to 14.3%) 
   360 days 5.9% 18.9% 7.9% 8.5% 
 (5.0% to 7.0%) (13.6% to 26.0%) (5.0% to 12.5%) (3.0% to 22.9%) 
Patients who Switched within 360 Days 
of OAC initiation† 
126 (4.7%) 27 (15.8%) 15 (6.1%) 3 (4.6%) 
Patients who Switched at any Time† 175 (6.5%) 30 (17.5%) 18 (7.3%) 4 (6.2%) 
     
OAC Prescribed After Initial OAC‡:      
   Warfarin - 14  (46.7%) 9  (50.0%) 3  (75.0%) 
   Dabigatran 58  (33.1%) - 3  (16.7%) 0  
   Rivaroxaban 87  (49.7%) 12  (40.0%) - 1  (25.0%) 
   Apixaban 30  (17.1%) 4  (13.3%) 6  (33.3%) - 
† Percentages are based on the number of patients prescribed each treatment.  
‡ Percentages are based on the number of patients within each treatment who switched OAC at any time. 
OAC = oral anticoagulant; CI = confidence interval 
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Supplemental Figure 1. Product-limit estimate of the cumulative incidence of first OAC 
prescription by CHA2DS2-VASc risk score.  Death is treated as a competing event. 
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APPENDIX D: SUPPLEMENTAL MATERIAL FOR CHAPTER 4 
 
Supplemental Methods 
Propensity score estimation 
To estimate the propensity score for treatment, we used generalized boosted logistic regression 
(1, 2) with a dependent variable of treatment at index and independent variables that included 
all characteristics in Sets 1 and 2, the primary care practice, region of the practice, and year of 
AF diagnosis.  The boosted model was allowed to split to accommodate main effects and higher 
order effects up to 4-way interactions.  The estimated propensity scores were added to the final 
models to examine their impact on the model coefficients.  
 
Calculation of predicted probabilities 
Individual predicted probabilities (i.e., the cumulative incidence at 1 year or 365 days) for the jth 
of four competing clinical events were calculated as a function of the cumulative baseline 
subdistribution hazard at 365 days and the individual predictor values applied to the estimated 
event-specific model coefficients (3, 4):  
𝐹𝑗(365|𝑋)̂ = 1− exp⁡(− exp(𝑋𝛽?̂?)𝑗0(365)̂ ) 
The cumulative baseline subdistribution hazard, ⁡𝑗0(365)⁡̂ , was calculated by the software and 
corresponds to individuals with all independent variables equal to zero.      
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Supplemental Tables 
Supplemental Table 1. Fine-Gray competing risks regression model for the time to first 
clinical event by cause – 70% development sample (N=10,829) 
 Cause of First Clinical Event = Stroke 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.001 1.001 0.005 0.20 0.840 
OAC  -0.873 0.418 0.206 -4.23 <0.001 
Female 0.398 1.488 0.131 3.04 0.002 
Age 65-74 0.761 2.141 0.343 2.22 0.026 
Age 75-84 1.343 3.830 0.326 4.12 <0.001 
Age ≥85 1.538 4.654 0.338 4.55 <0.001 
Prior stroke or TIA 1.506 4.507 0.130 11.59 <0.001 
Heart failure 0.238 1.269 0.158 1.51 0.130 
Hypertension 0.611 1.842 0.296 2.06 0.039 
Diabetes mellitus 0.079 1.082 0.168 0.47 0.640 
Vascular disease 0.000 1.000 0.134 0.00 >0.999 
Prior major bleed 0.257 1.293 0.156 1.65 0.099 
Estimated GFR <30 mL/min -0.057 0.944 0.347 -0.17 0.870 
Estimated GFR ≥60 mL/min 0.191 1.210 0.142 1.34 0.180 
NSAIDs -0.747 0.474 0.454 -1.64 0.100 
Antiplatelet drugs 0.003 1.003 0.149 0.02 0.980 
Alcoholism or heavy drinking -0.295 0.745 0.976 -0.30 0.760 
Anemia -0.013 0.987 0.160 -0.08 0.930 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.360 
 
C-index (bootstrap) = 73.8 
Pseudo Log-likelihood = -2229  
Pseudo likelihood ratio test = 261  on 18 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  
Thrombocytopenia and rheumatoid arthritis were not considered for inclusion in the model for stroke because 
there were no events among patients with these characteristics and inclusion of these predictors would cause 
model instability. 
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Supplemental Table 1. Fine-Gray competing risks regression model for the time to first 
clinical event by cause – 70% development sample (N=10,829) 
 Cause of First Clinical Event = Extracranial 
Hemorrhage 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.003 0.997 0.003 -0.90 0.370 
OAC  0.231 1.259 0.135 1.71 0.087 
Female -0.165 0.847 0.106 -1.56 0.120 
Age 65-74 0.025 1.025 0.193 0.13 0.900 
Age 75-84 0.407 1.502 0.182 2.23 0.026 
Age ≥85 0.563 1.757 0.200 2.81 0.005 
Prior stroke or TIA 0.237 1.268 0.131 1.81 0.070 
Heart failure -0.012 0.988 0.136 -0.09 0.930 
Hypertension 0.028 1.028 0.202 0.14 0.890 
Diabetes mellitus -0.145 0.865 0.143 -1.01 0.310 
Vascular disease 0.200 1.222 0.113 1.78 0.075 
Prior major bleed 0.697 2.008 0.118 5.93 <0.001 
Estimated GFR <30 mL/min 0.339 1.404 0.243 1.40 0.160 
Estimated GFR ≥60 mL/min -0.178 0.837 0.116 -1.53 0.130 
NSAIDs -0.111 0.895 0.273 -0.41 0.690 
Antiplatelet drugs 0.018 1.018 0.111 0.16 0.870 
Alcoholism or heavy drinking -0.496 0.609 0.706 -0.70 0.480 
Anemia 0.274 1.315 0.130 2.11 0.035 
Thrombocytopenia 0.393 1.481 0.591 0.67 0.510 
Hyperthyroidism -1.223 0.294 0.584 -2.10 0.036 
Proteinuria 0.659 1.932 0.261 2.53 0.012 
      
Age (Wald test)     0.002 
Estimated GFR (Wald test)     0.062 
      
C-index (bootstrap) = 61.4 
Pseudo Log-likelihood = -3472 
Pseudo likelihood ratio test = 120 on 21 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 1. Fine-Gray competing risks regression model for the time to first 
clinical event by cause – 70% development sample (N=10,829) 
 Cause of First Clinical Event = Death 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.001 0.999 0.004 -0.24 0.810 
OAC  -0.457 0.633 0.153 -2.99 0.003 
Female -0.125 0.882 0.103 -1.22 0.220 
Age 65-74 0.871 2.389 0.273 3.19 0.001 
Age 75-84 1.417 4.126 0.264 5.37 <0.001 
Age ≥85 2.098 8.149 0.269 7.81 <0.001 
Prior stroke or TIA -0.045 0.956 0.137 -0.33 0.740 
Heart failure 0.999 2.715 0.107 9.37 <0.001 
Hypertension 0.121 1.129 0.219 0.56 0.580 
Diabetes mellitus 0.131 1.140 0.124 1.05 0.290 
Vascular disease 0.146 1.157 0.107 1.37 0.170 
Prior major bleed 0.028 1.028 0.126 0.22 0.820 
Estimated GFR <30 mL/min 0.487 1.628 0.207 2.36 0.018 
Estimated GFR ≥60 mL/min -0.149 0.862 0.107 -1.40 0.160 
NSAIDs 0.187 1.205 0.237 0.79 0.430 
Antiplatelet drugs -0.268 0.765 0.115 -2.34 0.020 
Alcoholism or heavy drinking 0.194 1.214 0.601 0.32 0.750 
Anemia 0.294 1.342 0.119 2.47 0.014 
Thrombocytopenia 0.622 1.863 0.473 1.32 0.190 
Current smoker 0.615 1.850 0.168 3.65 <0.001 
High risk of falls 0.440 1.552 0.151 2.92 0.004 
Corticosteroids 0.713 2.039 0.148 4.82 <0.001 
Antidepressants 0.756 2.130 0.133 5.70 <0.001 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.007 
 
C-index (bootstrap) = 65.3 
Pseudo Log-likelihood = -3658  
Pseudo likelihood ratio test = 460  on 23 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 2. Sensitivity analysis (landmark = 60 days post-diagnosis): Fine-
Gray competing risks regression model for the time to first clinical event by cause – 
eligible patients at 60 days post-AF (N=15,794) 
 Cause of First Clinical Event = Stroke 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.004 0.996 0.006 -0.66 0.510 
OAC  -0.652 0.521 0.171 -3.82 <0.001 
Female 0.219 1.245 0.107 2.05 0.040 
Age 65-74 0.460 1.585 0.240 1.92 0.055 
Age 75-84 0.880 2.411 0.229 3.84 <0.001 
Age ≥85 1.182 3.260 0.239 4.94 <0.001 
Prior stroke or TIA 1.480 4.393 0.109 13.63 <0.001 
Heart failure 0.080 1.083 0.137 0.58 0.560 
Hypertension 0.593 1.809 0.240 2.47 0.013 
Diabetes mellitus 0.151 1.163 0.137 1.11 0.270 
Vascular disease 0.065 1.068 0.110 0.59 0.550 
Prior major bleed 0.205 1.227 0.133 1.54 0.120 
Estimated GFR <30 mL/min -0.158 0.854 0.303 -0.52 0.600 
Estimated GFR ≥60 mL/min 0.086 1.090 0.116 0.74 0.460 
NSAIDs -0.414 0.661 0.284 -1.46 0.140 
Antiplatelet drugs -0.027 0.974 0.123 -0.22 0.830 
Alcoholism or heavy drinking -0.015 0.985 0.709 -0.02 0.980 
Anemia 0.030 1.030 0.136 0.22 0.830 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.590 
      
Pseudo Log-likelihood = -3442  
Pseudo likelihood ratio test = 318  on 18 df 
 
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  
Thrombocytopenia and rheumatoid arthritis were not considered for inclusion in the model for stroke because 
there were no events among patients with these characteristics and inclusion of these predictors would cause 
model instability. 
 
 
 
  
 493 
Supplemental Table 2. Sensitivity Analysis: Fine-Gray Competing Risks Regression 
Model for the Time to First Clinical Event of Intracranial Hemorrhage with Landmark = 60 
days  – Eligible Patients at 60 days post-AF (N=15,794) 
 Cause of First Clinical Event = ICH 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.001 1.000 0.011 0.08 0.930 
OAC  0.583 1.790 0.349 1.67 0.095 
Age ≥85 0.751 2.120 0.310 2.43 0.015 
Heart failure 0.652 1.920 0.308 2.12 0.034 
Prior major bleed 0.472 1.600 0.327 1.44 0.150 
      
Pseudo Log-likelihood = -496  
Pseudo likelihood ratio test = 17.5  on 4 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  Because 
of the limited number of events, the inclusion of predictors beyond days on index treatment and OAC was limited 
to three additional predictors which were screened based on their significance and selected to maximize the 
bootstrap c-index.   
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Supplemental Table 2. Sensitivity Analysia: Fine-Gray Competing Risks Regression 
Model for the Time to First Clinical Event of Extracranial Hemorrhage with Landmark = 60 
days – Eligible Patients at 60 days post-AF (N=15,794) 
 Cause = Extracranial Hemorrhage 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.001 1.001 0.004 0.37 0.710 
OAC  0.120 1.127 0.113 1.06 0.290 
Female -0.210 0.810 0.086 -2.46 0.014 
Age 65-74 0.240 1.271 0.156 1.54 0.120 
Age 75-84 0.565 1.759 0.150 3.77 <0.001 
Age ≥85 0.758 2.134 0.163 4.64 <0.001 
Prior stroke or TIA 0.057 1.058 0.113 0.50 0.620 
Heart failure -0.039 0.961 0.111 -0.35 0.720 
Hypertension -0.122 0.886 0.150 -0.81 0.420 
Diabetes mellitus -0.045 0.956 0.112 -0.40 0.690 
Vascular disease 0.232 1.261 0.089 2.60 0.009 
Prior major bleed 0.556 1.744 0.097 5.74 <0.001 
Estimated GFR <30 mL/min 0.367 1.444 0.201 1.82 0.068 
Estimated GFR ≥60 mL/min -0.142 0.867 0.094 -1.52 0.130 
NSAIDs 0.191 1.210 0.168 1.13 0.260 
Antiplatelet drugs -0.053 0.949 0.091 -0.58 0.560 
Alcoholism or heavy drinking -0.382 0.682 0.576 -0.66 0.510 
Anemia 0.307 1.359 0.105 2.92 0.004 
Thrombocytopenia -0.084 0.920 0.581 -0.14 0.890 
Hyperthyroidism -0.580 0.560 0.359 -1.62 0.110 
Proteinuria 0.516 1.676 0.216 2.39 0.017 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.027 
      
Pseudo Log-likelihood = -5651  
Pseudo likelihood ratio test = 142 on 21 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 2. Sensitivity Analysis: Fine-Gray Competing Risks Regression 
Model for the Time to First Clinical Event of Death with Landmark = 60 days – Eligible 
Patients at 60 days post-AF (N=15,794) 
 Cause of First Clinical Event = Death 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.001 0.999 0.004 -0.18 0.860 
OAC  -0.390 0.677 0.125 -3.11 0.002 
Female -0.168 0.845 0.085 -1.98 0.048 
Age 65-74 0.688 1.991 0.216 3.19 0.001 
Age 75-84 1.327 3.769 0.205 6.48 <0.001 
Age ≥85 2.133 8.436 0.209 10.23 <0.001 
Prior stroke or TIA -0.144 0.866 0.117 -1.24 0.220 
Heart failure 0.959 2.608 0.091 10.55 <0.001 
Hypertension 0.129 1.138 0.176 0.74 0.460 
Diabetes mellitus 0.280 1.323 0.103 2.71 0.007 
Vascular disease 0.120 1.127 0.090 1.33 0.180 
Prior major bleed 0.078 1.082 0.105 0.75 0.460 
Estimated GFR <30 mL/min 0.467 1.596 0.178 2.63 0.009 
Estimated GFR ≥60 mL/min -0.038 0.962 0.091 -0.42 0.670 
NSAIDs 0.168 1.183 0.180 0.93 0.350 
Antiplatelet drugs -0.218 0.804 0.092 -2.37 0.018 
Alcoholism or heavy drinking 0.548 1.730 0.395 1.39 0.170 
Anemia 0.281 1.324 0.100 2.81 0.005 
Thrombocytopenia 0.365 1.441 0.436 0.84 0.400 
Current smoker 0.686 1.986 0.138 4.97 <0.001 
High risk of falls 0.422 1.525 0.128 3.30 0.001 
Corticosteroids 0.784 2.191 0.110 7.10 <0.001 
Antidepressants 0.601 1.823 0.117 5.15 <0.001 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.016 
 
Pseudo Log-likelihood = -5416  
Pseudo likelihood ratio test = 634  on 23 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 3. Sensitivity analysis (landmark = 30 days post-diagnosis): Fine-
Gray competing risks regression model for the time to first clinical event by cause – 
eligible patients at 30 days post-AF (N=16,028) 
 Cause of First Clinical Event = Stroke 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.006 1.006 0.012 0.52 0.600 
OAC  -0.602 0.548 0.185 -3.26 0.001 
Female 0.251 1.285 0.103 2.43 0.015 
Age 65-74 0.676 1.967 0.244 2.77 0.006 
Age 75-84 1.005 2.733 0.237 4.25 <0.001 
Age ≥85 1.334 3.796 0.248 5.38 <0.001 
Prior stroke or TIA 1.481 4.398 0.104 14.22 <0.001 
Heart failure 0.034 1.034 0.136 0.25 0.800 
Hypertension 0.571 1.769 0.224 2.55 0.011 
Diabetes mellitus 0.073 1.075 0.136 0.54 0.590 
Vascular disease 0.092 1.097 0.108 0.85 0.390 
Prior major bleed 0.161 1.175 0.131 1.23 0.220 
Estimated GFR <30 mL/min -0.162 0.850 0.300 -0.54 0.590 
Estimated GFR ≥60 mL/min 0.115 1.122 0.113 1.02 0.310 
NSAIDs -0.122 0.885 0.225 -0.54 0.590 
Antiplatelet drugs -0.030 0.971 0.117 -0.26 0.800 
Alcoholism or heavy drinking -0.690 0.501 1.002 -0.69 0.490 
Anemia 0.073 1.076 0.131 0.56 0.580 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.440 
      
Pseudo Log-likelihood = -3652  
Pseudo likelihood ratio test = 317  on 18 df 
 
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  
Thrombocytopenia and rheumatoid arthritis were not considered for inclusion in the model for stroke because 
there were no events among patients with these characteristics and inclusion of these predictors would cause 
model instability. 
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Supplemental Table 3. Sensitivity Analysis: Fine-Gray Competing Risks Regression 
Model for the Time to First Clinical Event of Intracranial Hemorrhage with Landmark = 30 
days  – Eligible Patients at 30 days post-AF (N=16,028) 
 Cause of First Clinical Event = ICH 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.022 1.020 0.026 0.84 0.400 
OAC  0.342 1.410 0.432 0.79 0.430 
Age ≥85 1.091 2.980 0.298 3.66 <0.001 
Heart failure 0.143 1.150 0.371 0.38 0.700 
Prior major bleed 0.619 1.860 0.336 1.84 0.066 
      
Pseudo Log-likelihood = -458  
Pseudo likelihood ratio test = 19.9  on 5 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  Because 
of the limited number of events, the inclusion of predictors beyond days on index treatment and OAC was limited 
to three additional predictors which were screened based on their significance and selected to maximize the 
bootstrap c-index.   
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Supplemental Table 3. Sensitivity Analysis: Fine-Gray Competing Risks Regression 
Model for the Time to First Clinical Event of Extracranial Hemorrhage with Landmark = 30 
days – Eligible Patients at 30 days post-AF (N=16,028) 
 Cause = Extracranial Hemorrhage 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.005 0.995 0.008 -0.70 0.480 
OAC  0.113 1.120 0.118 0.96 0.340 
Female -0.219 0.803 0.085 -2.59 0.010 
Age 65-74 0.283 1.327 0.152 1.86 0.062 
Age 75-84 0.555 1.741 0.147 3.77 <0.001 
Age ≥85 0.761 2.140 0.160 4.75 <0.001 
Prior stroke or TIA 0.060 1.062 0.111 0.54 0.590 
Heart failure -0.103 0.903 0.116 -0.89 0.370 
Hypertension -0.189 0.828 0.136 -1.39 0.170 
Diabetes mellitus 0.011 1.011 0.111 0.10 0.920 
Vascular disease 0.228 1.256 0.088 2.59 0.010 
Prior major bleed 0.570 1.769 0.096 5.97 <0.001 
Estimated GFR <30 mL/min 0.157 1.170 0.216 0.73 0.470 
Estimated GFR ≥60 mL/min -0.171 0.842 0.092 -1.87 0.061 
NSAIDs 0.188 1.207 0.155 1.21 0.230 
Antiplatelet drugs 0.015 1.015 0.090 0.17 0.870 
Alcoholism or heavy drinking -0.319 0.727 0.574 -0.56 0.580 
Anemia 0.253 1.287 0.105 2.40 0.016 
Thrombocytopenia -0.126 0.881 0.579 -0.22 0.830 
Hyperthyroidism -0.465 0.628 0.340 -1.37 0.170 
Proteinuria 0.647 1.910 0.207 3.13 0.002 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.091 
      
Pseudo Log-likelihood = -5857  
Pseudo likelihood ratio test = 139 on 21 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 3. Sensitivity Analysis: Fine-Gray Competing Risks Regression 
Model for the Time to First Clinical Event of Death with Landmark = 30 days – Eligible 
Patients at 30 days post-AF (N=16,028) 
 Cause of First Clinical Event = Death 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.013 1.013 0.009 1.44 0.150 
OAC  -0.439 0.645 0.147 -2.99 0.003 
Female -0.188 0.828 0.088 -2.15 0.032 
Age 65-74 0.652 1.920 0.214 3.04 0.002 
Age 75-84 1.265 3.542 0.204 6.20 <0.001 
Age ≥85 2.062 7.858 0.209 9.86 <0.001 
Prior stroke or TIA -0.144 0.866 0.121 -1.19 0.230 
Heart failure 0.853 2.346 0.097 8.78 <0.001 
Hypertension 0.200 1.221 0.174 1.15 0.250 
Diabetes mellitus 0.266 1.305 0.107 2.50 0.012 
Vascular disease 0.094 1.098 0.094 1.00 0.320 
Prior major bleed 0.110 1.116 0.109 1.01 0.310 
Estimated GFR <30 mL/min 0.635 1.886 0.180 3.52 <0.001 
Estimated GFR ≥60 mL/min 0.005 1.005 0.096 0.05 0.960 
NSAIDs 0.236 1.266 0.166 1.42 0.160 
Antiplatelet drugs -0.184 0.832 0.093 -1.99 0.047 
Alcoholism or heavy drinking 0.732 2.080 0.401 1.83 0.068 
Anemia 0.301 1.351 0.103 2.93 0.003 
Thrombocytopenia 0.413 1.511 0.441 0.94 0.350 
Current smoker 0.639 1.895 0.145 4.41 <0.001 
High risk of falls 0.255 1.291 0.138 1.85 0.065 
Corticosteroids 0.699 2.012 0.116 6.04 <0.001 
Antidepressants 0.566 1.762 0.121 4.69 <0.001 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.001 
 
Pseudo Log-likelihood = -5112  
Pseudo likelihood ratio test = 513  on 23 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 4. Sensitivity analysis (propensity score adjustment): Fine-Gray 
competing risks regression model for the time to first clinical event of stroke – full study 
cohort (N=15,483) 
 Cause of First Clinical Event = Stroke 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.001 0.999 0.004 -0.27 0.790 
OAC  -0.785 0.456 0.170 -4.63 <0.001 
Female 0.241 1.273 0.110 2.20 0.028 
Age 65-74 0.485 1.625 0.253 1.92 0.055 
Age 75-84 1.038 2.822 0.237 4.37 <0.001 
Age ≥85 1.144 3.138 0.256 4.47 <0.001 
Prior stroke or TIA 1.598 4.942 0.119 13.43 <0.001 
Heart failure 0.153 1.166 0.139 1.10 0.270 
Hypertension 0.403 1.497 0.302 1.34 0.180 
Diabetes mellitus 0.060 1.062 0.144 0.42 0.680 
Vascular disease 0.031 1.032 0.115 0.27 0.790 
Prior major bleed 0.241 1.272 0.134 1.80 0.073 
Estimated GFR <30 mL/min -0.002 0.998 0.297 -0.01 >0.999 
Estimated GFR ≥60 mL/min 0.108 1.114 0.120 0.90 0.370 
NSAIDs -0.362 0.696 0.326 -1.11 0.270 
Antiplatelet drugs -0.474 0.622 0.296 -1.60 0.110 
Alcoholism or heavy drinking 0.357 1.429 0.572 0.62 0.530 
Anemia -0.036 0.965 0.140 -0.26 0.800 
Estimated propensity score -1.232 0.292 0.855 -1.44 0.150 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.650 
      
Pseudo Log-likelihood = -3247  
Pseudo likelihood ratio test = 326  on 19 df 
 
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  
Thrombocytopenia and rheumatoid arthritis were not considered for inclusion in the model for stroke because 
there were no events among patients with these characteristics and inclusion of these predictors would cause 
model instability.   
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Supplemental Table 4. Sensitivity analysis (propensity score adjustment): Fine-Gray 
competing risks regression model for the time to first clinical event of intracranial 
hemorrhage – full study cohort (N=15,483) 
 Cause of First Clinical Event = ICH 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC -0.003 0.997 0.007 -0.38 0.700 
OAC  0.809 2.246 0.362 2.24 0.025 
Age ≥85 0.843 2.324 0.324 2.60 0.009 
Heart failure 0.592 1.807 0.308 1.92 0.055 
Prior major bleed 0.778 2.177 0.308 2.53 0.011 
Estimated propensity score -0.473 0.623 0.735 -0.64 0.520 
      
Pseudo Log-likelihood = -482  
Pseudo likelihood ratio test = 24.3  on 6 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.  Because 
of the limited number of events, the inclusion of predictors beyond days on index treatment and OAC was limited 
to three additional predictors which were screened based on their significance and selected to maximize the 
bootstrap c-index.   
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Supplemental Table 4. Sensitivity analysis (propensity score adjustment): Fine-Gray 
competing risks regression model for the time to first clinical event of extracranial 
hemorrhage – full study cohort (N=15,483) 
 Cause = Extracranial Hemorrhage 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.001 1.001 0.002 0.57 0.570 
OAC  0.210 1.233 0.114 1.85 0.065 
Female -0.177 0.838 0.087 -2.03 0.042 
Age 65-74 0.145 1.156 0.159 0.91 0.360 
Age 75-84 0.449 1.566 0.154 2.92 0.004 
Age ≥85 0.586 1.797 0.168 3.50 <0.001 
Prior stroke or TIA 0.146 1.157 0.117 1.25 0.210 
Heart failure -0.098 0.907 0.114 -0.86 0.390 
Hypertension -0.159 0.853 0.226 -0.70 0.480 
Diabetes mellitus -0.041 0.960 0.115 -0.36 0.720 
Vascular disease 0.296 1.344 0.092 3.22 0.001 
Prior major bleed 0.655 1.924 0.097 6.77 <0.001 
Estimated GFR <30 mL/min 0.479 1.614 0.199 2.40 0.016 
Estimated GFR ≥60 mL/min -0.184 0.832 0.095 -1.92 0.054 
NSAIDs -0.161 0.852 0.228 -0.70 0.480 
Antiplatelet drugs -0.147 0.863 0.207 -0.71 0.480 
Alcoholism or heavy drinking -0.430 0.651 0.575 -0.75 0.450 
Anemia 0.303 1.353 0.106 2.85 0.004 
Thrombocytopenia 0.016 1.016 0.583 0.03 0.980 
Hyperthyroidism -0.851 0.427 0.413 -2.06 0.039 
Proteinuria 0.319 1.376 0.235 1.36 0.170 
Estimated propensity score -0.620 0.538 0.612 -1.01 0.310 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.002 
      
Pseudo Log-likelihood = -5352  
Pseudo likelihood ratio test = 160 on 22 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Table 4. Sensitivity analysis (propensity score adjustment): Fine-Gray 
competing risks regression model for the time to first clinical event of death – full study 
cohort (N=15,483) 
 Cause of First Clinical Event = Death 
Predictor Coef. Exp(coef) SE(coef) Z p-value 
Days on OAC 0.000 1.000 0.003 0.09 0.930 
OAC  -0.406 0.666 0.127 -3.21 0.001 
Female -0.175 0.839 0.085 -2.07 0.038 
Age 65-74 0.680 1.974 0.213 3.19 0.001 
Age 75-84 1.318 3.736 0.202 6.54 <0.001 
Age ≥85 1.972 7.182 0.210 9.40 <0.001 
Prior stroke or TIA -0.091 0.913 0.121 -0.75 0.450 
Heart failure 0.979 2.663 0.091 10.73 <0.001 
Hypertension 0.077 1.080 0.264 0.29 0.770 
Diabetes mellitus 0.215 1.240 0.103 2.09 0.037 
Vascular disease 0.113 1.120 0.090 1.26 0.210 
Prior major bleed 0.073 1.076 0.103 0.71 0.480 
Estimated GFR <30 mL/min 0.386 1.471 0.183 2.11 0.035 
Estimated GFR ≥60 mL/min -0.116 0.891 0.090 -1.28 0.200 
NSAIDs 0.239 1.269 0.196 1.22 0.220 
Antiplatelet drugs -0.334 0.716 0.255 -1.31 0.190 
Alcoholism or heavy drinking 0.715 2.045 0.329 2.17 0.030 
Anemia 0.311 1.365 0.098 3.16 0.002 
Thrombocytopenia 0.373 1.453 0.435 0.86 0.390 
Current smoker 0.567 1.763 0.143 3.98 <0.001 
High risk of falls 0.496 1.642 0.124 3.99 <0.001 
Corticosteroids 0.812 2.252 0.118 6.89 <0.001 
Antidepressants 0.723 2.060 0.112 6.45 <0.001 
Estimated propensity score -0.470 0.625 0.726 -0.65 0.520 
      
Age (Wald test)     <0.001 
Estimated GFR (Wald test)     0.018 
 
Pseudo Log-likelihood = -5489  
Pseudo likelihood ratio test = 652  on 24 df 
      
Competing first events included stroke, intracranial hemorrhage, extracranial hemorrhage, and death.   
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Supplemental Figures 
Supplemental Figure 1. CONSORT diagram
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Supplemental Figure 2. Cumulative incidence functions (Aalen-Johansen estimate) for 
competing events of stroke, intracranial hemorrhage, extracranial hemorrhage, and death 
– full study cohort (treatment = No OAC), N=8,379 
 
The cumulative incidence function is the probability that the event of interest will occur prior to a particular time t.  At 365 days post-
index, the cumulative incidences of stroke, ICH, ECH, and death were 3.4%, 0.3%, 3.9%, and 5.5%, respectively.  
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Supplemental Figure 3. Cumulative incidence functions (Aalen-Johansen estimate) for 
competing events of stroke, intracranial hemorrhage, extracranial hemorrhage, and death 
– full study cohort (treatment = OAC), N=7,104 
 
The cumulative incidence function is the probability that the event of interest will occur prior to a particular time t.  At 365 days post-
index, the cumulative incidences of stroke, ICH, ECH, and death were 1.7%, 0.5%, 4.9%, and 3.5%, respectively.  
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Supplemental Figure 4. Subdistribution hazard ratio (95% CI) of first clinical event by 
cause for all potential predictors as main effects from Fine-Gray completing risks 
regression models – development sample (N=10,829)  
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Supplemental Figure 4. Subdistribution hazard ratio (95% CI) of first clinical event by 
cause for all potential predictors as main effects from Fine-Gray completing risks 
regression models – development sample (N=10,829)  
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Supplemental Figure 4. Subdistribution hazard ratio (95% CI) of first clinical event by 
cause for all potential predictors as main effects from Fine-Gray completing risks 
regression models – development sample (N=10,829)  
 
 
 
 
 
  
 510 
Supplemental Figure 5. Calibration plot for stroke as a first clinical event – validation 
sample (N=4,654) 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the development model to the observations in the validation sample and averaging the predictions 
within four approximately equal-sized groups defined by the quartiles.  The observed cumulative incidence (95% CI) at one year, 
plotted on the y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence 
lies along the diagonal reference line, the prediction model is considered to be well-calibrated. 
 
 
 511 
Supplemental Figure 6. Calibration plot for extracranial hemorrhage as a first clinical 
event – validation sample (N=4,654) 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the development model to the observations in the validation sample and averaging the predictions 
within four approximately equal-sized groups defined by the quartiles.  The observed cumulative incidence (95% CI) at one year, 
plotted on the y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence 
lies along the diagonal reference line, the prediction model is considered to be well-calibrated. 
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Supplemental Figure 7. Calibration plot for death as a first clinical event – validation 
sample (N=4,654) 
 
The average predicted 1-year event risk, plotted on the x-axis, was calculated by applying the baseline cumulative subdistribution 
hazard and the coefficients from the development model to the observations in the validation sample and averaging the predictions 
within four approximately equal-sized groups defined by the quartiles.  The observed cumulative incidence (95% CI) at one year, 
plotted on the y-axis, was calculated using the nonparametric Aalen-Johansen estimator.  When the observed cumulative incidence 
lies along the diagonal reference line, the prediction model is considered to be well-calibrated. 
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Supplemental Figure 8. Average predicted 1-year risks of clinical events – full study 
cohort, N=15,483  
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Supplemental Figure 9. Predicted 1-year risks of clinical events for patients at moderate 
stroke risk with none, moderate, and severe kidney dysfunction  
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Supplemental Figure 10. Overlapping histograms of estimated propensity scores 
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APPENDIX E: SUPPLEMENTAL MATERIAL FOR CHAPTER 5 
 
Supplemental Methods 
 
1. Generation of events and event times 
Once the treatment status has been determined, patients can experience one of four competing 
events (stroke, ICH, ECH, and death) or remain event-free. Events were simulated using the 
following steps: 
1. Simulate whether or not a competing event occurred within 365 days by 
generating a binary (Bernoulli) random variable, E: 
𝐸~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(1, 𝑝𝐸) 
𝑝𝐸 =∑𝐹𝑗(365|𝑋)
4
𝑗=1
 
𝐹𝑗(365|𝑋) is the cumulative incidence of clinical event j at 365 days given the 
treatment and other patient characteristics X and is a function of the event-
specific model coefficients and the cumulative baseline subdistribution hazard at 
365 days: 
𝐹𝑗(365|𝑋) = 1 − exp⁡(−exp⁡(𝑋𝛽𝑗)𝑗0(365)  
 
If E = 0, the patient did not experience an event and the simulation ends.   If E = 
1, the patient experienced an event and the simulation continues with the 
following steps. 
 
2. Simulate which of the events occurred by generating a multinomial random variable, 𝜀:   
𝜀~𝑀𝑢𝑙𝑡𝑖𝑛𝑜𝑚𝑖𝑎𝑙(1, 𝜋⁡) 
𝜋 is a vector of four event probabilities (𝜋1,⁡𝜋2, 𝜋3, 𝜋4), 
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𝜋𝑗 = 𝑝𝑟𝑜𝑏(𝜀 = 𝑗|𝑡 ≤ 365⁡𝑑𝑎𝑦𝑠) = ⁡
𝐹𝑗(365|𝑋)⁡
∑ 𝐹𝑗(365|𝑋)
4
𝑗=1
 
3. Simulate an event time, t, for the event: 
Generate a random variable 𝑢~𝑈𝑛𝑖𝑓𝑜𝑟𝑚(0,1).  
Using a grid search, solve the following for the value of t: 
𝑢 =
𝐹𝑗(𝑡|𝑋)⁡
𝐹𝑗(365|𝑋)⁡
 
4. Simulate death following a stroke, ICH or ECH:  
Generate a random variable 𝑝𝐷~𝐼𝑛𝑣𝑒𝑟𝑠𝑒⁡𝑏𝑒𝑡𝑎(𝛼𝑗,𝑎𝑔𝑒, 𝛽𝑗,𝑎𝑔𝑒), with event- and age 
category-specific parameters. 
Then simulate a Bernoulli random variable, D: 
𝐷~𝐵𝑖𝑛𝑜𝑚𝑖𝑎𝑙(1, 𝑝𝐷). 
If D=1, the patient died following the non-fatal competing event.  If D=0, he or she 
survived. 
5. If the patient survived a stroke or ICH, simulate the severity (minor, moderate, or severe) 
of his or her event, S:   
Given 𝜃 is a vector of probabilities for each severity (𝜃𝑀𝑖𝑛,𝜃𝑀𝑜𝑑 , 𝜃𝑆𝑒𝑣), 
 𝑆~𝑀𝑢𝑙𝑡𝑖𝑛𝑜𝑚𝑖𝑎𝑙(1, 𝜃⁡) 
 
2. Probability of competing clinical event 
From the Fine Gray competing risks framework, the probability of a first competing clinical event 
j at time t and conditional on patient characteristics X, is defined as: 
 𝐹𝑗(𝑡|𝑋) = 1 − exp⁡(− exp(𝑋𝛽𝑗)𝑗𝑜 (𝑡)),  
where 𝛽𝑗 represents a vector of model coefficients for event j and 𝑗0(𝑡) is an unspecified 
baseline cumulative subdistribution function for event j. 
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2.1. Baseline cumulative subdistribution functions 
The baseline cumulative subdistribution functions were parameterized from Weibull models 
(naively estimated by censoring competing events): 𝑗0(𝑡) = 𝑗𝑡
𝛾𝑗.  For each clinical event, the 
scale () and shape (𝛾) parameters (on the log scale) were estimated from Weibull models for 
which the predictor values were equal to zero (to represent the unspecified baseline subset of 
patients).  The Weibull model provides a separate estimate for ln⁡𝛾 and ln is obtained from the 
Weibull model coefficients:  
𝑙𝑛 = α + ∑𝑋𝛽𝑊𝑒𝑖𝑏𝑢𝑙𝑙  
Then  = exp(α + ∑𝑋𝛽𝑊𝑒𝑖𝑏𝑢𝑙𝑙) = exp⁡(α) when all 𝑋 = 0.   
And 𝛾 = exp⁡( ln⁡𝛾).  The parameters ln⁡𝛾 and ln are correlated as reflected in the variance-
covariance matrix.  
The log-scale Weibull parameters and their variance-covariance matrix are provided below.  
In addition, overlay plots show the fit of each Weibull model to the non-parametric estimate of 
the baseline cumulative subdistribution function.  The deviations between the non-parametric 
estimate and the Weibull estimate are trivial on the absolute probability scale.  For example, for 
stroke, the non-parametric estimate of the baseline cumulative subdistribution function is 
0.0048, whereas the baseline cumulative hazard estimate from the Weibull is 0.0051.  These 
values are equivalent to baseline 1-year probabilities of 0.0048 and 0.0051, a difference of 
0.03%. 
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2.1.1. Baseline cumulative subdistribution of stroke 
 
Maximum likelihood estimates 
ln (constant) ln⁡𝛾 (Weibull parameter) 
-10.08563   -.20474296 
 
Variance-covariance matrix 
 ln  ln⁡𝛾 
ln .17488145  
ln⁡𝛾 -.0116703   .00248272 
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2.1.2. Baseline cumulative subdistribution of intracranial hemorrhage 
 
Maximum likelihood estimates 
ln (constant) ln⁡𝛾 (Weibull parameter) 
-11.481795 -.14727061 
 
Variance-covariance matrix 
 ln  ln⁡𝛾 
ln .50195538  
ln⁡𝛾 -.08529728 .01707227 
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2.1.3. Baseline cumulative subdistribution of extracranial hemorrhage 
Maximum likelihood estimates 
ln (constant) ln⁡𝛾 (Weibull parameter) 
-9.1003454 -.08482845 
 
Variance-covariance matrix 
 ln  ln⁡𝛾 
ln .09421771  
ln⁡𝛾 -.00826145 .0015522 
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2.1.4. Baseline cumulative subdistribution of death 
Maximum likelihood estimates 
ln (constant) ln⁡𝛾 (Weibull parameter) 
-9.7235527 -.17401739 
 
Variance-covariance matrix 
 ln  ln⁡𝛾 
ln .10823921  
ln⁡𝛾 -.00703008   .00143766 
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2.2. Fine Gray competing risks regression coefficients 
The regression coefficients 𝛽𝑗 and their corresponding variance-covariance matrices were 
estimated in earlier work.  In each section below, we have listed the event-specific parameter 
estimates, which are indexed by number for reference to the corresponding variance or 
covariance.   
 
2.2.1. Regression coefficients for stroke 
 
Coefficient estimates 
1 2 3 4 5 6 7 8 
daysdxindx oac female age6574 age7584 age85plus strokeTIA priorHF 
-0.001047171 -0.805102548 0.247740637 0.448960163 0.986940606 1.219280339 1.521335594 0.140365295 
 
9 10 11 12 13 14 15 16 
priorHTN priorDM vascdis priorbled eGFRlt30 eGFRge60 concnsaid concplate 
0.600396832 0.057325389 0.017127536 0.238662150 0.003273173 0.111240968 
-
0.350976592 
-
0.085964938 
 
17 18 
hvyalc anemia 
0.347940559 -0.031937350 
 
 
Variance-covariance matrix 
 
[,1] [,2] [,3] [,4] [,5] [,6] [,7] [,8] 
[1,] 0.0000177 -0.0004908 0.0000308 0.0000451 0.0000408 0.0000439 0.0000138 -0.0000555 
[2,] -0.0004908 0.0290410 -0.0018405 -0.0020836 -0.0022768 -0.0013127 -0.0013464 0.0023164 
[3,] 0.0000308 -0.0018405 0.0120531 -0.0016854 -0.0021042 -0.0028983 0.0005101 0.0001513 
[4,] 0.0000451 -0.0020836 -0.0016854 0.0626392 0.0469645 0.0475404 -0.0031232 -0.0001796 
[5,] 0.0000408 -0.0022768 -0.0021042 0.0469645 0.0557428 0.0508766 -0.0052968 -0.0029782 
[6,] 0.0000439 -0.0013127 -0.0028983 0.0475404 0.0508766 0.0620318 -0.0072771 -0.0061581 
[7,] 0.0000138 -0.0013464 0.0005101 -0.0031232 -0.0052968 -0.0072771 0.0123433 0.0011708 
[8,] -0.0000555 0.0023164 0.0001513 -0.0001796 -0.0029782 -0.0061581 0.0011708 0.0189631 
[9,] -0.0000020 -0.0001194 -0.0015433 -0.0018965 -0.0058867 -0.0019320 -0.0004592 -0.0042742 
[10,] 0.0000558 -0.0011953 0.0020750 -0.0007115 -0.0010258 0.0004133 -0.0003645 -0.0004044 
[11,] 0.0000411 -0.0004376 0.0013839 -0.0008235 -0.0025003 -0.0016076 -0.0001075 -0.0035426 
[12,] 0.0000389 -0.0010426 -0.0005275 -0.0007956 -0.0001689 -0.0003849 -0.0000419 -0.0008471 
[13,] -0.0000289 0.0030040 -0.0010588 0.0014261 -0.0019333 -0.0016798 0.0018375 -0.0016553 
[14,] 0.0000114 -0.0014051 0.0015676 0.0027861 0.0036828 0.0063676 0.0006211 0.0002660 
[15,] -0.0000512 0.0029089 0.0010450 0.0002422 -0.0003628 -0.0000730 0.0003693 -0.0036110 
[16,] -0.0000981 0.0087923 -0.0005843 -0.0007584 -0.0000640 0.0001485 -0.0030532 0.0010356 
[17,] -0.0001267 0.0037906 0.0021748 -0.0181236 -0.0094369 -0.0084291 0.0024213 0.0074660 
[18,] -0.0000062 0.0003884 -0.0006046 0.0008868 -0.0014433 -0.0019605 0.0008077 0.0001588 
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 [,9] [,10] [,11] [,12] [,13] [,14] [,15] [,16] 
[1,] -0.0000020 0.0000558 0.0000411 0.0000389 -0.0000289 0.0000114 -0.0000512 -0.0000981 
[2,] -0.0001194 -0.0011953 -0.0004376 -0.0010426 0.0030040 -0.0014051 0.0029089 0.0087923 
[3,] -0.0015433 0.0020750 0.0013839 -0.0005275 -0.0010588 0.0015676 0.0010450 -0.0005843 
[4,] -0.0018965 -0.0007115 -0.0008235 -0.0007956 0.0014261 0.0027861 0.0002422 -0.0007584 
[5,] -0.0058867 -0.0010258 -0.0025003 -0.0001689 -0.0019333 0.0036828 -0.0003628 -0.0000640 
[6,] -0.0019320 0.0004133 -0.0016076 -0.0003849 -0.0016798 0.0063676 -0.0000730 0.0001485 
[7,] -0.0004592 -0.0003645 -0.0001075 -0.0000419 0.0018375 0.0006211 0.0003693 -0.0030532 
[8,] -0.0042742 -0.0004044 -0.0035426 -0.0008471 -0.0016553 0.0002660 -0.0036110 0.0010356 
[9,] 0.0629934 -0.0027200 -0.0006911 -0.0025491 -0.0002464 0.0005640 0.0030041 -0.0036573 
[10,] -0.0027200 0.0207535 -0.0010371 -0.0010198 -0.0003675 0.0009425 0.0025324 0.0002117 
[11,] -0.0006911 -0.0010371 0.0128975 -0.0012651 -0.0001387 -0.0005189 0.0014956 -0.0016495 
[12,] -0.0025491 -0.0010198 -0.0012651 0.0180166 -0.0027250 0.0003297 -0.0024566 -0.0000094 
[13,] -0.0002464 -0.0003675 -0.0001387 -0.0027250 0.0879675 0.0079116 0.0002396 0.0009391 
[14,] 0.0005640 0.0009425 -0.0005189 0.0003297 0.0079116 0.0144145 0.0013648 -0.0010261 
[15,] 0.0030041 0.0025324 0.0014956 -0.0024566 0.0002396 0.0013648 0.1058061 0.0006279 
[16,] -0.0036573 0.0002117 -0.0016495 -0.0000094 0.0009391 -0.0010261 0.0006279 0.0159883 
[17,] -0.0191399 -0.0003619 -0.0046550 -0.0045059 -0.0032246 0.0005268 0.0007156 0.0034553 
[18,] -0.0023456 -0.0015347 0.0013407 -0.0009991 -0.0014276 0.0004087 -0.0049360 0.0008948 
 
 [,17] [,18] 
[1,] -0.0001267 -0.0000062 
[2,] 0.0037906 0.0003884 
[3,] 0.0021748 -0.0006046 
[4,] -0.0181236 0.0008868 
[5,] -0.0094369 -0.0014433 
[6,] -0.0084291 -0.0019605 
[7,] 0.0024213 0.0008077 
[8,] 0.0074660 0.0001588 
[9,] -0.0191399 -0.0023456 
[10,] -0.0003619 -0.0015347 
[11,] -0.0046550 0.0013407 
[12,] -0.0045059 -0.0009991 
[13,] -0.0032246 -0.0014276 
[14,] 0.0005268 0.0004087 
[15,] 0.0007156 -0.0049360 
[16,] 0.0034553 0.0008948 
[17,] 0.3258309 0.0052516 
[18,] 0.0052516 0.0196335 
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2.2.2. Regression coefficients for intracranial hemorrhage 
Coefficient estimates 
1 2 3 4 5 
daysdxindx oac age85plus priorHF priorbled 
-0.0019885 0.7380352 0.8825208 0.5913643 0.7799962 
 
Variance-covariance matrix 
 
[,1] [,2] [,3] [,4] [,5] 
[1,] 0.00005068 -0.00115329 0.00059232 0.00025381 0.00020492 
[2,] -0.00115329 0.11410105 0.01751692 -0.02714742 -0.01009316 
[3,] 0.00059232 0.01751692 0.09615889 -0.01797279 -0.01235495 
[4,] 0.00025381 -0.02714742 -0.01797279 0.09484759 -0.00785230 
[5,] 0.00020492 -0.01009316 -0.01235495 -0.00785230 0.09484552 
 
2.2.3. Regression coefficients for extracranial hemorrhage 
Coefficient estimates 
1 2 3 4 5 6 7 8 
daysdxindx oac female age6574 age7584 age85plus strokeTIA priorHF 
0.0014181 0.2038581 -0.1740686 0.1264429 0.4285228 0.6178652 0.1100741 -0.1085911 
 
9 10 11 12 13 14 15 16 
priorHTN priorDM vascdis priorbled eGFRlt30 eGFRge60 concnsaid concplate 
-0.0032424 -0.0427975 0.2859529 0.6537739 0.4799258 -0.1821895 -0.1544958 0.0442699 
 
17 18 19 20 21 
hvyalc anemia thrombocy hyperthy protein 
-0.4327031 0.3058561 0.0298583 -0.8528912 0.32092105 
 
Variance-covariance matrix 
 
[,1] [,2] [,3] [,4] [,5] [,6] [,7] 
[1,] 0.000006129 -0.000174535 -0.000005372 -0.000005169 -0.000005983 0.000001636 -0.000006904 
[2,] -0.000174535 0.012930390 0.000367849 -0.000315311 -0.000659467 0.000491589 -0.001279461 
[3,] -0.000005372 0.000367849 0.007591735 -0.001836826 -0.002471765 -0.002797046 0.000560529 
[4,] -0.000005169 -0.000315311 -0.001836826 0.024694810 0.017428990 0.017746340 -0.000939965 
[5,] -0.000005983 -0.000659467 -0.002471765 0.017428990 0.022813750 0.019335280 -0.001485993 
[6,] 0.000001636 0.000491589 -0.002797046 0.017746340 0.019335280 0.027560520 -0.002181070 
[7,] -0.000006904 -0.001279461 0.000560529 -0.000939965 -0.001485993 -0.002181070 0.012409600 
[8,] -0.000007953 0.000108620 -0.000216531 0.000707788 0.000107539 -0.000989663 0.000494158 
[9,] 0.000002399 -0.001410330 -0.001544898 -0.000233311 -0.000748237 0.000410423 0.000214396 
[10,] 0.000003310 -0.000554742 -0.000146837 0.000523056 0.001524551 0.001989041 -0.000024905 
[11,] 0.000001963 -0.000031735 0.000954449 -0.000730191 -0.001700638 -0.001767708 -0.000386212 
[12,] 0.000003382 0.000234275 0.000587191 -0.000804556 -0.000842938 -0.000347874 -0.000413619 
[13,] 0.000022844 -0.000475395 -0.000875882 0.001163636 0.002096859 0.000567126 -0.004238647 
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[14,] -0.000011079 0.000952441 0.000649717 0.000917771 0.002352123 0.002892690 -0.000508922 
[15,] 0.000013595 0.000184768 -0.000970694 0.000314147 0.000389859 0.002443721 0.001926217 
[16,] -0.000041183 0.003459473 0.000251238 -0.000427902 -0.001033173 -0.001084030 -0.000395856 
[17,] -0.000002043 -0.001765454 -0.000140072 0.008844568 0.011885060 0.014995280 0.000835156 
[18,] -0.000020787 0.001026144 0.000387207 -0.001503946 -0.001685163 -0.003021073 -0.001129091 
[19,] -0.000068081 0.004120786 0.000225658 -0.000400722 0.001046178 0.006299914 -0.000967763 
[20,] 0.000005011 0.001155672 -0.002339280 -0.004211638 -0.003288220 -0.002838150 -0.002784269 
[21,] 0.000000457 -0.000324928 0.002265529 -0.000914692 -0.002567392 -0.002948912 -0.000732554 
 
 [,8] [,9] [,10] [,11] [,12] [,13] [,14] 
[1,] -0.000007953 0.000002399 0.000003310 0.000001963 0.000003382 0.000022844 -0.000011079 
[2,] 0.000108620 -0.001410330 -0.000554742 -0.000031735 0.000234275 -0.000475395 0.000952441 
[3,] -0.000216531 -0.001544898 -0.000146837 0.000954449 0.000587191 -0.000875882 0.000649717 
[4,] 0.000707788 -0.000233311 0.000523056 -0.000730191 -0.000804556 0.001163636 0.000917771 
[5,] 0.000107539 -0.000748237 0.001524551 -0.001700638 -0.000842938 0.002096859 0.002352123 
[6,] -0.000989663 0.000410423 0.001989041 -0.001767708 -0.000347874 0.000567126 0.002892690 
[7,] 0.000494158 0.000214396 -0.000024905 -0.000386212 -0.000413619 -0.004238647 -0.000508922 
[8,] 0.012895940 -0.000924228 -0.001154046 -0.002215147 -0.000923789 -0.001723852 0.001133092 
[9,] -0.000924228 0.027855270 -0.000060566 -0.002002880 -0.000064250 0.000018964 0.000326282 
[10,] -0.001154046 -0.000060566 0.013227340 -0.000596031 -0.000345372 0.000409371 0.000422583 
[11,] -0.002215147 -0.002002880 -0.000596031 0.008261181 -0.000826315 -0.000077306 0.000111010 
[12,] -0.000923789 -0.000064250 -0.000345372 -0.000826315 0.009353681 -0.000166110 0.000333280 
[13,] -0.001723852 0.000018964 0.000409371 -0.000077306 -0.000166110 0.039696240 0.004597075 
[14,] 0.001133092 0.000326282 0.000422583 0.000111010 0.000333280 0.004597075 0.009095957 
[15,] 0.000605540 0.000302269 -0.000466048 -0.000912393 -0.000313681 -0.001736525 -0.000438952 
[16,] 0.000468119 -0.001326276 -0.000669470 -0.000646059 -0.000297779 0.000553156 0.000054054 
[17,] -0.003977253 0.002897583 0.000964457 -0.001064729 0.003061885 -0.002895992 -0.001268463 
[18,] -0.000166179 -0.000500084 -0.001908885 -0.000302369 -0.000301229 0.000292111 0.000953934 
[19,] -0.001559451 -0.001328624 0.000774016 0.001857284 -0.002799989 -0.002117851 0.004142428 
[20,] 0.000755443 0.001168542 0.000653054 -0.000836693 -0.001189935 -0.000833434 -0.001103981 
[21,] 0.000597265 -0.001926891 -0.006042327 -0.000831534 -0.001930633 -0.006406376 0.001863422 
 
 [,15] [,16] [,17] [,18] [,19] [,20] [,21] 
[1,] 0.000013595 -0.000041183 -0.000002043 -0.000020787 -0.000068081 0.000005011 0.000000457 
[2,] 0.000184768 0.003459473 -0.001765454 0.001026144 0.004120786 0.001155672 -0.000324928 
[3,] -0.000970694 0.000251238 -0.000140072 0.000387207 0.000225658 -0.002339280 0.002265529 
[4,] 0.000314147 -0.000427902 0.008844568 -0.001503946 -0.000400722 -0.004211638 -0.000914692 
[5,] 0.000389859 -0.001033173 0.011885060 -0.001685163 0.001046178 -0.003288220 -0.002567392 
[6,] 0.002443721 -0.001084030 0.014995280 -0.003021073 0.006299914 -0.002838150 -0.002948912 
[7,] 0.001926217 -0.000395856 0.000835156 -0.001129091 -0.000967763 -0.002784269 -0.000732554 
[8,] 0.000605540 0.000468119 -0.003977253 -0.000166179 -0.001559451 0.000755443 0.000597265 
[9,] 0.000302269 -0.001326276 0.002897583 -0.000500084 -0.001328624 0.001168542 -0.001926891 
[10,] -0.000466048 -0.000669470 0.000964457 -0.001908885 0.000774016 0.000653054 -0.006042327 
[11,] -0.000912393 -0.000646059 -0.001064729 -0.000302369 0.001857284 -0.000836693 -0.000831534 
[12,] -0.000313681 -0.000297779 0.003061885 -0.000301229 -0.002799989 -0.001189935 -0.001930633 
[13,] -0.001736525 0.000553156 -0.002895992 0.000292111 -0.002117851 -0.000833434 -0.006406376 
[14,] -0.000438952 0.000054054 -0.001268463 0.000953934 0.004142428 -0.001103981 0.001863422 
[15,] 0.052062810 -0.000275853 0.000768881 0.000525735 -0.001175077 -0.001097196 0.000290398 
[16,] -0.000275853 0.008435509 0.002714124 -0.000288730 0.001430975 0.000624872 0.001133830 
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[17,] 0.000768881 0.002714124 0.330779200 -0.003607928 0.003867307 0.000643800 -0.006455149 
[18,] 0.000525735 -0.000288730 -0.003607928 0.011299360 -0.000219566 0.000255634 0.002195172 
[19,] -0.001175077 0.001430975 0.003867307 -0.000219566 0.339455700 0.051683270 -0.007031650 
[20,] -0.001097196 0.000624872 0.000643800 0.000255634 0.051683270 0.170811300 -0.002556521 
[21,] 0.000290398 0.001133830 -0.006455149 0.002195172 -0.007031650 -0.002556521 0.054936610 
        
 
2.2.4. Regression coefficients for death 
Coefficient estimates 
1 2 3 4 5 6 7 8 
daysdxindx oac female age6574 age7584 age85plus strokeTIA priorHF 
0.0002740 -0.4130627 -0.1724706 0.6650501 1.3006753 1.9939245 -0.1150091 0.9721498 
 
9 10 11 12 13 14 15 16 
priorHTN priorDM vascdis priorbled eGFRlt30 eGFRge60 concnsaid concplate 
0.2039104 0.2129837 0.1052658 0.0719251 0.3892419 -0.1152895 0.2431852 -0.1857449 
 
17 18 19 20 21 22 23 
hvyalc anemia thrombocy smokecurr fallrisk ccortster cantidep 
0.7141461 0.3124458 0.3826548 0.5697080 0.4969736 0.8122039 0.7283863 
 
Variance-covariance matrix 
 
[,1] [,2] [,3] [,4] [,5] [,6] [,7] 
[1,] 0.00000792 -0.00022414 -0.00000418 0.00001669 0.00000841 0.00001442 -0.00002197 
[2,] -0.00022414 0.01602054 0.00102840 -0.00167425 -0.00215527 -0.00075101 -0.00098972 
[3,] -0.00000418 0.00102840 0.00717125 -0.00153441 -0.00207078 -0.00230590 -0.00064644 
[4,] 0.00001669 -0.00167425 -0.00153441 0.04526609 0.03469455 0.03494260 -0.00078859 
[5,] 0.00000841 -0.00215527 -0.00207078 0.03469455 0.04040133 0.03674749 -0.00117493 
[6,] 0.00001442 -0.00075101 -0.00230590 0.03494260 0.03674749 0.04226563 -0.00109951 
[7,] -0.00002197 -0.00098972 -0.00064644 -0.00078859 -0.00117493 -0.00109951 0.01317403 
[8,] 0.00001395 -0.00077428 -0.00023873 0.00001042 -0.00046366 -0.00169738 0.00022152 
[9,] 0.00002546 -0.00118240 -0.00038247 -0.00074706 -0.00064684 -0.00063046 0.00031238 
[10,] 0.00000716 -0.00003582 0.00019809 -0.00090226 -0.00107013 -0.00061845 -0.00048492 
[11,] 0.00000112 -0.00019155 0.00106004 -0.00074560 -0.00169331 -0.00155430 -0.00098093 
[12,] 0.00001309 -0.00049926 -0.00009995 0.00017425 0.00087250 0.00128483 0.00015190 
[13,] 0.00002070 0.00117746 0.00109974 0.00246185 0.00158109 0.00196080 -0.00183002 
[14,] 0.00001271 0.00047273 0.00037737 0.00237946 0.00345769 0.00463853 -0.00025315 
[15,] -0.00003681 0.00302893 -0.00052224 0.00482031 0.00250019 0.00292790 -0.00012867 
[16,] -0.00004309 0.00524764 0.00056770 -0.00100669 -0.00076370 -0.00085675 -0.00049486 
[17,] 0.00001450 -0.00201777 0.00069616 0.00215155 0.00423095 0.00524861 -0.00094481 
[18,] -0.00001194 0.00014262 -0.00048819 0.00010964 -0.00006563 -0.00138534 -0.00020041 
[19,] 0.00009342 -0.00109774 -0.00000006 0.00155866 0.00137552 0.00053983 0.00111728 
[20,] 0.00001283 0.00038318 0.00102808 0.00046331 0.00196602 0.00290477 -0.00070241 
[21,] 0.00001729 -0.00083006 -0.00034734 0.00028720 -0.00129268 -0.00123102 -0.00056537 
[22,] 0.00001488 0.00037713 0.00042879 -0.00180217 -0.00233279 -0.00223341 -0.00041362 
[23,] -0.00001212 0.00158467 -0.00098975 0.00249577 0.00247903 0.00225724 0.00013159 
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 [,8] [,9] [,10] [,11] [,12] [,13] [,14] 
[1,] 0.00001395 0.00002546 0.00000716 0.00000112 0.00001309 0.00002070 0.00001271 
[2,] -0.00077428 -0.00118240 -0.00003582 -0.00019155 -0.00049926 0.00117746 0.00047273 
[3,] -0.00023873 -0.00038247 0.00019809 0.00106004 -0.00009995 0.00109974 0.00037737 
[4,] 0.00001042 -0.00074706 -0.00090226 -0.00074560 0.00017425 0.00246185 0.00237946 
[5,] -0.00046366 -0.00064684 -0.00107013 -0.00169331 0.00087250 0.00158109 0.00345769 
[6,] -0.00169738 -0.00063046 -0.00061845 -0.00155430 0.00128483 0.00196080 0.00463853 
[7,] 0.00022152 0.00031238 -0.00048492 -0.00098093 0.00015190 -0.00183002 -0.00025315 
[8,] 0.00812816 -0.00142994 -0.00008818 -0.00198805 0.00031421 -0.00088600 0.00053079 
[9,] -0.00142994 0.03505037 -0.00039426 -0.00128120 0.00068555 -0.00048181 0.00080450 
[10,] -0.00008818 -0.00039426 0.01062456 -0.00083921 -0.00002876 -0.00171944 0.00044165 
[11,] -0.00198805 -0.00128120 -0.00083921 0.00793572 -0.00077445 -0.00013914 -0.00032484 
[12,] 0.00031421 0.00068555 -0.00002876 -0.00077445 0.01061390 -0.00050321 0.00038756 
[13,] -0.00088600 -0.00048181 -0.00171944 -0.00013914 -0.00050321 0.03322573 0.00425629 
[14,] 0.00053079 0.00080450 0.00044165 -0.00032484 0.00038756 0.00425629 0.00814601 
[15,] 0.00008752 0.00109726 -0.00033291 0.00007764 -0.00039079 -0.00053328 -0.00050366 
[16,] -0.00003774 -0.00005448 0.00012344 -0.00102606 -0.00043099 0.00014616 0.00027300 
[17,] -0.00287254 0.00363013 0.00195537 0.00111166 -0.00054295 -0.00376348 -0.00201699 
[18,] -0.00090172 0.00053152 -0.00061765 -0.00051376 -0.00049229 -0.00120607 0.00015577 
[19,] -0.00077585 -0.00077334 0.00152727 -0.00262148 -0.00050432 0.00053080 0.00068652 
[20,] -0.00004891 -0.00019403 0.00008077 0.00025983 0.00094834 0.00241681 0.00092549 
[21,] -0.00001687 -0.00008205 0.00097074 -0.00006015 -0.00084629 -0.00100301 0.00046798 
[22,] -0.00018609 0.00157084 0.00032464 -0.00015914 -0.00087101 -0.00054791 0.00014521 
[23,] 0.00026908 0.00029737 -0.00058555 -0.00090396 -0.00027723 0.00082472 0.00073482 
 
 [,15] [,16] [,17] [,18] [,19] 
[1,] -0.00003681 -0.00004309 0.00001450 -0.00001194 0.00009342 
[2,] 0.00302893 0.00524764 -0.00201777 0.00014262 -0.00109774 
[3,] -0.00052224 0.00056770 0.00069616 -0.00048819 -0.00000006 
[4,] 0.00482031 -0.00100669 0.00215155 0.00010964 0.00155866 
[5,] 0.00250019 -0.00076370 0.00423095 -0.00006563 0.00137552 
[6,] 0.00292790 -0.00085675 0.00524861 -0.00138534 0.00053983 
[7,] -0.00012867 -0.00049486 -0.00094481 -0.00020041 0.00111728 
[8,] 0.00008752 -0.00003774 -0.00287254 -0.00090172 -0.00077585 
[9,] 0.00109726 -0.00005448 0.00363013 0.00053152 -0.00077334 
[10,] -0.00033291 0.00012344 0.00195537 -0.00061765 0.00152727 
[11,] 0.00007764 -0.00102606 0.00111166 -0.00051376 -0.00262148 
[12,] -0.00039079 -0.00043099 -0.00054295 -0.00049229 -0.00050432 
[13,] -0.00053328 0.00014616 -0.00376348 -0.00120607 0.00053080 
[14,] -0.00050366 0.00027300 -0.00201699 0.00015577 0.00068652 
[15,] 0.03825585 0.00020265 0.00078907 -0.00055449 0.00113675 
[16,] 0.00020265 0.00910582 -0.00053407 0.00002575 0.00267400 
[17,] 0.00078907 -0.00053407 0.10826970 0.00230431 0.00131805 
[18,] -0.00055449 0.00002575 0.00230431 0.00966253 -0.00177505 
[19,] 0.00113675 0.00267400 0.00131805 -0.00177505 0.18882420 
[20,] -0.00105973 -0.00009808 -0.00625443 -0.00022754 -0.00355343 
[21,] -0.00133014 -0.00049274 -0.00109364 -0.00076658 -0.00274102 
[22,] -0.00092294 0.00019194 -0.00112468 -0.00099342 0.00123039 
 530 
[23,] 0.00112219 0.00121294 -0.00223907 -0.00002099 0.00348355 
 
 [,20] [,21] [,22] [,23] 
[1,] 0.00001283 0.00001729 0.00001488 -0.00001212 
[2,] 0.00038318 -0.00083006 0.00037713 0.00158467 
[3,] 0.00102808 -0.00034734 0.00042879 -0.00098975 
[4,] 0.00046331 0.00028720 -0.00180217 0.00249577 
[5,] 0.00196602 -0.00129268 -0.00233279 0.00247903 
[6,] 0.00290477 -0.00123102 -0.00223341 0.00225724 
[7,] -0.00070241 -0.00056537 -0.00041362 0.00013159 
[8,] -0.00004891 -0.00001687 -0.00018609 0.00026908 
[9,] -0.00019403 -0.00008205 0.00157084 0.00029737 
[10,] 0.00008077 0.00097074 0.00032464 -0.00058555 
[11,] 0.00025983 -0.00006015 -0.00015914 -0.00090396 
[12,] 0.00094834 -0.00084629 -0.00087101 -0.00027723 
[13,] 0.00241681 -0.00100301 -0.00054791 0.00082472 
[14,] 0.00092549 0.00046798 0.00014521 0.00073482 
[15,] -0.00105973 -0.00133014 -0.00092294 0.00112219 
[16,] -0.00009808 -0.00049274 0.00019194 0.00121294 
[17,] -0.00625443 -0.00109364 -0.00112468 -0.00223907 
[18,] -0.00022754 -0.00076658 -0.00099342 -0.00002099 
[19,] -0.00355343 -0.00274102 0.00123039 0.00348355 
[20,] 0.02024285 -0.00012067 -0.00069816 -0.00066804 
[21,] -0.00012067 0.01541102 -0.00091649 -0.00259133 
[22,] -0.00069816 -0.00091649 0.01388495 -0.00017399 
[23,] -0.00066804 -0.00259133 -0.00017399 0.01239496 
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3. 30-day mortality risk (age-specific) after competing clinical event 
We used the data on clinical events and mortality from our earlier study cohort to estimate the 
probability that a patient would die within 30 days from a first event of stroke, intracranial 
hemorrhage, or extracranial hemorrhage.   The cross-tabulations below show the relative 
frequency of 30-day mortality by age category.  The number of events, e, and the number of 
patients, n, in each age category are used as parameters of the beta distributions: =e and =n-
e.  If no events occurred within an age category, we assumed a weak, non-informative prior by 
adding 1 to the numerator and denominator.      
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Frequency (n, %) of 30-day mortality after stroke as a first event 
 
Event Fatal  Age Category 
Within 30 Days? <65 65-74 75-84 ≥85 
No 21 52 129 75 
 95.45 86.67 82.17 62.50 
Yes 1 8 28 45 
 4.55 13.33 17.83 37.50 
Total 22 60 157 120 
 100.00 100.00 100.00 100.00 
 
    
Frequency (n, %) of 30-day mortality after intracranial hemorrhage as a first event 
 
Event Fatal  Age Category 
Within 30 Days? <65 65-74 75-84 ≥85 
No 2 7 15 9 
 100.00 70.00 68.18 50.00 
Yes 0 3 7 9 
 0.00 30.00 31.82 50.00 
Total 2 10 22 18 
 100.00 100.00 100.00 100.00 
 
 
Frequency (n, %) of 30-day mortality after extracranial hemorrhage as a first event 
 
Event Fatal  Age Category 
Within 30 Days? <65 65-74 75-84 ≥85 
No 63 120 221 120 
 100.00 96.77 91.70 82.76 
Yes 0 4 20 25 
 0.00 3.23 8.30 17.24 
Total 63 124 241 145 
 100.00 100.00 100.00 100.00 
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Supplemental Tables 
Supplemental Table 1.  Characteristics of Patients with Incident Atrial Fibrillation at 3 Months Post-AF Diagnosis (T0) 
Variable Definition 
Treatment (OAC)  Any oral anticoagulant prescribed at time zero (no OAC vs. OAC) 
Days on OAC treatment Days on OAC since AF diagnosis = 0 (assumes OAC prescribed at time zero) 
Female Female sex  
Age category  Age (years): <65, 65-74, 75-84, ≥85  
Prior stroke or TIA Any prior ischemic stroke or transient ischemic attack  
Heart failure  Diagnosed with heart failure   
Hypertension Diagnosed with hypertension or concurrent use of antihypertensive medication  
Diabetes mellitus Diagnosed with diabetes or concurrent treatment with oral hypoglycemic agent or insulin  
Vascular disease Diagnosed with MI, angina pectoris, aortic plaque, intermittent claudication, arterial  
thrombosis, venous thrombosis; or had prior PCI or CABG  
Prior major bleed Intracranial hemorrhage or any prior major bleed associated with hospitalization 
Estimated GFR  Most recent kidney function (mL/min), estimated using MDRD equation:   <30 mL/min, 30-59 
mL/min, ≥60 mL/min 
NSAID use Concurrent use of NSAIDs  
Antiplatelet use  Concurrent use of antiplatelet drugs (e.g., clopidogrel, dypridamole)  
Alcoholism or heavy drinking Ever had a diagnosis for alcoholism, a referral to alcohol abuse treatment, or reported heavy 
drinking in 12 months prior  
Anemia Diagnosed with anemia    
Thrombocytopenia Diagnosed with thrombocytopenia    
Proteinuria Diagnosed with proteinuria   
Current smoker Current smoker, including passive 
High risk of falls Diagnosed with dementia or Parkinson disease or concurrent use of psychotropic drugs 
(antipsychotics, antidepressants, and benzodiazepines)  
Antidepressants Concurrent use of antidepressants  
Corticosteroids Concurrent use of systemic corticosteroids (oral, intravenous, intramuscular)  
OAC = oral anticoagulant; AF = atrial fibrillation; TIA = transient ischemic attack;  MI = myocardial infarction; PCI = percutaneous coronary intervention; CABG = 
coronary artery bypass graft; eGFR = estimate glomerular filtration rate; MDRD = Modification in Diet for Renal Disease; NSAID = nonsteroidal anti-inflammatory 
drug 
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Supplemental Table 2. Parameters of the Individual-Based Simulation     
 
Simulation Model Component / 
Parameter 
Base-
Case 
Value 
 
Distribution 
 
Source 
Probability of Event j at t days = 𝐹𝑗(𝑡|𝑋) = 1 − exp⁡(− exp(𝑋𝛽𝑗)𝑗𝑜 (𝑡)) 
     Baseline cumulative subdistribution hazard of event j at t days: 𝑗0(𝑡) = 𝑗𝑡
𝛾𝑗 
    
     Weibull parameters: ln𝑗, ln𝛾𝑗 Event-
specific 
Multivariate 
normal 
Weibull parameter 
estimates (log scale) and 
variance-covariance 
matrices (Supplemental 
Material) 
      
     Regression coefficients for  
     subdistribution hazard of event j:⁡𝛽𝑗 
 
Event-
specific 
 
Multivariate 
normal 
 
Fine-Gray competing risks 
regression model 
estimates and variance-
covariance matrices 
(Supplemental Material) 
 
Mortality Risk (age-specific) after 
Competing Clinical Event, % 
  Frequency tables of 30-
day mortality by age 
(Supplemental Material)       Stroke   
         <65 5 Beta (1,21) 
         65-74 13 Beta (8,52) 
         75-84 18 Beta (28,129) 
         ≥85 38 Beta (45,75) 
      Intracranial hemorrhage   
         <65 25 Beta (1,3) 
         65-74 30 Beta (3,7) 
         75-84 32 Beta (7,15) 
         ≥85 50 Beta (9,9) 
      Extracranial hemorrhage   
         <65 2 Beta (1,64) 
         65-74 3 Beta (4,120) 
         75-84 8 Beta (20,221) 
         ≥85 17 Beta (25,120) 
 
Stroke / ICH Severity, % 
   
      Minor (NIHSS 0-3) 59 
23 
18 
Dirichlet 
(436,169,133) 
Published literature (8) 
      Moderate (NIHSS 4-10)  
      Severe (NIHSS >10)   
 
Health Utility Weights 
   
      Well with atrial fibrillation 0.81 - Published literature (9) 
      Death 0 -  
      Stroke or ICH in first 30 days  /  
      thereafter: 
  Published literature (8) 
         Minor (NIHSS 0-3) 0.73 / 0.76 -  
         Moderate (NIHSS 4-10) 0.50 / 0.62 -  
         Severe (NIHSS >10) 0.13 / 0.38 -  
      Extracranial hemorrhage in first 14  
      days / thereafter 
0.75 / 0.81 - Published literature (8) 
NIHSS = NIH stroke scale 
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Supplemental Figures 
 
Supplemental Figure 1. Mean and 95% Confidence Interval for Number of Overall 
Competing Events (10,000 runs) 
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Supplemental Figure 2. Mean and 95% Confidence Interval for Number of Strokes (10,000 
runs) 
 
 
 
 
 537 
Supplemental Figure 3. Mean and 95% Confidence Interval for Number of Intracranial 
Hemorrhages (10,000 runs) 
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Supplemental Figure 4. Mean and 95% Confidence Interval for Number of Extracranial 
Hemorrhages (10,000 runs) 
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Supplemental Figure 5. Mean and 95% Confidence Interval for Number of Deaths as 
Competing Event (10,000 runs) 
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Supplemental Figure 6. Mean and 95% Confidence Interval for Total QALMs (10,000 runs) 
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Supplemental Figure 7. Complement Cumulative Distribution Plot of Overall Competing 
Events Avoided vs. Current Treatment Patterns for Four Superior Treatment Selection 
Rules 
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Supplemental Figure 8. Complement Cumulative Distribution Plot of Strokes Avoided vs. 
Current Treatment Patterns for Four Superior Treatment Selection Rules 
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Supplemental Figure 9. Complement Cumulative Distribution Plot of Total Deaths 
Avoided vs. Current Treatment Patterns for Four Superior Treatment Selection Rules 
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Supplemental Figure 10. Complement Cumulative Distribution Plot of Extracranial 
Hemorrhages Avoided vs. Current Treatment Patterns for Four Superior Treatment 
Selection Rules 
 
 
 
 
 
 
 
 
 
 
